data_2o4e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2o4e _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -94.2 146.38 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.436 ' N ' HG11 ' A' ' 31' ' ' VAL . 12.6 t -68.1 -36.3 79.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 56.44 109.24 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.159 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.468 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 3.2 m -151.32 141.23 21.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.522 0.677 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.468 ' CG2' ' HA2' ' A' ' 153' ' ' GLY . 21.9 m -95.82 143.3 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.693 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -102.8 105.2 15.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.035 178.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HG ' ' HD2' ' A' ' 156' ' ' LYS . 12.1 tp -109.02 125.21 51.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.22 121.91 15.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 156' ' ' LYS . . . -149.32 162.76 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.382 . . . . 0.0 111.68 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -70.71 -28.91 65.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 74.24 24.26 1.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.656 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -164.92 128.28 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.2 p -146.14 107.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.131 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.58 126.83 30.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.178 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.27 124.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.85 -19.2 18.73 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.684 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -110.42 173.11 6.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.662 0.267 . . . . 0.0 110.749 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -114.53 167.62 10.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -108.8 161.43 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -136.08 93.71 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.564 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 m -105.06 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.455 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 120' ' ' LYS . . . -76.41 72.98 1.87 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.176 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 36' ' ' SER . 12.5 p -78.38 99.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.957 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.76 -118.42 3.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.782 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -120.4 135.14 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.014 0.435 . . . . 0.0 111.921 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -36.47 7.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -158.99 131.34 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.323 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.12 90.62 1.37 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.463 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 14.7 p -111.39 114.83 48.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 73.6 m-20 102.68 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.055 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 149' ' ' HIS . . . -145.93 133.63 21.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.777 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -100.82 86.16 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.582 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.5 125.83 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.519 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 3.5 m-85 -118.41 -37.85 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.487 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.24 112.79 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.994 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 2.6 t80 -85.75 135.77 33.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 111.508 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -148.06 110.01 4.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.275 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CE2' ' CG1' ' A' ' 53' ' ' VAL . 11.7 p90 -128.04 171.42 11.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.429 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.72 101.14 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.687 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -77.21 153.66 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.923 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.26 114.34 20.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 37.2 p90 -122.83 -172.37 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.13 126.17 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -82.47 -32.19 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -74.99 -29.75 60.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.39 -52.81 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 4.7 m-85 -93.43 171.91 8.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.3 115.75 4.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.71 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 92' ' ' ALA . 17.7 t80 -48.42 148.65 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 48.7 t -130.6 -84.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -157.37 138.65 13.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -82.7 153.77 25.17 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.217 1.008 . . . . 0.0 111.757 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.49 174.7 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.218 -177.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -154.66 -165.64 2.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.71 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -161.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -95.59 37.77 1.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.53 -39.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.96 140.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.924 0.393 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.14 118.66 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.026 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 84' ' ' SER . 6.3 t -116.83 129.96 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -137.23 120.0 16.26 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.63 148.34 22.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.087 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -131.84 106.69 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.659 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -55.02 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.137 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.9 tp -83.0 -25.12 8.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.836 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -165.33 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.453 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 61.15 32.13 79.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.452 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 120.8 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 4.4 m -149.24 155.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -97.05 152.53 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.928 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.6 p -126.66 146.83 31.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.445 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 59.6 mt -115.74 107.41 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' TYR . 9.9 t -104.77 140.92 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 111.543 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -164.48 136.89 4.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.45 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -83.5 111.24 18.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.212 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.55 28.8 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.125 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.7 p -104.04 -27.97 11.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.04 6.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.217 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.34 158.55 35.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 37.2 Cg_endo -66.0 164.14 28.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.532 2.155 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HB2' HD23 ' A' ' 118' ' ' LEU . 1.9 pp -55.25 131.78 69.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.406 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 96.3 Cg_endo -86.81 145.17 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB3' HG21 ' A' ' 55' ' ' ILE . . . -97.45 168.75 10.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.92 35.11 13.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.14 157.79 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.611 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.6 t -50.86 105.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.54 -30.93 18.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.21 157.71 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.733 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HB3' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -153.84 131.94 11.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -104.62 105.03 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.628 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.401 HG12 ' CD1' ' A' ' 83' ' ' ILE . 26.0 m -75.22 109.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.874 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 72' ' ' TYR . 2.8 mm? -83.15 169.13 16.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 1.7 tpm_? -110.86 118.87 37.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -86.49 67.27 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.243 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.88 -4.76 59.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.45 123.72 2.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.491 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.608 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -39.66 160.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.606 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -177.41 60.8 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.767 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.51 119.74 6.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.286 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.3 13.18 68.83 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.648 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.08 69.93 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 2.0 p-10 -59.56 146.29 41.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.448 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.46 165.11 13.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.857 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.5 115.51 9.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.0 111.178 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -96.15 95.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.728 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.478 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -111.67 -163.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.704 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.89 21.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.22 96.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.87 -178.53 4.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 111.366 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.8 m -156.68 141.66 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 88.38 1.5 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.326 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 14.4 t0 -52.92 160.61 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.67 76.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.584 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -55.72 -26.73 46.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 111.053 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.96 23.18 5.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mt -117.73 170.04 9.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 77.5 t -109.12 142.23 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 143' ' ' ASP . 55.8 m80 -119.38 92.39 3.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -48.62 97.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.33 164.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.163 0.506 . . . . 0.0 111.69 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -57.56 -148.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.551 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -170.4 174.58 44.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.468 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.2 m -145.44 162.36 37.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 154.07 39.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.973 0.416 . . . . 0.0 111.152 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.463 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -132.22 164.08 27.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.936 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 1.2 p -141.77 115.57 9.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.983 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.35 135.74 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.412 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -105.32 108.19 19.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 11.4 mt -82.99 116.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -98.46 139.78 19.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.92 145.69 55.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 0.0 111.139 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.469 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.337 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG11 ' N ' ' A' ' 59' ' ' VAL . 65.7 t -68.65 155.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.54 ' N ' HG12 ' A' ' 31' ' ' VAL . 8.4 t -72.59 -43.76 62.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.809 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 68.6 114.09 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.225 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -158.16 134.98 9.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.507 0.67 . . . . 0.0 111.977 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 26.5 m -96.27 143.87 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.7 t -103.85 106.75 17.36 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.318 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.439 ' CD2' HG22 ' A' ' 154' ' ' THR . 6.7 tp -107.38 117.41 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.952 0.406 . . . . 0.0 111.329 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -140.28 139.2 35.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.4 171.42 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -30.86 67.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.534 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 71.88 31.03 2.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.68 130.34 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.947 0.403 . . . . 0.0 111.944 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.1 p -147.57 107.85 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.137 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.89 126.42 29.65 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.135 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.35 130.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 112.717 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.98 -20.46 35.92 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.357 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -105.62 172.45 6.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.317 . . . . 0.0 110.659 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -100.71 167.72 10.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 111.095 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -110.4 159.55 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -137.24 92.65 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.95 96.56 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.411 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.66 70.72 3.0 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.903 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG1' ' CE2' ' A' ' 68' ' ' PHE . 7.1 p -78.38 94.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.06 -129.98 6.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.438 HG22 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -111.44 128.98 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.562 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.5 t0 -93.37 -28.78 15.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 177.34 136.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.493 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.47 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 1.8 pp -153.2 91.56 1.53 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.865 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.691 ' N ' HG11 ' A' ' 31' ' ' VAL . 14.5 p -100.82 114.72 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.994 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 78.8 m-20 105.85 39.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.935 0.894 . . . . 0.0 111.554 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -171.02 148.28 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.64 82.53 1.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.733 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 112.14 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -101.76 -32.21 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.21 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.13 112.56 6.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.429 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.8 t80 -108.46 96.66 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 111.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.52 110.46 23.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.326 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE2' ' CG1' ' A' ' 102' ' ' VAL . 34.7 p90 -101.87 160.55 14.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.341 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -111.38 105.28 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.762 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 128.56 34.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.96 115.2 29.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.615 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.6 p90 -139.53 -169.13 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.167 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.56 140.97 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.75 -27.37 16.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -59.49 -30.38 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . . . -117.62 -47.14 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.195 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.456 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.31 -176.81 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.988 0.423 . . . . 0.0 111.008 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 43.9 tp10 -166.27 155.93 11.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.496 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' HG22 ' A' ' 100' ' ' VAL . 36.6 t80 -94.92 148.96 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -132.22 -78.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.032 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -161.06 134.75 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.18 148.91 27.17 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 122.31 1.052 . . . . 0.0 111.701 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 174.58 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.098 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.55 -165.65 2.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.82 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -159.79 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.49 36.66 1.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.69 -42.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.21 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.08 146.02 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -105.3 103.3 12.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.1 t -92.45 153.71 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -163.24 113.54 1.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.03 166.15 11.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.271 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.86 107.44 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.653 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttp -54.69 94.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.11 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -80.68 -23.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.655 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.82 -166.77 0.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.24 133.56 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.54 29.24 63.53 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.516 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -173.33 120.05 0.33 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.834 0.35 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.653 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 6.4 m -150.05 155.05 8.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.793 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.3 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.162 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 9.2 p -128.14 93.41 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.772 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.14 111.24 16.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.3 151.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.607 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.9 p -160.81 136.2 7.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.517 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 p -78.34 110.68 13.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.46 30.31 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.133 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.5 p -102.55 -31.58 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 125.97 -22.6 6.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -110.11 159.19 32.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.63 0.253 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.46 179.52 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.583 2.189 . . . . 0.0 112.214 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.83 132.28 79.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.94 -39.67 31.58 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.522 2.148 . . . . 0.0 112.204 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 61.55 166.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.108 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 15.78 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -166.7 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.281 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.1 t -70.99 104.87 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -33.49 20.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.2 131.64 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.212 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -112.62 117.23 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.447 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.41 105.02 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.3 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -75.79 130.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.921 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.425 HD23 ' CD1' ' A' ' 72' ' ' TYR . 71.8 mt -113.24 111.51 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.847 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 14.1 tpp85 -55.0 111.47 0.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.0 68.31 7.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -85.83 -5.35 59.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.389 0.614 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.48 123.41 2.53 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.644 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.641 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -41.95 162.13 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.319 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.439 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -173.69 57.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.913 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 3.5 pt-20 -56.02 117.25 3.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.196 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.03 -0.73 67.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.765 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -59.17 88.08 0.01 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.407 ' ND2' HG22 ' A' ' 157' ' ' THR . 4.3 m120 -59.92 163.68 4.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 111.533 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' LYS . 3.5 mt -140.3 112.93 8.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.868 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.32 125.67 51.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.506 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.1 m -110.12 94.81 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.715 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.457 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 18.6 p -100.76 -168.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.44 21.16 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.886 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 100.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.505 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.58 169.99 8.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.422 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.48 -179.47 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.846 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.61 84.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -55.63 154.49 6.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.978 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.58 -46.46 93.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.46 -29.47 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.15 -25.44 6.06 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.385 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.49 170.17 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.46 139.73 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -114.01 90.44 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 103.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.718 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.514 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.55 -176.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 111.711 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 33' ' ' GLY . . . -69.29 -159.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.404 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.94 171.22 33.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.187 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.439 HG22 ' CD2' ' A' ' 37' ' ' LEU . 66.4 m -152.9 149.13 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -114.68 148.85 37.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 157' ' ' THR . 1.6 tppp? -131.81 163.89 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.332 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.598 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -142.88 124.62 15.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.934 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -114.4 138.36 44.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.13 105.75 16.12 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.893 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.641 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 10.5 mt -82.44 117.08 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.439 0.637 . . . . 0.0 109.437 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.25 137.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.549 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.17 145.57 55.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.015 0.436 . . . . 0.0 110.946 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.433 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.93 0.395 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -60.6 155.7 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.807 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.5 t -81.33 -46.7 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 67.83 114.63 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.605 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.496 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -150.95 148.41 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.256 0.55 . . . . 0.0 111.574 179.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 154' ' ' THR . 5.8 m -99.87 128.88 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.569 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -92.03 106.84 18.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.825 178.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -97.48 123.29 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.082 0.467 . . . . 0.0 111.523 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -134.88 101.15 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.015 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.3 141.58 33.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -25.75 67.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.25 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' HG13 ' A' ' 158' ' ' VAL . 18.3 mt-10 74.55 23.08 1.96 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.566 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' N ' HG11 ' A' ' 158' ' ' VAL . 3.7 tt0 -164.98 128.34 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 2.8 p -146.14 108.0 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -68.2 122.86 19.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.781 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.02 131.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 121.469 0.652 . . . . 0.0 112.641 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.04 -23.71 32.73 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.125 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -96.68 172.99 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.692 0.282 . . . . 0.0 110.43 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -94.93 167.78 11.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tp -154.93 108.08 2.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 1.9 pm0 -110.37 146.73 35.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 98.12 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -67.52 65.88 0.27 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.441 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' SER . 13.5 p -80.92 102.48 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.64 -123.28 3.6 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.548 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -111.59 137.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 111.737 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -36.14 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -166.29 131.4 2.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.537 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.444 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.1 tt -152.57 96.6 2.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 10.1 p -122.99 109.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' N ' HG22 ' A' ' 31' ' ' VAL . 65.7 m-20 128.61 20.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.403 1.081 . . . . 0.0 111.414 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.31 175.76 11.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -130.2 85.38 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.64 127.53 31.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 7.1 m-85 -111.09 -45.43 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.152 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.7 112.71 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.237 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 34.2 t80 -97.6 95.02 7.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -106.07 110.15 22.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CD1' ' CG1' ' A' ' 102' ' ' VAL . 4.4 p90 -112.19 171.16 7.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.104 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.416 ' HB ' ' OD1' ' A' ' 138' ' ' ASN . 53.4 m -120.68 107.67 13.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 21.2 tp -79.15 133.35 36.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -116.83 109.03 16.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.443 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 15.1 p90 -125.04 -166.74 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -120.44 102.8 8.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 111.119 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.44 -28.16 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.63 -47.24 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 129' ' ' ALA . . . -116.87 32.87 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -167.31 -176.48 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.421 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.92 108.95 0.31 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CE1' ' HB1' ' A' ' 92' ' ' ALA . 8.5 t80 -54.49 149.32 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.7 t -128.65 -79.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -160.89 145.08 13.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.85 150.56 26.48 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.215 1.007 . . . . 0.0 111.659 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.08 151.31 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.295 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -174.87 129.78 0.31 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.729 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.16 -168.2 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 t0 63.93 63.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.89 25.41 59.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.96 114.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 111.051 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -113.33 121.66 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.473 ' CG2' ' CG2' ' A' ' 102' ' ' VAL . 8.7 p -113.17 153.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.231 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -137.7 123.99 20.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.307 0.575 . . . . 0.0 111.58 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.67 153.53 17.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.761 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 107.11 5.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 111.719 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.681 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 7.4 tttt -55.24 117.38 3.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.561 HG21 ' HA ' ' A' ' 100' ' ' VAL . 4.5 tp -109.15 -25.47 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 163.82 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.0 124.22 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 68.57 30.11 72.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.453 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -174.01 123.21 0.32 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.935 0.397 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.681 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 10.0 m -149.9 154.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.426 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -96.92 152.86 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 112.013 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.3 p -124.35 150.82 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.49 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 mt -124.1 108.75 12.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.072 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.446 ' CG2' HG23 ' A' ' 90' ' ' VAL . 97.6 t -102.68 136.64 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.401 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 p -164.39 134.74 4.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -88.88 130.9 35.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.058 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.07 29.35 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 -26.38 9.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.025 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.27 -24.07 10.13 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.125 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -89.38 155.94 48.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.681 0.277 . . . . 0.0 110.663 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 60.5 Cg_endo -72.68 156.16 53.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.57 2.18 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 66' ' ' TYR . 1.9 pp -51.99 133.44 39.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 86.6 Cg_endo -84.72 145.35 10.25 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.408 2.072 . . . . 0.0 111.49 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 55' ' ' ILE . . . -98.51 169.19 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 111.317 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.93 33.89 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.482 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -161.1 157.58 26.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.34 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.34 105.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 113' ' ' PRO . 1.4 mm? -89.57 -31.28 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' HG22 ' A' ' 90' ' ' VAL . . . -164.38 135.67 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 128.9 40.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.697 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -107.13 112.73 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.47 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 50' ' ' GLU . 18.7 m -75.3 96.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.513 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 72' ' ' TYR . 36.1 mt -83.17 110.81 18.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.1 tpp85 -55.37 110.93 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.78 70.46 5.13 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -2.39 58.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.444 0.64 . . . . 0.0 109.562 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.64 123.55 2.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.611 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.612 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 8.8 ttpt -51.87 142.5 15.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.691 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.464 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . . . -146.55 63.73 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.14 111.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.71 43.22 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.641 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -70.69 66.96 0.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.518 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.85 131.69 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.121 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.6 139.28 47.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.941 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.88 110.61 14.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.902 0.382 . . . . 0.0 111.477 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.416 HG13 ' CE2' ' A' ' 68' ' ' PHE . 21.0 m -99.4 95.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.7 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.45 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 13.8 p -103.65 -165.62 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.45 ' ND2' ' C ' ' A' ' 137' ' ' THR . 2.2 p30 43.52 21.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.976 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -63.83 96.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.791 0.329 . . . . 0.0 110.507 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -101.18 167.47 10.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.385 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -128.82 -179.59 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.87 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.5 87.2 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.435 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 17.3 t70 -53.32 162.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.041 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.84 -52.11 55.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.19 -30.83 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.781 0.324 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.41 -28.09 4.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.424 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.78 150.93 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.62 149.8 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.435 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 24.8 m-70 -123.54 90.55 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.593 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.69 107.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.482 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.32 -177.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.418 . . . . 0.0 111.42 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -70.1 -148.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.347 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.23 37.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.151 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.441 ' N ' HG21 ' A' ' 35' ' ' VAL . 67.9 m -164.16 146.67 9.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.759 0.314 . . . . 0.0 110.573 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 154' ' ' THR . 18.1 pt-20 -107.05 167.81 9.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.948 0.404 . . . . 0.0 111.543 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 0.0 OUTLIER -139.61 163.74 31.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.232 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.451 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.2 p -142.4 119.55 11.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -116.34 138.05 48.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.161 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -106.79 105.54 15.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 12.6 mt -80.46 129.32 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -114.13 129.54 69.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.819 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.8 145.31 41.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.237 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.48 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.931 0.396 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 13.4 t -78.57 146.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.41 ' N ' HG11 ' A' ' 31' ' ' VAL . 12.6 t -74.42 -32.6 62.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 57.05 114.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.209 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' GLU . 13.3 t -147.56 156.44 42.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG21 ' N ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -106.2 129.64 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.035 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -91.41 107.44 19.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.059 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 156' ' ' LYS . 5.6 mt -96.7 120.26 36.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.439 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -140.18 101.2 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.77 149.64 32.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.444 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.49 -22.25 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.427 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 67.06 24.38 9.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.549 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -164.96 128.93 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.97 0.414 . . . . 0.0 111.995 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 3.1 p -145.51 108.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.207 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.88 125.34 26.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.292 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.38 130.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 121.517 0.675 . . . . 0.0 112.705 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.91 -23.65 30.38 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.34 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.03 172.34 7.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -105.85 167.7 9.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.088 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' CD1' HG12 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.93 158.26 24.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.63 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -137.48 92.35 2.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.741 0.305 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 7.6 p -112.07 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.05 0.453 . . . . 0.0 110.461 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -90.01 81.66 1.41 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.468 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 36' ' ' SER . 14.8 p -78.61 99.53 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.33 -117.47 4.34 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.59 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -121.43 127.23 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.491 . . . . 0.0 112.186 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -26.15 13.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.6 mp0 -165.41 136.47 3.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.97 91.49 0.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.213 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.3 p -103.1 115.45 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.508 ' C ' HG22 ' A' ' 31' ' ' VAL . 71.0 m-20 101.48 23.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.214 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.49 134.26 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.989 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 19.6 tt0 -105.14 83.71 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.472 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.82 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 10.8 m-85 -104.14 -33.35 8.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.21 9.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.786 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.455 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 1.5 t80 -87.53 137.42 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 111.436 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -147.89 109.43 4.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.182 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 102' ' ' VAL . 8.2 p90 -130.85 171.31 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.447 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.83 111.24 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.773 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.25 156.17 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.776 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -130.35 104.41 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.445 ' CD1' HD22 ' A' ' 123' ' ' LEU . 12.0 p90 -122.79 -168.35 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -100.94 147.75 25.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.017 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -105.13 14.66 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -110.17 -31.02 7.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.0 -45.56 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 1.3 m-85 -93.59 -177.86 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -170.34 112.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.435 ' CD1' HG22 ' A' ' 100' ' ' VAL . 44.6 t80 -53.35 154.41 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.9 t -134.49 -73.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -163.36 143.62 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.88 155.72 23.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.918 0.866 . . . . 0.0 111.583 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.414 ' CD1' ' HG3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -131.51 154.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.882 -1.508 . . . . 0.0 112.65 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.54 -164.82 1.26 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.784 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.66 -157.99 0.63 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.774 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -93.87 36.78 1.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.87 -41.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.945 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.413 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 13.1 t -87.46 153.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.689 0.28 . . . . 0.0 110.694 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -110.15 120.7 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.127 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.447 HG21 ' CG2' ' A' ' 104' ' ' VAL . 20.2 t -109.29 145.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.417 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.1 t30 -160.81 105.44 1.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.59 -177.04 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 111.52 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.716 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 6.8 tttt -54.01 95.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.165 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.2 tp -75.55 -25.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -167.4 -173.21 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.37 132.18 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 56.84 33.03 62.72 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -173.94 120.27 0.29 Allowed 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.68 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 4.4 m -149.9 156.09 7.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.663 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.42 151.8 22.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.8 p -119.53 143.32 31.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.141 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -128.18 98.5 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.651 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 8.5 p -105.83 157.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.154 0.502 . . . . 0.0 111.785 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -163.35 136.83 5.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.124 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.25 104.3 7.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.304 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.52 -16.08 62.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.207 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -65.23 -34.81 79.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.87 -18.86 21.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.92 156.96 49.24 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HB3' ' CE1' ' A' ' 64' ' ' PHE . 33.3 Cg_endo -64.66 142.05 75.39 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.607 2.205 . . . . 0.0 112.34 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.404 ' HB3' HD12 ' A' ' 118' ' ' LEU . 8.1 mt -54.49 106.92 0.73 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.83 147.69 94.48 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.438 2.092 . . . . 0.0 111.838 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -101.52 175.47 5.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.183 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 18.61 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.92 -165.75 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.4 t -84.48 104.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 112' ' ' LEU . 2.0 mm? -90.03 -32.81 16.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.977 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.36 131.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HB3' ' CA ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -128.04 159.17 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.81 148.16 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.7 103.67 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.747 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.445 HD22 ' CD1' ' A' ' 72' ' ' TYR . 9.3 mt -90.41 108.81 20.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.885 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 17.7 ttm180 -55.4 112.56 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.711 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -80.1 71.73 6.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.31 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -87.43 -3.93 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 109.588 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.71 123.57 2.46 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.518 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.688 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -49.19 140.79 9.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.579 -178.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -143.37 62.99 1.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.541 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.98 121.61 9.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.485 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.45 18.83 79.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.691 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -68.99 71.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.895 0.378 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.424 ' ND2' HG22 ' A' ' 157' ' ' THR . 1.0 OUTLIER -45.31 132.22 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.025 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.406 ' CD2' ' CD1' ' A' ' 123' ' ' LEU . 5.4 mp -117.87 129.69 55.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.933 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.7 p -108.22 121.06 44.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.939 0.4 . . . . 0.0 111.489 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.65 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.527 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.468 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.4 p -109.98 -164.65 0.94 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.468 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.78 17.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.092 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.71 95.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.88 8.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 111.618 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 66' ' ' TYR . 26.7 m -139.87 -179.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.914 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.27 89.67 0.4 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.425 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . 5.2 p30 -62.07 168.35 3.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.67 22.21 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.904 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.09 -23.42 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 111.337 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.18 -17.9 28.8 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.415 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.3 170.46 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.01 120.47 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 143' ' ' ASP . 45.6 m-70 -92.46 92.71 8.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.91 102.52 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.515 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.36 167.41 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 111.738 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -58.01 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.658 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.1 171.16 40.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.301 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 155' ' ' GLU . 50.9 m -165.2 155.95 14.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.656 0.265 . . . . 0.0 110.77 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 154' ' ' THR . 18.2 pt-20 -118.6 170.14 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 37' ' ' LEU . 1.3 tppt? -143.14 166.22 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' ND2' ' A' ' 133' ' ' ASN . 3.2 p -143.17 120.57 11.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.634 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -114.66 126.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 105.46 17.75 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 14.2 mt -81.07 120.65 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -104.45 131.65 52.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.817 -178.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.74 145.88 38.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 43.3 t -74.48 149.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' HG11 ' A' ' 31' ' ' VAL . 15.0 t -65.66 -36.21 83.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.907 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 58.53 109.94 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . 7.5 t -155.55 143.19 19.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.567 0.699 . . . . 0.0 111.943 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.95 143.95 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.842 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -100.31 106.38 18.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.613 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' A' ' 154' ' ' THR . 4.3 tp -103.87 119.95 39.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.484 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -139.26 101.4 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.57 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.53 151.37 51.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.413 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.93 -28.05 65.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.339 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.3 mt-10 67.68 23.42 8.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.431 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -164.81 123.9 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 0.0 111.772 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.9 p -144.89 108.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.289 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.433 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.16 127.33 32.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -29.33 131.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.24 -21.48 42.99 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.532 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -97.73 172.33 7.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 110.638 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -112.4 167.73 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.146 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 tp -130.2 153.42 48.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.523 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -135.65 93.45 2.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.92 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 37' ' ' LEU . 7.2 p -104.16 98.1 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.613 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 120' ' ' LYS . . . -89.37 87.05 1.44 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.867 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 8.3 p -78.93 95.18 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.71 -128.82 6.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.634 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.65 128.9 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.053 0.454 . . . . 0.0 111.859 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -97.58 -30.06 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 1.6 mp0 -167.35 135.12 2.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.024 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.53 90.84 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.9 p -115.53 126.97 73.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.975 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 75.7 m-20 104.38 15.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.786 0.834 . . . . 0.0 112.064 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 149' ' ' HIS . . . -141.85 176.35 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.42 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.1 tt0 -129.98 83.17 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.8 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.1 120.73 11.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 4.1 m-85 -120.37 -43.17 2.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.3 118.31 17.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.048 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 1.4 t80 -85.96 137.9 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -147.66 109.85 4.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.455 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 136' ' ' VAL . 14.7 p90 -139.48 171.17 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.417 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -124.19 115.75 21.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.884 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 111.16 21.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.69 104.61 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 111.129 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.436 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 38.2 p90 -107.91 -168.44 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.631 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.31 104.72 14.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -67.25 -26.72 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.91 -29.19 62.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.144 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.43 -40.35 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.381 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.21 -176.88 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -165.2 121.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CD1' HG22 ' A' ' 100' ' ' VAL . 26.5 t80 -56.43 150.67 14.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.0 t -132.46 -71.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -172.94 140.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.57 149.57 27.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.118 0.961 . . . . 0.0 111.45 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.7 153.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.511 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.68 -167.01 1.4 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.977 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.26 -158.54 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -95.61 36.92 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.83 -45.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.621 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.66 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.244 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.37 124.19 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.093 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.444 HG21 ' CG2' ' A' ' 104' ' ' VAL . 3.0 t -115.8 136.22 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -148.94 116.57 6.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.07 153.53 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -133.48 107.36 7.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.667 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.613 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 11.4 tmtt? -55.15 95.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.3 tp -84.51 -25.93 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.875 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -166.57 177.62 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.768 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 130.11 40.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 58.78 33.21 72.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.43 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -173.77 118.96 0.28 Allowed 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.613 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 3.5 m -149.84 154.68 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -89.21 152.27 21.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.91 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -128.28 96.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.668 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mt -86.69 102.77 14.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 7.9 p -107.3 153.59 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.288 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.5 138.51 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.381 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.1 m -76.47 104.59 7.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.283 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -13.92 62.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.607 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -65.41 -28.46 69.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.85 -23.1 12.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.954 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.68 155.09 45.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 110.546 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -64.93 153.85 76.11 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.587 2.191 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 118' ' ' LEU . 1.8 pp -52.91 132.62 48.75 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 94.1 Cg_endo -88.91 144.99 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.773 2.315 . . . . 0.0 112.209 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . -94.57 170.69 9.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.178 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 32.91 12.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -163.5 158.2 20.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.598 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.8 t -52.96 105.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -85.41 -32.33 22.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.961 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.73 135.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 52' ' ' GLY . 0.3 OUTLIER -126.3 149.58 49.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.675 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.0 t -113.06 154.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.532 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.85 95.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.04 108.31 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 37.3 ttm180 -64.97 117.6 7.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -76.77 72.78 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.505 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -87.96 -3.62 58.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 0.0 109.438 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.39 123.49 2.58 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.407 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.683 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.6 ttmt -48.82 138.02 11.73 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.393 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.412 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -143.66 62.91 1.36 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.575 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.12 116.16 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.404 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.89 19.53 59.35 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.702 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 66.28 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.116 0.484 . . . . 0.0 110.455 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.453 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 1.1 t-20 -42.39 129.73 3.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.421 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.2 150.28 29.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.07 121.45 14.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.0 111.579 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 68' ' ' PHE . 8.9 p -99.71 95.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.599 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.484 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.4 p -100.3 -165.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.789 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.37 19.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.065 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 87.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.933 0.397 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.38 162.11 13.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.436 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 66' ' ' TYR . 28.5 m -130.32 128.79 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.947 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.77 83.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.694 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 22.8 t70 -57.77 140.8 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.816 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.84 76.08 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.728 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.7 -29.59 66.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.14 15.04 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.746 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.62 115.11 28.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 110.769 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.08 141.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 61' ' ' ALA . 50.9 m80 -104.8 99.0 8.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.87 102.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.43 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.27 -176.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.784 -178.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.907 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -75.83 -161.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.408 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.65 34.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.412 HG23 ' CD2' ' A' ' 37' ' ' LEU . 90.8 m -153.69 146.48 24.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.723 0.297 . . . . 0.0 110.849 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.81 161.96 15.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 111.261 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.411 ' HE2' ' HG ' ' A' ' 37' ' ' LEU . 3.9 tppt? -139.99 169.19 18.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.6 p -142.15 115.93 9.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.592 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.52 126.17 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 105.72 17.91 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 10.2 mt -80.72 122.59 36.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.433 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.13 132.98 51.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.623 -178.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.03 145.21 42.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.154 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.5 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.662 HG22 ' N ' ' A' ' 60' ' ' ASN . 15.2 t -60.64 151.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -74.52 -46.69 37.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 76.09 112.27 0.12 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.692 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.75 139.16 11.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.0 111.428 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 m -98.93 141.15 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.45 106.38 18.68 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.826 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 154' ' ' THR . 6.2 tp -107.17 106.58 17.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 111.355 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -121.94 118.65 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.412 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.74 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.493 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.82 -27.4 68.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.1 22.89 2.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.414 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.53 128.19 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.995 0.426 . . . . 0.0 112.114 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.4 p -132.52 168.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.735 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tm0? -131.56 118.49 20.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.1 t -28.57 130.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.488 0.661 . . . . 0.0 112.477 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.62 64.49 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.776 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.98 173.73 6.34 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.331 0.252 . . . . 0.0 110.473 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -119.03 131.39 55.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.91 154.99 20.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 93.47 2.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.06 98.17 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' CA ' ' CG ' ' A' ' 120' ' ' LYS . . . -87.75 86.05 1.51 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.89 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 12.5 p -82.18 95.24 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -100.62 -127.63 6.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.981 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.445 HG12 ' CD2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -115.31 130.29 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 111.724 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.94 -39.3 11.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.07 132.79 0.51 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' CD2' HG12 ' A' ' 55' ' ' ILE . 1.3 pp -157.25 113.69 2.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.539 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.562 ' C ' HG22 ' A' ' 31' ' ' VAL . 12.6 p -128.89 100.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.662 ' N ' HG22 ' A' ' 31' ' ' VAL . 19.0 m-20 139.57 23.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.404 1.065 . . . . 0.0 111.737 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.67 147.42 6.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.776 0.322 . . . . 0.0 111.213 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -105.22 85.87 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 112.93 2.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 25.3 m-85 -99.77 -32.75 10.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.155 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.94 112.61 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.433 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 35.6 t80 -102.79 130.67 49.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -135.06 119.25 17.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.856 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CD2' ' CG1' ' A' ' 102' ' ' VAL . 24.7 p90 -120.63 155.99 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 103.39 8.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.457 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -77.36 156.13 31.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.348 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -124.0 104.4 8.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 18.6 p90 -118.44 -166.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.65 143.15 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.81 -25.21 15.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.012 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -62.14 -29.42 70.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.039 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.52 -43.92 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.258 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -93.16 169.27 10.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.636 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -159.2 119.71 3.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 23.7 t80 -57.32 153.7 11.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 39.6 t -131.49 -72.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.38 143.94 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.819 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.54 150.78 25.0 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.251 1.024 . . . . 0.0 111.538 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.13 153.39 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.336 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.13 -174.43 2.71 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -159.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.745 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.78 36.64 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.92 -39.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.184 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.18 159.96 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.979 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -115.98 113.05 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 91' ' ' ASN . 2.1 t -104.23 155.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -166.24 110.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.399 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.99 158.14 15.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -145.83 107.15 4.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.713 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 20.4 tttt -55.14 117.03 3.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.312 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.495 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.5 tp -111.22 -23.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.847 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -167.86 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.24 -75.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . -106.22 53.12 0.65 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.408 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -174.21 129.74 0.37 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 14.5 m -149.59 155.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.879 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.5 152.41 20.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.532 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 10.3 p -139.44 122.17 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.878 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.72 108.92 19.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 11.9 p -106.7 148.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.414 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -155.91 136.48 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.44 104.5 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.5 tp -72.42 -12.85 61.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 p -65.27 -30.27 71.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.04 -18.98 18.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.412 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.93 147.87 34.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 51.3 Cg_exo -53.97 -178.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.476 2.117 . . . . 0.0 112.446 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -58.57 123.0 64.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.62 -43.82 24.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.463 2.109 . . . . 0.0 112.129 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 62.34 167.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.17 19.75 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.216 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.44 -168.62 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.439 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.73 104.99 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.419 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -83.63 -34.7 25.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -174.35 132.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 111.297 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.458 ' CG ' ' CA ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -121.59 137.85 54.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.374 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.9 t -99.3 135.93 32.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.83 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.47 97.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 72' ' ' TYR . 44.7 mt -92.28 108.42 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 29.5 ttm180 -69.7 116.39 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.02 73.71 4.57 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.252 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -3.6 59.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.544 0.688 . . . . 0.0 109.503 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.88 123.0 2.7 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.121 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.601 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.9 ttpp -44.94 154.12 0.15 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.329 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.47 59.79 0.22 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.917 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 6.8 tt0 -55.81 117.18 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.972 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.55 61.59 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.371 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.3 t -70.5 87.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 110.397 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.99 162.83 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.516 . . . . 0.0 111.401 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -143.91 104.85 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.645 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -100.1 131.3 46.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.645 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 68' ' ' PHE . 26.8 t -111.12 94.69 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.532 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.49 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -99.79 -164.45 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.676 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.23 22.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.021 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.9 m -61.63 100.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 110.436 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 173.17 6.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.4 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.51 -179.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.24 85.46 0.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -55.61 -174.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.09 -38.4 10.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.17 -29.45 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.6 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.655 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.69 170.32 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.23 129.49 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -106.41 91.09 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.0 109.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.413 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.79 -176.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.226 0.536 . . . . 0.0 111.599 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -68.86 -160.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.374 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.62 168.7 34.36 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.365 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 37' ' ' LEU . 88.2 m -155.77 148.12 23.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.786 0.326 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.81 153.27 33.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 1.1 tppp? -135.31 167.03 21.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.238 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.1 p -142.83 134.65 26.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.3 m -125.4 129.96 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.31 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.87 107.27 19.09 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.01 0.433 . . . . 0.0 110.484 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.6 mt -76.79 120.48 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.62 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.445 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.12 128.32 59.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -178.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.74 146.13 37.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.769 0.318 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.8 t -82.64 151.17 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.763 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' GLY . 5.3 t -90.82 -30.99 16.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.51 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 55.31 132.1 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.575 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.443 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.69 159.09 43.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.202 0.525 . . . . 0.0 111.605 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 ' N ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.18 123.56 68.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.271 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -92.24 109.57 20.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.386 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 3.8 mt -97.1 120.74 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -133.49 101.37 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.344 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.63 152.86 39.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.427 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.05 -26.43 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.393 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.9 mt-10 66.56 24.25 10.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.381 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.83 117.22 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.796 0.332 . . . . 0.0 111.598 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.0 p -136.87 107.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.65 128.36 36.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.238 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 125' ' ' ALA . 2.0 t -31.02 132.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-O 121.5 0.667 . . . . 0.0 112.709 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 -24.01 32.98 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.39 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.85 172.47 7.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 0.0 110.631 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.63 151.69 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 50' ' ' GLU . 21.1 tp -104.48 153.4 21.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.407 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 3.1 pt-20 -136.75 93.29 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 110.649 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 37' ' ' LEU . 7.2 p -107.01 97.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.795 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.41 ' CA ' ' CG ' ' A' ' 120' ' ' LYS . . . -82.02 82.59 1.59 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.623 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.432 HG13 ' CE1' ' A' ' 68' ' ' PHE . 9.7 p -78.63 95.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.761 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.29 -134.71 8.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.69 136.44 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.83 -36.34 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.57 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 177.15 131.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.436 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.09 103.49 4.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.764 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.4 p -94.76 110.18 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.562 ' C ' HG22 ' A' ' 31' ' ' VAL . 69.3 m-20 98.68 26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.435 0.694 . . . . 0.0 112.333 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.9 150.2 48.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.227 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -128.78 66.29 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.112 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' CB ' ' HB ' ' A' ' 141' ' ' VAL . . . -62.49 144.08 56.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.049 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-85 -120.23 -35.38 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.51 112.68 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 68' ' ' PHE . 41.6 t80 -86.16 148.27 25.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.991 0.425 . . . . 0.0 111.458 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -147.67 111.27 4.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' ' CG1' ' A' ' 102' ' ' VAL . 16.5 p90 -122.97 156.16 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 111.557 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.19 103.15 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.418 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -77.09 156.05 31.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -126.8 104.49 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 18.7 p90 -118.3 -167.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.4 113.59 21.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -27.98 65.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.08 -46.65 86.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.035 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' CB ' ' CB ' ' A' ' 129' ' ' ALA . . . -109.59 20.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -164.33 -179.69 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -171.56 113.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.706 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 92' ' ' ALA . 25.1 t80 -51.01 149.27 3.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.0 t -129.1 -82.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.01 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -156.17 134.8 11.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.76 151.2 26.25 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.12 0.962 . . . . 0.0 111.478 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -126.97 158.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.421 -177.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 1.8 t -121.21 -164.68 1.15 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.794 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -93.0 -157.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.754 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.5 37.67 1.12 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.93 0.395 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.12 -39.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 29.5 t -87.05 154.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.639 0.257 . . . . 0.0 110.773 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.91 121.41 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 84' ' ' SER . 5.2 t -109.11 155.23 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -162.78 110.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.86 156.21 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.39 107.09 5.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.229 0.538 . . . . 0.0 111.536 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.1 tttm -54.71 96.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.477 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -84.83 -22.76 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.589 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -166.76 2.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . -99.28 52.41 1.08 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.364 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -174.19 126.14 0.34 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.5 m -148.71 155.03 9.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.698 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -97.24 152.49 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.3 p -133.47 121.97 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.139 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.85 98.97 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 88' ' ' VAL . 7.7 p -98.31 149.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.33 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 p -151.61 135.54 16.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.421 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.21 111.56 12.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.912 0.386 . . . . 0.0 111.309 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.28 29.68 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.006 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -106.79 -29.71 9.37 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.988 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.95 -20.8 14.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.166 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -97.39 155.83 36.89 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 56.4 Cg_endo -70.51 173.61 11.38 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.545 2.163 . . . . 0.0 112.446 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.412 ' CD2' ' HB2' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.27 109.23 1.53 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.26 -22.33 73.97 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.397 2.065 . . . . 0.0 112.147 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 55.97 177.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.876 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.52 25.78 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.634 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -159.31 155.85 27.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 t -45.62 104.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -31.13 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -174.3 134.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.123 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -126.58 116.76 21.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.404 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 76.1 t -86.99 111.18 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.65 111.24 11.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.026 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.434 HD23 ' CD1' ' A' ' 72' ' ' TYR . 35.8 mt -92.9 169.28 10.57 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.426 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 8.6 ttm180 -116.44 123.39 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . . . -88.72 72.12 8.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.341 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.03 -6.68 57.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 109.706 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.87 123.62 2.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.739 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.628 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.8 ttmt -44.46 162.37 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.517 -1.219 . . . . 0.0 112.349 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -177.84 61.67 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.79 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 5.4 tt0 -55.27 111.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 23.26 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.138 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.31 65.96 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.895 0.379 . . . . 0.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -44.86 132.88 6.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.161 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.74 134.61 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.951 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 p -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.888 0.375 . . . . 0.0 111.405 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -107.16 94.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.814 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.2 p -99.7 -164.11 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.547 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 40.54 25.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.9 p -68.56 93.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.62 170.17 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.3 m -129.32 179.87 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.989 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.56 64.06 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.452 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.48 138.67 45.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.78 58.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.612 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -56.49 -28.1 58.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.6 -1.24 36.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.852 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.62 131.62 56.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.9 t -76.88 123.93 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.05 92.0 5.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.623 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.54 107.28 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.659 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -84.39 169.01 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.263 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -57.48 -153.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.723 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.41 165.48 31.91 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.224 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.437 ' N ' HG21 ' A' ' 35' ' ' VAL . 36.8 m -161.03 147.33 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.734 0.302 . . . . 0.0 110.647 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.9 173.82 6.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 3.8 tppt? -144.72 168.69 19.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.081 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 133' ' ' ASN . 1.9 p -142.43 115.66 8.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.04 127.38 68.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -97.49 105.79 18.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.628 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 14.9 mt -83.92 116.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.397 0.617 . . . . 0.0 109.748 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.5 143.47 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.677 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.75 146.36 54.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.898 0.38 . . . . 0.0 110.924 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.928 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.831 0.348 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.583 HG22 ' C ' ' A' ' 59' ' ' VAL . 29.6 t -61.06 155.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.0 t -78.73 -47.15 17.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.834 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 72.03 113.12 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.672 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.5 m -156.57 138.42 14.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.455 0.645 . . . . 0.0 111.507 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 19.8 m -91.48 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 1.8 t -90.95 134.29 34.6 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.183 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -110.73 118.69 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -140.7 116.94 10.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.48 144.29 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.672 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.05 -27.0 66.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.055 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 4.8 mt-10 73.17 21.86 3.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.691 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 158' ' ' VAL . 1.7 tm-20 -165.15 127.66 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 160' ' ' ILE . 2.9 p -146.16 107.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.353 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -65.4 123.93 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -28.91 130.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.629 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.1 -23.05 24.12 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -107.9 174.97 5.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 110.413 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -128.78 148.25 50.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.59 128.19 51.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.619 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 3.4 pt-20 -101.43 131.34 47.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.384 . . . . 0.0 111.19 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 11.1 t -108.4 97.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -70.19 62.09 0.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.102 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.2 p -81.17 112.45 19.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.291 . . . . 0.0 110.396 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 66' ' ' TYR . . . -126.61 -91.24 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.618 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.65 134.86 51.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.075 0.464 . . . . 0.0 111.985 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -102.64 -38.93 7.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' N ' ' HB2' ' A' ' 34' ' ' SER . 77.2 mm-40 -159.35 129.0 5.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.006 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -153.19 90.84 1.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.729 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.583 ' C ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -121.45 110.74 28.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.561 ' N ' HG22 ' A' ' 31' ' ' VAL . 72.6 m-20 127.6 17.92 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.499 1.119 . . . . 0.0 111.493 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . . . -157.79 -178.04 7.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.966 0.413 . . . . 0.0 111.078 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -137.0 76.57 1.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.589 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.9 111.93 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.511 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 111' ' ' PRO . 11.3 m-85 -89.37 -34.4 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.048 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.03 112.35 8.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.36 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 68' ' ' PHE . 11.3 t80 -98.68 94.12 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 0.0 110.918 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -100.5 135.94 41.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 66' ' ' TYR . 47.0 p90 -140.97 171.21 14.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.238 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.29 91.2 3.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.635 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.2 tt -77.03 152.96 34.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.108 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -131.41 155.93 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 21.0 p90 -155.55 -169.34 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.67 140.89 28.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -105.84 -13.75 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -96.26 25.81 4.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . . . -170.6 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.905 0.384 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 2.1 m-85 -93.3 -176.89 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -170.85 111.84 0.38 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.46 ' CD1' HG22 ' A' ' 100' ' ' VAL . 18.2 t80 -50.14 152.83 1.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 66.9 t -131.04 -78.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.61 143.2 8.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.864 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.23 26.95 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-O 122.04 0.924 . . . . 0.0 111.439 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -140.35 151.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.268 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -129.6 -176.17 3.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.077 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -160.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.88 23.49 4.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.59 -44.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.906 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.05 143.27 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.687 0.28 . . . . 0.0 110.626 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -117.23 109.41 16.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.412 HG21 ' CA ' ' A' ' 104' ' ' VAL . 7.1 p -102.18 144.13 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.918 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.18 124.81 29.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -98.06 161.27 13.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.682 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.21 107.05 5.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 111.719 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.649 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.28 95.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.08 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -83.91 -30.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.882 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.18 -168.38 2.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.407 ' HB3' ' CB ' ' A' ' 74' ' ' GLU . 4.6 m-20 -84.31 130.07 34.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.34 31.67 70.48 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.345 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -173.75 122.08 0.33 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.649 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 6.3 m -149.89 154.7 8.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.731 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -85.75 152.26 23.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.184 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 9.2 p -125.48 136.99 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.308 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 mt -123.79 109.69 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 111.087 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 11.7 p -109.86 147.32 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 112.018 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 p -164.78 135.44 4.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.029 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m -73.68 104.18 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -17.56 63.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.182 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -65.36 -32.91 74.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.02 -17.11 20.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.91 155.29 37.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.653 0.264 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HG3' ' CE2' ' A' ' 64' ' ' PHE . 37.4 Cg_exo -60.13 164.85 11.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.558 2.172 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.82 113.65 7.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.64 -20.88 67.03 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.3 2.0 . . . . 0.0 112.282 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 62.93 173.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.79 24.28 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -142.21 -164.34 1.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.323 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -91.49 104.63 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.421 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 3.1 mm? -91.97 -33.65 14.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -157.72 136.76 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.5 ' O ' HG13 ' A' ' 83' ' ' ILE . 2.2 mtpt -135.16 100.71 4.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.271 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.84 114.36 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 m -87.19 108.05 17.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.198 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.426 HD11 ' CE2' ' A' ' 72' ' ' TYR . 2.8 mm? -85.57 108.44 17.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 20.3 ttm180 -55.54 117.09 3.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -84.59 69.39 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.217 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -87.55 -3.93 58.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.58 123.71 2.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.544 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.2 ttpt -42.63 155.13 0.05 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.325 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -168.56 58.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.799 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 7.3 pt-20 -55.73 111.65 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.224 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.5 -12.65 39.47 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.519 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 t -54.65 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 2.1 p-10 -83.6 138.66 33.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.261 0.553 . . . . 0.0 112.19 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 123' ' ' LEU . 4.7 mp -110.77 132.14 54.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.615 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.4 126.5 46.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.019 0.438 . . . . 0.0 111.65 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.424 HG13 ' CE2' ' A' ' 68' ' ' PHE . 22.5 m -101.51 94.72 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.665 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 20.9 p -100.63 -169.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.695 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.72 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.928 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER -64.98 105.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 0.0 110.607 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -178.47 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.293 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 149' ' ' HIS . 4.0 m -141.45 -179.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.67 81.82 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.956 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 27.6 t0 -45.92 160.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 111.271 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.05 97.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -66.52 -31.34 72.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.317 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.04 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.39 168.89 2.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 56.6 t -123.99 141.56 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.574 ' CD2' HG22 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -114.14 94.23 4.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -46.97 104.62 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.743 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.444 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -85.71 -176.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -72.5 -158.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.28 168.85 35.99 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.231 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.413 HG23 ' HG ' ' A' ' 37' ' ' LEU . 44.4 m -164.7 163.95 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 110.662 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 154' ' ' THR . 15.9 pt-20 -134.64 177.44 7.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.169 0.509 . . . . 0.0 111.692 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HB2' HD13 ' A' ' 37' ' ' LEU . 10.3 tppt? -146.59 169.74 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 0.6 OUTLIER -141.64 115.9 9.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.42 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -104.61 137.94 31.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.226 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.77 105.38 15.58 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.571 179.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 12.6 mt -83.63 121.44 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 121.305 0.574 . . . . 0.0 109.621 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.498 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -104.24 148.8 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.396 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.71 145.66 48.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.902 0.382 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.468 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.862 0.363 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' ' 60' ' ' ASN . 23.7 t -60.65 155.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.404 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 8.7 t -81.47 -46.04 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.759 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 74.43 117.4 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.301 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' GLU . 7.6 t -163.48 136.77 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.19 0.519 . . . . 0.0 111.465 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.5 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.631 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -91.55 106.3 18.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.089 178.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 6.4 tp -112.35 116.86 31.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -140.35 108.48 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.279 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.6 161.95 35.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.563 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.373 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 69.24 24.87 5.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.703 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' HG11 ' A' ' 158' ' ' VAL . 28.3 tt0 -164.71 125.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.6 p -147.6 107.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.343 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -67.92 126.32 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.131 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.45 127.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.81 12.85 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.628 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -175.63 2.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.87 148.61 52.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 pp -97.01 159.93 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.26 93.57 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.439 ' CG2' ' CD1' ' A' ' 37' ' ' LEU . 8.3 p -102.37 98.16 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -84.35 79.94 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.559 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.6 p -78.46 102.92 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.96 -130.12 5.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.096 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.36 127.42 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.624 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -96.81 -37.06 10.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' SER . 22.4 mp0 -162.09 130.77 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.169 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.6 tt -158.86 91.05 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.636 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' C ' HG22 ' A' ' 31' ' ' VAL . 13.4 p -118.65 104.25 15.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.603 ' N ' HG22 ' A' ' 31' ' ' VAL . 34.3 m-20 134.0 23.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 111.519 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . . . -152.68 -170.9 3.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.642 0.258 . . . . 0.0 110.75 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -139.7 82.21 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.36 . . . . 0.0 110.661 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 121.19 12.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.276 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.424 ' CD1' ' HA2' ' A' ' 144' ' ' GLY . 3.7 m-85 -117.8 -40.68 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.2 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -86.07 135.7 33.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.388 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.71 109.62 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CZ ' ' CG1' ' A' ' 53' ' ' VAL . 12.2 p90 -124.82 171.24 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.54 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 104.58 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.512 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 tt -77.11 153.48 34.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -127.56 107.35 9.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.7 p90 -122.67 -168.54 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.04 139.97 37.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.071 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -24.66 15.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.15 -28.27 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -120.76 -44.68 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.316 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 1.5 m-85 -93.31 -178.38 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 3.2 tt0 -171.61 115.66 0.39 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.292 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CD1' HG22 ' A' ' 100' ' ' VAL . 36.5 t80 -46.49 134.49 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.488 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 33.6 t -106.41 -81.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -162.14 137.73 7.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.65 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.57 146.28 29.26 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.987 0.899 . . . . 0.0 111.342 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.62 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.444 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.44 163.65 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.916 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.92 -160.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.9 37.56 1.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.816 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.1 -40.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.015 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.9 m -86.95 169.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 0.0 110.918 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.83 144.47 45.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 t -141.86 140.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -156.97 107.8 2.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.31 178.25 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -154.39 110.93 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.667 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.9 tttm -53.99 95.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.181 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 100' ' ' VAL . 7.1 tp -78.51 -24.52 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.727 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.74 -166.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.751 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.9 132.97 34.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.91 29.85 65.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.423 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 122.17 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.667 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 6.4 m -149.3 155.12 8.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.722 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -92.71 151.75 19.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.969 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 4.0 p -127.51 137.14 58.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.862 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -119.79 102.86 8.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.406 HG13 ' CB ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -108.03 155.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.058 0.456 . . . . 0.0 111.424 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 p -164.41 137.16 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 104.83 6.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.977 0.418 . . . . 0.0 111.297 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -93.29 26.32 2.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.114 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.4 p -99.02 -31.49 11.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.995 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.37 5.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.144 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.28 158.21 32.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.692 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -65.38 -175.72 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.548 2.165 . . . . 0.0 112.473 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -54.87 114.6 7.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.44 -38.87 31.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.052 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 65.61 168.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.4 16.14 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.071 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.42 -166.81 2.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.338 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.45 105.07 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.796 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.432 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -86.58 -31.17 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -169.15 135.52 1.7 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.874 0.368 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.412 ' HG2' ' CA ' ' A' ' 52' ' ' GLY . 4.2 mtmt -124.92 112.34 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.595 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -99.8 96.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.43 119.87 24.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.03 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 3.1 mm? -87.01 169.36 12.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.6 tpm_? -106.57 119.35 39.05 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.94 68.13 8.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.452 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.83 -6.42 58.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.47 124.06 2.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.714 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.64 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.3 ttpp -40.74 158.01 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.373 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.61 58.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.743 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.2 pm0 -55.66 117.18 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.221 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 20.93 51.01 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.478 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -71.15 65.54 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.046 0.451 . . . . 0.0 110.309 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.22 131.71 4.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.517 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.08 150.15 31.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.49 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -133.95 125.88 29.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 111.618 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.46 94.77 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.683 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.489 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -101.66 -159.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.67 22.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -62.51 82.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.15 141.08 46.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.093 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.35 150.69 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 99.61 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.895 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 27.1 t0 -50.37 161.99 0.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 110.961 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 64' ' ' PHE . . . -59.49 -45.05 96.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.547 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.15 -31.17 72.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.42 -28.22 3.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.44 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.72 168.74 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.92 148.33 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 38.4 m-70 -125.5 91.06 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.2 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.8 104.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.113 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.507 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 -177.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.328 0.585 . . . . 0.0 112.079 -178.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -60.89 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.349 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.93 176.73 34.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.413 HG22 ' CB ' ' A' ' 37' ' ' LEU . 51.5 m -164.96 145.47 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.554 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.422 ' O ' HD22 ' A' ' 37' ' ' LEU . 9.9 pt-20 -107.07 163.43 13.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.166 0.508 . . . . 0.0 111.7 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.476 ' HD2' ' CG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.5 164.06 28.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.592 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.446 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.3 p -142.71 115.42 8.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.29 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -113.02 128.8 69.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 111.227 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.27 105.69 17.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.712 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 15.4 mt -83.22 115.96 26.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.479 0.657 . . . . 0.0 109.717 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.424 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.78 141.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.65 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.11 146.07 55.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.018 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.435 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.945 0.402 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.629 HG22 ' C ' ' A' ' 59' ' ' VAL . 4.2 t -76.16 151.68 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -69.21 -47.97 63.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.765 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 77.91 107.22 0.18 Allowed Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.064 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.0 t -166.11 136.2 3.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.45 0.643 . . . . 0.0 111.762 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' CG2' ' HA2' ' A' ' 153' ' ' GLY . 27.4 m -95.66 144.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.504 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 t -105.54 111.5 24.23 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.586 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.409 HD23 ' HB ' ' A' ' 53' ' ' VAL . 3.6 mt -97.25 125.53 41.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.044 0.449 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.16 101.38 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.308 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.92 152.28 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.485 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.64 -29.11 67.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.236 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.49 24.93 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.455 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' HG11 ' A' ' 158' ' ' VAL . 20.1 tt0 -164.68 128.08 2.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.859 0.361 . . . . 0.0 111.925 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.6 p -148.4 107.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.259 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tt0 -68.32 128.13 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.036 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.86 132.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.14 -21.85 38.51 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.96 173.45 6.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.56 167.34 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' A' ' 77' ' ' PHE . 3.7 pp -125.41 160.72 28.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -136.67 110.19 7.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.964 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 12.7 t -109.61 97.67 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.981 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -76.78 68.15 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.636 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CG1' ' CZ ' ' A' ' 68' ' ' PHE . 10.3 p -78.19 95.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.18 -122.49 4.6 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.98 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.54 130.81 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 112.138 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -101.72 -32.8 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB2' ' CB ' ' A' ' 34' ' ' SER . 36.4 mt-10 -157.2 128.66 6.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.418 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.429 ' CD1' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -161.22 90.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.92 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.629 ' C ' HG22 ' A' ' 31' ' ' VAL . 13.9 p -125.57 106.02 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.608 ' N ' HG22 ' A' ' 31' ' ' VAL . 1.2 m120 131.5 18.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.462 1.101 . . . . 0.0 111.418 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . . . -148.43 -179.41 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.945 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -126.4 77.16 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.936 0.398 . . . . 0.0 110.58 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.404 ' HA ' ' CG2' ' A' ' 141' ' ' VAL . . . -62.47 112.1 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.6 m-85 -115.72 -59.88 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.802 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.23 112.62 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.433 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 1.5 t80 -86.16 138.65 31.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -147.55 110.27 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.265 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 53' ' ' VAL . 12.9 p90 -137.69 171.55 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -131.99 106.09 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.656 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.408 ' CD1' HG11 ' A' ' 121' ' ' VAL . 1.3 mt -77.29 157.19 30.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.825 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -121.62 104.37 9.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.97 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.9 p90 -114.95 -167.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.05 132.38 54.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.38 -28.02 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -60.24 -30.28 69.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.981 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.83 -46.26 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 1.4 m-85 -93.34 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.751 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -165.29 113.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.773 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CG ' HG22 ' A' ' 100' ' ' VAL . 20.0 t80 -46.68 155.91 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -137.73 -81.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -152.42 131.64 12.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.007 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.06 149.54 26.86 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.304 1.049 . . . . 0.0 111.774 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -133.4 174.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.073 -177.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -168.33 2.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.811 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.91 -161.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.17 37.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.816 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 -37.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 t -86.71 143.86 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -106.27 107.08 17.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 111.005 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -105.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -143.43 117.9 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.349 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.72 173.01 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.946 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.22 107.33 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.443 . . . . 0.0 111.697 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.686 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.5 tttp -54.77 115.19 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.271 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.6 tp -111.5 -22.37 5.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.919 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.79 -166.84 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.58 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -101.42 50.84 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.591 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.61 129.83 0.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 17.4 m -150.1 155.2 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -80.94 152.05 28.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.352 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 8.9 p -134.13 110.7 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.403 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 mt -88.54 114.34 25.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.907 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 13.4 t -107.43 137.73 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.508 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -164.27 136.21 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.392 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.37 104.49 15.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.211 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.85 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.3 p -65.34 -34.76 79.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.84 -19.76 30.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.382 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.33 154.64 71.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 55.6 Cg_endo -70.42 157.99 57.43 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.658 2.239 . . . . 0.0 112.364 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.5 mt -59.9 111.1 3.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.89 -21.35 73.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.395 2.064 . . . . 0.0 112.26 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 65.1 175.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.602 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.72 24.27 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 110.383 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.81 -166.62 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.201 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.9 104.69 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.42 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.7 mm? -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -160.05 135.23 8.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.843 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 83' ' ' ILE . 10.3 mtpt -128.22 100.87 6.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.034 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 70' ' ' LEU . 11.8 p -81.29 107.02 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 110.268 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 23.0 t -75.69 106.9 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.037 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 72' ' ' TYR . 12.1 mt -89.99 169.22 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 5.5 ttm180 -114.38 122.99 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -91.57 68.96 5.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.294 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.51 -5.68 58.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.413 0.625 . . . . 0.0 109.529 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.03 123.83 2.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.49 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.64 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.3 ttmt -41.59 159.94 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.272 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.415 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -174.98 57.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.017 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.3 mt-10 -56.18 113.39 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.097 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.31 46.97 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.544 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.5 m -61.06 86.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.936 0.398 . . . . 0.0 110.235 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -58.67 171.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.654 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -146.84 108.72 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.116 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.4 p -97.46 122.58 40.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.439 . . . . 0.0 111.407 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.447 ' CG2' ' CD1' ' A' ' 68' ' ' PHE . 7.2 p -107.48 95.16 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.457 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.4 p -102.45 -166.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.573 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.91 20.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 m -61.88 88.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.55 166.33 11.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.486 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 63' ' ' ALA . 13.2 p -140.33 159.95 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.982 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.36 91.39 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.648 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -48.61 161.46 0.13 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.37 78.39 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.12 -30.47 65.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.49 -26.85 4.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.595 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.3 mt -68.39 169.98 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.66 148.22 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 61' ' ' ALA . 73.8 m80 -119.22 90.85 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -49.98 102.03 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.449 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.38 -176.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.325 0.583 . . . . 0.0 111.659 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 33' ' ' GLY . . . -70.62 -158.08 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.417 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -161.2 171.73 37.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.034 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 155' ' ' GLU . 55.1 m -158.85 146.52 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.425 ' N ' HG23 ' A' ' 154' ' ' THR . 11.1 tt0 -107.97 151.79 25.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.033 0.444 . . . . 0.0 111.413 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 134' ' ' LEU . 6.5 tppt? -128.97 167.49 17.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.975 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.17 126.21 16.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.11 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.413 HG21 ' CZ ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -113.3 131.6 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.14 106.45 18.75 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.833 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 11.4 mt -85.44 116.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.384 0.612 . . . . 0.0 109.922 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.01 146.21 8.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.556 -178.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.98 145.91 54.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.662 HG22 ' N ' ' A' ' 60' ' ' ASN . 13.1 t -60.54 147.76 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -70.89 -45.54 64.19 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 73.51 109.43 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.583 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.524 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -159.49 138.71 11.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.603 0.716 . . . . 0.0 111.754 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 21.3 m -98.26 141.52 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 21.3 p -100.6 111.01 23.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.14 126.48 42.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.081 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 101.55 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.93 151.32 35.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -61.47 -28.3 69.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.7 mt-10 72.92 24.31 2.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.605 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -164.81 128.37 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.849 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 43' ' ' VAL . 4.1 p -144.58 108.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.394 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.25 125.25 26.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.038 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -28.86 130.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.01 -15.0 52.09 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.753 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.34 171.36 7.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.736 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -106.63 167.81 9.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -120.2 150.99 39.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.63 93.28 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.493 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 27.3 m -106.88 97.06 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.103 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -76.91 76.36 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.659 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CG1' ' CD2' ' A' ' 68' ' ' PHE . 12.5 p -78.54 95.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -105.79 -129.79 6.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.828 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.72 132.01 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 111.69 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 5.1 t0 -97.84 -31.43 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.122 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -178.17 133.4 0.15 Allowed 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.485 0.66 . . . . 0.0 111.894 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' CD2' HG12 ' A' ' 55' ' ' ILE . 1.3 pp -159.41 115.52 2.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.634 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.566 ' C ' HG22 ' A' ' 31' ' ' VAL . 13.8 p -133.53 102.38 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.662 ' N ' HG22 ' A' ' 31' ' ' VAL . 22.4 m-20 138.37 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.384 1.053 . . . . 0.0 111.914 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -160.3 174.44 14.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.33 87.02 2.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.84 112.67 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.446 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -103.6 -35.3 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.129 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.49 112.38 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.348 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 68' ' ' PHE . 67.2 t80 -99.11 152.02 20.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.19 116.94 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.891 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 5.7 p90 -117.8 140.18 50.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.081 0.467 . . . . 0.0 111.459 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 94.17 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -80.02 139.68 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -111.65 104.36 12.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 38.9 p90 -100.16 -170.79 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.75 126.15 42.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.192 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -85.45 -17.26 37.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.021 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -96.47 29.21 2.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.868 0.366 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.86 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.25 170.52 9.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -153.11 109.09 3.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 14.4 t80 -53.23 143.72 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 41.5 t -123.09 -72.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.33 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.69 142.71 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . . . -82.94 153.62 24.95 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 122.125 0.965 . . . . 0.0 111.655 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.84 152.68 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.455 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.91 -173.22 2.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.761 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.92 -158.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -93.5 37.41 1.06 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.6 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.315 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.74 157.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.04 102.99 10.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.65 120.76 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -134.14 118.38 17.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.23 0.538 . . . . 0.0 111.526 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.94 146.79 24.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.013 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -132.44 106.81 8.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.399 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.657 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 12.2 tttp -55.47 95.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -81.34 -30.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.809 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.32 -168.02 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.62 128.83 34.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 59.12 33.23 73.75 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.549 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' C ' ' CG1' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -173.71 121.41 0.32 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.657 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 3.9 m -149.71 155.58 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.643 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -96.94 152.46 18.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.986 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.5 p -128.67 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.968 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.08 108.16 14.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 11.8 p -108.47 137.55 39.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.09 0.472 . . . . 0.0 111.042 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.8 p -161.83 135.86 6.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -78.91 104.42 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.39 -13.01 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.0 p -65.21 -27.17 68.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.34 -20.74 12.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.35 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.44 142.34 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.625 0.25 . . . . 0.0 110.661 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 50.7 Cg_exo -54.0 150.91 29.13 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.446 2.097 . . . . 0.0 112.358 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -56.3 128.61 73.38 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.714 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 13.0 Cg_exo -69.9 -159.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.541 2.161 . . . . 0.0 112.318 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.91 166.87 32.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 14.7 9.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.85 -165.79 1.8 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.078 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.78 104.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -86.83 -34.95 19.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.404 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -166.81 131.87 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 3.8 mtpt -117.05 120.92 39.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.497 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.6 p -88.85 142.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.4 t -113.7 117.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 72' ' ' TYR . 2.5 mt -115.79 108.52 16.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.49 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 26.6 ttm180 -64.18 115.25 4.81 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -74.27 74.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.378 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.34 -4.28 59.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.486 0.66 . . . . 0.0 109.452 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.72 123.48 2.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.352 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.675 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 16.9 ttmt -47.59 139.96 6.53 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.365 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -146.16 62.25 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.852 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.34 112.9 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.92 49.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.607 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.71 66.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.327 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.44 ' HA ' HG22 ' A' ' 157' ' ' THR . 1.0 OUTLIER -43.38 133.28 4.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.301 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.82 116.0 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.841 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 p -109.76 128.65 55.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.598 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 m -106.13 94.96 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.718 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.458 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 p -97.27 -163.78 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.64 21.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.959 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.6 m -59.06 101.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 165.28 12.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.72 125.48 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.21 100.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.584 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.15 161.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -28.18 72.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.71 -34.8 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.54 2.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.5 mt -72.89 161.24 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.45 136.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.102 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 78.1 m80 -109.74 90.67 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -51.08 107.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.467 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.39 177.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.612 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 33' ' ' GLY . . . -62.36 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.974 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.13 168.56 41.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.399 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 35' ' ' VAL . 65.4 m -156.21 146.83 21.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.4 ' N ' HG23 ' A' ' 154' ' ' THR . 0.7 OUTLIER -112.2 167.77 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 111.435 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 2.9 tppt? -139.57 168.8 19.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.246 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 133' ' ' ASN . 4.3 p -142.32 115.83 9.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.742 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.53 126.67 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.05 105.88 18.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.789 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 12.4 mt -78.76 122.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.02 131.2 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.594 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.18 145.02 44.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.043 0.449 . . . . 0.0 111.214 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.493 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.898 0.38 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 25.2 t -82.02 146.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.466 ' N ' HG11 ' A' ' 31' ' ' VAL . 12.3 t -66.82 -35.14 79.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 56.18 108.19 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.035 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.463 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 22.6 t -153.43 138.82 17.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.707 0.765 . . . . 0.0 111.977 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 154' ' ' THR . 34.1 m -91.02 145.3 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.247 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 t -104.9 107.57 18.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.492 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 154' ' ' THR . 6.8 mt -96.8 111.6 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.173 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -140.18 101.47 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.0 158.45 43.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -56.86 -23.45 44.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 65.62 23.02 11.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.444 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.87 128.26 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 0.0 111.854 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.455 HG11 HG12 ' A' ' 160' ' ' ILE . 3.1 p -143.14 108.78 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.192 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -71.59 126.5 29.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.612 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.1 t -29.08 133.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.477 0.656 . . . . 0.0 112.723 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.12 -26.88 22.53 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.126 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -90.02 172.65 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 5.8 m120 -110.31 137.44 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.02 149.92 21.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -136.21 101.66 4.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.32 97.96 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.62 67.62 2.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.607 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' SER . 8.5 p -78.4 95.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.005 0.431 . . . . 0.0 110.515 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.06 -120.07 4.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.107 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -116.92 133.4 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.015 0.435 . . . . 0.0 111.993 -179.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.49 -37.89 8.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.5 mt-10 -155.62 130.79 9.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.122 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 31' ' ' VAL . 10.3 tt -156.66 90.97 1.19 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.502 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 14.3 p -110.98 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.521 ' C ' HG22 ' A' ' 31' ' ' VAL . 69.9 m-20 100.38 20.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.715 0.806 . . . . 0.0 111.797 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.2 139.14 35.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.673 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 80.65 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.619 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.41 111.84 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 22.4 m-85 -113.53 -31.33 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.23 114.78 9.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CE1' HD12 ' A' ' 55' ' ' ILE . 1.1 t80 -85.59 127.18 34.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.12 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -141.62 109.93 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 102' ' ' VAL . 15.0 p90 -140.69 171.11 14.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.985 0.421 . . . . 0.0 111.315 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -117.36 114.49 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.663 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.39 151.27 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.48 104.57 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.457 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 17.2 p90 -129.24 -167.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -112.73 139.85 48.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.053 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.67 -28.79 15.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.37 -47.59 85.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.973 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' CB ' ' CB ' ' A' ' 129' ' ' ALA . . . -99.81 -46.5 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.194 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 2.0 m-85 -93.36 166.5 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -152.18 112.67 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.441 ' CD1' HG22 ' A' ' 100' ' ' VAL . 31.5 t80 -54.12 151.65 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 48.1 t -130.24 -70.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.885 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -172.52 141.86 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.636 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.57 148.43 28.04 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.14 0.971 . . . . 0.0 111.721 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -127.34 152.25 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.074 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.55 -169.59 1.53 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.969 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.55 -159.81 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.81 35.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.37 -46.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.083 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.65 173.5 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.963 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -121.23 139.28 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.13 109.28 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.14 119.11 31.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.11 172.27 7.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 107.38 3.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 tttp -55.38 95.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.948 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 100' ' ' VAL . 5.1 tp -86.45 -28.95 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.41 -174.84 5.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.88 136.54 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 56.94 27.08 56.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.457 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -173.35 123.6 0.39 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.679 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 16.5 m -150.27 154.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.885 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.29 152.13 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.924 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -131.82 93.58 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.905 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.1 mt -75.97 115.28 15.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.83 145.35 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.016 0.436 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.7 p -164.32 136.03 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.363 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -84.53 104.62 14.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.54 -15.07 63.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -65.34 -34.75 79.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.78 -16.9 25.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.446 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.34 160.6 29.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 39.2 Cg_exo -56.85 173.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mp -67.67 134.16 92.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.746 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.51 -38.73 71.14 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.508 2.139 . . . . 0.0 112.256 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 59.05 162.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.9 15.75 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 -163.29 1.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.254 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.419 ' CG1' ' CG ' ' A' ' 120' ' ' LYS . 39.1 t -76.86 105.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.9 mm? -95.62 -30.18 13.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -158.96 136.03 9.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.421 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -132.93 111.12 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.323 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -86.09 114.83 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 48' ' ' ASN . 54.8 t -75.62 105.44 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.841 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.407 HD21 ' CG ' ' A' ' 72' ' ' TYR . 24.7 mt -103.13 108.49 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.598 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 38.4 ttm180 -68.9 117.79 11.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.96 80.75 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.872 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.43 -5.27 58.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.3 123.5 2.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.185 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.573 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.3 ttpt -61.33 131.37 50.11 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.81 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' CB ' ' CB ' ' A' ' 76' ' ' ALA . . . -133.38 75.84 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.64 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.99 110.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 111.033 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.78 14.61 39.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.553 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.02 86.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 110.276 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -60.17 151.36 27.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 156' ' ' LYS . 3.5 mp -146.52 139.28 25.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.88 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.0 t -134.98 134.7 40.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.091 0.472 . . . . 0.0 111.6 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.456 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 48.4 t -105.02 95.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.482 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.486 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.6 p -102.73 -169.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.486 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.47 20.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.948 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.9 m -64.26 97.8 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.344 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 171.6 7.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.7 m -144.31 125.11 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.999 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 78.36 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.636 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -59.41 138.34 57.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.858 0.361 . . . . 0.0 110.8 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.5 -28.05 61.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.678 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.13 -27.91 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 110.958 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.96 -11.21 22.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.743 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -114.52 121.02 42.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.6 p -73.4 126.16 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -95.1 93.2 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.078 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -51.15 110.56 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.475 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 168.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 112.135 -178.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -61.03 -141.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.37 176.05 46.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.469 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.421 ' N ' HG21 ' A' ' 35' ' ' VAL . 17.9 m -159.68 149.12 18.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.7 0.286 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -104.32 154.54 19.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 111.588 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.634 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -147.66 155.13 41.45 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.634 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.7 p -138.76 135.27 34.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.59 125.52 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.527 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.87 105.7 17.79 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 20.1 mt -76.16 143.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -130.74 133.51 63.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.685 -177.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.1 144.52 19.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.231 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.458 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.822 0.344 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 32' ' ' THR . 79.7 t -71.9 152.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.616 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.0 t -60.52 -43.5 97.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.345 0.593 . . . . 0.0 109.493 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.814 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 66.49 102.92 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.754 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.431 ' HB3' ' N ' ' A' ' 57' ' ' GLU . 18.9 t -160.73 138.73 9.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.517 0.675 . . . . 0.0 112.166 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 151' ' ' ILE . 34.0 m -97.32 134.67 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.266 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 3.8 t -92.11 108.05 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.704 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' A' ' 154' ' ' THR . 10.0 tp -97.23 124.52 41.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -140.55 106.99 5.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.687 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.65 165.53 30.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.525 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.88 -27.53 44.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.701 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.3 OUTLIER 71.97 23.04 3.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.54 129.08 2.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.8 p -146.58 107.91 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.46 125.36 26.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.215 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -29.23 131.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.15 -20.05 46.65 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.439 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -99.56 172.33 7.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -121.52 130.01 53.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.849 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.45 133.47 55.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.79 154.01 28.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.566 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.9 m -125.9 98.22 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -69.58 64.49 0.62 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.473 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.483 ' CG1' ' CZ ' ' A' ' 68' ' ' PHE . 9.1 p -78.25 95.53 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.667 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.33 -122.56 4.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.032 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.24 129.75 65.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.776 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.495 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 24.3 t70 -99.19 -37.36 9.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' N ' ' HB3' ' A' ' 34' ' ' SER . 29.2 mt-10 -159.11 130.02 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.589 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 1.1 tt -159.55 91.58 1.0 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.251 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.597 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -122.06 107.07 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 63.2 m-20 130.18 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.435 1.094 . . . . 0.0 111.543 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.92 162.56 38.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -113.85 83.88 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.29 111.78 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.526 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -102.26 -38.71 7.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.93 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.91 112.31 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.112 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.4 t80 -105.2 94.34 5.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.864 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -109.12 133.28 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 53' ' ' VAL . 47.9 p90 -135.99 171.27 14.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 111.421 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.411 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -119.0 102.71 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.071 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tt -76.88 157.32 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.096 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -127.27 130.47 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.496 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 1.8 p90 -140.97 -167.42 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.548 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.03 136.3 53.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.07 -6.35 45.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.59 31.26 2.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.32 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.651 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 3.0 m-85 -100.32 -177.08 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.76 108.86 0.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 72' ' ' TYR . 17.9 t80 -48.55 147.65 2.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 60.1 t -127.69 -80.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -161.42 138.84 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . . . -82.92 150.54 26.41 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 122.01 0.91 . . . . 0.0 111.279 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -128.28 152.38 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.501 -177.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 15.1 p -115.65 -176.93 3.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.72 -156.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -93.65 36.77 1.08 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.875 0.369 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.79 -38.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.216 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.6 t -87.06 159.03 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -114.85 117.02 29.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 84' ' ' SER . 10.8 t -115.41 131.98 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.56 115.61 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -95.76 149.8 21.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -136.51 106.86 6.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.696 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 24.5 tttt -55.52 120.38 7.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.362 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.4 tp -112.06 -23.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.834 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.54 -179.19 7.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 111.152 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.496 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -106.07 60.57 0.37 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.27 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -174.0 123.72 0.33 Allowed 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.696 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.3 m -148.81 155.41 8.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.637 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -99.11 152.34 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.067 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.3 p -125.21 147.63 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.394 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.38 109.92 18.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.28 137.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 111.524 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.3 p -164.25 136.06 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.448 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -79.37 104.39 9.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.242 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -14.78 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.5 p -65.26 -28.87 69.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.0 -17.74 22.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.454 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -99.18 147.66 33.58 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 52.4 Cg_exo -54.16 169.88 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.23 113.96 7.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 -21.22 51.72 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.406 2.071 . . . . 0.0 112.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 59.56 169.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.849 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.12 27.05 14.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 110.602 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -155.38 154.5 32.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.365 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.414 ' CG1' ' CG ' ' A' ' 120' ' ' LYS . 26.9 t -47.43 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.224 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.1 mm? -92.05 -29.3 16.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -163.0 136.4 5.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.74 0.305 . . . . 0.0 111.513 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 83' ' ' ILE . 7.2 mtpt -131.85 100.75 5.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.428 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.69 107.04 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 13.9 p -83.89 124.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -99.49 114.06 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.411 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 24.5 ttm180 -54.95 116.81 2.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -87.63 67.94 9.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.255 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 -0.83 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.481 0.658 . . . . 0.0 109.312 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.16 123.39 2.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.235 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.7 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.0 ttpt -45.44 142.19 2.32 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.627 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.407 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -149.07 59.61 1.04 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.713 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -56.05 118.61 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.167 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.36 13.59 70.49 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.51 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.6 t -70.35 66.56 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.469 . . . . 0.0 110.144 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -43.97 138.28 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.482 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.17 127.14 53.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.458 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.406 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -119.84 126.39 50.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.123 0.487 . . . . 0.0 111.957 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.87 94.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.479 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -105.82 -159.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.783 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.52 104.74 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 0.0 110.371 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.09 167.17 9.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.493 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 m -141.65 120.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.962 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.71 98.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.669 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -55.81 161.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.74 79.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.87 -46.23 25.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.14 -27.84 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.4 119.31 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.971 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.27 153.42 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -122.13 90.61 3.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.69 103.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.266 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.488 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.45 -176.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 111.947 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.814 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -64.63 -160.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.53 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.1 -174.29 23.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.019 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.537 HG22 ' CD2' ' A' ' 37' ' ' LEU . 11.6 t -160.62 -171.03 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.429 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.462 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 14.0 tt0 -161.8 157.85 24.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.456 ' HE2' HD21 ' A' ' 37' ' ' LEU . 2.2 tppm? -143.17 168.73 19.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.186 0.517 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 133' ' ' ASN . 2.5 p -141.67 115.7 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.415 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.9 119.11 58.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 105.89 18.09 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.7 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 6.9 mt -78.25 119.68 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.2 132.77 48.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.692 -178.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.12 145.84 45.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.511 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.794 0.331 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.0 t -76.26 151.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.764 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 33' ' ' GLY . 1.5 t -84.65 -33.16 23.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 52.19 121.74 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.549 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.5 146.37 31.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.211 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 153' ' ' GLY . 28.7 m -96.07 135.99 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 3.6 t -90.96 107.11 18.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.246 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' CD2' HG21 ' A' ' 154' ' ' THR . 13.1 tp -97.48 106.26 18.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.833 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -140.95 101.03 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.03 166.16 24.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 111.274 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -69.68 -35.87 75.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.626 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 68.29 31.46 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.169 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -164.21 116.47 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.3 p -133.14 165.48 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.901 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tt0 -129.47 113.04 14.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 128' ' ' LYS . 2.1 t -28.11 119.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 121.59 -27.61 6.22 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.43 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -175.37 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.74 0.305 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.66 165.06 12.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.188 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.8 tp -117.54 156.76 27.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -136.45 93.95 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.146 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -103.63 98.13 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.703 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.53 68.2 3.21 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.4 p -78.61 95.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.05 -129.74 6.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.865 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.51 138.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 111.543 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -37.48 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.04 131.99 0.05 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.551 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.62 95.51 3.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.526 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.9 m -85.27 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.578 ' C ' HG22 ' A' ' 31' ' ' VAL . 53.1 m-20 96.68 31.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.29 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 149' ' ' HIS . . . -141.39 149.77 41.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.362 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.5 mt-10 -119.76 71.3 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.723 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 141' ' ' VAL . . . -62.09 122.42 15.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.234 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -105.93 -32.84 8.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.654 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.84 112.3 7.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.04 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CE2' ' CD1' ' A' ' 68' ' ' PHE . 21.9 t80 -104.25 94.69 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.1 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -102.42 130.23 49.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 66' ' ' TYR . 41.6 p90 -132.85 171.11 14.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -132.7 97.27 4.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.186 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 157.71 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.432 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -116.54 104.57 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 24.4 p90 -111.24 -167.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.96 125.54 51.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.78 -40.82 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.803 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.68 -35.54 80.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.46 -57.95 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.429 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 8.3 m-85 -93.44 165.38 12.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -145.02 109.74 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.417 ' CG ' HG22 ' A' ' 100' ' ' VAL . 22.1 t80 -54.01 140.46 31.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 39.9 t -119.52 -72.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -169.04 143.57 3.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.74 147.73 28.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 122.169 0.985 . . . . 0.0 111.698 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.41 152.83 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.474 -177.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -166.36 1.16 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.52 -157.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.27 36.25 1.06 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.09 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.969 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.88 160.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.782 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -112.03 136.71 51.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.959 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.37 105.46 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.34 114.89 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.611 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.27 -176.98 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.12 107.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.388 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.655 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttm -54.82 111.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.039 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -102.58 -28.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.86 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.31 170.71 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.32 133.75 45.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.13 28.48 64.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.323 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.448 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 5.8 ptmt -173.66 122.98 0.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.655 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 20.9 m -150.27 155.92 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.28 152.05 22.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.313 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -131.17 95.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.525 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.88 114.7 19.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.081 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.7 m -111.58 153.56 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.692 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -164.69 136.71 4.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.467 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.7 m -85.36 104.47 15.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.51 -12.19 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.681 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -65.28 -30.86 71.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.38 -19.12 22.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.27 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.39 147.17 34.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 44.6 Cg_exo -56.45 176.27 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.547 2.165 . . . . 0.0 112.365 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.04 121.96 49.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.813 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 -36.85 62.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.282 1.988 . . . . 0.0 112.158 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 59.91 163.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.888 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 28.62 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.492 . . . . 0.0 110.241 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -164.48 156.48 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.996 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.403 HG11 ' NZ ' ' A' ' 120' ' ' LYS . 30.9 t -44.4 104.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.26 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 -29.98 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.969 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.79 135.7 4.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.797 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.403 ' NZ ' HG11 ' A' ' 117' ' ' VAL . 12.9 mtmm -124.86 113.69 18.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.66 110.45 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.452 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 41.7 t -76.92 106.29 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.433 HD23 ' CG ' ' A' ' 72' ' ' TYR . 10.2 mt -106.21 108.6 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.768 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 39.3 ttm180 -69.05 117.92 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -68.55 80.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.185 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.413 ' HG2' ' HG2' ' A' ' 124' ' ' ARG . 4.8 mm-40 -86.06 -12.81 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 109.55 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.79 124.35 2.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.564 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.608 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 7.3 ttpp -45.56 155.9 0.14 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.11 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.7 56.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -56.21 98.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.677 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 110.59 26.77 4.66 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.911 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 65.81 0.25 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.918 0.39 . . . . 0.0 111.067 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 157' ' ' THR . 1.8 t-20 -45.04 110.53 0.24 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.111 0.481 . . . . 0.0 112.003 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.02 165.2 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.868 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.9 t -158.37 119.74 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.385 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.448 ' CG1' ' CD2' ' A' ' 68' ' ' PHE . 35.6 t -87.16 94.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.441 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.456 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.2 p -100.19 -170.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' C ' ' A' ' 137' ' ' THR . 4.2 p30 43.23 23.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.757 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.438 ' HB2' ' CD1' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -64.61 93.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.575 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.24 167.5 10.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.136 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 16.3 m -140.18 129.39 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.59 77.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 24.7 t0 -57.14 146.86 26.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.6 -26.38 73.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.89 -44.32 82.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.28 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.26 -10.22 4.12 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.853 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.64 132.22 56.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.26 115.19 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.152 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.443 ' CD2' ' HB1' ' A' ' 61' ' ' ALA . 77.2 m-70 -86.34 95.0 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.71 108.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.792 0.329 . . . . 0.0 110.187 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.516 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.23 166.42 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -56.16 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 35' ' ' VAL . . . -159.08 -167.97 20.49 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.892 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.572 HG21 ' CD2' ' A' ' 37' ' ' LEU . 6.8 t -166.09 179.58 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.958 0.379 . . . . 0.0 111.56 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 tm-20 -143.51 143.8 31.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.639 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -149.44 155.32 40.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.14 0.495 . . . . 0.0 111.232 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.639 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 8.2 p -128.73 140.22 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.219 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.65 139.03 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 111.49 23.78 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.027 0.441 . . . . 0.0 111.12 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.3 mt -88.16 127.5 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -112.13 132.19 61.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.077 -177.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.07 145.86 49.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.223 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.821 0.343 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.597 HG11 ' N ' ' A' ' 59' ' ' VAL . 77.5 t -100.7 153.2 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.581 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.3 t -64.05 -42.5 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.448 0.642 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 61.96 104.93 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.214 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 40.9 t -156.31 136.48 12.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.697 0.76 . . . . 0.0 112.213 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' CG1' HD12 ' A' ' 151' ' ' ILE . 34.2 m -93.35 145.47 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.492 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 17.9 p -104.38 113.31 26.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 156' ' ' LYS . 5.5 mt -96.79 121.38 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 111.32 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.1 101.3 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.365 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.08 32.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.88 -22.72 59.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.529 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 2.3 mp0 66.68 23.35 10.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -165.12 127.89 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.7 p -144.54 106.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.164 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.16 133.07 47.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.489 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -33.83 133.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.57 -22.48 35.74 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.515 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.13 172.18 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -104.34 153.57 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.67 161.03 14.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.57 93.57 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.723 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.2 t -105.67 97.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -85.96 59.08 4.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.157 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 68' ' ' PHE . 9.6 p -78.04 95.35 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.581 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -112.31 -117.58 3.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.037 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 131.38 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 112.046 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 7.3 t0 -103.53 -35.84 8.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -155.89 127.82 7.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.611 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 90.7 1.7 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.27 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.597 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -115.19 116.53 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 73.8 m-20 103.15 33.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.934 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -169.31 133.46 1.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -91.96 82.06 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.348 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 111.86 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 30.3 m-85 -104.94 -33.82 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.884 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.51 112.3 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.111 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.426 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.2 t80 -109.71 95.03 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.967 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -109.18 143.86 38.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CD1' ' CG1' ' A' ' 136' ' ' VAL . 18.6 p90 -146.41 171.27 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.013 0.435 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -126.29 99.72 5.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 156.08 31.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.27 112.99 18.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.435 ' CG ' HD21 ' A' ' 123' ' ' LEU . 26.1 p90 -126.22 -168.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -106.06 134.55 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.72 -29.86 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.09 -41.92 99.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.64 -47.94 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -93.38 172.37 8.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.712 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -160.7 114.13 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG22 ' A' ' 100' ' ' VAL . 31.9 t80 -54.16 153.46 5.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 87.1 t -132.8 -77.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.02 140.61 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.736 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 102' ' ' VAL . . . -82.85 149.47 27.12 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.93 152.63 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.339 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.13 -165.37 1.31 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.898 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -90.89 -157.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -93.72 36.75 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.399 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.18 -38.73 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 89' ' ' PHE . 19.8 t -86.83 149.29 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.926 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' N ' HG13 ' A' ' 88' ' ' VAL . 11.2 t80 -111.28 103.11 11.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.44 142.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.021 0.438 . . . . 0.0 110.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -156.46 118.84 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.305 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.95 -178.9 4.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.413 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 107.85 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.0 111.54 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.699 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 17.8 tttt -54.53 95.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.0 tp -78.12 -27.11 14.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.833 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -165.3 -166.78 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -86.71 134.68 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.28 29.38 60.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -173.62 121.36 0.33 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 120.941 0.4 . . . . 0.0 109.977 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.699 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 11.8 m -150.07 155.51 7.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.665 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -93.3 151.87 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.28 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.4 p -123.67 129.65 74.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.47 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.8 mt -101.84 104.69 15.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.332 . . . . 0.0 110.714 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.69 135.68 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.494 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -164.46 136.76 4.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.437 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 88.6 p -88.2 117.26 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.112 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.41 27.71 2.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.298 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.6 p -102.41 -27.65 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.78 -16.81 23.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.315 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.43 147.62 34.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 51.2 Cg_exo -54.1 172.96 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.496 2.131 . . . . 0.0 112.306 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mp -59.28 128.0 84.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.784 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 -34.05 98.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.376 2.051 . . . . 0.0 112.11 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 58.56 163.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.979 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.94 15.52 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -146.83 -165.72 2.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.31 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.71 104.84 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.763 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.9 mm? -94.35 -29.56 14.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.034 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -149.56 134.14 17.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -126.09 101.81 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.25 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.338 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.59 97.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.737 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.435 HD21 ' CG ' ' A' ' 72' ' ' TYR . 76.9 mt -84.17 113.74 21.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.912 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.2 tpm_? -59.01 113.28 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.68 68.2 7.95 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.49 -6.19 59.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 109.574 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.31 123.59 2.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.578 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.584 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.6 ttmm -41.94 162.47 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.318 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -173.43 58.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.018 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.5 tt0 -56.22 116.05 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.119 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.88 15.89 58.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.567 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.67 66.62 0.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 110.252 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -44.49 140.55 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.264 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.83 128.72 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.416 ' CA ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -115.57 129.83 56.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.696 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.461 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 39.5 t -106.42 95.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.609 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.471 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 15.9 p -100.11 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.76 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.35 21.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.995 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -61.92 105.54 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.358 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 175.13 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.355 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.74 126.56 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.008 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.79 104.42 2.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.714 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 13.0 p30 -58.87 -174.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.719 0.295 . . . . 0.0 110.857 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.75 16.58 60.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.909 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.98 -32.17 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.61 -16.96 3.52 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.061 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.99 170.16 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.995 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.1 p -120.8 125.72 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 79.1 m80 -96.12 90.54 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.945 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -49.42 106.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.45 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.43 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.451 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -76.19 -146.37 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.677 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.52 41.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.716 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 155' ' ' GLU . 24.0 m -161.14 153.34 20.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 8.7 tt0 -110.0 161.98 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 1.3 tppt? -139.5 166.75 23.73 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 133' ' ' ASN . 2.1 p -142.23 116.21 9.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.67 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.65 122.37 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.253 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.42 105.85 17.95 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.679 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 18.1 mt -80.49 112.45 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.597 0.713 . . . . 0.0 109.842 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.55 131.77 40.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.038 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.01 145.84 49.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.077 0.465 . . . . 0.0 110.957 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.628 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 60' ' ' ASN . 14.6 t -60.74 155.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -77.5 -46.85 21.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.827 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 71.26 114.21 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.208 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLU . 6.7 t -162.08 136.7 6.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.138 0.494 . . . . 0.0 111.542 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG21 ' HB ' ' A' ' 154' ' ' THR . 5.8 m -91.41 134.1 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.553 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 t -96.42 107.44 19.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.341 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.407 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 3.7 mt -97.1 117.3 30.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.251 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.49 101.42 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.08 160.19 41.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 111.241 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -31.67 68.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 69.41 24.2 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.5 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -165.04 122.83 1.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.813 0.34 . . . . 0.0 111.657 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.7 p -143.34 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.51 132.19 47.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.421 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 2.0 t -32.76 132.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-O 121.549 0.69 . . . . 0.0 112.776 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.85 -24.89 30.34 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.536 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.3 171.85 8.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.746 0.307 . . . . 0.0 110.666 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -116.46 150.89 37.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.407 ' CD2' ' CG1' ' A' ' 158' ' ' VAL . 6.8 tp -130.08 142.1 50.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.51 117.05 24.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG2' ' CD2' ' A' ' 37' ' ' LEU . 7.1 p -93.55 98.65 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -69.19 69.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.9 p -78.58 95.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.19 -135.1 8.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.809 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.51 127.37 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.553 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -94.29 -37.34 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 34' ' ' SER . 22.9 mp0 -161.07 132.21 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -162.49 91.61 0.77 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.108 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.0 p -121.46 109.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.578 ' N ' HG22 ' A' ' 31' ' ' VAL . 63.9 m-20 130.41 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.451 1.101 . . . . 0.0 111.606 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -150.41 -179.16 6.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.699 0.285 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.93 85.16 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.362 . . . . 0.0 110.575 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 141' ' ' VAL . . . -62.59 111.94 2.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.145 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.3 m-85 -115.28 -49.12 2.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.67 112.3 17.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.997 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 1.5 t80 -85.75 136.6 33.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.453 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -147.62 109.64 4.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.271 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD1' ' CG1' ' A' ' 136' ' ' VAL . 29.9 p90 -130.24 171.27 13.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.364 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 104.84 8.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 149.73 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.118 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -125.28 104.64 8.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.425 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 19.1 p90 -121.33 -170.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -97.64 136.79 37.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -93.6 -26.8 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -76.54 -29.78 56.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.103 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -108.78 -49.32 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.327 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 158' ' ' VAL . 5.0 m-85 -93.31 -177.08 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ARG . 2.0 tt0 -170.28 108.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CG ' HG22 ' A' ' 100' ' ' VAL . 38.9 t80 -47.47 152.73 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.399 . . . . 0.0 111.119 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.3 t -134.53 -78.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -153.47 148.73 26.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.25 147.96 26.02 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.207 1.003 . . . . 0.0 111.638 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -133.78 174.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.103 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.67 -177.29 5.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -61.97 -161.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.713 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 36.71 1.1 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.44 -40.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.26 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.98 146.86 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -108.25 103.04 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.96 132.17 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -145.4 109.73 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.82 -179.23 4.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.342 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -161.11 117.92 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.387 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.686 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 tttt -54.03 113.35 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.389 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -109.49 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -158.44 172.91 17.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.839 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.85 131.91 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.25 29.47 63.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -173.57 129.87 0.43 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 18.2 m -150.06 155.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.925 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.26 147.35 28.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -130.68 129.89 64.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -111.05 109.94 20.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 66' ' ' TYR . 4.1 t -106.17 144.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.508 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.38 139.78 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.305 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -88.57 104.34 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.108 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.75 -17.83 64.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 p -65.23 -34.81 79.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.22 -19.9 28.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.389 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.73 153.77 43.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 40.9 Cg_exo -56.72 164.8 5.43 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.629 2.219 . . . . 0.0 112.437 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 118' ' ' LEU . 2.3 mp -59.33 127.55 84.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.749 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.85 -32.14 96.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.409 2.072 . . . . 0.0 112.085 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 58.44 162.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 15.04 9.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.25 -164.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.218 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 t -78.97 104.66 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.57 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.4 ' CD1' ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.55 -33.23 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.407 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -168.68 133.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.319 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 83' ' ' ILE . 3.9 mtmt -122.92 100.76 7.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.06 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.25 110.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 110.437 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.5 t -75.55 115.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.787 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.09 169.12 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.642 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 12.8 tpp180 -115.28 125.16 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 45' ' ' VAL . . . -92.08 73.12 5.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.546 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -87.74 -5.11 58.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.435 0.636 . . . . 0.0 109.639 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.563 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.647 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 4.3 ttmm -49.74 134.2 20.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.176 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.402 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -138.69 64.29 1.49 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.47 114.42 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.151 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.51 21.25 52.07 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.02 66.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 0.8 OUTLIER -46.98 142.78 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.858 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.68 165.05 16.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.801 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.19 106.24 3.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 21.8 t -96.4 94.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.456 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -103.33 -160.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.81 19.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.7 m -59.81 90.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.123 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' HG22 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -116.44 138.47 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.212 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 63' ' ' ALA . 10.4 p -115.01 153.29 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.03 100.19 2.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.786 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -52.51 162.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.779 0.324 . . . . 0.0 111.128 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.39 -43.88 95.51 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.548 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.22 -30.85 71.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.98 -27.76 3.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.536 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.7 155.34 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 140' ' ' SER . 12.1 p -114.43 138.63 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 55.8 m80 -110.52 96.93 6.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.153 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.56 104.99 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.159 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.471 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.39 -176.76 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -68.1 -158.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.577 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -154.88 175.35 32.96 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.434 ' HB ' HG21 ' A' ' 35' ' ' VAL . 86.0 m -164.12 146.73 9.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.925 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.75 166.7 10.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.624 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -152.4 154.67 36.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.879 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.624 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.9 p -126.77 143.6 51.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.605 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.41 HG22 ' CZ ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -134.69 130.02 52.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.58 105.93 16.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 120.933 0.397 . . . . 0.0 111.011 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 20.8 mt -80.15 115.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.491 0.662 . . . . 0.0 109.455 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -97.29 128.74 48.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.116 -178.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.08 145.9 29.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.107 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.524 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.622 HG22 ' N ' ' A' ' 60' ' ' ASN . 24.9 t -60.68 155.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.442 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -84.44 -45.06 13.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.778 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 71.01 120.28 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.422 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' GLU . 7.8 t -162.95 140.47 7.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.06 0.457 . . . . 0.0 111.421 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.415 ' CG1' ' HA2' ' A' ' 153' ' ' GLY . 11.2 m -97.82 129.26 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.37 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 56' ' ' ASP . 47.5 p -95.01 108.21 20.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.948 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.442 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 1.4 mt -97.71 122.09 40.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.55 112.28 10.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.595 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.01 155.6 37.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.48 -29.15 66.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 69.98 23.87 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.624 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' N ' HG11 ' A' ' 158' ' ' VAL . 19.9 tt0 -164.68 128.95 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 112.112 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -134.03 171.19 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.117 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.5 tt0 -133.05 120.15 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.0 t -28.72 132.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 121.576 0.703 . . . . 0.0 112.381 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.05 49.55 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.28 174.92 10.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.515 0.326 . . . . 0.0 110.15 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -127.42 147.93 50.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.875 0.369 . . . . 0.0 110.986 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -102.52 164.12 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -130.0 93.32 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.682 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' A' ' 37' ' ' LEU . 8.0 p -103.16 97.9 6.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -91.48 85.2 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.258 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 3.5 p -78.55 95.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 110.086 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.37 -134.9 8.2 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.499 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -103.08 134.63 43.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 111.606 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 22.1 t0 -103.28 -34.32 8.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.425 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB3' ' CG2' ' A' ' 32' ' ' THR . 4.0 mp0 -165.54 134.05 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.926 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 tt -162.27 91.61 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.759 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.583 ' C ' HG22 ' A' ' 31' ' ' VAL . 11.9 p -119.31 103.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.622 ' N ' HG22 ' A' ' 31' ' ' VAL . 35.2 m-20 133.1 24.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.262 1.025 . . . . 0.0 111.413 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.6 171.95 18.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 86.05 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.716 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.5 133.52 55.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 12.7 m-85 -127.63 -42.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.04 112.44 15.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -85.98 100.66 12.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.029 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -109.33 112.44 24.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CE1' ' CG1' ' A' ' 53' ' ' VAL . 50.4 p90 -142.97 171.54 13.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.8 t -128.48 121.29 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' CD1' ' CG1' ' A' ' 121' ' ' VAL . 7.2 tt -95.03 126.34 40.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -98.32 106.59 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 50.0 p90 -107.13 -169.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.702 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.69 120.27 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -29.46 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -27.42 69.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.95 -44.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.384 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 160' ' ' ILE . 0.8 OUTLIER -93.14 161.06 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -145.65 130.39 18.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.441 ' CD1' HG22 ' A' ' 100' ' ' VAL . 19.5 t80 -55.02 149.13 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.406 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 55.7 t -132.16 -85.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -160.4 135.84 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.88 150.58 26.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.147 0.975 . . . . 0.0 111.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.19 153.29 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.571 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.25 -165.89 1.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.5 -157.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.618 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.6 37.15 1.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.863 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.67 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.169 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.5 t -86.74 158.85 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.36 125.38 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.415 HG22 ' CG1' ' A' ' 104' ' ' VAL . 3.5 t -122.57 135.93 61.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.33 120.53 7.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.612 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.96 156.77 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 107.25 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.174 0.512 . . . . 0.0 111.337 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.664 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.3 ttpt -55.1 95.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 100' ' ' VAL . 7.5 tp -82.73 -22.21 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.765 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.8 -166.74 0.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.81 133.18 33.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.87 29.56 62.0 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -173.26 121.59 0.36 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.664 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 7.1 m -149.91 154.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.676 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.09 152.16 22.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.204 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 8.6 p -126.45 93.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.15 111.0 17.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.415 ' CG1' HG22 ' A' ' 90' ' ' VAL . 4.2 m -117.25 158.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.022 0.439 . . . . 0.0 111.804 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -164.49 136.09 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.265 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -79.01 113.67 17.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 31.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.983 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.2 p -109.65 -34.64 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.48 -21.84 11.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.142 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -91.17 155.69 44.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.757 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 59.1 Cg_endo -72.4 174.5 11.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.481 2.121 . . . . 0.0 112.476 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HG ' HD13 ' A' ' 118' ' ' LEU . 4.0 tt -54.49 107.55 0.9 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.86 -32.11 94.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.344 2.029 . . . . 0.0 111.926 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . 59.77 170.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.168 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.6 16.15 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.087 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -148.26 -179.85 7.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' CG1' ' CG ' ' A' ' 120' ' ' LYS . 47.0 t -70.95 105.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.649 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.427 HD13 ' HG ' ' A' ' 112' ' ' LEU . 2.3 mm? -87.56 -31.55 19.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.214 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.582 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -166.11 131.0 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.679 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.405 ' CG ' ' CG1' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -119.89 118.6 31.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 70' ' ' LEU . 7.1 p -97.98 94.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.182 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 m -75.63 118.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.026 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 2.4 mm? -92.24 169.2 10.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.0 tpm_? -105.51 118.25 36.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -90.86 71.07 6.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.785 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.36 -4.3 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.96 124.31 2.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.042 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.619 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 3.1 ptmt -40.6 163.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -178.2 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.971 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 pt-20 -55.63 112.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.69 4.14 39.85 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.647 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.84 87.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.932 0.396 . . . . 0.0 110.24 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -60.49 166.68 2.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.5 mp -140.13 104.84 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.649 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.41 130.14 45.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.227 0.537 . . . . 0.0 112.093 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.6 m -115.4 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.17 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.496 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 7.5 p -108.91 -167.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.547 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.2 OUTLIER 37.41 29.87 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.449 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 89.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.034 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.95 171.66 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.357 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.33 122.46 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 99.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -56.41 162.53 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.41 -29.16 70.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.61 -49.05 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.6 -28.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.392 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.33 170.2 16.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.23 153.39 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -123.03 94.82 4.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.23 104.97 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.504 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.53 -176.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.778 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -67.93 -160.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -159.78 175.54 36.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 1.3 t -162.93 -170.91 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.849 -0.207 . . . . 0.0 110.574 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -151.21 152.06 32.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.198 0.523 . . . . 0.0 112.061 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 134' ' ' LEU . 4.1 tppt? -129.34 169.26 15.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.867 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.01 144.38 32.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -134.24 126.37 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -90.35 116.13 28.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.775 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 4.6 mt -85.56 116.66 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.69 -178.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.89 146.6 51.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.016 0.436 . . . . 0.0 111.016 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.502 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 12.3 t -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' GLY . 6.7 t -80.42 -32.27 37.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 52.43 120.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.596 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.47 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 28.6 t -149.94 155.01 39.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.277 0.56 . . . . 0.0 111.944 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -108.06 123.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -92.13 107.38 19.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mt -97.16 126.59 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.27 101.42 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.2 154.56 41.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.346 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.57 -26.62 61.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.2 mt-10 68.58 23.53 7.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.424 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 158' ' ' VAL . 27.0 tt0 -164.7 126.55 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.6 p -128.62 171.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.493 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tt0 -133.83 113.4 12.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' GLN . 1.8 t -28.37 114.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 125.06 -25.6 5.75 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.884 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -175.52 2.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.913 0.387 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -114.9 167.74 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -114.74 159.43 20.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.469 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.54 98.05 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -82.1 71.48 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.153 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.22 97.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.965 0.412 . . . . 0.0 110.872 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.35 -128.47 5.79 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.852 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.432 HD12 ' CE1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -112.05 134.8 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.037 0.446 . . . . 0.0 111.431 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.02 -33.05 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.234 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -174.46 130.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.642 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HG ' ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -152.61 91.67 1.59 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.093 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 10.6 p -100.11 117.82 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' C ' HG22 ' A' ' 31' ' ' VAL . 69.6 m-20 100.78 22.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.596 0.758 . . . . 0.0 112.352 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.69 138.59 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.8 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.1 mp0 -102.19 87.18 3.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 112.12 2.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.312 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.42 -32.06 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.63 111.96 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.432 ' CE1' HD12 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -87.45 136.5 32.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.341 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -147.83 109.86 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.314 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CD2' ' CG1' ' A' ' 102' ' ' VAL . 5.0 p90 -125.0 171.12 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.375 . . . . 0.0 111.352 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 115.56 17.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.587 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.3 141.45 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -119.96 104.59 10.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.568 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.42 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 50.3 p90 -133.0 -170.87 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.82 132.43 54.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -27.39 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -56.31 -30.04 62.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.35 -48.15 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 123' ' ' LEU . 1.1 m-85 -93.38 178.9 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -171.7 119.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 92' ' ' ALA . 15.2 t80 -54.54 156.02 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.714 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 58.4 t -130.46 -84.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.07 132.14 12.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.83 150.19 26.72 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.141 0.972 . . . . 0.0 111.649 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.99 152.38 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.353 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -115.07 -168.41 1.38 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -93.87 -160.12 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.86 37.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.29 -42.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.167 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.08 173.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.336 . . . . 0.0 110.977 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 156.82 26.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.85 123.94 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -134.01 110.78 9.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.028 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.15 131.02 44.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.311 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -118.84 108.04 14.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 12.8 tttt -70.51 97.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.831 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -78.1 -0.06 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' N ' HD13 ' A' ' 95' ' ' ILE . 0.3 OUTLIER 178.12 -168.76 0.08 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.35 115.39 27.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 79.92 38.72 18.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.075 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -172.68 123.42 0.44 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.61 131.86 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.593 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 15.7 ttp180 -101.28 151.97 21.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.848 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.8 p -123.59 157.29 29.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 111.824 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.408 ' N ' HG21 ' A' ' 102' ' ' VAL . 84.8 mt -123.56 106.94 11.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.525 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.1 t -105.27 143.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 111.686 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 p -164.29 136.17 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.08 112.22 23.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 111.258 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mt -93.77 31.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.929 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -109.7 -30.92 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.968 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.65 -20.67 11.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.223 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -94.43 155.93 39.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.615 0.245 . . . . 0.0 110.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 177.07 7.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.574 2.183 . . . . 0.0 112.547 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.408 ' CD2' ' CD2' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -56.72 119.15 27.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.901 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.62 -42.41 39.95 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.931 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 66.08 163.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.29 15.49 10.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.271 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.2 -169.76 3.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.284 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 104.92 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.584 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -96.81 -28.79 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.479 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -155.16 129.4 8.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -118.96 101.01 7.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.534 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 9.6 p -95.8 97.97 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.51 124.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.067 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 4.2 mp -95.33 169.19 10.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.792 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -111.28 120.4 42.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.492 . . . . 0.0 112.069 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -89.72 69.52 7.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.991 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.5 -9.51 47.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.34 0.591 . . . . 0.0 109.623 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.49 124.3 3.1 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.736 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.642 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.4 ttpp -43.66 155.24 0.08 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.433 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.82 59.51 0.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.892 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.53 116.27 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.188 -179.111 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.7 18.56 51.26 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.334 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.71 66.55 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.939 0.399 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.96 133.93 4.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.255 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.42 118.31 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.1 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 p -99.6 124.15 44.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.553 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.22 95.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.546 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.8 p -111.98 -159.78 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.761 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 20.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -68.05 92.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.26 163.85 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.39 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.07 130.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.68 82.84 0.93 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 9.1 t70 -55.18 139.96 40.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.76 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.2 -38.39 25.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.06 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -53.51 -26.58 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.56 10.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.668 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.18 170.15 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.9 p -120.51 122.98 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 5.3 m-70 -92.74 99.62 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.081 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.33 110.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.467 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -84.23 171.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.208 0.528 . . . . 0.0 111.922 -178.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -58.4 -146.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.487 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.55 167.44 37.73 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.518 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.408 ' N ' HG21 ' A' ' 35' ' ' VAL . 9.5 m -168.14 148.74 4.95 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -118.6 179.12 4.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.622 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 1.5 tppt? -144.7 168.85 19.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 133' ' ' ASN . 4.0 p -142.12 115.78 9.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.68 122.12 68.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.291 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -89.3 112.34 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.555 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 2.4 mt -81.62 120.65 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.375 0.607 . . . . 0.0 109.634 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.431 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.49 131.25 55.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.922 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.74 146.06 47.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.094 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.489 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.779 0.324 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 32' ' ' THR . 72.5 t -68.03 153.25 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.62 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.4 t -62.91 -43.09 99.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.376 0.607 . . . . 0.0 109.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.839 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 65.66 104.71 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.536 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.407 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 7.6 t -162.35 133.73 5.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.419 0.628 . . . . 0.0 112.105 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.2 m -91.68 143.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.546 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.0 t -93.9 111.63 23.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -97.08 120.51 37.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.141 0.496 . . . . 0.0 111.596 -179.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.22 129.93 22.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.59 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.06 155.38 1.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.651 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -29.22 68.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.354 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 72.45 24.7 2.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.62 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 158' ' ' VAL . 2.3 tt0 -164.82 128.15 2.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 0.0 112.013 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.0 p -143.97 107.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.332 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -69.91 127.71 33.81 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.8 t -29.26 131.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 112.727 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.14 -18.54 56.52 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.422 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.54 172.89 6.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.776 0.322 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.39 149.1 47.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -102.56 164.28 11.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.67 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.69 93.88 3.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.82 98.02 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -84.91 80.6 1.82 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' SER . 14.9 p -78.35 97.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.172 0.51 . . . . 0.0 110.754 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -101.74 -128.7 6.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.96 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 131.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.605 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.8 t0 -100.68 -36.41 9.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -158.21 131.57 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.651 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -163.34 91.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.246 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.592 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.32 107.84 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 64.2 m-20 130.22 20.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.55 1.14 . . . . 0.0 111.637 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' A' ' 149' ' ' HIS . . . -155.69 165.82 35.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.771 0.319 . . . . 0.0 110.795 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.52 85.11 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.62 120.24 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 111' ' ' PRO . 5.5 m-85 -112.71 -30.92 6.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.74 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.42 112.5 7.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.69 132.82 34.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.192 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.46 110.01 4.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.648 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 10.0 p90 -127.84 171.12 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.137 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.77 113.03 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.789 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -92.77 153.36 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.003 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.16 137.97 54.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.763 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 46.1 p90 -140.46 -175.28 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.92 120.21 40.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -78.32 -3.78 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.35 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.1 20.8 8.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.855 0.36 . . . . 0.0 111.1 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.58 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.584 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 2.8 m-85 -107.17 155.27 20.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.5 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -151.88 131.11 12.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -53.15 150.84 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 47.6 t -126.62 -84.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -157.91 132.49 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.73 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.87 145.65 29.33 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.176 0.988 . . . . 0.0 111.437 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.44 154.8 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.56 -1.654 . . . . 0.0 112.64 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -165.09 1.14 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -91.0 -158.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.11 37.15 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 -38.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.01 155.51 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -112.41 112.79 24.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 91' ' ' ASN . 3.6 t -101.95 155.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.3 t30 -164.12 109.29 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.5 140.07 32.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.202 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -120.38 108.43 14.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.71 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.03 -29.17 43.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.987 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 178.16 -168.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.205 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.41 123.51 24.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 64.16 41.05 98.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.184 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.38 127.33 0.54 Allowed 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.88 136.17 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -174.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -107.28 152.2 24.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.365 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 13.9 p -129.89 146.32 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.431 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.3 mt -131.69 98.39 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.316 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.12 160.73 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.419 . . . . 0.0 111.655 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 p -163.86 135.4 4.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.324 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p -77.19 110.68 12.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.305 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.8 tp -92.87 29.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.956 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 p -108.94 -27.2 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.971 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.25 -18.02 12.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.225 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -101.84 157.11 34.31 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.28 . . . . 0.0 110.719 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 62.3 Cg_endo -73.5 -175.54 2.09 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.537 2.158 . . . . 0.0 112.459 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.52 114.53 7.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.91 -39.54 32.46 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.563 2.176 . . . . 0.0 112.126 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 67.71 168.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.56 15.81 10.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.127 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.62 -168.54 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.414 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.87 105.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -86.24 -32.66 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.533 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -168.03 131.42 1.6 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.754 0.312 . . . . 0.0 111.262 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.62 113.93 24.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.481 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.52 95.08 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.233 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.0 m -75.6 115.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.841 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 134' ' ' LEU . 3.6 mm? -83.6 169.33 15.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.954 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.477 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -108.74 124.9 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.999 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -100.47 69.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.782 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -5.45 55.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.483 0.659 . . . . 0.0 109.448 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.69 124.27 2.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.453 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.731 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.9 ttpt -44.11 135.02 4.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.562 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.413 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -144.27 59.77 1.35 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.852 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.93 -5.28 59.53 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -56.25 91.32 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.321 . . . . 0.0 110.543 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.27 160.04 22.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.194 0.521 . . . . 0.0 111.499 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 156' ' ' LYS . 4.7 mp -137.08 104.3 5.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.612 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.2 p -102.37 125.45 49.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 154' ' ' THR . 19.5 m -111.32 94.95 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.472 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -99.05 -161.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.472 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.24 19.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -60.26 101.32 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.471 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.14 173.1 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.427 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.95 127.23 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.34 97.89 0.89 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.428 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 32.0 t0 -55.26 161.57 1.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.95 -34.95 91.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.45 -31.59 68.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.99 -31.96 2.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.436 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -69.14 170.08 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.36 150.53 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.447 ' CD2' ' CB ' ' A' ' 61' ' ' ALA . 88.8 m-70 -121.77 95.16 4.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -55.85 105.56 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.433 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.38 -176.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.331 0.586 . . . . 0.0 111.742 -179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -65.68 -156.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.49 166.97 36.16 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.417 ' CG2' ' HG ' ' A' ' 37' ' ' LEU . 14.9 m -163.14 155.68 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -126.58 173.08 9.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.316 0.579 . . . . 0.0 112.088 -179.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 134' ' ' LEU . 1.4 tppt? -139.56 168.7 19.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -143.09 116.33 8.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -104.73 130.47 55.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.484 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.58 18.7 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.414 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.731 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 7.1 mt -78.89 119.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.44 0.638 . . . . 0.0 109.712 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.5 136.96 33.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.82 145.03 53.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 111.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.509 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.63 HG11 ' N ' ' A' ' 59' ' ' VAL . 61.5 t -89.72 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.533 ' N ' HG12 ' A' ' 31' ' ' VAL . 8.7 t -73.06 -42.54 62.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 59.1 110.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.286 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 30.6 t -150.11 140.01 21.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.731 0.777 . . . . 0.0 111.956 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.5 m -93.36 144.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.066 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -103.07 107.55 18.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.756 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 HD12 ' CG2' ' A' ' 154' ' ' THR . 6.0 mt -96.88 112.51 24.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -136.25 117.42 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.8 164.2 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.307 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 -29.51 68.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.486 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 66.71 33.36 6.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -164.22 120.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 111.772 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.0 p -127.79 167.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.6 tm0? -130.46 118.27 20.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.2 t -28.55 131.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 121.575 0.703 . . . . 0.0 112.355 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.48 13.19 61.83 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.618 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -132.08 174.61 10.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.497 0.319 . . . . 0.0 110.238 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -123.59 149.27 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.861 0.363 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.18 160.05 17.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.572 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -136.14 93.76 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.27 97.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 120' ' ' LYS . . . -79.6 96.33 1.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.927 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 36' ' ' SER . 10.2 p -87.18 95.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.46 -137.4 9.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.83 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.04 134.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 0.0 111.641 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.11 -33.44 11.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -168.39 134.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.6 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.83 90.99 1.42 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.358 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.63 ' N ' HG11 ' A' ' 31' ' ' VAL . 14.2 p -110.12 116.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 73.0 m-20 102.34 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.843 0.857 . . . . 0.0 111.932 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . . . -169.52 143.05 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 82.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 111.77 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.655 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -100.74 -34.33 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.745 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.02 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.064 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 20.1 t80 -108.88 94.84 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -100.11 110.27 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.199 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CE2' ' CG1' ' A' ' 53' ' ' VAL . 14.6 p90 -102.3 171.4 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.42 . . . . 0.0 111.549 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.443 ' HB ' ' ND2' ' A' ' 138' ' ' ASN . 81.5 m -135.85 100.95 4.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.488 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.43 154.54 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -123.58 104.32 8.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.432 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.1 p90 -114.59 -167.3 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.959 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.32 123.94 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.4 -30.45 53.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -63.8 -30.97 72.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' CB ' ' CB ' ' A' ' 129' ' ' ALA . . . -109.75 -50.93 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -93.33 -176.97 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 109.65 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.99 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 17.6 t80 -51.96 147.77 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 39.3 t -132.3 -74.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -166.91 140.01 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.1 151.97 25.52 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 122.195 0.997 . . . . 0.0 111.525 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.15 174.39 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.375 -1.739 . . . . 0.0 112.167 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -144.7 -165.69 2.21 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -93.99 -158.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.36 36.68 1.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.882 0.373 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.94 -42.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.117 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -89.98 148.42 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -103.15 137.69 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 91' ' ' ASN . 25.1 t -133.7 144.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.416 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.3 t30 -155.33 116.99 4.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.568 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.53 157.05 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -141.05 107.26 5.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.659 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 22.3 tttt -55.11 115.01 1.99 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.2 tp -109.81 -25.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.881 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -160.1 165.69 31.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -66.87 128.69 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 62.73 30.69 77.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -173.77 122.86 0.34 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.907 0.384 . . . . 0.0 110.058 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 12.9 m -150.09 155.57 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 152.37 20.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 9.4 p -127.97 139.94 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.89 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.57 107.27 16.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.88 147.0 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.56 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 p -164.49 136.1 4.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.504 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.7 p -83.99 104.88 14.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.94 31.15 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.152 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -99.02 -33.1 10.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.12 -25.1 6.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.307 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.57 155.07 41.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.845 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.36 173.67 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.58 2.187 . . . . 0.0 112.376 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.89 116.87 17.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.12 -30.08 89.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.353 2.035 . . . . 0.0 111.844 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.49 169.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.278 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.15 17.86 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.08 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.02 -164.44 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.36 104.62 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.914 0.388 . . . . 0.0 110.605 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.43 -32.84 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -172.69 132.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.31 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HB3' ' CA ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -122.66 132.09 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.556 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.8 p -104.47 118.43 51.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.367 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.2 m -92.89 118.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.7 109.88 21.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.98 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.0 tpp85 -55.17 117.45 3.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.89 71.76 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.531 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.9 -3.28 58.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.538 0.685 . . . . 0.0 109.41 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.43 123.14 2.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.206 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.579 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.8 ttpm? -46.02 157.55 0.12 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.259 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.404 ' CB ' ' CB ' ' A' ' 76' ' ' ALA . . . -169.77 59.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.773 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.16 116.03 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.937 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.87 21.61 49.56 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.261 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.14 70.91 0.16 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.044 0.45 . . . . 0.0 110.377 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.447 ' ND2' HG22 ' A' ' 157' ' ' THR . 1.7 t-20 -43.8 121.87 2.55 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.22 161.07 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.159 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 150.41 26.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.346 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 68' ' ' PHE . 15.2 t -123.33 95.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.475 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.7 p -101.55 -166.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.94 22.86 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.123 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -65.17 107.07 1.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.84 0.352 . . . . 0.0 110.523 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.95 171.26 7.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.44 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.3 m -144.69 132.26 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.703 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.71 96.38 1.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.898 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 23.8 t0 -55.98 161.82 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.767 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.37 -27.94 73.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -74.48 -47.59 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.96 -25.75 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.58 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.52 158.01 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.993 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.89 115.01 47.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 7.5 m-70 -87.5 93.19 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -48.3 108.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.238 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.533 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.35 166.58 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.27 0.557 . . . . 0.0 111.738 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -59.5 -144.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.327 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.81 -177.21 40.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.108 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.411 ' CG2' HD12 ' A' ' 37' ' ' LEU . 25.4 m -161.24 148.95 15.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.723 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.407 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 15.6 tt0 -102.01 158.14 16.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.276 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.631 ' HG3' ' N ' ' A' ' 157' ' ' THR . 1.5 tppp? -151.28 164.23 37.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.555 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.631 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 4.0 p -142.62 153.91 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.768 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.05 133.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.849 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -99.42 115.03 28.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.159 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.8 mt -86.76 118.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -100.66 128.35 52.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.194 -178.007 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -55.96 146.63 21.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.182 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.494 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.802 0.334 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.86 73.33 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -102.69 173.91 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.61 132.99 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -132.15 176.85 8.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -152.39 33.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -156.7 141.98 17.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 m80 60.43 175.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.52 166.54 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -176.61 -175.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m 60.7 105.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 t -109.55 -53.8 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.64 160.28 19.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.53 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.8 mt -114.12 -38.65 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.84 150.73 77.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -32.35 101.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.616 2.878 . . . . 0.0 113.244 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -153.44 -68.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.89 -154.16 20.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.35 168.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -108.57 -31.84 7.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -176.97 4.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 169.29 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 141.82 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.87 154.52 50.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tp -95.73 -40.7 9.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 136.68 58.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.9 -176.7 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.26 177.13 8.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.24 77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.57 125.22 35.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -94.2 146.38 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.436 ' N ' HG11 ' A' ' 31' ' ' VAL . 12.6 t -68.1 -36.3 79.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 56.44 109.24 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.159 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.468 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 3.2 m -151.32 141.23 21.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.522 0.677 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.468 ' CG2' ' HA2' ' A' ' 153' ' ' GLY . 21.9 m -95.82 143.3 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.693 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -102.8 105.2 15.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.035 178.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HG ' ' HD2' ' A' ' 156' ' ' LYS . 12.1 tp -109.02 125.21 51.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -140.22 121.91 15.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 156' ' ' LYS . . . -149.32 162.76 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.382 . . . . 0.0 111.68 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -70.71 -28.91 65.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 74.24 24.26 1.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.656 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -164.92 128.28 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.2 p -146.14 107.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.131 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.58 126.83 30.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.178 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.27 124.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.85 -19.2 18.73 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.684 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -110.42 173.11 6.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.662 0.267 . . . . 0.0 110.749 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -114.53 167.62 10.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -108.8 161.43 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -136.08 93.71 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.564 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 m -105.06 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.455 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 120' ' ' LYS . . . -76.41 72.98 1.87 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.176 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 36' ' ' SER . 12.5 p -78.38 99.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.957 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.76 -118.42 3.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.782 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -120.4 135.14 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.014 0.435 . . . . 0.0 111.921 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -36.47 7.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -158.99 131.34 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.323 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.12 90.62 1.37 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.463 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 14.7 p -111.39 114.83 48.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 73.6 m-20 102.68 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.055 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 149' ' ' HIS . . . -145.93 133.63 21.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.777 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -100.82 86.16 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.582 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.5 125.83 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.519 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 3.5 m-85 -118.41 -37.85 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.487 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.24 112.79 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.994 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 2.6 t80 -85.75 135.77 33.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 111.508 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -148.06 110.01 4.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.275 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CE2' ' CG1' ' A' ' 53' ' ' VAL . 11.7 p90 -128.04 171.42 11.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.429 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.72 101.14 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.687 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -77.21 153.66 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.923 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.26 114.34 20.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 37.2 p90 -122.83 -172.37 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.13 126.17 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -82.47 -32.19 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -74.99 -29.75 60.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.39 -52.81 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 4.7 m-85 -93.43 171.91 8.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.3 115.75 4.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.71 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 92' ' ' ALA . 17.7 t80 -48.42 148.65 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 48.7 t -130.6 -84.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -157.37 138.65 13.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -82.7 153.77 25.17 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.217 1.008 . . . . 0.0 111.757 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.49 174.7 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.218 -177.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -154.66 -165.64 2.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.71 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -161.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -95.59 37.77 1.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.53 -39.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.96 140.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.924 0.393 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.14 118.66 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.026 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 84' ' ' SER . 6.3 t -116.83 129.96 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -137.23 120.0 16.26 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.63 148.34 22.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.087 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -131.84 106.69 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.659 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -55.02 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.137 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.9 tp -83.0 -25.12 8.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.836 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -165.33 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.453 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 61.15 32.13 79.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.452 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 120.8 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 4.4 m -149.24 155.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -97.05 152.53 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.928 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.6 p -126.66 146.83 31.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.445 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 59.6 mt -115.74 107.41 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' TYR . 9.9 t -104.77 140.92 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 111.543 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -164.48 136.89 4.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.45 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -83.5 111.24 18.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.212 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.55 28.8 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.125 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.7 p -104.04 -27.97 11.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.04 6.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.217 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.34 158.55 35.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 37.2 Cg_endo -66.0 164.14 28.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.532 2.155 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HB2' HD23 ' A' ' 118' ' ' LEU . 1.9 pp -55.25 131.78 69.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.406 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 96.3 Cg_endo -86.81 145.17 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB3' HG21 ' A' ' 55' ' ' ILE . . . -97.45 168.75 10.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.92 35.11 13.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.14 157.79 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.611 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.6 t -50.86 105.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.54 -30.93 18.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.21 157.71 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.733 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HB3' ' HA2' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -153.84 131.94 11.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -104.62 105.03 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.628 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.401 HG12 ' CD1' ' A' ' 83' ' ' ILE . 26.0 m -75.22 109.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.874 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 72' ' ' TYR . 2.8 mm? -83.15 169.13 16.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 1.7 tpm_? -110.86 118.87 37.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -86.49 67.27 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.243 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.88 -4.76 59.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.45 123.72 2.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.491 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.608 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -39.66 160.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.606 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -177.41 60.8 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.767 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.51 119.74 6.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.286 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.3 13.18 68.83 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.648 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.08 69.93 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 2.0 p-10 -59.56 146.29 41.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.448 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.46 165.11 13.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.857 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.5 115.51 9.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.0 111.178 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -96.15 95.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.728 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.478 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -111.67 -163.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.704 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.89 21.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.22 96.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.87 -178.53 4.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 111.366 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.8 m -156.68 141.66 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 88.38 1.5 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.326 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 14.4 t0 -52.92 160.61 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.67 76.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.584 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -55.72 -26.73 46.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 111.053 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.96 23.18 5.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mt -117.73 170.04 9.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 77.5 t -109.12 142.23 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 143' ' ' ASP . 55.8 m80 -119.38 92.39 3.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -48.62 97.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.33 164.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.163 0.506 . . . . 0.0 111.69 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -57.56 -148.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.551 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -170.4 174.58 44.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.468 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.2 m -145.44 162.36 37.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 154.07 39.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.973 0.416 . . . . 0.0 111.152 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.463 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -132.22 164.08 27.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.936 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 1.2 p -141.77 115.57 9.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.983 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.35 135.74 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.412 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -105.32 108.19 19.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 11.4 mt -82.99 116.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -98.46 139.78 19.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.92 145.69 55.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 0.0 111.139 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.46 -133.25 0.62 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.469 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.63 176.02 8.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.862 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.24 -65.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.457 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -141.27 100.95 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.316 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -130.29 -56.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -73.22 79.85 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -173.34 120.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.31 79.69 3.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.935 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.09 154.92 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -162.34 35.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 60.72 95.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 m -98.44 35.29 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t -87.0 79.88 8.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.83 -126.17 8.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.32 -46.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.4 82.99 2.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -32.33 -37.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.618 2.879 . . . . 0.0 113.355 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.08 155.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.87 -161.38 33.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.499 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.58 148.27 51.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -91.63 177.3 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ttm 60.53 106.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.93 101.81 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.179 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -130.73 92.12 3.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 121.31 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -146.12 86.79 1.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -102.13 -64.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 177.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.51 109.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.12 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.92 36.89 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.39 120.62 25.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG11 ' N ' ' A' ' 59' ' ' VAL . 65.7 t -68.65 155.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.54 ' N ' HG12 ' A' ' 31' ' ' VAL . 8.4 t -72.59 -43.76 62.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.809 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 68.6 114.09 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.225 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 t -158.16 134.98 9.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.507 0.67 . . . . 0.0 111.977 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 26.5 m -96.27 143.87 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.7 t -103.85 106.75 17.36 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.318 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.439 ' CD2' HG22 ' A' ' 154' ' ' THR . 6.7 tp -107.38 117.41 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.952 0.406 . . . . 0.0 111.329 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -140.28 139.2 35.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.4 171.42 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -30.86 67.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.534 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 71.88 31.03 2.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.68 130.34 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.947 0.403 . . . . 0.0 111.944 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.1 p -147.57 107.85 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.137 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.89 126.42 29.65 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.135 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.35 130.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 112.717 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.98 -20.46 35.92 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.357 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -105.62 172.45 6.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.317 . . . . 0.0 110.659 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -100.71 167.72 10.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 111.095 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -110.4 159.55 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -137.24 92.65 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.95 96.56 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.411 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.66 70.72 3.0 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.903 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG1' ' CE2' ' A' ' 68' ' ' PHE . 7.1 p -78.38 94.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.06 -129.98 6.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.438 HG22 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -111.44 128.98 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.562 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.5 t0 -93.37 -28.78 15.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 177.34 136.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.493 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.47 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 1.8 pp -153.2 91.56 1.53 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.865 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.691 ' N ' HG11 ' A' ' 31' ' ' VAL . 14.5 p -100.82 114.72 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.994 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 78.8 m-20 105.85 39.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.935 0.894 . . . . 0.0 111.554 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -171.02 148.28 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.64 82.53 1.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.733 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 112.14 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -101.76 -32.21 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.21 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.13 112.56 6.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.429 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.8 t80 -108.46 96.66 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 111.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.52 110.46 23.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.326 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE2' ' CG1' ' A' ' 102' ' ' VAL . 34.7 p90 -101.87 160.55 14.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.341 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -111.38 105.28 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.762 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 128.56 34.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.96 115.2 29.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.615 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.6 p90 -139.53 -169.13 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.167 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.56 140.97 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.75 -27.37 16.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -59.49 -30.38 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . . . -117.62 -47.14 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.195 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.456 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.31 -176.81 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.988 0.423 . . . . 0.0 111.008 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 43.9 tp10 -166.27 155.93 11.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.496 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.426 ' CD1' HG22 ' A' ' 100' ' ' VAL . 36.6 t80 -94.92 148.96 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -132.22 -78.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.032 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -161.06 134.75 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.18 148.91 27.17 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 122.31 1.052 . . . . 0.0 111.701 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 174.58 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.098 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.55 -165.65 2.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.82 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -159.79 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.49 36.66 1.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.69 -42.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.21 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.08 146.02 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -105.3 103.3 12.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.1 t -92.45 153.71 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -163.24 113.54 1.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.03 166.15 11.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.271 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.86 107.44 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.653 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttp -54.69 94.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.11 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -80.68 -23.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.655 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.82 -166.77 0.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.24 133.56 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.54 29.24 63.53 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.516 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -173.33 120.05 0.33 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.834 0.35 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.653 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 6.4 m -150.05 155.05 8.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.793 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.3 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.162 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 9.2 p -128.14 93.41 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.772 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.14 111.24 16.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.3 151.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.607 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.9 p -160.81 136.2 7.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.517 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.1 p -78.34 110.68 13.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 tt -94.46 30.31 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.133 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.5 p -102.55 -31.58 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 125.97 -22.6 6.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -110.11 159.19 32.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.63 0.253 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.46 179.52 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.583 2.189 . . . . 0.0 112.214 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.83 132.28 79.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.94 -39.67 31.58 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.522 2.148 . . . . 0.0 112.204 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 61.55 166.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.108 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 15.78 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -166.7 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.281 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.1 t -70.99 104.87 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -33.49 20.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.2 131.64 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.212 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -112.62 117.23 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.447 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.41 105.02 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.3 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.2 m -75.79 130.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.921 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.425 HD23 ' CD1' ' A' ' 72' ' ' TYR . 71.8 mt -113.24 111.51 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.847 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 14.1 tpp85 -55.0 111.47 0.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.0 68.31 7.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -85.83 -5.35 59.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.389 0.614 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.48 123.41 2.53 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.644 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.641 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -41.95 162.13 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.319 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.439 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -173.69 57.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.913 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 3.5 pt-20 -56.02 117.25 3.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.196 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.03 -0.73 67.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.765 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -59.17 88.08 0.01 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.407 ' ND2' HG22 ' A' ' 157' ' ' THR . 4.3 m120 -59.92 163.68 4.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 111.533 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' LYS . 3.5 mt -140.3 112.93 8.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.868 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.32 125.67 51.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.506 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.1 m -110.12 94.81 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.715 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.457 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 18.6 p -100.76 -168.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.44 21.16 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.886 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 100.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.505 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.58 169.99 8.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.422 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.48 -179.47 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.846 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.61 84.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -55.63 154.49 6.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.978 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.58 -46.46 93.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.46 -29.47 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.15 -25.44 6.06 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.385 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.49 170.17 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.46 139.73 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -114.01 90.44 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 103.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.718 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.514 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.55 -176.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 111.711 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 33' ' ' GLY . . . -69.29 -159.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.404 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.94 171.22 33.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.187 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.439 HG22 ' CD2' ' A' ' 37' ' ' LEU . 66.4 m -152.9 149.13 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -114.68 148.85 37.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 157' ' ' THR . 1.6 tppp? -131.81 163.89 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.332 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.598 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -142.88 124.62 15.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.934 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -114.4 138.36 44.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.13 105.75 16.12 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.893 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.641 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 10.5 mt -82.44 117.08 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.439 0.637 . . . . 0.0 109.437 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.25 137.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.549 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.17 145.57 55.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.015 0.436 . . . . 0.0 110.946 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.41 159.09 14.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 170.03 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.928 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 mtm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.86 0.362 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.06 -85.53 0.48 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.565 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -114.06 174.25 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.8 125.76 29.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -86.66 -59.76 2.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -105.02 -177.64 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.97 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -84.75 105.09 15.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -129.27 -45.85 1.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -59.87 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -106.52 127.17 53.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.66 31.15 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m 60.17 36.87 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.78 145.45 16.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.07 -31.29 12.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.78 82.62 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -32.27 135.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.586 2.857 . . . . 0.0 113.306 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -98.35 35.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.49 140.95 10.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.584 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -31.53 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 60.25 86.46 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.04 32.31 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -101.45 -74.52 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.0 -43.22 2.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.15 155.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -98.54 32.59 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.47 170.49 22.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.74 -176.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.5 -76.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 53.27 101.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -60.6 155.7 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.807 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.5 t -81.33 -46.7 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 67.83 114.63 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.605 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.496 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -150.95 148.41 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.256 0.55 . . . . 0.0 111.574 179.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 154' ' ' THR . 5.8 m -99.87 128.88 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.569 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -92.03 106.84 18.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.825 178.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -97.48 123.29 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.082 0.467 . . . . 0.0 111.523 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -134.88 101.15 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.015 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.3 141.58 33.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -25.75 67.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.25 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' HG13 ' A' ' 158' ' ' VAL . 18.3 mt-10 74.55 23.08 1.96 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.566 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' N ' HG11 ' A' ' 158' ' ' VAL . 3.7 tt0 -164.98 128.34 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 2.8 p -146.14 108.0 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -68.2 122.86 19.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.781 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.02 131.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 121.469 0.652 . . . . 0.0 112.641 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.04 -23.71 32.73 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.125 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -96.68 172.99 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.692 0.282 . . . . 0.0 110.43 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -94.93 167.78 11.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.7 tp -154.93 108.08 2.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 1.9 pm0 -110.37 146.73 35.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 98.12 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -67.52 65.88 0.27 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.441 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' SER . 13.5 p -80.92 102.48 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.64 -123.28 3.6 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.548 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -111.59 137.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 111.737 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -36.14 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -166.29 131.4 2.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.537 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.444 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.1 tt -152.57 96.6 2.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 10.1 p -122.99 109.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' N ' HG22 ' A' ' 31' ' ' VAL . 65.7 m-20 128.61 20.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.403 1.081 . . . . 0.0 111.414 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.31 175.76 11.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -130.2 85.38 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.64 127.53 31.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 7.1 m-85 -111.09 -45.43 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.152 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.7 112.71 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.237 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 34.2 t80 -97.6 95.02 7.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -106.07 110.15 22.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CD1' ' CG1' ' A' ' 102' ' ' VAL . 4.4 p90 -112.19 171.16 7.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.104 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.416 ' HB ' ' OD1' ' A' ' 138' ' ' ASN . 53.4 m -120.68 107.67 13.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 21.2 tp -79.15 133.35 36.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -116.83 109.03 16.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 15.1 p90 -125.04 -166.74 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -120.44 102.8 8.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 111.119 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.44 -28.16 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.63 -47.24 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 129' ' ' ALA . . . -116.87 32.87 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -167.31 -176.48 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.421 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.92 108.95 0.31 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CE1' ' HB1' ' A' ' 92' ' ' ALA . 8.5 t80 -54.49 149.32 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.7 t -128.65 -79.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -160.89 145.08 13.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.85 150.56 26.48 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.215 1.007 . . . . 0.0 111.659 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.08 151.31 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.295 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -174.87 129.78 0.31 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.729 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.16 -168.2 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 t0 63.93 63.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.89 25.41 59.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.96 114.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 111.051 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -113.33 121.66 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.473 ' CG2' ' CG2' ' A' ' 102' ' ' VAL . 8.7 p -113.17 153.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.231 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -137.7 123.99 20.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.307 0.575 . . . . 0.0 111.58 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.67 153.53 17.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.761 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 107.11 5.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 111.719 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.681 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 7.4 tttt -55.24 117.38 3.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.561 HG21 ' HA ' ' A' ' 100' ' ' VAL . 4.5 tp -109.15 -25.47 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 163.82 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.0 124.22 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 68.57 30.11 72.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.453 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -174.01 123.21 0.32 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.935 0.397 . . . . 0.0 110.121 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.681 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 10.0 m -149.9 154.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.426 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -96.92 152.86 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 112.013 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.3 p -124.35 150.82 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.49 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 mt -124.1 108.75 12.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.072 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 ' CG2' HG23 ' A' ' 90' ' ' VAL . 97.6 t -102.68 136.64 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.401 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 p -164.39 134.74 4.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -88.88 130.9 35.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.058 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.07 29.35 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 -26.38 9.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.025 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.27 -24.07 10.13 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.125 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -89.38 155.94 48.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.681 0.277 . . . . 0.0 110.663 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 60.5 Cg_endo -72.68 156.16 53.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.57 2.18 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 66' ' ' TYR . 1.9 pp -51.99 133.44 39.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 86.6 Cg_endo -84.72 145.35 10.25 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.408 2.072 . . . . 0.0 111.49 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 55' ' ' ILE . . . -98.51 169.19 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 111.317 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.93 33.89 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.482 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -161.1 157.58 26.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.34 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.34 105.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 113' ' ' PRO . 1.4 mm? -89.57 -31.28 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' HG22 ' A' ' 90' ' ' VAL . . . -164.38 135.67 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 128.9 40.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.697 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -107.13 112.73 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.47 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 50' ' ' GLU . 18.7 m -75.3 96.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.513 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 72' ' ' TYR . 36.1 mt -83.17 110.81 18.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.1 tpp85 -55.37 110.93 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.78 70.46 5.13 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -2.39 58.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.444 0.64 . . . . 0.0 109.562 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.64 123.55 2.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.611 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.612 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 8.8 ttpt -51.87 142.5 15.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.691 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.464 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . . . -146.55 63.73 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.14 111.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.71 43.22 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.641 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -70.69 66.96 0.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.518 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.85 131.69 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.121 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.6 139.28 47.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.941 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.88 110.61 14.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.902 0.382 . . . . 0.0 111.477 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.416 HG13 ' CE2' ' A' ' 68' ' ' PHE . 21.0 m -99.4 95.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.7 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.45 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 13.8 p -103.65 -165.62 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.45 ' ND2' ' C ' ' A' ' 137' ' ' THR . 2.2 p30 43.52 21.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.976 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -63.83 96.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.791 0.329 . . . . 0.0 110.507 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -101.18 167.47 10.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.385 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -128.82 -179.59 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.87 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.5 87.2 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.435 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 17.3 t70 -53.32 162.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.041 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.84 -52.11 55.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.19 -30.83 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.781 0.324 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.41 -28.09 4.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.424 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.78 150.93 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.62 149.8 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.435 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 24.8 m-70 -123.54 90.55 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.593 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.69 107.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.482 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.32 -177.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.418 . . . . 0.0 111.42 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -70.1 -148.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.347 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.23 37.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.151 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.441 ' N ' HG21 ' A' ' 35' ' ' VAL . 67.9 m -164.16 146.67 9.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.759 0.314 . . . . 0.0 110.573 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 154' ' ' THR . 18.1 pt-20 -107.05 167.81 9.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.948 0.404 . . . . 0.0 111.543 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 0.0 OUTLIER -139.61 163.74 31.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.232 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.451 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.2 p -142.4 119.55 11.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -116.34 138.05 48.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.161 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -106.79 105.54 15.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 12.6 mt -80.46 129.32 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -114.13 129.54 69.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.819 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.8 145.31 41.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.237 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.74 92.05 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.48 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -177.78 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.09 43.02 0.19 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.7 t -140.94 170.55 15.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.48 148.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 59.98 163.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 60.33 103.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -144.28 99.87 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -105.98 -66.11 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.966 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -170.57 126.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -175.85 -65.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m 60.52 177.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -91.65 -62.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.06 161.56 23.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.442 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.486 0.184 . . . . 0.0 110.925 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 14' ' ' LEU . 17.9 m 51.75 152.33 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.49 -38.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.635 2.89 . . . . 0.0 113.282 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 114.12 0.57 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.516 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 m 60.62 -170.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.936 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -145.22 -61.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 63.85 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.39 31.34 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.03 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t 60.56 95.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 31.75 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.9 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 tp -154.46 164.68 38.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.18 30.81 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.6 -177.8 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.35 146.64 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.73 73.45 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.24 100.96 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 13.4 t -78.57 146.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.41 ' N ' HG11 ' A' ' 31' ' ' VAL . 12.6 t -74.42 -32.6 62.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 57.05 114.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.209 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' GLU . 13.3 t -147.56 156.44 42.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG21 ' N ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -106.2 129.64 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.035 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -91.41 107.44 19.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.059 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 156' ' ' LYS . 5.6 mt -96.7 120.26 36.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.439 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -140.18 101.2 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.77 149.64 32.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.444 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.49 -22.25 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.427 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 67.06 24.38 9.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.549 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -164.96 128.93 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.97 0.414 . . . . 0.0 111.995 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 3.1 p -145.51 108.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.207 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.88 125.34 26.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.292 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.38 130.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 121.517 0.675 . . . . 0.0 112.705 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.91 -23.65 30.38 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.34 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.03 172.34 7.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -105.85 167.7 9.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.088 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.415 ' CD1' HG12 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.93 158.26 24.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.63 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -137.48 92.35 2.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.741 0.305 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 7.6 p -112.07 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.05 0.453 . . . . 0.0 110.461 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -90.01 81.66 1.41 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.468 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 36' ' ' SER . 14.8 p -78.61 99.53 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.33 -117.47 4.34 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.59 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -121.43 127.23 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.491 . . . . 0.0 112.186 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -26.15 13.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.6 mp0 -165.41 136.47 3.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.97 91.49 0.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.213 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.3 p -103.1 115.45 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.508 ' C ' HG22 ' A' ' 31' ' ' VAL . 71.0 m-20 101.48 23.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.214 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.49 134.26 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.989 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 19.6 tt0 -105.14 83.71 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.472 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.82 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 111' ' ' PRO . 10.8 m-85 -104.14 -33.35 8.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.21 9.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.786 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.455 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 1.5 t80 -87.53 137.42 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 111.436 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -147.89 109.43 4.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.182 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 102' ' ' VAL . 8.2 p90 -130.85 171.31 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.447 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.83 111.24 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.773 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.25 156.17 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.776 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -130.35 104.41 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.445 ' CD1' HD22 ' A' ' 123' ' ' LEU . 12.0 p90 -122.79 -168.35 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -100.94 147.75 25.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.017 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -105.13 14.66 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -110.17 -31.02 7.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.0 -45.56 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 1.3 m-85 -93.59 -177.86 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -170.34 112.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.435 ' CD1' HG22 ' A' ' 100' ' ' VAL . 44.6 t80 -53.35 154.41 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.9 t -134.49 -73.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -163.36 143.62 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.88 155.72 23.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.918 0.866 . . . . 0.0 111.583 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.414 ' CD1' ' HG3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -131.51 154.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.882 -1.508 . . . . 0.0 112.65 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.54 -164.82 1.26 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.784 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.66 -157.99 0.63 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.774 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -93.87 36.78 1.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.87 -41.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.945 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.413 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 13.1 t -87.46 153.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.689 0.28 . . . . 0.0 110.694 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -110.15 120.7 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.127 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.447 HG21 ' CG2' ' A' ' 104' ' ' VAL . 20.2 t -109.29 145.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.417 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.1 t30 -160.81 105.44 1.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.59 -177.04 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 111.52 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.716 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 6.8 tttt -54.01 95.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.165 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.2 tp -75.55 -25.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -167.4 -173.21 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.37 132.18 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 56.84 33.03 62.72 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -173.94 120.27 0.29 Allowed 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.68 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 4.4 m -149.9 156.09 7.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.663 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -103.42 151.8 22.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.8 p -119.53 143.32 31.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.141 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -128.18 98.5 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.651 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 8.5 p -105.83 157.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.154 0.502 . . . . 0.0 111.785 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -163.35 136.83 5.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.124 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.25 104.3 7.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.304 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.52 -16.08 62.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.207 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -65.23 -34.81 79.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.87 -18.86 21.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.92 156.96 49.24 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HB3' ' CE1' ' A' ' 64' ' ' PHE . 33.3 Cg_endo -64.66 142.05 75.39 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.607 2.205 . . . . 0.0 112.34 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.404 ' HB3' HD12 ' A' ' 118' ' ' LEU . 8.1 mt -54.49 106.92 0.73 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.83 147.69 94.48 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.438 2.092 . . . . 0.0 111.838 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . -101.52 175.47 5.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.183 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 18.61 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.92 -165.75 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.4 t -84.48 104.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 112' ' ' LEU . 2.0 mm? -90.03 -32.81 16.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.977 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.36 131.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HB3' ' CA ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -128.04 159.17 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.81 148.16 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.3 m -110.7 103.67 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.747 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.445 HD22 ' CD1' ' A' ' 72' ' ' TYR . 9.3 mt -90.41 108.81 20.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.885 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 17.7 ttm180 -55.4 112.56 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.711 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -80.1 71.73 6.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.31 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -87.43 -3.93 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 109.588 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.71 123.57 2.46 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.518 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.688 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -49.19 140.79 9.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.579 -178.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -143.37 62.99 1.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.541 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.98 121.61 9.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.485 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.45 18.83 79.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.691 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -68.99 71.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.895 0.378 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.424 ' ND2' HG22 ' A' ' 157' ' ' THR . 1.0 OUTLIER -45.31 132.22 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.025 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.406 ' CD2' ' CD1' ' A' ' 123' ' ' LEU . 5.4 mp -117.87 129.69 55.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.933 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.7 p -108.22 121.06 44.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.939 0.4 . . . . 0.0 111.489 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.65 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.527 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.468 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.4 p -109.98 -164.65 0.94 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.468 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.78 17.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.092 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.71 95.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.88 8.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 111.618 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 66' ' ' TYR . 26.7 m -139.87 -179.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.914 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.27 89.67 0.4 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.425 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . 5.2 p30 -62.07 168.35 3.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.67 22.21 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.904 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.09 -23.42 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 111.337 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.18 -17.9 28.8 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.415 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.3 170.46 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.01 120.47 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 143' ' ' ASP . 45.6 m-70 -92.46 92.71 8.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.91 102.52 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.515 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.36 167.41 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 111.738 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -58.01 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.658 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.1 171.16 40.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.301 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 155' ' ' GLU . 50.9 m -165.2 155.95 14.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.656 0.265 . . . . 0.0 110.77 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 154' ' ' THR . 18.2 pt-20 -118.6 170.14 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 37' ' ' LEU . 1.3 tppt? -143.14 166.22 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' ND2' ' A' ' 133' ' ' ASN . 3.2 p -143.17 120.57 11.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.634 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -114.66 126.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 105.46 17.75 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 14.2 mt -81.07 120.65 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -104.45 131.65 52.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.817 -178.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.74 145.88 38.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.11 -50.61 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 165' ' ' SER . 7.9 t -92.81 -143.44 0.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.082 0.468 . . . . 0.0 110.962 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 164' ' ' THR . 3.0 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.869 0.366 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.71 73.06 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.588 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 t -106.23 91.29 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -134.19 93.04 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -165.15 100.37 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -106.76 -178.03 3.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 60.66 -178.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -60.43 -66.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -162.53 147.76 12.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -133.17 35.45 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 m -104.49 35.35 2.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -151.74 143.95 23.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.23 -68.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.16 -31.38 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -89.43 150.0 43.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -32.23 141.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.551 2.834 . . . . 0.0 113.32 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -176.43 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.09 128.85 1.08 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -71.63 -66.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -115.8 129.65 56.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.4 mtp -88.1 -37.34 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.45 176.4 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 t -156.85 35.57 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -133.44 126.42 31.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.822 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.03 146.18 35.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -119.85 77.53 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER 60.31 167.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.721 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 27' ' ' GLU . . . -123.76 178.17 5.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.31 76.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.03 118.8 36.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 43.3 t -74.48 149.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.487 ' N ' HG11 ' A' ' 31' ' ' VAL . 15.0 t -65.66 -36.21 83.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.907 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 58.53 109.94 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . 7.5 t -155.55 143.19 19.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.567 0.699 . . . . 0.0 111.943 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.95 143.95 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.842 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -100.31 106.38 18.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.613 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' A' ' 154' ' ' THR . 4.3 tp -103.87 119.95 39.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.484 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -139.26 101.4 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.57 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.53 151.37 51.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.413 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.93 -28.05 65.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.339 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.3 mt-10 67.68 23.42 8.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.431 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -164.81 123.9 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 0.0 111.772 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.9 p -144.89 108.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.289 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.433 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.16 127.33 32.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -29.33 131.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.24 -21.48 42.99 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.532 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -97.73 172.33 7.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 110.638 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -112.4 167.73 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.146 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 tp -130.2 153.42 48.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.523 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -135.65 93.45 2.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.92 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 37' ' ' LEU . 7.2 p -104.16 98.1 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.613 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 120' ' ' LYS . . . -89.37 87.05 1.44 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.867 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 8.3 p -78.93 95.18 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.71 -128.82 6.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.634 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.65 128.9 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.053 0.454 . . . . 0.0 111.859 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -97.58 -30.06 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 1.6 mp0 -167.35 135.12 2.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.024 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.53 90.84 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.9 p -115.53 126.97 73.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.975 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 75.7 m-20 104.38 15.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.786 0.834 . . . . 0.0 112.064 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 149' ' ' HIS . . . -141.85 176.35 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.42 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.1 tt0 -129.98 83.17 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.8 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.1 120.73 11.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 4.1 m-85 -120.37 -43.17 2.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.3 118.31 17.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.048 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 1.4 t80 -85.96 137.9 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -147.66 109.85 4.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.455 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 136' ' ' VAL . 14.7 p90 -139.48 171.17 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.417 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -124.19 115.75 21.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.884 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 111.16 21.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.69 104.61 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 111.129 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 38.2 p90 -107.91 -168.44 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.631 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.31 104.72 14.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -67.25 -26.72 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.91 -29.19 62.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.144 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.43 -40.35 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.381 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.21 -176.88 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -165.2 121.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CD1' HG22 ' A' ' 100' ' ' VAL . 26.5 t80 -56.43 150.67 14.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.0 t -132.46 -71.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -172.94 140.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.57 149.57 27.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.118 0.961 . . . . 0.0 111.45 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.7 153.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.511 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.68 -167.01 1.4 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.977 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.26 -158.54 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -95.61 36.92 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.83 -45.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.621 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.66 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.244 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.37 124.19 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.093 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.444 HG21 ' CG2' ' A' ' 104' ' ' VAL . 3.0 t -115.8 136.22 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -148.94 116.57 6.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.07 153.53 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -133.48 107.36 7.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.667 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.613 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 11.4 tmtt? -55.15 95.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.3 tp -84.51 -25.93 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.875 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -166.57 177.62 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.768 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 130.11 40.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 58.78 33.21 72.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.43 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -173.77 118.96 0.28 Allowed 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.613 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 3.5 m -149.84 154.68 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -89.21 152.27 21.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.91 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -128.28 96.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.668 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mt -86.69 102.77 14.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' ' 66' ' ' TYR . 7.9 p -107.3 153.59 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.288 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.5 138.51 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.381 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.1 m -76.47 104.59 7.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.283 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -13.92 62.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.607 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -65.41 -28.46 69.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.85 -23.1 12.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.954 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.68 155.09 45.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 110.546 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -64.93 153.85 76.11 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.587 2.191 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 118' ' ' LEU . 1.8 pp -52.91 132.62 48.75 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 94.1 Cg_endo -88.91 144.99 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.773 2.315 . . . . 0.0 112.209 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . -94.57 170.69 9.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.178 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 32.91 12.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -163.5 158.2 20.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.598 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.8 t -52.96 105.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -85.41 -32.33 22.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.961 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.73 135.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 52' ' ' GLY . 0.3 OUTLIER -126.3 149.58 49.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.675 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.0 t -113.06 154.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.532 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.85 95.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.04 108.31 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 37.3 ttm180 -64.97 117.6 7.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -76.77 72.78 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.505 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -87.96 -3.62 58.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 0.0 109.438 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.39 123.49 2.58 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.407 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.683 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.6 ttmt -48.82 138.02 11.73 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.393 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.412 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -143.66 62.91 1.36 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.575 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.12 116.16 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.404 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.89 19.53 59.35 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.702 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 66.28 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.116 0.484 . . . . 0.0 110.455 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.453 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 1.1 t-20 -42.39 129.73 3.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.421 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.2 150.28 29.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.07 121.45 14.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.0 111.579 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 68' ' ' PHE . 8.9 p -99.71 95.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.599 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.484 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.4 p -100.3 -165.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.789 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.37 19.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.065 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 87.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.933 0.397 . . . . 0.0 110.227 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.38 162.11 13.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.436 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 66' ' ' TYR . 28.5 m -130.32 128.79 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.947 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.77 83.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.694 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 22.8 t70 -57.77 140.8 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.816 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.84 76.08 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.728 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.7 -29.59 66.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.14 15.04 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.746 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.62 115.11 28.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 110.769 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.1 p -73.08 141.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 61' ' ' ALA . 50.9 m80 -104.8 99.0 8.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.87 102.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.43 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.27 -176.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.784 -178.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.907 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -75.83 -161.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.408 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.65 34.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.412 HG23 ' CD2' ' A' ' 37' ' ' LEU . 90.8 m -153.69 146.48 24.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.723 0.297 . . . . 0.0 110.849 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.81 161.96 15.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 111.261 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.411 ' HE2' ' HG ' ' A' ' 37' ' ' LEU . 3.9 tppt? -139.99 169.19 18.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.6 p -142.15 115.93 9.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.592 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.52 126.17 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 105.72 17.91 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 10.2 mt -80.72 122.59 36.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.433 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.13 132.98 51.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.623 -178.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.03 145.21 42.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.154 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.61 -138.4 10.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -179.11 3.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.912 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.67 -121.32 1.15 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t 60.37 35.54 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 0.0 110.972 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.2 p -135.61 179.15 6.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -160.29 124.79 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -118.81 31.6 6.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.52 -50.29 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -65.58 -31.12 71.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 61.9 153.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -132.85 167.15 20.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -104.5 31.79 4.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.5 p -82.26 133.49 35.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.12 -108.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.3 mp 60.3 96.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 m -130.94 152.73 81.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.31 -53.36 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.537 2.825 . . . . 0.0 113.318 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -169.47 116.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.96 -177.86 15.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 m -71.43 129.22 38.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -60.36 157.14 14.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.07 80.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.823 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 122.63 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.3 m -97.24 83.39 3.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -148.47 152.56 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -156.74 146.51 20.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mttm 60.62 84.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.42 168.47 19.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.71 63.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.51 77.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.079 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -112.93 111.62 22.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.662 HG22 ' N ' ' A' ' 60' ' ' ASN . 15.2 t -60.64 151.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -74.52 -46.69 37.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 76.09 112.27 0.12 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.692 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.75 139.16 11.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.0 111.428 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 m -98.93 141.15 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.45 106.38 18.68 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.826 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 154' ' ' THR . 6.2 tp -107.17 106.58 17.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 111.355 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -121.94 118.65 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.412 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.74 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.493 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.82 -27.4 68.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.1 22.89 2.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.414 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.53 128.19 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.995 0.426 . . . . 0.0 112.114 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.4 p -132.52 168.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.735 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tm0? -131.56 118.49 20.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.1 t -28.57 130.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.488 0.661 . . . . 0.0 112.477 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.62 64.49 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.776 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.98 173.73 6.34 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.331 0.252 . . . . 0.0 110.473 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -119.03 131.39 55.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.91 154.99 20.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 93.47 2.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.06 98.17 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' CA ' ' CG ' ' A' ' 120' ' ' LYS . . . -87.75 86.05 1.51 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.89 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 12.5 p -82.18 95.24 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -100.62 -127.63 6.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.981 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.445 HG12 ' CD2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -115.31 130.29 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 111.724 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.94 -39.3 11.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.07 132.79 0.51 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' CD2' HG12 ' A' ' 55' ' ' ILE . 1.3 pp -157.25 113.69 2.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.539 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.562 ' C ' HG22 ' A' ' 31' ' ' VAL . 12.6 p -128.89 100.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' N ' HG22 ' A' ' 31' ' ' VAL . 19.0 m-20 139.57 23.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.404 1.065 . . . . 0.0 111.737 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.67 147.42 6.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.776 0.322 . . . . 0.0 111.213 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -105.22 85.87 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 112.93 2.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 25.3 m-85 -99.77 -32.75 10.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.155 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.94 112.61 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.433 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 35.6 t80 -102.79 130.67 49.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -135.06 119.25 17.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.856 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CD2' ' CG1' ' A' ' 102' ' ' VAL . 24.7 p90 -120.63 155.99 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 103.39 8.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.457 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -77.36 156.13 31.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.348 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -124.0 104.4 8.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 18.6 p90 -118.44 -166.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.65 143.15 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.81 -25.21 15.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.012 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -62.14 -29.42 70.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.039 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.52 -43.92 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.258 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -93.16 169.27 10.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.636 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -159.2 119.71 3.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 23.7 t80 -57.32 153.7 11.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 39.6 t -131.49 -72.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.38 143.94 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.819 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.54 150.78 25.0 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.251 1.024 . . . . 0.0 111.538 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.13 153.39 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.336 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.13 -174.43 2.71 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -159.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.745 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.78 36.64 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.92 -39.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.184 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.18 159.96 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.979 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -115.98 113.05 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 91' ' ' ASN . 2.1 t -104.23 155.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -166.24 110.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.399 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.99 158.14 15.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -145.83 107.15 4.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.713 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 20.4 tttt -55.14 117.03 3.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.312 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.495 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.5 tp -111.22 -23.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.847 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -167.86 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.24 -75.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . -106.22 53.12 0.65 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.408 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -174.21 129.74 0.37 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 14.5 m -149.59 155.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.879 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.5 152.41 20.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.532 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 10.3 p -139.44 122.17 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.878 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.72 108.92 19.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 11.9 p -106.7 148.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.414 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -155.91 136.48 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.44 104.5 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.5 tp -72.42 -12.85 61.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 p -65.27 -30.27 71.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.04 -18.98 18.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.412 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.93 147.87 34.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 51.3 Cg_exo -53.97 -178.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.476 2.117 . . . . 0.0 112.446 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -58.57 123.0 64.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.62 -43.82 24.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.463 2.109 . . . . 0.0 112.129 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 62.34 167.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.17 19.75 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.216 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.44 -168.62 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.439 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.73 104.99 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.419 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -83.63 -34.7 25.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -174.35 132.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 111.297 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.458 ' CG ' ' CA ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -121.59 137.85 54.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.374 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 68.9 t -99.3 135.93 32.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.83 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.6 t -93.47 97.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 72' ' ' TYR . 44.7 mt -92.28 108.42 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 29.5 ttm180 -69.7 116.39 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.02 73.71 4.57 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.252 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -3.6 59.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.544 0.688 . . . . 0.0 109.503 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.88 123.0 2.7 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.121 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.601 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.9 ttpp -44.94 154.12 0.15 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.329 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.47 59.79 0.22 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.917 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 6.8 tt0 -55.81 117.18 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.972 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.55 61.59 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.371 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.3 t -70.5 87.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 110.397 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.99 162.83 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.516 . . . . 0.0 111.401 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -143.91 104.85 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.645 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -100.1 131.3 46.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.645 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 68' ' ' PHE . 26.8 t -111.12 94.69 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.532 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.49 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -99.79 -164.45 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.676 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.23 22.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.021 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.9 m -61.63 100.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 110.436 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 173.17 6.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.4 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.51 -179.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.24 85.46 0.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -55.61 -174.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.09 -38.4 10.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.17 -29.45 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.6 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.655 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.69 170.32 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.23 129.49 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -106.41 91.09 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.0 109.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.413 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.79 -176.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.226 0.536 . . . . 0.0 111.599 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -68.86 -160.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.374 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.62 168.7 34.36 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.365 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 37' ' ' LEU . 88.2 m -155.77 148.12 23.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.786 0.326 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.81 153.27 33.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 1.1 tppp? -135.31 167.03 21.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.238 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.1 p -142.83 134.65 26.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.3 m -125.4 129.96 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.31 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.87 107.27 19.09 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.01 0.433 . . . . 0.0 110.484 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.6 mt -76.79 120.48 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.62 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.445 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.12 128.32 59.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -178.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.74 146.13 37.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.97 176.11 41.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.54 172.45 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.951 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.879 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.62 -174.91 13.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.05 98.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.84 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -107.97 -35.65 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -106.3 164.02 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -165.05 -70.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -144.37 34.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -81.45 -56.3 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -132.59 31.82 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m170 64.09 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -167.02 137.02 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -132.45 102.99 5.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.77 -85.05 1.82 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mt 60.4 32.12 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.82 82.17 26.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -32.34 148.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.532 2.821 . . . . 0.0 113.352 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 60.59 110.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.35 152.24 3.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.0 -52.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -153.88 -53.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.8 ttt -143.93 142.15 30.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.95 109.13 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -143.84 138.02 28.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.67 31.86 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.17 -53.78 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -106.79 154.56 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -168.34 165.71 12.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.5 121.06 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.42 77.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.189 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -119.31 112.4 19.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.8 t -82.64 151.17 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.763 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' GLY . 5.3 t -90.82 -30.99 16.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.51 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 55.31 132.1 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.575 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.443 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.69 159.09 43.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.202 0.525 . . . . 0.0 111.605 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 ' N ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.18 123.56 68.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.271 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -92.24 109.57 20.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.386 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 3.8 mt -97.1 120.74 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -133.49 101.37 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.344 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.63 152.86 39.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.427 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.05 -26.43 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.393 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.9 mt-10 66.56 24.25 10.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.381 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.83 117.22 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.796 0.332 . . . . 0.0 111.598 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.0 p -136.87 107.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.65 128.36 36.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.238 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 125' ' ' ALA . 2.0 t -31.02 132.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-O 121.5 0.667 . . . . 0.0 112.709 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 -24.01 32.98 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.39 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.85 172.47 7.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 0.0 110.631 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.63 151.69 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 50' ' ' GLU . 21.1 tp -104.48 153.4 21.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 3.1 pt-20 -136.75 93.29 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 110.649 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 37' ' ' LEU . 7.2 p -107.01 97.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.795 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.41 ' CA ' ' CG ' ' A' ' 120' ' ' LYS . . . -82.02 82.59 1.59 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.623 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.432 HG13 ' CE1' ' A' ' 68' ' ' PHE . 9.7 p -78.63 95.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.761 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.29 -134.71 8.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.69 136.44 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.83 -36.34 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.57 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 177.15 131.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.436 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.09 103.49 4.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.764 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.4 p -94.76 110.18 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.562 ' C ' HG22 ' A' ' 31' ' ' VAL . 69.3 m-20 98.68 26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.435 0.694 . . . . 0.0 112.333 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.9 150.2 48.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.227 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -128.78 66.29 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.112 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' CB ' ' HB ' ' A' ' 141' ' ' VAL . . . -62.49 144.08 56.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.049 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 111' ' ' PRO . 17.6 m-85 -120.23 -35.38 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.51 112.68 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 68' ' ' PHE . 41.6 t80 -86.16 148.27 25.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.991 0.425 . . . . 0.0 111.458 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -147.67 111.27 4.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' ' CG1' ' A' ' 102' ' ' VAL . 16.5 p90 -122.97 156.16 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 111.557 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.19 103.15 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.418 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -77.09 156.05 31.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -126.8 104.49 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 18.7 p90 -118.3 -167.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.4 113.59 21.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -27.98 65.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.08 -46.65 86.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.035 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' CB ' ' CB ' ' A' ' 129' ' ' ALA . . . -109.59 20.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -164.33 -179.69 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -171.56 113.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.706 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 92' ' ' ALA . 25.1 t80 -51.01 149.27 3.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.0 t -129.1 -82.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.01 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -156.17 134.8 11.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.76 151.2 26.25 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.12 0.962 . . . . 0.0 111.478 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -126.97 158.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.421 -177.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 1.8 t -121.21 -164.68 1.15 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.794 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -93.0 -157.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.754 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.5 37.67 1.12 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.93 0.395 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.12 -39.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 29.5 t -87.05 154.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.639 0.257 . . . . 0.0 110.773 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.91 121.41 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 84' ' ' SER . 5.2 t -109.11 155.23 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -162.78 110.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.86 156.21 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.39 107.09 5.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.229 0.538 . . . . 0.0 111.536 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.1 tttm -54.71 96.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.477 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -84.83 -22.76 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.589 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -166.76 2.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . -99.28 52.41 1.08 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.364 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -174.19 126.14 0.34 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.5 m -148.71 155.03 9.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.698 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -97.24 152.49 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.3 p -133.47 121.97 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.139 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.85 98.97 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 88' ' ' VAL . 7.7 p -98.31 149.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.33 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 p -151.61 135.54 16.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.421 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.21 111.56 12.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.912 0.386 . . . . 0.0 111.309 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.28 29.68 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.006 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -106.79 -29.71 9.37 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.988 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.95 -20.8 14.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.166 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -97.39 155.83 36.89 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 56.4 Cg_endo -70.51 173.61 11.38 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.545 2.163 . . . . 0.0 112.446 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.412 ' CD2' ' HB2' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.27 109.23 1.53 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.26 -22.33 73.97 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.397 2.065 . . . . 0.0 112.147 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 55.97 177.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.876 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.52 25.78 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.634 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -159.31 155.85 27.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 t -45.62 104.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -31.13 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -174.3 134.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.123 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -126.58 116.76 21.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.404 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 76.1 t -86.99 111.18 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.65 111.24 11.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.026 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.434 HD23 ' CD1' ' A' ' 72' ' ' TYR . 35.8 mt -92.9 169.28 10.57 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.426 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 8.6 ttm180 -116.44 123.39 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . . . -88.72 72.12 8.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.341 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.03 -6.68 57.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 109.706 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.87 123.62 2.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.739 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.628 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.8 ttmt -44.46 162.37 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.517 -1.219 . . . . 0.0 112.349 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -177.84 61.67 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.79 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 5.4 tt0 -55.27 111.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 23.26 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.138 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.31 65.96 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.895 0.379 . . . . 0.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -44.86 132.88 6.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.161 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.74 134.61 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.951 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 p -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.888 0.375 . . . . 0.0 111.405 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.7 m -107.16 94.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.814 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.2 p -99.7 -164.11 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.547 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 40.54 25.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.9 p -68.56 93.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.62 170.17 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.3 m -129.32 179.87 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.989 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.56 64.06 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.452 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.48 138.67 45.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.78 58.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.612 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -56.49 -28.1 58.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.6 -1.24 36.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.852 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.62 131.62 56.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.9 t -76.88 123.93 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.05 92.0 5.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.623 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.54 107.28 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.659 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -84.39 169.01 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.263 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -57.48 -153.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.723 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.41 165.48 31.91 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.224 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.437 ' N ' HG21 ' A' ' 35' ' ' VAL . 36.8 m -161.03 147.33 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.734 0.302 . . . . 0.0 110.647 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.9 173.82 6.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 3.8 tppt? -144.72 168.69 19.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.081 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 133' ' ' ASN . 1.9 p -142.43 115.66 8.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.04 127.38 68.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -97.49 105.79 18.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.628 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 14.9 mt -83.92 116.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.397 0.617 . . . . 0.0 109.748 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.5 143.47 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.677 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.75 146.36 54.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.898 0.38 . . . . 0.0 110.924 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.6 3.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.48 175.91 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.914 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.9 -62.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.52 87.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m 60.36 35.16 20.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -159.1 154.45 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.981 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 60.47 171.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 64.15 -78.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -98.42 96.19 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.9 m170 60.37 108.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -112.59 169.1 9.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -99.29 91.43 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.38 -78.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.99 46.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.394 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.2 -31.61 55.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.15 82.17 48.66 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -32.31 -44.55 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.654 2.903 . . . . 0.0 113.285 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -97.06 -53.97 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 -53.19 4.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 m -65.85 -51.15 61.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -138.9 160.16 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.67 155.69 17.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.09 108.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -113.95 31.65 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -62.51 141.68 58.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -67.86 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -177.62 38.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -109.09 163.38 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.17 98.24 4.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.17 77.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.989 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -101.83 115.85 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.583 HG22 ' C ' ' A' ' 59' ' ' VAL . 29.6 t -61.06 155.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.0 t -78.73 -47.15 17.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.834 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 72.03 113.12 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.672 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.5 m -156.57 138.42 14.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.455 0.645 . . . . 0.0 111.507 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 19.8 m -91.48 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 1.8 t -90.95 134.29 34.6 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.183 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -110.73 118.69 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -140.7 116.94 10.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.48 144.29 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.672 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.05 -27.0 66.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.055 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 4.8 mt-10 73.17 21.86 3.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.691 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' N ' HG13 ' A' ' 158' ' ' VAL . 1.7 tm-20 -165.15 127.66 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 160' ' ' ILE . 2.9 p -146.16 107.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.353 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -65.4 123.93 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -28.91 130.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.629 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.1 -23.05 24.12 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -107.9 174.97 5.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 110.413 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -128.78 148.25 50.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.59 128.19 51.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.619 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 3.4 pt-20 -101.43 131.34 47.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.384 . . . . 0.0 111.19 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 11.1 t -108.4 97.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -70.19 62.09 0.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.102 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.2 p -81.17 112.45 19.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.291 . . . . 0.0 110.396 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 66' ' ' TYR . . . -126.61 -91.24 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.618 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.65 134.86 51.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.075 0.464 . . . . 0.0 111.985 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -102.64 -38.93 7.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' N ' ' HB2' ' A' ' 34' ' ' SER . 77.2 mm-40 -159.35 129.0 5.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.006 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -153.19 90.84 1.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.729 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.583 ' C ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -121.45 110.74 28.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.561 ' N ' HG22 ' A' ' 31' ' ' VAL . 72.6 m-20 127.6 17.92 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.499 1.119 . . . . 0.0 111.493 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . . . -157.79 -178.04 7.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.966 0.413 . . . . 0.0 111.078 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -137.0 76.57 1.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.589 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.9 111.93 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.511 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 111' ' ' PRO . 11.3 m-85 -89.37 -34.4 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.048 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.03 112.35 8.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.36 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 68' ' ' PHE . 11.3 t80 -98.68 94.12 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 0.0 110.918 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -100.5 135.94 41.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 66' ' ' TYR . 47.0 p90 -140.97 171.21 14.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.238 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.29 91.2 3.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.635 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.2 tt -77.03 152.96 34.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.108 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -131.41 155.93 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.461 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 21.0 p90 -155.55 -169.34 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.67 140.89 28.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -105.84 -13.75 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -96.26 25.81 4.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . . . -170.6 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.905 0.384 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 2.1 m-85 -93.3 -176.89 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -170.85 111.84 0.38 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.46 ' CD1' HG22 ' A' ' 100' ' ' VAL . 18.2 t80 -50.14 152.83 1.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 66.9 t -131.04 -78.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.61 143.2 8.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.864 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.23 26.95 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-O 122.04 0.924 . . . . 0.0 111.439 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -140.35 151.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.268 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -129.6 -176.17 3.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.077 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -160.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.88 23.49 4.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.59 -44.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.906 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.05 143.27 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.687 0.28 . . . . 0.0 110.626 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -117.23 109.41 16.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.412 HG21 ' CA ' ' A' ' 104' ' ' VAL . 7.1 p -102.18 144.13 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.918 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.18 124.81 29.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -98.06 161.27 13.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.682 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.21 107.05 5.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 111.719 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.649 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.28 95.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.08 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -83.91 -30.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.882 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.18 -168.38 2.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.407 ' HB3' ' CB ' ' A' ' 74' ' ' GLU . 4.6 m-20 -84.31 130.07 34.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.34 31.67 70.48 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.345 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -173.75 122.08 0.33 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.649 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 6.3 m -149.89 154.7 8.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.731 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -85.75 152.26 23.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.184 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 9.2 p -125.48 136.99 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.308 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 mt -123.79 109.69 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 111.087 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 11.7 p -109.86 147.32 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 112.018 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 p -164.78 135.44 4.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.029 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m -73.68 104.18 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.66 -17.56 63.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.182 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -65.36 -32.91 74.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.02 -17.11 20.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.91 155.29 37.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.653 0.264 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HG3' ' CE2' ' A' ' 64' ' ' PHE . 37.4 Cg_exo -60.13 164.85 11.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.558 2.172 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.82 113.65 7.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.64 -20.88 67.03 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.3 2.0 . . . . 0.0 112.282 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 62.93 173.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.79 24.28 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -142.21 -164.34 1.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.323 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -91.49 104.63 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.421 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 3.1 mm? -91.97 -33.65 14.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -157.72 136.76 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.5 ' O ' HG13 ' A' ' 83' ' ' ILE . 2.2 mtpt -135.16 100.71 4.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.271 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.84 114.36 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.1 m -87.19 108.05 17.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.198 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD11 ' CE2' ' A' ' 72' ' ' TYR . 2.8 mm? -85.57 108.44 17.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 20.3 ttm180 -55.54 117.09 3.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -84.59 69.39 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.217 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -87.55 -3.93 58.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.58 123.71 2.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.544 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.2 ttpt -42.63 155.13 0.05 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.325 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . . . -168.56 58.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.799 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 7.3 pt-20 -55.73 111.65 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.224 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.5 -12.65 39.47 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.519 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 t -54.65 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 2.1 p-10 -83.6 138.66 33.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.261 0.553 . . . . 0.0 112.19 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 123' ' ' LEU . 4.7 mp -110.77 132.14 54.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.615 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.4 126.5 46.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.019 0.438 . . . . 0.0 111.65 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.424 HG13 ' CE2' ' A' ' 68' ' ' PHE . 22.5 m -101.51 94.72 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.665 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 20.9 p -100.63 -169.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.695 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.72 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.928 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER -64.98 105.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 0.0 110.607 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -178.47 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.293 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 149' ' ' HIS . 4.0 m -141.45 -179.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.67 81.82 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.956 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 27.6 t0 -45.92 160.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 111.271 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.05 97.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -66.52 -31.34 72.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.317 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.04 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.39 168.89 2.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 56.6 t -123.99 141.56 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.574 ' CD2' HG22 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -114.14 94.23 4.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -46.97 104.62 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.743 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.444 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -85.71 -176.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -72.5 -158.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.28 168.85 35.99 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.231 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.413 HG23 ' HG ' ' A' ' 37' ' ' LEU . 44.4 m -164.7 163.95 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 110.662 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 154' ' ' THR . 15.9 pt-20 -134.64 177.44 7.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.169 0.509 . . . . 0.0 111.692 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HB2' HD13 ' A' ' 37' ' ' LEU . 10.3 tppt? -146.59 169.74 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 0.6 OUTLIER -141.64 115.9 9.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.42 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -104.61 137.94 31.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.226 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.77 105.38 15.58 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.571 179.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 12.6 mt -83.63 121.44 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 121.305 0.574 . . . . 0.0 109.621 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.498 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -104.24 148.8 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.396 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.71 145.66 48.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.902 0.382 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.73 -174.38 33.5 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.57 -176.93 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.332 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.871 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.856 0.36 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.42 -35.33 2.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.01 -70.21 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -80.87 112.58 18.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -123.13 31.99 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.816 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -176.61 92.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -91.32 141.97 28.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -108.99 36.04 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 62.47 118.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.0 m80 60.93 159.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -130.8 -73.91 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -127.97 -74.61 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.69 117.47 0.45 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.72 -36.27 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -128.53 83.45 66.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -32.29 -59.51 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.614 2.876 . . . . 0.0 113.285 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.07 173.2 7.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.1 69.15 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.6 m -132.38 172.18 12.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.802 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -82.71 -60.21 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.71 142.0 28.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.47 36.51 2.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.3 m -155.19 147.75 24.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.7 -67.38 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.62 155.9 38.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.92 106.52 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -158.0 178.64 9.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.02 30.91 20.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.34 77.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -94.83 101.43 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 ' N ' ' A' ' 60' ' ' ASN . 23.7 t -60.65 155.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.404 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 8.7 t -81.47 -46.04 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.759 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 74.43 117.4 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.301 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' GLU . 7.6 t -163.48 136.77 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.19 0.519 . . . . 0.0 111.465 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.5 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.631 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -91.55 106.3 18.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.089 178.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 6.4 tp -112.35 116.86 31.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -140.35 108.48 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.279 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.6 161.95 35.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.563 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.373 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 69.24 24.87 5.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.703 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' HG11 ' A' ' 158' ' ' VAL . 28.3 tt0 -164.71 125.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.6 p -147.6 107.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.343 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -67.92 126.32 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.131 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.45 127.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.81 12.85 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.628 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -175.63 2.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.87 148.61 52.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 pp -97.01 159.93 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.26 93.57 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.439 ' CG2' ' CD1' ' A' ' 37' ' ' LEU . 8.3 p -102.37 98.16 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -84.35 79.94 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.559 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.6 p -78.46 102.92 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.96 -130.12 5.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.096 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.36 127.42 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.624 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -96.81 -37.06 10.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' SER . 22.4 mp0 -162.09 130.77 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.169 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.6 tt -158.86 91.05 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.636 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' C ' HG22 ' A' ' 31' ' ' VAL . 13.4 p -118.65 104.25 15.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.603 ' N ' HG22 ' A' ' 31' ' ' VAL . 34.3 m-20 134.0 23.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 111.519 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . . . -152.68 -170.9 3.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.642 0.258 . . . . 0.0 110.75 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -139.7 82.21 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.36 . . . . 0.0 110.661 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 121.19 12.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.276 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.424 ' CD1' ' HA2' ' A' ' 144' ' ' GLY . 3.7 m-85 -117.8 -40.68 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.2 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -86.07 135.7 33.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.388 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.71 109.62 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CZ ' ' CG1' ' A' ' 53' ' ' VAL . 12.2 p90 -124.82 171.24 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.54 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 104.58 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.512 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 tt -77.11 153.48 34.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -127.56 107.35 9.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.7 p90 -122.67 -168.54 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.04 139.97 37.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.071 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -24.66 15.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.15 -28.27 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -120.76 -44.68 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.316 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 1.5 m-85 -93.31 -178.38 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 3.2 tt0 -171.61 115.66 0.39 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.292 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CD1' HG22 ' A' ' 100' ' ' VAL . 36.5 t80 -46.49 134.49 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.488 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 33.6 t -106.41 -81.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -162.14 137.73 7.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.65 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.57 146.28 29.26 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.987 0.899 . . . . 0.0 111.342 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.62 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.444 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.44 163.65 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.916 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.92 -160.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.9 37.56 1.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.816 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.1 -40.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.015 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.9 m -86.95 169.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 0.0 110.918 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.83 144.47 45.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 t -141.86 140.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -156.97 107.8 2.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.31 178.25 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -154.39 110.93 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.667 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.9 tttm -53.99 95.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.181 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 100' ' ' VAL . 7.1 tp -78.51 -24.52 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.727 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.74 -166.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.751 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.9 132.97 34.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.91 29.85 65.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.423 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 122.17 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.667 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 6.4 m -149.3 155.12 8.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.722 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -92.71 151.75 19.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.969 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 4.0 p -127.51 137.14 58.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.862 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -119.79 102.86 8.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.406 HG13 ' CB ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -108.03 155.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.058 0.456 . . . . 0.0 111.424 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 p -164.41 137.16 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 m -75.81 104.83 6.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.977 0.418 . . . . 0.0 111.297 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -93.29 26.32 2.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.114 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.4 p -99.02 -31.49 11.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.995 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.37 5.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.144 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.28 158.21 32.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.692 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -65.38 -175.72 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.548 2.165 . . . . 0.0 112.473 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -54.87 114.6 7.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.44 -38.87 31.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.052 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 65.61 168.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.4 16.14 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.071 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.42 -166.81 2.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.338 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -78.45 105.07 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.796 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.432 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -86.58 -31.17 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -169.15 135.52 1.7 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.874 0.368 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' HG2' ' CA ' ' A' ' 52' ' ' GLY . 4.2 mtmt -124.92 112.34 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.595 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -99.8 96.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.43 119.87 24.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.03 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 3.1 mm? -87.01 169.36 12.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.6 tpm_? -106.57 119.35 39.05 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.94 68.13 8.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.452 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.83 -6.42 58.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.47 124.06 2.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.714 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.64 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.3 ttpp -40.74 158.01 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.373 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.61 58.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.743 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.2 pm0 -55.66 117.18 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.221 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 20.93 51.01 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.478 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.0 t -71.15 65.54 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.046 0.451 . . . . 0.0 110.309 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.22 131.71 4.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.517 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.08 150.15 31.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.49 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -133.95 125.88 29.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 111.618 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.46 94.77 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.683 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.489 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -101.66 -159.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.67 22.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -62.51 82.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.15 141.08 46.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.093 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.35 150.69 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 99.61 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.895 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 27.1 t0 -50.37 161.99 0.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 110.961 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 64' ' ' PHE . . . -59.49 -45.05 96.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.547 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.15 -31.17 72.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.42 -28.22 3.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.44 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.72 168.74 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.92 148.33 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 38.4 m-70 -125.5 91.06 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.2 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.8 104.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.113 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.507 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 -177.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.328 0.585 . . . . 0.0 112.079 -178.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -60.89 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.349 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.93 176.73 34.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.413 HG22 ' CB ' ' A' ' 37' ' ' LEU . 51.5 m -164.96 145.47 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.554 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.422 ' O ' HD22 ' A' ' 37' ' ' LEU . 9.9 pt-20 -107.07 163.43 13.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.166 0.508 . . . . 0.0 111.7 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.476 ' HD2' ' CG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.5 164.06 28.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.592 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.446 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.3 p -142.71 115.42 8.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.29 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -113.02 128.8 69.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 111.227 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.27 105.69 17.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.712 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 15.4 mt -83.22 115.96 26.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.479 0.657 . . . . 0.0 109.717 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.424 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.78 141.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.65 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.11 146.07 55.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.018 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.3 -147.13 7.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.435 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -50.36 177.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.048 0.451 . . . . 0.0 111.389 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.492 ' N ' ' OG1' ' A' ' 164' ' ' THR . 14.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.922 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.835 0.35 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.73 43.4 1.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.11 166.18 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 m -131.98 178.31 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -98.6 34.11 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.25 -39.46 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 60.36 89.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -132.4 -177.98 4.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -126.85 98.33 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -131.5 -46.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.35 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.95 -70.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.64 -110.12 0.68 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.32 81.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.949 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.72 88.42 4.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.47 145.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.57 2.847 . . . . 0.0 113.203 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 60.76 31.21 20.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.25 93.02 0.88 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.459 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -138.59 147.14 42.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.907 0.384 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -40.04 14.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 ttm 60.53 171.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.72 -169.66 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.43 -68.33 0.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -83.18 147.32 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.817 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.72 -70.5 0.7 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 179.95 -53.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.31 178.79 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.91 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.6 77.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -96.04 126.21 41.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.629 HG22 ' C ' ' A' ' 59' ' ' VAL . 4.2 t -76.16 151.68 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -69.21 -47.97 63.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.765 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 77.91 107.22 0.18 Allowed Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.064 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.0 t -166.11 136.2 3.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.45 0.643 . . . . 0.0 111.762 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' CG2' ' HA2' ' A' ' 153' ' ' GLY . 27.4 m -95.66 144.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.504 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 t -105.54 111.5 24.23 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.586 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.409 HD23 ' HB ' ' A' ' 53' ' ' VAL . 3.6 mt -97.25 125.53 41.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.044 0.449 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.16 101.38 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.308 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.92 152.28 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.485 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.64 -29.11 67.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.236 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.49 24.93 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.455 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' HG11 ' A' ' 158' ' ' VAL . 20.1 tt0 -164.68 128.08 2.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.859 0.361 . . . . 0.0 111.925 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.6 p -148.4 107.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.259 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tt0 -68.32 128.13 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.036 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.86 132.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.14 -21.85 38.51 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.96 173.45 6.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.56 167.34 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' A' ' 77' ' ' PHE . 3.7 pp -125.41 160.72 28.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -136.67 110.19 7.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.964 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 12.7 t -109.61 97.67 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.981 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -76.78 68.15 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.636 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CG1' ' CZ ' ' A' ' 68' ' ' PHE . 10.3 p -78.19 95.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.18 -122.49 4.6 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.98 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.54 130.81 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 112.138 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -101.72 -32.8 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB2' ' CB ' ' A' ' 34' ' ' SER . 36.4 mt-10 -157.2 128.66 6.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.418 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.429 ' CD1' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -161.22 90.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.92 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.629 ' C ' HG22 ' A' ' 31' ' ' VAL . 13.9 p -125.57 106.02 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.608 ' N ' HG22 ' A' ' 31' ' ' VAL . 1.2 m120 131.5 18.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.462 1.101 . . . . 0.0 111.418 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . . . -148.43 -179.41 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.945 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -126.4 77.16 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.936 0.398 . . . . 0.0 110.58 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.404 ' HA ' ' CG2' ' A' ' 141' ' ' VAL . . . -62.47 112.1 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.6 m-85 -115.72 -59.88 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.802 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.23 112.62 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.433 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 1.5 t80 -86.16 138.65 31.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -147.55 110.27 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.265 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CZ ' ' CG1' ' A' ' 53' ' ' VAL . 12.9 p90 -137.69 171.55 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -131.99 106.09 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.656 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.408 ' CD1' HG11 ' A' ' 121' ' ' VAL . 1.3 mt -77.29 157.19 30.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.825 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -121.62 104.37 9.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.97 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.9 p90 -114.95 -167.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.05 132.38 54.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.38 -28.02 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -60.24 -30.28 69.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.981 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.83 -46.26 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 1.4 m-85 -93.34 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.751 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -165.29 113.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.773 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CG ' HG22 ' A' ' 100' ' ' VAL . 20.0 t80 -46.68 155.91 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -137.73 -81.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -152.42 131.64 12.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.007 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.06 149.54 26.86 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.304 1.049 . . . . 0.0 111.774 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -133.4 174.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.073 -177.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -168.33 2.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.811 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.91 -161.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.17 37.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.816 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 -37.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.1 t -86.71 143.86 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -106.27 107.08 17.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 111.005 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -105.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -143.43 117.9 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.349 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.72 173.01 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.946 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.22 107.33 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.443 . . . . 0.0 111.697 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.686 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.5 tttp -54.77 115.19 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.271 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.6 tp -111.5 -22.37 5.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.919 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.79 -166.84 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.58 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -101.42 50.84 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.591 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.61 129.83 0.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 17.4 m -150.1 155.2 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -80.94 152.05 28.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.352 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 8.9 p -134.13 110.7 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.403 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 mt -88.54 114.34 25.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.907 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 13.4 t -107.43 137.73 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.508 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -164.27 136.21 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.392 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.37 104.49 15.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.211 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.85 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.3 p -65.34 -34.76 79.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.84 -19.76 30.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.382 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.33 154.64 71.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 55.6 Cg_endo -70.42 157.99 57.43 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.658 2.239 . . . . 0.0 112.364 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.5 mt -59.9 111.1 3.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.89 -21.35 73.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.395 2.064 . . . . 0.0 112.26 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 65.1 175.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.602 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.72 24.27 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 110.383 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.81 -166.62 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.201 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.9 104.69 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.42 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.7 mm? -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -160.05 135.23 8.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.843 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 83' ' ' ILE . 10.3 mtpt -128.22 100.87 6.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.034 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 70' ' ' LEU . 11.8 p -81.29 107.02 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 110.268 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 23.0 t -75.69 106.9 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.037 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 72' ' ' TYR . 12.1 mt -89.99 169.22 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 5.5 ttm180 -114.38 122.99 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -91.57 68.96 5.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.294 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.51 -5.68 58.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.413 0.625 . . . . 0.0 109.529 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.03 123.83 2.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.49 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.64 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.3 ttmt -41.59 159.94 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.272 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.415 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -174.98 57.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.017 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.3 mt-10 -56.18 113.39 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.097 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.31 46.97 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.544 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.5 m -61.06 86.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.936 0.398 . . . . 0.0 110.235 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -58.67 171.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.654 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -146.84 108.72 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.116 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.4 p -97.46 122.58 40.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.439 . . . . 0.0 111.407 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.447 ' CG2' ' CD1' ' A' ' 68' ' ' PHE . 7.2 p -107.48 95.16 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.457 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.4 p -102.45 -166.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.573 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.91 20.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 m -61.88 88.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.55 166.33 11.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.486 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 63' ' ' ALA . 13.2 p -140.33 159.95 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.982 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -97.36 91.39 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.648 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -48.61 161.46 0.13 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.37 78.39 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.12 -30.47 65.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.49 -26.85 4.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.595 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.3 mt -68.39 169.98 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.66 148.22 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 61' ' ' ALA . 73.8 m80 -119.22 90.85 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -49.98 102.03 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.449 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -89.38 -176.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.325 0.583 . . . . 0.0 111.659 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 33' ' ' GLY . . . -70.62 -158.08 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.417 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -161.2 171.73 37.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.034 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 155' ' ' GLU . 55.1 m -158.85 146.52 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.425 ' N ' HG23 ' A' ' 154' ' ' THR . 11.1 tt0 -107.97 151.79 25.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.033 0.444 . . . . 0.0 111.413 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 134' ' ' LEU . 6.5 tppt? -128.97 167.49 17.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.975 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.17 126.21 16.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.11 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.413 HG21 ' CZ ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -113.3 131.6 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.14 106.45 18.75 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.833 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 11.4 mt -85.44 116.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.384 0.612 . . . . 0.0 109.922 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.01 146.21 8.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.556 -178.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.98 145.91 54.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.84 -171.44 45.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -176.81 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.301 . . . . 0.0 110.894 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.941 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.74 102.46 0.31 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.53 110.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.309 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.35 -177.99 3.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -100.07 -38.94 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.06 111.5 4.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -96.85 175.96 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.6 m80 60.61 81.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.14 176.78 9.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -100.43 137.44 38.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.19 -57.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.3 m -74.81 -63.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.48 59.53 1.62 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 110.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 110.847 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.39 136.02 60.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.026 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -32.36 109.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.477 2.784 . . . . 0.0 113.221 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.56 -71.59 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.51 60.25 1.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.509 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -141.99 83.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -147.38 151.05 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.9 mtm -148.79 -68.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.04 -73.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.8 p -152.54 168.24 26.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.51 150.29 24.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.0 115.6 30.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -176.56 -40.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -156.5 -176.89 6.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -127.67 80.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.75 62.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -111.32 112.48 24.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.662 HG22 ' N ' ' A' ' 60' ' ' ASN . 13.1 t -60.54 147.76 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -70.89 -45.54 64.19 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 73.51 109.43 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.583 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.524 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -159.49 138.71 11.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.603 0.716 . . . . 0.0 111.754 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 21.3 m -98.26 141.52 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 21.3 p -100.6 111.01 23.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.14 126.48 42.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.081 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 101.55 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.93 151.32 35.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -61.47 -28.3 69.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.7 mt-10 72.92 24.31 2.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.605 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -164.81 128.37 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.849 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 43' ' ' VAL . 4.1 p -144.58 108.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.394 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.25 125.25 26.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.038 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -28.86 130.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.01 -15.0 52.09 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.753 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.34 171.36 7.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.736 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -106.63 167.81 9.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -120.2 150.99 39.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.63 93.28 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.493 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 120' ' ' LYS . 27.3 m -106.88 97.06 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.103 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -76.91 76.36 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.659 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CG1' ' CD2' ' A' ' 68' ' ' PHE . 12.5 p -78.54 95.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -105.79 -129.79 6.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.828 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.72 132.01 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 111.69 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 5.1 t0 -97.84 -31.43 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.122 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -178.17 133.4 0.15 Allowed 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.485 0.66 . . . . 0.0 111.894 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' CD2' HG12 ' A' ' 55' ' ' ILE . 1.3 pp -159.41 115.52 2.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.634 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.566 ' C ' HG22 ' A' ' 31' ' ' VAL . 13.8 p -133.53 102.38 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' N ' HG22 ' A' ' 31' ' ' VAL . 22.4 m-20 138.37 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.384 1.053 . . . . 0.0 111.914 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -160.3 174.44 14.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.33 87.02 2.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.84 112.67 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.446 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -103.6 -35.3 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.129 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.49 112.38 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.348 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 68' ' ' PHE . 67.2 t80 -99.11 152.02 20.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.19 116.94 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.891 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 5.7 p90 -117.8 140.18 50.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.081 0.467 . . . . 0.0 111.459 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 94.17 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -80.02 139.68 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -111.65 104.36 12.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 38.9 p90 -100.16 -170.79 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.75 126.15 42.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.192 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -85.45 -17.26 37.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.021 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -96.47 29.21 2.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.868 0.366 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.86 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CZ ' HD12 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.25 170.52 9.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -153.11 109.09 3.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 14.4 t80 -53.23 143.72 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 41.5 t -123.09 -72.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.33 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.69 142.71 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . . . -82.94 153.62 24.95 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 122.125 0.965 . . . . 0.0 111.655 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.84 152.68 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.455 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.91 -173.22 2.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.761 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.92 -158.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -93.5 37.41 1.06 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.6 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.315 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.74 157.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.04 102.99 10.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.65 120.76 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -134.14 118.38 17.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.23 0.538 . . . . 0.0 111.526 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.94 146.79 24.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.013 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -132.44 106.81 8.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.399 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.657 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 12.2 tttp -55.47 95.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -81.34 -30.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.809 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.32 -168.02 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.62 128.83 34.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 59.12 33.23 73.75 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.549 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' C ' ' CG1' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -173.71 121.41 0.32 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.657 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 3.9 m -149.71 155.58 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.643 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -96.94 152.46 18.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.986 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.5 p -128.67 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.968 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.08 108.16 14.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 11.8 p -108.47 137.55 39.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.09 0.472 . . . . 0.0 111.042 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.8 p -161.83 135.86 6.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -78.91 104.42 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.39 -13.01 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.0 p -65.21 -27.17 68.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.34 -20.74 12.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.35 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.44 142.34 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.625 0.25 . . . . 0.0 110.661 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 50.7 Cg_exo -54.0 150.91 29.13 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.446 2.097 . . . . 0.0 112.358 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -56.3 128.61 73.38 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.714 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 13.0 Cg_exo -69.9 -159.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.541 2.161 . . . . 0.0 112.318 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.91 166.87 32.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 14.7 9.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.85 -165.79 1.8 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.078 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.78 104.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -86.83 -34.95 19.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.404 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -166.81 131.87 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 3.8 mtpt -117.05 120.92 39.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.497 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.6 p -88.85 142.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.4 t -113.7 117.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 72' ' ' TYR . 2.5 mt -115.79 108.52 16.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.49 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 26.6 ttm180 -64.18 115.25 4.81 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -74.27 74.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.378 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.34 -4.28 59.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.486 0.66 . . . . 0.0 109.452 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.72 123.48 2.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.352 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.675 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 16.9 ttmt -47.59 139.96 6.53 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.365 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -146.16 62.25 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.852 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.34 112.9 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.92 49.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.607 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.71 66.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.327 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.44 ' HA ' HG22 ' A' ' 157' ' ' THR . 1.0 OUTLIER -43.38 133.28 4.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.301 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.82 116.0 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.841 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 p -109.76 128.65 55.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.598 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 m -106.13 94.96 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.718 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.458 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 p -97.27 -163.78 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.64 21.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.959 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.6 m -59.06 101.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 165.28 12.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.72 125.48 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.013 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.21 100.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.584 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.15 161.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -28.18 72.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.71 -34.8 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.54 2.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.5 mt -72.89 161.24 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.45 136.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.102 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 78.1 m80 -109.74 90.67 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -51.08 107.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.467 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.39 177.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.612 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 33' ' ' GLY . . . -62.36 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.974 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.13 168.56 41.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.399 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 35' ' ' VAL . 65.4 m -156.21 146.83 21.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.4 ' N ' HG23 ' A' ' 154' ' ' THR . 0.7 OUTLIER -112.2 167.77 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 111.435 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 2.9 tppt? -139.57 168.8 19.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.246 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 133' ' ' ASN . 4.3 p -142.32 115.83 9.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.742 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.53 126.67 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.05 105.88 18.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.789 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 12.4 mt -78.76 122.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.02 131.2 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.594 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.18 145.02 44.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.043 0.449 . . . . 0.0 111.214 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.54 -140.82 5.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.97 178.74 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.847 -179.978 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtm . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 97.68 1.02 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -169.35 110.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -84.92 126.43 33.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -96.79 -31.61 12.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -171.35 133.32 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -98.97 34.02 2.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -90.77 -33.88 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.31 112.68 9.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -64.97 148.7 51.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.6 t -105.92 170.8 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 -31.38 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.78 -84.23 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.87 100.43 3.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.53 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 21.4 t -58.84 -52.68 73.07 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.53 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 71.3 Cg_exo -32.29 144.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.292 2.661 . . . . 0.0 113.397 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -31.07 23.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.75 23.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.467 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 m -61.08 -36.31 79.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -106.19 141.87 36.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.1 mtt -79.62 -57.3 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.38 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m 60.6 97.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.67 31.18 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.82 174.0 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -73.89 -39.29 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.27 164.72 29.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.0 31.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.66 37.62 22.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.37 106.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.976 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 25.2 t -82.02 146.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.466 ' N ' HG11 ' A' ' 31' ' ' VAL . 12.3 t -66.82 -35.14 79.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 56.18 108.19 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.035 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.463 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 22.6 t -153.43 138.82 17.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.707 0.765 . . . . 0.0 111.977 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 154' ' ' THR . 34.1 m -91.02 145.3 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.247 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 t -104.9 107.57 18.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.492 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 154' ' ' THR . 6.8 mt -96.8 111.6 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.173 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -140.18 101.47 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.0 158.45 43.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -56.86 -23.45 44.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 65.62 23.02 11.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.444 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.87 128.26 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 0.0 111.854 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.455 HG11 HG12 ' A' ' 160' ' ' ILE . 3.1 p -143.14 108.78 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.192 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -71.59 126.5 29.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.612 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.1 t -29.08 133.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.477 0.656 . . . . 0.0 112.723 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.12 -26.88 22.53 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.126 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -90.02 172.65 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 5.8 m120 -110.31 137.44 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.02 149.92 21.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -136.21 101.66 4.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.32 97.96 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.62 67.62 2.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.607 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' SER . 8.5 p -78.4 95.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.005 0.431 . . . . 0.0 110.515 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.06 -120.07 4.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.107 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -116.92 133.4 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.015 0.435 . . . . 0.0 111.993 -179.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.49 -37.89 8.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.5 mt-10 -155.62 130.79 9.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.122 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 31' ' ' VAL . 10.3 tt -156.66 90.97 1.19 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.502 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 14.3 p -110.98 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.521 ' C ' HG22 ' A' ' 31' ' ' VAL . 69.9 m-20 100.38 20.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.715 0.806 . . . . 0.0 111.797 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.2 139.14 35.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.673 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 80.65 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.619 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.41 111.84 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 22.4 m-85 -113.53 -31.33 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.23 114.78 9.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CE1' HD12 ' A' ' 55' ' ' ILE . 1.1 t80 -85.59 127.18 34.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.12 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -141.62 109.93 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 102' ' ' VAL . 15.0 p90 -140.69 171.11 14.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.985 0.421 . . . . 0.0 111.315 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -117.36 114.49 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.663 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.39 151.27 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.48 104.57 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.457 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 17.2 p90 -129.24 -167.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -112.73 139.85 48.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.053 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.67 -28.79 15.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.37 -47.59 85.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.973 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' CB ' ' CB ' ' A' ' 129' ' ' ALA . . . -99.81 -46.5 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.194 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 2.0 m-85 -93.36 166.5 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -152.18 112.67 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.441 ' CD1' HG22 ' A' ' 100' ' ' VAL . 31.5 t80 -54.12 151.65 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 48.1 t -130.24 -70.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.885 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -172.52 141.86 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.636 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.57 148.43 28.04 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.14 0.971 . . . . 0.0 111.721 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -127.34 152.25 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.074 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.55 -169.59 1.53 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.969 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.55 -159.81 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.81 35.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.37 -46.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.083 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.65 173.5 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.963 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -121.23 139.28 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.13 109.28 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.14 119.11 31.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.11 172.27 7.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 107.38 3.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 tttp -55.38 95.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.948 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 100' ' ' VAL . 5.1 tp -86.45 -28.95 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.41 -174.84 5.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.88 136.54 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 56.94 27.08 56.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.457 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -173.35 123.6 0.39 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.679 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 16.5 m -150.27 154.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.885 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.29 152.13 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.924 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -131.82 93.58 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.905 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.1 mt -75.97 115.28 15.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.83 145.35 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.016 0.436 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.7 p -164.32 136.03 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.363 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.1 m -84.53 104.62 14.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.54 -15.07 63.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -65.34 -34.75 79.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.78 -16.9 25.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.446 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.34 160.6 29.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 39.2 Cg_exo -56.85 173.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mp -67.67 134.16 92.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.746 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.51 -38.73 71.14 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.508 2.139 . . . . 0.0 112.256 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 59.05 162.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.9 15.75 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 -163.29 1.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.254 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.419 ' CG1' ' CG ' ' A' ' 120' ' ' LYS . 39.1 t -76.86 105.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.9 mm? -95.62 -30.18 13.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -158.96 136.03 9.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.421 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -132.93 111.12 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.323 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -86.09 114.83 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 48' ' ' ASN . 54.8 t -75.62 105.44 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.841 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.407 HD21 ' CG ' ' A' ' 72' ' ' TYR . 24.7 mt -103.13 108.49 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.598 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 38.4 ttm180 -68.9 117.79 11.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.96 80.75 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.872 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.43 -5.27 58.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.3 123.5 2.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.185 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.573 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.3 ttpt -61.33 131.37 50.11 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.81 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' CB ' ' CB ' ' A' ' 76' ' ' ALA . . . -133.38 75.84 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.64 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.99 110.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 111.033 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.78 14.61 39.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.553 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.02 86.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 110.276 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -60.17 151.36 27.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 156' ' ' LYS . 3.5 mp -146.52 139.28 25.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.88 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.0 t -134.98 134.7 40.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.091 0.472 . . . . 0.0 111.6 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.456 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 48.4 t -105.02 95.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.482 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.486 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.6 p -102.73 -169.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.486 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.47 20.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.948 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.9 m -64.26 97.8 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.344 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.74 171.6 7.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.7 m -144.31 125.11 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.999 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 78.36 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.636 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -59.41 138.34 57.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.858 0.361 . . . . 0.0 110.8 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.5 -28.05 61.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.678 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.13 -27.91 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 110.958 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.96 -11.21 22.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.743 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -114.52 121.02 42.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.6 p -73.4 126.16 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -95.1 93.2 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.078 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -51.15 110.56 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.475 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 168.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 112.135 -178.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -61.03 -141.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.37 176.05 46.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.469 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.421 ' N ' HG21 ' A' ' 35' ' ' VAL . 17.9 m -159.68 149.12 18.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.7 0.286 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -104.32 154.54 19.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 111.588 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.634 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -147.66 155.13 41.45 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.634 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.7 p -138.76 135.27 34.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.59 125.52 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.527 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.87 105.7 17.79 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 20.1 mt -76.16 143.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -130.74 133.51 63.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.685 -177.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.1 144.52 19.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -116.68 -137.94 6.11 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.458 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.12 176.08 6.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.895 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.734 0.302 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.83 -116.05 5.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.439 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -79.75 166.75 21.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -32.65 74.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -106.18 158.4 16.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 m170 60.51 -177.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -131.98 -173.62 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 60.27 159.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -85.9 150.53 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -70.69 -59.15 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 t -132.04 135.66 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -159.73 -177.76 6.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.92 76.91 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 tt -132.03 -61.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 t 63.78 81.98 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.018 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -32.25 123.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.63 2.887 . . . . 0.0 113.276 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 112.4 18.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.01 -147.47 4.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.544 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -143.07 92.98 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -96.66 -40.69 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.5 mtt -104.75 -52.04 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.61 103.75 7.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.98 161.48 33.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -104.99 100.98 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 pp -93.64 79.51 4.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.6 -62.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -148.24 178.24 8.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.8 142.82 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.38 77.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -86.67 106.94 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 32' ' ' THR . 79.7 t -71.9 152.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.616 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.0 t -60.52 -43.5 97.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.345 0.593 . . . . 0.0 109.493 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.814 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 66.49 102.92 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.754 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.431 ' HB3' ' N ' ' A' ' 57' ' ' GLU . 18.9 t -160.73 138.73 9.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.517 0.675 . . . . 0.0 112.166 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 151' ' ' ILE . 34.0 m -97.32 134.67 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.266 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 3.8 t -92.11 108.05 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.704 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' A' ' 154' ' ' THR . 10.0 tp -97.23 124.52 41.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -140.55 106.99 5.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.687 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.65 165.53 30.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.525 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.88 -27.53 44.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.701 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.3 OUTLIER 71.97 23.04 3.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.54 129.08 2.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.8 p -146.58 107.91 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.46 125.36 26.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.215 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -29.23 131.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.15 -20.05 46.65 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.439 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -99.56 172.33 7.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -121.52 130.01 53.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.849 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.45 133.47 55.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.79 154.01 28.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.566 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.9 m -125.9 98.22 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -69.58 64.49 0.62 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.473 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.483 ' CG1' ' CZ ' ' A' ' 68' ' ' PHE . 9.1 p -78.25 95.53 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.667 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.33 -122.56 4.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.032 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.24 129.75 65.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.776 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.495 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 24.3 t70 -99.19 -37.36 9.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' N ' ' HB3' ' A' ' 34' ' ' SER . 29.2 mt-10 -159.11 130.02 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.589 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 1.1 tt -159.55 91.58 1.0 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.251 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.597 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -122.06 107.07 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 63.2 m-20 130.18 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.435 1.094 . . . . 0.0 111.543 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.92 162.56 38.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -113.85 83.88 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.29 111.78 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.526 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -102.26 -38.71 7.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.93 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.91 112.31 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.112 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.4 t80 -105.2 94.34 5.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.864 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -109.12 133.28 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CZ ' ' CG1' ' A' ' 53' ' ' VAL . 47.9 p90 -135.99 171.27 14.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 111.421 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.411 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -119.0 102.71 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.071 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tt -76.88 157.32 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.096 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -127.27 130.47 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.496 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 1.8 p90 -140.97 -167.42 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.548 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.03 136.3 53.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.07 -6.35 45.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.59 31.26 2.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.32 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.651 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 3.0 m-85 -100.32 -177.08 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.76 108.86 0.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 72' ' ' TYR . 17.9 t80 -48.55 147.65 2.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 60.1 t -127.69 -80.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -161.42 138.84 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . . . -82.92 150.54 26.41 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 122.01 0.91 . . . . 0.0 111.279 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -128.28 152.38 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.501 -177.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 15.1 p -115.65 -176.93 3.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.72 -156.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -93.65 36.77 1.08 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.875 0.369 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.79 -38.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.216 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.6 t -87.06 159.03 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -114.85 117.02 29.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 84' ' ' SER . 10.8 t -115.41 131.98 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.56 115.61 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -95.76 149.8 21.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -136.51 106.86 6.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.696 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 24.5 tttt -55.52 120.38 7.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.362 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.4 tp -112.06 -23.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.834 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.54 -179.19 7.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 111.152 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.496 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -106.07 60.57 0.37 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.27 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -174.0 123.72 0.33 Allowed 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.696 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.3 m -148.81 155.41 8.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.637 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -99.11 152.34 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.067 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.3 p -125.21 147.63 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.394 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.38 109.92 18.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.28 137.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 111.524 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.3 p -164.25 136.06 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.448 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -79.37 104.39 9.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.242 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.51 -14.78 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.5 p -65.26 -28.87 69.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.0 -17.74 22.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.454 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -99.18 147.66 33.58 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 52.4 Cg_exo -54.16 169.88 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.1 mt -58.23 113.96 7.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 -21.22 51.72 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.406 2.071 . . . . 0.0 112.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 59.56 169.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.849 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.12 27.05 14.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 110.602 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -155.38 154.5 32.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.365 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.414 ' CG1' ' CG ' ' A' ' 120' ' ' LYS . 26.9 t -47.43 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.224 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.1 mm? -92.05 -29.3 16.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -163.0 136.4 5.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.74 0.305 . . . . 0.0 111.513 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 83' ' ' ILE . 7.2 mtpt -131.85 100.75 5.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.428 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.69 107.04 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 13.9 p -83.89 124.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -99.49 114.06 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.411 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 24.5 ttm180 -54.95 116.81 2.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -87.63 67.94 9.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.255 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 -0.83 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.481 0.658 . . . . 0.0 109.312 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.16 123.39 2.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.235 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.7 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.0 ttpt -45.44 142.19 2.32 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.627 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.407 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -149.07 59.61 1.04 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.713 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -56.05 118.61 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.167 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.36 13.59 70.49 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.51 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.6 t -70.35 66.56 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.469 . . . . 0.0 110.144 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -43.97 138.28 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.482 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.17 127.14 53.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.458 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.406 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -119.84 126.39 50.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.123 0.487 . . . . 0.0 111.957 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.87 94.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.479 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -105.82 -159.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.783 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.52 104.74 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 0.0 110.371 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.09 167.17 9.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.493 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 m -141.65 120.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.962 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.71 98.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.669 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -55.81 161.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.74 79.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.87 -46.23 25.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.14 -27.84 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.4 119.31 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.971 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.27 153.42 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -122.13 90.61 3.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.69 103.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.266 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.488 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.45 -176.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 111.947 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.814 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -64.63 -160.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.53 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.1 -174.29 23.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.019 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.537 HG22 ' CD2' ' A' ' 37' ' ' LEU . 11.6 t -160.62 -171.03 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.429 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.462 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 14.0 tt0 -161.8 157.85 24.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.456 ' HE2' HD21 ' A' ' 37' ' ' LEU . 2.2 tppm? -143.17 168.73 19.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.186 0.517 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 133' ' ' ASN . 2.5 p -141.67 115.7 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.415 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.9 119.11 58.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 105.89 18.09 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.7 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 6.9 mt -78.25 119.68 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.2 132.77 48.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.692 -178.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.12 145.84 45.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 168.31 120.2 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.511 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.67 170.29 9.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.861 -179.954 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.04 58.16 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -72.09 161.27 31.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 t -65.22 79.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -114.99 -178.24 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t60 60.81 31.65 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.61 -64.18 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -87.12 158.11 19.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.33 29.23 7.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 58.01 31.08 20.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.7 158.24 15.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.11 -170.07 3.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.72 -124.51 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mt -121.57 128.42 51.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 t -104.89 81.86 0.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -32.35 -55.8 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.534 2.823 . . . . 0.0 113.287 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -164.32 -56.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.13 75.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -167.37 97.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -146.07 160.44 41.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 60.49 32.48 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -170.45 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t -136.14 -57.3 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.854 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -154.22 117.73 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -93.95 -31.43 14.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -83.6 -30.81 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 61.29 158.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.93 137.39 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.37 77.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -92.11 93.66 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.0 t -76.26 151.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.764 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 33' ' ' GLY . 1.5 t -84.65 -33.16 23.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 52.19 121.74 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.549 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.5 146.37 31.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.211 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 153' ' ' GLY . 28.7 m -96.07 135.99 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 3.6 t -90.96 107.11 18.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.246 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' CD2' HG21 ' A' ' 154' ' ' THR . 13.1 tp -97.48 106.26 18.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.833 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -140.95 101.03 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.03 166.16 24.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 111.274 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -69.68 -35.87 75.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.626 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 68.29 31.46 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.169 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -164.21 116.47 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.3 p -133.14 165.48 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.901 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tt0 -129.47 113.04 14.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 128' ' ' LYS . 2.1 t -28.11 119.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 121.59 -27.61 6.22 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.43 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -175.37 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.74 0.305 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.66 165.06 12.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.188 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.8 tp -117.54 156.76 27.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -136.45 93.95 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.146 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -103.63 98.13 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.703 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.53 68.2 3.21 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.4 p -78.61 95.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.05 -129.74 6.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.865 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.51 138.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 111.543 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -37.48 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.04 131.99 0.05 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.551 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.62 95.51 3.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.526 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.9 m -85.27 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.578 ' C ' HG22 ' A' ' 31' ' ' VAL . 53.1 m-20 96.68 31.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.29 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 149' ' ' HIS . . . -141.39 149.77 41.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.362 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.5 mt-10 -119.76 71.3 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.723 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 141' ' ' VAL . . . -62.09 122.42 15.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.234 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -105.93 -32.84 8.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.654 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.84 112.3 7.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.04 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CE2' ' CD1' ' A' ' 68' ' ' PHE . 21.9 t80 -104.25 94.69 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.1 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -102.42 130.23 49.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 66' ' ' TYR . 41.6 p90 -132.85 171.11 14.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -132.7 97.27 4.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.186 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.2 157.71 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.432 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -116.54 104.57 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 24.4 p90 -111.24 -167.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.96 125.54 51.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.78 -40.82 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.803 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.68 -35.54 80.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.46 -57.95 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.429 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 8.3 m-85 -93.44 165.38 12.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -145.02 109.74 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.417 ' CG ' HG22 ' A' ' 100' ' ' VAL . 22.1 t80 -54.01 140.46 31.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 39.9 t -119.52 -72.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -169.04 143.57 3.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.74 147.73 28.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 122.169 0.985 . . . . 0.0 111.698 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.41 152.83 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.474 -177.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -166.36 1.16 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.52 -157.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.27 36.25 1.06 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.09 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.969 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.88 160.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.782 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -112.03 136.71 51.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.959 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.37 105.46 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.34 114.89 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.611 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.27 -176.98 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.12 107.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.388 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.655 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttm -54.82 111.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.039 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -102.58 -28.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.86 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.31 170.71 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.32 133.75 45.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.13 28.48 64.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.323 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.448 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 5.8 ptmt -173.66 122.98 0.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.655 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 20.9 m -150.27 155.92 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.28 152.05 22.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.313 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -131.17 95.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.525 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.88 114.7 19.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.081 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.7 m -111.58 153.56 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.692 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -164.69 136.71 4.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.467 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.7 m -85.36 104.47 15.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.51 -12.19 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.681 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -65.28 -30.86 71.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.38 -19.12 22.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.27 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.39 147.17 34.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 44.6 Cg_exo -56.45 176.27 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.547 2.165 . . . . 0.0 112.365 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.04 121.96 49.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.813 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 -36.85 62.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.282 1.988 . . . . 0.0 112.158 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 59.91 163.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.888 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 28.62 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.492 . . . . 0.0 110.241 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -164.48 156.48 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.996 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.403 HG11 ' NZ ' ' A' ' 120' ' ' LYS . 30.9 t -44.4 104.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.26 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 -29.98 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.969 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.79 135.7 4.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.797 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.403 ' NZ ' HG11 ' A' ' 117' ' ' VAL . 12.9 mtmm -124.86 113.69 18.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.66 110.45 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.452 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 41.7 t -76.92 106.29 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.433 HD23 ' CG ' ' A' ' 72' ' ' TYR . 10.2 mt -106.21 108.6 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.768 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 39.3 ttm180 -69.05 117.92 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -68.55 80.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.185 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.413 ' HG2' ' HG2' ' A' ' 124' ' ' ARG . 4.8 mm-40 -86.06 -12.81 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 109.55 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.79 124.35 2.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.564 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.608 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 7.3 ttpp -45.56 155.9 0.14 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.11 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.7 56.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -56.21 98.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.677 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 110.59 26.77 4.66 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.911 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 65.81 0.25 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.918 0.39 . . . . 0.0 111.067 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 157' ' ' THR . 1.8 t-20 -45.04 110.53 0.24 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.111 0.481 . . . . 0.0 112.003 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.02 165.2 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.868 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.9 t -158.37 119.74 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.385 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.448 ' CG1' ' CD2' ' A' ' 68' ' ' PHE . 35.6 t -87.16 94.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.441 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.456 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.2 p -100.19 -170.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' C ' ' A' ' 137' ' ' THR . 4.2 p30 43.23 23.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.757 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.438 ' HB2' ' CD1' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -64.61 93.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.575 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.24 167.5 10.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.136 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 16.3 m -140.18 129.39 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.59 77.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 24.7 t0 -57.14 146.86 26.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.6 -26.38 73.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.89 -44.32 82.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.28 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.26 -10.22 4.12 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.853 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.64 132.22 56.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.26 115.19 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.152 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.443 ' CD2' ' HB1' ' A' ' 61' ' ' ALA . 77.2 m-70 -86.34 95.0 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.71 108.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.792 0.329 . . . . 0.0 110.187 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.516 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.23 166.42 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -56.16 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 35' ' ' VAL . . . -159.08 -167.97 20.49 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.892 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.572 HG21 ' CD2' ' A' ' 37' ' ' LEU . 6.8 t -166.09 179.58 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.958 0.379 . . . . 0.0 111.56 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 tm-20 -143.51 143.8 31.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.639 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -149.44 155.32 40.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.14 0.495 . . . . 0.0 111.232 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.639 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 8.2 p -128.73 140.22 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.219 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.65 139.03 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 111.49 23.78 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.027 0.441 . . . . 0.0 111.12 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.3 mt -88.16 127.5 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -112.13 132.19 61.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.077 -177.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.07 145.86 49.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.223 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.14 159.24 24.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.5 179.88 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.857 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.938 179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.735 0.303 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.92 178.01 53.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 p -85.64 99.46 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.94 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.95 -60.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -64.67 170.18 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 86.51 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -143.02 35.64 1.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -119.03 -170.23 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 m170 60.66 110.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -96.26 142.89 27.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.2 m -114.16 118.48 34.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.14 146.87 27.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.6 -128.58 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.482 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.89 162.39 34.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.31 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -169.07 88.27 0.61 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -32.46 120.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.658 2.905 . . . . 0.0 113.24 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -91.56 -61.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.13 -105.53 1.17 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 p -63.33 177.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 110.813 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.6 31.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.804 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 60.01 171.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.7 160.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.08 29.14 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 58.47 33.55 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.99 -62.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.897 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.1 tttp 61.01 162.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -101.05 154.09 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.77 -174.67 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 71.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.24 142.66 30.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.597 HG11 ' N ' ' A' ' 59' ' ' VAL . 77.5 t -100.7 153.2 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.581 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.3 t -64.05 -42.5 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.448 0.642 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 61.96 104.93 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.214 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 40.9 t -156.31 136.48 12.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.697 0.76 . . . . 0.0 112.213 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' CG1' HD12 ' A' ' 151' ' ' ILE . 34.2 m -93.35 145.47 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.492 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 17.9 p -104.38 113.31 26.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 156' ' ' LYS . 5.5 mt -96.79 121.38 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 111.32 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.1 101.3 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.365 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.08 32.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.88 -22.72 59.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.529 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 2.3 mp0 66.68 23.35 10.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -165.12 127.89 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.7 p -144.54 106.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.164 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.16 133.07 47.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.489 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -33.83 133.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.57 -22.48 35.74 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.515 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.13 172.18 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -104.34 153.57 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.67 161.03 14.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -136.57 93.57 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.723 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.2 t -105.67 97.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -85.96 59.08 4.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.157 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 68' ' ' PHE . 9.6 p -78.04 95.35 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.581 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -112.31 -117.58 3.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.037 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.5 131.38 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 112.046 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 7.3 t0 -103.53 -35.84 8.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -155.89 127.82 7.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.611 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 90.7 1.7 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.27 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.597 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -115.19 116.53 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 73.8 m-20 103.15 33.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.934 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -169.31 133.46 1.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -91.96 82.06 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.348 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 111.86 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 30.3 m-85 -104.94 -33.82 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.884 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.51 112.3 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.111 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.426 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.2 t80 -109.71 95.03 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.967 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -109.18 143.86 38.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CD1' ' CG1' ' A' ' 136' ' ' VAL . 18.6 p90 -146.41 171.27 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.013 0.435 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -126.29 99.72 5.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 156.08 31.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.27 112.99 18.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.435 ' CG ' HD21 ' A' ' 123' ' ' LEU . 26.1 p90 -126.22 -168.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -106.06 134.55 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.72 -29.86 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.09 -41.92 99.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.64 -47.94 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -93.38 172.37 8.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.712 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -160.7 114.13 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CD1' HG22 ' A' ' 100' ' ' VAL . 31.9 t80 -54.16 153.46 5.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 87.1 t -132.8 -77.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.02 140.61 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.736 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 102' ' ' VAL . . . -82.85 149.47 27.12 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.93 152.63 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.339 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.13 -165.37 1.31 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.898 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -90.89 -157.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -93.72 36.75 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.399 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.18 -38.73 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 89' ' ' PHE . 19.8 t -86.83 149.29 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.926 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' N ' HG13 ' A' ' 88' ' ' VAL . 11.2 t80 -111.28 103.11 11.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.44 142.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.021 0.438 . . . . 0.0 110.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -156.46 118.84 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.305 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.95 -178.9 4.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.413 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 107.85 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.0 111.54 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.699 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 17.8 tttt -54.53 95.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.0 tp -78.12 -27.11 14.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.833 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -165.3 -166.78 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -86.71 134.68 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.28 29.38 60.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -173.62 121.36 0.33 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 120.941 0.4 . . . . 0.0 109.977 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.699 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 11.8 m -150.07 155.51 7.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.665 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -93.3 151.87 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.28 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.4 p -123.67 129.65 74.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.47 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.8 mt -101.84 104.69 15.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.332 . . . . 0.0 110.714 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.69 135.68 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.494 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -164.46 136.76 4.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.437 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 88.6 p -88.2 117.26 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.112 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.41 27.71 2.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.298 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.6 p -102.41 -27.65 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.78 -16.81 23.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.315 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.43 147.62 34.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 51.2 Cg_exo -54.1 172.96 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.496 2.131 . . . . 0.0 112.306 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mp -59.28 128.0 84.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.784 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 -34.05 98.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.376 2.051 . . . . 0.0 112.11 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 58.56 163.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.979 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.94 15.52 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -146.83 -165.72 2.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.31 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.71 104.84 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.763 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.423 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 1.9 mm? -94.35 -29.56 14.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.034 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -149.56 134.14 17.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -126.09 101.81 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.25 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.338 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.59 97.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.737 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.435 HD21 ' CG ' ' A' ' 72' ' ' TYR . 76.9 mt -84.17 113.74 21.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.912 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.2 tpm_? -59.01 113.28 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.68 68.2 7.95 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.49 -6.19 59.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 109.574 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.31 123.59 2.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.578 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.584 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.6 ttmm -41.94 162.47 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.318 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 128' ' ' LYS . . . -173.43 58.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.018 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.5 tt0 -56.22 116.05 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.119 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.88 15.89 58.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.567 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.67 66.62 0.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 110.252 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -44.49 140.55 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.264 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.83 128.72 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.416 ' CA ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -115.57 129.83 56.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.696 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.461 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 39.5 t -106.42 95.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.609 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.471 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 15.9 p -100.11 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.76 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.35 21.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.995 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -61.92 105.54 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.358 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 175.13 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.355 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.74 126.56 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.008 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.79 104.42 2.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.714 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 13.0 p30 -58.87 -174.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.719 0.295 . . . . 0.0 110.857 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.75 16.58 60.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.909 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.98 -32.17 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.61 -16.96 3.52 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.061 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.99 170.16 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.995 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.1 p -120.8 125.72 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 143' ' ' ASP . 79.1 m80 -96.12 90.54 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.945 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -49.42 106.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.45 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.43 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.451 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -76.19 -146.37 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.677 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.52 41.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.716 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 155' ' ' GLU . 24.0 m -161.14 153.34 20.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 8.7 tt0 -110.0 161.98 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 1.3 tppt? -139.5 166.75 23.73 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 133' ' ' ASN . 2.1 p -142.23 116.21 9.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.67 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.65 122.37 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.253 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.42 105.85 17.95 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.679 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 18.1 mt -80.49 112.45 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.597 0.713 . . . . 0.0 109.842 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.55 131.77 40.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.038 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.01 145.84 49.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.077 0.465 . . . . 0.0 110.957 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.81 110.65 0.45 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.628 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.47 175.12 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.897 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.841 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.805 0.336 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.35 152.52 5.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.549 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.28 124.61 49.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 m -131.98 -67.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -98.47 35.14 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -102.28 -176.3 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 t60 60.65 94.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -176.1 87.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -76.45 110.66 11.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -105.32 -32.43 8.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 t -146.24 119.54 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -131.25 165.57 23.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.42 -152.5 6.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mt -146.81 137.91 24.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -105.29 82.43 0.75 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -32.48 107.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.606 2.871 . . . . 0.0 113.248 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -61.3 -44.78 96.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.68 11.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -176.35 95.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.822 0.344 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -129.5 132.98 47.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.8 tpt -82.16 -31.35 30.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.45 122.05 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -161.93 -74.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.67 158.59 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.823 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mp 60.53 -176.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -99.92 80.78 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -60.41 -177.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.783 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -174.04 -169.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.22 78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.6 133.54 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.105 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 60' ' ' ASN . 14.6 t -60.74 155.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -77.5 -46.85 21.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.827 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 71.26 114.21 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.208 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLU . 6.7 t -162.08 136.7 6.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.138 0.494 . . . . 0.0 111.542 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG21 ' HB ' ' A' ' 154' ' ' THR . 5.8 m -91.41 134.1 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.553 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 t -96.42 107.44 19.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.341 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.407 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 3.7 mt -97.1 117.3 30.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.251 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.49 101.42 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.08 160.19 41.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 111.241 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -31.67 68.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 69.41 24.2 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.5 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -165.04 122.83 1.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.813 0.34 . . . . 0.0 111.657 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 2.7 p -143.34 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.51 132.19 47.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.421 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 2.0 t -32.76 132.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-O 121.549 0.69 . . . . 0.0 112.776 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.85 -24.89 30.34 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.536 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.3 171.85 8.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.746 0.307 . . . . 0.0 110.666 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -116.46 150.89 37.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' CD2' ' CG1' ' A' ' 158' ' ' VAL . 6.8 tp -130.08 142.1 50.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.51 117.05 24.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG2' ' CD2' ' A' ' 37' ' ' LEU . 7.1 p -93.55 98.65 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -69.19 69.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.9 p -78.58 95.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.19 -135.1 8.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.809 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.51 127.37 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.553 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -94.29 -37.34 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 34' ' ' SER . 22.9 mp0 -161.07 132.21 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -162.49 91.61 0.77 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.108 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.0 p -121.46 109.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.578 ' N ' HG22 ' A' ' 31' ' ' VAL . 63.9 m-20 130.41 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.451 1.101 . . . . 0.0 111.606 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -150.41 -179.16 6.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.699 0.285 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.93 85.16 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.362 . . . . 0.0 110.575 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 141' ' ' VAL . . . -62.59 111.94 2.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.145 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.3 m-85 -115.28 -49.12 2.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.67 112.3 17.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.997 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 1.5 t80 -85.75 136.6 33.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.453 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -147.62 109.64 4.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.271 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD1' ' CG1' ' A' ' 136' ' ' VAL . 29.9 p90 -130.24 171.27 13.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.364 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 104.84 8.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 149.73 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.118 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -125.28 104.64 8.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.425 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 19.1 p90 -121.33 -170.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -97.64 136.79 37.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -93.6 -26.8 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -76.54 -29.78 56.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.103 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -108.78 -49.32 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.327 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 158' ' ' VAL . 5.0 m-85 -93.31 -177.08 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ARG . 2.0 tt0 -170.28 108.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CG ' HG22 ' A' ' 100' ' ' VAL . 38.9 t80 -47.47 152.73 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.399 . . . . 0.0 111.119 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.3 t -134.53 -78.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -153.47 148.73 26.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -102.25 147.96 26.02 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.207 1.003 . . . . 0.0 111.638 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -133.78 174.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.103 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.67 -177.29 5.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -61.97 -161.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.713 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 36.71 1.1 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.44 -40.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.26 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.98 146.86 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -108.25 103.04 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.96 132.17 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -145.4 109.73 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.82 -179.23 4.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.342 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -161.11 117.92 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.387 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.686 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 tttt -54.03 113.35 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.389 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -109.49 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -158.44 172.91 17.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.839 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.85 131.91 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.25 29.47 63.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -173.57 129.87 0.43 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 18.2 m -150.06 155.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.925 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.26 147.35 28.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 7.1 p -130.68 129.89 64.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -111.05 109.94 20.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 66' ' ' TYR . 4.1 t -106.17 144.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.508 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.38 139.78 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.305 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -88.57 104.34 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.108 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.75 -17.83 64.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 p -65.23 -34.81 79.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.22 -19.9 28.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.389 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.73 153.77 43.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 40.9 Cg_exo -56.72 164.8 5.43 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.629 2.219 . . . . 0.0 112.437 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 118' ' ' LEU . 2.3 mp -59.33 127.55 84.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.749 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.85 -32.14 96.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.409 2.072 . . . . 0.0 112.085 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 58.44 162.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 15.04 9.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.25 -164.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.218 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 t -78.97 104.66 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.57 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.4 ' CD1' ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.55 -33.23 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -168.68 133.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.319 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 83' ' ' ILE . 3.9 mtmt -122.92 100.76 7.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.06 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.25 110.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 110.437 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.5 t -75.55 115.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.787 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -102.09 169.12 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.642 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 12.8 tpp180 -115.28 125.16 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 45' ' ' VAL . . . -92.08 73.12 5.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.546 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -87.74 -5.11 58.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.435 0.636 . . . . 0.0 109.639 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.563 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.647 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 4.3 ttmm -49.74 134.2 20.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.176 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.402 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -138.69 64.29 1.49 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.47 114.42 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.151 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.51 21.25 52.07 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.02 66.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 0.8 OUTLIER -46.98 142.78 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.858 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.68 165.05 16.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.801 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.19 106.24 3.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 21.8 t -96.4 94.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.456 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -103.33 -160.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.81 19.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 74.7 m -59.81 90.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.123 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' HG22 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -116.44 138.47 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.212 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 63' ' ' ALA . 10.4 p -115.01 153.29 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.03 100.19 2.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.786 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -52.51 162.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.779 0.324 . . . . 0.0 111.128 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.39 -43.88 95.51 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.548 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.22 -30.85 71.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.98 -27.76 3.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.536 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.7 155.34 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 140' ' ' SER . 12.1 p -114.43 138.63 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 55.8 m80 -110.52 96.93 6.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.153 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.56 104.99 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.159 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.471 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.39 -176.76 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -68.1 -158.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.577 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -154.88 175.35 32.96 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.434 ' HB ' HG21 ' A' ' 35' ' ' VAL . 86.0 m -164.12 146.73 9.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.925 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.75 166.7 10.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.624 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -152.4 154.67 36.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.879 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.624 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.9 p -126.77 143.6 51.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.605 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.41 HG22 ' CZ ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -134.69 130.02 52.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.58 105.93 16.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 120.933 0.397 . . . . 0.0 111.011 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 20.8 mt -80.15 115.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.491 0.662 . . . . 0.0 109.455 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -97.29 128.74 48.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.116 -178.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.08 145.9 29.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.107 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.08 -118.47 4.47 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.524 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.39 172.77 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.946 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtp . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.805 0.336 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.92 102.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m 60.36 -178.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.26 -58.67 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -149.13 141.56 24.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -101.96 34.21 2.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -128.48 165.31 20.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -105.39 109.45 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.17 112.63 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -28.78 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.006 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 p -151.36 131.56 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -104.91 -59.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.59 109.79 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.44 -53.71 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.74 0.305 . . . . 0.0 110.823 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.6 m -78.93 150.18 74.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -32.26 140.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.65 2.9 . . . . 0.0 113.25 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -138.49 -60.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.28 78.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.91 178.7 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.796 0.332 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -105.73 -171.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 tpt 68.59 -67.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 109.96 7.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.077 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -100.03 178.31 4.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 78.77 4.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -151.6 116.96 5.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.55 39.67 17.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.94 168.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.87 134.65 52.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.3 77.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.09 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -114.34 108.4 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.622 HG22 ' N ' ' A' ' 60' ' ' ASN . 24.9 t -60.68 155.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.442 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -84.44 -45.06 13.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.778 ' O ' ' HB1' ' A' ' 152' ' ' ALA . . . 71.01 120.28 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.422 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' GLU . 7.8 t -162.95 140.47 7.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.06 0.457 . . . . 0.0 111.421 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' CG1' ' HA2' ' A' ' 153' ' ' GLY . 11.2 m -97.82 129.26 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.37 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 56' ' ' ASP . 47.5 p -95.01 108.21 20.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.948 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 1.4 mt -97.71 122.09 40.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.55 112.28 10.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.595 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.01 155.6 37.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.48 -29.15 66.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 69.98 23.87 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.624 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' N ' HG11 ' A' ' 158' ' ' VAL . 19.9 tt0 -164.68 128.95 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 112.112 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -134.03 171.19 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.117 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.5 tt0 -133.05 120.15 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.0 t -28.72 132.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 121.576 0.703 . . . . 0.0 112.381 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.05 49.55 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.28 174.92 10.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.515 0.326 . . . . 0.0 110.15 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -127.42 147.93 50.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.875 0.369 . . . . 0.0 110.986 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -102.52 164.12 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -130.0 93.32 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.682 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' A' ' 37' ' ' LEU . 8.0 p -103.16 97.9 6.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -91.48 85.2 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.258 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 3.5 p -78.55 95.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 110.086 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.37 -134.9 8.2 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.499 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -103.08 134.63 43.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 111.606 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 22.1 t0 -103.28 -34.32 8.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.425 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB3' ' CG2' ' A' ' 32' ' ' THR . 4.0 mp0 -165.54 134.05 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.926 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 tt -162.27 91.61 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.759 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.583 ' C ' HG22 ' A' ' 31' ' ' VAL . 11.9 p -119.31 103.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.622 ' N ' HG22 ' A' ' 31' ' ' VAL . 35.2 m-20 133.1 24.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.262 1.025 . . . . 0.0 111.413 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.6 171.95 18.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 86.05 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.716 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.5 133.52 55.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 12.7 m-85 -127.63 -42.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.04 112.44 15.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -85.98 100.66 12.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.029 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -109.33 112.44 24.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CE1' ' CG1' ' A' ' 53' ' ' VAL . 50.4 p90 -142.97 171.54 13.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.8 t -128.48 121.29 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' CD1' ' CG1' ' A' ' 121' ' ' VAL . 7.2 tt -95.03 126.34 40.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -98.32 106.59 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 50.0 p90 -107.13 -169.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.702 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.69 120.27 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -29.46 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -27.42 69.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.95 -44.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.384 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 160' ' ' ILE . 0.8 OUTLIER -93.14 161.06 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -145.65 130.39 18.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.441 ' CD1' HG22 ' A' ' 100' ' ' VAL . 19.5 t80 -55.02 149.13 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.406 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 55.7 t -132.16 -85.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -160.4 135.84 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.88 150.58 26.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.147 0.975 . . . . 0.0 111.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.19 153.29 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.571 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.25 -165.89 1.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.5 -157.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.618 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.6 37.15 1.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.863 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.67 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.169 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.5 t -86.74 158.85 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.36 125.38 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.415 HG22 ' CG1' ' A' ' 104' ' ' VAL . 3.5 t -122.57 135.93 61.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.33 120.53 7.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.612 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.96 156.77 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 107.25 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.174 0.512 . . . . 0.0 111.337 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.664 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.3 ttpt -55.1 95.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 100' ' ' VAL . 7.5 tp -82.73 -22.21 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.765 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.8 -166.74 0.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.81 133.18 33.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.87 29.56 62.0 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -173.26 121.59 0.36 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.664 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 7.1 m -149.91 154.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.676 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.09 152.16 22.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.204 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 8.6 p -126.45 93.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.15 111.0 17.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 ' CG1' HG22 ' A' ' 90' ' ' VAL . 4.2 m -117.25 158.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.022 0.439 . . . . 0.0 111.804 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -164.49 136.09 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.265 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -79.01 113.67 17.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 31.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.983 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.2 p -109.65 -34.64 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.48 -21.84 11.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.142 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -91.17 155.69 44.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.757 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 59.1 Cg_endo -72.4 174.5 11.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.481 2.121 . . . . 0.0 112.476 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HG ' HD13 ' A' ' 118' ' ' LEU . 4.0 tt -54.49 107.55 0.9 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.86 -32.11 94.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.344 2.029 . . . . 0.0 111.926 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 55' ' ' ILE . . . 59.77 170.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.168 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.6 16.15 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.087 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -148.26 -179.85 7.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.405 ' CG1' ' CG ' ' A' ' 120' ' ' LYS . 47.0 t -70.95 105.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.649 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.427 HD13 ' HG ' ' A' ' 112' ' ' LEU . 2.3 mm? -87.56 -31.55 19.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.214 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.582 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -166.11 131.0 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.679 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' CG ' ' CG1' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -119.89 118.6 31.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 70' ' ' LEU . 7.1 p -97.98 94.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.182 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 m -75.63 118.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.026 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 2.4 mm? -92.24 169.2 10.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.0 tpm_? -105.51 118.25 36.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -90.86 71.07 6.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.785 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.36 -4.3 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.96 124.31 2.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.042 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.619 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 3.1 ptmt -40.6 163.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -178.2 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.971 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 pt-20 -55.63 112.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.69 4.14 39.85 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.647 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.84 87.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.932 0.396 . . . . 0.0 110.24 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -60.49 166.68 2.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.5 mp -140.13 104.84 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.649 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.41 130.14 45.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.227 0.537 . . . . 0.0 112.093 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.6 m -115.4 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.17 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.496 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 7.5 p -108.91 -167.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.547 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.2 OUTLIER 37.41 29.87 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.449 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 89.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.034 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.95 171.66 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.357 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.33 122.46 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 99.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -56.41 162.53 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.41 -29.16 70.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.61 -49.05 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.6 -28.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.392 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.33 170.2 16.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.23 153.39 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -123.03 94.82 4.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.23 104.97 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.504 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.53 -176.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.778 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -67.93 -160.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -159.78 175.54 36.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 1.3 t -162.93 -170.91 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.849 -0.207 . . . . 0.0 110.574 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -151.21 152.06 32.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.198 0.523 . . . . 0.0 112.061 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 134' ' ' LEU . 4.1 tppt? -129.34 169.26 15.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.867 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.01 144.38 32.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -134.24 126.37 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -90.35 116.13 28.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.775 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 4.6 mt -85.56 116.66 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.69 -178.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.89 146.6 51.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.016 0.436 . . . . 0.0 111.016 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.94 161.78 35.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -50.12 177.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.362 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.479 ' N ' ' OG1' ' A' ' 164' ' ' THR . 67.1 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.99 158.13 53.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -106.34 178.24 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.99 99.67 3.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.75 143.3 30.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -135.8 178.26 7.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.41 156.87 28.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -172.29 -53.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -132.15 124.29 28.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 60.24 -176.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -140.66 -60.3 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t 60.38 88.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.61 82.88 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.35 -44.42 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.474 ' HB ' ' CD ' ' A' ' 16' ' ' PRO . 13.3 t -159.46 -64.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' CD ' ' HB ' ' A' ' 15' ' ' VAL . 94.5 Cg_exo -32.11 123.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.31 2.673 . . . . 0.0 113.289 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -62.8 -58.11 8.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.24 168.74 24.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 -31.36 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m170 60.35 35.74 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -76.94 81.51 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.85 112.52 1.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.17 -59.1 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -113.13 80.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.4 -44.25 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -151.34 -47.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 60.49 166.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.59 165.99 21.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.54 31.66 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -81.01 122.63 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 12.3 t -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' GLY . 6.7 t -80.42 -32.27 37.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 52.43 120.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.596 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.47 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 28.6 t -149.94 155.01 39.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.277 0.56 . . . . 0.0 111.944 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -108.06 123.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -92.13 107.38 19.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mt -97.16 126.59 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.27 101.42 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.2 154.56 41.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.346 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.57 -26.62 61.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 3.2 mt-10 68.58 23.53 7.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.424 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 158' ' ' VAL . 27.0 tt0 -164.7 126.55 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.6 p -128.62 171.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.493 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.2 tt0 -133.83 113.4 12.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 44' ' ' GLN . 1.8 t -28.37 114.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 125.06 -25.6 5.75 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.884 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -175.52 2.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.913 0.387 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -114.9 167.74 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -114.74 159.43 20.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.469 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.54 98.05 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -82.1 71.48 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.153 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.22 97.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.965 0.412 . . . . 0.0 110.872 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.35 -128.47 5.79 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.852 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.432 HD12 ' CE1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -112.05 134.8 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.037 0.446 . . . . 0.0 111.431 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.02 -33.05 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.234 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -174.46 130.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.642 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HG ' ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -152.61 91.67 1.59 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.093 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 10.6 p -100.11 117.82 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' C ' HG22 ' A' ' 31' ' ' VAL . 69.6 m-20 100.78 22.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.596 0.758 . . . . 0.0 112.352 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.69 138.59 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.8 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.1 mp0 -102.19 87.18 3.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 112.12 2.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.312 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.42 -32.06 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.63 111.96 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.432 ' CE1' HD12 ' A' ' 55' ' ' ILE . 0.8 OUTLIER -87.45 136.5 32.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.341 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -147.83 109.86 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.314 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CD2' ' CG1' ' A' ' 102' ' ' VAL . 5.0 p90 -125.0 171.12 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.375 . . . . 0.0 111.352 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 115.56 17.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.587 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.3 141.45 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -119.96 104.59 10.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.568 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.42 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 50.3 p90 -133.0 -170.87 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.82 132.43 54.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -27.39 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -56.31 -30.04 62.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.35 -48.15 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 123' ' ' LEU . 1.1 m-85 -93.38 178.9 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -171.7 119.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 92' ' ' ALA . 15.2 t80 -54.54 156.02 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.714 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 58.4 t -130.46 -84.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.07 132.14 12.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.83 150.19 26.72 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.141 0.972 . . . . 0.0 111.649 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.99 152.38 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.353 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -115.07 -168.41 1.38 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -93.87 -160.12 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.86 37.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.29 -42.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.167 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.08 173.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.336 . . . . 0.0 110.977 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 156.82 26.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.85 123.94 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -134.01 110.78 9.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.028 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.15 131.02 44.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.311 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -118.84 108.04 14.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 12.8 tttt -70.51 97.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.831 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -78.1 -0.06 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' N ' HD13 ' A' ' 95' ' ' ILE . 0.3 OUTLIER 178.12 -168.76 0.08 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.35 115.39 27.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 79.92 38.72 18.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.075 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -172.68 123.42 0.44 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.61 131.86 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.593 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 15.7 ttp180 -101.28 151.97 21.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.848 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.8 p -123.59 157.29 29.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 111.824 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.408 ' N ' HG21 ' A' ' 102' ' ' VAL . 84.8 mt -123.56 106.94 11.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.525 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.1 t -105.27 143.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 111.686 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 p -164.29 136.17 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.08 112.22 23.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 111.258 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mt -93.77 31.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.929 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -109.7 -30.92 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.968 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.65 -20.67 11.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.223 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -94.43 155.93 39.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.615 0.245 . . . . 0.0 110.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 177.07 7.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.574 2.183 . . . . 0.0 112.547 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.408 ' CD2' ' CD2' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -56.72 119.15 27.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.901 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.62 -42.41 39.95 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.931 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 66.08 163.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.29 15.49 10.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.271 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.2 -169.76 3.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.284 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 104.92 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.584 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -96.81 -28.79 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.479 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -155.16 129.4 8.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -118.96 101.01 7.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.534 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 9.6 p -95.8 97.97 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.51 124.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.067 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 4.2 mp -95.33 169.19 10.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.792 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -111.28 120.4 42.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.492 . . . . 0.0 112.069 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -89.72 69.52 7.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.991 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.5 -9.51 47.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.34 0.591 . . . . 0.0 109.623 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.49 124.3 3.1 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.736 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.642 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.4 ttpp -43.66 155.24 0.08 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.433 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.82 59.51 0.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.892 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.53 116.27 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.188 -179.111 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.7 18.56 51.26 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.334 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.71 66.55 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.939 0.399 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.96 133.93 4.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.255 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.42 118.31 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.1 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 p -99.6 124.15 44.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.553 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.22 95.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.546 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.8 p -111.98 -159.78 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.761 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 20.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -68.05 92.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.26 163.85 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.39 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.07 130.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.68 82.84 0.93 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 9.1 t70 -55.18 139.96 40.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.76 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.2 -38.39 25.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.06 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -53.51 -26.58 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.56 10.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.668 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.18 170.15 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.9 p -120.51 122.98 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 5.3 m-70 -92.74 99.62 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.081 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.33 110.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.467 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -84.23 171.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.208 0.528 . . . . 0.0 111.922 -178.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -58.4 -146.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.487 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.55 167.44 37.73 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.518 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.408 ' N ' HG21 ' A' ' 35' ' ' VAL . 9.5 m -168.14 148.74 4.95 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -118.6 179.12 4.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.622 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 1.5 tppt? -144.7 168.85 19.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 133' ' ' ASN . 4.0 p -142.12 115.78 9.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.68 122.12 68.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.291 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -89.3 112.34 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.555 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 2.4 mt -81.62 120.65 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.375 0.607 . . . . 0.0 109.634 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.431 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.49 131.25 55.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.922 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.74 146.06 47.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.094 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -160.97 -109.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.489 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 174.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.912 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.734 0.302 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.07 39.21 5.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.8 p -84.37 130.36 34.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.992 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -153.82 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -169.44 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -147.01 169.1 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -98.88 139.84 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.67 163.31 34.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -155.33 31.69 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -159.53 120.82 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.45 -175.59 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 m -155.4 159.12 39.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.87 46.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.53 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mt -135.75 163.92 29.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.0 m -106.71 150.17 39.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.27 -50.68 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.591 2.86 . . . . 0.0 113.318 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -131.87 134.04 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.53 37.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.98 -47.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -66.48 179.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.33 93.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.27 149.97 43.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.064 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -146.03 168.07 21.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.31 -64.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.32 126.54 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -140.14 -67.67 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.931 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.25 -176.88 4.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.77 172.02 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.21 55.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -80.81 122.34 27.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 32' ' ' THR . 72.5 t -68.03 153.25 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.62 ' N ' HG12 ' A' ' 31' ' ' VAL . 9.4 t -62.91 -43.09 99.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.376 0.607 . . . . 0.0 109.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.839 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 65.66 104.71 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.536 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.407 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 7.6 t -162.35 133.73 5.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.419 0.628 . . . . 0.0 112.105 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.2 m -91.68 143.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.546 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.0 t -93.9 111.63 23.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -97.08 120.51 37.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.141 0.496 . . . . 0.0 111.596 -179.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.22 129.93 22.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.59 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.06 155.38 1.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.651 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -29.22 68.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.354 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 72.45 24.7 2.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.62 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 158' ' ' VAL . 2.3 tt0 -164.82 128.15 2.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 0.0 112.013 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.0 p -143.97 107.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.332 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -69.91 127.71 33.81 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.8 t -29.26 131.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 112.727 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.14 -18.54 56.52 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.422 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.54 172.89 6.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.776 0.322 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.39 149.1 47.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -102.56 164.28 11.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.67 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.69 93.88 3.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.82 98.02 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -84.91 80.6 1.82 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' SER . 14.9 p -78.35 97.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.172 0.51 . . . . 0.0 110.754 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -101.74 -128.7 6.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.96 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 131.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.605 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.8 t0 -100.68 -36.41 9.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -158.21 131.57 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.651 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -163.34 91.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.246 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.592 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.32 107.84 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 64.2 m-20 130.22 20.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.55 1.14 . . . . 0.0 111.637 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' A' ' 149' ' ' HIS . . . -155.69 165.82 35.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.771 0.319 . . . . 0.0 110.795 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.52 85.11 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.62 120.24 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 111' ' ' PRO . 5.5 m-85 -112.71 -30.92 6.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.74 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.42 112.5 7.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -85.69 132.82 34.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.192 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.46 110.01 4.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.648 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 10.0 p90 -127.84 171.12 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.137 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.77 113.03 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.789 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -92.77 153.36 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.003 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.16 137.97 54.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.763 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 46.1 p90 -140.46 -175.28 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.92 120.21 40.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -78.32 -3.78 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.35 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.1 20.8 8.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.855 0.36 . . . . 0.0 111.1 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -177.58 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.584 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CZ ' HD13 ' A' ' 160' ' ' ILE . 2.8 m-85 -107.17 155.27 20.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.5 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -151.88 131.11 12.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -53.15 150.84 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 47.6 t -126.62 -84.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -157.91 132.49 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.73 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.87 145.65 29.33 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.176 0.988 . . . . 0.0 111.437 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.44 154.8 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.56 -1.654 . . . . 0.0 112.64 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -165.09 1.14 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -91.0 -158.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.11 37.15 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 -38.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.01 155.51 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -112.41 112.79 24.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 91' ' ' ASN . 3.6 t -101.95 155.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.3 t30 -164.12 109.29 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -97.5 140.07 32.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.202 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -120.38 108.43 14.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.71 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.03 -29.17 43.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.987 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 178.16 -168.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.205 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.41 123.51 24.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 64.16 41.05 98.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.184 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.38 127.33 0.54 Allowed 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.88 136.17 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -174.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -107.28 152.2 24.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.365 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 13.9 p -129.89 146.32 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.431 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.3 mt -131.69 98.39 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.316 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 m -98.12 160.73 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.419 . . . . 0.0 111.655 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 p -163.86 135.4 4.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.324 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p -77.19 110.68 12.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.305 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.8 tp -92.87 29.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.956 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 p -108.94 -27.2 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.971 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.25 -18.02 12.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.225 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -101.84 157.11 34.31 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.28 . . . . 0.0 110.719 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 62.3 Cg_endo -73.5 -175.54 2.09 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.537 2.158 . . . . 0.0 112.459 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.52 114.53 7.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.91 -39.54 32.46 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.563 2.176 . . . . 0.0 112.126 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 67.71 168.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.56 15.81 10.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.127 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.62 -168.54 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.414 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.87 105.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.41 ' HB2' ' CA ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -86.24 -32.66 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.533 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -168.03 131.42 1.6 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.754 0.312 . . . . 0.0 111.262 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.62 113.93 24.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.481 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.52 95.08 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.233 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.0 m -75.6 115.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.841 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 134' ' ' LEU . 3.6 mm? -83.6 169.33 15.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.954 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.477 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -108.74 124.9 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.999 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -100.47 69.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.782 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -5.45 55.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.483 0.659 . . . . 0.0 109.448 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.69 124.27 2.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.453 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.731 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.9 ttpt -44.11 135.02 4.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.562 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.413 ' H ' ' HB ' ' A' ' 160' ' ' ILE . . . -144.27 59.77 1.35 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.852 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.93 -5.28 59.53 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -56.25 91.32 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.321 . . . . 0.0 110.543 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.27 160.04 22.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.194 0.521 . . . . 0.0 111.499 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 156' ' ' LYS . 4.7 mp -137.08 104.3 5.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.612 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.2 p -102.37 125.45 49.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 154' ' ' THR . 19.5 m -111.32 94.95 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.472 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -99.05 -161.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.472 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.24 19.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.6 m -60.26 101.32 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.471 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.14 173.1 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.427 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.4 m -147.95 127.23 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.34 97.89 0.89 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.428 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 32.0 t0 -55.26 161.57 1.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.95 -34.95 91.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.45 -31.59 68.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.99 -31.96 2.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.436 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -69.14 170.08 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.36 150.53 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.447 ' CD2' ' CB ' ' A' ' 61' ' ' ALA . 88.8 m-70 -121.77 95.16 4.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -55.85 105.56 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.433 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.38 -176.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.331 0.586 . . . . 0.0 111.742 -179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 33' ' ' GLY . . . -65.68 -156.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.49 166.97 36.16 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.417 ' CG2' ' HG ' ' A' ' 37' ' ' LEU . 14.9 m -163.14 155.68 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -126.58 173.08 9.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.316 0.579 . . . . 0.0 112.088 -179.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 134' ' ' LEU . 1.4 tppt? -139.56 168.7 19.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -143.09 116.33 8.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -104.73 130.47 55.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.484 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.58 18.7 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.414 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.731 ' HB ' ' HA ' ' A' ' 128' ' ' LYS . 7.1 mt -78.89 119.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.44 0.638 . . . . 0.0 109.712 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.5 136.96 33.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.82 145.03 53.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 111.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.97 150.01 19.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.509 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.36 173.9 10.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.0 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.904 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.793 0.33 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.42 47.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.4 p -77.59 113.68 15.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 111.003 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -144.13 172.11 13.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -171.54 -42.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -92.77 179.67 5.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -135.89 115.09 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -69.15 -68.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -150.58 103.64 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -140.03 82.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 m -106.48 152.96 22.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -139.51 174.94 10.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.52 -76.77 1.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tt 60.73 44.95 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.534 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 21.2 t -58.14 -52.76 72.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.49 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 71.6 Cg_exo -32.3 132.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.309 2.673 . . . . 0.0 113.315 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 mtt-85 -84.5 -178.7 6.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.97 107.93 2.16 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -134.66 164.07 28.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -106.61 -178.51 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtt -97.44 96.68 8.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.2 137.15 14.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.26 124.12 49.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -41.4 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.41 114.6 26.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -60.43 157.32 14.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.16 -171.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.98 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.63 122.47 8.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.26 39.75 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.12 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -77.96 135.7 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.63 HG11 ' N ' ' A' ' 59' ' ' VAL . 61.5 t -89.72 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.533 ' N ' HG12 ' A' ' 31' ' ' VAL . 8.7 t -73.06 -42.54 62.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 59.1 110.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.286 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 30.6 t -150.11 140.01 21.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.731 0.777 . . . . 0.0 111.956 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.5 m -93.36 144.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.066 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -103.07 107.55 18.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.756 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 HD12 ' CG2' ' A' ' 154' ' ' THR . 6.0 mt -96.88 112.51 24.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -136.25 117.42 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.8 164.2 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.307 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 -29.51 68.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.486 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 66.71 33.36 6.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -164.22 120.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 111.772 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.0 p -127.79 167.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.6 tm0? -130.46 118.27 20.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.2 t -28.55 131.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 121.575 0.703 . . . . 0.0 112.355 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.48 13.19 61.83 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.618 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -132.08 174.61 10.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.497 0.319 . . . . 0.0 110.238 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -123.59 149.27 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.861 0.363 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.18 160.05 17.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.572 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -136.14 93.76 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.27 97.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 120' ' ' LYS . . . -79.6 96.33 1.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.927 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 36' ' ' SER . 10.2 p -87.18 95.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.46 -137.4 9.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.83 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.04 134.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 0.0 111.641 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.11 -33.44 11.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -168.39 134.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.6 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.83 90.99 1.42 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.358 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.63 ' N ' HG11 ' A' ' 31' ' ' VAL . 14.2 p -110.12 116.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 73.0 m-20 102.34 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.843 0.857 . . . . 0.0 111.932 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . . . -169.52 143.05 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 82.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 111.77 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.655 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -100.74 -34.33 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.745 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.02 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.064 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 20.1 t80 -108.88 94.84 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -100.11 110.27 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.199 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CE2' ' CG1' ' A' ' 53' ' ' VAL . 14.6 p90 -102.3 171.4 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.42 . . . . 0.0 111.549 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.443 ' HB ' ' ND2' ' A' ' 138' ' ' ASN . 81.5 m -135.85 100.95 4.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.488 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.43 154.54 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.225 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -123.58 104.32 8.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.432 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.1 p90 -114.59 -167.3 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.959 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.32 123.94 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.4 -30.45 53.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -63.8 -30.97 72.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' CB ' ' CB ' ' A' ' 129' ' ' ALA . . . -109.75 -50.93 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -93.33 -176.97 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 109.65 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.99 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 17.6 t80 -51.96 147.77 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 39.3 t -132.3 -74.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -166.91 140.01 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.1 151.97 25.52 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 122.195 0.997 . . . . 0.0 111.525 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.15 174.39 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.375 -1.739 . . . . 0.0 112.167 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -144.7 -165.69 2.21 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -93.99 -158.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.36 36.68 1.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.882 0.373 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.94 -42.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.117 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -89.98 148.42 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.822 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -103.15 137.69 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 91' ' ' ASN . 25.1 t -133.7 144.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.416 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.3 t30 -155.33 116.99 4.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.568 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.53 157.05 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -141.05 107.26 5.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.659 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 22.3 tttt -55.11 115.01 1.99 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 100' ' ' VAL . 1.2 tp -109.81 -25.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.881 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -160.1 165.69 31.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -66.87 128.69 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 62.73 30.69 77.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -173.77 122.86 0.34 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.907 0.384 . . . . 0.0 110.058 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 12.9 m -150.09 155.57 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 152.37 20.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 9.4 p -127.97 139.94 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.89 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.57 107.27 16.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.88 147.0 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.56 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 p -164.49 136.1 4.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.504 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.7 p -83.99 104.88 14.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.94 31.15 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.152 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -99.02 -33.1 10.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.12 -25.1 6.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.307 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.57 155.07 41.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.845 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.36 173.67 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.58 2.187 . . . . 0.0 112.376 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.89 116.87 17.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.12 -30.08 89.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.353 2.035 . . . . 0.0 111.844 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 56.49 169.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.278 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.15 17.86 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.08 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.02 -164.44 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.36 104.62 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.914 0.388 . . . . 0.0 110.605 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.43 -32.84 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -172.69 132.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.31 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HB3' ' CA ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -122.66 132.09 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.556 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.8 p -104.47 118.43 51.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.367 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.2 m -92.89 118.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.7 109.88 21.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.98 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.0 tpp85 -55.17 117.45 3.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.89 71.76 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.531 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.9 -3.28 58.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.538 0.685 . . . . 0.0 109.41 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.43 123.14 2.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.206 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.579 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.8 ttpm? -46.02 157.55 0.12 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.259 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.404 ' CB ' ' CB ' ' A' ' 76' ' ' ALA . . . -169.77 59.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.773 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.16 116.03 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.937 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.87 21.61 49.56 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.261 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.14 70.91 0.16 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.044 0.45 . . . . 0.0 110.377 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.447 ' ND2' HG22 ' A' ' 157' ' ' THR . 1.7 t-20 -43.8 121.87 2.55 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.22 161.07 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.159 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 150.41 26.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.346 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 68' ' ' PHE . 15.2 t -123.33 95.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.475 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.7 p -101.55 -166.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.94 22.86 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.123 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -65.17 107.07 1.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.84 0.352 . . . . 0.0 110.523 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.95 171.26 7.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.44 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.3 m -144.69 132.26 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.703 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.71 96.38 1.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.898 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 23.8 t0 -55.98 161.82 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.767 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.37 -27.94 73.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -74.48 -47.59 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.96 -25.75 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.58 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.52 158.01 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.993 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.89 115.01 47.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 7.5 m-70 -87.5 93.19 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -48.3 108.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.238 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.533 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.35 166.58 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.27 0.557 . . . . 0.0 111.738 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 33' ' ' GLY . . . -59.5 -144.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.327 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.81 -177.21 40.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.108 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.411 ' CG2' HD12 ' A' ' 37' ' ' LEU . 25.4 m -161.24 148.95 15.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.723 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.407 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 15.6 tt0 -102.01 158.14 16.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.276 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.631 ' HG3' ' N ' ' A' ' 157' ' ' THR . 1.5 tppp? -151.28 164.23 37.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.555 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.631 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 4.0 p -142.62 153.91 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.768 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.05 133.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.849 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -99.42 115.03 28.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.159 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.8 mt -86.76 118.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -100.66 128.35 52.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.194 -178.007 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -55.96 146.63 21.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.182 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.74 -80.68 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.494 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 165' ' ' SER . 7.8 t -80.03 -143.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.469 ' N ' ' OG1' ' A' ' 164' ' ' THR . 29.1 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 61' ' ' ALA . 21.8 t -94.2 146.38 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 57' ' ' GLU . 12.6 t -68.1 -36.3 79.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.44 109.24 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.159 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.651 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 3.2 m -151.32 141.23 21.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.522 0.677 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.9 m -95.82 143.3 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.693 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -102.8 105.2 15.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.035 178.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 156' ' ' LYS . 12.1 tp -109.02 125.21 51.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.6 tt0 -140.22 121.91 15.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.019 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -149.32 162.76 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.382 . . . . 0.0 111.68 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -70.71 -28.91 65.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 74.24 24.26 1.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.656 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 7.7 tt0 -164.92 128.28 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.2 p -146.14 107.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.131 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.58 126.83 30.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.178 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.27 124.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 113.85 -19.2 18.73 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.684 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 43' ' ' VAL . 2.9 tt0 -110.42 173.11 6.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.662 0.267 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -114.53 167.62 10.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.741 ' O ' HG12 ' A' ' 122' ' ' VAL . 18.1 mt -108.8 161.43 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -136.08 93.71 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.564 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 39' ' ' ALA . 7.9 m -105.06 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.455 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.791 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.41 72.98 1.87 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.176 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -78.38 99.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.957 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.76 -118.42 3.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.782 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -120.4 135.14 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.014 0.435 . . . . 0.0 111.921 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -36.47 7.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 32' ' ' THR . 81.8 mm-40 -158.99 131.34 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.323 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -154.12 90.62 1.37 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.463 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.774 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.7 p -111.39 114.83 48.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.6 m-20 102.68 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.055 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -145.93 133.63 21.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.777 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.6 tp10 -100.82 86.16 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.582 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.091 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.5 125.83 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.519 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 3.5 m-85 -118.41 -37.85 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.487 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.24 112.79 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.994 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 2.6 t80 -85.75 135.77 33.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 111.508 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -148.06 110.01 4.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.275 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.6 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 11.7 p90 -128.04 171.42 11.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.429 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.72 101.14 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.687 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.796 HD21 HD22 ' A' ' 134' ' ' LEU . 8.0 tt -77.21 153.66 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.923 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.26 114.34 20.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.668 ' HA ' HD23 ' A' ' 134' ' ' LEU . 37.2 p90 -122.83 -172.37 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.13 126.17 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -82.47 -32.19 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -74.99 -29.75 60.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.881 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -107.39 -52.81 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 160' ' ' ILE . 4.7 m-85 -93.43 171.91 8.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.3 115.75 4.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.71 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.601 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.7 t80 -48.42 148.65 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' A' ' 122' ' ' VAL . 48.7 t -130.6 -84.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.871 ' O ' HG22 ' A' ' 122' ' ' VAL . 24.7 mm-40 -157.37 138.65 13.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.197 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.7 153.77 25.17 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.217 1.008 . . . . 0.0 111.757 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.877 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.49 174.7 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.218 -177.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.473 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -154.66 -165.64 2.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.71 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -161.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -95.59 37.77 1.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.53 -39.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.57 HG13 ' C ' ' A' ' 105' ' ' SER . 21.7 t -86.96 140.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.924 0.393 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -97.14 118.66 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.026 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 104' ' ' VAL . 6.3 t -116.83 129.96 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -137.23 120.0 16.26 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.63 148.34 22.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.087 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -131.84 106.69 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.676 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -55.02 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.137 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.9 tp -83.0 -25.12 8.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.836 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -165.33 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 61.15 32.13 79.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.452 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.418 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.51 120.8 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.823 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.24 155.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -97.05 152.53 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.928 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.6 p -126.66 146.83 31.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.445 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 59.6 mt -115.74 107.41 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.757 HG11 ' CD1' ' A' ' 118' ' ' LEU . 9.9 t -104.77 140.92 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 111.543 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.57 ' C ' HG13 ' A' ' 88' ' ' VAL . 1.8 p -164.48 136.89 4.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -83.5 111.24 18.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.212 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -93.55 28.8 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.125 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.7 p -104.04 -27.97 11.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.04 6.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.217 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.34 158.55 35.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 37.2 Cg_endo -66.0 164.14 28.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.532 2.155 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.091 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -55.25 131.78 69.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.424 ' O ' HD23 ' A' ' 118' ' ' LEU . 96.3 Cg_endo -86.81 145.17 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -97.45 168.75 10.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.92 35.11 13.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.14 157.79 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.611 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.791 HG13 ' HA3' ' A' ' 52' ' ' GLY . 36.6 t -50.86 105.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.757 ' CD1' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.54 -30.93 18.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -176.21 157.71 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.733 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.736 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -153.84 131.94 11.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.574 ' O ' HD22 ' A' ' 123' ' ' LEU . 95.3 t -104.62 105.03 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.628 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.877 ' CG1' HD11 ' A' ' 83' ' ' ILE . 26.0 m -75.22 109.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.874 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 121' ' ' VAL . 2.8 mm? -83.15 169.13 16.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 1.7 tpm_? -110.86 118.87 37.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -86.49 67.27 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.243 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.88 -4.76 59.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.45 123.72 2.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.491 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -39.66 160.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.606 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.41 60.8 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.767 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.51 119.74 6.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.286 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 133' ' ' ASN . . . 86.3 13.18 68.83 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.648 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.813 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -69.08 69.93 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.545 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.2 OUTLIER -59.56 146.29 41.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.448 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -117.46 165.11 13.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.857 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.5 115.51 9.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.0 111.178 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 53' ' ' VAL . 2.6 m -96.15 95.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.3 p -111.67 -163.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.704 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.89 21.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -69.22 96.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -94.87 -178.53 4.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 111.366 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.8 m -156.68 141.66 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 88.38 1.5 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.326 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.531 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 14.4 t0 -52.92 160.61 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.67 76.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.584 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -55.72 -26.73 46.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 111.053 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.96 23.18 5.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mt -117.73 170.04 9.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 140' ' ' SER . 77.5 t -109.12 142.23 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.531 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 41.6 m-70 -119.38 92.39 3.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -48.62 97.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.33 164.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.163 0.506 . . . . 0.0 111.69 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.56 -148.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.551 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -170.4 174.58 44.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.468 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.749 HG22 HD23 ' A' ' 37' ' ' LEU . 52.2 m -145.44 162.36 37.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 110.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -123.54 154.07 39.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.973 0.416 . . . . 0.0 111.152 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -132.22 164.08 27.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.936 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 133' ' ' ASN . 1.2 p -141.77 115.57 9.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.983 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.35 135.74 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.412 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -105.32 108.19 19.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -82.99 116.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -98.46 139.78 19.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.92 145.69 55.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 0.0 111.139 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.469 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.337 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 59' ' ' VAL . 65.7 t -68.65 155.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 59' ' ' VAL . 8.4 t -72.59 -43.76 62.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 68.6 114.09 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.225 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.843 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 17.5 t -158.16 134.98 9.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.507 0.67 . . . . 0.0 111.977 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.513 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -96.27 143.87 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.7 t -103.85 106.75 17.36 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.318 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 154' ' ' THR . 6.7 tp -107.38 117.41 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.952 0.406 . . . . 0.0 111.329 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -140.28 139.2 35.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.487 ' HB3' ' HZ3' ' A' ' 156' ' ' LYS . . . -177.4 171.42 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -30.86 67.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.534 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' C ' HG12 ' A' ' 158' ' ' VAL . 0.3 OUTLIER 71.88 31.03 2.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' CD ' HD11 ' A' ' 161' ' ' ILE . 2.1 tm-20 -164.68 130.34 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.947 0.403 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -147.57 107.85 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.137 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.495 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.89 126.42 29.65 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.135 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.35 130.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 112.717 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.98 -20.46 35.92 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.357 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -105.62 172.45 6.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.317 . . . . 0.0 110.659 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -100.71 167.72 10.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 111.095 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.813 HD12 HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -110.4 159.55 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' H ' HD23 ' A' ' 49' ' ' LEU . 4.5 mm-40 -137.24 92.65 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 0.0 110.638 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 49' ' ' LEU . 2.1 m -109.95 96.56 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.411 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.65 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -85.66 70.72 3.0 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.903 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 136' ' ' VAL . 7.1 p -78.38 94.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 118' ' ' LEU . . . -103.06 -129.98 6.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.637 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.723 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -111.44 128.98 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.562 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.5 t0 -93.37 -28.78 15.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 177.34 136.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.493 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 HG12 ' A' ' 55' ' ' ILE . 1.8 pp -153.2 91.56 1.53 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.865 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.687 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.5 p -100.82 114.72 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.994 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.668 ' HB2' HG22 ' A' ' 31' ' ' VAL . 78.8 m-20 105.85 39.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.935 0.894 . . . . 0.0 111.554 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -171.02 148.28 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.64 82.53 1.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.733 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 112.14 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.64 ' O ' HD13 ' A' ' 112' ' ' LEU . 15.8 m-85 -101.76 -32.21 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.13 112.56 6.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.511 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.8 t80 -108.46 96.66 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 111.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.52 110.46 23.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.326 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.969 ' CE2' HG11 ' A' ' 102' ' ' VAL . 34.7 p90 -101.87 160.55 14.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.341 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -111.38 105.28 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.762 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -77.34 128.56 34.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.569 ' N ' HD13 ' A' ' 70' ' ' LEU . 3.0 m-80 -110.96 115.2 29.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.615 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.6 p90 -139.53 -169.13 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.167 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.56 140.97 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.75 -27.37 16.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -59.49 -30.38 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -117.62 -47.14 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.195 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.31 -176.81 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.988 0.423 . . . . 0.0 111.008 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 43.9 tp10 -166.27 155.93 11.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.496 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.6 t80 -94.92 148.96 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -132.22 -78.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.032 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 122' ' ' VAL . 6.1 mm-40 -161.06 134.75 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.18 148.91 27.17 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 122.31 1.052 . . . . 0.0 111.701 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.689 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 174.58 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.098 -177.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.701 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -146.55 -165.65 2.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.82 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -159.79 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.49 36.66 1.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.69 -42.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.21 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 106' ' ' SER . 17.2 t -87.08 146.02 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -105.3 103.3 12.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.701 HG23 ' OG ' ' A' ' 84' ' ' SER . 5.1 t -92.45 153.71 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.24 113.54 1.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.03 166.15 11.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.271 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.86 107.44 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttp -54.69 94.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.11 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -80.68 -23.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.655 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.82 -166.77 0.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.24 133.56 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.54 29.24 63.53 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.516 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' C ' HG13 ' A' ' 100' ' ' VAL . 1.6 ptpm? -173.33 120.05 0.33 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.834 0.35 . . . . 0.0 110.069 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -150.05 155.05 8.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.793 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.3 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.162 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.969 HG11 ' CE2' ' A' ' 68' ' ' PHE . 9.2 p -128.14 93.41 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.772 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.14 111.24 16.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.53 HG23 ' CG2' ' A' ' 90' ' ' VAL . 14.8 p -112.3 151.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.607 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.424 ' C ' HG13 ' A' ' 88' ' ' VAL . 7.9 p -160.81 136.2 7.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 88' ' ' VAL . 1.1 p -78.34 110.68 13.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.2 tt -94.46 30.31 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.133 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.5 p -102.55 -31.58 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 125.97 -22.6 6.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -110.11 159.19 32.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.63 0.253 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.46 179.52 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.583 2.189 . . . . 0.0 112.214 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 118' ' ' LEU . 3.4 mp -56.83 132.28 79.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.94 -39.67 31.58 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.522 2.148 . . . . 0.0 112.204 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 61.55 166.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.108 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 15.78 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -166.7 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.281 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.65 HG13 ' HA3' ' A' ' 52' ' ' GLY . 38.1 t -70.99 104.87 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.581 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.07 -33.49 20.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.2 131.64 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.212 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 mtmt -112.62 117.23 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.447 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.0 p -99.41 105.02 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.3 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 81' ' ' GLU . 24.2 m -75.79 130.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.921 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.8 mt -113.24 111.51 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.847 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 14.1 tpp85 -55.0 111.47 0.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.0 68.31 7.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -85.83 -5.35 59.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.389 0.614 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.48 123.41 2.53 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.644 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.729 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 18.0 ttmt -41.95 162.13 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.319 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.838 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.69 57.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.913 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 3.5 pt-20 -56.02 117.25 3.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.196 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.03 -0.73 67.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.765 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.838 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.3 m -59.17 88.08 0.01 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.437 ' ND2' HG22 ' A' ' 157' ' ' THR . 4.3 m120 -59.92 163.68 4.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 111.533 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 70' ' ' LEU . 3.5 mt -140.3 112.93 8.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.868 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.32 125.67 51.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.506 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 53' ' ' VAL . 12.1 m -110.12 94.81 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.715 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.6 p -100.76 -168.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 21.16 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.886 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 100.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.505 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.58 169.99 8.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.422 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 66' ' ' TYR . 31.1 m -132.48 -179.47 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.61 84.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -55.63 154.49 6.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.978 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.58 -46.46 93.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.46 -29.47 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.15 -25.44 6.06 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.385 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.49 170.17 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.46 139.73 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -114.01 90.44 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 103.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.718 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.513 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.55 -176.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 111.711 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -69.29 -159.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.404 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -155.94 171.22 33.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.187 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 37' ' ' LEU . 66.4 m -152.9 149.13 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -114.68 148.85 37.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.6 tppp? -131.81 163.89 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.332 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.591 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -142.88 124.62 15.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.934 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.805 HG11 HD11 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -114.4 138.36 44.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.13 105.75 16.12 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.893 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.5 mt -82.44 117.08 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.439 0.637 . . . . 0.0 109.437 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.25 137.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.549 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.17 145.57 55.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.015 0.436 . . . . 0.0 110.946 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.433 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.93 0.395 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -60.6 155.7 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.807 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 57' ' ' GLU . 6.5 t -81.33 -46.7 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 67.83 114.63 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.605 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.662 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -150.95 148.41 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.256 0.55 . . . . 0.0 111.574 179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 154' ' ' THR . 5.8 m -99.87 128.88 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.569 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -92.03 106.84 18.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.825 178.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 154' ' ' THR . 4.6 mt -97.48 123.29 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.082 0.467 . . . . 0.0 111.523 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -134.88 101.15 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.015 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.3 141.58 33.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -25.75 67.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.25 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 74.55 23.08 1.96 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.566 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HG2' HD11 ' A' ' 161' ' ' ILE . 3.7 tt0 -164.98 128.34 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.99 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.14 108.0 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -68.2 122.86 19.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.781 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.02 131.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 121.469 0.652 . . . . 0.0 112.641 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.04 -23.71 32.73 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.125 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -96.68 172.99 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.692 0.282 . . . . 0.0 110.43 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -94.93 167.78 11.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 158' ' ' VAL . 4.7 tp -154.93 108.08 2.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HB3' HG12 ' A' ' 122' ' ' VAL . 1.9 pm0 -110.37 146.73 35.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 98.12 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.735 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -67.52 65.88 0.27 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.441 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 136' ' ' VAL . 13.5 p -80.92 102.48 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.64 -123.28 3.6 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.548 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.779 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -111.59 137.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 111.737 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -36.14 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.417 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.5 mp0 -166.29 131.4 2.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.537 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 141' ' ' VAL . 1.1 tt -152.57 96.6 2.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 59' ' ' VAL . 10.1 p -122.99 109.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.559 ' N ' HG22 ' A' ' 31' ' ' VAL . 65.7 m-20 128.61 20.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.403 1.081 . . . . 0.0 111.414 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -161.31 175.76 11.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.087 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -130.2 85.38 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -63.64 127.53 31.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.519 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.494 ' C ' HD23 ' A' ' 112' ' ' LEU . 7.1 m-85 -111.09 -45.43 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.152 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.7 112.71 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.237 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 112' ' ' LEU . 34.2 t80 -97.6 95.02 7.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -106.07 110.15 22.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.4 p90 -112.19 171.16 7.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.104 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.4 m -120.68 107.67 13.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.493 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.525 HD11 HD23 ' A' ' 134' ' ' LEU . 21.2 tp -79.15 133.35 36.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -116.83 109.03 16.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 15.1 p90 -125.04 -166.74 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.4 t70 -120.44 102.8 8.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 111.119 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.44 -28.16 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.63 -47.24 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -116.87 32.87 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.478 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -167.31 -176.48 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.421 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.92 108.95 0.31 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 100' ' ' VAL . 8.5 t80 -54.49 149.32 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.79 ' HB ' HG23 ' A' ' 122' ' ' VAL . 59.7 t -128.65 -79.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.859 ' O ' HG22 ' A' ' 122' ' ' VAL . 13.3 mm-40 -160.89 145.08 13.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.85 150.56 26.48 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.215 1.007 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -124.08 151.31 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.295 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.665 ' HB2' HG12 ' A' ' 90' ' ' VAL . 1.4 m -174.87 129.78 0.31 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.729 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.16 -168.2 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 t0 63.93 63.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.89 25.41 59.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 86' ' ' ASP . 21.6 t -140.96 114.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 111.051 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -113.33 121.66 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 84' ' ' SER . 8.7 p -113.17 153.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.231 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -137.7 123.99 20.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.307 0.575 . . . . 0.0 111.58 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.67 153.53 17.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.761 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 107.11 5.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 111.719 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 7.4 tttt -55.24 117.38 3.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.716 HG22 ' HA ' ' A' ' 100' ' ' VAL . 4.5 tp -109.15 -25.47 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 163.82 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.0 124.22 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 68.57 30.11 72.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.453 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.9 ptmt -174.01 123.21 0.32 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.935 0.397 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HA ' HG22 ' A' ' 95' ' ' ILE . 10.0 m -149.9 154.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.426 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -96.92 152.86 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 112.013 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.3 p -124.35 150.82 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.49 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.4 mt -124.1 108.75 12.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.072 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.661 HG22 ' CG2' ' A' ' 90' ' ' VAL . 97.6 t -102.68 136.64 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.401 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 p -164.39 134.74 4.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -88.88 130.9 35.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.058 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.07 29.35 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 -26.38 9.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.025 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.27 -24.07 10.13 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.125 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -89.38 155.94 48.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.681 0.277 . . . . 0.0 110.663 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 60.5 Cg_endo -72.68 156.16 53.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.57 2.18 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -51.99 133.44 39.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.878 ' O ' HD21 ' A' ' 118' ' ' LEU . 86.6 Cg_endo -84.72 145.35 10.25 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.408 2.072 . . . . 0.0 111.49 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.779 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -98.51 169.19 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 111.317 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.93 33.89 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.482 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.665 ' O ' HD22 ' A' ' 118' ' ' LEU . 13.6 tt0 -161.1 157.58 26.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.735 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.3 t -55.34 105.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 113' ' ' PRO . 1.4 mm? -89.57 -31.28 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . . . -164.38 135.67 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 128.9 40.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.697 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 70' ' ' LEU . 50.2 t -107.13 112.73 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.7 m -75.3 96.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.513 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.488 ' CD1' HD21 ' A' ' 134' ' ' LEU . 36.1 mt -83.17 110.81 18.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.1 tpp85 -55.37 110.93 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.78 70.46 5.13 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -2.39 58.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.444 0.64 . . . . 0.0 109.562 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.64 123.55 2.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.611 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.652 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 8.8 ttpt -51.87 142.5 15.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.691 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.55 63.73 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.14 111.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.71 43.22 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.641 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.806 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -70.69 66.96 0.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.518 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.85 131.69 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.121 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.525 HD23 HD11 ' A' ' 70' ' ' LEU . 5.6 mp -111.6 139.28 47.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.941 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.88 110.61 14.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.902 0.382 . . . . 0.0 111.477 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 53' ' ' VAL . 21.0 m -99.4 95.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.7 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.45 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 13.8 p -103.65 -165.62 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.45 ' ND2' ' C ' ' A' ' 137' ' ' THR . 2.2 p30 43.52 21.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.976 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.505 ' OG ' HD11 ' A' ' 151' ' ' ILE . 5.6 t -63.83 96.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.791 0.329 . . . . 0.0 110.507 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -101.18 167.47 10.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.385 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 58' ' ' LEU . 4.9 m -128.82 -179.59 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.87 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.5 87.2 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.32 162.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.84 -52.11 55.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.19 -30.83 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.781 0.324 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.41 -28.09 4.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.424 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.78 150.93 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.62 149.8 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -123.54 90.55 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.69 107.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.505 HD11 ' OG ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.32 -177.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.418 . . . . 0.0 111.42 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.1 -148.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.347 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.23 37.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.151 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 37' ' ' LEU . 67.9 m -164.16 146.67 9.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.759 0.314 . . . . 0.0 110.573 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -107.05 167.81 9.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.948 0.404 . . . . 0.0 111.543 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.685 ' HD2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.61 163.74 31.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.232 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.451 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.2 p -142.4 119.55 11.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.34 138.05 48.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.161 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -106.79 105.54 15.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -80.46 129.32 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -114.13 129.54 69.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.819 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.8 145.31 41.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.237 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.48 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.931 0.396 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 61' ' ' ALA . 13.4 t -78.57 146.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' GLY . 12.6 t -74.42 -32.6 62.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 57.05 114.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.209 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 13.3 t -147.56 156.44 42.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG23 ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -106.2 129.64 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.035 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -91.41 107.44 19.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.059 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.912 HD12 HG22 ' A' ' 154' ' ' THR . 5.6 mt -96.7 120.26 36.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.439 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -140.18 101.2 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.77 149.64 32.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.444 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.49 -22.25 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.427 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.53 ' C ' HG12 ' A' ' 158' ' ' VAL . 2.8 mp0 67.06 24.38 9.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.549 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -164.96 128.93 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.97 0.414 . . . . 0.0 111.995 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.93 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -145.51 108.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.207 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.88 125.34 26.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.292 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.6 t -29.38 130.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 121.517 0.675 . . . . 0.0 112.705 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.91 -23.65 30.38 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.34 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.03 172.34 7.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -105.85 167.7 9.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.088 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.883 HD11 HG11 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.93 158.26 24.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.63 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' H ' HD23 ' A' ' 49' ' ' LEU . 5.4 mp0 -137.48 92.35 2.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.741 0.305 . . . . 0.0 110.294 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -112.07 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.05 0.453 . . . . 0.0 110.461 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -90.01 81.66 1.41 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.468 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 136' ' ' VAL . 14.8 p -78.61 99.53 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.33 -117.47 4.34 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.59 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.768 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -121.43 127.23 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.491 . . . . 0.0 112.186 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -101.12 -26.15 13.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.6 mp0 -165.41 136.47 3.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.738 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -169.97 91.49 0.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.213 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.835 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.3 p -103.1 115.45 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.734 ' HB2' HG22 ' A' ' 31' ' ' VAL . 20.9 m120 101.48 23.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.214 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -144.49 134.26 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.989 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 19.6 tt0 -105.14 83.71 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.472 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.82 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.8 m-85 -104.14 -33.35 8.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.21 9.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.786 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.775 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 t80 -87.53 137.42 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 111.436 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -147.89 109.43 4.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.182 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CE2' HG11 ' A' ' 102' ' ' VAL . 8.2 p90 -130.85 171.31 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.447 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.83 111.24 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.773 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -77.25 156.17 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.776 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -130.35 104.41 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.44 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 12.0 p90 -122.79 -168.35 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -100.94 147.75 25.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.017 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -105.13 14.66 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -110.17 -31.02 7.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.787 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -113.0 -45.56 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.3 m-85 -93.59 -177.86 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -170.34 112.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 44.6 t80 -53.35 154.41 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 122' ' ' VAL . 46.9 t -134.49 -73.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.86 ' O ' HG22 ' A' ' 122' ' ' VAL . 4.9 mt-10 -163.36 143.62 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.88 155.72 23.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.918 0.866 . . . . 0.0 111.583 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -131.51 154.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.882 -1.508 . . . . 0.0 112.65 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.674 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -123.54 -164.82 1.26 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.784 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 88' ' ' VAL . 13.9 p-10 -96.66 -157.99 0.63 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.774 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -93.87 36.78 1.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.87 -41.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.945 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 112' ' ' LEU . 13.1 t -87.46 153.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.689 0.28 . . . . 0.0 110.694 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.722 ' HB2' HD23 ' A' ' 107' ' ' LEU . 2.7 t80 -110.15 120.7 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.127 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 104' ' ' VAL . 20.2 t -109.29 145.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -160.81 105.44 1.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.541 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.59 -177.04 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 111.52 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.716 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 6.8 tttt -54.01 95.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.165 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.815 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.2 tp -75.55 -25.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -167.4 -173.21 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.37 132.18 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 56.84 33.03 62.72 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.408 ' C ' HG13 ' A' ' 100' ' ' VAL . 11.9 ptpt -173.94 120.27 0.29 Allowed 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.815 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.9 156.09 7.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.663 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.717 HH21 HD21 ' A' ' 103' ' ' LEU . 2.6 ttt180 -103.42 151.8 22.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.8 p -119.53 143.32 31.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.141 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.717 HD21 HH21 ' A' ' 101' ' ' ARG . 80.1 mt -128.18 98.5 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.651 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 66' ' ' TYR . 8.5 p -105.83 157.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.154 0.502 . . . . 0.0 111.785 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.496 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.5 p -163.35 136.83 5.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.124 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' HG13 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -77.25 104.3 7.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.304 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 89' ' ' PHE . 3.4 mm? -71.52 -16.08 62.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.207 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -65.23 -34.81 79.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.87 -18.86 21.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.92 156.96 49.24 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 33.3 Cg_endo -64.66 142.05 75.39 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.607 2.205 . . . . 0.0 112.34 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 88' ' ' VAL . 8.1 mt -54.49 106.92 0.73 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.535 ' O ' HD21 ' A' ' 118' ' ' LEU . 37.0 Cg_exo -60.83 147.69 94.48 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.438 2.092 . . . . 0.0 111.838 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.768 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -101.52 175.47 5.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.183 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 18.61 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.92 -165.75 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.4 t -84.48 104.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 112' ' ' LEU . 2.0 mm? -90.03 -32.81 16.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.977 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.36 131.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.745 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -128.04 159.17 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 70' ' ' LEU . 9.9 p -130.81 148.16 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.917 HG13 HD11 ' A' ' 83' ' ' ILE . 29.3 m -110.7 103.67 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.747 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.643 ' CD1' HD21 ' A' ' 134' ' ' LEU . 9.3 mt -90.41 108.81 20.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.885 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 17.7 ttm180 -55.4 112.56 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.711 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -80.1 71.73 6.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.31 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -87.43 -3.93 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 109.588 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.71 123.57 2.46 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.518 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.732 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -49.19 140.79 9.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.579 -178.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -143.37 62.99 1.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.541 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.98 121.61 9.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.485 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.45 18.83 79.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.691 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 28.7 t -68.99 71.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.895 0.378 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -45.31 132.22 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.025 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.643 HD21 ' CD1' ' A' ' 123' ' ' LEU . 5.4 mp -117.87 129.69 55.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.933 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.7 p -108.22 121.06 44.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.939 0.4 . . . . 0.0 111.489 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 53' ' ' VAL . 21.3 t -104.65 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 p -109.98 -164.65 0.94 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.78 17.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.606 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -64.71 95.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.88 8.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 111.618 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 66' ' ' TYR . 26.7 m -139.87 -179.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.914 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.27 89.67 0.4 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 5.2 p30 -62.07 168.35 3.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.67 22.21 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.904 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 147' ' ' LEU . 2.6 mt-10 -55.09 -23.42 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 111.337 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.18 -17.9 28.8 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.415 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' GLU . 3.0 mp -65.3 170.46 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.01 120.47 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 143' ' ' ASP . 45.6 m-70 -92.46 92.71 8.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.91 102.52 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.36 167.41 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 111.738 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.01 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.658 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.1 171.16 40.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.301 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.912 HG22 HD12 ' A' ' 37' ' ' LEU . 50.9 m -165.2 155.95 14.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.656 0.265 . . . . 0.0 110.77 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -118.6 170.14 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.534 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -143.14 166.22 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -143.17 120.57 11.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.634 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -114.66 126.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -91.66 105.46 17.75 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.93 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.2 mt -81.07 120.65 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -104.45 131.65 52.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.817 -178.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.74 145.88 38.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 60' ' ' ASN . 43.3 t -74.48 149.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 57' ' ' GLU . 15.0 t -65.66 -36.21 83.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 58.53 109.94 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.913 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.5 t -155.55 143.19 19.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.567 0.699 . . . . 0.0 111.943 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HD11 ' A' ' 151' ' ' ILE . 35.7 m -101.95 143.95 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.842 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -100.31 106.38 18.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.613 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.92 HD21 ' HB2' ' A' ' 156' ' ' LYS . 4.3 tp -103.87 119.95 39.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.484 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.547 ' N ' HD12 ' A' ' 37' ' ' LEU . 40.8 tp10 -139.26 101.4 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.666 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -134.53 151.37 51.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.413 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.93 -28.05 65.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.339 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.3 mt-10 67.68 23.42 8.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.431 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 18.3 tt0 -164.81 123.9 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 0.0 111.772 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -144.89 108.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.289 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.16 127.33 32.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -29.33 131.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.24 -21.48 42.99 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.532 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -97.73 172.33 7.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 110.638 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -112.4 167.73 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.146 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.443 HD22 HG11 ' A' ' 158' ' ' VAL . 9.9 tp -130.2 153.42 48.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 15.2 mp0 -135.65 93.45 2.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.92 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' ALA . 7.2 p -104.16 98.1 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.613 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.801 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -89.37 87.05 1.44 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.867 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 136' ' ' VAL . 8.3 p -78.93 95.18 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.71 -128.82 6.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.634 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.585 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.65 128.9 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.053 0.454 . . . . 0.0 111.859 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 18.5 t0 -97.58 -30.06 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' HG21 ' A' ' 32' ' ' THR . 1.6 mp0 -167.35 135.12 2.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.024 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -161.53 90.84 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.379 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.738 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.9 p -115.53 126.97 73.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.975 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.748 ' HB2' HG22 ' A' ' 31' ' ' VAL . 25.0 m120 104.38 15.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.786 0.834 . . . . 0.0 112.064 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.724 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.85 176.35 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.42 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.1 tt0 -129.98 83.17 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.8 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.683 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.1 120.73 11.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.7 ' C ' HD23 ' A' ' 112' ' ' LEU . 4.1 m-85 -120.37 -43.17 2.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.639 ' N ' HD23 ' A' ' 112' ' ' LEU . . . -134.3 118.31 17.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.048 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 t80 -85.96 137.9 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -147.66 109.85 4.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.455 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 136' ' ' VAL . 14.7 p90 -139.48 171.17 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.19 115.75 21.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.884 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.665 ' CD2' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -88.14 111.16 21.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 1.2 p-10 -95.69 104.61 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 38.2 p90 -107.91 -168.44 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.631 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.31 104.72 14.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HB2' ' N ' ' A' ' 98' ' ' GLY . 14.2 tp10 -67.25 -26.72 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.91 -29.19 62.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.144 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.903 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -124.43 -40.35 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.381 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.21 -176.88 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -165.2 121.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 26.5 t80 -56.43 150.67 14.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.0 t -132.46 -71.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.6 pp20? -172.94 140.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 149.57 27.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.118 0.961 . . . . 0.0 111.45 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -115.7 153.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.511 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.752 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -120.68 -167.01 1.4 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.26 -158.54 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -95.61 36.92 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.83 -45.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.621 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.752 HG23 ' OG ' ' A' ' 84' ' ' SER . 32.8 m -86.66 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.244 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.37 124.19 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.093 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.746 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 t -115.8 136.22 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -148.94 116.57 6.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -97.07 153.53 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -133.48 107.36 7.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.667 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 11.4 tmtt? -55.15 95.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.799 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.3 tp -84.51 -25.93 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.875 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -166.57 177.62 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.768 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 130.11 40.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 58.78 33.21 72.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.43 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' ASN . 13.2 ptpt -173.77 118.96 0.28 Allowed 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.799 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.5 m -149.84 154.68 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -89.21 152.27 21.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.91 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.1 p -128.28 96.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.668 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mt -86.69 102.77 14.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.9 p -107.3 153.59 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.288 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -164.5 138.51 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.381 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.622 ' OG ' HG12 ' A' ' 88' ' ' VAL . 47.1 m -76.47 104.59 7.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.283 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -13.92 62.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.607 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -65.41 -28.46 69.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.85 -23.1 12.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.954 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.68 155.09 45.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 110.546 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -64.93 153.85 76.11 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.587 2.191 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.72 HD13 HD21 ' A' ' 118' ' ' LEU . 1.8 pp -52.91 132.62 48.75 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 94.1 Cg_endo -88.91 144.99 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.773 2.315 . . . . 0.0 112.209 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -94.57 170.69 9.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.178 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 32.91 12.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -163.5 158.2 20.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.598 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HA3' ' A' ' 52' ' ' GLY . 33.8 t -52.96 105.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -85.41 -32.33 22.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.961 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.45 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.73 135.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.797 ' HD3' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -126.3 149.58 49.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.675 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' A' ' 70' ' ' LEU . 42.0 t -113.06 154.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.532 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' GLU . 23.1 t -119.85 95.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.599 HD21 HD22 ' A' ' 70' ' ' LEU . 1.2 mm? -88.04 108.31 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.483 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 37.3 ttm180 -64.97 117.6 7.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -76.77 72.78 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.505 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -87.96 -3.62 58.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 0.0 109.438 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.39 123.49 2.58 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.407 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.731 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.6 ttmt -48.82 138.02 11.73 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.393 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.903 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -143.66 62.91 1.36 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.575 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.12 116.16 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.404 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.89 19.53 59.35 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.702 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.835 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.9 66.28 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.116 0.484 . . . . 0.0 110.455 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.453 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 1.1 t-20 -42.39 129.73 3.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.421 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 132' ' ' SER . 5.2 mp -111.2 150.28 29.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.51 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.07 121.45 14.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.0 111.579 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 53' ' ' VAL . 8.9 p -99.71 95.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.599 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.4 p -100.3 -165.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.789 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.37 19.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.065 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -63.35 87.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.933 0.397 . . . . 0.0 110.227 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.664 ' HB2' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -106.38 162.11 13.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.436 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.898 ' O ' HG23 ' A' ' 148' ' ' VAL . 28.5 m -130.32 128.79 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.947 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.77 83.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.694 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 22.8 t70 -57.77 140.8 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.816 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.84 76.08 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.728 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.7 -29.59 66.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.14 15.04 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.746 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.62 115.11 28.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 110.769 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 141' ' ' VAL . 14.1 p -73.08 141.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -104.8 99.0 8.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.87 102.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.602 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.27 -176.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.784 -178.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -75.83 -161.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.408 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.65 34.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.791 HG22 HD23 ' A' ' 37' ' ' LEU . 90.8 m -153.69 146.48 24.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.723 0.297 . . . . 0.0 110.849 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.81 161.96 15.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 111.261 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.92 ' HB2' HD21 ' A' ' 37' ' ' LEU . 3.9 tppt? -139.99 169.19 18.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.6 p -142.15 115.93 9.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.592 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -110.52 126.17 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 105.72 17.91 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.2 mt -80.72 122.59 36.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.13 132.98 51.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.623 -178.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.03 145.21 42.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.154 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.5 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 60' ' ' ASN . 15.2 t -60.64 151.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 33' ' ' GLY . 14.6 t -74.52 -46.69 37.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 76.09 112.27 0.12 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.692 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.899 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -159.75 139.16 11.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.0 111.428 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD11 ' A' ' 151' ' ' ILE . 19.1 m -98.93 141.15 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.527 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.45 106.38 18.68 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.826 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 HG22 ' A' ' 154' ' ' THR . 6.2 tp -107.17 106.58 17.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 111.355 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -121.94 118.65 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.412 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.74 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.493 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.82 -27.4 68.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 73.1 22.89 2.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.414 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 158' ' ' VAL . 41.6 tt0 -164.53 128.19 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.995 0.426 . . . . 0.0 112.114 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.4 p -132.52 168.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.735 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.577 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tm0? -131.56 118.49 20.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.1 t -28.57 130.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.488 0.661 . . . . 0.0 112.477 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.62 64.49 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.776 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.98 173.73 6.34 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.331 0.252 . . . . 0.0 110.473 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.524 ' HB3' HG13 ' A' ' 122' ' ' VAL . 16.9 m-80 -119.03 131.39 55.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.094 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.648 ' CD1' HG11 ' A' ' 158' ' ' VAL . 15.4 tp -86.91 154.99 20.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.21 93.47 2.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -105.06 98.17 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -87.75 86.05 1.51 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.89 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -82.18 95.24 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -100.62 -127.63 6.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.981 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.942 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -115.31 130.29 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 111.724 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.94 -39.3 11.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.07 132.79 0.51 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.942 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -157.25 113.69 2.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.539 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.6 p -128.89 100.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 31' ' ' VAL . 4.7 m120 139.57 23.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.404 1.065 . . . . 0.0 111.737 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.67 147.42 6.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.776 0.322 . . . . 0.0 111.213 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -105.22 85.87 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 112.93 2.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 25.3 m-85 -99.77 -32.75 10.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.155 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.94 112.61 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.942 ' O ' HG12 ' A' ' 104' ' ' VAL . 35.6 t80 -102.79 130.67 49.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.627 ' CG ' HD23 ' A' ' 103' ' ' LEU . 10.7 m-20 -135.06 119.25 17.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.856 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.923 ' CE2' HG11 ' A' ' 102' ' ' VAL . 24.7 p90 -120.63 155.99 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -123.42 103.39 8.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.457 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 121' ' ' VAL . 1.1 pt? -77.36 156.13 31.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.348 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -124.0 104.4 8.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.695 ' HB3' HD11 ' A' ' 134' ' ' LEU . 18.6 p90 -118.44 -166.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -114.65 143.15 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.81 -25.21 15.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.012 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -62.14 -29.42 70.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.039 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -124.52 -43.92 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -93.16 169.27 10.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.636 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -159.2 119.71 3.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 23.7 t80 -57.32 153.7 11.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.6 t -131.49 -72.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 122' ' ' VAL . 15.4 pt-20 -170.38 143.94 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.819 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -84.54 150.78 25.0 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.251 1.024 . . . . 0.0 111.538 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.13 153.39 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.336 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.13 -174.43 2.71 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -159.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.745 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.78 36.64 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.92 -39.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.184 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 89' ' ' PHE . 14.1 t -87.18 159.96 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.979 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' N ' HG12 ' A' ' 88' ' ' VAL . 33.3 t80 -115.98 113.05 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 104' ' ' VAL . 2.1 t -104.23 155.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 22.6 t-20 -166.24 110.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.399 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.99 158.14 15.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -145.83 107.15 4.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.73 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 20.4 tttt -55.14 117.03 3.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.312 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.5 tp -111.22 -23.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.847 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -167.86 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.24 -75.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 72' ' ' TYR . . . -106.22 53.12 0.65 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.408 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.3 ptmt -174.21 129.74 0.37 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.73 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 14.5 m -149.59 155.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.879 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.591 ' HD2' HG23 ' A' ' 69' ' ' THR . 0.9 OUTLIER -91.5 152.41 20.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.532 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.923 HG11 ' CE2' ' A' ' 68' ' ' PHE . 10.3 p -139.44 122.17 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.878 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.627 HD23 ' CG ' ' A' ' 67' ' ' ASP . 17.3 mt -109.72 108.92 19.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.9 p -106.7 148.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.414 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -155.91 136.48 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.44 104.5 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.5 tp -72.42 -12.85 61.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 p -65.27 -30.27 71.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.04 -18.98 18.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.412 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.93 147.87 34.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.3 Cg_exo -53.97 -178.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.476 2.117 . . . . 0.0 112.446 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.785 HD11 ' HG ' ' A' ' 118' ' ' LEU . 8.5 tt -58.57 123.0 64.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.62 -43.82 24.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.463 2.109 . . . . 0.0 112.129 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . . . 62.34 167.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.17 19.75 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.216 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.44 -168.62 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.439 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.693 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.5 t -74.73 104.99 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.728 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -83.63 -34.7 25.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -174.35 132.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 111.297 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.669 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -121.59 137.85 54.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.374 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.749 HG21 HD22 ' A' ' 70' ' ' LEU . 68.9 t -99.3 135.93 32.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.83 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 81' ' ' GLU . 47.6 t -93.47 97.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.887 HD11 HD21 ' A' ' 134' ' ' LEU . 44.7 mt -92.28 108.42 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG21 ' A' ' 80' ' ' VAL . 29.5 ttm180 -69.7 116.39 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.02 73.71 4.57 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.252 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -3.6 59.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.544 0.688 . . . . 0.0 109.503 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.88 123.0 2.7 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.121 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.646 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.9 ttpp -44.94 154.12 0.15 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.329 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.697 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -162.47 59.79 0.22 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.917 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 6.8 tt0 -55.81 117.18 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.972 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.55 61.59 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.371 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.697 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 41.3 t -70.5 87.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 110.397 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -57.99 162.83 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.516 . . . . 0.0 111.401 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.887 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -143.91 104.85 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.645 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -100.1 131.3 46.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.645 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 53' ' ' VAL . 26.8 t -111.12 94.69 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.532 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.5 p -99.79 -164.45 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.676 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.23 22.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.021 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 151' ' ' ILE . 27.9 m -61.63 100.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 110.436 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 173.17 6.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.4 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.51 -179.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.24 85.46 0.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -55.61 -174.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.09 -38.4 10.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.17 -29.45 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.6 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.655 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.69 170.32 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.23 129.49 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -106.41 91.09 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.0 109.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.539 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -89.79 -176.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.226 0.536 . . . . 0.0 111.599 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.86 -160.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.374 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.62 168.7 34.36 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.365 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.842 HG22 HD23 ' A' ' 37' ' ' LEU . 88.2 m -155.77 148.12 23.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.786 0.326 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.81 153.27 33.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 tppp? -135.31 167.03 21.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.238 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.1 p -142.83 134.65 26.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 49' ' ' LEU . 1.3 m -125.4 129.96 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.31 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.87 107.27 19.09 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.01 0.433 . . . . 0.0 110.484 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.6 mt -76.79 120.48 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.62 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.12 128.32 59.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -178.119 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.74 146.13 37.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.769 0.318 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 61' ' ' ALA . 6.8 t -82.64 151.17 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.763 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' GLY . 5.3 t -90.82 -30.99 16.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 55.31 132.1 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.575 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.69 159.09 43.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.202 0.525 . . . . 0.0 111.605 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG21 ' HA2' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -112.18 123.56 68.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.271 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -92.24 109.57 20.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.386 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.897 HD12 HG22 ' A' ' 154' ' ' THR . 3.8 mt -97.1 120.74 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' HG22 ' A' ' 117' ' ' VAL . 4.5 tm-20 -133.49 101.37 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.344 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -146.63 152.86 39.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.05 -26.43 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.393 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 66.56 24.25 10.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.381 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.83 117.22 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.796 0.332 . . . . 0.0 111.598 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -136.87 107.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.65 128.36 36.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.238 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.428 HG23 ' CG2' ' A' ' 160' ' ' ILE . 2.0 t -31.02 132.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-O 121.5 0.667 . . . . 0.0 112.709 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 -24.01 32.98 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.39 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.85 172.47 7.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 0.0 110.631 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.63 151.69 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 122' ' ' VAL . 21.1 tp -104.48 153.4 21.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 3.1 pt-20 -136.75 93.29 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 110.649 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.2 p -107.01 97.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.795 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.02 82.59 1.59 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.623 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 136' ' ' VAL . 9.7 p -78.63 95.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.761 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.29 -134.71 8.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.69 136.44 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -96.83 -36.34 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.57 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 177.15 131.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.436 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.879 HD13 ' HB3' ' A' ' 61' ' ' ALA . 2.7 pp -141.09 103.49 4.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.764 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.824 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.4 p -94.76 110.18 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 20.2 m120 98.68 26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.435 0.694 . . . . 0.0 112.333 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -136.9 150.2 48.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.227 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -128.78 66.29 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.112 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.49 144.08 56.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.049 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.718 ' O ' HD13 ' A' ' 112' ' ' LEU . 17.6 m-85 -120.23 -35.38 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.51 112.68 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.766 ' O ' HG12 ' A' ' 104' ' ' VAL . 41.6 t80 -86.16 148.27 25.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.991 0.425 . . . . 0.0 111.458 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.618 ' OD1' HD23 ' A' ' 103' ' ' LEU . 7.0 m-20 -147.67 111.27 4.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.916 ' CE2' HG11 ' A' ' 102' ' ' VAL . 16.5 p90 -122.97 156.16 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 111.557 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.19 103.15 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.418 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 123' ' ' LEU . 1.5 pt? -77.09 156.05 31.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.8 104.49 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 18.7 p90 -118.3 -167.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.4 113.59 21.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -27.98 65.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.08 -46.65 86.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.035 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.03 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.59 20.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -164.33 -179.69 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -171.56 113.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.706 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.613 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.1 t80 -51.01 149.27 3.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.0 t -129.1 -82.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.01 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 122' ' ' VAL . 11.0 mt-10 -156.17 134.8 11.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.76 151.2 26.25 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.12 0.962 . . . . 0.0 111.478 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.88 HD12 ' HE2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -126.97 158.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.421 -177.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.532 ' CB ' HG23 ' A' ' 90' ' ' VAL . 1.8 t -121.21 -164.68 1.15 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.794 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -93.0 -157.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.754 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.5 37.67 1.12 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.93 0.395 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.12 -39.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 29.5 t -87.05 154.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.639 0.257 . . . . 0.0 110.773 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.91 121.41 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.582 HG22 ' HB ' ' A' ' 104' ' ' VAL . 5.2 t -109.11 155.23 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 22.3 t-20 -162.78 110.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.86 156.21 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.39 107.09 5.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.229 0.538 . . . . 0.0 111.536 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.1 tttm -54.71 96.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.477 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -84.83 -22.76 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.589 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -166.76 2.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -99.28 52.41 1.08 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.364 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.5 ptmt -174.19 126.14 0.34 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 95' ' ' ILE . 5.5 m -148.71 155.03 9.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.698 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -97.24 152.49 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.916 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.3 p -133.47 121.97 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.139 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.618 HD23 ' OD1' ' A' ' 67' ' ' ASP . 14.2 mt -107.85 98.97 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.7 p -98.31 149.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.33 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 p -151.61 135.54 16.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.421 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.21 111.56 12.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.912 0.386 . . . . 0.0 111.309 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.28 29.68 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.006 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -106.79 -29.71 9.37 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.988 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.95 -20.8 14.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.166 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -97.39 155.83 36.89 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 56.4 Cg_endo -70.51 173.61 11.38 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.545 2.163 . . . . 0.0 112.446 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.27 109.23 1.53 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.26 -22.33 73.97 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.397 2.065 . . . . 0.0 112.147 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 55.97 177.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.876 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.52 25.78 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.634 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -159.31 155.85 27.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.9 t -45.62 104.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 0.0 111.274 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.672 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.48 -31.13 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.962 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -174.3 134.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.123 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.88 ' HE2' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -126.58 116.76 21.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 76.1 t -86.99 111.18 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 83' ' ' ILE . 21.9 t -75.65 111.24 11.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.026 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 70' ' ' LEU . 35.8 mt -92.9 169.28 10.57 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 8.6 ttm180 -116.44 123.39 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.72 72.12 8.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.341 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.03 -6.68 57.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 109.706 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.87 123.62 2.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.739 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.668 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.8 ttmt -44.46 162.37 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.517 -1.219 . . . . 0.0 112.349 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.03 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.84 61.67 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.79 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 5.4 tt0 -55.27 111.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 23.26 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.138 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.31 65.96 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.895 0.379 . . . . 0.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -44.86 132.88 6.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.161 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.639 HD21 HD11 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -118.74 134.61 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.951 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 p -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.888 0.375 . . . . 0.0 111.405 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 53' ' ' VAL . 15.7 m -107.16 94.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.814 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.2 p -99.7 -164.11 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.547 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 40.54 25.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 151' ' ' ILE . 1.9 p -68.56 93.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.62 170.17 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m -129.32 179.87 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.989 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.56 64.06 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.452 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.48 138.67 45.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.78 58.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.612 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -56.49 -28.1 58.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.6 -1.24 36.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.852 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.62 131.62 56.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.9 t -76.88 123.93 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.05 92.0 5.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.623 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.54 107.28 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.659 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.39 169.01 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.263 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.618 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.48 -153.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.723 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -154.41 165.48 31.91 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.224 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.897 HG22 HD12 ' A' ' 37' ' ' LEU . 36.8 m -161.03 147.33 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.734 0.302 . . . . 0.0 110.647 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.9 173.82 6.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.675 ' HB2' HD13 ' A' ' 37' ' ' LEU . 3.8 tppt? -144.72 168.69 19.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.081 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.431 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 1.9 p -142.43 115.66 8.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.04 127.38 68.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -97.49 105.79 18.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.9 mt -83.92 116.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.397 0.617 . . . . 0.0 109.748 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.5 143.47 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.677 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.75 146.36 54.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.898 0.38 . . . . 0.0 110.924 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.928 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.831 0.348 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.588 HG22 ' C ' ' A' ' 59' ' ' VAL . 29.6 t -61.06 155.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.0 t -78.73 -47.15 17.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 72.03 113.12 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.672 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.9 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.5 m -156.57 138.42 14.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.455 0.645 . . . . 0.0 111.507 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 19.8 m -91.48 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.8 t -90.95 134.29 34.6 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.183 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.818 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -110.73 118.69 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 tt0 -140.7 116.94 10.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -169.48 144.29 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.672 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.05 -27.0 66.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.055 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' C ' HG12 ' A' ' 158' ' ' VAL . 4.8 mt-10 73.17 21.86 3.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.691 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 158' ' ' VAL . 1.7 tm-20 -165.15 127.66 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.873 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -146.16 107.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.353 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -65.4 123.93 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -28.91 130.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.629 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.1 -23.05 24.12 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -107.9 174.97 5.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 110.413 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -128.78 148.25 50.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.59 128.19 51.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.619 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 3.4 pt-20 -101.43 131.34 47.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.384 . . . . 0.0 111.19 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 39' ' ' ALA . 11.1 t -108.4 97.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -70.19 62.09 0.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.102 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 136' ' ' VAL . 7.2 p -81.17 112.45 19.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.291 . . . . 0.0 110.396 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 118' ' ' LEU . . . -126.61 -91.24 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.618 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.527 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -135.65 134.86 51.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.075 0.464 . . . . 0.0 111.985 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -102.64 -38.93 7.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HA ' ' HZ3' ' A' ' 115' ' ' LYS . 77.2 mm-40 -159.35 129.0 5.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.006 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.767 HD21 ' CD2' ' A' ' 149' ' ' HIS . 1.0 OUTLIER -153.19 90.84 1.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.729 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 ' C ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -121.45 110.74 28.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.563 ' N ' HG22 ' A' ' 31' ' ' VAL . 72.6 m-20 127.6 17.92 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.499 1.119 . . . . 0.0 111.493 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -157.79 -178.04 7.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.966 0.413 . . . . 0.0 111.078 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -137.0 76.57 1.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.589 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.9 111.93 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.511 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 11.3 m-85 -89.37 -34.4 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.048 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.03 112.35 8.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.36 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' H ' HD11 ' A' ' 112' ' ' LEU . 11.3 t80 -98.68 94.12 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 0.0 110.918 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD2' HD23 ' A' ' 103' ' ' LEU . 9.1 t0 -100.5 135.94 41.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 102' ' ' VAL . 47.0 p90 -140.97 171.21 14.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.238 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.29 91.2 3.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.635 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.783 ' HB2' HG12 ' A' ' 136' ' ' VAL . 8.2 tt -77.03 152.96 34.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.108 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' HD23 ' A' ' 70' ' ' LEU . 28.0 p30 -131.41 155.93 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.989 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 21.0 p90 -155.55 -169.34 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.67 140.89 28.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -105.84 -13.75 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -96.26 25.81 4.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.765 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -170.6 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.905 0.384 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.745 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.1 m-85 -93.3 -176.89 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -170.85 111.84 0.38 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.644 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 18.2 t80 -50.14 152.83 1.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.809 ' HB ' HG23 ' A' ' 122' ' ' VAL . 66.9 t -131.04 -78.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -163.61 143.2 8.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.864 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.63 150.23 26.95 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-O 122.04 0.924 . . . . 0.0 111.439 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -140.35 151.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.268 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -129.6 -176.17 3.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.077 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -160.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.88 23.49 4.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.59 -44.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.906 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 105' ' ' SER . 16.3 t -97.05 143.27 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.687 0.28 . . . . 0.0 110.626 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -117.23 109.41 16.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 103' ' ' LEU . 7.1 p -102.18 144.13 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.918 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -132.18 124.81 29.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -98.06 161.27 13.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.682 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.21 107.05 5.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 111.719 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.668 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.28 95.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.08 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -83.91 -30.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.882 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.18 -168.38 2.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.429 ' HB3' ' CB ' ' A' ' 74' ' ' GLU . 4.6 m-20 -84.31 130.07 34.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.34 31.67 70.48 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.345 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.416 ' C ' HG13 ' A' ' 100' ' ' VAL . 12.8 ptpt -173.75 122.08 0.33 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.848 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.3 m -149.89 154.7 8.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.731 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -85.75 152.26 23.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.184 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.2 p -125.48 136.99 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.308 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.467 ' C ' HG23 ' A' ' 90' ' ' VAL . 12.0 mt -123.79 109.69 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 111.087 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.7 p -109.86 147.32 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 112.018 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 88' ' ' VAL . 2.7 p -164.78 135.44 4.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.029 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 88' ' ' VAL . 17.1 m -73.68 104.18 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -69.66 -17.56 63.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.182 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -65.36 -32.91 74.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.02 -17.11 20.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.91 155.29 37.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.653 0.264 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 37.4 Cg_exo -60.13 164.85 11.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.558 2.172 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.915 HD22 HD12 ' A' ' 118' ' ' LEU . 91.1 mt -59.82 113.65 7.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.64 -20.88 67.03 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.3 2.0 . . . . 0.0 112.282 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 62.93 173.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HZ3' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 56.79 24.28 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -142.21 -164.34 1.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.323 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.69 HG13 ' HA3' ' A' ' 52' ' ' GLY . 29.1 t -91.49 104.63 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.408 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.915 HD12 HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -91.97 -33.65 14.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -157.72 136.76 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.512 ' O ' HG13 ' A' ' 83' ' ' ILE . 2.2 mtpt -135.16 100.71 4.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.271 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.84 114.36 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.809 HG23 ' HB ' ' A' ' 80' ' ' VAL . 9.1 m -87.19 108.05 17.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.198 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -85.57 108.44 17.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 20.3 ttm180 -55.54 117.09 3.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -84.59 69.39 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.217 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -87.55 -3.93 58.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.58 123.71 2.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.544 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.738 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.2 ttpt -42.63 155.13 0.05 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.325 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -168.56 58.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.799 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 7.3 pt-20 -55.73 111.65 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.224 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.5 -12.65 39.47 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.519 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.571 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 39.9 t -54.65 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 0.7 OUTLIER -83.6 138.66 33.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.261 0.553 . . . . 0.0 112.19 -178.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 134' ' ' LEU . 4.7 mp -110.77 132.14 54.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.615 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.4 126.5 46.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.019 0.438 . . . . 0.0 111.65 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 53' ' ' VAL . 22.5 m -101.51 94.72 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.665 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 139' ' ' SER . 20.9 p -100.63 -169.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.695 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.72 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.928 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER -64.98 105.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 0.0 110.607 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -178.47 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.293 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 148' ' ' VAL . 4.0 m -141.45 -179.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.67 81.82 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.956 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 27.6 t0 -45.92 160.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 111.271 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.05 97.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -66.52 -31.34 72.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.317 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.04 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.39 168.89 2.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.811 HG22 ' O ' ' A' ' 141' ' ' VAL . 56.6 t -123.99 141.56 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.052 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.767 ' CD2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.14 94.23 4.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -46.97 104.62 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.743 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.451 HD11 ' HE1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -85.71 -176.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -72.5 -158.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.28 168.85 35.99 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.231 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.797 ' HB ' HD23 ' A' ' 37' ' ' LEU . 44.4 m -164.7 163.95 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 110.662 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 154' ' ' THR . 15.9 pt-20 -134.64 177.44 7.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.169 0.509 . . . . 0.0 111.692 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.818 ' HE2' HD12 ' A' ' 37' ' ' LEU . 10.3 tppt? -146.59 169.74 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 0.6 OUTLIER -141.64 115.9 9.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.42 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -104.61 137.94 31.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.226 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.77 105.38 15.58 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.571 179.382 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -83.63 121.44 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 121.305 0.574 . . . . 0.0 109.621 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -104.24 148.8 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.396 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.71 145.66 48.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.902 0.382 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.468 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.862 0.363 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 23.7 t -60.65 155.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -81.47 -46.04 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 74.43 117.4 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.301 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.956 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -163.48 136.77 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.19 0.519 . . . . 0.0 111.465 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.5 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.631 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -91.55 106.3 18.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.089 178.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.915 HD23 HG22 ' A' ' 154' ' ' THR . 6.4 tp -112.35 116.86 31.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -140.35 108.48 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.279 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 156' ' ' LYS . . . -138.6 161.95 35.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.563 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.373 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 69.24 24.87 5.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.703 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 158' ' ' VAL . 28.3 tt0 -164.71 125.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -147.6 107.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.343 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -67.92 126.32 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.131 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.442 HG23 ' CG2' ' A' ' 160' ' ' ILE . 1.5 t -29.45 127.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.81 12.85 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.628 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -175.63 2.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.87 148.61 52.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.818 HD22 HG11 ' A' ' 158' ' ' VAL . 4.2 pp -97.01 159.93 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HA ' HG12 ' A' ' 122' ' ' VAL . 3.7 mt-10 -128.26 93.57 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.3 p -102.37 98.16 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.835 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.35 79.94 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.559 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 136' ' ' VAL . 9.6 p -78.46 102.92 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.96 -130.12 5.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.096 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -109.36 127.42 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.624 -179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 28.1 t0 -96.81 -37.06 10.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 22.4 mp0 -162.09 130.77 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.169 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 1.6 tt -158.86 91.05 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.636 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.4 p -118.65 104.25 15.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.582 ' N ' HG22 ' A' ' 31' ' ' VAL . 7.5 m120 134.0 23.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 111.519 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -152.68 -170.9 3.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.642 0.258 . . . . 0.0 110.75 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -139.7 82.21 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.36 . . . . 0.0 110.661 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.37 121.19 12.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.276 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' HA2' ' A' ' 144' ' ' GLY . 3.7 m-85 -117.8 -40.68 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.2 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.557 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.4 t80 -86.07 135.7 33.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.388 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.71 109.62 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.792 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.2 p90 -124.82 171.24 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.54 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 104.58 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.512 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 71' ' ' ASN . 5.2 tt -77.11 153.48 34.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 111.141 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' HD23 ' A' ' 70' ' ' LEU . 5.6 m120 -127.56 107.35 9.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' HB3' HD22 ' A' ' 134' ' ' LEU . 16.7 p90 -122.67 -168.54 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.04 139.97 37.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.071 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -24.66 15.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.15 -28.27 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.744 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -120.76 -44.68 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.5 m-85 -93.31 -178.38 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 3.2 tt0 -171.61 115.66 0.39 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.292 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.837 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.5 t80 -46.49 134.49 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.737 ' HB ' HG23 ' A' ' 122' ' ' VAL . 33.6 t -106.41 -81.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 122' ' ' VAL . 20.2 mm-40 -162.14 137.73 7.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.65 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 121' ' ' VAL . . . -82.57 146.28 29.26 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.987 0.899 . . . . 0.0 111.342 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.57 154.62 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.444 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.816 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -115.44 163.65 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.916 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.92 -160.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.9 37.56 1.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.816 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.1 -40.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.015 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.816 HG23 ' OG ' ' A' ' 84' ' ' SER . 8.9 m -86.95 169.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 0.0 110.918 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.83 144.47 45.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 104' ' ' VAL . 7.5 t -141.86 140.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -156.97 107.8 2.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.837 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.31 178.25 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -154.39 110.93 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.9 tttm -53.99 95.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.181 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.842 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.1 tp -78.51 -24.52 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.727 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.74 -166.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.751 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.9 132.97 34.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.91 29.85 65.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.423 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HE3' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -173.91 122.17 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.842 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -149.3 155.12 8.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.722 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 16.9 tpp85 -92.71 151.75 19.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.969 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 68' ' ' PHE . 4.0 p -127.51 137.14 58.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.862 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -119.79 102.86 8.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.901 HG11 ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -108.03 155.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.058 0.456 . . . . 0.0 111.424 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 p -164.41 137.16 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.715 ' HA ' HG12 ' A' ' 88' ' ' VAL . 10.4 m -75.81 104.83 6.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.977 0.418 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.1 tt -93.29 26.32 2.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.114 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.4 p -99.02 -31.49 11.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.995 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.37 5.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.144 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.28 158.21 32.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.692 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -65.38 -175.72 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.548 2.165 . . . . 0.0 112.473 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.713 ' CD2' HD21 ' A' ' 118' ' ' LEU . 0.8 OUTLIER -54.87 114.6 7.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.44 -38.87 31.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.052 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.61 168.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.4 16.14 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.071 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.42 -166.81 2.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.338 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.835 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.7 t -78.45 105.07 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.796 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.58 -31.17 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.901 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -169.15 135.52 1.7 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.874 0.368 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.821 ' HD3' HG11 ' A' ' 117' ' ' VAL . 4.2 mtmt -124.92 112.34 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.595 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 82' ' ' ALA . 24.9 t -99.8 96.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' VAL . 19.2 m -75.43 119.87 24.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.03 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 3.1 mm? -87.01 169.36 12.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.678 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.6 tpm_? -106.57 119.35 39.05 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.94 68.13 8.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.452 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.83 -6.42 58.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.47 124.06 2.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.714 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.681 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.3 ttpp -40.74 158.01 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.373 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.744 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -171.61 58.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.743 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.2 pm0 -55.66 117.18 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.221 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 20.93 51.01 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.478 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.543 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 8.0 t -71.15 65.54 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.046 0.451 . . . . 0.0 110.309 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.22 131.71 4.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.517 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -112.08 150.15 31.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.49 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -133.95 125.88 29.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 111.618 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 53' ' ' VAL . 23.3 m -113.46 94.77 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.683 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.5 p -101.66 -159.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.67 22.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.473 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -62.51 82.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.15 141.08 46.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.093 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.072 HG21 ' HB1' ' A' ' 63' ' ' ALA . 7.8 p -118.35 150.69 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 99.61 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.895 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 27.1 t0 -50.37 161.99 0.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 110.961 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 64' ' ' PHE . . . -59.49 -45.05 96.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.547 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.15 -31.17 72.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.42 -28.22 3.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.44 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.72 168.74 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 141' ' ' VAL . 8.0 p -122.92 148.33 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 38.4 m-70 -125.5 91.06 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.2 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.8 104.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.113 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.502 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 -177.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.328 0.585 . . . . 0.0 112.079 -178.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -60.89 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.349 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.93 176.73 34.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.915 HG22 HD23 ' A' ' 37' ' ' LEU . 51.5 m -164.96 145.47 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.554 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.07 163.43 13.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.166 0.508 . . . . 0.0 111.7 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.645 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -133.5 164.06 28.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.592 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.446 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.3 p -142.71 115.42 8.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.29 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.818 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.02 128.8 69.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 111.227 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.27 105.69 17.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.712 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.844 HD11 ' CE2' ' A' ' 77' ' ' PHE . 15.4 mt -83.22 115.96 26.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.479 0.657 . . . . 0.0 109.717 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.78 141.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.65 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.11 146.07 55.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.018 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.435 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.898 ' N ' HD21 ' A' ' 60' ' ' ASN . 26.9 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.945 0.402 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.2 t -76.16 151.68 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.9 t -69.21 -47.97 63.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 151' ' ' ILE . . . 77.91 107.22 0.18 Allowed Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.064 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.965 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.0 t -166.11 136.2 3.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.45 0.643 . . . . 0.0 111.762 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 151' ' ' ILE . 27.4 m -95.66 144.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.504 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 6.2 t -105.54 111.5 24.23 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.072 HD12 HG22 ' A' ' 154' ' ' THR . 3.6 mt -97.25 125.53 41.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.044 0.449 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.16 101.38 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.308 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -145.92 152.28 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.485 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.64 -29.11 67.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.236 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.49 24.93 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.455 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 158' ' ' VAL . 20.1 tt0 -164.68 128.08 2.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.859 0.361 . . . . 0.0 111.925 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -148.4 107.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.259 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.2 tt0 -68.32 128.13 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.036 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.86 132.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.14 -21.85 38.51 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.96 173.45 6.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.56 167.34 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.637 ' CD1' HG23 ' A' ' 51' ' ' VAL . 3.7 pp -125.41 160.72 28.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -136.67 110.19 7.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.964 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 39' ' ' ALA . 12.7 t -109.61 97.67 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.981 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.78 68.15 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.636 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.0 HG21 HG11 ' A' ' 136' ' ' VAL . 10.3 p -78.19 95.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.18 -122.49 4.6 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.98 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.54 130.81 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 112.138 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.0 t70 -101.72 -32.8 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 32' ' ' THR . 36.4 mt-10 -157.2 128.66 6.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.418 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -161.22 90.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.92 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.9 p -125.57 106.02 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.898 HD21 ' N ' ' A' ' 30' ' ' GLU . 11.8 m-20 131.5 18.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.462 1.101 . . . . 0.0 111.418 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . . . -148.43 -179.41 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.945 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 2.8 mm-40 -126.4 77.16 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.936 0.398 . . . . 0.0 110.58 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.47 112.1 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.6 m-85 -115.72 -59.88 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.802 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.23 112.62 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.589 ' OH ' HD11 ' A' ' 151' ' ' ILE . 1.5 t80 -86.16 138.65 31.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -147.55 110.27 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.265 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 102' ' ' VAL . 12.9 p90 -137.69 171.55 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.99 106.09 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.693 HD22 HD23 ' A' ' 134' ' ' LEU . 1.3 mt -77.29 157.19 30.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.825 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -121.62 104.37 9.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.97 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.9 p90 -114.95 -167.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.3 t70 -112.05 132.38 54.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.38 -28.02 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -60.24 -30.28 69.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.981 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.83 -46.26 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.4 m-85 -93.34 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.751 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -165.29 113.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.773 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.749 ' CD1' HG21 ' A' ' 100' ' ' VAL . 20.0 t80 -46.68 155.91 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -137.73 -81.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 14.4 pt-20 -152.42 131.64 12.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.06 149.54 26.86 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.304 1.049 . . . . 0.0 111.774 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -133.4 174.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.073 -177.457 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -168.33 2.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.811 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.91 -161.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.17 37.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.816 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 -37.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' SER . 30.1 t -86.71 143.86 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -106.27 107.08 17.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 111.005 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -105.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -143.43 117.9 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.349 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.72 173.01 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.946 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.22 107.33 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.443 . . . . 0.0 111.697 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.5 tttp -54.77 115.19 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.271 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.6 tp -111.5 -22.37 5.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.919 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.79 -166.84 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.58 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -101.42 50.84 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.591 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.61 129.83 0.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.749 HG21 ' CD1' ' A' ' 79' ' ' TYR . 17.4 m -150.1 155.2 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -80.94 152.05 28.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.352 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 68' ' ' PHE . 8.9 p -134.13 110.7 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.403 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 mt -88.54 114.34 25.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.907 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.623 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 13.4 t -107.43 137.73 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.508 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.472 ' C ' HG13 ' A' ' 88' ' ' VAL . 3.8 p -164.27 136.21 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.37 104.49 15.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.211 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.85 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.3 p -65.34 -34.76 79.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.84 -19.76 30.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.382 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.33 154.64 71.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 55.6 Cg_endo -70.42 157.99 57.43 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.658 2.239 . . . . 0.0 112.364 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 ' CD1' ' A' ' 118' ' ' LEU . 35.5 mt -59.9 111.1 3.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.8 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.89 -21.35 73.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.395 2.064 . . . . 0.0 112.26 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.1 175.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.602 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.72 24.27 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 110.383 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.81 -166.62 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.201 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.769 HG13 ' HA3' ' A' ' 52' ' ' GLY . 21.5 t -85.9 104.69 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.635 ' CD1' HD22 ' A' ' 112' ' ' LEU . 1.7 mm? -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -160.05 135.23 8.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.843 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.711 ' HD2' HG11 ' A' ' 117' ' ' VAL . 10.3 mtpt -128.22 100.87 6.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.034 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.8 p -81.29 107.02 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 110.268 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 83' ' ' ILE . 23.0 t -75.69 106.9 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.037 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 134' ' ' LEU . 12.1 mt -89.99 169.22 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 5.5 ttm180 -114.38 122.99 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -91.57 68.96 5.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.294 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.51 -5.68 58.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.413 0.625 . . . . 0.0 109.529 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.03 123.83 2.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.49 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.3 ttmt -41.59 159.94 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.272 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.782 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -174.98 57.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.017 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.3 mt-10 -56.18 113.39 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.097 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' ND2' ' A' ' 133' ' ' ASN . . . 103.27 -2.31 46.97 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.544 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.782 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 2.5 m -61.06 86.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.936 0.398 . . . . 0.0 110.235 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 131' ' ' GLY . 1.6 m-80 -58.67 171.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.654 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -146.84 108.72 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.116 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.4 p -97.46 122.58 40.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.439 . . . . 0.0 111.407 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 53' ' ' VAL . 7.2 p -107.48 95.16 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 p -102.45 -166.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.573 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.91 20.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.014 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 m -61.88 88.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.55 166.33 11.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.486 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 63' ' ' ALA . 13.2 p -140.33 159.95 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.982 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -97.36 91.39 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.648 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 17.1 t70 -48.61 161.46 0.13 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.37 78.39 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.12 -30.47 65.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.49 -26.85 4.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.595 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.3 mt -68.39 169.98 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.66 148.22 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -119.22 90.85 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -49.98 102.03 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.589 HD11 ' OH ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -89.38 -176.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.325 0.583 . . . . 0.0 111.659 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.62 -158.08 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -161.2 171.73 37.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.034 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 1.072 HG22 HD12 ' A' ' 37' ' ' LEU . 55.1 m -158.85 146.52 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.97 151.79 25.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.033 0.444 . . . . 0.0 111.413 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 37' ' ' LEU . 6.5 tppt? -128.97 167.49 17.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.975 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.17 126.21 16.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.11 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -113.3 131.6 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.14 106.45 18.75 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.833 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.84 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -85.44 116.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.384 0.612 . . . . 0.0 109.922 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.01 146.21 8.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.556 -178.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.98 145.91 54.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 60' ' ' ASN . 13.1 t -60.54 147.76 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 57' ' ' GLU . 14.6 t -70.89 -45.54 64.19 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.467 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 73.51 109.43 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.583 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -159.49 138.71 11.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.603 0.716 . . . . 0.0 111.754 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.3 m -98.26 141.52 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 21.3 p -100.6 111.01 23.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 154' ' ' THR . 3.2 mt -97.14 126.48 42.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 101.55 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -147.93 151.32 35.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -61.47 -28.3 69.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.7 mt-10 72.92 24.31 2.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.605 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG2' HD11 ' A' ' 161' ' ' ILE . 12.6 tt0 -164.81 128.37 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.849 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.882 ' O ' HG23 ' A' ' 160' ' ' ILE . 4.1 p -144.58 108.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.394 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.25 125.25 26.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.038 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -28.86 130.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.01 -15.0 52.09 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.753 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 43' ' ' VAL . 5.4 tp10 -106.34 171.36 7.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.736 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -106.63 167.81 9.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 158' ' ' VAL . 11.2 mt -120.2 150.99 39.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.63 93.28 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.493 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.944 HG12 ' CB ' ' A' ' 39' ' ' ALA . 27.3 m -106.88 97.06 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.103 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.815 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.91 76.36 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.659 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 136' ' ' VAL . 12.5 p -78.54 95.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -105.79 -129.79 6.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.828 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.72 132.01 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 111.69 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 5.1 t0 -97.84 -31.43 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.122 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -178.17 133.4 0.15 Allowed 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.485 0.66 . . . . 0.0 111.894 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -159.41 115.52 2.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.634 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.8 p -133.53 102.38 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.594 ' N ' HG22 ' A' ' 31' ' ' VAL . 5.0 m120 138.37 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.384 1.053 . . . . 0.0 111.914 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.3 174.44 14.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.33 87.02 2.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.84 112.67 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.446 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -103.6 -35.3 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.129 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.49 112.38 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.348 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.826 ' O ' HG12 ' A' ' 104' ' ' VAL . 67.2 t80 -99.11 152.02 20.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.19 116.94 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.891 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.903 ' O ' HG12 ' A' ' 102' ' ' VAL . 5.7 p90 -117.8 140.18 50.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.081 0.467 . . . . 0.0 111.459 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 94.17 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.773 HD12 HG13 ' A' ' 136' ' ' VAL . 2.2 tp -80.02 139.68 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -111.65 104.36 12.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.846 ' HA ' HD23 ' A' ' 134' ' ' LEU . 38.9 p90 -100.16 -170.79 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.75 126.15 42.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.192 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -85.45 -17.26 37.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.021 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -96.47 29.21 2.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.868 0.366 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.906 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -171.86 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.25 170.52 9.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -153.11 109.09 3.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.539 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 14.4 t80 -53.23 143.72 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' ARG . 41.5 t -123.09 -72.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.33 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.69 142.71 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.94 153.62 24.95 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 122.125 0.965 . . . . 0.0 111.655 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.84 152.68 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.455 -177.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -124.91 -173.22 2.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.92 -158.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -93.5 37.41 1.06 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.6 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.315 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 89' ' ' PHE . 11.2 t -86.74 157.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.422 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -115.04 102.99 10.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 119' ' ' ALA . 3.5 t -104.65 120.76 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -134.14 118.38 17.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.23 0.538 . . . . 0.0 111.526 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.94 146.79 24.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.013 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -132.44 106.81 8.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.399 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 12.2 tttp -55.47 95.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.811 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -81.34 -30.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.809 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.32 -168.02 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.62 128.83 34.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 59.12 33.23 73.75 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.549 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -173.71 121.41 0.32 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.811 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.9 m -149.71 155.58 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.643 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -96.94 152.46 18.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.986 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.5 p -128.67 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.968 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.08 108.16 14.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.8 p -108.47 137.55 39.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.09 0.472 . . . . 0.0 111.042 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.8 p -161.83 135.86 6.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -78.91 104.42 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.39 -13.01 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.0 p -65.21 -27.17 68.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.34 -20.74 12.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.35 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.44 142.34 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.625 0.25 . . . . 0.0 110.661 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 50.7 Cg_exo -54.0 150.91 29.13 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.446 2.097 . . . . 0.0 112.358 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -56.3 128.61 73.38 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.714 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.836 ' O ' HD12 ' A' ' 112' ' ' LEU . 13.0 Cg_exo -69.9 -159.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.541 2.161 . . . . 0.0 112.318 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.586 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -155.91 166.87 32.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 14.7 9.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.85 -165.79 1.8 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.078 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.815 HG13 ' HA3' ' A' ' 52' ' ' GLY . 30.6 t -84.78 104.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -86.83 -34.95 19.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -166.81 131.87 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HD2' HG11 ' A' ' 117' ' ' VAL . 3.8 mtpt -117.05 120.92 39.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.497 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.673 HG11 HD22 ' A' ' 70' ' ' LEU . 8.6 p -88.85 142.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 83' ' ' ILE . 23.4 t -113.7 117.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.658 HD22 ' CD1' ' A' ' 72' ' ' TYR . 2.5 mt -115.79 108.52 16.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.49 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 80' ' ' VAL . 26.6 ttm180 -64.18 115.25 4.81 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -74.27 74.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.378 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.34 -4.28 59.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.486 0.66 . . . . 0.0 109.452 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.72 123.48 2.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.352 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 16.9 ttmt -47.59 139.96 6.53 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.365 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.906 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.16 62.25 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.852 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.34 112.9 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.92 49.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.607 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.327 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.38 133.28 4.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.301 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -117.82 116.0 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.841 179.265 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 p -109.76 128.65 55.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.598 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 53' ' ' VAL . 9.6 m -106.13 94.96 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.3 p -97.27 -163.78 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.64 21.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.959 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.478 ' HB3' HD11 ' A' ' 151' ' ' ILE . 73.6 m -59.06 101.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -113.5 165.28 12.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' VAL . 27.6 m -143.72 125.48 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.013 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.21 100.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.584 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.15 161.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -28.18 72.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.71 -34.8 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.54 2.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 147' ' ' LEU . 13.5 mt -72.89 161.24 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 140' ' ' SER . 11.5 p -113.45 136.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.102 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -109.74 90.67 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -51.08 107.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.39 177.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.612 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -62.36 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.974 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.13 168.56 41.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.399 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.949 HG22 HD12 ' A' ' 37' ' ' LEU . 65.4 m -156.21 146.83 21.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.2 167.77 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 111.435 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' A' ' 37' ' ' LEU . 2.9 tppt? -139.57 168.8 19.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.246 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.425 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.3 p -142.32 115.83 9.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.742 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG22 HD11 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -110.53 126.67 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.13 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.05 105.88 18.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.789 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.882 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.4 mt -78.76 122.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.02 131.2 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.594 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.18 145.02 44.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.043 0.449 . . . . 0.0 111.214 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.493 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.898 0.38 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 61' ' ' ALA . 25.2 t -82.02 146.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -66.82 -35.14 79.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.665 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.18 108.19 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.035 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.547 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 t -153.43 138.82 17.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.707 0.765 . . . . 0.0 111.977 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 151' ' ' ILE . 34.1 m -91.02 145.3 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.247 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 t -104.9 107.57 18.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.492 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 154' ' ' THR . 6.8 mt -96.8 111.6 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.173 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -140.18 101.47 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.483 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -144.0 158.45 43.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -56.86 -23.45 44.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.8 mt-10 65.62 23.02 11.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.444 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.554 ' CD ' HD11 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -164.87 128.26 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 0.0 111.854 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.921 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -143.14 108.78 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.192 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.59 126.5 29.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.612 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.1 t -29.08 133.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.477 0.656 . . . . 0.0 112.723 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.12 -26.88 22.53 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.126 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -90.02 172.65 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.488 ' HB3' HG13 ' A' ' 122' ' ' VAL . 5.8 m120 -110.31 137.44 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.699 HD11 HG11 ' A' ' 158' ' ' VAL . 21.6 tp -92.02 149.92 21.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HD12 ' A' ' 83' ' ' ILE . 6.2 tt0 -136.21 101.66 4.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' CB ' ' A' ' 39' ' ' ALA . 5.8 m -106.32 97.96 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.778 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -77.62 67.62 2.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.607 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 136' ' ' VAL . 8.5 p -78.4 95.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.005 0.431 . . . . 0.0 110.515 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.06 -120.07 4.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.107 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.92 133.4 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.015 0.435 . . . . 0.0 111.993 -179.317 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.49 -37.89 8.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.5 mt-10 -155.62 130.79 9.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.122 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.941 HD21 ' HB3' ' A' ' 61' ' ' ALA . 10.3 tt -156.66 90.97 1.19 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.502 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.76 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.3 p -110.98 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.9 m-20 100.38 20.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.715 0.806 . . . . 0.0 111.797 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.941 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -140.2 139.14 35.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.673 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -101.06 80.65 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.619 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.41 111.84 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 22.4 m-85 -113.53 -31.33 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.23 114.78 9.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.685 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.1 t80 -85.59 127.18 34.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.12 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -141.62 109.93 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.855 ' CD1' HG13 ' A' ' 136' ' ' VAL . 15.0 p90 -140.69 171.11 14.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.985 0.421 . . . . 0.0 111.315 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.36 114.49 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.663 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.518 HD12 HG22 ' A' ' 136' ' ' VAL . 23.7 tp -77.39 151.27 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.48 104.57 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' HD21 ' A' ' 134' ' ' LEU . 17.2 p90 -129.24 -167.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -112.73 139.85 48.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.053 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.67 -28.79 15.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.37 -47.59 85.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.973 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.928 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -99.81 -46.5 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.194 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.0 m-85 -93.36 166.5 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -152.18 112.67 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 123' ' ' LEU . 31.5 t80 -54.12 151.65 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 124' ' ' ARG . 48.1 t -130.24 -70.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.885 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 122' ' ' VAL . 5.8 pt-20 -172.52 141.86 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.636 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 148.43 28.04 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.14 0.971 . . . . 0.0 111.721 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 152.25 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.074 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.669 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -113.55 -169.59 1.53 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.969 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.55 -159.81 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.81 35.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.37 -46.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.083 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.665 HG23 ' OG ' ' A' ' 84' ' ' SER . 28.4 m -90.65 173.5 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -121.23 139.28 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 104' ' ' VAL . 2.4 t -136.13 109.28 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -121.14 119.11 31.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.11 172.27 7.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 107.38 3.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.695 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 tttp -55.38 95.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.948 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 100' ' ' VAL . 5.1 tp -86.45 -28.95 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.41 -174.84 5.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.88 136.54 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 56.94 27.08 56.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.457 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -173.35 123.6 0.39 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.703 ' HA ' HG22 ' A' ' 95' ' ' ILE . 16.5 m -150.27 154.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.885 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.524 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -81.29 152.13 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.924 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.82 93.58 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.905 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.1 mt -75.97 115.28 15.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 90' ' ' VAL . 11.3 t -112.83 145.35 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.016 0.436 . . . . 0.0 111.483 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.7 p -164.32 136.03 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.363 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.603 ' CB ' HG12 ' A' ' 88' ' ' VAL . 32.1 m -84.53 104.62 14.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.54 -15.07 63.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -65.34 -34.75 79.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.78 -16.9 25.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.446 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.34 160.6 29.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 39.2 Cg_exo -56.85 173.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 66' ' ' TYR . 3.8 mp -67.67 134.16 92.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.51 -38.73 71.14 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.508 2.139 . . . . 0.0 112.256 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HA ' HD21 ' A' ' 118' ' ' LEU . . . 59.05 162.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.968 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.9 15.75 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 -163.29 1.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.254 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.824 HG11 ' HD3' ' A' ' 120' ' ' LYS . 39.1 t -76.86 105.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -95.62 -30.18 13.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -158.96 136.03 9.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.421 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.824 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -132.93 111.12 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.323 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 70' ' ' LEU . 56.3 t -86.09 114.83 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD11 ' A' ' 83' ' ' ILE . 54.8 t -75.62 105.44 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.841 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 79' ' ' TYR . 24.7 mt -103.13 108.49 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.598 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.516 ' H ' HG23 ' A' ' 80' ' ' VAL . 38.4 ttm180 -68.9 117.79 11.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.96 80.75 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.872 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.43 -5.27 58.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.3 123.5 2.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.185 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.3 ttpt -61.33 131.37 50.11 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.81 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -133.38 75.84 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.64 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.99 110.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 111.033 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.78 14.61 39.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.553 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.588 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -61.02 86.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 110.276 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 3.1 m-80 -60.17 151.36 27.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 132' ' ' SER . 3.5 mp -146.52 139.28 25.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.88 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.0 t -134.98 134.7 40.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.091 0.472 . . . . 0.0 111.6 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.855 HG13 ' CD1' ' A' ' 68' ' ' PHE . 48.4 t -105.02 95.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.482 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.6 p -102.73 -169.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.47 20.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.948 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 151' ' ' ILE . 49.9 m -64.26 97.8 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.344 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.412 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -103.74 171.6 7.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 58' ' ' LEU . 19.7 m -144.31 125.11 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 78.36 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.636 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 23.0 t0 -59.41 138.34 57.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.858 0.361 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.5 -28.05 61.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.678 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.13 -27.91 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 110.958 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.96 -11.21 22.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.743 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -114.52 121.02 42.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.6 p -73.4 126.16 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -95.1 93.2 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.078 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -51.15 110.56 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.36 168.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 112.135 -178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -61.03 -141.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.37 176.05 46.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.469 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 37' ' ' LEU . 17.9 m -159.68 149.12 18.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.7 0.286 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -104.32 154.54 19.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 111.588 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.647 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -147.66 155.13 41.45 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.647 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.7 p -138.76 135.27 34.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -119.59 125.52 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.527 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.87 105.7 17.79 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.921 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.1 mt -76.16 143.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -130.74 133.51 63.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.685 -177.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.1 144.52 19.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.231 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.458 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.822 0.344 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 HD23 ' A' ' 58' ' ' LEU . 79.7 t -71.9 152.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.0 t -60.52 -43.5 97.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.345 0.593 . . . . 0.0 109.493 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 66.49 102.92 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.754 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.902 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 18.9 t -160.73 138.73 9.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.517 0.675 . . . . 0.0 112.166 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 151' ' ' ILE . 34.0 m -97.32 134.67 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.266 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 3.8 t -92.11 108.05 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.704 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.598 HD22 ' CG2' ' A' ' 154' ' ' THR . 10.0 tp -97.23 124.52 41.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -140.55 106.99 5.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.687 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -147.65 165.53 30.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.525 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 49' ' ' LEU . 11.0 mt -78.88 -27.53 44.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.701 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.3 OUTLIER 71.97 23.04 3.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HG2' HD11 ' A' ' 161' ' ' ILE . 10.8 tt0 -164.54 129.08 2.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.58 107.91 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.46 125.36 26.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.215 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -29.23 131.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.15 -20.05 46.65 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.439 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -99.56 172.33 7.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB3' HG21 ' A' ' 122' ' ' VAL . 10.0 m-80 -121.52 130.01 53.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -118.45 133.47 55.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.824 ' HG2' HD11 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -113.79 154.01 28.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.566 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 51' ' ' VAL . 24.9 m -125.9 98.22 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.696 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.58 64.49 0.62 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.473 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 136' ' ' VAL . 9.1 p -78.25 95.53 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.667 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.33 -122.56 4.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.032 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.504 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -111.24 129.75 65.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.776 -179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 24.3 t70 -99.19 -37.36 9.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.712 ' HB3' HG21 ' A' ' 32' ' ' THR . 29.2 mt-10 -159.11 130.02 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.589 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 HG11 ' A' ' 31' ' ' VAL . 1.1 tt -159.55 91.58 1.0 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.251 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.733 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -122.06 107.07 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.55 ' CA ' HG22 ' A' ' 31' ' ' VAL . 63.2 m-20 130.18 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.435 1.094 . . . . 0.0 111.543 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -157.92 162.56 38.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -113.85 83.88 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -63.29 111.78 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.526 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -102.26 -38.71 7.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.93 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.91 112.31 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.112 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.4 t80 -105.2 94.34 5.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.864 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -109.12 133.28 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.631 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 47.9 p90 -135.99 171.27 14.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 111.421 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.0 102.71 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.071 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.064 HD21 HD23 ' A' ' 134' ' ' LEU . 9.8 tt -76.88 157.32 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.096 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.692 ' N ' HD23 ' A' ' 70' ' ' LEU . 6.9 m120 -127.27 130.47 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 1.8 p90 -140.97 -167.42 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.548 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.03 136.3 53.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' CB ' ' HB2' ' A' ' 97' ' ' ASP . 33.3 tt0 -94.07 -6.35 45.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.286 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.59 31.26 2.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.897 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.32 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.651 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 160' ' ' ILE . 3.0 m-85 -100.32 -177.08 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.76 108.86 0.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.9 t80 -48.55 147.65 2.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 122' ' ' VAL . 60.1 t -127.69 -80.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 122' ' ' VAL . 4.8 mt-10 -161.42 138.84 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.92 150.54 26.41 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 122.01 0.91 . . . . 0.0 111.279 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.28 152.38 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.501 -177.497 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.574 ' HB3' HG23 ' A' ' 90' ' ' VAL . 15.1 p -115.65 -176.93 3.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.72 -156.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -93.65 36.77 1.08 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.875 0.369 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.79 -38.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.216 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 89' ' ' PHE . 26.6 t -87.06 159.03 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.4 t80 -114.85 117.02 29.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 104' ' ' VAL . 10.8 t -115.41 131.98 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.56 115.61 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -95.76 149.8 21.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -136.51 106.86 6.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.713 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 24.5 tttt -55.52 120.38 7.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.362 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.4 tp -112.06 -23.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.834 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.54 -179.19 7.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 111.152 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -47.2 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -106.07 60.57 0.37 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.27 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -174.0 123.72 0.33 Allowed 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.3 m -148.81 155.41 8.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.637 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -99.11 152.34 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.067 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.615 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.3 p -125.21 147.63 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.394 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.38 109.92 18.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 90' ' ' VAL . 21.4 t -109.28 137.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 111.524 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.3 p -164.25 136.06 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.448 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -79.37 104.39 9.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.242 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -70.51 -14.78 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.462 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.5 p -65.26 -28.87 69.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.0 -17.74 22.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.454 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -99.18 147.66 33.58 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 52.4 Cg_exo -54.16 169.88 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 63' ' ' ALA . 51.1 mt -58.23 113.96 7.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 -21.22 51.72 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.406 2.071 . . . . 0.0 112.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 59.56 169.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.849 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.12 27.05 14.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 110.602 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 118' ' ' LEU . 16.7 tt0 -155.38 154.5 32.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.696 HG13 ' HA3' ' A' ' 52' ' ' GLY . 26.9 t -47.43 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.224 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 116' ' ' GLU . 1.1 mm? -92.05 -29.3 16.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -163.0 136.4 5.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.74 0.305 . . . . 0.0 111.513 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.64 ' HD2' HG11 ' A' ' 117' ' ' VAL . 7.2 mtpt -131.85 100.75 5.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.428 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 82' ' ' ALA . 93.1 t -91.69 107.04 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.9 p -83.89 124.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -99.49 114.06 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.411 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 24.5 ttm180 -54.95 116.81 2.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -87.63 67.94 9.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.255 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 -0.83 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.481 0.658 . . . . 0.0 109.312 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.16 123.39 2.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.235 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.74 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.0 ttpt -45.44 142.19 2.32 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.627 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -149.07 59.61 1.04 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.713 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -56.05 118.61 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.167 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.36 13.59 70.49 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.51 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.776 ' O ' HD12 ' A' ' 134' ' ' LEU . 29.6 t -70.35 66.56 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.469 . . . . 0.0 110.144 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.456 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -43.97 138.28 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.482 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.064 HD23 HD21 ' A' ' 70' ' ' LEU . 4.6 mp -119.17 127.14 53.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.458 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.413 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -119.84 126.39 50.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.123 0.487 . . . . 0.0 111.957 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 53' ' ' VAL . 18.7 m -113.87 94.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.3 p -105.82 -159.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.783 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.56 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.422 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -63.52 104.74 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 0.0 110.371 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.09 167.17 9.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.493 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 58' ' ' LEU . 8.4 m -141.65 120.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.962 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.71 98.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.669 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -55.81 161.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.74 79.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.87 -46.23 25.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.14 -27.84 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.4 119.31 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.971 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.27 153.42 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -122.13 90.61 3.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.69 103.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.266 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.45 -176.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 111.947 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -64.63 -160.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.53 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.1 -174.29 23.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.019 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.598 ' CG2' HD22 ' A' ' 37' ' ' LEU . 11.6 t -160.62 -171.03 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.429 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 14.0 tt0 -161.8 157.85 24.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 41' ' ' GLU . 2.2 tppm? -143.17 168.73 19.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.186 0.517 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.5 p -141.67 115.7 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.415 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -109.9 119.11 58.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.188 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 105.89 18.09 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.9 mt -78.25 119.68 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.2 132.77 48.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.692 -178.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.12 145.84 45.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.511 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.794 0.331 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.84 HG21 ' HB2' ' A' ' 61' ' ' ALA . 17.0 t -76.26 151.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.764 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 33' ' ' GLY . 1.5 t -84.65 -33.16 23.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.609 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.19 121.74 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.549 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.606 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.5 146.37 31.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.211 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 153' ' ' GLY . 28.7 m -96.07 135.99 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 3.6 t -90.96 107.11 18.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.246 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.829 ' HB2' HG21 ' A' ' 154' ' ' THR . 13.1 tp -97.48 106.26 18.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.833 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -140.95 101.03 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -137.03 166.16 24.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 111.274 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -69.68 -35.87 75.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.626 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' HA ' HG13 ' A' ' 158' ' ' VAL . 5.6 mt-10 68.29 31.46 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 161' ' ' ILE . 15.7 tt0 -164.21 116.47 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.3 p -133.14 165.48 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.901 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.541 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -129.47 113.04 14.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 128' ' ' LYS . 2.1 t -28.11 119.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 121.59 -27.61 6.22 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.43 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -102.47 -175.37 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.74 0.305 . . . . 0.0 110.478 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.65 ' HB3' HG13 ' A' ' 122' ' ' VAL . 23.6 m-80 -113.66 165.06 12.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.188 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.8 tp -117.54 156.76 27.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -136.45 93.95 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.146 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' A' ' 39' ' ' ALA . 8.1 p -103.63 98.13 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.703 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.682 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.53 68.2 3.21 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.924 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 136' ' ' VAL . 7.4 p -78.61 95.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.05 -129.74 6.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.865 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -105.51 138.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 111.543 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -98.55 -37.48 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.04 131.99 0.05 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.551 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -135.62 95.51 3.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.526 178.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -85.27 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.766 ' HB2' HG22 ' A' ' 31' ' ' VAL . 14.6 m120 96.68 31.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.29 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.39 149.77 41.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.362 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.5 mt-10 -119.76 71.3 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.723 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.09 122.42 15.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.234 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -105.93 -32.84 8.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.654 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.84 112.3 7.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.04 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 112' ' ' LEU . 21.9 t80 -104.25 94.69 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.1 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -102.42 130.23 49.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.749 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 41.6 p90 -132.85 171.11 14.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -132.7 97.27 4.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.186 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.826 ' CD1' HG11 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -77.2 157.71 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.432 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -116.54 104.57 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 24.4 p90 -111.24 -167.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -106.96 125.54 51.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.78 -40.82 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.803 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.68 -35.54 80.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -96.46 -57.95 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 160' ' ' ILE . 8.3 m-85 -93.44 165.38 12.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -145.02 109.74 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.657 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 22.1 t80 -54.01 140.46 31.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.9 t -119.52 -72.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 3.2 mt-10 -169.04 143.57 3.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.74 147.73 28.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 122.169 0.985 . . . . 0.0 111.698 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.41 152.83 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.474 -177.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -166.36 1.16 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.52 -157.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.27 36.25 1.06 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.09 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.969 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 89' ' ' PHE . 38.1 t -86.88 160.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.782 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.613 ' HB2' HD13 ' A' ' 107' ' ' LEU . 12.8 t80 -112.03 136.71 51.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.959 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 104' ' ' VAL . 2.5 t -134.37 105.46 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -122.34 114.89 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.611 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.657 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.27 -176.98 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.12 107.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.388 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttm -54.82 111.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.039 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -102.58 -28.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.86 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.31 170.71 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.32 133.75 45.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.13 28.48 64.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.323 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.448 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 5.8 ptmt -173.66 122.98 0.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.67 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 20.9 m -150.27 155.92 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -88.28 152.05 22.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.313 -178.406 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.749 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.17 95.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.525 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.88 114.7 19.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.081 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 90' ' ' VAL . 20.7 m -111.58 153.56 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.692 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -164.69 136.71 4.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.467 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.7 m -85.36 104.47 15.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 89' ' ' PHE . 4.4 mp -72.51 -12.19 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.681 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -65.28 -30.86 71.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.38 -19.12 22.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.27 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.39 147.17 34.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 44.6 Cg_exo -56.45 176.27 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.547 2.165 . . . . 0.0 112.365 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -57.04 121.96 49.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.813 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 -36.85 62.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.282 1.988 . . . . 0.0 112.158 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 59.91 163.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.888 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 28.62 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.492 . . . . 0.0 110.241 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -164.48 156.48 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.996 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.789 HG11 ' HD3' ' A' ' 120' ' ' LYS . 30.9 t -44.4 104.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.26 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -95.47 -29.98 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.969 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.914 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -163.79 135.7 4.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.797 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.789 ' HD3' HG11 ' A' ' 117' ' ' VAL . 12.9 mtmm -124.86 113.69 18.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.826 HG11 ' CD1' ' A' ' 70' ' ' LEU . 7.1 p -86.66 110.45 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.452 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.777 HG22 HD11 ' A' ' 83' ' ' ILE . 41.7 t -76.92 106.29 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 79' ' ' TYR . 10.2 mt -106.21 108.6 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.768 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.529 ' HB2' HG21 ' A' ' 80' ' ' VAL . 39.3 ttm180 -69.05 117.92 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -68.55 80.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.185 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 124' ' ' ARG . 4.8 mm-40 -86.06 -12.81 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 109.55 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.79 124.35 2.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.564 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 7.3 ttpp -45.56 155.9 0.14 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.11 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -161.7 56.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -56.21 98.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.677 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 110.59 26.77 4.66 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.911 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -69.97 65.81 0.25 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.918 0.39 . . . . 0.0 111.067 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.51 ' HA ' HG22 ' A' ' 157' ' ' THR . 1.8 t-20 -45.04 110.53 0.24 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.111 0.481 . . . . 0.0 112.003 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 132' ' ' SER . 2.0 mp -106.02 165.2 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.868 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.9 t -158.37 119.74 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.385 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 53' ' ' VAL . 35.6 t -87.16 94.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.441 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.456 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.2 p -100.19 -170.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' C ' ' A' ' 137' ' ' THR . 4.2 p30 43.23 23.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.757 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -64.61 93.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.575 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -97.24 167.5 10.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.136 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -140.18 129.39 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.59 77.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 24.7 t0 -57.14 146.86 26.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.6 -26.38 73.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.89 -44.32 82.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.28 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.26 -10.22 4.12 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.853 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -117.64 132.22 56.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.755 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.5 p -77.26 115.19 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.152 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 141' ' ' VAL . 77.2 m-70 -86.34 95.0 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.71 108.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.792 0.329 . . . . 0.0 110.187 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.516 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.23 166.42 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -56.16 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 35' ' ' VAL . . . -159.08 -167.97 20.49 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.892 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.829 HG21 ' HB2' ' A' ' 37' ' ' LEU . 6.8 t -166.09 179.58 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.958 0.379 . . . . 0.0 111.56 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 tm-20 -143.51 143.8 31.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.809 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -149.44 155.32 40.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.14 0.495 . . . . 0.0 111.232 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.648 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 8.2 p -128.73 140.22 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.219 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -119.65 139.03 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 111.49 23.78 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.027 0.441 . . . . 0.0 111.12 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.688 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.3 mt -88.16 127.5 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -112.13 132.19 61.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.077 -177.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.07 145.86 49.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.223 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.821 0.343 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.831 HG11 HD13 ' A' ' 58' ' ' LEU . 77.5 t -100.7 153.2 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 59' ' ' VAL . 9.3 t -64.05 -42.5 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.448 0.642 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.675 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 61.96 104.93 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.214 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 40.9 t -156.31 136.48 12.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.697 0.76 . . . . 0.0 112.213 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 151' ' ' ILE . 34.2 m -93.35 145.47 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.492 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 17.9 p -104.38 113.31 26.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.014 HD12 HG22 ' A' ' 154' ' ' THR . 5.5 mt -96.79 121.38 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 111.32 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.1 101.3 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.365 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -151.15 152.08 32.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.45 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.88 -22.72 59.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.529 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 2.3 mp0 66.68 23.35 10.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -165.12 127.89 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -144.54 106.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.164 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -69.16 133.07 47.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.489 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -33.83 133.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.57 -22.48 35.74 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.515 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.13 172.18 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -104.34 153.57 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 158' ' ' VAL . 62.2 tp -93.67 161.03 14.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 21.7 mt-10 -136.57 93.57 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.723 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 25.2 t -105.67 97.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 117' ' ' VAL . . . -85.96 59.08 4.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.157 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 53' ' ' VAL . 9.6 p -78.04 95.35 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.581 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -112.31 -117.58 3.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.037 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.617 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.5 131.38 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 112.046 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 7.3 t0 -103.53 -35.84 8.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -155.89 127.82 7.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.611 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.831 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -150.11 90.7 1.7 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.27 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -115.19 116.53 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.8 m-20 103.15 33.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.934 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -169.31 133.46 1.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -91.96 82.06 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.348 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 111.86 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 112' ' ' LEU . 30.3 m-85 -104.94 -33.82 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.884 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.51 112.3 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.111 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 112' ' ' LEU . 15.2 t80 -109.71 95.03 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.967 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -109.18 143.86 38.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.717 ' CD1' HG13 ' A' ' 136' ' ' VAL . 18.6 p90 -146.41 171.27 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.013 0.435 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -126.29 99.72 5.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -77.2 156.08 31.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -122.27 112.99 18.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HA ' HD23 ' A' ' 134' ' ' LEU . 26.1 p90 -126.22 -168.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.646 ' OD2' ' HB3' ' A' ' 76' ' ' ALA . 2.2 p-10 -106.06 134.55 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.971 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.72 -29.86 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.09 -41.92 99.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -102.64 -47.94 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -93.38 172.37 8.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.712 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -160.7 114.13 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.725 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 31.9 t80 -54.16 153.46 5.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' HG23 ' A' ' 122' ' ' VAL . 87.1 t -132.8 -77.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -166.02 140.61 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.736 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.85 149.47 27.12 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.89 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.93 152.63 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.339 -177.358 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -123.13 -165.37 1.31 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.898 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -90.89 -157.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -93.72 36.75 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.399 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.18 -38.73 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 106' ' ' SER . 19.8 t -86.83 149.29 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.926 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -111.28 103.11 11.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 104' ' ' VAL . 2.5 t -105.44 142.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.021 0.438 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -156.46 118.84 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.305 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.725 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.95 -178.9 4.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.413 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -157.31 107.85 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.0 111.54 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 17.8 tttt -54.53 95.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.0 tp -78.12 -27.11 14.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.833 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -165.3 -166.78 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -86.71 134.68 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.28 29.38 60.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 100' ' ' VAL . 3.0 ptpt -173.62 121.36 0.33 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 120.941 0.4 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 95' ' ' ILE . 11.8 m -150.07 155.51 7.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.665 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.563 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 6.9 ttp180 -93.3 151.87 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.28 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.4 p -123.67 129.65 74.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.47 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.413 HD11 ' NZ ' ' A' ' 93' ' ' LYS . 15.8 mt -101.84 104.69 15.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.332 . . . . 0.0 110.714 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 119' ' ' ALA . 23.1 t -103.69 135.68 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.494 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -164.46 136.76 4.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.437 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 88' ' ' VAL . 88.6 p -88.2 117.26 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.41 27.71 2.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.298 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.6 p -102.41 -27.65 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.78 -16.81 23.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.315 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.43 147.62 34.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.2 Cg_exo -54.1 172.96 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.496 2.131 . . . . 0.0 112.306 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 66' ' ' TYR . 3.0 mp -59.28 128.0 84.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 118' ' ' LEU . 31.8 Cg_exo -58.54 -34.05 98.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.376 2.051 . . . . 0.0 112.11 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.56 163.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.94 15.52 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -146.83 -165.72 2.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.31 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.576 HG13 ' CA ' ' A' ' 52' ' ' GLY . 38.9 t -78.71 104.84 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.763 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -94.35 -29.56 14.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.034 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -149.56 134.14 17.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HG3' HG11 ' A' ' 117' ' ' VAL . 7.3 mtmt -126.09 101.81 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 70' ' ' LEU . 9.0 p -92.25 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.338 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.89 ' CG1' HD11 ' A' ' 83' ' ' ILE . 35.7 m -75.59 97.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.737 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.17 113.74 21.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.912 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.2 tpm_? -59.01 113.28 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.68 68.2 7.95 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.49 -6.19 59.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 109.574 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.31 123.59 2.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.578 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.697 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.6 ttmm -41.94 162.47 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.318 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.859 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.43 58.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.018 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.5 tt0 -56.22 116.05 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.119 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.88 15.89 58.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.567 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.859 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.67 66.62 0.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 110.252 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -44.49 140.55 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.264 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -126.83 128.72 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.96 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.431 ' CA ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -115.57 129.83 56.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.696 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 68' ' ' PHE . 39.5 t -106.42 95.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.609 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.9 p -100.11 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.76 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.35 21.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.995 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -61.92 105.54 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.358 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 175.13 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.355 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 149' ' ' HIS . 32.8 m -153.74 126.56 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.008 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.79 104.42 2.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.714 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 13.0 p30 -58.87 -174.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.719 0.295 . . . . 0.0 110.857 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.75 16.58 60.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.909 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.98 -32.17 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.61 -16.96 3.52 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.061 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.99 170.16 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.995 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 148' ' ' VAL . 12.1 p -120.8 125.72 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 141' ' ' VAL . 79.1 m80 -96.12 90.54 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.945 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -49.42 106.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.43 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.451 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -76.19 -146.37 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.677 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.52 41.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.716 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 1.014 HG22 HD12 ' A' ' 37' ' ' LEU . 24.0 m -161.14 153.34 20.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.434 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 8.7 tt0 -110.0 161.98 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -139.5 166.75 23.73 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.435 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.1 p -142.23 116.21 9.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.67 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -111.65 122.37 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.253 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.42 105.85 17.95 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.679 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 18.1 mt -80.49 112.45 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.597 0.713 . . . . 0.0 109.842 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -94.55 131.77 40.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.038 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.01 145.84 49.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.077 0.465 . . . . 0.0 110.957 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.628 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 14.6 t -60.74 155.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -77.5 -46.85 21.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.26 114.21 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.208 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.943 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 6.7 t -162.08 136.7 6.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.138 0.494 . . . . 0.0 111.542 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 154' ' ' THR . 5.8 m -91.41 134.1 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.553 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 t -96.42 107.44 19.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.341 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.837 HD12 HG22 ' A' ' 154' ' ' THR . 3.7 mt -97.1 117.3 30.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.251 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.49 101.42 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.57 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -144.08 160.19 41.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -31.67 68.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' C ' HG12 ' A' ' 158' ' ' VAL . 11.1 mt-10 69.41 24.2 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.5 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HD21 ' A' ' 49' ' ' LEU . 6.8 tt0 -165.04 122.83 1.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.813 0.34 . . . . 0.0 111.657 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -143.34 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -67.51 132.19 47.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.573 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.0 t -32.76 132.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-O 121.549 0.69 . . . . 0.0 112.776 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.85 -24.89 30.34 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.536 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.3 171.85 8.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.746 0.307 . . . . 0.0 110.666 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -116.46 150.89 37.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.785 HD23 HG11 ' A' ' 158' ' ' VAL . 6.8 tp -130.08 142.1 50.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.862 ' HG2' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -123.51 117.05 24.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.1 p -93.55 98.65 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.19 69.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 53' ' ' VAL . 7.9 p -78.58 95.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.19 -135.1 8.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.809 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -107.51 127.37 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.553 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -94.29 -37.34 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 32' ' ' THR . 22.9 mp0 -161.07 132.21 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HG ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -162.49 91.61 0.77 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.108 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.0 p -121.46 109.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.565 ' N ' HG22 ' A' ' 31' ' ' VAL . 63.9 m-20 130.41 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.451 1.101 . . . . 0.0 111.606 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -150.41 -179.16 6.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.699 0.285 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER -126.93 85.16 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.362 . . . . 0.0 110.575 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.59 111.94 2.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.145 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.3 m-85 -115.28 -49.12 2.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.67 112.3 17.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.997 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.552 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 t80 -85.75 136.6 33.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.453 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -147.62 109.64 4.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.271 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 29.9 p90 -130.24 171.27 13.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.364 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 104.84 8.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.864 HD13 HG11 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -77.35 149.73 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.118 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -125.28 104.64 8.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HA ' HD23 ' A' ' 134' ' ' LEU . 19.1 p90 -121.33 -170.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -97.64 136.79 37.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -93.6 -26.8 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -76.54 -29.78 56.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.103 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -108.78 -49.32 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.327 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CE2' HD11 ' A' ' 160' ' ' ILE . 5.0 m-85 -93.31 -177.08 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ARG . 2.0 tt0 -170.28 108.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.806 ' HA ' HD23 ' A' ' 123' ' ' LEU . 38.9 t80 -47.47 152.73 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.399 . . . . 0.0 111.119 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.3 t -134.53 -78.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 122' ' ' VAL . 4.2 mt-10 -153.47 148.73 26.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.457 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -102.25 147.96 26.02 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.207 1.003 . . . . 0.0 111.638 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.791 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -133.78 174.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.103 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.67 -177.29 5.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HG23 ' A' ' 88' ' ' VAL . 20.1 p-10 -61.97 -161.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.713 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 36.71 1.1 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.44 -40.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.26 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.473 HG23 ' OD1' ' A' ' 85' ' ' ASP . 16.4 t -86.98 146.86 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -108.25 103.04 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.801 ' CG2' HG13 ' A' ' 104' ' ' VAL . 2.6 t -101.96 132.17 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.4 109.73 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.82 -179.23 4.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.342 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -161.11 117.92 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.387 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 tttt -54.03 113.35 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.389 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -109.49 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -158.44 172.91 17.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.839 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.85 131.91 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.25 29.47 63.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.441 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.8 ptmt -173.57 129.87 0.43 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.727 ' HA ' HG22 ' A' ' 95' ' ' ILE . 18.2 m -150.06 155.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.925 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -83.26 147.35 28.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 -178.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.1 p -130.68 129.89 64.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -111.05 109.94 20.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 90' ' ' VAL . 4.1 t -106.17 144.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.508 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.438 ' C ' HG13 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -164.38 139.78 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.305 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -88.57 104.34 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.108 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -67.75 -17.83 64.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 p -65.23 -34.81 79.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.22 -19.9 28.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.389 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.73 153.77 43.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 40.9 Cg_exo -56.72 164.8 5.43 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.629 2.219 . . . . 0.0 112.437 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 118' ' ' LEU . 2.3 mp -59.33 127.55 84.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.749 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.85 -32.14 96.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.409 2.072 . . . . 0.0 112.085 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.44 162.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 15.04 9.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.25 -164.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.218 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.841 HG11 ' HD3' ' A' ' 120' ' ' LYS . 31.0 t -78.97 104.66 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.57 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.55 -33.23 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 90' ' ' VAL . . . -168.68 133.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.319 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.841 ' HD3' HG11 ' A' ' 117' ' ' VAL . 3.9 mtmt -122.92 100.76 7.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.06 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.864 HG11 HD13 ' A' ' 70' ' ' LEU . 11.4 p -74.25 110.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 110.437 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.862 HG22 ' HG2' ' A' ' 50' ' ' GLU . 15.5 t -75.55 115.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.787 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 79' ' ' TYR . 15.9 mt -102.09 169.12 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.642 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 12.8 tpp180 -115.28 125.16 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -92.08 73.12 5.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.546 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -87.74 -5.11 58.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.435 0.636 . . . . 0.0 109.639 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.563 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 4.3 ttmm -49.74 134.2 20.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.176 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -138.69 64.29 1.49 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.47 114.42 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.151 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.51 21.25 52.07 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.814 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -71.02 66.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 0.8 OUTLIER -46.98 142.78 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.858 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -121.68 165.05 16.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.801 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.19 106.24 3.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 21.8 t -96.4 94.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.3 p -103.33 -160.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.81 19.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HD11 ' A' ' 151' ' ' ILE . 74.7 m -59.81 90.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.123 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.45 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -116.44 138.47 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.212 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 148' ' ' VAL . 10.4 p -115.01 153.29 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.03 100.19 2.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.786 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 25.9 t0 -52.51 162.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.779 0.324 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.39 -43.88 95.51 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.548 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.22 -30.85 71.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.98 -27.76 3.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.536 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.7 155.34 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 141' ' ' VAL . 12.1 p -114.43 138.63 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -110.52 96.93 6.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.56 104.99 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.159 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.39 -176.76 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.1 -158.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.577 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -154.88 175.35 32.96 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 37' ' ' LEU . 86.0 m -164.12 146.73 9.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.925 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 11.2 pt-20 -101.75 166.7 10.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.635 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -152.4 154.67 36.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.879 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.635 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.9 p -126.77 143.6 51.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.605 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.69 130.02 52.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.58 105.93 16.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 120.933 0.397 . . . . 0.0 111.011 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.8 mt -80.15 115.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.491 0.662 . . . . 0.0 109.455 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.29 128.74 48.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.116 -178.157 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.08 145.9 29.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.107 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.524 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 60' ' ' ASN . 24.9 t -60.68 155.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -84.44 -45.06 13.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.01 120.28 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.422 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.8 t -162.95 140.47 7.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.06 0.457 . . . . 0.0 111.421 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 154' ' ' THR . 11.2 m -97.82 129.26 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.37 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 56' ' ' ASP . 47.5 p -95.01 108.21 20.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.948 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.077 HD12 HG23 ' A' ' 154' ' ' THR . 1.4 mt -97.71 122.09 40.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.55 112.28 10.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.595 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -153.01 155.6 37.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 111.417 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.48 -29.15 66.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 69.98 23.87 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.624 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' N ' HG12 ' A' ' 158' ' ' VAL . 19.9 tt0 -164.68 128.95 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 112.112 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -134.03 171.19 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.117 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.5 tt0 -133.05 120.15 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.0 t -28.72 132.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 121.576 0.703 . . . . 0.0 112.381 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.05 49.55 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.28 174.92 10.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.515 0.326 . . . . 0.0 110.15 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -127.42 147.93 50.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.875 0.369 . . . . 0.0 110.986 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -102.52 164.12 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 122' ' ' VAL . 11.6 mt-10 -130.0 93.32 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.682 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 p -103.16 97.9 6.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -91.48 85.2 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.258 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 136' ' ' VAL . 3.5 p -78.55 95.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 110.086 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -96.37 -134.9 8.2 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.499 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -103.08 134.63 43.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 111.606 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 22.1 t0 -103.28 -34.32 8.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.425 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 32' ' ' THR . 4.0 mp0 -165.54 134.05 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.926 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 141' ' ' VAL . 1.6 tt -162.27 91.61 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.759 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 59' ' ' VAL . 11.9 p -119.31 103.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 7.6 m120 133.1 24.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.262 1.025 . . . . 0.0 111.413 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -160.6 171.95 18.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -121.19 86.05 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.716 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.59 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -62.5 133.52 55.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 12.7 m-85 -127.63 -42.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.04 112.44 15.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.752 ' O ' HG22 ' A' ' 104' ' ' VAL . 5.4 t80 -85.98 100.66 12.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -109.33 112.44 24.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 50.4 p90 -142.97 171.54 13.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.8 t -128.48 121.29 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 ' CG1' ' A' ' 121' ' ' VAL . 7.2 tt -95.03 126.34 40.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -98.32 106.59 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.455 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 50.0 p90 -107.13 -169.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.702 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.69 120.27 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -29.46 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -27.42 69.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.704 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -125.95 -44.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.384 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.8 OUTLIER -93.14 161.06 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -145.65 130.39 18.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD1' HG21 ' A' ' 100' ' ' VAL . 19.5 t80 -55.02 149.13 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 55.7 t -132.16 -85.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 122' ' ' VAL . 58.1 mm-40 -160.4 135.84 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.88 150.58 26.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.147 0.975 . . . . 0.0 111.393 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.682 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -120.19 153.29 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.571 -177.17 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -117.25 -165.89 1.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.714 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.5 -157.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.618 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.6 37.15 1.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.863 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.67 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.169 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 89' ' ' PHE . 40.5 t -86.74 158.85 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.2 t80 -112.36 125.38 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.952 HG22 ' CG1' ' A' ' 104' ' ' VAL . 3.5 t -122.57 135.93 61.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -149.33 120.53 7.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.612 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.96 156.77 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 107.25 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.174 0.512 . . . . 0.0 111.337 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.3 ttpt -55.1 95.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.5 tp -82.73 -22.21 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.765 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.8 -166.74 0.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.81 133.18 33.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.87 29.56 62.0 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' C ' HG13 ' A' ' 100' ' ' VAL . 13.3 ptpt -173.26 121.59 0.36 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 95' ' ' ILE . 7.1 m -149.91 154.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.676 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.09 152.16 22.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.204 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 8.6 p -126.45 93.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.15 111.0 17.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.952 ' CG1' HG22 ' A' ' 90' ' ' VAL . 4.2 m -117.25 158.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.022 0.439 . . . . 0.0 111.804 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -164.49 136.09 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.265 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -79.01 113.67 17.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 31.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.983 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.2 p -109.65 -34.64 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.48 -21.84 11.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.142 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -91.17 155.69 44.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.757 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 59.1 Cg_endo -72.4 174.5 11.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.481 2.121 . . . . 0.0 112.476 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 114' ' ' ALA . 4.0 tt -54.49 107.55 0.9 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.86 -32.11 94.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.344 2.029 . . . . 0.0 111.926 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.733 ' H ' HD23 ' A' ' 112' ' ' LEU . . . 59.77 170.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.168 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.6 16.15 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.087 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -148.26 -179.85 7.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.0 t -70.95 105.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.649 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 114' ' ' ALA . 2.3 mm? -87.56 -31.55 19.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.214 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -166.11 131.0 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.679 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -119.89 118.6 31.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.9 ' CG1' HD13 ' A' ' 70' ' ' LEU . 7.1 p -97.98 94.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.182 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 81' ' ' GLU . 21.5 m -75.63 118.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 134' ' ' LEU . 2.4 mm? -92.24 169.2 10.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.0 tpm_? -105.51 118.25 36.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -90.86 71.07 6.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.785 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.36 -4.3 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.96 124.31 2.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.042 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.669 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 3.1 ptmt -40.6 163.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.704 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -178.2 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.971 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 pt-20 -55.63 112.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.408 ' O ' ' ND2' ' A' ' 133' ' ' ASN . . . 105.69 4.14 39.85 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.647 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -62.84 87.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.932 0.396 . . . . 0.0 110.24 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.798 ' C ' HD12 ' A' ' 134' ' ' LEU . 1.7 m-80 -60.49 166.68 2.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 133' ' ' ASN . 9.5 mp -140.13 104.84 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.649 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.41 130.14 45.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.227 0.537 . . . . 0.0 112.093 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 53' ' ' VAL . 30.6 m -115.4 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.17 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 -167.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.547 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.41 29.87 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.449 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB3' HD11 ' A' ' 151' ' ' ILE . 50.6 m -62.34 89.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.034 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.95 171.66 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.357 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.013 HG21 HD11 ' A' ' 58' ' ' LEU . 15.4 m -147.33 122.46 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 99.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 46.4 t0 -56.41 162.53 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.41 -29.16 70.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.61 -49.05 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.6 -28.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.392 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.33 170.2 16.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.23 153.39 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -123.03 94.82 4.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.23 104.97 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.503 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.53 -176.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -67.93 -160.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -159.78 175.54 36.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 1.077 HG23 HD12 ' A' ' 37' ' ' LEU . 1.3 t -162.93 -170.91 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.849 -0.207 . . . . 0.0 110.574 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -151.21 152.06 32.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.198 0.523 . . . . 0.0 112.061 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 37' ' ' LEU . 4.1 tppt? -129.34 169.26 15.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.867 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.01 144.38 32.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.59 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -134.24 126.37 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -90.35 116.13 28.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.775 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 77' ' ' PHE . 4.6 mt -85.56 116.66 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.69 -178.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.89 146.6 51.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.016 0.436 . . . . 0.0 111.016 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.502 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 61' ' ' ALA . 12.3 t -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' GLY . 6.7 t -80.42 -32.27 37.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.43 120.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.596 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.602 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 28.6 t -149.94 155.01 39.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.277 0.56 . . . . 0.0 111.944 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -108.06 123.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -92.13 107.38 19.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 154' ' ' THR . 1.9 mt -97.16 126.59 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.27 101.42 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.734 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -146.2 154.56 41.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.346 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.57 -26.62 61.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.58 23.53 7.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.424 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 158' ' ' VAL . 27.0 tt0 -164.7 126.55 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 160' ' ' ILE . 3.6 p -128.62 171.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.493 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -133.83 113.4 12.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.512 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.8 t -28.37 114.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 125.06 -25.6 5.75 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.884 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.8 -175.52 2.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.913 0.387 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -114.9 167.74 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.747 HD11 HG11 ' A' ' 158' ' ' VAL . 1.3 tp -114.74 159.43 20.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.469 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.8 m -105.54 98.05 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.476 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.785 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.1 71.48 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.153 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.68 HG21 HG11 ' A' ' 136' ' ' VAL . 8.2 p -78.22 97.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.965 0.412 . . . . 0.0 110.872 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.35 -128.47 5.79 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.852 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -112.05 134.8 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.037 0.446 . . . . 0.0 111.431 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.02 -33.05 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.234 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 3.4 pt-20 -174.46 130.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.642 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -152.61 91.67 1.59 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.093 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 31' ' ' VAL . 10.6 p -100.11 117.82 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 31' ' ' VAL . 19.9 m120 100.78 22.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.596 0.758 . . . . 0.0 112.352 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.851 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -142.69 138.59 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.8 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.1 mp0 -102.19 87.18 3.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -62.2 112.12 2.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.42 -32.06 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.63 111.96 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.666 ' HD1' HG12 ' A' ' 141' ' ' VAL . 0.8 OUTLIER -87.45 136.5 32.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.341 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.495 ' OD2' HD23 ' A' ' 103' ' ' LEU . 8.3 t0 -147.83 109.86 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.314 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.703 ' CD1' HG13 ' A' ' 136' ' ' VAL . 5.0 p90 -125.0 171.12 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.375 . . . . 0.0 111.352 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 115.56 17.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.587 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 136' ' ' VAL . 10.5 tp -77.3 141.45 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.257 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -119.96 104.59 10.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.568 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.426 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 50.3 p90 -133.0 -170.87 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.82 132.43 54.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -27.39 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -56.31 -30.04 62.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.35 -48.15 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.17 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.38 178.9 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -171.7 119.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.734 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 15.2 t80 -54.54 156.02 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.714 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 122' ' ' VAL . 58.4 t -130.46 -84.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 14.2 pt-20 -153.07 132.14 12.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.83 150.19 26.72 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.141 0.972 . . . . 0.0 111.649 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.543 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.99 152.38 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.353 -177.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.6 ' HB2' HG23 ' A' ' 88' ' ' VAL . 51.9 p -115.07 -168.41 1.38 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.852 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -93.87 -160.12 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.86 37.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.29 -42.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.167 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 106' ' ' SER . 28.3 m -96.08 173.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.336 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 156.82 26.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.575 HG13 ' CG2' ' A' ' 102' ' ' VAL . 21.5 t -147.85 123.94 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -134.01 110.78 9.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.028 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.734 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.15 131.02 44.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.311 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -118.84 108.04 14.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HA ' HG23 ' A' ' 100' ' ' VAL . 12.8 tttt -70.51 97.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.831 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -78.1 -0.06 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.12 -168.76 0.08 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.35 115.39 27.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 79.92 38.72 18.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.075 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -172.68 123.42 0.44 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 94' ' ' LYS . 12.4 p -151.61 131.86 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.593 -174.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 15.7 ttp180 -101.28 151.97 21.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.848 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.575 ' CG2' HG13 ' A' ' 90' ' ' VAL . 12.8 p -123.59 157.29 29.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 111.824 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.495 HD23 ' OD2' ' A' ' 67' ' ' ASP . 84.8 mt -123.56 106.94 11.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.525 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 118' ' ' LEU . 11.1 t -105.27 143.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 111.686 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 p -164.29 136.17 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.767 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -89.08 112.22 23.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 111.258 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mt -93.77 31.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.929 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -109.7 -30.92 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.968 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.65 -20.67 11.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.223 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -94.43 155.93 39.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.615 0.245 . . . . 0.0 110.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 177.07 7.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.574 2.183 . . . . 0.0 112.547 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -56.72 119.15 27.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.901 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.62 -42.41 39.95 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.931 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.765 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 66.08 163.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.29 15.49 10.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.271 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.2 -169.76 3.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.284 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.785 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.6 t -74.04 104.92 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -96.81 -28.79 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -155.16 129.4 8.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -118.96 101.01 7.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.534 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.6 p -95.8 97.97 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 81' ' ' GLU . 20.2 m -75.51 124.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.067 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.733 ' CD2' HD21 ' A' ' 134' ' ' LEU . 4.2 mp -95.33 169.19 10.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.792 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.474 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -111.28 120.4 42.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.492 . . . . 0.0 112.069 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -89.72 69.52 7.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.991 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.5 -9.51 47.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.34 0.591 . . . . 0.0 109.623 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.49 124.3 3.1 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.736 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.691 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.4 ttpp -43.66 155.24 0.08 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.433 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.771 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -165.82 59.51 0.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.892 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.53 116.27 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.188 -179.111 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.7 18.56 51.26 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.334 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.771 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.55 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.939 0.399 . . . . 0.0 110.456 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.96 133.93 4.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.255 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.733 HD21 ' CD2' ' A' ' 123' ' ' LEU . 1.2 mp -116.42 118.31 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.1 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 p -99.6 124.15 44.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.553 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.775 HG22 HD12 ' A' ' 70' ' ' LEU . 25.0 t -110.22 95.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.546 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -111.98 -159.78 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.761 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.56 20.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.601 ' CB ' HD11 ' A' ' 151' ' ' ILE . 26.9 m -68.05 92.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.26 163.85 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.39 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.666 HG12 ' HD1' ' A' ' 66' ' ' TYR . 27.6 m -139.07 130.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.68 82.84 0.93 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 9.1 t70 -55.18 139.96 40.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.76 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.2 -38.39 25.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.06 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -53.51 -26.58 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.56 10.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.668 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.18 170.15 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 148' ' ' VAL . 10.9 p -120.51 122.98 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 5.3 m-70 -92.74 99.62 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.081 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.33 110.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' A' ' 139' ' ' SER . 0.3 OUTLIER -84.23 171.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.208 0.528 . . . . 0.0 111.922 -178.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.4 -146.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.487 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.55 167.44 37.73 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.518 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.83 HG22 HD12 ' A' ' 37' ' ' LEU . 9.5 m -168.14 148.74 4.95 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -118.6 179.12 4.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.622 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.64 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppt? -144.7 168.85 19.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.0 p -142.12 115.78 9.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -114.68 122.12 68.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.291 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -89.3 112.34 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.555 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.822 HG23 HG13 ' A' ' 43' ' ' VAL . 2.4 mt -81.62 120.65 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.375 0.607 . . . . 0.0 109.634 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.49 131.25 55.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.922 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.74 146.06 47.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.094 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.489 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.779 0.324 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.749 HG11 HD23 ' A' ' 58' ' ' LEU . 72.5 t -68.03 153.25 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.683 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.4 t -62.91 -43.09 99.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.376 0.607 . . . . 0.0 109.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 65.66 104.71 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.536 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.904 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -162.35 133.73 5.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.419 0.628 . . . . 0.0 112.105 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 151' ' ' ILE . 23.2 m -91.68 143.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.546 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.0 t -93.9 111.63 23.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.796 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -97.08 120.51 37.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.141 0.496 . . . . 0.0 111.596 -179.116 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -141.22 129.93 22.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.59 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -176.06 155.38 1.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -29.22 68.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.354 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.4 mt-10 72.45 24.7 2.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.62 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' CG ' HD11 ' A' ' 161' ' ' ILE . 2.3 tt0 -164.82 128.15 2.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 0.0 112.013 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -143.97 107.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.332 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -69.91 127.71 33.81 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.8 t -29.26 131.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 112.727 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.14 -18.54 56.52 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.422 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.54 172.89 6.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.776 0.322 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.39 149.1 47.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.662 HD22 HG11 ' A' ' 158' ' ' VAL . 3.1 pp -102.56 164.28 11.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HA ' HG12 ' A' ' 122' ' ' VAL . 40.1 tt0 -135.69 93.88 3.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -103.82 98.02 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.91 80.6 1.82 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 136' ' ' VAL . 14.9 p -78.35 97.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.172 0.51 . . . . 0.0 110.754 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -101.74 -128.7 6.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.96 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -110.68 131.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.605 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.8 t0 -100.68 -36.41 9.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HB3' HG21 ' A' ' 32' ' ' THR . 21.4 mt-10 -158.21 131.57 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.651 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.749 HD23 HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -163.34 91.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.246 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.708 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.32 107.84 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.554 ' CA ' HG22 ' A' ' 31' ' ' VAL . 64.2 m-20 130.22 20.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.55 1.14 . . . . 0.0 111.637 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -155.69 165.82 35.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.771 0.319 . . . . 0.0 110.795 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.52 85.11 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.62 120.24 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 5.5 m-85 -112.71 -30.92 6.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.74 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.42 112.5 7.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' O ' HG22 ' A' ' 104' ' ' VAL . 1.1 t80 -85.69 132.82 34.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.46 110.01 4.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.648 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 10.0 p90 -127.84 171.12 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.137 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 101' ' ' ARG . 0.3 OUTLIER -128.77 113.03 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.789 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 HG11 ' A' ' 121' ' ' VAL . 7.9 tt -92.77 153.36 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.003 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 70' ' ' LEU . 7.2 m120 -123.16 137.97 54.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.763 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 46.1 p90 -140.46 -175.28 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.92 120.21 40.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -78.32 -3.78 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.35 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.1 20.8 8.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.855 0.36 . . . . 0.0 111.1 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.813 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.58 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.584 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.783 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -107.17 155.27 20.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.5 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -151.88 131.11 12.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.763 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.0 t80 -53.15 150.84 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.726 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 122' ' ' VAL . 47.6 t -126.62 -84.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 122' ' ' VAL . 3.5 mt-10 -157.91 132.49 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.73 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.87 145.65 29.33 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.176 0.988 . . . . 0.0 111.437 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -126.44 154.8 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.56 -1.654 . . . . 0.0 112.64 -177.164 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.827 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -120.09 -165.09 1.14 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.77 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -91.0 -158.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.11 37.15 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 -38.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.01 155.51 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -112.41 112.79 24.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.874 HG22 HG12 ' A' ' 104' ' ' VAL . 3.6 t -101.95 155.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 22.1 t-20 -164.12 109.29 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.763 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.5 140.07 32.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.202 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -120.38 108.43 14.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.71 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.03 -29.17 43.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.987 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 178.16 -168.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.205 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.41 123.51 24.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 64.16 41.05 98.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.184 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.38 127.33 0.54 Allowed 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 79' ' ' TYR . 10.3 p -151.88 136.17 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.3 tpp85 -107.28 152.2 24.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.365 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 13.9 p -129.89 146.32 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.431 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.3 mt -131.69 98.39 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.316 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 90' ' ' VAL . 1.3 m -98.12 160.73 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.419 . . . . 0.0 111.655 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 p -163.86 135.4 4.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.324 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p -77.19 110.68 12.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.305 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.8 tp -92.87 29.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.956 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 p -108.94 -27.2 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.971 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.25 -18.02 12.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.225 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -101.84 157.11 34.31 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.28 . . . . 0.0 110.719 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 62.3 Cg_endo -73.5 -175.54 2.09 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.537 2.158 . . . . 0.0 112.459 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.704 ' CD2' HD21 ' A' ' 118' ' ' LEU . 1.3 tt -56.52 114.53 7.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.91 -39.54 32.46 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.563 2.176 . . . . 0.0 112.126 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 67.71 168.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.56 15.81 10.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.127 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.62 -168.54 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.414 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.2 t -76.87 105.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.785 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.24 -32.66 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -168.03 131.42 1.6 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.754 0.312 . . . . 0.0 111.262 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -115.62 113.93 24.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.481 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.9 HG11 HD13 ' A' ' 70' ' ' LEU . 7.2 p -97.52 95.08 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.233 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 81' ' ' GLU . 26.0 m -75.6 115.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.841 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.677 ' CD2' HD21 ' A' ' 134' ' ' LEU . 3.6 mm? -83.6 169.33 15.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.954 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -108.74 124.9 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.999 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -100.47 69.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.782 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -5.45 55.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.483 0.659 . . . . 0.0 109.448 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.69 124.27 2.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.453 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.9 ttpt -44.11 135.02 4.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.562 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.813 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -144.27 59.77 1.35 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.852 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 133' ' ' ASN . . . 98.93 -5.28 59.53 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.55 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.787 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.1 m -56.25 91.32 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.321 . . . . 0.0 110.543 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 134' ' ' LEU . 2.2 m-80 -65.27 160.04 22.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.194 0.521 . . . . 0.0 111.499 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 133' ' ' ASN . 4.7 mp -137.08 104.3 5.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.612 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.2 p -102.37 125.45 49.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 53' ' ' VAL . 19.5 m -111.32 94.95 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.3 p -99.05 -161.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.24 19.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 151' ' ' ILE . 66.6 m -60.26 101.32 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.14 173.1 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.427 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.719 HG21 HD11 ' A' ' 58' ' ' LEU . 3.4 m -147.95 127.23 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.34 97.89 0.89 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.26 161.57 1.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.95 -34.95 91.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.45 -31.59 68.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.99 -31.96 2.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.436 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -69.14 170.08 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.36 150.53 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -121.77 95.16 4.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.157 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -55.85 105.56 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.552 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.38 -176.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.331 0.586 . . . . 0.0 111.742 -179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -65.68 -156.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.49 166.97 36.16 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.667 ' HB ' HD23 ' A' ' 37' ' ' LEU . 14.9 m -163.14 155.68 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -126.58 173.08 9.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.316 0.579 . . . . 0.0 112.088 -179.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.796 ' HE2' HD12 ' A' ' 37' ' ' LEU . 1.4 tppt? -139.56 168.7 19.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -143.09 116.33 8.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.662 HG11 HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -104.73 130.47 55.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.484 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.58 18.7 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.414 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.1 mt -78.89 119.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.44 0.638 . . . . 0.0 109.712 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.506 HD11 ' CG ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.5 136.96 33.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.82 145.03 53.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 111.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.509 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 60' ' ' ASN . 61.5 t -89.72 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.444 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -73.06 -42.54 62.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 59.1 110.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.286 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.502 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 30.6 t -150.11 140.01 21.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.731 0.777 . . . . 0.0 111.956 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -93.36 144.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.066 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -103.07 107.55 18.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.756 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.871 HD12 HG22 ' A' ' 154' ' ' THR . 6.0 mt -96.88 112.51 24.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -136.25 117.42 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -166.8 164.2 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.307 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -68.33 -29.51 68.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.486 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 1.2 mt-10 66.71 33.36 6.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -164.22 120.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 111.772 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.0 p -127.79 167.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.564 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.6 tm0? -130.46 118.27 20.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.2 t -28.55 131.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 121.575 0.703 . . . . 0.0 112.355 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.48 13.19 61.83 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.618 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -132.08 174.61 10.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.497 0.319 . . . . 0.0 110.238 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -123.59 149.27 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.861 0.363 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.717 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -112.18 160.05 17.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -136.14 93.76 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p -103.27 97.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.6 96.33 1.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.927 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 53' ' ' VAL . 10.2 p -87.18 95.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.46 -137.4 9.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.83 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.727 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -108.04 134.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 0.0 111.641 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.11 -33.44 11.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.7 mp0 -168.39 134.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.6 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -153.83 90.99 1.42 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.358 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.641 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.2 p -110.12 116.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.0 m-20 102.34 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.843 0.857 . . . . 0.0 111.932 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -169.52 143.05 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 82.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.75 111.77 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.655 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -100.74 -34.33 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.745 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.02 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.064 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 20.1 t80 -108.88 94.84 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -100.11 110.27 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.199 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.862 ' O ' HG12 ' A' ' 102' ' ' VAL . 14.6 p90 -102.3 171.4 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.42 . . . . 0.0 111.549 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 m -135.85 100.95 4.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.488 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 121' ' ' VAL . 8.7 tt -79.43 154.54 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.225 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.467 ' N ' HD23 ' A' ' 70' ' ' LEU . 5.6 m120 -123.58 104.32 8.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.438 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.1 p90 -114.59 -167.3 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.959 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.32 123.94 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.4 -30.45 53.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -63.8 -30.97 72.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.027 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.75 -50.93 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -93.33 -176.97 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 109.65 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.99 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.533 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.6 t80 -51.96 147.77 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 122' ' ' VAL . 39.3 t -132.3 -74.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.829 ' O ' HG22 ' A' ' 122' ' ' VAL . 5.9 mt-10 -166.91 140.01 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.1 151.97 25.52 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 122.195 0.997 . . . . 0.0 111.525 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.15 174.39 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.375 -1.739 . . . . 0.0 112.167 -177.402 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -144.7 -165.69 2.21 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -93.99 -158.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.36 36.68 1.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.882 0.373 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.94 -42.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.117 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 105' ' ' SER . 13.0 t -89.98 148.42 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -103.15 137.69 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.44 HG13 ' CG2' ' A' ' 102' ' ' VAL . 25.1 t -133.7 144.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -155.33 116.99 4.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.568 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.53 157.05 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -141.05 107.26 5.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 22.3 tttt -55.11 115.01 1.99 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.2 tp -109.81 -25.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.881 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -160.1 165.69 31.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -66.87 128.69 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 62.73 30.69 77.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' C ' HG13 ' A' ' 100' ' ' VAL . 20.9 ptmt -173.77 122.86 0.34 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.907 0.384 . . . . 0.0 110.058 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.675 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 12.9 m -150.09 155.57 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 152.37 20.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.4 p -127.97 139.94 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.89 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.57 107.27 16.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 118' ' ' LEU . 4.6 t -106.88 147.0 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.56 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.45 ' C ' HG13 ' A' ' 88' ' ' VAL . 22.1 p -164.49 136.1 4.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.504 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 88' ' ' VAL . 93.7 p -83.99 104.88 14.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -94.94 31.15 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.152 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -99.02 -33.1 10.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.12 -25.1 6.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.307 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.57 155.07 41.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.845 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.36 173.67 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.58 2.187 . . . . 0.0 112.376 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.733 ' HG ' HD11 ' A' ' 118' ' ' LEU . 1.6 mp -58.89 116.87 17.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.12 -30.08 89.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.353 2.035 . . . . 0.0 111.844 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.727 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 56.49 169.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.278 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.15 17.86 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.08 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.02 -164.44 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.556 HG11 ' HE3' ' A' ' 120' ' ' LYS . 21.5 t -80.36 104.62 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.914 0.388 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.733 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -92.43 -32.84 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -172.69 132.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.31 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.818 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -122.66 132.09 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.556 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 70' ' ' LEU . 11.8 p -104.47 118.43 51.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.367 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.846 ' CG1' HD11 ' A' ' 83' ' ' ILE . 20.2 m -92.89 118.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.7 109.88 21.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.98 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.0 tpp85 -55.17 117.45 3.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.89 71.76 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.531 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.9 -3.28 58.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.538 0.685 . . . . 0.0 109.41 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.43 123.14 2.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.206 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.627 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.8 ttpm? -46.02 157.55 0.12 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.259 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.027 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -169.77 59.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.773 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.8 OUTLIER -56.16 116.03 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.937 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.87 21.61 49.56 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.261 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.752 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -68.14 70.91 0.16 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.044 0.45 . . . . 0.0 110.377 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 1.7 t-20 -43.8 121.87 2.55 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.643 HD23 HD11 ' A' ' 70' ' ' LEU . 5.8 mp -116.22 161.07 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.159 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 150.41 26.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.346 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 68' ' ' PHE . 15.2 t -123.33 95.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.7 p -101.55 -166.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.94 22.86 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -65.17 107.07 1.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.84 0.352 . . . . 0.0 110.523 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.95 171.26 7.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.44 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 58' ' ' LEU . 11.3 m -144.69 132.26 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.703 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.71 96.38 1.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.898 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -55.98 161.82 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.767 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.37 -27.94 73.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -74.48 -47.59 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.96 -25.75 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.58 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.52 158.01 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.993 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 148' ' ' VAL . 14.6 p -115.89 115.01 47.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -87.5 93.19 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -48.3 108.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.238 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.535 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.35 166.58 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.27 0.557 . . . . 0.0 111.738 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -59.5 -144.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.327 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 35' ' ' VAL . . . -170.81 -177.21 40.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.108 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.871 HG22 HD12 ' A' ' 37' ' ' LEU . 25.4 m -161.24 148.95 15.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.723 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 15.6 tt0 -102.01 158.14 16.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.276 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.793 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppp? -151.28 164.23 37.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.555 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.628 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 4.0 p -142.62 153.91 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.768 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.05 133.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.849 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -99.42 115.03 28.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.159 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.8 mt -86.76 118.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -100.66 128.35 52.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.194 -178.007 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -55.96 146.63 21.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.182 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.494 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.802 0.334 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.86 73.33 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -102.69 173.91 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.61 132.99 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -132.15 176.85 8.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -152.39 33.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -156.7 141.98 17.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 m80 60.43 175.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.52 166.54 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -176.61 -175.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m 60.7 105.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 t -109.55 -53.8 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.64 160.28 19.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.53 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 14' ' ' LEU . 12.8 mt -114.12 -38.65 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.84 150.73 77.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -32.35 101.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.616 2.878 . . . . 0.0 113.244 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -153.44 -68.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.89 -154.16 20.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.35 168.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -108.57 -31.84 7.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -176.97 4.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 169.29 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 141.82 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.87 154.52 50.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tp -95.73 -40.7 9.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 136.68 58.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.9 -176.7 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.26 177.13 8.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 60' ' ' ASN . . . -175.24 77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.57 125.22 35.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 61' ' ' ALA . 21.8 t -94.2 146.38 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 57' ' ' GLU . 12.6 t -68.1 -36.3 79.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.44 109.24 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.159 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.651 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 3.2 m -151.32 141.23 21.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.522 0.677 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.9 m -95.82 143.3 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.693 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -102.8 105.2 15.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.035 178.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 156' ' ' LYS . 12.1 tp -109.02 125.21 51.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.6 tt0 -140.22 121.91 15.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.019 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -149.32 162.76 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.382 . . . . 0.0 111.68 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -70.71 -28.91 65.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 74.24 24.26 1.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.656 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 7.7 tt0 -164.92 128.28 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.2 p -146.14 107.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.131 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.58 126.83 30.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.178 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.27 124.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 113.85 -19.2 18.73 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.684 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 43' ' ' VAL . 2.9 tt0 -110.42 173.11 6.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.662 0.267 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -114.53 167.62 10.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.741 ' O ' HG12 ' A' ' 122' ' ' VAL . 18.1 mt -108.8 161.43 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -136.08 93.71 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.564 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 39' ' ' ALA . 7.9 m -105.06 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.455 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.791 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.41 72.98 1.87 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.176 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -78.38 99.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.957 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.76 -118.42 3.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.782 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -120.4 135.14 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.014 0.435 . . . . 0.0 111.921 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -36.47 7.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 32' ' ' THR . 81.8 mm-40 -158.99 131.34 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.323 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -154.12 90.62 1.37 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.463 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.774 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.7 p -111.39 114.83 48.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.6 m-20 102.68 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.055 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -145.93 133.63 21.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.777 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.6 tp10 -100.82 86.16 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.582 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.091 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.5 125.83 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.519 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 3.5 m-85 -118.41 -37.85 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.487 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.24 112.79 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.994 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 2.6 t80 -85.75 135.77 33.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 111.508 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -148.06 110.01 4.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.275 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 11.7 p90 -128.04 171.42 11.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.429 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.72 101.14 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.687 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.796 HD21 HD22 ' A' ' 134' ' ' LEU . 8.0 tt -77.21 153.66 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.923 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -122.26 114.34 20.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.668 ' HA ' HD23 ' A' ' 134' ' ' LEU . 37.2 p90 -122.83 -172.37 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.13 126.17 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -82.47 -32.19 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -74.99 -29.75 60.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.881 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -107.39 -52.81 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 160' ' ' ILE . 4.7 m-85 -93.43 171.91 8.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.3 115.75 4.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.71 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.601 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.7 t80 -48.42 148.65 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' A' ' 122' ' ' VAL . 48.7 t -130.6 -84.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.871 ' O ' HG22 ' A' ' 122' ' ' VAL . 24.7 mm-40 -157.37 138.65 13.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.197 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.7 153.77 25.17 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.217 1.008 . . . . 0.0 111.757 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.877 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.49 174.7 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.218 -177.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.473 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -154.66 -165.64 2.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.71 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -161.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -95.59 37.77 1.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.53 -39.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.57 HG13 ' C ' ' A' ' 105' ' ' SER . 21.7 t -86.96 140.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.924 0.393 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -97.14 118.66 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.026 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 104' ' ' VAL . 6.3 t -116.83 129.96 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -137.23 120.0 16.26 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.63 148.34 22.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.087 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -131.84 106.69 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.676 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -55.02 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.137 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.9 tp -83.0 -25.12 8.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.836 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -165.33 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 61.15 32.13 79.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.452 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.51 120.8 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.823 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.24 155.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -97.05 152.53 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.928 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.6 p -126.66 146.83 31.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.445 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 59.6 mt -115.74 107.41 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.757 HG11 ' CD1' ' A' ' 118' ' ' LEU . 9.9 t -104.77 140.92 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 111.543 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.57 ' C ' HG13 ' A' ' 88' ' ' VAL . 1.8 p -164.48 136.89 4.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -83.5 111.24 18.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.212 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -93.55 28.8 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.125 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.7 p -104.04 -27.97 11.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.04 6.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.217 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.34 158.55 35.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 37.2 Cg_endo -66.0 164.14 28.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.532 2.155 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.091 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -55.25 131.78 69.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.424 ' O ' HD23 ' A' ' 118' ' ' LEU . 96.3 Cg_endo -86.81 145.17 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -97.45 168.75 10.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.92 35.11 13.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.14 157.79 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.611 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.791 HG13 ' HA3' ' A' ' 52' ' ' GLY . 36.6 t -50.86 105.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.757 ' CD1' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.54 -30.93 18.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -176.21 157.71 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.733 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.736 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -153.84 131.94 11.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.574 ' O ' HD22 ' A' ' 123' ' ' LEU . 95.3 t -104.62 105.03 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.628 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.877 ' CG1' HD11 ' A' ' 83' ' ' ILE . 26.0 m -75.22 109.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.874 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 121' ' ' VAL . 2.8 mm? -83.15 169.13 16.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 1.7 tpm_? -110.86 118.87 37.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -86.49 67.27 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.243 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.88 -4.76 59.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.45 123.72 2.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.491 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -39.66 160.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.606 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.41 60.8 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.767 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.51 119.74 6.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.286 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 133' ' ' ASN . . . 86.3 13.18 68.83 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.648 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.813 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -69.08 69.93 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.545 ' HB3' HG22 ' A' ' 157' ' ' THR . 0.2 OUTLIER -59.56 146.29 41.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.448 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -117.46 165.11 13.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.857 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.5 115.51 9.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.0 111.178 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 53' ' ' VAL . 2.6 m -96.15 95.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.3 p -111.67 -163.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.704 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.89 21.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -69.22 96.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -94.87 -178.53 4.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 111.366 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.8 m -156.68 141.66 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 88.38 1.5 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.326 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.531 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 14.4 t0 -52.92 160.61 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.67 76.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.584 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -55.72 -26.73 46.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 111.053 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.96 23.18 5.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mt -117.73 170.04 9.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 140' ' ' SER . 77.5 t -109.12 142.23 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.531 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 41.6 m-70 -119.38 92.39 3.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -48.62 97.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.33 164.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.163 0.506 . . . . 0.0 111.69 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.56 -148.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.551 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -170.4 174.58 44.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.468 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.749 HG22 HD23 ' A' ' 37' ' ' LEU . 52.2 m -145.44 162.36 37.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 110.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -123.54 154.07 39.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.973 0.416 . . . . 0.0 111.152 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -132.22 164.08 27.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.936 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 133' ' ' ASN . 1.2 p -141.77 115.57 9.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.983 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.35 135.74 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.412 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -105.32 108.19 19.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -82.99 116.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -98.46 139.78 19.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.92 145.69 55.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 0.0 111.139 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.46 -133.25 0.62 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.469 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -84.63 176.02 8.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 164' ' ' THR . 1.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.24 -65.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.457 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -141.27 100.95 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.316 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -130.29 -56.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -73.22 79.85 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -173.34 120.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.31 79.69 3.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.935 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.09 154.92 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -162.34 35.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 60.72 95.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 m -98.44 35.29 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t -87.0 79.88 8.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.83 -126.17 8.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.32 -46.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.4 82.99 2.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -32.33 -37.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.618 2.879 . . . . 0.0 113.355 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.08 155.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.87 -161.38 33.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.499 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.58 148.27 51.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -91.63 177.3 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ttm 60.53 106.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.93 101.81 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.179 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -130.73 92.12 3.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 121.31 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -146.12 86.79 1.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -102.13 -64.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 177.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.51 109.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.12 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.92 36.89 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.39 120.62 25.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 59' ' ' VAL . 65.7 t -68.65 155.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 59' ' ' VAL . 8.4 t -72.59 -43.76 62.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 68.6 114.09 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.225 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.843 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 17.5 t -158.16 134.98 9.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.507 0.67 . . . . 0.0 111.977 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.513 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -96.27 143.87 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.7 t -103.85 106.75 17.36 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.318 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 154' ' ' THR . 6.7 tp -107.38 117.41 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.952 0.406 . . . . 0.0 111.329 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -140.28 139.2 35.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.487 ' HB3' ' HZ3' ' A' ' 156' ' ' LYS . . . -177.4 171.42 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -30.86 67.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.534 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' C ' HG12 ' A' ' 158' ' ' VAL . 0.3 OUTLIER 71.88 31.03 2.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' CD ' HD11 ' A' ' 161' ' ' ILE . 2.1 tm-20 -164.68 130.34 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.947 0.403 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -147.57 107.85 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.137 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.495 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.89 126.42 29.65 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.135 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.35 130.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 112.717 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.98 -20.46 35.92 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.357 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -105.62 172.45 6.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.317 . . . . 0.0 110.659 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -100.71 167.72 10.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 111.095 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.813 HD12 HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -110.4 159.55 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' H ' HD23 ' A' ' 49' ' ' LEU . 4.5 mm-40 -137.24 92.65 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 0.0 110.638 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 49' ' ' LEU . 2.1 m -109.95 96.56 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.411 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.65 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -85.66 70.72 3.0 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.903 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 136' ' ' VAL . 7.1 p -78.38 94.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 118' ' ' LEU . . . -103.06 -129.98 6.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.637 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.723 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -111.44 128.98 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.562 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.5 t0 -93.37 -28.78 15.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 177.34 136.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.493 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 HG12 ' A' ' 55' ' ' ILE . 1.8 pp -153.2 91.56 1.53 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.865 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.687 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.5 p -100.82 114.72 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.994 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.668 ' HB2' HG22 ' A' ' 31' ' ' VAL . 78.8 m-20 105.85 39.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.935 0.894 . . . . 0.0 111.554 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -171.02 148.28 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.64 82.53 1.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.733 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 112.14 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.64 ' O ' HD13 ' A' ' 112' ' ' LEU . 15.8 m-85 -101.76 -32.21 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.13 112.56 6.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.511 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.8 t80 -108.46 96.66 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 111.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.52 110.46 23.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.326 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.969 ' CE2' HG11 ' A' ' 102' ' ' VAL . 34.7 p90 -101.87 160.55 14.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.341 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -111.38 105.28 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.762 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -77.34 128.56 34.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.569 ' N ' HD13 ' A' ' 70' ' ' LEU . 3.0 m-80 -110.96 115.2 29.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.615 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.6 p90 -139.53 -169.13 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.167 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.56 140.97 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.75 -27.37 16.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -59.49 -30.38 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -117.62 -47.14 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.195 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.31 -176.81 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.988 0.423 . . . . 0.0 111.008 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 43.9 tp10 -166.27 155.93 11.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.496 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.6 t80 -94.92 148.96 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -132.22 -78.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.032 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 122' ' ' VAL . 6.1 mm-40 -161.06 134.75 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.18 148.91 27.17 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 122.31 1.052 . . . . 0.0 111.701 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.689 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 174.58 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.098 -177.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.701 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -146.55 -165.65 2.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.82 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -159.79 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.49 36.66 1.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.69 -42.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.21 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 106' ' ' SER . 17.2 t -87.08 146.02 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -105.3 103.3 12.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.701 HG23 ' OG ' ' A' ' 84' ' ' SER . 5.1 t -92.45 153.71 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.24 113.54 1.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.03 166.15 11.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.271 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.86 107.44 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttp -54.69 94.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.11 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -80.68 -23.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.655 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.82 -166.77 0.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.24 133.56 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.54 29.24 63.53 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.516 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' C ' HG13 ' A' ' 100' ' ' VAL . 1.6 ptpm? -173.33 120.05 0.33 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.834 0.35 . . . . 0.0 110.069 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -150.05 155.05 8.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.793 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.3 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.162 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.969 HG11 ' CE2' ' A' ' 68' ' ' PHE . 9.2 p -128.14 93.41 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.772 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.14 111.24 16.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.53 HG23 ' CG2' ' A' ' 90' ' ' VAL . 14.8 p -112.3 151.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.607 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.424 ' C ' HG13 ' A' ' 88' ' ' VAL . 7.9 p -160.81 136.2 7.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 88' ' ' VAL . 1.1 p -78.34 110.68 13.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.2 tt -94.46 30.31 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.133 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.5 p -102.55 -31.58 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 125.97 -22.6 6.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -110.11 159.19 32.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.63 0.253 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.46 179.52 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.583 2.189 . . . . 0.0 112.214 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 118' ' ' LEU . 3.4 mp -56.83 132.28 79.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.94 -39.67 31.58 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.522 2.148 . . . . 0.0 112.204 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 61.55 166.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.108 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 15.78 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -166.7 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.281 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.65 HG13 ' HA3' ' A' ' 52' ' ' GLY . 38.1 t -70.99 104.87 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.581 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.07 -33.49 20.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.2 131.64 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.212 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 mtmt -112.62 117.23 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.447 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.0 p -99.41 105.02 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.3 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 81' ' ' GLU . 24.2 m -75.79 130.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.921 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.8 mt -113.24 111.51 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.847 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 14.1 tpp85 -55.0 111.47 0.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.0 68.31 7.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -85.83 -5.35 59.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.389 0.614 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.48 123.41 2.53 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.644 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.729 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 18.0 ttmt -41.95 162.13 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.319 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.838 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.69 57.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.913 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 3.5 pt-20 -56.02 117.25 3.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.196 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.03 -0.73 67.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.765 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.838 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.3 m -59.17 88.08 0.01 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.437 ' ND2' HG22 ' A' ' 157' ' ' THR . 4.3 m120 -59.92 163.68 4.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 111.533 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 70' ' ' LEU . 3.5 mt -140.3 112.93 8.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.868 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.32 125.67 51.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.506 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 53' ' ' VAL . 12.1 m -110.12 94.81 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.715 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.6 p -100.76 -168.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 21.16 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.886 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 100.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.505 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.58 169.99 8.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.422 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 66' ' ' TYR . 31.1 m -132.48 -179.47 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.61 84.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -55.63 154.49 6.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.978 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.58 -46.46 93.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.46 -29.47 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.15 -25.44 6.06 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.385 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.49 170.17 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.46 139.73 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -114.01 90.44 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 103.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.718 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.513 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.55 -176.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 111.711 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -69.29 -159.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.404 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -155.94 171.22 33.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.187 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 37' ' ' LEU . 66.4 m -152.9 149.13 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -114.68 148.85 37.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.6 tppp? -131.81 163.89 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.332 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.591 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -142.88 124.62 15.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.934 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.805 HG11 HD11 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -114.4 138.36 44.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.13 105.75 16.12 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.893 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.5 mt -82.44 117.08 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.439 0.637 . . . . 0.0 109.437 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.25 137.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.549 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.17 145.57 55.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.015 0.436 . . . . 0.0 110.946 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.41 159.09 14.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 170.03 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.928 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 mtm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.86 0.362 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.06 -85.53 0.48 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.565 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -114.06 174.25 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.8 125.76 29.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -86.66 -59.76 2.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -105.02 -177.64 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.97 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -84.75 105.09 15.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -129.27 -45.85 1.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -59.87 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -106.52 127.17 53.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.66 31.15 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m 60.17 36.87 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.78 145.45 16.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -97.07 -31.29 12.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 0.0 110.918 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.78 82.62 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -32.27 135.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.586 2.857 . . . . 0.0 113.306 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -98.35 35.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.49 140.95 10.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.584 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -31.53 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 60.25 86.46 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.04 32.31 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -101.45 -74.52 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.0 -43.22 2.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 61.15 155.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' N ' HD23 ' A' ' 25' ' ' LEU . 8.0 tttt -98.54 32.59 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.47 170.49 22.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.74 -176.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.86 ' HB1' ' ND2' ' A' ' 60' ' ' ASN . . . -90.5 -76.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 53.27 101.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -60.6 155.7 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.807 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 57' ' ' GLU . 6.5 t -81.33 -46.7 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 67.83 114.63 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.605 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.662 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -150.95 148.41 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.256 0.55 . . . . 0.0 111.574 179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 154' ' ' THR . 5.8 m -99.87 128.88 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.569 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -92.03 106.84 18.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.825 178.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 154' ' ' THR . 4.6 mt -97.48 123.29 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.082 0.467 . . . . 0.0 111.523 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -134.88 101.15 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.015 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.3 141.58 33.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -25.75 67.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.25 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 74.55 23.08 1.96 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.566 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HG2' HD11 ' A' ' 161' ' ' ILE . 3.7 tt0 -164.98 128.34 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.99 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.14 108.0 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -68.2 122.86 19.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.781 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.02 131.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 121.469 0.652 . . . . 0.0 112.641 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.04 -23.71 32.73 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.125 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -96.68 172.99 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.692 0.282 . . . . 0.0 110.43 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -94.93 167.78 11.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 158' ' ' VAL . 4.7 tp -154.93 108.08 2.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HB3' HG12 ' A' ' 122' ' ' VAL . 1.9 pm0 -110.37 146.73 35.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 98.12 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.735 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -67.52 65.88 0.27 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.441 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 136' ' ' VAL . 13.5 p -80.92 102.48 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.64 -123.28 3.6 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.548 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.779 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -111.59 137.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 111.737 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -36.14 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.417 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.5 mp0 -166.29 131.4 2.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.537 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 141' ' ' VAL . 1.1 tt -152.57 96.6 2.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 59' ' ' VAL . 10.1 p -122.99 109.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.86 ' ND2' ' HB1' ' A' ' 29' ' ' ALA . 12.0 m120 128.61 20.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.403 1.081 . . . . 0.0 111.414 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -161.31 175.76 11.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.087 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -130.2 85.38 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -63.64 127.53 31.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.519 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.494 ' C ' HD23 ' A' ' 112' ' ' LEU . 7.1 m-85 -111.09 -45.43 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.152 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.7 112.71 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.237 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 112' ' ' LEU . 34.2 t80 -97.6 95.02 7.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -106.07 110.15 22.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.4 p90 -112.19 171.16 7.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.104 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.4 m -120.68 107.67 13.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.493 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.525 HD11 HD23 ' A' ' 134' ' ' LEU . 21.2 tp -79.15 133.35 36.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -116.83 109.03 16.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 15.1 p90 -125.04 -166.74 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.4 t70 -120.44 102.8 8.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 111.119 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.44 -28.16 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.63 -47.24 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -116.87 32.87 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.478 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -167.31 -176.48 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.421 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.92 108.95 0.31 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 100' ' ' VAL . 8.5 t80 -54.49 149.32 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.79 ' HB ' HG23 ' A' ' 122' ' ' VAL . 59.7 t -128.65 -79.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.859 ' O ' HG22 ' A' ' 122' ' ' VAL . 13.3 mm-40 -160.89 145.08 13.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.85 150.56 26.48 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.215 1.007 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -124.08 151.31 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.295 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.665 ' HB2' HG12 ' A' ' 90' ' ' VAL . 1.4 m -174.87 129.78 0.31 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.729 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.16 -168.2 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 t0 63.93 63.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.89 25.41 59.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 86' ' ' ASP . 21.6 t -140.96 114.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 111.051 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -113.33 121.66 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 84' ' ' SER . 8.7 p -113.17 153.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.231 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -137.7 123.99 20.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.307 0.575 . . . . 0.0 111.58 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.67 153.53 17.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.761 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 107.11 5.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 111.719 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 7.4 tttt -55.24 117.38 3.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.716 HG22 ' HA ' ' A' ' 100' ' ' VAL . 4.5 tp -109.15 -25.47 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 163.82 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.0 124.22 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 68.57 30.11 72.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.453 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.9 ptmt -174.01 123.21 0.32 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.935 0.397 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HA ' HG22 ' A' ' 95' ' ' ILE . 10.0 m -149.9 154.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.426 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -96.92 152.86 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 112.013 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.3 p -124.35 150.82 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.49 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.4 mt -124.1 108.75 12.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.072 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.661 HG22 ' CG2' ' A' ' 90' ' ' VAL . 97.6 t -102.68 136.64 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.401 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 p -164.39 134.74 4.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -88.88 130.9 35.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.058 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.07 29.35 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 -26.38 9.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.025 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.27 -24.07 10.13 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.125 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -89.38 155.94 48.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.681 0.277 . . . . 0.0 110.663 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 60.5 Cg_endo -72.68 156.16 53.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.57 2.18 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -51.99 133.44 39.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.878 ' O ' HD21 ' A' ' 118' ' ' LEU . 86.6 Cg_endo -84.72 145.35 10.25 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.408 2.072 . . . . 0.0 111.49 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.779 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -98.51 169.19 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 111.317 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.93 33.89 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.482 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.665 ' O ' HD22 ' A' ' 118' ' ' LEU . 13.6 tt0 -161.1 157.58 26.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.735 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.3 t -55.34 105.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 113' ' ' PRO . 1.4 mm? -89.57 -31.28 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . . . -164.38 135.67 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 128.9 40.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.697 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 70' ' ' LEU . 50.2 t -107.13 112.73 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.7 m -75.3 96.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.513 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.488 ' CD1' HD21 ' A' ' 134' ' ' LEU . 36.1 mt -83.17 110.81 18.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.1 tpp85 -55.37 110.93 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.78 70.46 5.13 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -2.39 58.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.444 0.64 . . . . 0.0 109.562 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.64 123.55 2.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.611 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.652 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 8.8 ttpt -51.87 142.5 15.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.691 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.55 63.73 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.14 111.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.71 43.22 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.641 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.806 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -70.69 66.96 0.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.518 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.85 131.69 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.121 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.525 HD23 HD11 ' A' ' 70' ' ' LEU . 5.6 mp -111.6 139.28 47.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.941 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.88 110.61 14.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.902 0.382 . . . . 0.0 111.477 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 53' ' ' VAL . 21.0 m -99.4 95.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.7 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.45 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 13.8 p -103.65 -165.62 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.45 ' ND2' ' C ' ' A' ' 137' ' ' THR . 2.2 p30 43.52 21.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.976 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.505 ' OG ' HD11 ' A' ' 151' ' ' ILE . 5.6 t -63.83 96.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.791 0.329 . . . . 0.0 110.507 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -101.18 167.47 10.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.385 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 58' ' ' LEU . 4.9 m -128.82 -179.59 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.87 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.5 87.2 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.32 162.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.84 -52.11 55.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.19 -30.83 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.781 0.324 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.41 -28.09 4.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.424 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.78 150.93 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.62 149.8 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -123.54 90.55 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.69 107.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.505 HD11 ' OG ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.32 -177.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.418 . . . . 0.0 111.42 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.1 -148.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.347 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.23 37.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.151 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 37' ' ' LEU . 67.9 m -164.16 146.67 9.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.759 0.314 . . . . 0.0 110.573 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -107.05 167.81 9.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.948 0.404 . . . . 0.0 111.543 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.685 ' HD2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.61 163.74 31.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.232 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.451 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.2 p -142.4 119.55 11.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.34 138.05 48.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.161 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -106.79 105.54 15.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -80.46 129.32 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -114.13 129.54 69.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.819 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.8 145.31 41.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.237 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.74 92.05 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.48 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -71.27 -177.78 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.483 ' H ' HG22 ' A' ' 164' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.09 43.02 0.19 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.7 t -140.94 170.55 15.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.48 148.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 59.98 163.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 60.33 103.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -144.28 99.87 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.98 -66.11 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.966 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -170.57 126.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -175.85 -65.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m 60.52 177.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -91.65 -62.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.06 161.56 23.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.442 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.681 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.486 0.184 . . . . 0.0 110.925 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 14' ' ' LEU . 17.9 m 51.75 152.33 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.49 -38.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.635 2.89 . . . . 0.0 113.282 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 114.12 0.57 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.516 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 m 60.62 -170.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.936 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -145.22 -61.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 63.85 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.39 31.34 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.03 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t 60.56 95.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 31.75 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.9 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 25' ' ' LEU . 9.5 tp -154.46 164.68 38.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.18 30.81 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.6 -177.8 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.35 146.64 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.73 73.45 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.24 100.96 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 61' ' ' ALA . 13.4 t -78.57 146.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' GLY . 12.6 t -74.42 -32.6 62.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 57.05 114.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.209 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 13.3 t -147.56 156.44 42.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG23 ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -106.2 129.64 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.035 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -91.41 107.44 19.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.059 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.912 HD12 HG22 ' A' ' 154' ' ' THR . 5.6 mt -96.7 120.26 36.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.439 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -140.18 101.2 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.77 149.64 32.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.444 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.49 -22.25 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.427 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' C ' HG12 ' A' ' 158' ' ' VAL . 2.8 mp0 67.06 24.38 9.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.549 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -164.96 128.93 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.97 0.414 . . . . 0.0 111.995 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.93 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -145.51 108.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.207 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.88 125.34 26.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.292 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.6 t -29.38 130.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 121.517 0.675 . . . . 0.0 112.705 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.91 -23.65 30.38 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.34 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.03 172.34 7.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -105.85 167.7 9.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.088 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.883 HD11 HG11 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.93 158.26 24.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.63 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' H ' HD23 ' A' ' 49' ' ' LEU . 5.4 mp0 -137.48 92.35 2.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.741 0.305 . . . . 0.0 110.294 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -112.07 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.05 0.453 . . . . 0.0 110.461 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -90.01 81.66 1.41 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.468 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 136' ' ' VAL . 14.8 p -78.61 99.53 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.33 -117.47 4.34 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.59 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.768 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -121.43 127.23 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.491 . . . . 0.0 112.186 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -101.12 -26.15 13.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.6 mp0 -165.41 136.47 3.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.738 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -169.97 91.49 0.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.213 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.835 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.3 p -103.1 115.45 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.734 ' HB2' HG22 ' A' ' 31' ' ' VAL . 20.9 m120 101.48 23.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.214 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -144.49 134.26 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.989 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 19.6 tt0 -105.14 83.71 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.472 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.82 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.8 m-85 -104.14 -33.35 8.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.21 9.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.786 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.775 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 t80 -87.53 137.42 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 111.436 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -147.89 109.43 4.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.182 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CE2' HG11 ' A' ' 102' ' ' VAL . 8.2 p90 -130.85 171.31 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.447 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.83 111.24 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.773 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -77.25 156.17 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.776 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -130.35 104.41 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.44 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 12.0 p90 -122.79 -168.35 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -100.94 147.75 25.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.017 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -105.13 14.66 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -110.17 -31.02 7.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.787 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -113.0 -45.56 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.3 m-85 -93.59 -177.86 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -170.34 112.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 44.6 t80 -53.35 154.41 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 122' ' ' VAL . 46.9 t -134.49 -73.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.86 ' O ' HG22 ' A' ' 122' ' ' VAL . 4.9 mt-10 -163.36 143.62 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.88 155.72 23.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.918 0.866 . . . . 0.0 111.583 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -131.51 154.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.882 -1.508 . . . . 0.0 112.65 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.674 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -123.54 -164.82 1.26 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.784 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 88' ' ' VAL . 13.9 p-10 -96.66 -157.99 0.63 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.774 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -93.87 36.78 1.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.87 -41.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.945 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 112' ' ' LEU . 13.1 t -87.46 153.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.689 0.28 . . . . 0.0 110.694 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.722 ' HB2' HD23 ' A' ' 107' ' ' LEU . 2.7 t80 -110.15 120.7 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.127 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 104' ' ' VAL . 20.2 t -109.29 145.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -160.81 105.44 1.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.541 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.59 -177.04 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 111.52 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.716 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 6.8 tttt -54.01 95.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.165 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.815 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.2 tp -75.55 -25.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -167.4 -173.21 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.37 132.18 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 56.84 33.03 62.72 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.408 ' C ' HG13 ' A' ' 100' ' ' VAL . 11.9 ptpt -173.94 120.27 0.29 Allowed 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.815 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.9 156.09 7.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.663 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.717 HH21 HD21 ' A' ' 103' ' ' LEU . 2.6 ttt180 -103.42 151.8 22.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.8 p -119.53 143.32 31.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.141 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.717 HD21 HH21 ' A' ' 101' ' ' ARG . 80.1 mt -128.18 98.5 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.651 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 66' ' ' TYR . 8.5 p -105.83 157.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.154 0.502 . . . . 0.0 111.785 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.496 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.5 p -163.35 136.83 5.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.124 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' HG13 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -77.25 104.3 7.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.304 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 89' ' ' PHE . 3.4 mm? -71.52 -16.08 62.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.207 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -65.23 -34.81 79.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.87 -18.86 21.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.92 156.96 49.24 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 33.3 Cg_endo -64.66 142.05 75.39 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.607 2.205 . . . . 0.0 112.34 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 88' ' ' VAL . 8.1 mt -54.49 106.92 0.73 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.535 ' O ' HD21 ' A' ' 118' ' ' LEU . 37.0 Cg_exo -60.83 147.69 94.48 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.438 2.092 . . . . 0.0 111.838 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.768 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -101.52 175.47 5.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.183 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 18.61 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.92 -165.75 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.4 t -84.48 104.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 112' ' ' LEU . 2.0 mm? -90.03 -32.81 16.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.977 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.36 131.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.745 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -128.04 159.17 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 70' ' ' LEU . 9.9 p -130.81 148.16 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.917 HG13 HD11 ' A' ' 83' ' ' ILE . 29.3 m -110.7 103.67 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.747 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.643 ' CD1' HD21 ' A' ' 134' ' ' LEU . 9.3 mt -90.41 108.81 20.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.885 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 17.7 ttm180 -55.4 112.56 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.711 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -80.1 71.73 6.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.31 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -87.43 -3.93 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 109.588 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.71 123.57 2.46 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.518 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.732 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -49.19 140.79 9.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.579 -178.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -143.37 62.99 1.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.541 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.98 121.61 9.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.485 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.45 18.83 79.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.691 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 28.7 t -68.99 71.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.895 0.378 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -45.31 132.22 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.025 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.643 HD21 ' CD1' ' A' ' 123' ' ' LEU . 5.4 mp -117.87 129.69 55.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.933 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.7 p -108.22 121.06 44.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.939 0.4 . . . . 0.0 111.489 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 53' ' ' VAL . 21.3 t -104.65 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 p -109.98 -164.65 0.94 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.78 17.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.606 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -64.71 95.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.88 8.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 111.618 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 66' ' ' TYR . 26.7 m -139.87 -179.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.914 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.27 89.67 0.4 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 5.2 p30 -62.07 168.35 3.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.67 22.21 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.904 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 147' ' ' LEU . 2.6 mt-10 -55.09 -23.42 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 111.337 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.18 -17.9 28.8 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.415 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' GLU . 3.0 mp -65.3 170.46 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.01 120.47 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 143' ' ' ASP . 45.6 m-70 -92.46 92.71 8.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.91 102.52 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.36 167.41 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 111.738 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.01 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.658 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.1 171.16 40.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.301 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.912 HG22 HD12 ' A' ' 37' ' ' LEU . 50.9 m -165.2 155.95 14.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.656 0.265 . . . . 0.0 110.77 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -118.6 170.14 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.534 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -143.14 166.22 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -143.17 120.57 11.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.634 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -114.66 126.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -91.66 105.46 17.75 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.93 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.2 mt -81.07 120.65 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -104.45 131.65 52.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.817 -178.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.74 145.88 38.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.11 -50.61 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 165' ' ' SER . 7.9 t -92.81 -143.44 0.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.082 0.468 . . . . 0.0 110.962 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 164' ' ' THR . 3.0 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.869 0.366 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.71 73.06 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.588 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 t -106.23 91.29 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -134.19 93.04 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -165.15 100.37 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -106.76 -178.03 3.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 60.66 -178.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -60.43 -66.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -162.53 147.76 12.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -133.17 35.45 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 m -104.49 35.35 2.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -151.74 143.95 23.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.23 -68.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.76 HD12 HG13 ' A' ' 15' ' ' VAL . 3.5 pp -64.16 -31.38 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.76 HG13 HD12 ' A' ' 14' ' ' LEU . 12.2 m -89.43 150.0 43.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -32.23 141.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.551 2.834 . . . . 0.0 113.32 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -176.43 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.09 128.85 1.08 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -71.63 -66.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -115.8 129.65 56.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.4 mtp -88.1 -37.34 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.45 176.4 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 t -156.85 35.57 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -133.44 126.42 31.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.822 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.03 146.18 35.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -119.85 77.53 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER 60.31 167.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.721 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 27' ' ' GLU . . . -123.76 178.17 5.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.31 76.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.03 118.8 36.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 60' ' ' ASN . 43.3 t -74.48 149.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 57' ' ' GLU . 15.0 t -65.66 -36.21 83.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 58.53 109.94 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.913 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.5 t -155.55 143.19 19.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.567 0.699 . . . . 0.0 111.943 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HD11 ' A' ' 151' ' ' ILE . 35.7 m -101.95 143.95 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.842 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -100.31 106.38 18.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.613 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.92 HD21 ' HB2' ' A' ' 156' ' ' LYS . 4.3 tp -103.87 119.95 39.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.484 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.547 ' N ' HD12 ' A' ' 37' ' ' LEU . 40.8 tp10 -139.26 101.4 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.666 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -134.53 151.37 51.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.413 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.93 -28.05 65.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.339 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.3 mt-10 67.68 23.42 8.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.431 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 18.3 tt0 -164.81 123.9 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 0.0 111.772 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -144.89 108.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.289 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.16 127.33 32.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -29.33 131.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.24 -21.48 42.99 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.532 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -97.73 172.33 7.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 110.638 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -112.4 167.73 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.146 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.443 HD22 HG11 ' A' ' 158' ' ' VAL . 9.9 tp -130.2 153.42 48.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 15.2 mp0 -135.65 93.45 2.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.92 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' ALA . 7.2 p -104.16 98.1 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.613 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.801 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -89.37 87.05 1.44 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.867 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 136' ' ' VAL . 8.3 p -78.93 95.18 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.71 -128.82 6.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.634 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.585 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.65 128.9 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.053 0.454 . . . . 0.0 111.859 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 18.5 t0 -97.58 -30.06 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' HG21 ' A' ' 32' ' ' THR . 1.6 mp0 -167.35 135.12 2.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.024 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -161.53 90.84 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.379 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.738 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.9 p -115.53 126.97 73.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.975 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.748 ' HB2' HG22 ' A' ' 31' ' ' VAL . 25.0 m120 104.38 15.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.786 0.834 . . . . 0.0 112.064 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.724 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.85 176.35 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.42 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.1 tt0 -129.98 83.17 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.8 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.683 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.1 120.73 11.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.7 ' C ' HD23 ' A' ' 112' ' ' LEU . 4.1 m-85 -120.37 -43.17 2.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.639 ' N ' HD23 ' A' ' 112' ' ' LEU . . . -134.3 118.31 17.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.048 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 t80 -85.96 137.9 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -147.66 109.85 4.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.455 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 136' ' ' VAL . 14.7 p90 -139.48 171.17 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.19 115.75 21.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.884 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.665 ' CD2' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -88.14 111.16 21.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 1.2 p-10 -95.69 104.61 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 38.2 p90 -107.91 -168.44 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.631 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.31 104.72 14.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HB2' ' N ' ' A' ' 98' ' ' GLY . 14.2 tp10 -67.25 -26.72 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.91 -29.19 62.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.144 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.903 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -124.43 -40.35 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.381 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.21 -176.88 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -165.2 121.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 26.5 t80 -56.43 150.67 14.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.0 t -132.46 -71.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.6 pp20? -172.94 140.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 149.57 27.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.118 0.961 . . . . 0.0 111.45 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -115.7 153.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.511 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.752 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -120.68 -167.01 1.4 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.26 -158.54 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -95.61 36.92 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.83 -45.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.621 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.752 HG23 ' OG ' ' A' ' 84' ' ' SER . 32.8 m -86.66 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.244 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.37 124.19 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.093 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.746 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 t -115.8 136.22 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -148.94 116.57 6.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -97.07 153.53 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -133.48 107.36 7.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.667 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 11.4 tmtt? -55.15 95.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.799 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.3 tp -84.51 -25.93 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.875 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -166.57 177.62 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.768 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 130.11 40.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 58.78 33.21 72.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.43 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' ASN . 13.2 ptpt -173.77 118.96 0.28 Allowed 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.799 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.5 m -149.84 154.68 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -89.21 152.27 21.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.91 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.1 p -128.28 96.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.668 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mt -86.69 102.77 14.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.9 p -107.3 153.59 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.288 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -164.5 138.51 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.381 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.622 ' OG ' HG12 ' A' ' 88' ' ' VAL . 47.1 m -76.47 104.59 7.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.283 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -13.92 62.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.607 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -65.41 -28.46 69.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.85 -23.1 12.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.954 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.68 155.09 45.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 110.546 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -64.93 153.85 76.11 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.587 2.191 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.72 HD13 HD21 ' A' ' 118' ' ' LEU . 1.8 pp -52.91 132.62 48.75 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 94.1 Cg_endo -88.91 144.99 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.773 2.315 . . . . 0.0 112.209 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -94.57 170.69 9.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.178 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 32.91 12.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -163.5 158.2 20.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.598 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HA3' ' A' ' 52' ' ' GLY . 33.8 t -52.96 105.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -85.41 -32.33 22.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.961 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.45 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.73 135.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.797 ' HD3' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -126.3 149.58 49.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.675 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' A' ' 70' ' ' LEU . 42.0 t -113.06 154.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.532 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' GLU . 23.1 t -119.85 95.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.599 HD21 HD22 ' A' ' 70' ' ' LEU . 1.2 mm? -88.04 108.31 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.483 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 37.3 ttm180 -64.97 117.6 7.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -76.77 72.78 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.505 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -87.96 -3.62 58.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 0.0 109.438 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.39 123.49 2.58 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.407 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.731 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.6 ttmt -48.82 138.02 11.73 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.393 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.903 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -143.66 62.91 1.36 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.575 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.12 116.16 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.404 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.89 19.53 59.35 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.702 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.835 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.9 66.28 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.116 0.484 . . . . 0.0 110.455 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.453 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 1.1 t-20 -42.39 129.73 3.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.421 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 132' ' ' SER . 5.2 mp -111.2 150.28 29.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.51 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.07 121.45 14.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.0 111.579 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 53' ' ' VAL . 8.9 p -99.71 95.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.599 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.4 p -100.3 -165.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.789 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.37 19.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.065 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -63.35 87.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.933 0.397 . . . . 0.0 110.227 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.664 ' HB2' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -106.38 162.11 13.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.436 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.898 ' O ' HG23 ' A' ' 148' ' ' VAL . 28.5 m -130.32 128.79 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.947 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.77 83.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.694 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 22.8 t70 -57.77 140.8 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.816 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.84 76.08 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.728 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.7 -29.59 66.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.14 15.04 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.746 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.62 115.11 28.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 110.769 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 141' ' ' VAL . 14.1 p -73.08 141.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -104.8 99.0 8.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.87 102.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.602 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.27 -176.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.784 -178.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -75.83 -161.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.408 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.65 34.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.791 HG22 HD23 ' A' ' 37' ' ' LEU . 90.8 m -153.69 146.48 24.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.723 0.297 . . . . 0.0 110.849 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.81 161.96 15.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 111.261 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.92 ' HB2' HD21 ' A' ' 37' ' ' LEU . 3.9 tppt? -139.99 169.19 18.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.6 p -142.15 115.93 9.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.592 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -110.52 126.17 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 105.72 17.91 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.2 mt -80.72 122.59 36.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.13 132.98 51.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.623 -178.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.03 145.21 42.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.154 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.61 -138.4 10.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -73.19 -179.11 3.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 110.966 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.459 ' H ' HG22 ' A' ' 164' ' ' THR . 2.1 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.67 -121.32 1.15 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t 60.37 35.54 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 0.0 110.972 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.2 p -135.61 179.15 6.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -160.29 124.79 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -118.81 31.6 6.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.52 -50.29 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -65.58 -31.12 71.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 61.9 153.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -132.85 167.15 20.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -104.5 31.79 4.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.5 p -82.26 133.49 35.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.12 -108.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.3 mp 60.3 96.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 m -130.94 152.73 81.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.31 -53.36 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.537 2.825 . . . . 0.0 113.318 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -169.47 116.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.96 -177.86 15.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 m -71.43 129.22 38.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -60.36 157.14 14.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.07 80.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.823 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 122.63 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.3 m -97.24 83.39 3.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -148.47 152.56 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD12 ' HE2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -156.74 146.51 20.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HE2' HD12 ' A' ' 25' ' ' LEU . 24.7 mttm 60.62 84.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.42 168.47 19.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.71 63.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.51 77.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.079 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -112.93 111.62 22.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 60' ' ' ASN . 15.2 t -60.64 151.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 33' ' ' GLY . 14.6 t -74.52 -46.69 37.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 76.09 112.27 0.12 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.692 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.899 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -159.75 139.16 11.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.0 111.428 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD11 ' A' ' 151' ' ' ILE . 19.1 m -98.93 141.15 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.527 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.45 106.38 18.68 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.826 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 HG22 ' A' ' 154' ' ' THR . 6.2 tp -107.17 106.58 17.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 111.355 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -121.94 118.65 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.412 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.74 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.493 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.82 -27.4 68.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 73.1 22.89 2.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.414 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 158' ' ' VAL . 41.6 tt0 -164.53 128.19 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.995 0.426 . . . . 0.0 112.114 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.4 p -132.52 168.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.735 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.577 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tm0? -131.56 118.49 20.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.1 t -28.57 130.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.488 0.661 . . . . 0.0 112.477 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.62 64.49 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.776 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.98 173.73 6.34 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.331 0.252 . . . . 0.0 110.473 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.524 ' HB3' HG13 ' A' ' 122' ' ' VAL . 16.9 m-80 -119.03 131.39 55.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.094 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.648 ' CD1' HG11 ' A' ' 158' ' ' VAL . 15.4 tp -86.91 154.99 20.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.21 93.47 2.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -105.06 98.17 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -87.75 86.05 1.51 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.89 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -82.18 95.24 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -100.62 -127.63 6.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.981 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.942 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -115.31 130.29 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 111.724 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.94 -39.3 11.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.07 132.79 0.51 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.942 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -157.25 113.69 2.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.539 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.6 p -128.89 100.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 31' ' ' VAL . 19.0 m-20 139.57 23.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.404 1.065 . . . . 0.0 111.737 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.67 147.42 6.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.776 0.322 . . . . 0.0 111.213 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -105.22 85.87 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 112.93 2.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 25.3 m-85 -99.77 -32.75 10.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.155 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.94 112.61 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.942 ' O ' HG12 ' A' ' 104' ' ' VAL . 35.6 t80 -102.79 130.67 49.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.627 ' CG ' HD23 ' A' ' 103' ' ' LEU . 10.7 m-20 -135.06 119.25 17.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.856 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.923 ' CE2' HG11 ' A' ' 102' ' ' VAL . 24.7 p90 -120.63 155.99 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -123.42 103.39 8.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.457 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 121' ' ' VAL . 1.1 pt? -77.36 156.13 31.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.348 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -124.0 104.4 8.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.695 ' HB3' HD11 ' A' ' 134' ' ' LEU . 18.6 p90 -118.44 -166.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -114.65 143.15 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.81 -25.21 15.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.012 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -62.14 -29.42 70.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.039 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -124.52 -43.92 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -93.16 169.27 10.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.636 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -159.2 119.71 3.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 23.7 t80 -57.32 153.7 11.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.6 t -131.49 -72.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 122' ' ' VAL . 15.4 pt-20 -170.38 143.94 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.819 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -84.54 150.78 25.0 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.251 1.024 . . . . 0.0 111.538 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.13 153.39 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.336 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.13 -174.43 2.71 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -159.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.745 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.78 36.64 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.92 -39.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.184 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 89' ' ' PHE . 14.1 t -87.18 159.96 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.979 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' N ' HG12 ' A' ' 88' ' ' VAL . 33.3 t80 -115.98 113.05 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 104' ' ' VAL . 2.1 t -104.23 155.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 22.6 t-20 -166.24 110.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.399 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.99 158.14 15.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -145.83 107.15 4.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.73 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 20.4 tttt -55.14 117.03 3.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.312 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.5 tp -111.22 -23.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.847 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -167.86 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.24 -75.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 72' ' ' TYR . . . -106.22 53.12 0.65 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.408 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.3 ptmt -174.21 129.74 0.37 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.73 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 14.5 m -149.59 155.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.879 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.591 ' HD2' HG23 ' A' ' 69' ' ' THR . 0.9 OUTLIER -91.5 152.41 20.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.532 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.923 HG11 ' CE2' ' A' ' 68' ' ' PHE . 10.3 p -139.44 122.17 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.878 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.627 HD23 ' CG ' ' A' ' 67' ' ' ASP . 17.3 mt -109.72 108.92 19.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.9 p -106.7 148.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.414 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -155.91 136.48 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.44 104.5 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.5 tp -72.42 -12.85 61.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 p -65.27 -30.27 71.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.04 -18.98 18.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.412 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.93 147.87 34.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.3 Cg_exo -53.97 -178.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.476 2.117 . . . . 0.0 112.446 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.785 HD11 ' HG ' ' A' ' 118' ' ' LEU . 8.5 tt -58.57 123.0 64.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.62 -43.82 24.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.463 2.109 . . . . 0.0 112.129 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . . . 62.34 167.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.17 19.75 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.216 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.44 -168.62 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.439 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.693 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.5 t -74.73 104.99 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.728 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -83.63 -34.7 25.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -174.35 132.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 111.297 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.669 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -121.59 137.85 54.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.374 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.749 HG21 HD22 ' A' ' 70' ' ' LEU . 68.9 t -99.3 135.93 32.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.83 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 81' ' ' GLU . 47.6 t -93.47 97.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.887 HD11 HD21 ' A' ' 134' ' ' LEU . 44.7 mt -92.28 108.42 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG21 ' A' ' 80' ' ' VAL . 29.5 ttm180 -69.7 116.39 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.02 73.71 4.57 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.252 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -3.6 59.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.544 0.688 . . . . 0.0 109.503 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.88 123.0 2.7 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.121 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.646 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.9 ttpp -44.94 154.12 0.15 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.329 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.697 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -162.47 59.79 0.22 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.917 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 6.8 tt0 -55.81 117.18 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.972 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.55 61.59 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.371 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.697 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 41.3 t -70.5 87.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 110.397 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -57.99 162.83 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.516 . . . . 0.0 111.401 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.887 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -143.91 104.85 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.645 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -100.1 131.3 46.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.645 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 53' ' ' VAL . 26.8 t -111.12 94.69 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.532 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.5 p -99.79 -164.45 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.676 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.23 22.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.021 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 151' ' ' ILE . 27.9 m -61.63 100.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 110.436 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 173.17 6.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.4 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.51 -179.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.24 85.46 0.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -55.61 -174.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.09 -38.4 10.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.17 -29.45 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.6 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.655 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.69 170.32 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.23 129.49 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -106.41 91.09 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.0 109.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.539 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -89.79 -176.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.226 0.536 . . . . 0.0 111.599 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.86 -160.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.374 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.62 168.7 34.36 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.365 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.842 HG22 HD23 ' A' ' 37' ' ' LEU . 88.2 m -155.77 148.12 23.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.786 0.326 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.81 153.27 33.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 tppp? -135.31 167.03 21.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.238 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.1 p -142.83 134.65 26.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 49' ' ' LEU . 1.3 m -125.4 129.96 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.31 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.87 107.27 19.09 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.01 0.433 . . . . 0.0 110.484 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.6 mt -76.79 120.48 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.62 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.12 128.32 59.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -178.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.74 146.13 37.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.97 176.11 41.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.54 172.45 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.951 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.879 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.62 -174.91 13.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.05 98.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.84 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -107.97 -35.65 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -106.3 164.02 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -165.05 -70.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -144.37 34.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -81.45 -56.3 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -132.59 31.82 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m170 64.09 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -167.02 137.02 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -132.45 102.99 5.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.77 -85.05 1.82 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mt 60.4 32.12 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.4 m -137.82 82.17 26.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -32.34 148.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.532 2.821 . . . . 0.0 113.352 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 60.59 110.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.35 152.24 3.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.0 -52.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -153.88 -53.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.8 ttt -143.93 142.15 30.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.95 109.13 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -143.84 138.02 28.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.67 31.86 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.17 -53.78 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -106.79 154.56 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -168.34 165.71 12.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.5 121.06 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.42 77.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.189 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -119.31 112.4 19.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 61' ' ' ALA . 6.8 t -82.64 151.17 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.763 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' GLY . 5.3 t -90.82 -30.99 16.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 55.31 132.1 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.575 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.69 159.09 43.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.202 0.525 . . . . 0.0 111.605 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG21 ' HA2' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -112.18 123.56 68.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.271 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -92.24 109.57 20.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.386 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.897 HD12 HG22 ' A' ' 154' ' ' THR . 3.8 mt -97.1 120.74 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' HG22 ' A' ' 117' ' ' VAL . 4.5 tm-20 -133.49 101.37 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.344 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -146.63 152.86 39.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.05 -26.43 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.393 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 66.56 24.25 10.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.381 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.83 117.22 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.796 0.332 . . . . 0.0 111.598 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -136.87 107.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.65 128.36 36.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.238 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG23 ' CG2' ' A' ' 160' ' ' ILE . 2.0 t -31.02 132.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-O 121.5 0.667 . . . . 0.0 112.709 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 -24.01 32.98 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.39 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.85 172.47 7.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 0.0 110.631 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.63 151.69 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 122' ' ' VAL . 21.1 tp -104.48 153.4 21.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 3.1 pt-20 -136.75 93.29 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 110.649 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.2 p -107.01 97.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.795 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.02 82.59 1.59 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.623 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 136' ' ' VAL . 9.7 p -78.63 95.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.761 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.29 -134.71 8.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.69 136.44 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -96.83 -36.34 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.57 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 177.15 131.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.436 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.879 HD13 ' HB3' ' A' ' 61' ' ' ALA . 2.7 pp -141.09 103.49 4.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.764 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.824 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.4 p -94.76 110.18 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 20.2 m120 98.68 26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.435 0.694 . . . . 0.0 112.333 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -136.9 150.2 48.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.227 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -128.78 66.29 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.112 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.49 144.08 56.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.049 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.718 ' O ' HD13 ' A' ' 112' ' ' LEU . 17.6 m-85 -120.23 -35.38 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.51 112.68 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.766 ' O ' HG12 ' A' ' 104' ' ' VAL . 41.6 t80 -86.16 148.27 25.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.991 0.425 . . . . 0.0 111.458 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.618 ' OD1' HD23 ' A' ' 103' ' ' LEU . 7.0 m-20 -147.67 111.27 4.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.916 ' CE2' HG11 ' A' ' 102' ' ' VAL . 16.5 p90 -122.97 156.16 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 111.557 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.19 103.15 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.418 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 123' ' ' LEU . 1.5 pt? -77.09 156.05 31.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.8 104.49 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 18.7 p90 -118.3 -167.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.4 113.59 21.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -27.98 65.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.08 -46.65 86.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.035 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.03 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.59 20.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -164.33 -179.69 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -171.56 113.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.706 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.613 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.1 t80 -51.01 149.27 3.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.0 t -129.1 -82.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.01 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 122' ' ' VAL . 11.0 mt-10 -156.17 134.8 11.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.76 151.2 26.25 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.12 0.962 . . . . 0.0 111.478 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.88 HD12 ' HE2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -126.97 158.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.421 -177.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.532 ' CB ' HG23 ' A' ' 90' ' ' VAL . 1.8 t -121.21 -164.68 1.15 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.794 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -93.0 -157.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.754 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.5 37.67 1.12 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.93 0.395 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.12 -39.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 29.5 t -87.05 154.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.639 0.257 . . . . 0.0 110.773 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.91 121.41 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.582 HG22 ' HB ' ' A' ' 104' ' ' VAL . 5.2 t -109.11 155.23 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 22.3 t-20 -162.78 110.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.86 156.21 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.39 107.09 5.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.229 0.538 . . . . 0.0 111.536 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.1 tttm -54.71 96.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.477 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -84.83 -22.76 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.589 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -166.76 2.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -99.28 52.41 1.08 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.364 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.5 ptmt -174.19 126.14 0.34 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 95' ' ' ILE . 5.5 m -148.71 155.03 9.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.698 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -97.24 152.49 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.916 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.3 p -133.47 121.97 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.139 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.618 HD23 ' OD1' ' A' ' 67' ' ' ASP . 14.2 mt -107.85 98.97 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.7 p -98.31 149.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.33 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 p -151.61 135.54 16.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.421 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.21 111.56 12.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.912 0.386 . . . . 0.0 111.309 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.28 29.68 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.006 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -106.79 -29.71 9.37 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.988 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.95 -20.8 14.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.166 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -97.39 155.83 36.89 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 56.4 Cg_endo -70.51 173.61 11.38 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.545 2.163 . . . . 0.0 112.446 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.27 109.23 1.53 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.26 -22.33 73.97 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.397 2.065 . . . . 0.0 112.147 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 55.97 177.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.876 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.52 25.78 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.634 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -159.31 155.85 27.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.9 t -45.62 104.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 0.0 111.274 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.672 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.48 -31.13 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.962 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -174.3 134.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.123 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.88 ' HE2' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -126.58 116.76 21.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 76.1 t -86.99 111.18 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 83' ' ' ILE . 21.9 t -75.65 111.24 11.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.026 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 70' ' ' LEU . 35.8 mt -92.9 169.28 10.57 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 8.6 ttm180 -116.44 123.39 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.72 72.12 8.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.341 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.03 -6.68 57.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 109.706 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.87 123.62 2.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.739 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.668 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.8 ttmt -44.46 162.37 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.517 -1.219 . . . . 0.0 112.349 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.03 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.84 61.67 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.79 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 5.4 tt0 -55.27 111.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 23.26 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.138 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.31 65.96 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.895 0.379 . . . . 0.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -44.86 132.88 6.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.161 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.639 HD21 HD11 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -118.74 134.61 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.951 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 p -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.888 0.375 . . . . 0.0 111.405 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 53' ' ' VAL . 15.7 m -107.16 94.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.814 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.2 p -99.7 -164.11 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.547 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 40.54 25.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 151' ' ' ILE . 1.9 p -68.56 93.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.62 170.17 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m -129.32 179.87 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.989 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.56 64.06 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.452 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.48 138.67 45.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.78 58.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.612 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -56.49 -28.1 58.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.6 -1.24 36.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.852 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.62 131.62 56.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.9 t -76.88 123.93 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.05 92.0 5.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.623 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.54 107.28 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.659 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.39 169.01 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.263 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.618 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.48 -153.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.723 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -154.41 165.48 31.91 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.224 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.897 HG22 HD12 ' A' ' 37' ' ' LEU . 36.8 m -161.03 147.33 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.734 0.302 . . . . 0.0 110.647 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.9 173.82 6.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.675 ' HB2' HD13 ' A' ' 37' ' ' LEU . 3.8 tppt? -144.72 168.69 19.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.081 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.431 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 1.9 p -142.43 115.66 8.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.04 127.38 68.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -97.49 105.79 18.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.9 mt -83.92 116.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.397 0.617 . . . . 0.0 109.748 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.5 143.47 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.677 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.75 146.36 54.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.898 0.38 . . . . 0.0 110.924 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.6 3.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -107.48 175.91 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.421 ' H ' HG22 ' A' ' 164' ' ' THR . 48.4 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.9 -62.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.52 87.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m 60.36 35.16 20.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -159.1 154.45 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.981 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 60.47 171.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 64.15 -78.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -98.42 96.19 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.9 m170 60.37 108.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -112.59 169.1 9.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -99.29 91.43 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.38 -78.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.99 46.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.394 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -77.2 -31.61 55.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' VAL . 18.5 m -134.15 82.17 48.66 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -32.31 -44.55 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.654 2.903 . . . . 0.0 113.285 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -97.06 -53.97 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 -53.19 4.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 m -65.85 -51.15 61.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -138.9 160.16 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.67 155.69 17.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.09 108.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -113.95 31.65 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -62.51 141.68 58.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -67.86 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -177.62 38.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -109.09 163.38 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.17 98.24 4.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.17 77.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.989 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -101.83 115.85 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.588 HG22 ' C ' ' A' ' 59' ' ' VAL . 29.6 t -61.06 155.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.0 t -78.73 -47.15 17.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 72.03 113.12 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.672 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.9 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.5 m -156.57 138.42 14.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.455 0.645 . . . . 0.0 111.507 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 19.8 m -91.48 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.8 t -90.95 134.29 34.6 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.183 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.818 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -110.73 118.69 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 tt0 -140.7 116.94 10.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -169.48 144.29 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.672 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.05 -27.0 66.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.055 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' C ' HG12 ' A' ' 158' ' ' VAL . 4.8 mt-10 73.17 21.86 3.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.691 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 158' ' ' VAL . 1.7 tm-20 -165.15 127.66 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.873 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -146.16 107.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.353 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -65.4 123.93 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -28.91 130.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.629 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.1 -23.05 24.12 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -107.9 174.97 5.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 110.413 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -128.78 148.25 50.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.59 128.19 51.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.619 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 3.4 pt-20 -101.43 131.34 47.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.384 . . . . 0.0 111.19 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 39' ' ' ALA . 11.1 t -108.4 97.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -70.19 62.09 0.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.102 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 136' ' ' VAL . 7.2 p -81.17 112.45 19.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.291 . . . . 0.0 110.396 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 118' ' ' LEU . . . -126.61 -91.24 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.618 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.527 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -135.65 134.86 51.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.075 0.464 . . . . 0.0 111.985 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -102.64 -38.93 7.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HA ' ' HZ3' ' A' ' 115' ' ' LYS . 77.2 mm-40 -159.35 129.0 5.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.006 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.767 HD21 ' CD2' ' A' ' 149' ' ' HIS . 1.0 OUTLIER -153.19 90.84 1.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.729 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 ' C ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -121.45 110.74 28.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.563 ' N ' HG22 ' A' ' 31' ' ' VAL . 72.6 m-20 127.6 17.92 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.499 1.119 . . . . 0.0 111.493 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -157.79 -178.04 7.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.966 0.413 . . . . 0.0 111.078 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -137.0 76.57 1.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.589 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.9 111.93 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.511 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 11.3 m-85 -89.37 -34.4 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.048 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.03 112.35 8.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.36 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' H ' HD11 ' A' ' 112' ' ' LEU . 11.3 t80 -98.68 94.12 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 0.0 110.918 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD2' HD23 ' A' ' 103' ' ' LEU . 9.1 t0 -100.5 135.94 41.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 102' ' ' VAL . 47.0 p90 -140.97 171.21 14.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.238 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.29 91.2 3.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.635 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.783 ' HB2' HG12 ' A' ' 136' ' ' VAL . 8.2 tt -77.03 152.96 34.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.108 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' HD23 ' A' ' 70' ' ' LEU . 28.0 p30 -131.41 155.93 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.989 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 21.0 p90 -155.55 -169.34 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.67 140.89 28.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -105.84 -13.75 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -96.26 25.81 4.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.765 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -170.6 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.905 0.384 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.745 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.1 m-85 -93.3 -176.89 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -170.85 111.84 0.38 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.644 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 18.2 t80 -50.14 152.83 1.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.809 ' HB ' HG23 ' A' ' 122' ' ' VAL . 66.9 t -131.04 -78.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -163.61 143.2 8.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.864 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.63 150.23 26.95 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-O 122.04 0.924 . . . . 0.0 111.439 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -140.35 151.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.268 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -129.6 -176.17 3.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.077 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -160.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.88 23.49 4.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.59 -44.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.906 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 105' ' ' SER . 16.3 t -97.05 143.27 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.687 0.28 . . . . 0.0 110.626 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -117.23 109.41 16.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 103' ' ' LEU . 7.1 p -102.18 144.13 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.918 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -132.18 124.81 29.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -98.06 161.27 13.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.682 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.21 107.05 5.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 111.719 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.668 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.28 95.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.08 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -83.91 -30.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.882 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.18 -168.38 2.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.429 ' HB3' ' CB ' ' A' ' 74' ' ' GLU . 4.6 m-20 -84.31 130.07 34.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.34 31.67 70.48 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.345 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.416 ' C ' HG13 ' A' ' 100' ' ' VAL . 12.8 ptpt -173.75 122.08 0.33 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.848 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.3 m -149.89 154.7 8.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.731 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -85.75 152.26 23.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.184 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.2 p -125.48 136.99 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.308 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.467 ' C ' HG23 ' A' ' 90' ' ' VAL . 12.0 mt -123.79 109.69 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 111.087 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.7 p -109.86 147.32 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 112.018 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 88' ' ' VAL . 2.7 p -164.78 135.44 4.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.029 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 88' ' ' VAL . 17.1 m -73.68 104.18 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -69.66 -17.56 63.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.182 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -65.36 -32.91 74.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.02 -17.11 20.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.91 155.29 37.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.653 0.264 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 37.4 Cg_exo -60.13 164.85 11.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.558 2.172 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.915 HD22 HD12 ' A' ' 118' ' ' LEU . 91.1 mt -59.82 113.65 7.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.64 -20.88 67.03 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.3 2.0 . . . . 0.0 112.282 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 62.93 173.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HZ3' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 56.79 24.28 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -142.21 -164.34 1.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.323 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.69 HG13 ' HA3' ' A' ' 52' ' ' GLY . 29.1 t -91.49 104.63 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.408 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.915 HD12 HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -91.97 -33.65 14.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -157.72 136.76 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.512 ' O ' HG13 ' A' ' 83' ' ' ILE . 2.2 mtpt -135.16 100.71 4.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.271 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.84 114.36 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.809 HG23 ' HB ' ' A' ' 80' ' ' VAL . 9.1 m -87.19 108.05 17.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.198 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -85.57 108.44 17.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 20.3 ttm180 -55.54 117.09 3.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -84.59 69.39 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.217 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -87.55 -3.93 58.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.58 123.71 2.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.544 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.738 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.2 ttpt -42.63 155.13 0.05 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.325 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -168.56 58.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.799 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 7.3 pt-20 -55.73 111.65 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.224 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.5 -12.65 39.47 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.519 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.571 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 39.9 t -54.65 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 0.7 OUTLIER -83.6 138.66 33.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.261 0.553 . . . . 0.0 112.19 -178.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 134' ' ' LEU . 4.7 mp -110.77 132.14 54.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.615 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.4 126.5 46.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.019 0.438 . . . . 0.0 111.65 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 53' ' ' VAL . 22.5 m -101.51 94.72 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.665 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 139' ' ' SER . 20.9 p -100.63 -169.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.695 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.72 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.928 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER -64.98 105.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 0.0 110.607 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -178.47 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.293 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 148' ' ' VAL . 4.0 m -141.45 -179.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.67 81.82 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.956 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 27.6 t0 -45.92 160.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 111.271 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.05 97.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -66.52 -31.34 72.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.317 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.04 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.39 168.89 2.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.811 HG22 ' O ' ' A' ' 141' ' ' VAL . 56.6 t -123.99 141.56 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.052 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.767 ' CD2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.14 94.23 4.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -46.97 104.62 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.743 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.451 HD11 ' HE1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -85.71 -176.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -72.5 -158.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.28 168.85 35.99 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.231 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.797 ' HB ' HD23 ' A' ' 37' ' ' LEU . 44.4 m -164.7 163.95 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 110.662 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 154' ' ' THR . 15.9 pt-20 -134.64 177.44 7.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.169 0.509 . . . . 0.0 111.692 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.818 ' HE2' HD12 ' A' ' 37' ' ' LEU . 10.3 tppt? -146.59 169.74 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 0.6 OUTLIER -141.64 115.9 9.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.42 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -104.61 137.94 31.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.226 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.77 105.38 15.58 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.571 179.382 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -83.63 121.44 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 121.305 0.574 . . . . 0.0 109.621 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -104.24 148.8 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.396 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.71 145.66 48.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.902 0.382 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.73 -174.38 33.5 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -104.57 -176.93 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.332 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.478 ' H ' HG22 ' A' ' 164' ' ' THR . 1.8 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.856 0.36 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.42 -35.33 2.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.01 -70.21 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -80.87 112.58 18.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -123.13 31.99 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.816 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -176.61 92.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -91.32 141.97 28.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -108.99 36.04 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 62.47 118.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.0 m80 60.93 159.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -130.8 -73.91 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -127.97 -74.61 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.69 117.47 0.45 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.709 HD12 ' H ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -111.72 -36.27 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 110.911 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 17' ' ' ARG . 38.3 t -128.53 83.45 66.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -32.29 -59.51 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.614 2.876 . . . . 0.0 113.285 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.744 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -97.07 173.2 7.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.1 69.15 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.6 m -132.38 172.18 12.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.802 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -82.71 -60.21 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.71 142.0 28.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.47 36.51 2.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.3 m -155.19 147.75 24.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -135.7 -67.38 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD23 ' HB3' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -152.62 155.9 38.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.9 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.92 106.52 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -158.0 178.64 9.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.02 30.91 20.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.34 77.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -94.83 101.43 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 23.7 t -60.65 155.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -81.47 -46.04 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 74.43 117.4 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.301 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.956 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -163.48 136.77 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.19 0.519 . . . . 0.0 111.465 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.5 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.631 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -91.55 106.3 18.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.089 178.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.915 HD23 HG22 ' A' ' 154' ' ' THR . 6.4 tp -112.35 116.86 31.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -140.35 108.48 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.279 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 156' ' ' LYS . . . -138.6 161.95 35.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.563 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.373 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 69.24 24.87 5.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.703 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 158' ' ' VAL . 28.3 tt0 -164.71 125.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -147.6 107.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.343 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -67.92 126.32 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.131 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.442 HG23 ' CG2' ' A' ' 160' ' ' ILE . 1.5 t -29.45 127.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.81 12.85 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.628 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -175.63 2.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.87 148.61 52.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.818 HD22 HG11 ' A' ' 158' ' ' VAL . 4.2 pp -97.01 159.93 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HA ' HG12 ' A' ' 122' ' ' VAL . 3.7 mt-10 -128.26 93.57 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.3 p -102.37 98.16 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.835 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.35 79.94 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.559 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 136' ' ' VAL . 9.6 p -78.46 102.92 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.96 -130.12 5.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.096 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -109.36 127.42 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.624 -179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 28.1 t0 -96.81 -37.06 10.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 22.4 mp0 -162.09 130.77 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.169 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 1.6 tt -158.86 91.05 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.636 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.4 p -118.65 104.25 15.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.582 ' N ' HG22 ' A' ' 31' ' ' VAL . 34.3 m-20 134.0 23.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 111.519 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -152.68 -170.9 3.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.642 0.258 . . . . 0.0 110.75 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -139.7 82.21 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.36 . . . . 0.0 110.661 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.37 121.19 12.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.276 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' HA2' ' A' ' 144' ' ' GLY . 3.7 m-85 -117.8 -40.68 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.2 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.557 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.4 t80 -86.07 135.7 33.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.388 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.71 109.62 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.792 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.2 p90 -124.82 171.24 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.54 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 104.58 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.512 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 71' ' ' ASN . 5.2 tt -77.11 153.48 34.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 111.141 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' HD23 ' A' ' 70' ' ' LEU . 5.6 m120 -127.56 107.35 9.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' HB3' HD22 ' A' ' 134' ' ' LEU . 16.7 p90 -122.67 -168.54 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.04 139.97 37.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.071 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -24.66 15.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.15 -28.27 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.744 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -120.76 -44.68 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.5 m-85 -93.31 -178.38 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 3.2 tt0 -171.61 115.66 0.39 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.292 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.837 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.5 t80 -46.49 134.49 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.737 ' HB ' HG23 ' A' ' 122' ' ' VAL . 33.6 t -106.41 -81.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 122' ' ' VAL . 20.2 mm-40 -162.14 137.73 7.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.65 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 121' ' ' VAL . . . -82.57 146.28 29.26 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.987 0.899 . . . . 0.0 111.342 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.57 154.62 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.444 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.816 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -115.44 163.65 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.916 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.92 -160.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.9 37.56 1.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.816 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.1 -40.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.015 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.816 HG23 ' OG ' ' A' ' 84' ' ' SER . 8.9 m -86.95 169.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 0.0 110.918 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.83 144.47 45.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 104' ' ' VAL . 7.5 t -141.86 140.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -156.97 107.8 2.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.837 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.31 178.25 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -154.39 110.93 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.9 tttm -53.99 95.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.181 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.842 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.1 tp -78.51 -24.52 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.727 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.74 -166.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.751 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.9 132.97 34.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.91 29.85 65.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.423 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HE3' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -173.91 122.17 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.842 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -149.3 155.12 8.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.722 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 16.9 tpp85 -92.71 151.75 19.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.969 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 68' ' ' PHE . 4.0 p -127.51 137.14 58.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.862 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -119.79 102.86 8.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.901 HG11 ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -108.03 155.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.058 0.456 . . . . 0.0 111.424 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 p -164.41 137.16 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.715 ' HA ' HG12 ' A' ' 88' ' ' VAL . 10.4 m -75.81 104.83 6.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.977 0.418 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.1 tt -93.29 26.32 2.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.114 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.4 p -99.02 -31.49 11.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.995 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.37 5.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.144 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.28 158.21 32.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.692 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -65.38 -175.72 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.548 2.165 . . . . 0.0 112.473 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.713 ' CD2' HD21 ' A' ' 118' ' ' LEU . 0.8 OUTLIER -54.87 114.6 7.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.44 -38.87 31.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.052 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.61 168.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.4 16.14 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.071 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.42 -166.81 2.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.338 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.835 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.7 t -78.45 105.07 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.796 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.58 -31.17 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.901 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -169.15 135.52 1.7 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.874 0.368 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.821 ' HD3' HG11 ' A' ' 117' ' ' VAL . 4.2 mtmt -124.92 112.34 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.595 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 82' ' ' ALA . 24.9 t -99.8 96.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' VAL . 19.2 m -75.43 119.87 24.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.03 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 3.1 mm? -87.01 169.36 12.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.678 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.6 tpm_? -106.57 119.35 39.05 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.94 68.13 8.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.452 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.83 -6.42 58.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.47 124.06 2.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.714 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.681 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.3 ttpp -40.74 158.01 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.373 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.744 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -171.61 58.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.743 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.2 pm0 -55.66 117.18 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.221 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 20.93 51.01 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.478 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.543 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 8.0 t -71.15 65.54 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.046 0.451 . . . . 0.0 110.309 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.22 131.71 4.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.517 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -112.08 150.15 31.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.49 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -133.95 125.88 29.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 111.618 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 53' ' ' VAL . 23.3 m -113.46 94.77 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.683 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.5 p -101.66 -159.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.67 22.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.473 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -62.51 82.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.15 141.08 46.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.093 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.072 HG21 ' HB1' ' A' ' 63' ' ' ALA . 7.8 p -118.35 150.69 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 99.61 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.895 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 27.1 t0 -50.37 161.99 0.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 110.961 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 64' ' ' PHE . . . -59.49 -45.05 96.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.547 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.15 -31.17 72.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.42 -28.22 3.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.44 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.72 168.74 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 141' ' ' VAL . 8.0 p -122.92 148.33 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 38.4 m-70 -125.5 91.06 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.2 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.8 104.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.113 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.502 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 -177.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.328 0.585 . . . . 0.0 112.079 -178.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -60.89 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.349 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.93 176.73 34.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.915 HG22 HD23 ' A' ' 37' ' ' LEU . 51.5 m -164.96 145.47 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.554 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.07 163.43 13.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.166 0.508 . . . . 0.0 111.7 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.645 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -133.5 164.06 28.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.592 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.446 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.3 p -142.71 115.42 8.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.29 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.818 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.02 128.8 69.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 111.227 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.27 105.69 17.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.712 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.844 HD11 ' CE2' ' A' ' 77' ' ' PHE . 15.4 mt -83.22 115.96 26.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.479 0.657 . . . . 0.0 109.717 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.78 141.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.65 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.11 146.07 55.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.018 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.3 -147.13 7.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.435 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -50.36 177.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.048 0.451 . . . . 0.0 111.389 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.492 ' N ' ' OG1' ' A' ' 164' ' ' THR . 14.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.922 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.835 0.35 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.73 43.4 1.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.11 166.18 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 m -131.98 178.31 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -98.6 34.11 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.25 -39.46 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 60.36 89.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -132.4 -177.98 4.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -126.85 98.33 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -131.5 -46.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.35 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.95 -70.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.64 -110.12 0.68 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.32 81.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.949 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.72 88.42 4.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.47 145.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.57 2.847 . . . . 0.0 113.203 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 60.76 31.21 20.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.25 93.02 0.88 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.459 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -138.59 147.14 42.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.907 0.384 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -40.04 14.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 ttm 60.53 171.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.72 -169.66 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.43 -68.33 0.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -83.18 147.32 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.817 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.72 -70.5 0.7 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 179.95 -53.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.31 178.79 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.91 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.6 77.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -96.04 126.21 41.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.2 t -76.16 151.68 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.9 t -69.21 -47.97 63.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 151' ' ' ILE . . . 77.91 107.22 0.18 Allowed Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.064 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.965 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.0 t -166.11 136.2 3.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.45 0.643 . . . . 0.0 111.762 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 151' ' ' ILE . 27.4 m -95.66 144.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.504 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 6.2 t -105.54 111.5 24.23 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.072 HD12 HG22 ' A' ' 154' ' ' THR . 3.6 mt -97.25 125.53 41.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.044 0.449 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.16 101.38 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.308 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -145.92 152.28 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.485 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.64 -29.11 67.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.236 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.49 24.93 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.455 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 158' ' ' VAL . 20.1 tt0 -164.68 128.08 2.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.859 0.361 . . . . 0.0 111.925 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -148.4 107.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.259 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.2 tt0 -68.32 128.13 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.036 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.86 132.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.14 -21.85 38.51 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.96 173.45 6.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.56 167.34 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.637 ' CD1' HG23 ' A' ' 51' ' ' VAL . 3.7 pp -125.41 160.72 28.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -136.67 110.19 7.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.964 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 39' ' ' ALA . 12.7 t -109.61 97.67 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.981 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.78 68.15 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.636 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.0 HG21 HG11 ' A' ' 136' ' ' VAL . 10.3 p -78.19 95.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.18 -122.49 4.6 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.98 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.54 130.81 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 112.138 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.0 t70 -101.72 -32.8 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 32' ' ' THR . 36.4 mt-10 -157.2 128.66 6.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.418 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -161.22 90.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.92 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.9 p -125.57 106.02 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.566 ' N ' HG22 ' A' ' 31' ' ' VAL . 1.2 m120 131.5 18.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.462 1.101 . . . . 0.0 111.418 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . . . -148.43 -179.41 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.945 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 2.8 mm-40 -126.4 77.16 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.936 0.398 . . . . 0.0 110.58 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.47 112.1 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.6 m-85 -115.72 -59.88 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.802 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.23 112.62 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.589 ' OH ' HD11 ' A' ' 151' ' ' ILE . 1.5 t80 -86.16 138.65 31.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -147.55 110.27 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.265 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 102' ' ' VAL . 12.9 p90 -137.69 171.55 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.99 106.09 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.693 HD22 HD23 ' A' ' 134' ' ' LEU . 1.3 mt -77.29 157.19 30.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.825 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -121.62 104.37 9.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.97 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.9 p90 -114.95 -167.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.3 t70 -112.05 132.38 54.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.38 -28.02 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -60.24 -30.28 69.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.981 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.83 -46.26 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.4 m-85 -93.34 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.751 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -165.29 113.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.773 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.749 ' CD1' HG21 ' A' ' 100' ' ' VAL . 20.0 t80 -46.68 155.91 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -137.73 -81.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 14.4 pt-20 -152.42 131.64 12.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.06 149.54 26.86 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.304 1.049 . . . . 0.0 111.774 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -133.4 174.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.073 -177.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -168.33 2.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.811 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.91 -161.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.17 37.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.816 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 -37.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' SER . 30.1 t -86.71 143.86 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -106.27 107.08 17.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 111.005 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -105.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -143.43 117.9 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.349 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.72 173.01 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.946 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.22 107.33 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.443 . . . . 0.0 111.697 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.5 tttp -54.77 115.19 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.271 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.6 tp -111.5 -22.37 5.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.919 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.79 -166.84 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.58 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -101.42 50.84 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.591 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.61 129.83 0.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.749 HG21 ' CD1' ' A' ' 79' ' ' TYR . 17.4 m -150.1 155.2 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -80.94 152.05 28.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.352 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 68' ' ' PHE . 8.9 p -134.13 110.7 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.403 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 mt -88.54 114.34 25.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.907 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.623 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 13.4 t -107.43 137.73 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.508 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.472 ' C ' HG13 ' A' ' 88' ' ' VAL . 3.8 p -164.27 136.21 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.37 104.49 15.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.211 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.85 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.3 p -65.34 -34.76 79.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.84 -19.76 30.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.382 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.33 154.64 71.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 55.6 Cg_endo -70.42 157.99 57.43 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.658 2.239 . . . . 0.0 112.364 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 ' CD1' ' A' ' 118' ' ' LEU . 35.5 mt -59.9 111.1 3.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.8 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.89 -21.35 73.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.395 2.064 . . . . 0.0 112.26 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.1 175.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.602 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.72 24.27 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 110.383 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.81 -166.62 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.201 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.769 HG13 ' HA3' ' A' ' 52' ' ' GLY . 21.5 t -85.9 104.69 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.635 ' CD1' HD22 ' A' ' 112' ' ' LEU . 1.7 mm? -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -160.05 135.23 8.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.843 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.711 ' HD2' HG11 ' A' ' 117' ' ' VAL . 10.3 mtpt -128.22 100.87 6.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.034 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.8 p -81.29 107.02 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 110.268 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 83' ' ' ILE . 23.0 t -75.69 106.9 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.037 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 134' ' ' LEU . 12.1 mt -89.99 169.22 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 5.5 ttm180 -114.38 122.99 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -91.57 68.96 5.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.294 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.51 -5.68 58.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.413 0.625 . . . . 0.0 109.529 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.03 123.83 2.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.49 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.3 ttmt -41.59 159.94 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.272 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.782 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -174.98 57.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.017 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.3 mt-10 -56.18 113.39 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.097 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' ND2' ' A' ' 133' ' ' ASN . . . 103.27 -2.31 46.97 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.544 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.782 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 2.5 m -61.06 86.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.936 0.398 . . . . 0.0 110.235 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 131' ' ' GLY . 1.6 m-80 -58.67 171.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.654 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -146.84 108.72 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.116 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.4 p -97.46 122.58 40.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.439 . . . . 0.0 111.407 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 53' ' ' VAL . 7.2 p -107.48 95.16 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.4 p -102.45 -166.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.573 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.91 20.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.014 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 m -61.88 88.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.55 166.33 11.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.486 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 63' ' ' ALA . 13.2 p -140.33 159.95 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.982 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -97.36 91.39 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.648 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 17.1 t70 -48.61 161.46 0.13 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.37 78.39 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.12 -30.47 65.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.49 -26.85 4.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.595 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.3 mt -68.39 169.98 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.66 148.22 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -119.22 90.85 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -49.98 102.03 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.589 HD11 ' OH ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -89.38 -176.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.325 0.583 . . . . 0.0 111.659 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.62 -158.08 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -161.2 171.73 37.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.034 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 1.072 HG22 HD12 ' A' ' 37' ' ' LEU . 55.1 m -158.85 146.52 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.97 151.79 25.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.033 0.444 . . . . 0.0 111.413 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 37' ' ' LEU . 6.5 tppt? -128.97 167.49 17.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.975 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.17 126.21 16.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.11 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -113.3 131.6 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.14 106.45 18.75 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.833 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.84 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -85.44 116.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.384 0.612 . . . . 0.0 109.922 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.01 146.21 8.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.556 -178.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.98 145.91 54.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.84 -171.44 45.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -75.76 -176.81 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.301 . . . . 0.0 110.894 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.486 ' H ' HG22 ' A' ' 164' ' ' THR . 8.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.74 102.46 0.31 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.53 110.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.309 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.35 -177.99 3.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -100.07 -38.94 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.06 111.5 4.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -96.85 175.96 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.6 m80 60.61 81.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.14 176.78 9.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -100.43 137.44 38.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.19 -57.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.3 m -74.81 -63.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.48 59.53 1.62 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 110.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 110.847 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG13 ' HD2' ' A' ' 16' ' ' PRO . 22.0 t -78.39 136.02 60.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.026 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' HG13 ' A' ' 15' ' ' VAL . 80.7 Cg_exo -32.36 109.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.477 2.784 . . . . 0.0 113.221 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.56 -71.59 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.51 60.25 1.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.509 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -141.99 83.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -147.38 151.05 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.9 mtm -148.79 -68.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.04 -73.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.8 p -152.54 168.24 26.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.51 150.29 24.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.0 115.6 30.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -176.56 -40.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -156.5 -176.89 6.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -127.67 80.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.75 62.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -111.32 112.48 24.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 60' ' ' ASN . 13.1 t -60.54 147.76 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 57' ' ' GLU . 14.6 t -70.89 -45.54 64.19 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 73.51 109.43 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.583 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -159.49 138.71 11.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.603 0.716 . . . . 0.0 111.754 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.3 m -98.26 141.52 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 21.3 p -100.6 111.01 23.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 154' ' ' THR . 3.2 mt -97.14 126.48 42.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 101.55 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -147.93 151.32 35.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -61.47 -28.3 69.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.7 mt-10 72.92 24.31 2.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.605 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG2' HD11 ' A' ' 161' ' ' ILE . 12.6 tt0 -164.81 128.37 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.849 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.882 ' O ' HG23 ' A' ' 160' ' ' ILE . 4.1 p -144.58 108.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.394 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.25 125.25 26.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.038 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -28.86 130.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.01 -15.0 52.09 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.753 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 43' ' ' VAL . 5.4 tp10 -106.34 171.36 7.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.736 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -106.63 167.81 9.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 158' ' ' VAL . 11.2 mt -120.2 150.99 39.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.63 93.28 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.493 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.944 HG12 ' CB ' ' A' ' 39' ' ' ALA . 27.3 m -106.88 97.06 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.103 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.815 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.91 76.36 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.659 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 136' ' ' VAL . 12.5 p -78.54 95.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -105.79 -129.79 6.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.828 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.72 132.01 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 111.69 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 5.1 t0 -97.84 -31.43 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.122 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -178.17 133.4 0.15 Allowed 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.485 0.66 . . . . 0.0 111.894 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -159.41 115.52 2.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.634 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.8 p -133.53 102.38 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.594 ' N ' HG22 ' A' ' 31' ' ' VAL . 22.4 m-20 138.37 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.384 1.053 . . . . 0.0 111.914 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.3 174.44 14.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.33 87.02 2.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.84 112.67 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.446 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -103.6 -35.3 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.129 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.49 112.38 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.348 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.826 ' O ' HG12 ' A' ' 104' ' ' VAL . 67.2 t80 -99.11 152.02 20.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.19 116.94 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.891 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.903 ' O ' HG12 ' A' ' 102' ' ' VAL . 5.7 p90 -117.8 140.18 50.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.081 0.467 . . . . 0.0 111.459 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 94.17 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.773 HD12 HG13 ' A' ' 136' ' ' VAL . 2.2 tp -80.02 139.68 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -111.65 104.36 12.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.846 ' HA ' HD23 ' A' ' 134' ' ' LEU . 38.9 p90 -100.16 -170.79 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.75 126.15 42.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.192 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -85.45 -17.26 37.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.021 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -96.47 29.21 2.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.868 0.366 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.906 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -171.86 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.25 170.52 9.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -153.11 109.09 3.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.539 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 14.4 t80 -53.23 143.72 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' ARG . 41.5 t -123.09 -72.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.33 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.69 142.71 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.94 153.62 24.95 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 122.125 0.965 . . . . 0.0 111.655 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.84 152.68 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.455 -177.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -124.91 -173.22 2.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.92 -158.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -93.5 37.41 1.06 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.6 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.315 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 89' ' ' PHE . 11.2 t -86.74 157.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.422 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -115.04 102.99 10.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 119' ' ' ALA . 3.5 t -104.65 120.76 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -134.14 118.38 17.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.23 0.538 . . . . 0.0 111.526 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.94 146.79 24.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.013 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -132.44 106.81 8.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.399 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 12.2 tttp -55.47 95.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.811 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -81.34 -30.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.809 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.32 -168.02 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.62 128.83 34.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 59.12 33.23 73.75 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.549 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -173.71 121.41 0.32 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.811 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.9 m -149.71 155.58 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.643 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -96.94 152.46 18.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.986 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.5 p -128.67 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.968 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.08 108.16 14.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.8 p -108.47 137.55 39.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.09 0.472 . . . . 0.0 111.042 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.8 p -161.83 135.86 6.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -78.91 104.42 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.39 -13.01 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.0 p -65.21 -27.17 68.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.34 -20.74 12.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.35 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.44 142.34 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.625 0.25 . . . . 0.0 110.661 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 50.7 Cg_exo -54.0 150.91 29.13 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.446 2.097 . . . . 0.0 112.358 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -56.3 128.61 73.38 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.714 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.836 ' O ' HD12 ' A' ' 112' ' ' LEU . 13.0 Cg_exo -69.9 -159.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.541 2.161 . . . . 0.0 112.318 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.586 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -155.91 166.87 32.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 14.7 9.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.85 -165.79 1.8 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.078 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.815 HG13 ' HA3' ' A' ' 52' ' ' GLY . 30.6 t -84.78 104.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -86.83 -34.95 19.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -166.81 131.87 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HD2' HG11 ' A' ' 117' ' ' VAL . 3.8 mtpt -117.05 120.92 39.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.497 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.673 HG11 HD22 ' A' ' 70' ' ' LEU . 8.6 p -88.85 142.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 83' ' ' ILE . 23.4 t -113.7 117.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.658 HD22 ' CD1' ' A' ' 72' ' ' TYR . 2.5 mt -115.79 108.52 16.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.49 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 80' ' ' VAL . 26.6 ttm180 -64.18 115.25 4.81 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -74.27 74.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.378 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.34 -4.28 59.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.486 0.66 . . . . 0.0 109.452 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.72 123.48 2.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.352 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 16.9 ttmt -47.59 139.96 6.53 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.365 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.906 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.16 62.25 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.852 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.34 112.9 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.92 49.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.607 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.327 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.38 133.28 4.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.301 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -117.82 116.0 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.841 179.265 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 p -109.76 128.65 55.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.598 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 53' ' ' VAL . 9.6 m -106.13 94.96 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.3 p -97.27 -163.78 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.64 21.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.959 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.478 ' HB3' HD11 ' A' ' 151' ' ' ILE . 73.6 m -59.06 101.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -113.5 165.28 12.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' VAL . 27.6 m -143.72 125.48 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.013 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.21 100.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.584 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.15 161.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -28.18 72.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.71 -34.8 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.54 2.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 147' ' ' LEU . 13.5 mt -72.89 161.24 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 140' ' ' SER . 11.5 p -113.45 136.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.102 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -109.74 90.67 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -51.08 107.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.39 177.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.612 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -62.36 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.974 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.13 168.56 41.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.399 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.949 HG22 HD12 ' A' ' 37' ' ' LEU . 65.4 m -156.21 146.83 21.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.2 167.77 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 111.435 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' A' ' 37' ' ' LEU . 2.9 tppt? -139.57 168.8 19.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.246 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.425 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.3 p -142.32 115.83 9.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.742 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.48 HG22 HD11 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -110.53 126.67 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.13 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.05 105.88 18.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.789 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.882 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.4 mt -78.76 122.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.02 131.2 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.594 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.18 145.02 44.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.043 0.449 . . . . 0.0 111.214 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.54 -140.82 5.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -59.97 178.74 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.982 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 164' ' ' THR . 1.4 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtm . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 97.68 1.02 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -169.35 110.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -84.92 126.43 33.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -96.79 -31.61 12.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -171.35 133.32 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -98.97 34.02 2.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -90.77 -33.88 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.31 112.68 9.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -64.97 148.7 51.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.6 t -105.92 170.8 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 -31.38 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.78 -84.23 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.87 100.43 3.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 21.4 t -58.84 -52.68 73.07 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.53 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 71.3 Cg_exo -32.29 144.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.292 2.661 . . . . 0.0 113.397 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -31.07 23.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.75 23.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.467 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 m -61.08 -36.31 79.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -106.19 141.87 36.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.1 mtt -79.62 -57.3 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.38 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m 60.6 97.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.67 31.18 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.82 174.0 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -73.89 -39.29 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.27 164.72 29.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.0 31.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 60' ' ' ASN . . . 59.66 37.62 22.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.37 106.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.976 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 61' ' ' ALA . 25.2 t -82.02 146.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -66.82 -35.14 79.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.665 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.18 108.19 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.035 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.547 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 t -153.43 138.82 17.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.707 0.765 . . . . 0.0 111.977 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 151' ' ' ILE . 34.1 m -91.02 145.3 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.247 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 t -104.9 107.57 18.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.492 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 154' ' ' THR . 6.8 mt -96.8 111.6 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.173 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -140.18 101.47 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.483 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -144.0 158.45 43.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -56.86 -23.45 44.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.8 mt-10 65.62 23.02 11.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.444 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.554 ' CD ' HD11 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -164.87 128.26 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 0.0 111.854 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.921 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -143.14 108.78 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.192 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.59 126.5 29.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.612 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.1 t -29.08 133.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.477 0.656 . . . . 0.0 112.723 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.12 -26.88 22.53 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.126 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -90.02 172.65 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.488 ' HB3' HG13 ' A' ' 122' ' ' VAL . 5.8 m120 -110.31 137.44 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.699 HD11 HG11 ' A' ' 158' ' ' VAL . 21.6 tp -92.02 149.92 21.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HD12 ' A' ' 83' ' ' ILE . 6.2 tt0 -136.21 101.66 4.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' CB ' ' A' ' 39' ' ' ALA . 5.8 m -106.32 97.96 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.778 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -77.62 67.62 2.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.607 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 136' ' ' VAL . 8.5 p -78.4 95.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.005 0.431 . . . . 0.0 110.515 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.06 -120.07 4.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.107 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.92 133.4 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.015 0.435 . . . . 0.0 111.993 -179.317 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.49 -37.89 8.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.5 mt-10 -155.62 130.79 9.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.122 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.941 HD21 ' HB3' ' A' ' 61' ' ' ALA . 10.3 tt -156.66 90.97 1.19 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.502 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.76 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.3 p -110.98 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.9 m-20 100.38 20.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.715 0.806 . . . . 0.0 111.797 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.941 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -140.2 139.14 35.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.673 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -101.06 80.65 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.619 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.41 111.84 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 22.4 m-85 -113.53 -31.33 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.23 114.78 9.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.685 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.1 t80 -85.59 127.18 34.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.12 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -141.62 109.93 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.855 ' CD1' HG13 ' A' ' 136' ' ' VAL . 15.0 p90 -140.69 171.11 14.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.985 0.421 . . . . 0.0 111.315 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.36 114.49 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.663 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.518 HD12 HG22 ' A' ' 136' ' ' VAL . 23.7 tp -77.39 151.27 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.48 104.57 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' HD21 ' A' ' 134' ' ' LEU . 17.2 p90 -129.24 -167.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -112.73 139.85 48.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.053 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.67 -28.79 15.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.37 -47.59 85.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.973 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.928 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -99.81 -46.5 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.194 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.0 m-85 -93.36 166.5 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -152.18 112.67 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 123' ' ' LEU . 31.5 t80 -54.12 151.65 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 124' ' ' ARG . 48.1 t -130.24 -70.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.885 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 122' ' ' VAL . 5.8 pt-20 -172.52 141.86 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.636 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 148.43 28.04 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.14 0.971 . . . . 0.0 111.721 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 152.25 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.074 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.669 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -113.55 -169.59 1.53 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.969 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.55 -159.81 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.81 35.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.37 -46.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.083 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.665 HG23 ' OG ' ' A' ' 84' ' ' SER . 28.4 m -90.65 173.5 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -121.23 139.28 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 104' ' ' VAL . 2.4 t -136.13 109.28 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -121.14 119.11 31.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.11 172.27 7.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 107.38 3.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.695 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 tttp -55.38 95.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.948 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 100' ' ' VAL . 5.1 tp -86.45 -28.95 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.41 -174.84 5.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.88 136.54 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 56.94 27.08 56.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.457 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -173.35 123.6 0.39 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.703 ' HA ' HG22 ' A' ' 95' ' ' ILE . 16.5 m -150.27 154.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.885 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.524 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -81.29 152.13 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.924 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.82 93.58 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.905 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.1 mt -75.97 115.28 15.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 90' ' ' VAL . 11.3 t -112.83 145.35 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.016 0.436 . . . . 0.0 111.483 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.7 p -164.32 136.03 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.363 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.603 ' CB ' HG12 ' A' ' 88' ' ' VAL . 32.1 m -84.53 104.62 14.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.54 -15.07 63.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -65.34 -34.75 79.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.78 -16.9 25.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.446 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.34 160.6 29.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 39.2 Cg_exo -56.85 173.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 66' ' ' TYR . 3.8 mp -67.67 134.16 92.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.51 -38.73 71.14 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.508 2.139 . . . . 0.0 112.256 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HA ' HD21 ' A' ' 118' ' ' LEU . . . 59.05 162.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.968 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.9 15.75 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 -163.29 1.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.254 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.824 HG11 ' HD3' ' A' ' 120' ' ' LYS . 39.1 t -76.86 105.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -95.62 -30.18 13.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -158.96 136.03 9.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.421 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.824 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -132.93 111.12 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.323 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 70' ' ' LEU . 56.3 t -86.09 114.83 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD11 ' A' ' 83' ' ' ILE . 54.8 t -75.62 105.44 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.841 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 79' ' ' TYR . 24.7 mt -103.13 108.49 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.598 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.516 ' H ' HG23 ' A' ' 80' ' ' VAL . 38.4 ttm180 -68.9 117.79 11.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.96 80.75 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.872 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.43 -5.27 58.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.3 123.5 2.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.185 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.3 ttpt -61.33 131.37 50.11 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.81 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -133.38 75.84 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.64 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.99 110.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 111.033 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.78 14.61 39.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.553 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.588 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -61.02 86.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 110.276 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 3.1 m-80 -60.17 151.36 27.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 132' ' ' SER . 3.5 mp -146.52 139.28 25.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.88 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.0 t -134.98 134.7 40.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.091 0.472 . . . . 0.0 111.6 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.855 HG13 ' CD1' ' A' ' 68' ' ' PHE . 48.4 t -105.02 95.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.482 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.6 p -102.73 -169.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.47 20.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.948 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 151' ' ' ILE . 49.9 m -64.26 97.8 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.344 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.412 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -103.74 171.6 7.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 58' ' ' LEU . 19.7 m -144.31 125.11 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 78.36 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.636 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 23.0 t0 -59.41 138.34 57.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.858 0.361 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.5 -28.05 61.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.678 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.13 -27.91 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 110.958 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.96 -11.21 22.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.743 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -114.52 121.02 42.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.6 p -73.4 126.16 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -95.1 93.2 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.078 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -51.15 110.56 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.36 168.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 112.135 -178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -61.03 -141.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.37 176.05 46.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.469 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 37' ' ' LEU . 17.9 m -159.68 149.12 18.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.7 0.286 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -104.32 154.54 19.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 111.588 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.647 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -147.66 155.13 41.45 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.647 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.7 p -138.76 135.27 34.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -119.59 125.52 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.527 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.87 105.7 17.79 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.921 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.1 mt -76.16 143.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -130.74 133.51 63.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.685 -177.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.1 144.52 19.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -116.68 -137.94 6.11 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.458 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -74.12 176.08 6.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.482 ' H ' HG22 ' A' ' 164' ' ' THR . 32.2 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.734 0.302 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.83 -116.05 5.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.439 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -79.75 166.75 21.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -32.65 74.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -106.18 158.4 16.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 m170 60.51 -177.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -131.98 -173.62 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 60.27 159.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -85.9 150.53 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -70.69 -59.15 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 t -132.04 135.66 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -159.73 -177.76 6.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.92 76.91 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 tt -132.03 -61.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 t 63.78 81.98 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.018 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -32.25 123.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.63 2.887 . . . . 0.0 113.276 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 112.4 18.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.01 -147.47 4.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.544 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -143.07 92.98 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -96.66 -40.69 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.5 mtt -104.75 -52.04 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.61 103.75 7.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.98 161.48 33.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -104.99 100.98 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.1 pp -93.64 79.51 4.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.6 -62.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -148.24 178.24 8.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.8 142.82 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.38 77.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -86.67 106.94 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 HD23 ' A' ' 58' ' ' LEU . 79.7 t -71.9 152.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.0 t -60.52 -43.5 97.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.345 0.593 . . . . 0.0 109.493 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 66.49 102.92 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.754 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.902 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 18.9 t -160.73 138.73 9.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.517 0.675 . . . . 0.0 112.166 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 151' ' ' ILE . 34.0 m -97.32 134.67 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.266 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 3.8 t -92.11 108.05 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.704 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.598 HD22 ' CG2' ' A' ' 154' ' ' THR . 10.0 tp -97.23 124.52 41.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -140.55 106.99 5.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.687 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -147.65 165.53 30.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.525 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 49' ' ' LEU . 11.0 mt -78.88 -27.53 44.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.701 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.3 OUTLIER 71.97 23.04 3.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HG2' HD11 ' A' ' 161' ' ' ILE . 10.8 tt0 -164.54 129.08 2.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.58 107.91 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.46 125.36 26.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.215 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -29.23 131.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.15 -20.05 46.65 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.439 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -99.56 172.33 7.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB3' HG21 ' A' ' 122' ' ' VAL . 10.0 m-80 -121.52 130.01 53.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -118.45 133.47 55.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.824 ' HG2' HD11 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -113.79 154.01 28.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.566 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 51' ' ' VAL . 24.9 m -125.9 98.22 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.696 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.58 64.49 0.62 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.473 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 136' ' ' VAL . 9.1 p -78.25 95.53 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.667 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.33 -122.56 4.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.032 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.504 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -111.24 129.75 65.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.776 -179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 24.3 t70 -99.19 -37.36 9.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.712 ' HB3' HG21 ' A' ' 32' ' ' THR . 29.2 mt-10 -159.11 130.02 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.589 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 HG11 ' A' ' 31' ' ' VAL . 1.1 tt -159.55 91.58 1.0 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.251 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.733 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -122.06 107.07 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.55 ' CA ' HG22 ' A' ' 31' ' ' VAL . 63.2 m-20 130.18 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.435 1.094 . . . . 0.0 111.543 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -157.92 162.56 38.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -113.85 83.88 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -63.29 111.78 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.526 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -102.26 -38.71 7.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.93 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.91 112.31 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.112 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.4 t80 -105.2 94.34 5.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.864 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -109.12 133.28 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.631 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 47.9 p90 -135.99 171.27 14.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 111.421 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.0 102.71 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.071 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.064 HD21 HD23 ' A' ' 134' ' ' LEU . 9.8 tt -76.88 157.32 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.096 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.692 ' N ' HD23 ' A' ' 70' ' ' LEU . 6.9 m120 -127.27 130.47 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 1.8 p90 -140.97 -167.42 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.548 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.03 136.3 53.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' CB ' ' HB2' ' A' ' 97' ' ' ASP . 33.3 tt0 -94.07 -6.35 45.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.286 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.59 31.26 2.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.897 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.32 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.651 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 160' ' ' ILE . 3.0 m-85 -100.32 -177.08 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.76 108.86 0.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.9 t80 -48.55 147.65 2.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 122' ' ' VAL . 60.1 t -127.69 -80.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 122' ' ' VAL . 4.8 mt-10 -161.42 138.84 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.92 150.54 26.41 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 122.01 0.91 . . . . 0.0 111.279 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.28 152.38 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.501 -177.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.574 ' HB3' HG23 ' A' ' 90' ' ' VAL . 15.1 p -115.65 -176.93 3.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.72 -156.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -93.65 36.77 1.08 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.875 0.369 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.79 -38.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.216 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 89' ' ' PHE . 26.6 t -87.06 159.03 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.4 t80 -114.85 117.02 29.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 104' ' ' VAL . 10.8 t -115.41 131.98 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.56 115.61 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -95.76 149.8 21.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -136.51 106.86 6.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.713 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 24.5 tttt -55.52 120.38 7.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.362 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.4 tp -112.06 -23.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.834 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.54 -179.19 7.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 111.152 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -47.2 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -106.07 60.57 0.37 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.27 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -174.0 123.72 0.33 Allowed 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.3 m -148.81 155.41 8.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.637 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -99.11 152.34 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.067 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.3 p -125.21 147.63 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.394 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.38 109.92 18.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 90' ' ' VAL . 21.4 t -109.28 137.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 111.524 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.3 p -164.25 136.06 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.448 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -79.37 104.39 9.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.242 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -70.51 -14.78 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.462 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.5 p -65.26 -28.87 69.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.0 -17.74 22.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.454 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -99.18 147.66 33.58 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 52.4 Cg_exo -54.16 169.88 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 63' ' ' ALA . 51.1 mt -58.23 113.96 7.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 -21.22 51.72 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.406 2.071 . . . . 0.0 112.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 59.56 169.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.849 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.12 27.05 14.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 110.602 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 118' ' ' LEU . 16.7 tt0 -155.38 154.5 32.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.696 HG13 ' HA3' ' A' ' 52' ' ' GLY . 26.9 t -47.43 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.224 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 116' ' ' GLU . 1.1 mm? -92.05 -29.3 16.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -163.0 136.4 5.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.74 0.305 . . . . 0.0 111.513 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.64 ' HD2' HG11 ' A' ' 117' ' ' VAL . 7.2 mtpt -131.85 100.75 5.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.428 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 82' ' ' ALA . 93.1 t -91.69 107.04 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.9 p -83.89 124.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -99.49 114.06 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.411 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 24.5 ttm180 -54.95 116.81 2.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -87.63 67.94 9.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.255 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 -0.83 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.481 0.658 . . . . 0.0 109.312 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.16 123.39 2.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.235 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.74 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.0 ttpt -45.44 142.19 2.32 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.627 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -149.07 59.61 1.04 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.713 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -56.05 118.61 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.167 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.36 13.59 70.49 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.51 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.776 ' O ' HD12 ' A' ' 134' ' ' LEU . 29.6 t -70.35 66.56 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.469 . . . . 0.0 110.144 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.456 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -43.97 138.28 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.482 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.064 HD23 HD21 ' A' ' 70' ' ' LEU . 4.6 mp -119.17 127.14 53.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.458 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.413 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -119.84 126.39 50.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.123 0.487 . . . . 0.0 111.957 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 53' ' ' VAL . 18.7 m -113.87 94.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.3 p -105.82 -159.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.783 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.56 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.422 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -63.52 104.74 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 0.0 110.371 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.09 167.17 9.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.493 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 58' ' ' LEU . 8.4 m -141.65 120.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.962 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.71 98.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.669 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -55.81 161.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.74 79.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.87 -46.23 25.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.14 -27.84 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.4 119.31 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.971 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.27 153.42 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -122.13 90.61 3.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.69 103.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.266 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.45 -176.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 111.947 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -64.63 -160.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.53 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.1 -174.29 23.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.019 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.598 ' CG2' HD22 ' A' ' 37' ' ' LEU . 11.6 t -160.62 -171.03 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.429 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 14.0 tt0 -161.8 157.85 24.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 41' ' ' GLU . 2.2 tppm? -143.17 168.73 19.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.186 0.517 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.5 p -141.67 115.7 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.415 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -109.9 119.11 58.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.188 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 105.89 18.09 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.9 mt -78.25 119.68 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.2 132.77 48.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.692 -178.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.12 145.84 45.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 168.31 120.2 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.511 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.67 170.29 9.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.861 -179.954 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.04 58.16 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -72.09 161.27 31.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 t -65.22 79.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -114.99 -178.24 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t60 60.81 31.65 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.61 -64.18 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.12 158.11 19.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.33 29.23 7.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 58.01 31.08 20.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.7 158.24 15.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.11 -170.07 3.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.72 -124.51 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mt -121.57 128.42 51.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 t -104.89 81.86 0.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -32.35 -55.8 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.534 2.823 . . . . 0.0 113.287 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -164.32 -56.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.13 75.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -167.37 97.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -146.07 160.44 41.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 60.49 32.48 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -170.45 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t -136.14 -57.3 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.854 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -154.22 117.73 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 25' ' ' LEU . 1.5 tt -93.95 -31.43 14.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -83.6 -30.81 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 61.29 158.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.93 137.39 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.37 77.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -92.11 93.66 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.84 HG21 ' HB2' ' A' ' 61' ' ' ALA . 17.0 t -76.26 151.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.764 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 33' ' ' GLY . 1.5 t -84.65 -33.16 23.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.609 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.19 121.74 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.549 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.606 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.5 146.37 31.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.211 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 153' ' ' GLY . 28.7 m -96.07 135.99 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 3.6 t -90.96 107.11 18.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.246 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.829 ' HB2' HG21 ' A' ' 154' ' ' THR . 13.1 tp -97.48 106.26 18.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.833 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -140.95 101.03 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -137.03 166.16 24.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 111.274 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -69.68 -35.87 75.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.626 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' HA ' HG13 ' A' ' 158' ' ' VAL . 5.6 mt-10 68.29 31.46 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 161' ' ' ILE . 15.7 tt0 -164.21 116.47 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.3 p -133.14 165.48 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.901 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.541 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -129.47 113.04 14.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 128' ' ' LYS . 2.1 t -28.11 119.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 121.59 -27.61 6.22 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.43 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -102.47 -175.37 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.74 0.305 . . . . 0.0 110.478 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.65 ' HB3' HG13 ' A' ' 122' ' ' VAL . 23.6 m-80 -113.66 165.06 12.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.188 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.8 tp -117.54 156.76 27.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -136.45 93.95 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.146 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' A' ' 39' ' ' ALA . 8.1 p -103.63 98.13 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.703 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.682 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.53 68.2 3.21 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.924 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 136' ' ' VAL . 7.4 p -78.61 95.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.05 -129.74 6.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.865 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -105.51 138.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 111.543 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -98.55 -37.48 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.04 131.99 0.05 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.551 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -135.62 95.51 3.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.526 178.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -85.27 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.766 ' HB2' HG22 ' A' ' 31' ' ' VAL . 14.6 m120 96.68 31.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.29 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.39 149.77 41.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.362 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.5 mt-10 -119.76 71.3 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.723 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.09 122.42 15.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.234 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -105.93 -32.84 8.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.654 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.84 112.3 7.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.04 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 112' ' ' LEU . 21.9 t80 -104.25 94.69 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.1 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -102.42 130.23 49.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.749 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 41.6 p90 -132.85 171.11 14.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -132.7 97.27 4.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.186 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.826 ' CD1' HG11 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -77.2 157.71 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.432 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -116.54 104.57 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 24.4 p90 -111.24 -167.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -106.96 125.54 51.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.78 -40.82 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.803 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.68 -35.54 80.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -96.46 -57.95 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 160' ' ' ILE . 8.3 m-85 -93.44 165.38 12.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -145.02 109.74 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.657 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 22.1 t80 -54.01 140.46 31.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.9 t -119.52 -72.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 3.2 mt-10 -169.04 143.57 3.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.74 147.73 28.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 122.169 0.985 . . . . 0.0 111.698 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.41 152.83 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.474 -177.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -166.36 1.16 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.52 -157.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.27 36.25 1.06 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.09 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.969 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 89' ' ' PHE . 38.1 t -86.88 160.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.782 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.613 ' HB2' HD13 ' A' ' 107' ' ' LEU . 12.8 t80 -112.03 136.71 51.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.959 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 104' ' ' VAL . 2.5 t -134.37 105.46 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -122.34 114.89 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.611 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.657 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.27 -176.98 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.12 107.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.388 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttm -54.82 111.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.039 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -102.58 -28.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.86 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.31 170.71 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.32 133.75 45.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.13 28.48 64.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.323 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.448 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 5.8 ptmt -173.66 122.98 0.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.67 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 20.9 m -150.27 155.92 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -88.28 152.05 22.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.313 -178.406 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.749 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.17 95.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.525 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.88 114.7 19.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.081 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 90' ' ' VAL . 20.7 m -111.58 153.56 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.692 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -164.69 136.71 4.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.467 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.7 m -85.36 104.47 15.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 89' ' ' PHE . 4.4 mp -72.51 -12.19 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.681 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -65.28 -30.86 71.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.38 -19.12 22.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.27 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.39 147.17 34.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 44.6 Cg_exo -56.45 176.27 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.547 2.165 . . . . 0.0 112.365 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -57.04 121.96 49.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.813 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 -36.85 62.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.282 1.988 . . . . 0.0 112.158 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 59.91 163.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.888 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 28.62 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.492 . . . . 0.0 110.241 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -164.48 156.48 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.996 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.789 HG11 ' HD3' ' A' ' 120' ' ' LYS . 30.9 t -44.4 104.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.26 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -95.47 -29.98 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.969 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.914 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -163.79 135.7 4.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.797 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.789 ' HD3' HG11 ' A' ' 117' ' ' VAL . 12.9 mtmm -124.86 113.69 18.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.826 HG11 ' CD1' ' A' ' 70' ' ' LEU . 7.1 p -86.66 110.45 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.452 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.777 HG22 HD11 ' A' ' 83' ' ' ILE . 41.7 t -76.92 106.29 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 79' ' ' TYR . 10.2 mt -106.21 108.6 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.768 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.529 ' HB2' HG21 ' A' ' 80' ' ' VAL . 39.3 ttm180 -69.05 117.92 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -68.55 80.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.185 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 124' ' ' ARG . 4.8 mm-40 -86.06 -12.81 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 109.55 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.79 124.35 2.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.564 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 7.3 ttpp -45.56 155.9 0.14 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.11 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -161.7 56.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -56.21 98.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.677 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 110.59 26.77 4.66 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.911 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -69.97 65.81 0.25 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.918 0.39 . . . . 0.0 111.067 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.51 ' HA ' HG22 ' A' ' 157' ' ' THR . 1.8 t-20 -45.04 110.53 0.24 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.111 0.481 . . . . 0.0 112.003 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 132' ' ' SER . 2.0 mp -106.02 165.2 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.868 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.9 t -158.37 119.74 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.385 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 53' ' ' VAL . 35.6 t -87.16 94.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.441 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.456 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.2 p -100.19 -170.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' C ' ' A' ' 137' ' ' THR . 4.2 p30 43.23 23.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.757 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -64.61 93.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.575 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -97.24 167.5 10.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.136 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -140.18 129.39 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.59 77.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 24.7 t0 -57.14 146.86 26.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.6 -26.38 73.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.89 -44.32 82.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.28 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.26 -10.22 4.12 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.853 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -117.64 132.22 56.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.755 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.5 p -77.26 115.19 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.152 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 141' ' ' VAL . 77.2 m-70 -86.34 95.0 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.71 108.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.792 0.329 . . . . 0.0 110.187 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.516 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.23 166.42 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -56.16 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 35' ' ' VAL . . . -159.08 -167.97 20.49 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.892 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.829 HG21 ' HB2' ' A' ' 37' ' ' LEU . 6.8 t -166.09 179.58 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.958 0.379 . . . . 0.0 111.56 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 tm-20 -143.51 143.8 31.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.809 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -149.44 155.32 40.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.14 0.495 . . . . 0.0 111.232 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.648 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 8.2 p -128.73 140.22 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.219 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -119.65 139.03 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 111.49 23.78 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.027 0.441 . . . . 0.0 111.12 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.688 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.3 mt -88.16 127.5 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -112.13 132.19 61.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.077 -177.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.07 145.86 49.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.223 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.14 159.24 24.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -102.5 179.88 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.857 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.461 ' H ' HG22 ' A' ' 164' ' ' THR . 57.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.938 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.735 0.303 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.92 178.01 53.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 p -85.64 99.46 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.94 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.95 -60.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -64.67 170.18 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 86.51 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -143.02 35.64 1.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -119.03 -170.23 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 m170 60.66 110.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -96.26 142.89 27.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.2 m -114.16 118.48 34.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.14 146.87 27.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.6 -128.58 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.482 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.89 162.39 34.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.31 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.2 p -169.07 88.27 0.61 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -32.46 120.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.658 2.905 . . . . 0.0 113.24 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -91.56 -61.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.13 -105.53 1.17 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 p -63.33 177.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 110.813 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.6 31.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.804 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 60.01 171.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.7 160.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.08 29.14 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 58.47 33.55 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.99 -62.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.897 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.1 tttp 61.01 162.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -101.05 154.09 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.77 -174.67 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 71.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.24 142.66 30.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.831 HG11 HD13 ' A' ' 58' ' ' LEU . 77.5 t -100.7 153.2 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 59' ' ' VAL . 9.3 t -64.05 -42.5 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.448 0.642 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.675 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 61.96 104.93 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.214 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 40.9 t -156.31 136.48 12.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.697 0.76 . . . . 0.0 112.213 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 151' ' ' ILE . 34.2 m -93.35 145.47 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.492 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 17.9 p -104.38 113.31 26.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.014 HD12 HG22 ' A' ' 154' ' ' THR . 5.5 mt -96.79 121.38 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 111.32 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.1 101.3 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.365 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -151.15 152.08 32.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.45 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.88 -22.72 59.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.529 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 2.3 mp0 66.68 23.35 10.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -165.12 127.89 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -144.54 106.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.164 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -69.16 133.07 47.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.489 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -33.83 133.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.57 -22.48 35.74 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.515 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.13 172.18 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -104.34 153.57 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 158' ' ' VAL . 62.2 tp -93.67 161.03 14.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 21.7 mt-10 -136.57 93.57 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.723 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 25.2 t -105.67 97.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 117' ' ' VAL . . . -85.96 59.08 4.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.157 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 53' ' ' VAL . 9.6 p -78.04 95.35 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.581 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -112.31 -117.58 3.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.037 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.617 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.5 131.38 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 112.046 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 7.3 t0 -103.53 -35.84 8.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -155.89 127.82 7.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.611 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.831 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -150.11 90.7 1.7 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.27 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -115.19 116.53 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.8 m-20 103.15 33.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.934 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -169.31 133.46 1.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -91.96 82.06 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.348 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 111.86 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 112' ' ' LEU . 30.3 m-85 -104.94 -33.82 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.884 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.51 112.3 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.111 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 112' ' ' LEU . 15.2 t80 -109.71 95.03 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.967 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -109.18 143.86 38.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.717 ' CD1' HG13 ' A' ' 136' ' ' VAL . 18.6 p90 -146.41 171.27 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.013 0.435 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -126.29 99.72 5.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -77.2 156.08 31.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.27 112.99 18.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HA ' HD23 ' A' ' 134' ' ' LEU . 26.1 p90 -126.22 -168.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.646 ' OD2' ' HB3' ' A' ' 76' ' ' ALA . 2.2 p-10 -106.06 134.55 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.971 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.72 -29.86 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.09 -41.92 99.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -102.64 -47.94 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -93.38 172.37 8.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.712 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -160.7 114.13 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.725 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 31.9 t80 -54.16 153.46 5.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' HG23 ' A' ' 122' ' ' VAL . 87.1 t -132.8 -77.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -166.02 140.61 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.736 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.85 149.47 27.12 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.89 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.93 152.63 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.339 -177.358 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -123.13 -165.37 1.31 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.898 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -90.89 -157.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -93.72 36.75 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.399 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.18 -38.73 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 106' ' ' SER . 19.8 t -86.83 149.29 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.926 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -111.28 103.11 11.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 104' ' ' VAL . 2.5 t -105.44 142.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.021 0.438 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -156.46 118.84 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.305 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.725 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.95 -178.9 4.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.413 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -157.31 107.85 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.0 111.54 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 17.8 tttt -54.53 95.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.0 tp -78.12 -27.11 14.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.833 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -165.3 -166.78 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -86.71 134.68 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.28 29.38 60.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 100' ' ' VAL . 3.0 ptpt -173.62 121.36 0.33 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 120.941 0.4 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 95' ' ' ILE . 11.8 m -150.07 155.51 7.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.665 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.563 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 6.9 ttp180 -93.3 151.87 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.28 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.4 p -123.67 129.65 74.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.47 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.413 HD11 ' NZ ' ' A' ' 93' ' ' LYS . 15.8 mt -101.84 104.69 15.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.332 . . . . 0.0 110.714 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 119' ' ' ALA . 23.1 t -103.69 135.68 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.494 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -164.46 136.76 4.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.437 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 88' ' ' VAL . 88.6 p -88.2 117.26 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.41 27.71 2.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.298 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.6 p -102.41 -27.65 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.78 -16.81 23.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.315 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.43 147.62 34.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.2 Cg_exo -54.1 172.96 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.496 2.131 . . . . 0.0 112.306 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 66' ' ' TYR . 3.0 mp -59.28 128.0 84.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 118' ' ' LEU . 31.8 Cg_exo -58.54 -34.05 98.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.376 2.051 . . . . 0.0 112.11 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.56 163.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.94 15.52 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -146.83 -165.72 2.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.31 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.576 HG13 ' CA ' ' A' ' 52' ' ' GLY . 38.9 t -78.71 104.84 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.763 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -94.35 -29.56 14.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.034 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -149.56 134.14 17.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HG3' HG11 ' A' ' 117' ' ' VAL . 7.3 mtmt -126.09 101.81 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 70' ' ' LEU . 9.0 p -92.25 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.338 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.89 ' CG1' HD11 ' A' ' 83' ' ' ILE . 35.7 m -75.59 97.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.737 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.17 113.74 21.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.912 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.2 tpm_? -59.01 113.28 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.68 68.2 7.95 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.49 -6.19 59.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 109.574 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.31 123.59 2.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.578 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.697 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.6 ttmm -41.94 162.47 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.318 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.859 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.43 58.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.018 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.5 tt0 -56.22 116.05 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.119 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.88 15.89 58.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.567 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.859 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.67 66.62 0.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 110.252 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -44.49 140.55 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.264 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -126.83 128.72 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.96 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.431 ' CA ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -115.57 129.83 56.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.696 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 68' ' ' PHE . 39.5 t -106.42 95.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.609 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.9 p -100.11 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.76 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.35 21.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.995 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -61.92 105.54 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.358 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 175.13 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.355 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 149' ' ' HIS . 32.8 m -153.74 126.56 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.008 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.79 104.42 2.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.714 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 13.0 p30 -58.87 -174.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.719 0.295 . . . . 0.0 110.857 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.75 16.58 60.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.909 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.98 -32.17 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.61 -16.96 3.52 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.061 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.99 170.16 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.995 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 148' ' ' VAL . 12.1 p -120.8 125.72 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 141' ' ' VAL . 79.1 m80 -96.12 90.54 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.945 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -49.42 106.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.43 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.451 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -76.19 -146.37 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.677 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.52 41.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.716 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 1.014 HG22 HD12 ' A' ' 37' ' ' LEU . 24.0 m -161.14 153.34 20.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.434 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 8.7 tt0 -110.0 161.98 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -139.5 166.75 23.73 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.435 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.1 p -142.23 116.21 9.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.67 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -111.65 122.37 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.253 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.42 105.85 17.95 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.679 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 18.1 mt -80.49 112.45 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.597 0.713 . . . . 0.0 109.842 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -94.55 131.77 40.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.038 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.01 145.84 49.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.077 0.465 . . . . 0.0 110.957 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.81 110.65 0.45 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.628 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -98.47 175.12 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.897 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.448 ' H ' HG22 ' A' ' 164' ' ' THR . 1.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.841 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.805 0.336 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.35 152.52 5.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.549 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.28 124.61 49.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 m -131.98 -67.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -98.47 35.14 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -102.28 -176.3 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 t60 60.65 94.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -176.1 87.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -76.45 110.66 11.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -105.32 -32.43 8.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 t -146.24 119.54 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -131.25 165.57 23.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.42 -152.5 6.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mt -146.81 137.91 24.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.4 m -105.29 82.43 0.75 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -32.48 107.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.606 2.871 . . . . 0.0 113.248 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -61.3 -44.78 96.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.68 11.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -176.35 95.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.822 0.344 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -129.5 132.98 47.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.8 tpt -82.16 -31.35 30.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.45 122.05 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -161.93 -74.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.67 158.59 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.823 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mp 60.53 -176.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -99.92 80.78 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -60.41 -177.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.783 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -174.04 -169.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB1' ' OD1' ' A' ' 60' ' ' ASN . . . -177.22 78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.6 133.54 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.105 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 14.6 t -60.74 155.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -77.5 -46.85 21.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.26 114.21 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.208 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.943 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 6.7 t -162.08 136.7 6.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.138 0.494 . . . . 0.0 111.542 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 154' ' ' THR . 5.8 m -91.41 134.1 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.553 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 t -96.42 107.44 19.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.341 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.837 HD12 HG22 ' A' ' 154' ' ' THR . 3.7 mt -97.1 117.3 30.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.251 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.49 101.42 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.57 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -144.08 160.19 41.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -31.67 68.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' C ' HG12 ' A' ' 158' ' ' VAL . 11.1 mt-10 69.41 24.2 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.5 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HD21 ' A' ' 49' ' ' LEU . 6.8 tt0 -165.04 122.83 1.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.813 0.34 . . . . 0.0 111.657 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -143.34 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -67.51 132.19 47.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.573 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.0 t -32.76 132.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-O 121.549 0.69 . . . . 0.0 112.776 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.85 -24.89 30.34 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.536 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.3 171.85 8.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.746 0.307 . . . . 0.0 110.666 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -116.46 150.89 37.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.785 HD23 HG11 ' A' ' 158' ' ' VAL . 6.8 tp -130.08 142.1 50.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.862 ' HG2' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -123.51 117.05 24.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.1 p -93.55 98.65 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.19 69.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 53' ' ' VAL . 7.9 p -78.58 95.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.19 -135.1 8.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.809 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -107.51 127.37 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.553 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -94.29 -37.34 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 32' ' ' THR . 22.9 mp0 -161.07 132.21 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HG ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -162.49 91.61 0.77 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.108 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.0 p -121.46 109.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.565 ' N ' HG22 ' A' ' 31' ' ' VAL . 63.9 m-20 130.41 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.451 1.101 . . . . 0.0 111.606 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -150.41 -179.16 6.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.699 0.285 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER -126.93 85.16 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.362 . . . . 0.0 110.575 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.59 111.94 2.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.145 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.3 m-85 -115.28 -49.12 2.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.67 112.3 17.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.997 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.552 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 t80 -85.75 136.6 33.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.453 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -147.62 109.64 4.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.271 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 29.9 p90 -130.24 171.27 13.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.364 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 104.84 8.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.864 HD13 HG11 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -77.35 149.73 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.118 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -125.28 104.64 8.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HA ' HD23 ' A' ' 134' ' ' LEU . 19.1 p90 -121.33 -170.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -97.64 136.79 37.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -93.6 -26.8 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -76.54 -29.78 56.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.103 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -108.78 -49.32 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.327 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CE2' HD11 ' A' ' 160' ' ' ILE . 5.0 m-85 -93.31 -177.08 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ARG . 2.0 tt0 -170.28 108.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.806 ' HA ' HD23 ' A' ' 123' ' ' LEU . 38.9 t80 -47.47 152.73 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.399 . . . . 0.0 111.119 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.3 t -134.53 -78.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 122' ' ' VAL . 4.2 mt-10 -153.47 148.73 26.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.457 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -102.25 147.96 26.02 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.207 1.003 . . . . 0.0 111.638 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.791 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -133.78 174.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.103 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.67 -177.29 5.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HG23 ' A' ' 88' ' ' VAL . 20.1 p-10 -61.97 -161.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.713 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 36.71 1.1 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.44 -40.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.26 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG23 ' OD1' ' A' ' 85' ' ' ASP . 16.4 t -86.98 146.86 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -108.25 103.04 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.801 ' CG2' HG13 ' A' ' 104' ' ' VAL . 2.6 t -101.96 132.17 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.4 109.73 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.82 -179.23 4.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.342 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -161.11 117.92 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.387 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 tttt -54.03 113.35 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.389 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -109.49 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -158.44 172.91 17.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.839 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.85 131.91 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.25 29.47 63.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.8 ptmt -173.57 129.87 0.43 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.727 ' HA ' HG22 ' A' ' 95' ' ' ILE . 18.2 m -150.06 155.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.925 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -83.26 147.35 28.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 -178.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.1 p -130.68 129.89 64.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -111.05 109.94 20.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 90' ' ' VAL . 4.1 t -106.17 144.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.508 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.438 ' C ' HG13 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -164.38 139.78 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.305 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -88.57 104.34 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.108 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -67.75 -17.83 64.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 p -65.23 -34.81 79.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.22 -19.9 28.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.389 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.73 153.77 43.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 40.9 Cg_exo -56.72 164.8 5.43 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.629 2.219 . . . . 0.0 112.437 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 118' ' ' LEU . 2.3 mp -59.33 127.55 84.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.749 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.85 -32.14 96.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.409 2.072 . . . . 0.0 112.085 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.44 162.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 15.04 9.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.25 -164.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.218 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.841 HG11 ' HD3' ' A' ' 120' ' ' LYS . 31.0 t -78.97 104.66 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.57 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.55 -33.23 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 90' ' ' VAL . . . -168.68 133.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.319 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.841 ' HD3' HG11 ' A' ' 117' ' ' VAL . 3.9 mtmt -122.92 100.76 7.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.06 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.864 HG11 HD13 ' A' ' 70' ' ' LEU . 11.4 p -74.25 110.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 110.437 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.862 HG22 ' HG2' ' A' ' 50' ' ' GLU . 15.5 t -75.55 115.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.787 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 79' ' ' TYR . 15.9 mt -102.09 169.12 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.642 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 12.8 tpp180 -115.28 125.16 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -92.08 73.12 5.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.546 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -87.74 -5.11 58.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.435 0.636 . . . . 0.0 109.639 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.563 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 4.3 ttmm -49.74 134.2 20.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.176 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -138.69 64.29 1.49 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.47 114.42 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.151 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.51 21.25 52.07 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.814 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -71.02 66.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 0.8 OUTLIER -46.98 142.78 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.858 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -121.68 165.05 16.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.801 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.19 106.24 3.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 21.8 t -96.4 94.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.3 p -103.33 -160.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.81 19.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HD11 ' A' ' 151' ' ' ILE . 74.7 m -59.81 90.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.123 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.45 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -116.44 138.47 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.212 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 148' ' ' VAL . 10.4 p -115.01 153.29 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.03 100.19 2.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.786 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 25.9 t0 -52.51 162.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.779 0.324 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.39 -43.88 95.51 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.548 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.22 -30.85 71.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.98 -27.76 3.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.536 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.7 155.34 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 141' ' ' VAL . 12.1 p -114.43 138.63 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -110.52 96.93 6.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.56 104.99 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.159 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.39 -176.76 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.1 -158.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.577 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -154.88 175.35 32.96 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 37' ' ' LEU . 86.0 m -164.12 146.73 9.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.925 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 11.2 pt-20 -101.75 166.7 10.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.635 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -152.4 154.67 36.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.879 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.635 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.9 p -126.77 143.6 51.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.605 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.69 130.02 52.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.58 105.93 16.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 120.933 0.397 . . . . 0.0 111.011 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.8 mt -80.15 115.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.491 0.662 . . . . 0.0 109.455 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.29 128.74 48.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.116 -178.157 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.08 145.9 29.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.107 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.08 -118.47 4.47 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.524 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.39 172.77 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.946 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtp . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.805 0.336 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.92 102.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m 60.36 -178.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.26 -58.67 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -149.13 141.56 24.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -101.96 34.21 2.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -128.48 165.31 20.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -105.39 109.45 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.17 112.63 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -58.74 -28.78 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.006 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 p -151.36 131.56 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -104.91 -59.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.59 109.79 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.44 -53.71 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.74 0.305 . . . . 0.0 110.823 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.6 m -78.93 150.18 74.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -32.26 140.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.65 2.9 . . . . 0.0 113.25 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -138.49 -60.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.28 78.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.91 178.7 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.796 0.332 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -105.73 -171.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 tpt 68.59 -67.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 109.96 7.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.077 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -100.03 178.31 4.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 78.77 4.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -151.6 116.96 5.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.55 39.67 17.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.94 168.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.87 134.65 52.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.3 77.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.09 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -114.34 108.4 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 60' ' ' ASN . 24.9 t -60.68 155.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -84.44 -45.06 13.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.01 120.28 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.422 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.8 t -162.95 140.47 7.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.06 0.457 . . . . 0.0 111.421 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 154' ' ' THR . 11.2 m -97.82 129.26 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.37 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 56' ' ' ASP . 47.5 p -95.01 108.21 20.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.948 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.077 HD12 HG23 ' A' ' 154' ' ' THR . 1.4 mt -97.71 122.09 40.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.55 112.28 10.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.595 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -153.01 155.6 37.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 111.417 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.48 -29.15 66.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 69.98 23.87 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.624 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' N ' HG12 ' A' ' 158' ' ' VAL . 19.9 tt0 -164.68 128.95 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 112.112 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -134.03 171.19 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.117 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.5 tt0 -133.05 120.15 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.0 t -28.72 132.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 121.576 0.703 . . . . 0.0 112.381 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.05 49.55 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.28 174.92 10.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.515 0.326 . . . . 0.0 110.15 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -127.42 147.93 50.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.875 0.369 . . . . 0.0 110.986 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -102.52 164.12 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 122' ' ' VAL . 11.6 mt-10 -130.0 93.32 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.682 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 p -103.16 97.9 6.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -91.48 85.2 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.258 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 136' ' ' VAL . 3.5 p -78.55 95.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 110.086 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -96.37 -134.9 8.2 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.499 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -103.08 134.63 43.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 111.606 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 22.1 t0 -103.28 -34.32 8.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.425 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 32' ' ' THR . 4.0 mp0 -165.54 134.05 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.926 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 141' ' ' VAL . 1.6 tt -162.27 91.61 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.759 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 59' ' ' VAL . 11.9 p -119.31 103.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 35.2 m-20 133.1 24.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.262 1.025 . . . . 0.0 111.413 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -160.6 171.95 18.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -121.19 86.05 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.716 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.59 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -62.5 133.52 55.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 12.7 m-85 -127.63 -42.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.04 112.44 15.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.752 ' O ' HG22 ' A' ' 104' ' ' VAL . 5.4 t80 -85.98 100.66 12.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -109.33 112.44 24.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 50.4 p90 -142.97 171.54 13.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.8 t -128.48 121.29 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 ' CG1' ' A' ' 121' ' ' VAL . 7.2 tt -95.03 126.34 40.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -98.32 106.59 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.455 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 50.0 p90 -107.13 -169.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.702 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.69 120.27 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -29.46 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -27.42 69.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.704 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -125.95 -44.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.384 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.8 OUTLIER -93.14 161.06 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -145.65 130.39 18.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD1' HG21 ' A' ' 100' ' ' VAL . 19.5 t80 -55.02 149.13 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 55.7 t -132.16 -85.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 122' ' ' VAL . 58.1 mm-40 -160.4 135.84 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.88 150.58 26.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.147 0.975 . . . . 0.0 111.393 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.682 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -120.19 153.29 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.571 -177.17 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -117.25 -165.89 1.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.714 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.5 -157.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.618 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.6 37.15 1.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.863 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.67 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.169 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 89' ' ' PHE . 40.5 t -86.74 158.85 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.2 t80 -112.36 125.38 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.952 HG22 ' CG1' ' A' ' 104' ' ' VAL . 3.5 t -122.57 135.93 61.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -149.33 120.53 7.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.612 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.96 156.77 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 107.25 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.174 0.512 . . . . 0.0 111.337 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.3 ttpt -55.1 95.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.5 tp -82.73 -22.21 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.765 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.8 -166.74 0.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.81 133.18 33.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.87 29.56 62.0 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' C ' HG13 ' A' ' 100' ' ' VAL . 13.3 ptpt -173.26 121.59 0.36 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 95' ' ' ILE . 7.1 m -149.91 154.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.676 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.09 152.16 22.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.204 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 8.6 p -126.45 93.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.15 111.0 17.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.952 ' CG1' HG22 ' A' ' 90' ' ' VAL . 4.2 m -117.25 158.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.022 0.439 . . . . 0.0 111.804 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -164.49 136.09 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.265 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -79.01 113.67 17.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 31.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.983 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.2 p -109.65 -34.64 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.48 -21.84 11.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.142 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -91.17 155.69 44.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.757 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 59.1 Cg_endo -72.4 174.5 11.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.481 2.121 . . . . 0.0 112.476 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 114' ' ' ALA . 4.0 tt -54.49 107.55 0.9 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.86 -32.11 94.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.344 2.029 . . . . 0.0 111.926 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.733 ' H ' HD23 ' A' ' 112' ' ' LEU . . . 59.77 170.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.168 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.6 16.15 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.087 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -148.26 -179.85 7.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.0 t -70.95 105.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.649 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 114' ' ' ALA . 2.3 mm? -87.56 -31.55 19.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.214 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -166.11 131.0 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.679 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -119.89 118.6 31.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.9 ' CG1' HD13 ' A' ' 70' ' ' LEU . 7.1 p -97.98 94.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.182 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 81' ' ' GLU . 21.5 m -75.63 118.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 134' ' ' LEU . 2.4 mm? -92.24 169.2 10.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.0 tpm_? -105.51 118.25 36.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -90.86 71.07 6.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.785 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.36 -4.3 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.96 124.31 2.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.042 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.669 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 3.1 ptmt -40.6 163.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.704 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -178.2 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.971 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 pt-20 -55.63 112.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.408 ' O ' ' ND2' ' A' ' 133' ' ' ASN . . . 105.69 4.14 39.85 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.647 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -62.84 87.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.932 0.396 . . . . 0.0 110.24 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.798 ' C ' HD12 ' A' ' 134' ' ' LEU . 1.7 m-80 -60.49 166.68 2.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 133' ' ' ASN . 9.5 mp -140.13 104.84 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.649 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.41 130.14 45.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.227 0.537 . . . . 0.0 112.093 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 53' ' ' VAL . 30.6 m -115.4 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.17 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 -167.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.547 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.41 29.87 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.449 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB3' HD11 ' A' ' 151' ' ' ILE . 50.6 m -62.34 89.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.034 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.95 171.66 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.357 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.013 HG21 HD11 ' A' ' 58' ' ' LEU . 15.4 m -147.33 122.46 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 99.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 46.4 t0 -56.41 162.53 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.41 -29.16 70.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.61 -49.05 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.6 -28.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.392 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.33 170.2 16.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.23 153.39 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -123.03 94.82 4.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.23 104.97 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.503 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.53 -176.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -67.93 -160.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -159.78 175.54 36.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 1.077 HG23 HD12 ' A' ' 37' ' ' LEU . 1.3 t -162.93 -170.91 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.849 -0.207 . . . . 0.0 110.574 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -151.21 152.06 32.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.198 0.523 . . . . 0.0 112.061 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 37' ' ' LEU . 4.1 tppt? -129.34 169.26 15.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.867 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.01 144.38 32.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.59 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -134.24 126.37 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -90.35 116.13 28.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.775 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 77' ' ' PHE . 4.6 mt -85.56 116.66 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.69 -178.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.89 146.6 51.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.016 0.436 . . . . 0.0 111.016 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.94 161.78 35.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -50.12 177.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.362 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.479 ' N ' ' OG1' ' A' ' 164' ' ' THR . 67.1 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.99 158.13 53.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -106.34 178.24 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.99 99.67 3.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.75 143.3 30.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -135.8 178.26 7.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.41 156.87 28.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -172.29 -53.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -132.15 124.29 28.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 60.24 -176.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -140.66 -60.3 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t 60.38 88.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.61 82.88 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 15' ' ' VAL . 5.0 mp -124.35 -44.42 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 14' ' ' LEU . 13.3 t -159.46 -64.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' CD ' ' HB ' ' A' ' 15' ' ' VAL . 94.5 Cg_exo -32.11 123.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.31 2.673 . . . . 0.0 113.289 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -62.8 -58.11 8.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.24 168.74 24.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 -31.36 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m170 60.35 35.74 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -76.94 81.51 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.85 112.52 1.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.17 -59.1 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' HD22 ' A' ' 25' ' ' LEU . 1.6 mptm? -113.13 80.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 24' ' ' LYS . 4.4 mm? -119.4 -44.25 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -151.34 -47.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 60.49 166.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.59 165.99 21.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.54 31.66 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -81.01 122.63 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 61' ' ' ALA . 12.3 t -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' GLY . 6.7 t -80.42 -32.27 37.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.43 120.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.596 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.602 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 28.6 t -149.94 155.01 39.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.277 0.56 . . . . 0.0 111.944 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -108.06 123.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -92.13 107.38 19.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 154' ' ' THR . 1.9 mt -97.16 126.59 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.27 101.42 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.734 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -146.2 154.56 41.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.346 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.57 -26.62 61.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.58 23.53 7.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.424 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 158' ' ' VAL . 27.0 tt0 -164.7 126.55 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 160' ' ' ILE . 3.6 p -128.62 171.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.493 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -133.83 113.4 12.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.512 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.8 t -28.37 114.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 125.06 -25.6 5.75 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.884 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.8 -175.52 2.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.913 0.387 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -114.9 167.74 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.747 HD11 HG11 ' A' ' 158' ' ' VAL . 1.3 tp -114.74 159.43 20.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.469 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.8 m -105.54 98.05 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.476 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.785 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.1 71.48 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.153 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.68 HG21 HG11 ' A' ' 136' ' ' VAL . 8.2 p -78.22 97.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.965 0.412 . . . . 0.0 110.872 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.35 -128.47 5.79 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.852 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -112.05 134.8 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.037 0.446 . . . . 0.0 111.431 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.02 -33.05 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.234 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 3.4 pt-20 -174.46 130.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.642 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -152.61 91.67 1.59 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.093 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 31' ' ' VAL . 10.6 p -100.11 117.82 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 31' ' ' VAL . 19.9 m120 100.78 22.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.596 0.758 . . . . 0.0 112.352 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.851 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -142.69 138.59 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.8 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.1 mp0 -102.19 87.18 3.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -62.2 112.12 2.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.42 -32.06 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.63 111.96 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.666 ' HD1' HG12 ' A' ' 141' ' ' VAL . 0.8 OUTLIER -87.45 136.5 32.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.341 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' OD2' HD23 ' A' ' 103' ' ' LEU . 8.3 t0 -147.83 109.86 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.314 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.703 ' CD1' HG13 ' A' ' 136' ' ' VAL . 5.0 p90 -125.0 171.12 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.375 . . . . 0.0 111.352 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 115.56 17.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.587 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 136' ' ' VAL . 10.5 tp -77.3 141.45 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.257 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -119.96 104.59 10.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.568 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.426 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 50.3 p90 -133.0 -170.87 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.82 132.43 54.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -27.39 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -56.31 -30.04 62.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.35 -48.15 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.17 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.38 178.9 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -171.7 119.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.734 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 15.2 t80 -54.54 156.02 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.714 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 122' ' ' VAL . 58.4 t -130.46 -84.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 14.2 pt-20 -153.07 132.14 12.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.83 150.19 26.72 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.141 0.972 . . . . 0.0 111.649 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.543 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.99 152.38 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.353 -177.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.6 ' HB2' HG23 ' A' ' 88' ' ' VAL . 51.9 p -115.07 -168.41 1.38 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.852 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -93.87 -160.12 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.86 37.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.29 -42.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.167 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 106' ' ' SER . 28.3 m -96.08 173.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.336 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 156.82 26.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.575 HG13 ' CG2' ' A' ' 102' ' ' VAL . 21.5 t -147.85 123.94 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -134.01 110.78 9.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.028 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.734 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.15 131.02 44.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.311 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -118.84 108.04 14.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HA ' HG23 ' A' ' 100' ' ' VAL . 12.8 tttt -70.51 97.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.831 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -78.1 -0.06 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.12 -168.76 0.08 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.35 115.39 27.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 79.92 38.72 18.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.075 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -172.68 123.42 0.44 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 94' ' ' LYS . 12.4 p -151.61 131.86 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.593 -174.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 15.7 ttp180 -101.28 151.97 21.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.848 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.575 ' CG2' HG13 ' A' ' 90' ' ' VAL . 12.8 p -123.59 157.29 29.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 111.824 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.495 HD23 ' OD2' ' A' ' 67' ' ' ASP . 84.8 mt -123.56 106.94 11.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.525 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 118' ' ' LEU . 11.1 t -105.27 143.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 111.686 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 p -164.29 136.17 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.767 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -89.08 112.22 23.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 111.258 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mt -93.77 31.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.929 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -109.7 -30.92 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.968 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.65 -20.67 11.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.223 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -94.43 155.93 39.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.615 0.245 . . . . 0.0 110.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 177.07 7.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.574 2.183 . . . . 0.0 112.547 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -56.72 119.15 27.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.901 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.62 -42.41 39.95 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.931 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.765 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 66.08 163.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.29 15.49 10.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.271 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.2 -169.76 3.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.284 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.785 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.6 t -74.04 104.92 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -96.81 -28.79 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -155.16 129.4 8.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -118.96 101.01 7.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.534 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.6 p -95.8 97.97 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 81' ' ' GLU . 20.2 m -75.51 124.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.067 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.733 ' CD2' HD21 ' A' ' 134' ' ' LEU . 4.2 mp -95.33 169.19 10.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.792 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.474 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -111.28 120.4 42.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.492 . . . . 0.0 112.069 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -89.72 69.52 7.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.991 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.5 -9.51 47.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.34 0.591 . . . . 0.0 109.623 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.49 124.3 3.1 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.736 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.691 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.4 ttpp -43.66 155.24 0.08 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.433 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.771 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -165.82 59.51 0.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.892 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.53 116.27 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.188 -179.111 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.7 18.56 51.26 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.334 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.771 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.55 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.939 0.399 . . . . 0.0 110.456 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.96 133.93 4.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.255 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.733 HD21 ' CD2' ' A' ' 123' ' ' LEU . 1.2 mp -116.42 118.31 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.1 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 p -99.6 124.15 44.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.553 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.775 HG22 HD12 ' A' ' 70' ' ' LEU . 25.0 t -110.22 95.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.546 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -111.98 -159.78 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.761 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.56 20.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.601 ' CB ' HD11 ' A' ' 151' ' ' ILE . 26.9 m -68.05 92.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.26 163.85 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.39 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.666 HG12 ' HD1' ' A' ' 66' ' ' TYR . 27.6 m -139.07 130.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.68 82.84 0.93 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 9.1 t70 -55.18 139.96 40.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.76 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.2 -38.39 25.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.06 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -53.51 -26.58 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.56 10.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.668 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.18 170.15 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 148' ' ' VAL . 10.9 p -120.51 122.98 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 5.3 m-70 -92.74 99.62 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.081 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.33 110.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' A' ' 139' ' ' SER . 0.3 OUTLIER -84.23 171.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.208 0.528 . . . . 0.0 111.922 -178.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.4 -146.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.487 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.55 167.44 37.73 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.518 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.83 HG22 HD12 ' A' ' 37' ' ' LEU . 9.5 m -168.14 148.74 4.95 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -118.6 179.12 4.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.622 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.64 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppt? -144.7 168.85 19.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.0 p -142.12 115.78 9.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -114.68 122.12 68.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.291 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -89.3 112.34 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.555 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.822 HG23 HG13 ' A' ' 43' ' ' VAL . 2.4 mt -81.62 120.65 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.375 0.607 . . . . 0.0 109.634 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.49 131.25 55.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.922 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.74 146.06 47.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.094 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -160.97 -109.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.489 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -62.83 174.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.462 ' H ' HG22 ' A' ' 164' ' ' THR . 5.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.734 0.302 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.07 39.21 5.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.8 p -84.37 130.36 34.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.992 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -153.82 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -169.44 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -147.01 169.1 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -98.88 139.84 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.67 163.31 34.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -155.33 31.69 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -159.53 120.82 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.45 -175.59 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 m -155.4 159.12 39.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.87 46.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.53 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mt -135.75 163.92 29.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.0 m -106.71 150.17 39.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.27 -50.68 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.591 2.86 . . . . 0.0 113.318 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -131.87 134.04 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.53 37.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.98 -47.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -66.48 179.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.33 93.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.27 149.97 43.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.064 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -146.03 168.07 21.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.31 -64.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -136.32 126.54 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.429 ' N ' HD23 ' A' ' 25' ' ' LEU . 14.4 tttt -140.14 -67.67 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.931 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.25 -176.88 4.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.77 172.02 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.21 55.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -80.81 122.34 27.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.749 HG11 HD23 ' A' ' 58' ' ' LEU . 72.5 t -68.03 153.25 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.683 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.4 t -62.91 -43.09 99.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.376 0.607 . . . . 0.0 109.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 65.66 104.71 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.536 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.904 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -162.35 133.73 5.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.419 0.628 . . . . 0.0 112.105 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 151' ' ' ILE . 23.2 m -91.68 143.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.546 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.0 t -93.9 111.63 23.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.796 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -97.08 120.51 37.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.141 0.496 . . . . 0.0 111.596 -179.116 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -141.22 129.93 22.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.59 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -176.06 155.38 1.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -29.22 68.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.354 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.4 mt-10 72.45 24.7 2.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.62 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' CG ' HD11 ' A' ' 161' ' ' ILE . 2.3 tt0 -164.82 128.15 2.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 0.0 112.013 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -143.97 107.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.332 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -69.91 127.71 33.81 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.8 t -29.26 131.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 112.727 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.14 -18.54 56.52 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.422 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.54 172.89 6.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.776 0.322 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.39 149.1 47.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.662 HD22 HG11 ' A' ' 158' ' ' VAL . 3.1 pp -102.56 164.28 11.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HA ' HG12 ' A' ' 122' ' ' VAL . 40.1 tt0 -135.69 93.88 3.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -103.82 98.02 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.91 80.6 1.82 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 136' ' ' VAL . 14.9 p -78.35 97.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.172 0.51 . . . . 0.0 110.754 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -101.74 -128.7 6.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.96 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -110.68 131.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.605 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.8 t0 -100.68 -36.41 9.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HB3' HG21 ' A' ' 32' ' ' THR . 21.4 mt-10 -158.21 131.57 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.651 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.749 HD23 HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -163.34 91.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.246 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.708 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.32 107.84 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.554 ' CA ' HG22 ' A' ' 31' ' ' VAL . 64.2 m-20 130.22 20.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.55 1.14 . . . . 0.0 111.637 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -155.69 165.82 35.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.771 0.319 . . . . 0.0 110.795 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.52 85.11 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.62 120.24 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 5.5 m-85 -112.71 -30.92 6.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.74 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.42 112.5 7.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' O ' HG22 ' A' ' 104' ' ' VAL . 1.1 t80 -85.69 132.82 34.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.46 110.01 4.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.648 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 10.0 p90 -127.84 171.12 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.137 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 101' ' ' ARG . 0.3 OUTLIER -128.77 113.03 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.789 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 HG11 ' A' ' 121' ' ' VAL . 7.9 tt -92.77 153.36 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.003 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 70' ' ' LEU . 7.2 m120 -123.16 137.97 54.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.763 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 46.1 p90 -140.46 -175.28 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.92 120.21 40.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -78.32 -3.78 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.35 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.1 20.8 8.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.855 0.36 . . . . 0.0 111.1 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.813 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.58 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.584 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.783 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -107.17 155.27 20.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.5 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -151.88 131.11 12.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.763 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.0 t80 -53.15 150.84 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.726 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 122' ' ' VAL . 47.6 t -126.62 -84.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 122' ' ' VAL . 3.5 mt-10 -157.91 132.49 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.73 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.87 145.65 29.33 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.176 0.988 . . . . 0.0 111.437 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -126.44 154.8 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.56 -1.654 . . . . 0.0 112.64 -177.164 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.827 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -120.09 -165.09 1.14 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.77 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -91.0 -158.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.11 37.15 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 -38.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.01 155.51 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -112.41 112.79 24.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.874 HG22 HG12 ' A' ' 104' ' ' VAL . 3.6 t -101.95 155.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 22.1 t-20 -164.12 109.29 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.763 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.5 140.07 32.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.202 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -120.38 108.43 14.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.71 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.03 -29.17 43.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.987 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 178.16 -168.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.205 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.41 123.51 24.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 64.16 41.05 98.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.184 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.38 127.33 0.54 Allowed 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 79' ' ' TYR . 10.3 p -151.88 136.17 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.3 tpp85 -107.28 152.2 24.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.365 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 13.9 p -129.89 146.32 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.431 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.3 mt -131.69 98.39 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.316 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 90' ' ' VAL . 1.3 m -98.12 160.73 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.419 . . . . 0.0 111.655 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 p -163.86 135.4 4.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.324 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p -77.19 110.68 12.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.305 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.8 tp -92.87 29.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.956 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 p -108.94 -27.2 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.971 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.25 -18.02 12.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.225 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -101.84 157.11 34.31 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.28 . . . . 0.0 110.719 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 62.3 Cg_endo -73.5 -175.54 2.09 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.537 2.158 . . . . 0.0 112.459 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.704 ' CD2' HD21 ' A' ' 118' ' ' LEU . 1.3 tt -56.52 114.53 7.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.91 -39.54 32.46 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.563 2.176 . . . . 0.0 112.126 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 67.71 168.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.56 15.81 10.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.127 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.62 -168.54 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.414 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.2 t -76.87 105.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.785 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.24 -32.66 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -168.03 131.42 1.6 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.754 0.312 . . . . 0.0 111.262 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -115.62 113.93 24.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.481 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.9 HG11 HD13 ' A' ' 70' ' ' LEU . 7.2 p -97.52 95.08 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.233 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 81' ' ' GLU . 26.0 m -75.6 115.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.841 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.677 ' CD2' HD21 ' A' ' 134' ' ' LEU . 3.6 mm? -83.6 169.33 15.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.954 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -108.74 124.9 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.999 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -100.47 69.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.782 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -5.45 55.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.483 0.659 . . . . 0.0 109.448 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.69 124.27 2.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.453 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.9 ttpt -44.11 135.02 4.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.562 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.813 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -144.27 59.77 1.35 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.852 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 133' ' ' ASN . . . 98.93 -5.28 59.53 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.55 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.787 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.1 m -56.25 91.32 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.321 . . . . 0.0 110.543 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 134' ' ' LEU . 2.2 m-80 -65.27 160.04 22.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.194 0.521 . . . . 0.0 111.499 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 133' ' ' ASN . 4.7 mp -137.08 104.3 5.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.612 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.2 p -102.37 125.45 49.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 53' ' ' VAL . 19.5 m -111.32 94.95 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.3 p -99.05 -161.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.24 19.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 151' ' ' ILE . 66.6 m -60.26 101.32 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.14 173.1 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.427 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.719 HG21 HD11 ' A' ' 58' ' ' LEU . 3.4 m -147.95 127.23 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.34 97.89 0.89 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.26 161.57 1.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.95 -34.95 91.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.45 -31.59 68.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.99 -31.96 2.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.436 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -69.14 170.08 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.36 150.53 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -121.77 95.16 4.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.157 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -55.85 105.56 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.552 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.38 -176.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.331 0.586 . . . . 0.0 111.742 -179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -65.68 -156.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.49 166.97 36.16 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.667 ' HB ' HD23 ' A' ' 37' ' ' LEU . 14.9 m -163.14 155.68 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -126.58 173.08 9.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.316 0.579 . . . . 0.0 112.088 -179.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.796 ' HE2' HD12 ' A' ' 37' ' ' LEU . 1.4 tppt? -139.56 168.7 19.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -143.09 116.33 8.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.662 HG11 HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -104.73 130.47 55.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.484 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.58 18.7 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.414 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.1 mt -78.89 119.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.44 0.638 . . . . 0.0 109.712 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.506 HD11 ' CG ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.5 136.96 33.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.82 145.03 53.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 111.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.97 150.01 19.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.509 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -133.36 173.9 10.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.0 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.488 ' H ' HG22 ' A' ' 164' ' ' THR . 2.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.793 0.33 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.42 47.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.4 p -77.59 113.68 15.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 111.003 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -144.13 172.11 13.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -171.54 -42.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -92.77 179.67 5.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -135.89 115.09 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -69.15 -68.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -150.58 103.64 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -140.03 82.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 m -106.48 152.96 22.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -139.51 174.94 10.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.52 -76.77 1.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tt 60.73 44.95 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 21.2 t -58.14 -52.76 72.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.49 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 71.6 Cg_exo -32.3 132.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.309 2.673 . . . . 0.0 113.315 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 mtt-85 -84.5 -178.7 6.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.97 107.93 2.16 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -134.66 164.07 28.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -106.61 -178.51 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtt -97.44 96.68 8.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.2 137.15 14.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.26 124.12 49.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -41.4 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD13 ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -90.41 114.6 26.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' HD13 ' A' ' 25' ' ' LEU . 18.3 mmtt -60.43 157.32 14.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.16 -171.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.98 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.63 122.47 8.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.26 39.75 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.12 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -77.96 135.7 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 60' ' ' ASN . 61.5 t -89.72 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.444 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -73.06 -42.54 62.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 59.1 110.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.286 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.502 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 30.6 t -150.11 140.01 21.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.731 0.777 . . . . 0.0 111.956 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -93.36 144.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.066 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -103.07 107.55 18.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.756 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.871 HD12 HG22 ' A' ' 154' ' ' THR . 6.0 mt -96.88 112.51 24.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -136.25 117.42 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -166.8 164.2 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.307 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -68.33 -29.51 68.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.486 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 1.2 mt-10 66.71 33.36 6.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -164.22 120.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 111.772 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.0 p -127.79 167.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.564 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.6 tm0? -130.46 118.27 20.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.2 t -28.55 131.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 121.575 0.703 . . . . 0.0 112.355 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.48 13.19 61.83 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.618 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -132.08 174.61 10.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.497 0.319 . . . . 0.0 110.238 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -123.59 149.27 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.861 0.363 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.717 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -112.18 160.05 17.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -136.14 93.76 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p -103.27 97.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.6 96.33 1.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.927 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 53' ' ' VAL . 10.2 p -87.18 95.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.46 -137.4 9.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.83 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.727 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -108.04 134.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 0.0 111.641 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.11 -33.44 11.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.7 mp0 -168.39 134.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.6 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -153.83 90.99 1.42 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.358 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.641 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.2 p -110.12 116.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.0 m-20 102.34 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.843 0.857 . . . . 0.0 111.932 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -169.52 143.05 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 82.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.75 111.77 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.655 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -100.74 -34.33 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.745 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.02 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.064 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 20.1 t80 -108.88 94.84 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -100.11 110.27 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.199 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.862 ' O ' HG12 ' A' ' 102' ' ' VAL . 14.6 p90 -102.3 171.4 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.42 . . . . 0.0 111.549 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 m -135.85 100.95 4.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.488 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 121' ' ' VAL . 8.7 tt -79.43 154.54 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.225 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.467 ' N ' HD23 ' A' ' 70' ' ' LEU . 5.6 m120 -123.58 104.32 8.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.438 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.1 p90 -114.59 -167.3 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.959 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.32 123.94 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.4 -30.45 53.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -63.8 -30.97 72.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.027 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.75 -50.93 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -93.33 -176.97 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 109.65 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.99 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.533 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.6 t80 -51.96 147.77 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 122' ' ' VAL . 39.3 t -132.3 -74.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.829 ' O ' HG22 ' A' ' 122' ' ' VAL . 5.9 mt-10 -166.91 140.01 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.1 151.97 25.52 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 122.195 0.997 . . . . 0.0 111.525 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.15 174.39 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.375 -1.739 . . . . 0.0 112.167 -177.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -144.7 -165.69 2.21 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -93.99 -158.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.36 36.68 1.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.882 0.373 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.94 -42.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.117 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 105' ' ' SER . 13.0 t -89.98 148.42 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -103.15 137.69 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.44 HG13 ' CG2' ' A' ' 102' ' ' VAL . 25.1 t -133.7 144.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -155.33 116.99 4.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.568 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.53 157.05 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -141.05 107.26 5.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 22.3 tttt -55.11 115.01 1.99 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.2 tp -109.81 -25.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.881 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -160.1 165.69 31.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -66.87 128.69 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 62.73 30.69 77.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' C ' HG13 ' A' ' 100' ' ' VAL . 20.9 ptmt -173.77 122.86 0.34 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.907 0.384 . . . . 0.0 110.058 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.675 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 12.9 m -150.09 155.57 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 152.37 20.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.4 p -127.97 139.94 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.89 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.57 107.27 16.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 118' ' ' LEU . 4.6 t -106.88 147.0 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.56 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.45 ' C ' HG13 ' A' ' 88' ' ' VAL . 22.1 p -164.49 136.1 4.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.504 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 88' ' ' VAL . 93.7 p -83.99 104.88 14.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -94.94 31.15 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.152 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -99.02 -33.1 10.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.12 -25.1 6.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.307 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.57 155.07 41.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.845 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.36 173.67 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.58 2.187 . . . . 0.0 112.376 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.733 ' HG ' HD11 ' A' ' 118' ' ' LEU . 1.6 mp -58.89 116.87 17.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.12 -30.08 89.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.353 2.035 . . . . 0.0 111.844 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.727 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 56.49 169.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.278 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.15 17.86 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.08 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.02 -164.44 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.556 HG11 ' HE3' ' A' ' 120' ' ' LYS . 21.5 t -80.36 104.62 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.914 0.388 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.733 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -92.43 -32.84 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -172.69 132.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.31 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.818 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -122.66 132.09 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.556 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 70' ' ' LEU . 11.8 p -104.47 118.43 51.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.367 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.846 ' CG1' HD11 ' A' ' 83' ' ' ILE . 20.2 m -92.89 118.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.7 109.88 21.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.98 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.0 tpp85 -55.17 117.45 3.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.89 71.76 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.531 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.9 -3.28 58.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.538 0.685 . . . . 0.0 109.41 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.43 123.14 2.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.206 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.627 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.8 ttpm? -46.02 157.55 0.12 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.259 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.027 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -169.77 59.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.773 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.8 OUTLIER -56.16 116.03 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.937 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.87 21.61 49.56 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.261 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.752 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -68.14 70.91 0.16 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.044 0.45 . . . . 0.0 110.377 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 1.7 t-20 -43.8 121.87 2.55 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.643 HD23 HD11 ' A' ' 70' ' ' LEU . 5.8 mp -116.22 161.07 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.159 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 150.41 26.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.346 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 68' ' ' PHE . 15.2 t -123.33 95.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.7 p -101.55 -166.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.94 22.86 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -65.17 107.07 1.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.84 0.352 . . . . 0.0 110.523 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.95 171.26 7.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.44 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 58' ' ' LEU . 11.3 m -144.69 132.26 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.703 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.71 96.38 1.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.898 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -55.98 161.82 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.767 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.37 -27.94 73.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -74.48 -47.59 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.96 -25.75 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.58 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.52 158.01 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.993 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 148' ' ' VAL . 14.6 p -115.89 115.01 47.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -87.5 93.19 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -48.3 108.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.238 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.535 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.35 166.58 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.27 0.557 . . . . 0.0 111.738 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -59.5 -144.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.327 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 35' ' ' VAL . . . -170.81 -177.21 40.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.108 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.871 HG22 HD12 ' A' ' 37' ' ' LEU . 25.4 m -161.24 148.95 15.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.723 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 15.6 tt0 -102.01 158.14 16.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.276 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.793 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppp? -151.28 164.23 37.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.555 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.628 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 4.0 p -142.62 153.91 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.768 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.05 133.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.849 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -99.42 115.03 28.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.159 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.8 mt -86.76 118.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -100.66 128.35 52.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.194 -178.007 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -55.96 146.63 21.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.182 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.74 -80.68 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.494 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 165' ' ' SER . 7.8 t -80.03 -143.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.495 ' N ' ' OG1' ' A' ' 164' ' ' THR . 29.1 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.358 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 61' ' ' ALA . 21.8 t -94.2 146.38 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 57' ' ' GLU . 12.6 t -68.1 -36.3 79.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.44 109.24 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.159 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.651 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 3.2 m -151.32 141.23 21.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.522 0.677 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.9 m -95.82 143.3 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.693 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -102.8 105.2 15.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.035 178.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 156' ' ' LYS . 12.1 tp -109.02 125.21 51.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.6 tt0 -140.22 121.91 15.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.019 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -149.32 162.76 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.382 . . . . 0.0 111.68 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -70.71 -28.91 65.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 74.24 24.26 1.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.656 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 7.7 tt0 -164.92 128.28 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.2 p -146.14 107.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.131 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.58 126.83 30.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.178 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.27 124.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 113.85 -19.2 18.73 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.684 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 43' ' ' VAL . 2.9 tt0 -110.42 173.11 6.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.662 0.267 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -114.53 167.62 10.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.741 ' O ' HG12 ' A' ' 122' ' ' VAL . 18.1 mt -108.8 161.43 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -136.08 93.71 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.564 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 39' ' ' ALA . 7.9 m -105.06 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.455 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.791 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.41 72.98 1.87 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.176 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -78.38 99.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.957 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.76 -118.42 3.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.782 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -120.4 135.14 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.014 0.435 . . . . 0.0 111.921 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -36.47 7.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 32' ' ' THR . 81.8 mm-40 -158.99 131.34 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.323 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -154.12 90.62 1.37 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.463 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.774 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.7 p -111.39 114.83 48.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.6 m-20 102.68 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.055 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -145.93 133.63 21.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.777 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.6 tp10 -100.82 86.16 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.582 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.091 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.5 125.83 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.519 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 3.5 m-85 -118.41 -37.85 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.487 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.24 112.79 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.994 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 2.6 t80 -85.75 135.77 33.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 111.508 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -148.06 110.01 4.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.275 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.6 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 11.7 p90 -128.04 171.42 11.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.429 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.72 101.14 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.687 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.796 HD21 HD22 ' A' ' 134' ' ' LEU . 8.0 tt -77.21 153.66 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.923 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.26 114.34 20.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.668 ' HA ' HD23 ' A' ' 134' ' ' LEU . 37.2 p90 -122.83 -172.37 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.13 126.17 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -82.47 -32.19 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -74.99 -29.75 60.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.881 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -107.39 -52.81 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 160' ' ' ILE . 4.7 m-85 -93.43 171.91 8.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.3 115.75 4.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.71 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.601 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.7 t80 -48.42 148.65 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' A' ' 122' ' ' VAL . 48.7 t -130.6 -84.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.871 ' O ' HG22 ' A' ' 122' ' ' VAL . 24.7 mm-40 -157.37 138.65 13.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.197 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.7 153.77 25.17 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.217 1.008 . . . . 0.0 111.757 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.877 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.49 174.7 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.218 -177.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.473 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -154.66 -165.64 2.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.71 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -161.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -95.59 37.77 1.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.53 -39.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.57 HG13 ' C ' ' A' ' 105' ' ' SER . 21.7 t -86.96 140.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.924 0.393 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -97.14 118.66 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.026 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 104' ' ' VAL . 6.3 t -116.83 129.96 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -137.23 120.0 16.26 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.63 148.34 22.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.087 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -131.84 106.69 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.676 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -55.02 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.137 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.9 tp -83.0 -25.12 8.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.836 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -165.33 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 61.15 32.13 79.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.452 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.418 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.51 120.8 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.823 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.24 155.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -97.05 152.53 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.928 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.6 p -126.66 146.83 31.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.445 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 59.6 mt -115.74 107.41 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.757 HG11 ' CD1' ' A' ' 118' ' ' LEU . 9.9 t -104.77 140.92 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 111.543 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.57 ' C ' HG13 ' A' ' 88' ' ' VAL . 1.8 p -164.48 136.89 4.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -83.5 111.24 18.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.212 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -93.55 28.8 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.125 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.7 p -104.04 -27.97 11.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.04 6.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.217 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.34 158.55 35.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 37.2 Cg_endo -66.0 164.14 28.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.532 2.155 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.091 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -55.25 131.78 69.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.424 ' O ' HD23 ' A' ' 118' ' ' LEU . 96.3 Cg_endo -86.81 145.17 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -97.45 168.75 10.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.92 35.11 13.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.14 157.79 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.611 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.791 HG13 ' HA3' ' A' ' 52' ' ' GLY . 36.6 t -50.86 105.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.757 ' CD1' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.54 -30.93 18.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -176.21 157.71 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.733 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.736 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -153.84 131.94 11.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.574 ' O ' HD22 ' A' ' 123' ' ' LEU . 95.3 t -104.62 105.03 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.628 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.877 ' CG1' HD11 ' A' ' 83' ' ' ILE . 26.0 m -75.22 109.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.874 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 121' ' ' VAL . 2.8 mm? -83.15 169.13 16.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 1.7 tpm_? -110.86 118.87 37.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -86.49 67.27 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.243 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.88 -4.76 59.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.45 123.72 2.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.491 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -39.66 160.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.606 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.41 60.8 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.767 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.51 119.74 6.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.286 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 133' ' ' ASN . . . 86.3 13.18 68.83 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.648 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.813 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -69.08 69.93 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.545 ' HB3' HG22 ' A' ' 157' ' ' THR . 2.0 p-10 -59.56 146.29 41.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.448 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -117.46 165.11 13.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.857 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.5 115.51 9.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.0 111.178 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 53' ' ' VAL . 2.6 m -96.15 95.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.478 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -111.67 -163.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.704 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.89 21.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -69.22 96.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -94.87 -178.53 4.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 111.366 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.8 m -156.68 141.66 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 88.38 1.5 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.326 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.42 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 14.4 t0 -52.92 160.61 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.67 76.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.584 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -55.72 -26.73 46.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 111.053 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.96 23.18 5.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mt -117.73 170.04 9.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 140' ' ' SER . 77.5 t -109.12 142.23 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 143' ' ' ASP . 55.8 m80 -119.38 92.39 3.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -48.62 97.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.33 164.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.163 0.506 . . . . 0.0 111.69 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.56 -148.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.551 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -170.4 174.58 44.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.468 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.749 HG22 HD23 ' A' ' 37' ' ' LEU . 52.2 m -145.44 162.36 37.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 110.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -123.54 154.07 39.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.973 0.416 . . . . 0.0 111.152 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -132.22 164.08 27.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.936 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 133' ' ' ASN . 1.2 p -141.77 115.57 9.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.983 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.35 135.74 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.412 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -105.32 108.19 19.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -82.99 116.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -98.46 139.78 19.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.92 145.69 55.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 0.0 111.139 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.469 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.809 0.337 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 59' ' ' VAL . 65.7 t -68.65 155.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 59' ' ' VAL . 8.4 t -72.59 -43.76 62.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 68.6 114.09 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.225 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.843 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 17.5 t -158.16 134.98 9.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.507 0.67 . . . . 0.0 111.977 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.513 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -96.27 143.87 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.7 t -103.85 106.75 17.36 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.318 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 154' ' ' THR . 6.7 tp -107.38 117.41 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.952 0.406 . . . . 0.0 111.329 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -140.28 139.2 35.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.487 ' HB3' ' HZ3' ' A' ' 156' ' ' LYS . . . -177.4 171.42 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -30.86 67.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.534 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' C ' HG12 ' A' ' 158' ' ' VAL . 0.3 OUTLIER 71.88 31.03 2.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' CD ' HD11 ' A' ' 161' ' ' ILE . 2.1 tm-20 -164.68 130.34 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.947 0.403 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -147.57 107.85 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.137 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.495 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.89 126.42 29.65 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.135 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.35 130.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 112.717 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.98 -20.46 35.92 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.357 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -105.62 172.45 6.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.317 . . . . 0.0 110.659 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -100.71 167.72 10.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 111.095 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.813 HD12 HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -110.4 159.55 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' H ' HD23 ' A' ' 49' ' ' LEU . 4.5 mm-40 -137.24 92.65 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 0.0 110.638 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 49' ' ' LEU . 2.1 m -109.95 96.56 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.411 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.65 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -85.66 70.72 3.0 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.903 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 136' ' ' VAL . 7.1 p -78.38 94.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 118' ' ' LEU . . . -103.06 -129.98 6.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.637 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.723 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -111.44 128.98 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.562 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.5 t0 -93.37 -28.78 15.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 177.34 136.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.493 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 HG12 ' A' ' 55' ' ' ILE . 1.8 pp -153.2 91.56 1.53 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.865 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.687 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.5 p -100.82 114.72 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.994 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.668 ' HB2' HG22 ' A' ' 31' ' ' VAL . 78.8 m-20 105.85 39.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.935 0.894 . . . . 0.0 111.554 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -171.02 148.28 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.64 82.53 1.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.733 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 112.14 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.64 ' O ' HD13 ' A' ' 112' ' ' LEU . 15.8 m-85 -101.76 -32.21 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.13 112.56 6.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.511 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.8 t80 -108.46 96.66 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 111.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.52 110.46 23.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.326 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.969 ' CE2' HG11 ' A' ' 102' ' ' VAL . 34.7 p90 -101.87 160.55 14.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.341 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -111.38 105.28 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.762 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -77.34 128.56 34.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.569 ' N ' HD13 ' A' ' 70' ' ' LEU . 3.0 m-80 -110.96 115.2 29.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.615 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.6 p90 -139.53 -169.13 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.167 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.56 140.97 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.75 -27.37 16.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -59.49 -30.38 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -117.62 -47.14 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.195 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.31 -176.81 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.988 0.423 . . . . 0.0 111.008 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 43.9 tp10 -166.27 155.93 11.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.496 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.6 t80 -94.92 148.96 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -132.22 -78.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.032 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 122' ' ' VAL . 6.1 mm-40 -161.06 134.75 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.18 148.91 27.17 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 122.31 1.052 . . . . 0.0 111.701 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.689 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 174.58 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.098 -177.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.701 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -146.55 -165.65 2.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.82 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -159.79 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.49 36.66 1.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.69 -42.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.21 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 106' ' ' SER . 17.2 t -87.08 146.02 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -105.3 103.3 12.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.701 HG23 ' OG ' ' A' ' 84' ' ' SER . 5.1 t -92.45 153.71 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -163.24 113.54 1.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.03 166.15 11.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.271 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.86 107.44 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttp -54.69 94.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.11 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -80.68 -23.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.655 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.82 -166.77 0.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.24 133.56 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.54 29.24 63.53 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.516 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' C ' HG13 ' A' ' 100' ' ' VAL . 1.6 ptpm? -173.33 120.05 0.33 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.834 0.35 . . . . 0.0 110.069 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -150.05 155.05 8.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.793 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.3 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.162 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.969 HG11 ' CE2' ' A' ' 68' ' ' PHE . 9.2 p -128.14 93.41 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.772 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.14 111.24 16.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.53 HG23 ' CG2' ' A' ' 90' ' ' VAL . 14.8 p -112.3 151.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.607 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.424 ' C ' HG13 ' A' ' 88' ' ' VAL . 7.9 p -160.81 136.2 7.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 88' ' ' VAL . 1.1 p -78.34 110.68 13.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.2 tt -94.46 30.31 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.133 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.5 p -102.55 -31.58 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 125.97 -22.6 6.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -110.11 159.19 32.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.63 0.253 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.46 179.52 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.583 2.189 . . . . 0.0 112.214 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 118' ' ' LEU . 3.4 mp -56.83 132.28 79.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.94 -39.67 31.58 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.522 2.148 . . . . 0.0 112.204 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 61.55 166.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.108 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 15.78 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -166.7 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.281 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.65 HG13 ' HA3' ' A' ' 52' ' ' GLY . 38.1 t -70.99 104.87 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.581 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.07 -33.49 20.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.2 131.64 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.212 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 mtmt -112.62 117.23 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.447 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.0 p -99.41 105.02 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.3 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 81' ' ' GLU . 24.2 m -75.79 130.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.921 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.8 mt -113.24 111.51 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.847 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 14.1 tpp85 -55.0 111.47 0.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.0 68.31 7.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -85.83 -5.35 59.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.389 0.614 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.48 123.41 2.53 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.644 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.729 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 18.0 ttmt -41.95 162.13 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.319 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.838 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.69 57.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.913 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 3.5 pt-20 -56.02 117.25 3.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.196 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.03 -0.73 67.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.765 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.838 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.3 m -59.17 88.08 0.01 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.437 ' ND2' HG22 ' A' ' 157' ' ' THR . 4.3 m120 -59.92 163.68 4.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 111.533 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 70' ' ' LEU . 3.5 mt -140.3 112.93 8.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.868 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.32 125.67 51.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.506 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 53' ' ' VAL . 12.1 m -110.12 94.81 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.715 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.457 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 18.6 p -100.76 -168.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.44 21.16 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.886 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 100.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.505 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.58 169.99 8.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.422 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 66' ' ' TYR . 31.1 m -132.48 -179.47 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.61 84.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -55.63 154.49 6.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.978 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.58 -46.46 93.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.46 -29.47 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.15 -25.44 6.06 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.385 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.49 170.17 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.46 139.73 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -114.01 90.44 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 103.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.718 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.513 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.55 -176.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 111.711 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -69.29 -159.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.404 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -155.94 171.22 33.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.187 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 37' ' ' LEU . 66.4 m -152.9 149.13 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -114.68 148.85 37.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.6 tppp? -131.81 163.89 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.332 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.591 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -142.88 124.62 15.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.934 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.805 HG11 HD11 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -114.4 138.36 44.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.13 105.75 16.12 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.893 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.5 mt -82.44 117.08 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.439 0.637 . . . . 0.0 109.437 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.25 137.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.549 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.17 145.57 55.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.015 0.436 . . . . 0.0 110.946 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.433 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.93 0.395 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -60.6 155.7 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.807 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 57' ' ' GLU . 6.5 t -81.33 -46.7 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 67.83 114.63 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.605 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.662 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -150.95 148.41 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.256 0.55 . . . . 0.0 111.574 179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 154' ' ' THR . 5.8 m -99.87 128.88 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.569 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -92.03 106.84 18.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.825 178.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 154' ' ' THR . 4.6 mt -97.48 123.29 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.082 0.467 . . . . 0.0 111.523 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -134.88 101.15 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.015 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.3 141.58 33.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -25.75 67.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.25 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 74.55 23.08 1.96 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.566 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HG2' HD11 ' A' ' 161' ' ' ILE . 3.7 tt0 -164.98 128.34 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.99 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.14 108.0 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -68.2 122.86 19.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.781 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.02 131.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 121.469 0.652 . . . . 0.0 112.641 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.04 -23.71 32.73 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.125 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -96.68 172.99 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.692 0.282 . . . . 0.0 110.43 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -94.93 167.78 11.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 158' ' ' VAL . 4.7 tp -154.93 108.08 2.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HB3' HG12 ' A' ' 122' ' ' VAL . 1.9 pm0 -110.37 146.73 35.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 98.12 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.735 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -67.52 65.88 0.27 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.441 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 136' ' ' VAL . 13.5 p -80.92 102.48 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.64 -123.28 3.6 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.548 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.779 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -111.59 137.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 111.737 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -36.14 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.417 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.5 mp0 -166.29 131.4 2.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.537 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 141' ' ' VAL . 1.1 tt -152.57 96.6 2.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 59' ' ' VAL . 10.1 p -122.99 109.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.559 ' N ' HG22 ' A' ' 31' ' ' VAL . 65.7 m-20 128.61 20.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.403 1.081 . . . . 0.0 111.414 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -161.31 175.76 11.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.087 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -130.2 85.38 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -63.64 127.53 31.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.519 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.494 ' C ' HD23 ' A' ' 112' ' ' LEU . 7.1 m-85 -111.09 -45.43 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.152 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.7 112.71 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.237 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 112' ' ' LEU . 34.2 t80 -97.6 95.02 7.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -106.07 110.15 22.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.4 p90 -112.19 171.16 7.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.104 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.4 m -120.68 107.67 13.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.493 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.525 HD11 HD23 ' A' ' 134' ' ' LEU . 21.2 tp -79.15 133.35 36.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -116.83 109.03 16.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 15.1 p90 -125.04 -166.74 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.4 t70 -120.44 102.8 8.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 111.119 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.44 -28.16 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.63 -47.24 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -116.87 32.87 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.478 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -167.31 -176.48 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.421 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.92 108.95 0.31 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 100' ' ' VAL . 8.5 t80 -54.49 149.32 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.79 ' HB ' HG23 ' A' ' 122' ' ' VAL . 59.7 t -128.65 -79.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.859 ' O ' HG22 ' A' ' 122' ' ' VAL . 13.3 mm-40 -160.89 145.08 13.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.85 150.56 26.48 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.215 1.007 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -124.08 151.31 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.295 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.665 ' HB2' HG12 ' A' ' 90' ' ' VAL . 1.4 m -174.87 129.78 0.31 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.729 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.16 -168.2 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 t0 63.93 63.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.89 25.41 59.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 86' ' ' ASP . 21.6 t -140.96 114.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 111.051 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -113.33 121.66 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 84' ' ' SER . 8.7 p -113.17 153.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.231 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -137.7 123.99 20.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.307 0.575 . . . . 0.0 111.58 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.67 153.53 17.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.761 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 107.11 5.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 111.719 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 7.4 tttt -55.24 117.38 3.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.716 HG22 ' HA ' ' A' ' 100' ' ' VAL . 4.5 tp -109.15 -25.47 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 163.82 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.0 124.22 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 68.57 30.11 72.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.453 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.9 ptmt -174.01 123.21 0.32 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.935 0.397 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HA ' HG22 ' A' ' 95' ' ' ILE . 10.0 m -149.9 154.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.426 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -96.92 152.86 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 112.013 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.3 p -124.35 150.82 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.49 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.4 mt -124.1 108.75 12.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.072 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.661 HG22 ' CG2' ' A' ' 90' ' ' VAL . 97.6 t -102.68 136.64 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.401 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 p -164.39 134.74 4.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -88.88 130.9 35.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.058 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.07 29.35 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 -26.38 9.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.025 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.27 -24.07 10.13 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.125 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -89.38 155.94 48.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.681 0.277 . . . . 0.0 110.663 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 60.5 Cg_endo -72.68 156.16 53.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.57 2.18 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -51.99 133.44 39.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.878 ' O ' HD21 ' A' ' 118' ' ' LEU . 86.6 Cg_endo -84.72 145.35 10.25 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.408 2.072 . . . . 0.0 111.49 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.779 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -98.51 169.19 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 111.317 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.93 33.89 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.482 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.665 ' O ' HD22 ' A' ' 118' ' ' LEU . 13.6 tt0 -161.1 157.58 26.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.735 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.3 t -55.34 105.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 113' ' ' PRO . 1.4 mm? -89.57 -31.28 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . . . -164.38 135.67 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 128.9 40.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.697 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 70' ' ' LEU . 50.2 t -107.13 112.73 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.7 m -75.3 96.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.513 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.488 ' CD1' HD21 ' A' ' 134' ' ' LEU . 36.1 mt -83.17 110.81 18.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.1 tpp85 -55.37 110.93 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.78 70.46 5.13 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -2.39 58.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.444 0.64 . . . . 0.0 109.562 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.64 123.55 2.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.611 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.652 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 8.8 ttpt -51.87 142.5 15.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.691 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.55 63.73 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.14 111.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.71 43.22 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.641 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.806 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -70.69 66.96 0.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.518 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.85 131.69 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.121 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.525 HD23 HD11 ' A' ' 70' ' ' LEU . 5.6 mp -111.6 139.28 47.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.941 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.88 110.61 14.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.902 0.382 . . . . 0.0 111.477 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 53' ' ' VAL . 21.0 m -99.4 95.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.7 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.45 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 13.8 p -103.65 -165.62 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.45 ' ND2' ' C ' ' A' ' 137' ' ' THR . 2.2 p30 43.52 21.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.976 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.505 ' OG ' HD11 ' A' ' 151' ' ' ILE . 5.6 t -63.83 96.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.791 0.329 . . . . 0.0 110.507 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -101.18 167.47 10.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.385 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 58' ' ' LEU . 4.9 m -128.82 -179.59 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.87 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.5 87.2 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.444 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 17.3 t70 -53.32 162.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.041 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.84 -52.11 55.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.19 -30.83 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.781 0.324 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.41 -28.09 4.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.424 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.78 150.93 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.62 149.8 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 24.8 m-70 -123.54 90.55 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.593 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.69 107.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.505 HD11 ' OG ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.32 -177.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.418 . . . . 0.0 111.42 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.1 -148.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.347 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.23 37.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.151 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 37' ' ' LEU . 67.9 m -164.16 146.67 9.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.759 0.314 . . . . 0.0 110.573 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -107.05 167.81 9.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.948 0.404 . . . . 0.0 111.543 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.685 ' HD2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.61 163.74 31.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.232 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.451 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.2 p -142.4 119.55 11.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.34 138.05 48.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.161 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -106.79 105.54 15.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -80.46 129.32 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -114.13 129.54 69.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.819 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.8 145.31 41.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.237 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.48 -179.926 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.931 0.396 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 61' ' ' ALA . 13.4 t -78.57 146.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' GLY . 12.6 t -74.42 -32.6 62.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 57.05 114.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.209 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 13.3 t -147.56 156.44 42.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG23 ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -106.2 129.64 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.035 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -91.41 107.44 19.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.059 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.912 HD12 HG22 ' A' ' 154' ' ' THR . 5.6 mt -96.7 120.26 36.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.439 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -140.18 101.2 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.77 149.64 32.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.444 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.49 -22.25 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.427 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.53 ' C ' HG12 ' A' ' 158' ' ' VAL . 2.8 mp0 67.06 24.38 9.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.549 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -164.96 128.93 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.97 0.414 . . . . 0.0 111.995 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.93 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -145.51 108.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.207 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.88 125.34 26.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.292 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.6 t -29.38 130.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 121.517 0.675 . . . . 0.0 112.705 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.91 -23.65 30.38 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.34 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.03 172.34 7.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -105.85 167.7 9.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.088 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.883 HD11 HG11 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.93 158.26 24.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.63 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' H ' HD23 ' A' ' 49' ' ' LEU . 5.4 mp0 -137.48 92.35 2.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.741 0.305 . . . . 0.0 110.294 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -112.07 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.05 0.453 . . . . 0.0 110.461 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -90.01 81.66 1.41 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.468 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 136' ' ' VAL . 14.8 p -78.61 99.53 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.33 -117.47 4.34 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.59 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.768 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -121.43 127.23 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.491 . . . . 0.0 112.186 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -101.12 -26.15 13.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.6 mp0 -165.41 136.47 3.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.738 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -169.97 91.49 0.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.213 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.835 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.3 p -103.1 115.45 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.734 ' HB2' HG22 ' A' ' 31' ' ' VAL . 71.0 m-20 101.48 23.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.214 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -144.49 134.26 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.989 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 19.6 tt0 -105.14 83.71 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.472 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.82 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.8 m-85 -104.14 -33.35 8.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.21 9.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.786 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.775 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 t80 -87.53 137.42 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 111.436 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -147.89 109.43 4.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.182 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CE2' HG11 ' A' ' 102' ' ' VAL . 8.2 p90 -130.85 171.31 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.447 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.83 111.24 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.773 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -77.25 156.17 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.776 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -130.35 104.41 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.44 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 12.0 p90 -122.79 -168.35 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -100.94 147.75 25.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.017 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -105.13 14.66 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -110.17 -31.02 7.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.787 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -113.0 -45.56 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.3 m-85 -93.59 -177.86 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -170.34 112.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 44.6 t80 -53.35 154.41 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 122' ' ' VAL . 46.9 t -134.49 -73.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.86 ' O ' HG22 ' A' ' 122' ' ' VAL . 4.9 mt-10 -163.36 143.62 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.88 155.72 23.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.918 0.866 . . . . 0.0 111.583 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -131.51 154.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.882 -1.508 . . . . 0.0 112.65 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.674 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -123.54 -164.82 1.26 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.784 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 88' ' ' VAL . 13.9 p-10 -96.66 -157.99 0.63 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.774 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -93.87 36.78 1.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.87 -41.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.945 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 112' ' ' LEU . 13.1 t -87.46 153.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.689 0.28 . . . . 0.0 110.694 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.722 ' HB2' HD23 ' A' ' 107' ' ' LEU . 2.7 t80 -110.15 120.7 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.127 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 104' ' ' VAL . 20.2 t -109.29 145.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.81 105.44 1.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.541 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.59 -177.04 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 111.52 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.716 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 6.8 tttt -54.01 95.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.165 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.815 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.2 tp -75.55 -25.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -167.4 -173.21 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.37 132.18 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 56.84 33.03 62.72 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.408 ' C ' HG13 ' A' ' 100' ' ' VAL . 11.9 ptpt -173.94 120.27 0.29 Allowed 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.815 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.9 156.09 7.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.663 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.717 HH21 HD21 ' A' ' 103' ' ' LEU . 2.6 ttt180 -103.42 151.8 22.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.8 p -119.53 143.32 31.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.141 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.717 HD21 HH21 ' A' ' 101' ' ' ARG . 80.1 mt -128.18 98.5 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.651 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 66' ' ' TYR . 8.5 p -105.83 157.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.154 0.502 . . . . 0.0 111.785 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.496 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.5 p -163.35 136.83 5.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.124 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' HG13 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -77.25 104.3 7.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.304 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 89' ' ' PHE . 3.4 mm? -71.52 -16.08 62.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.207 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -65.23 -34.81 79.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.87 -18.86 21.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.92 156.96 49.24 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 33.3 Cg_endo -64.66 142.05 75.39 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.607 2.205 . . . . 0.0 112.34 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 88' ' ' VAL . 8.1 mt -54.49 106.92 0.73 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.535 ' O ' HD21 ' A' ' 118' ' ' LEU . 37.0 Cg_exo -60.83 147.69 94.48 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.438 2.092 . . . . 0.0 111.838 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.768 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -101.52 175.47 5.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.183 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 18.61 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.92 -165.75 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.4 t -84.48 104.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 112' ' ' LEU . 2.0 mm? -90.03 -32.81 16.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.977 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.36 131.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.745 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -128.04 159.17 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 70' ' ' LEU . 9.9 p -130.81 148.16 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.917 HG13 HD11 ' A' ' 83' ' ' ILE . 29.3 m -110.7 103.67 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.747 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.643 ' CD1' HD21 ' A' ' 134' ' ' LEU . 9.3 mt -90.41 108.81 20.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.885 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 17.7 ttm180 -55.4 112.56 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.711 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -80.1 71.73 6.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.31 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -87.43 -3.93 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 109.588 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.71 123.57 2.46 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.518 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.732 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -49.19 140.79 9.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.579 -178.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -143.37 62.99 1.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.541 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.98 121.61 9.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.485 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.45 18.83 79.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.691 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 28.7 t -68.99 71.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.895 0.378 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -45.31 132.22 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.025 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.643 HD21 ' CD1' ' A' ' 123' ' ' LEU . 5.4 mp -117.87 129.69 55.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.933 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.7 p -108.22 121.06 44.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.939 0.4 . . . . 0.0 111.489 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 53' ' ' VAL . 21.3 t -104.65 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.468 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.4 p -109.98 -164.65 0.94 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.468 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.78 17.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.092 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.606 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -64.71 95.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.88 8.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 111.618 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 66' ' ' TYR . 26.7 m -139.87 -179.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.914 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.27 89.67 0.4 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 5.2 p30 -62.07 168.35 3.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.67 22.21 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.904 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 147' ' ' LEU . 2.6 mt-10 -55.09 -23.42 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 111.337 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.18 -17.9 28.8 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.415 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' GLU . 3.0 mp -65.3 170.46 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.01 120.47 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 143' ' ' ASP . 45.6 m-70 -92.46 92.71 8.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.91 102.52 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.36 167.41 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 111.738 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.01 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.658 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.1 171.16 40.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.301 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.912 HG22 HD12 ' A' ' 37' ' ' LEU . 50.9 m -165.2 155.95 14.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.656 0.265 . . . . 0.0 110.77 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -118.6 170.14 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.534 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -143.14 166.22 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -143.17 120.57 11.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.634 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -114.66 126.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -91.66 105.46 17.75 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.93 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.2 mt -81.07 120.65 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -104.45 131.65 52.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.817 -178.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.74 145.88 38.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 60' ' ' ASN . 43.3 t -74.48 149.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 57' ' ' GLU . 15.0 t -65.66 -36.21 83.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 58.53 109.94 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.913 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.5 t -155.55 143.19 19.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.567 0.699 . . . . 0.0 111.943 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HD11 ' A' ' 151' ' ' ILE . 35.7 m -101.95 143.95 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.842 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -100.31 106.38 18.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.613 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.92 HD21 ' HB2' ' A' ' 156' ' ' LYS . 4.3 tp -103.87 119.95 39.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.484 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.547 ' N ' HD12 ' A' ' 37' ' ' LEU . 40.8 tp10 -139.26 101.4 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.666 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -134.53 151.37 51.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.413 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.93 -28.05 65.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.339 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.3 mt-10 67.68 23.42 8.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.431 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 18.3 tt0 -164.81 123.9 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 0.0 111.772 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -144.89 108.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.289 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.16 127.33 32.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -29.33 131.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.24 -21.48 42.99 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.532 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -97.73 172.33 7.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 110.638 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -112.4 167.73 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.146 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.443 HD22 HG11 ' A' ' 158' ' ' VAL . 9.9 tp -130.2 153.42 48.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 15.2 mp0 -135.65 93.45 2.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.92 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' ALA . 7.2 p -104.16 98.1 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.613 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.801 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -89.37 87.05 1.44 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.867 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 136' ' ' VAL . 8.3 p -78.93 95.18 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.71 -128.82 6.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.634 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.585 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.65 128.9 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.053 0.454 . . . . 0.0 111.859 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 18.5 t0 -97.58 -30.06 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' HG21 ' A' ' 32' ' ' THR . 1.6 mp0 -167.35 135.12 2.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.024 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -161.53 90.84 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.379 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.738 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.9 p -115.53 126.97 73.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.975 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.748 ' HB2' HG22 ' A' ' 31' ' ' VAL . 75.7 m-20 104.38 15.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.786 0.834 . . . . 0.0 112.064 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.724 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.85 176.35 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.42 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.1 tt0 -129.98 83.17 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.8 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.683 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.1 120.73 11.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.7 ' C ' HD23 ' A' ' 112' ' ' LEU . 4.1 m-85 -120.37 -43.17 2.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.639 ' N ' HD23 ' A' ' 112' ' ' LEU . . . -134.3 118.31 17.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.048 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 t80 -85.96 137.9 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -147.66 109.85 4.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.455 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 136' ' ' VAL . 14.7 p90 -139.48 171.17 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.417 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -124.19 115.75 21.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.884 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.665 ' CD2' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -88.14 111.16 21.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 1.2 p-10 -95.69 104.61 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 38.2 p90 -107.91 -168.44 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.631 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.31 104.72 14.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HB2' ' N ' ' A' ' 98' ' ' GLY . 14.2 tp10 -67.25 -26.72 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.91 -29.19 62.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.144 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.903 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -124.43 -40.35 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.381 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.21 -176.88 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -165.2 121.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 26.5 t80 -56.43 150.67 14.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.0 t -132.46 -71.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.6 pp20? -172.94 140.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 149.57 27.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.118 0.961 . . . . 0.0 111.45 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -115.7 153.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.511 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.752 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -120.68 -167.01 1.4 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.26 -158.54 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -95.61 36.92 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.83 -45.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.621 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.752 HG23 ' OG ' ' A' ' 84' ' ' SER . 32.8 m -86.66 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.244 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.37 124.19 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.093 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.746 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 t -115.8 136.22 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -148.94 116.57 6.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -97.07 153.53 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -133.48 107.36 7.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.667 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 11.4 tmtt? -55.15 95.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.799 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.3 tp -84.51 -25.93 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.875 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -166.57 177.62 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.768 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 130.11 40.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 58.78 33.21 72.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.43 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' ASN . 13.2 ptpt -173.77 118.96 0.28 Allowed 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.799 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.5 m -149.84 154.68 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -89.21 152.27 21.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.91 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.1 p -128.28 96.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.668 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mt -86.69 102.77 14.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.9 p -107.3 153.59 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.288 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -164.5 138.51 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.381 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.622 ' OG ' HG12 ' A' ' 88' ' ' VAL . 47.1 m -76.47 104.59 7.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.283 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -13.92 62.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.607 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -65.41 -28.46 69.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.85 -23.1 12.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.954 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.68 155.09 45.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 110.546 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -64.93 153.85 76.11 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.587 2.191 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.72 HD13 HD21 ' A' ' 118' ' ' LEU . 1.8 pp -52.91 132.62 48.75 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 94.1 Cg_endo -88.91 144.99 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.773 2.315 . . . . 0.0 112.209 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -94.57 170.69 9.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.178 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 32.91 12.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -163.5 158.2 20.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.598 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HA3' ' A' ' 52' ' ' GLY . 33.8 t -52.96 105.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -85.41 -32.33 22.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.961 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.45 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.73 135.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.797 ' HD3' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -126.3 149.58 49.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.675 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' A' ' 70' ' ' LEU . 42.0 t -113.06 154.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.532 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' GLU . 23.1 t -119.85 95.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.599 HD21 HD22 ' A' ' 70' ' ' LEU . 1.2 mm? -88.04 108.31 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.483 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 37.3 ttm180 -64.97 117.6 7.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -76.77 72.78 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.505 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -87.96 -3.62 58.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 0.0 109.438 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.39 123.49 2.58 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.407 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.731 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.6 ttmt -48.82 138.02 11.73 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.393 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.903 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -143.66 62.91 1.36 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.575 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.12 116.16 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.404 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.89 19.53 59.35 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.702 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.835 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.9 66.28 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.116 0.484 . . . . 0.0 110.455 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.453 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 1.1 t-20 -42.39 129.73 3.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.421 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 132' ' ' SER . 5.2 mp -111.2 150.28 29.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.51 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.07 121.45 14.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.0 111.579 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 53' ' ' VAL . 8.9 p -99.71 95.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.599 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.484 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.4 p -100.3 -165.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.789 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.37 19.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.065 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -63.35 87.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.933 0.397 . . . . 0.0 110.227 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.664 ' HB2' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -106.38 162.11 13.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.436 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.898 ' O ' HG23 ' A' ' 148' ' ' VAL . 28.5 m -130.32 128.79 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.947 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.77 83.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.694 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 22.8 t70 -57.77 140.8 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.816 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.84 76.08 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.728 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.7 -29.59 66.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.14 15.04 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.746 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.62 115.11 28.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 110.769 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 141' ' ' VAL . 14.1 p -73.08 141.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -104.8 99.0 8.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.87 102.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.602 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.27 -176.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.784 -178.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -75.83 -161.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.408 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.65 34.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.791 HG22 HD23 ' A' ' 37' ' ' LEU . 90.8 m -153.69 146.48 24.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.723 0.297 . . . . 0.0 110.849 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.81 161.96 15.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 111.261 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.92 ' HB2' HD21 ' A' ' 37' ' ' LEU . 3.9 tppt? -139.99 169.19 18.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.6 p -142.15 115.93 9.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.592 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -110.52 126.17 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 105.72 17.91 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.2 mt -80.72 122.59 36.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.13 132.98 51.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.623 -178.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.03 145.21 42.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.154 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.5 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 60' ' ' ASN . 15.2 t -60.64 151.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 33' ' ' GLY . 14.6 t -74.52 -46.69 37.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 76.09 112.27 0.12 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.692 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.899 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -159.75 139.16 11.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.0 111.428 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD11 ' A' ' 151' ' ' ILE . 19.1 m -98.93 141.15 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.527 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.45 106.38 18.68 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.826 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 HG22 ' A' ' 154' ' ' THR . 6.2 tp -107.17 106.58 17.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 111.355 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -121.94 118.65 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.412 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.74 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.493 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.82 -27.4 68.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 73.1 22.89 2.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.414 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 158' ' ' VAL . 41.6 tt0 -164.53 128.19 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.995 0.426 . . . . 0.0 112.114 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.4 p -132.52 168.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.735 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.577 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tm0? -131.56 118.49 20.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.1 t -28.57 130.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.488 0.661 . . . . 0.0 112.477 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.62 64.49 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.776 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.98 173.73 6.34 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.331 0.252 . . . . 0.0 110.473 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.524 ' HB3' HG13 ' A' ' 122' ' ' VAL . 16.9 m-80 -119.03 131.39 55.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.094 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.648 ' CD1' HG11 ' A' ' 158' ' ' VAL . 15.4 tp -86.91 154.99 20.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.21 93.47 2.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -105.06 98.17 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -87.75 86.05 1.51 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.89 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -82.18 95.24 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -100.62 -127.63 6.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.981 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.942 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -115.31 130.29 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 111.724 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.94 -39.3 11.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.07 132.79 0.51 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.942 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -157.25 113.69 2.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.539 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.6 p -128.89 100.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 31' ' ' VAL . 19.0 m-20 139.57 23.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.404 1.065 . . . . 0.0 111.737 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.67 147.42 6.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.776 0.322 . . . . 0.0 111.213 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -105.22 85.87 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 112.93 2.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 25.3 m-85 -99.77 -32.75 10.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.155 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.94 112.61 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.942 ' O ' HG12 ' A' ' 104' ' ' VAL . 35.6 t80 -102.79 130.67 49.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.627 ' CG ' HD23 ' A' ' 103' ' ' LEU . 10.7 m-20 -135.06 119.25 17.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.856 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.923 ' CE2' HG11 ' A' ' 102' ' ' VAL . 24.7 p90 -120.63 155.99 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -123.42 103.39 8.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.457 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 121' ' ' VAL . 1.1 pt? -77.36 156.13 31.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.348 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -124.0 104.4 8.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.695 ' HB3' HD11 ' A' ' 134' ' ' LEU . 18.6 p90 -118.44 -166.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -114.65 143.15 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.81 -25.21 15.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.012 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -62.14 -29.42 70.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.039 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -124.52 -43.92 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -93.16 169.27 10.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.636 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -159.2 119.71 3.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 23.7 t80 -57.32 153.7 11.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.6 t -131.49 -72.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 122' ' ' VAL . 15.4 pt-20 -170.38 143.94 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.819 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -84.54 150.78 25.0 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.251 1.024 . . . . 0.0 111.538 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.13 153.39 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.336 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.13 -174.43 2.71 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -159.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.745 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.78 36.64 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.92 -39.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.184 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 89' ' ' PHE . 14.1 t -87.18 159.96 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.979 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' N ' HG12 ' A' ' 88' ' ' VAL . 33.3 t80 -115.98 113.05 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 104' ' ' VAL . 2.1 t -104.23 155.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -166.24 110.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.399 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.99 158.14 15.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -145.83 107.15 4.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.73 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 20.4 tttt -55.14 117.03 3.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.312 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.5 tp -111.22 -23.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.847 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -167.86 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.24 -75.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 72' ' ' TYR . . . -106.22 53.12 0.65 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.408 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.3 ptmt -174.21 129.74 0.37 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.73 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 14.5 m -149.59 155.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.879 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.591 ' HD2' HG23 ' A' ' 69' ' ' THR . 0.9 OUTLIER -91.5 152.41 20.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.532 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.923 HG11 ' CE2' ' A' ' 68' ' ' PHE . 10.3 p -139.44 122.17 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.878 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.627 HD23 ' CG ' ' A' ' 67' ' ' ASP . 17.3 mt -109.72 108.92 19.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.9 p -106.7 148.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.414 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -155.91 136.48 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.44 104.5 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.5 tp -72.42 -12.85 61.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 p -65.27 -30.27 71.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.04 -18.98 18.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.412 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.93 147.87 34.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.3 Cg_exo -53.97 -178.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.476 2.117 . . . . 0.0 112.446 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.785 HD11 ' HG ' ' A' ' 118' ' ' LEU . 8.5 tt -58.57 123.0 64.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.62 -43.82 24.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.463 2.109 . . . . 0.0 112.129 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . . . 62.34 167.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.17 19.75 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.216 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.44 -168.62 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.439 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.693 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.5 t -74.73 104.99 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.728 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -83.63 -34.7 25.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -174.35 132.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 111.297 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.669 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -121.59 137.85 54.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.374 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.749 HG21 HD22 ' A' ' 70' ' ' LEU . 68.9 t -99.3 135.93 32.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.83 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 81' ' ' GLU . 47.6 t -93.47 97.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.887 HD11 HD21 ' A' ' 134' ' ' LEU . 44.7 mt -92.28 108.42 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG21 ' A' ' 80' ' ' VAL . 29.5 ttm180 -69.7 116.39 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.02 73.71 4.57 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.252 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -3.6 59.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.544 0.688 . . . . 0.0 109.503 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.88 123.0 2.7 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.121 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.646 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.9 ttpp -44.94 154.12 0.15 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.329 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.697 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -162.47 59.79 0.22 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.917 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 6.8 tt0 -55.81 117.18 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.972 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.55 61.59 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.371 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.697 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 41.3 t -70.5 87.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 110.397 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.401 ' ND2' HG22 ' A' ' 157' ' ' THR . 5.0 m120 -57.99 162.83 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.516 . . . . 0.0 111.401 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.887 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -143.91 104.85 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.645 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -100.1 131.3 46.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.645 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 53' ' ' VAL . 26.8 t -111.12 94.69 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.532 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.49 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -99.79 -164.45 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.676 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.23 22.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.021 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 151' ' ' ILE . 27.9 m -61.63 100.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 110.436 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 173.17 6.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.4 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.51 -179.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.24 85.46 0.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -55.61 -174.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.09 -38.4 10.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.17 -29.45 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.6 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.655 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.69 170.32 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.23 129.49 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -106.41 91.09 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.0 109.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.539 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -89.79 -176.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.226 0.536 . . . . 0.0 111.599 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.86 -160.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.374 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.62 168.7 34.36 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.365 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.842 HG22 HD23 ' A' ' 37' ' ' LEU . 88.2 m -155.77 148.12 23.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.786 0.326 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.81 153.27 33.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 tppp? -135.31 167.03 21.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.238 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.1 p -142.83 134.65 26.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 49' ' ' LEU . 1.3 m -125.4 129.96 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.31 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.87 107.27 19.09 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.01 0.433 . . . . 0.0 110.484 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.6 mt -76.79 120.48 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.62 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.12 128.32 59.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -178.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.74 146.13 37.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.769 0.318 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 61' ' ' ALA . 6.8 t -82.64 151.17 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.763 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' GLY . 5.3 t -90.82 -30.99 16.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 55.31 132.1 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.575 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.69 159.09 43.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.202 0.525 . . . . 0.0 111.605 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG21 ' HA2' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -112.18 123.56 68.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.271 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -92.24 109.57 20.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.386 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.897 HD12 HG22 ' A' ' 154' ' ' THR . 3.8 mt -97.1 120.74 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' HG22 ' A' ' 117' ' ' VAL . 4.5 tm-20 -133.49 101.37 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.344 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -146.63 152.86 39.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.05 -26.43 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.393 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 66.56 24.25 10.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.381 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.83 117.22 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.796 0.332 . . . . 0.0 111.598 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -136.87 107.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.65 128.36 36.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.238 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.428 HG23 ' CG2' ' A' ' 160' ' ' ILE . 2.0 t -31.02 132.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-O 121.5 0.667 . . . . 0.0 112.709 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 -24.01 32.98 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.39 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.85 172.47 7.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 0.0 110.631 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.63 151.69 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 122' ' ' VAL . 21.1 tp -104.48 153.4 21.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 3.1 pt-20 -136.75 93.29 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 110.649 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.2 p -107.01 97.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.795 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.02 82.59 1.59 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.623 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 136' ' ' VAL . 9.7 p -78.63 95.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.761 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.29 -134.71 8.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.69 136.44 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -96.83 -36.34 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.57 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 177.15 131.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.436 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.879 HD13 ' HB3' ' A' ' 61' ' ' ALA . 2.7 pp -141.09 103.49 4.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.764 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.824 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.4 p -94.76 110.18 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.3 m-20 98.68 26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.435 0.694 . . . . 0.0 112.333 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -136.9 150.2 48.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.227 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -128.78 66.29 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.112 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.49 144.08 56.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.049 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.718 ' O ' HD13 ' A' ' 112' ' ' LEU . 17.6 m-85 -120.23 -35.38 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.51 112.68 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.766 ' O ' HG12 ' A' ' 104' ' ' VAL . 41.6 t80 -86.16 148.27 25.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.991 0.425 . . . . 0.0 111.458 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.618 ' OD1' HD23 ' A' ' 103' ' ' LEU . 7.0 m-20 -147.67 111.27 4.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.916 ' CE2' HG11 ' A' ' 102' ' ' VAL . 16.5 p90 -122.97 156.16 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 111.557 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.19 103.15 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.418 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 123' ' ' LEU . 1.5 pt? -77.09 156.05 31.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -126.8 104.49 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 18.7 p90 -118.3 -167.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.4 113.59 21.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -27.98 65.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.08 -46.65 86.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.035 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.03 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.59 20.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -164.33 -179.69 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -171.56 113.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.706 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.613 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.1 t80 -51.01 149.27 3.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.0 t -129.1 -82.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.01 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 122' ' ' VAL . 11.0 mt-10 -156.17 134.8 11.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.76 151.2 26.25 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.12 0.962 . . . . 0.0 111.478 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.88 HD12 ' HE2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -126.97 158.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.421 -177.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.532 ' CB ' HG23 ' A' ' 90' ' ' VAL . 1.8 t -121.21 -164.68 1.15 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.794 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -93.0 -157.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.754 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.5 37.67 1.12 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.93 0.395 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.12 -39.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 29.5 t -87.05 154.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.639 0.257 . . . . 0.0 110.773 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.91 121.41 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.582 HG22 ' HB ' ' A' ' 104' ' ' VAL . 5.2 t -109.11 155.23 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -162.78 110.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.86 156.21 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.39 107.09 5.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.229 0.538 . . . . 0.0 111.536 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.1 tttm -54.71 96.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.477 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -84.83 -22.76 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.589 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -166.76 2.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -99.28 52.41 1.08 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.364 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.5 ptmt -174.19 126.14 0.34 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 95' ' ' ILE . 5.5 m -148.71 155.03 9.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.698 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -97.24 152.49 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.916 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.3 p -133.47 121.97 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.139 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.618 HD23 ' OD1' ' A' ' 67' ' ' ASP . 14.2 mt -107.85 98.97 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.7 p -98.31 149.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.33 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 p -151.61 135.54 16.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.421 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.21 111.56 12.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.912 0.386 . . . . 0.0 111.309 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.28 29.68 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.006 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -106.79 -29.71 9.37 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.988 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.95 -20.8 14.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.166 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -97.39 155.83 36.89 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 56.4 Cg_endo -70.51 173.61 11.38 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.545 2.163 . . . . 0.0 112.446 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.27 109.23 1.53 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.26 -22.33 73.97 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.397 2.065 . . . . 0.0 112.147 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 55.97 177.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.876 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.52 25.78 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.634 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -159.31 155.85 27.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.9 t -45.62 104.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 0.0 111.274 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.672 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.48 -31.13 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.962 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -174.3 134.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.123 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.88 ' HE2' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -126.58 116.76 21.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 76.1 t -86.99 111.18 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 83' ' ' ILE . 21.9 t -75.65 111.24 11.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.026 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 70' ' ' LEU . 35.8 mt -92.9 169.28 10.57 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 8.6 ttm180 -116.44 123.39 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.72 72.12 8.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.341 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.03 -6.68 57.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 109.706 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.87 123.62 2.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.739 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.668 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.8 ttmt -44.46 162.37 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.517 -1.219 . . . . 0.0 112.349 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.03 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.84 61.67 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.79 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 5.4 tt0 -55.27 111.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 23.26 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.138 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.31 65.96 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.895 0.379 . . . . 0.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -44.86 132.88 6.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.161 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.639 HD21 HD11 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -118.74 134.61 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.951 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 p -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.888 0.375 . . . . 0.0 111.405 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 53' ' ' VAL . 15.7 m -107.16 94.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.814 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.2 p -99.7 -164.11 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.547 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 40.54 25.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 151' ' ' ILE . 1.9 p -68.56 93.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.62 170.17 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m -129.32 179.87 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.989 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.56 64.06 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.452 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.48 138.67 45.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.78 58.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.612 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -56.49 -28.1 58.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.6 -1.24 36.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.852 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.62 131.62 56.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.9 t -76.88 123.93 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.05 92.0 5.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.623 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.54 107.28 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.659 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.39 169.01 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.263 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.618 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.48 -153.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.723 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -154.41 165.48 31.91 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.224 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.897 HG22 HD12 ' A' ' 37' ' ' LEU . 36.8 m -161.03 147.33 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.734 0.302 . . . . 0.0 110.647 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.9 173.82 6.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.675 ' HB2' HD13 ' A' ' 37' ' ' LEU . 3.8 tppt? -144.72 168.69 19.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.081 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.431 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 1.9 p -142.43 115.66 8.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.04 127.38 68.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -97.49 105.79 18.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.9 mt -83.92 116.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.397 0.617 . . . . 0.0 109.748 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.5 143.47 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.677 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.75 146.36 54.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.898 0.38 . . . . 0.0 110.924 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.928 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.831 0.348 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.588 HG22 ' C ' ' A' ' 59' ' ' VAL . 29.6 t -61.06 155.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.0 t -78.73 -47.15 17.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 72.03 113.12 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.672 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.9 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.5 m -156.57 138.42 14.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.455 0.645 . . . . 0.0 111.507 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 19.8 m -91.48 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.8 t -90.95 134.29 34.6 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.183 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.818 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -110.73 118.69 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 tt0 -140.7 116.94 10.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -169.48 144.29 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.672 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.05 -27.0 66.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.055 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' C ' HG12 ' A' ' 158' ' ' VAL . 4.8 mt-10 73.17 21.86 3.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.691 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 158' ' ' VAL . 1.7 tm-20 -165.15 127.66 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.873 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -146.16 107.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.353 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -65.4 123.93 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -28.91 130.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.629 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.1 -23.05 24.12 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -107.9 174.97 5.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 110.413 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -128.78 148.25 50.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.59 128.19 51.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.619 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 3.4 pt-20 -101.43 131.34 47.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.384 . . . . 0.0 111.19 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 39' ' ' ALA . 11.1 t -108.4 97.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -70.19 62.09 0.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.102 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 136' ' ' VAL . 7.2 p -81.17 112.45 19.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.291 . . . . 0.0 110.396 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 118' ' ' LEU . . . -126.61 -91.24 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.618 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.527 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -135.65 134.86 51.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.075 0.464 . . . . 0.0 111.985 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -102.64 -38.93 7.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HA ' ' HZ3' ' A' ' 115' ' ' LYS . 77.2 mm-40 -159.35 129.0 5.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.006 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.767 HD21 ' CD2' ' A' ' 149' ' ' HIS . 1.0 OUTLIER -153.19 90.84 1.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.729 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 ' C ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -121.45 110.74 28.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.563 ' N ' HG22 ' A' ' 31' ' ' VAL . 72.6 m-20 127.6 17.92 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.499 1.119 . . . . 0.0 111.493 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -157.79 -178.04 7.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.966 0.413 . . . . 0.0 111.078 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -137.0 76.57 1.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.589 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.9 111.93 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.511 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 11.3 m-85 -89.37 -34.4 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.048 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.03 112.35 8.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.36 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' H ' HD11 ' A' ' 112' ' ' LEU . 11.3 t80 -98.68 94.12 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 0.0 110.918 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD2' HD23 ' A' ' 103' ' ' LEU . 9.1 t0 -100.5 135.94 41.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 102' ' ' VAL . 47.0 p90 -140.97 171.21 14.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.238 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.29 91.2 3.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.635 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.783 ' HB2' HG12 ' A' ' 136' ' ' VAL . 8.2 tt -77.03 152.96 34.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.108 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' HD23 ' A' ' 70' ' ' LEU . 28.0 p30 -131.41 155.93 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.989 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 21.0 p90 -155.55 -169.34 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.67 140.89 28.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -105.84 -13.75 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -96.26 25.81 4.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.765 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -170.6 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.905 0.384 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.745 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.1 m-85 -93.3 -176.89 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -170.85 111.84 0.38 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.644 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 18.2 t80 -50.14 152.83 1.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.809 ' HB ' HG23 ' A' ' 122' ' ' VAL . 66.9 t -131.04 -78.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -163.61 143.2 8.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.864 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.63 150.23 26.95 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-O 122.04 0.924 . . . . 0.0 111.439 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -140.35 151.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.268 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -129.6 -176.17 3.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.077 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -160.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.88 23.49 4.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.59 -44.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.906 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 105' ' ' SER . 16.3 t -97.05 143.27 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.687 0.28 . . . . 0.0 110.626 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -117.23 109.41 16.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 103' ' ' LEU . 7.1 p -102.18 144.13 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.918 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.18 124.81 29.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -98.06 161.27 13.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.682 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.21 107.05 5.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 111.719 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.668 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.28 95.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.08 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -83.91 -30.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.882 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.18 -168.38 2.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.429 ' HB3' ' CB ' ' A' ' 74' ' ' GLU . 4.6 m-20 -84.31 130.07 34.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.34 31.67 70.48 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.345 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.416 ' C ' HG13 ' A' ' 100' ' ' VAL . 12.8 ptpt -173.75 122.08 0.33 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.848 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.3 m -149.89 154.7 8.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.731 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -85.75 152.26 23.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.184 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.2 p -125.48 136.99 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.308 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.467 ' C ' HG23 ' A' ' 90' ' ' VAL . 12.0 mt -123.79 109.69 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 111.087 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.7 p -109.86 147.32 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 112.018 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 88' ' ' VAL . 2.7 p -164.78 135.44 4.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.029 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 88' ' ' VAL . 17.1 m -73.68 104.18 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -69.66 -17.56 63.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.182 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -65.36 -32.91 74.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.02 -17.11 20.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.91 155.29 37.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.653 0.264 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 37.4 Cg_exo -60.13 164.85 11.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.558 2.172 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.915 HD22 HD12 ' A' ' 118' ' ' LEU . 91.1 mt -59.82 113.65 7.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.64 -20.88 67.03 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.3 2.0 . . . . 0.0 112.282 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 62.93 173.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HZ3' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 56.79 24.28 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -142.21 -164.34 1.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.323 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.69 HG13 ' HA3' ' A' ' 52' ' ' GLY . 29.1 t -91.49 104.63 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.408 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.915 HD12 HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -91.97 -33.65 14.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -157.72 136.76 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.512 ' O ' HG13 ' A' ' 83' ' ' ILE . 2.2 mtpt -135.16 100.71 4.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.271 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.84 114.36 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.809 HG23 ' HB ' ' A' ' 80' ' ' VAL . 9.1 m -87.19 108.05 17.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.198 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -85.57 108.44 17.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 20.3 ttm180 -55.54 117.09 3.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -84.59 69.39 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.217 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -87.55 -3.93 58.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.58 123.71 2.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.544 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.738 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.2 ttpt -42.63 155.13 0.05 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.325 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -168.56 58.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.799 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 7.3 pt-20 -55.73 111.65 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.224 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.5 -12.65 39.47 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.519 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.571 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 39.9 t -54.65 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 2.1 p-10 -83.6 138.66 33.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.261 0.553 . . . . 0.0 112.19 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 134' ' ' LEU . 4.7 mp -110.77 132.14 54.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.615 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.4 126.5 46.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.019 0.438 . . . . 0.0 111.65 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 53' ' ' VAL . 22.5 m -101.51 94.72 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.665 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 20.9 p -100.63 -169.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.695 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.72 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.928 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER -64.98 105.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 0.0 110.607 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -178.47 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.293 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 148' ' ' VAL . 4.0 m -141.45 -179.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.67 81.82 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.956 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 27.6 t0 -45.92 160.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 111.271 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.05 97.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -66.52 -31.34 72.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.317 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.04 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.39 168.89 2.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.811 HG22 ' O ' ' A' ' 141' ' ' VAL . 56.6 t -123.99 141.56 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.052 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.767 ' CD2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.14 94.23 4.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -46.97 104.62 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.743 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.451 HD11 ' HE1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -85.71 -176.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -72.5 -158.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.28 168.85 35.99 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.231 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.797 ' HB ' HD23 ' A' ' 37' ' ' LEU . 44.4 m -164.7 163.95 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 110.662 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 154' ' ' THR . 15.9 pt-20 -134.64 177.44 7.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.169 0.509 . . . . 0.0 111.692 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.818 ' HE2' HD12 ' A' ' 37' ' ' LEU . 10.3 tppt? -146.59 169.74 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 0.6 OUTLIER -141.64 115.9 9.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.42 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -104.61 137.94 31.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.226 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.77 105.38 15.58 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.571 179.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -83.63 121.44 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 121.305 0.574 . . . . 0.0 109.621 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -104.24 148.8 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.396 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.71 145.66 48.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.902 0.382 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.468 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.862 0.363 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 23.7 t -60.65 155.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -81.47 -46.04 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 74.43 117.4 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.301 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.956 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -163.48 136.77 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.19 0.519 . . . . 0.0 111.465 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.5 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.631 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -91.55 106.3 18.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.089 178.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.915 HD23 HG22 ' A' ' 154' ' ' THR . 6.4 tp -112.35 116.86 31.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -140.35 108.48 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.279 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 156' ' ' LYS . . . -138.6 161.95 35.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.563 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.373 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 69.24 24.87 5.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.703 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 158' ' ' VAL . 28.3 tt0 -164.71 125.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -147.6 107.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.343 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -67.92 126.32 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.131 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.442 HG23 ' CG2' ' A' ' 160' ' ' ILE . 1.5 t -29.45 127.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.81 12.85 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.628 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -175.63 2.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.87 148.61 52.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.818 HD22 HG11 ' A' ' 158' ' ' VAL . 4.2 pp -97.01 159.93 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HA ' HG12 ' A' ' 122' ' ' VAL . 3.7 mt-10 -128.26 93.57 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.3 p -102.37 98.16 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.835 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.35 79.94 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.559 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 136' ' ' VAL . 9.6 p -78.46 102.92 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.96 -130.12 5.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.096 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -109.36 127.42 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.624 -179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 28.1 t0 -96.81 -37.06 10.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 22.4 mp0 -162.09 130.77 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.169 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 1.6 tt -158.86 91.05 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.636 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.4 p -118.65 104.25 15.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.582 ' N ' HG22 ' A' ' 31' ' ' VAL . 34.3 m-20 134.0 23.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 111.519 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -152.68 -170.9 3.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.642 0.258 . . . . 0.0 110.75 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -139.7 82.21 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.36 . . . . 0.0 110.661 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.37 121.19 12.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.276 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' HA2' ' A' ' 144' ' ' GLY . 3.7 m-85 -117.8 -40.68 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.2 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.557 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.4 t80 -86.07 135.7 33.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.388 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.71 109.62 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.792 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.2 p90 -124.82 171.24 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.54 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 104.58 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.512 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 71' ' ' ASN . 5.2 tt -77.11 153.48 34.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 111.141 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' HD23 ' A' ' 70' ' ' LEU . 3.3 m-80 -127.56 107.35 9.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' HB3' HD22 ' A' ' 134' ' ' LEU . 16.7 p90 -122.67 -168.54 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.04 139.97 37.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.071 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -24.66 15.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.15 -28.27 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.744 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -120.76 -44.68 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.5 m-85 -93.31 -178.38 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 3.2 tt0 -171.61 115.66 0.39 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.292 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.837 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.5 t80 -46.49 134.49 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.737 ' HB ' HG23 ' A' ' 122' ' ' VAL . 33.6 t -106.41 -81.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 122' ' ' VAL . 20.2 mm-40 -162.14 137.73 7.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.65 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 121' ' ' VAL . . . -82.57 146.28 29.26 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.987 0.899 . . . . 0.0 111.342 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.57 154.62 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.444 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.816 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -115.44 163.65 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.916 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.92 -160.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.9 37.56 1.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.816 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.1 -40.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.015 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.816 HG23 ' OG ' ' A' ' 84' ' ' SER . 8.9 m -86.95 169.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 0.0 110.918 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.83 144.47 45.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 104' ' ' VAL . 7.5 t -141.86 140.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -156.97 107.8 2.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.837 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.31 178.25 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -154.39 110.93 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.9 tttm -53.99 95.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.181 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.842 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.1 tp -78.51 -24.52 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.727 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.74 -166.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.751 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.9 132.97 34.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.91 29.85 65.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.423 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HE3' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -173.91 122.17 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.842 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -149.3 155.12 8.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.722 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 16.9 tpp85 -92.71 151.75 19.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.969 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 68' ' ' PHE . 4.0 p -127.51 137.14 58.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.862 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -119.79 102.86 8.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.901 HG11 ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -108.03 155.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.058 0.456 . . . . 0.0 111.424 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 p -164.41 137.16 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.715 ' HA ' HG12 ' A' ' 88' ' ' VAL . 10.4 m -75.81 104.83 6.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.977 0.418 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.1 tt -93.29 26.32 2.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.114 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.4 p -99.02 -31.49 11.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.995 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.37 5.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.144 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.28 158.21 32.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.692 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -65.38 -175.72 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.548 2.165 . . . . 0.0 112.473 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.713 ' CD2' HD21 ' A' ' 118' ' ' LEU . 0.8 OUTLIER -54.87 114.6 7.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.44 -38.87 31.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.052 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.61 168.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.4 16.14 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.071 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.42 -166.81 2.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.338 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.835 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.7 t -78.45 105.07 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.796 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.58 -31.17 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.901 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -169.15 135.52 1.7 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.874 0.368 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.821 ' HD3' HG11 ' A' ' 117' ' ' VAL . 4.2 mtmt -124.92 112.34 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.595 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 82' ' ' ALA . 24.9 t -99.8 96.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' VAL . 19.2 m -75.43 119.87 24.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.03 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 3.1 mm? -87.01 169.36 12.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.678 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.6 tpm_? -106.57 119.35 39.05 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.94 68.13 8.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.452 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.83 -6.42 58.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.47 124.06 2.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.714 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.681 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.3 ttpp -40.74 158.01 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.373 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.744 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -171.61 58.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.743 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.2 pm0 -55.66 117.18 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.221 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 20.93 51.01 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.478 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.543 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 8.0 t -71.15 65.54 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.046 0.451 . . . . 0.0 110.309 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.22 131.71 4.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.517 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -112.08 150.15 31.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.49 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -133.95 125.88 29.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 111.618 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 53' ' ' VAL . 23.3 m -113.46 94.77 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.683 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.489 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -101.66 -159.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.67 22.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.473 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -62.51 82.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.15 141.08 46.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.093 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.072 HG21 ' HB1' ' A' ' 63' ' ' ALA . 7.8 p -118.35 150.69 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 99.61 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.895 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 27.1 t0 -50.37 161.99 0.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 110.961 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 64' ' ' PHE . . . -59.49 -45.05 96.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.547 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.15 -31.17 72.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.42 -28.22 3.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.44 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.72 168.74 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 141' ' ' VAL . 8.0 p -122.92 148.33 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 38.4 m-70 -125.5 91.06 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.2 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.8 104.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.113 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.502 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 -177.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.328 0.585 . . . . 0.0 112.079 -178.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -60.89 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.349 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.93 176.73 34.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.915 HG22 HD23 ' A' ' 37' ' ' LEU . 51.5 m -164.96 145.47 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.554 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.07 163.43 13.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.166 0.508 . . . . 0.0 111.7 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.645 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -133.5 164.06 28.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.592 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.446 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.3 p -142.71 115.42 8.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.29 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.818 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.02 128.8 69.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 111.227 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.27 105.69 17.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.712 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.844 HD11 ' CE2' ' A' ' 77' ' ' PHE . 15.4 mt -83.22 115.96 26.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.479 0.657 . . . . 0.0 109.717 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.78 141.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.65 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.11 146.07 55.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.018 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.435 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.945 0.402 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.2 t -76.16 151.68 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.9 t -69.21 -47.97 63.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 151' ' ' ILE . . . 77.91 107.22 0.18 Allowed Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.064 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.965 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.0 t -166.11 136.2 3.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.45 0.643 . . . . 0.0 111.762 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 151' ' ' ILE . 27.4 m -95.66 144.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.504 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 6.2 t -105.54 111.5 24.23 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.072 HD12 HG22 ' A' ' 154' ' ' THR . 3.6 mt -97.25 125.53 41.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.044 0.449 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.16 101.38 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.308 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -145.92 152.28 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.485 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.64 -29.11 67.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.236 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.49 24.93 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.455 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 158' ' ' VAL . 20.1 tt0 -164.68 128.08 2.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.859 0.361 . . . . 0.0 111.925 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -148.4 107.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.259 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.2 tt0 -68.32 128.13 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.036 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.86 132.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.14 -21.85 38.51 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.96 173.45 6.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.56 167.34 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.637 ' CD1' HG23 ' A' ' 51' ' ' VAL . 3.7 pp -125.41 160.72 28.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -136.67 110.19 7.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.964 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 39' ' ' ALA . 12.7 t -109.61 97.67 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.981 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.78 68.15 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.636 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.0 HG21 HG11 ' A' ' 136' ' ' VAL . 10.3 p -78.19 95.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.18 -122.49 4.6 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.98 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.54 130.81 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 112.138 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.0 t70 -101.72 -32.8 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 32' ' ' THR . 36.4 mt-10 -157.2 128.66 6.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.418 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -161.22 90.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.92 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.9 p -125.57 106.02 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.566 ' N ' HG22 ' A' ' 31' ' ' VAL . 1.2 m120 131.5 18.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.462 1.101 . . . . 0.0 111.418 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . . . -148.43 -179.41 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.945 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 2.8 mm-40 -126.4 77.16 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.936 0.398 . . . . 0.0 110.58 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.47 112.1 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.6 m-85 -115.72 -59.88 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.802 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.23 112.62 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.589 ' OH ' HD11 ' A' ' 151' ' ' ILE . 1.5 t80 -86.16 138.65 31.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -147.55 110.27 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.265 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 102' ' ' VAL . 12.9 p90 -137.69 171.55 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -131.99 106.09 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.656 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.693 HD22 HD23 ' A' ' 134' ' ' LEU . 1.3 mt -77.29 157.19 30.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.825 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -121.62 104.37 9.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.97 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.9 p90 -114.95 -167.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.3 t70 -112.05 132.38 54.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.38 -28.02 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -60.24 -30.28 69.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.981 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.83 -46.26 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.4 m-85 -93.34 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.751 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -165.29 113.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.773 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.749 ' CD1' HG21 ' A' ' 100' ' ' VAL . 20.0 t80 -46.68 155.91 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -137.73 -81.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 14.4 pt-20 -152.42 131.64 12.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.06 149.54 26.86 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.304 1.049 . . . . 0.0 111.774 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -133.4 174.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.073 -177.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -168.33 2.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.811 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.91 -161.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.17 37.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.816 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 -37.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' SER . 30.1 t -86.71 143.86 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -106.27 107.08 17.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 111.005 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -105.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -143.43 117.9 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.349 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.72 173.01 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.946 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.22 107.33 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.443 . . . . 0.0 111.697 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.5 tttp -54.77 115.19 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.271 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.6 tp -111.5 -22.37 5.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.919 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.79 -166.84 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.58 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -101.42 50.84 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.591 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.61 129.83 0.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.749 HG21 ' CD1' ' A' ' 79' ' ' TYR . 17.4 m -150.1 155.2 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -80.94 152.05 28.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.352 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 68' ' ' PHE . 8.9 p -134.13 110.7 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.403 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 mt -88.54 114.34 25.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.907 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.623 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 13.4 t -107.43 137.73 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.508 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.472 ' C ' HG13 ' A' ' 88' ' ' VAL . 3.8 p -164.27 136.21 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.37 104.49 15.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.211 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.85 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.3 p -65.34 -34.76 79.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.84 -19.76 30.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.382 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.33 154.64 71.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 55.6 Cg_endo -70.42 157.99 57.43 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.658 2.239 . . . . 0.0 112.364 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 ' CD1' ' A' ' 118' ' ' LEU . 35.5 mt -59.9 111.1 3.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.8 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.89 -21.35 73.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.395 2.064 . . . . 0.0 112.26 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.1 175.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.602 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.72 24.27 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 110.383 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.81 -166.62 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.201 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.769 HG13 ' HA3' ' A' ' 52' ' ' GLY . 21.5 t -85.9 104.69 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.635 ' CD1' HD22 ' A' ' 112' ' ' LEU . 1.7 mm? -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -160.05 135.23 8.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.843 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.711 ' HD2' HG11 ' A' ' 117' ' ' VAL . 10.3 mtpt -128.22 100.87 6.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.034 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.8 p -81.29 107.02 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 110.268 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 83' ' ' ILE . 23.0 t -75.69 106.9 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.037 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 134' ' ' LEU . 12.1 mt -89.99 169.22 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 5.5 ttm180 -114.38 122.99 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -91.57 68.96 5.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.294 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.51 -5.68 58.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.413 0.625 . . . . 0.0 109.529 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.03 123.83 2.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.49 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.3 ttmt -41.59 159.94 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.272 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.782 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -174.98 57.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.017 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.3 mt-10 -56.18 113.39 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.097 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.31 46.97 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.544 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.782 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 2.5 m -61.06 86.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.936 0.398 . . . . 0.0 110.235 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.417 ' ND2' HG22 ' A' ' 157' ' ' THR . 3.5 m120 -58.67 171.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.654 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -146.84 108.72 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.116 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.4 p -97.46 122.58 40.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.439 . . . . 0.0 111.407 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 53' ' ' VAL . 7.2 p -107.48 95.16 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.457 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.4 p -102.45 -166.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.573 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.91 20.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 m -61.88 88.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.55 166.33 11.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.486 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 63' ' ' ALA . 13.2 p -140.33 159.95 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.982 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -97.36 91.39 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.648 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 17.1 t70 -48.61 161.46 0.13 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.37 78.39 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.12 -30.47 65.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.49 -26.85 4.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.595 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.3 mt -68.39 169.98 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.66 148.22 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -119.22 90.85 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -49.98 102.03 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.589 HD11 ' OH ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -89.38 -176.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.325 0.583 . . . . 0.0 111.659 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.62 -158.08 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -161.2 171.73 37.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.034 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 1.072 HG22 HD12 ' A' ' 37' ' ' LEU . 55.1 m -158.85 146.52 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.97 151.79 25.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.033 0.444 . . . . 0.0 111.413 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 37' ' ' LEU . 6.5 tppt? -128.97 167.49 17.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.975 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.417 HG22 ' ND2' ' A' ' 133' ' ' ASN . 0.8 OUTLIER -143.17 126.21 16.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.11 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -113.3 131.6 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.14 106.45 18.75 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.833 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.84 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -85.44 116.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.384 0.612 . . . . 0.0 109.922 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.01 146.21 8.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.556 -178.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.98 145.91 54.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 60' ' ' ASN . 13.1 t -60.54 147.76 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 57' ' ' GLU . 14.6 t -70.89 -45.54 64.19 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.467 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 73.51 109.43 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.583 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -159.49 138.71 11.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.603 0.716 . . . . 0.0 111.754 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.3 m -98.26 141.52 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 21.3 p -100.6 111.01 23.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 154' ' ' THR . 3.2 mt -97.14 126.48 42.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 101.55 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -147.93 151.32 35.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -61.47 -28.3 69.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.7 mt-10 72.92 24.31 2.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.605 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG2' HD11 ' A' ' 161' ' ' ILE . 12.6 tt0 -164.81 128.37 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.849 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.882 ' O ' HG23 ' A' ' 160' ' ' ILE . 4.1 p -144.58 108.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.394 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.25 125.25 26.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.038 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -28.86 130.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.01 -15.0 52.09 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.753 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 43' ' ' VAL . 5.4 tp10 -106.34 171.36 7.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.736 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -106.63 167.81 9.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 158' ' ' VAL . 11.2 mt -120.2 150.99 39.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.63 93.28 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.493 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.944 HG12 ' CB ' ' A' ' 39' ' ' ALA . 27.3 m -106.88 97.06 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.103 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.815 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.91 76.36 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.659 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 136' ' ' VAL . 12.5 p -78.54 95.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -105.79 -129.79 6.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.828 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.72 132.01 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 111.69 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 5.1 t0 -97.84 -31.43 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.122 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -178.17 133.4 0.15 Allowed 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.485 0.66 . . . . 0.0 111.894 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -159.41 115.52 2.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.634 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.8 p -133.53 102.38 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.594 ' N ' HG22 ' A' ' 31' ' ' VAL . 22.4 m-20 138.37 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.384 1.053 . . . . 0.0 111.914 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.3 174.44 14.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.33 87.02 2.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.84 112.67 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.446 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -103.6 -35.3 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.129 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.49 112.38 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.348 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.826 ' O ' HG12 ' A' ' 104' ' ' VAL . 67.2 t80 -99.11 152.02 20.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.19 116.94 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.891 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.903 ' O ' HG12 ' A' ' 102' ' ' VAL . 5.7 p90 -117.8 140.18 50.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.081 0.467 . . . . 0.0 111.459 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 94.17 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.773 HD12 HG13 ' A' ' 136' ' ' VAL . 2.2 tp -80.02 139.68 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -111.65 104.36 12.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.846 ' HA ' HD23 ' A' ' 134' ' ' LEU . 38.9 p90 -100.16 -170.79 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.75 126.15 42.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.192 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -85.45 -17.26 37.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.021 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -96.47 29.21 2.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.868 0.366 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.906 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -171.86 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.25 170.52 9.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -153.11 109.09 3.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.539 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 14.4 t80 -53.23 143.72 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' ARG . 41.5 t -123.09 -72.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.33 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.69 142.71 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.94 153.62 24.95 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 122.125 0.965 . . . . 0.0 111.655 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.84 152.68 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.455 -177.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -124.91 -173.22 2.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.92 -158.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -93.5 37.41 1.06 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.6 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.315 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 89' ' ' PHE . 11.2 t -86.74 157.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.422 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -115.04 102.99 10.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 119' ' ' ALA . 3.5 t -104.65 120.76 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -134.14 118.38 17.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.23 0.538 . . . . 0.0 111.526 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.94 146.79 24.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.013 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -132.44 106.81 8.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.399 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 12.2 tttp -55.47 95.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.811 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -81.34 -30.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.809 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.32 -168.02 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.62 128.83 34.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 59.12 33.23 73.75 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.549 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -173.71 121.41 0.32 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.811 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.9 m -149.71 155.58 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.643 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -96.94 152.46 18.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.986 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.5 p -128.67 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.968 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.08 108.16 14.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.8 p -108.47 137.55 39.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.09 0.472 . . . . 0.0 111.042 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.8 p -161.83 135.86 6.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -78.91 104.42 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.39 -13.01 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.0 p -65.21 -27.17 68.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.34 -20.74 12.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.35 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.44 142.34 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.625 0.25 . . . . 0.0 110.661 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 50.7 Cg_exo -54.0 150.91 29.13 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.446 2.097 . . . . 0.0 112.358 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -56.3 128.61 73.38 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.714 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.836 ' O ' HD12 ' A' ' 112' ' ' LEU . 13.0 Cg_exo -69.9 -159.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.541 2.161 . . . . 0.0 112.318 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.586 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -155.91 166.87 32.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 14.7 9.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.85 -165.79 1.8 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.078 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.815 HG13 ' HA3' ' A' ' 52' ' ' GLY . 30.6 t -84.78 104.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -86.83 -34.95 19.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -166.81 131.87 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HD2' HG11 ' A' ' 117' ' ' VAL . 3.8 mtpt -117.05 120.92 39.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.497 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.673 HG11 HD22 ' A' ' 70' ' ' LEU . 8.6 p -88.85 142.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 83' ' ' ILE . 23.4 t -113.7 117.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.658 HD22 ' CD1' ' A' ' 72' ' ' TYR . 2.5 mt -115.79 108.52 16.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.49 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 80' ' ' VAL . 26.6 ttm180 -64.18 115.25 4.81 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -74.27 74.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.378 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.34 -4.28 59.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.486 0.66 . . . . 0.0 109.452 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.72 123.48 2.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.352 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 16.9 ttmt -47.59 139.96 6.53 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.365 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.906 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.16 62.25 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.852 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.34 112.9 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.92 49.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.607 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.327 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.38 133.28 4.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.301 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -117.82 116.0 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.841 179.265 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 p -109.76 128.65 55.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.598 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 53' ' ' VAL . 9.6 m -106.13 94.96 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.458 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 p -97.27 -163.78 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.64 21.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.959 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.478 ' HB3' HD11 ' A' ' 151' ' ' ILE . 73.6 m -59.06 101.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -113.5 165.28 12.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' VAL . 27.6 m -143.72 125.48 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.013 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.21 100.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.584 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.15 161.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -28.18 72.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.71 -34.8 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.54 2.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 147' ' ' LEU . 13.5 mt -72.89 161.24 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 140' ' ' SER . 11.5 p -113.45 136.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.102 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -109.74 90.67 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -51.08 107.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.39 177.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.612 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -62.36 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.974 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.13 168.56 41.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.399 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.949 HG22 HD12 ' A' ' 37' ' ' LEU . 65.4 m -156.21 146.83 21.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.2 167.77 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 111.435 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' A' ' 37' ' ' LEU . 2.9 tppt? -139.57 168.8 19.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.246 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.425 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.3 p -142.32 115.83 9.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.742 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG22 HD11 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -110.53 126.67 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.13 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.05 105.88 18.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.789 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.882 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.4 mt -78.76 122.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.02 131.2 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.594 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.18 145.02 44.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.043 0.449 . . . . 0.0 111.214 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.493 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.898 0.38 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 61' ' ' ALA . 25.2 t -82.02 146.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -66.82 -35.14 79.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.665 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.18 108.19 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.035 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.547 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 t -153.43 138.82 17.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.707 0.765 . . . . 0.0 111.977 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 151' ' ' ILE . 34.1 m -91.02 145.3 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.247 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 t -104.9 107.57 18.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.492 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 154' ' ' THR . 6.8 mt -96.8 111.6 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.173 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -140.18 101.47 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.483 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -144.0 158.45 43.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -56.86 -23.45 44.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.8 mt-10 65.62 23.02 11.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.444 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.554 ' CD ' HD11 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -164.87 128.26 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 0.0 111.854 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.921 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -143.14 108.78 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.192 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.59 126.5 29.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.612 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.1 t -29.08 133.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.477 0.656 . . . . 0.0 112.723 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.12 -26.88 22.53 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.126 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -90.02 172.65 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.488 ' HB3' HG13 ' A' ' 122' ' ' VAL . 5.8 m120 -110.31 137.44 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.699 HD11 HG11 ' A' ' 158' ' ' VAL . 21.6 tp -92.02 149.92 21.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HD12 ' A' ' 83' ' ' ILE . 6.2 tt0 -136.21 101.66 4.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' CB ' ' A' ' 39' ' ' ALA . 5.8 m -106.32 97.96 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.778 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -77.62 67.62 2.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.607 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 136' ' ' VAL . 8.5 p -78.4 95.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.005 0.431 . . . . 0.0 110.515 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.06 -120.07 4.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.107 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.92 133.4 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.015 0.435 . . . . 0.0 111.993 -179.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.49 -37.89 8.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.5 mt-10 -155.62 130.79 9.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.122 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.941 HD21 ' HB3' ' A' ' 61' ' ' ALA . 10.3 tt -156.66 90.97 1.19 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.502 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.76 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.3 p -110.98 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.9 m-20 100.38 20.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.715 0.806 . . . . 0.0 111.797 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.941 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -140.2 139.14 35.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.673 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -101.06 80.65 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.619 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.41 111.84 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 22.4 m-85 -113.53 -31.33 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.23 114.78 9.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.685 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.1 t80 -85.59 127.18 34.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.12 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -141.62 109.93 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.855 ' CD1' HG13 ' A' ' 136' ' ' VAL . 15.0 p90 -140.69 171.11 14.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.985 0.421 . . . . 0.0 111.315 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -117.36 114.49 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.663 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.518 HD12 HG22 ' A' ' 136' ' ' VAL . 23.7 tp -77.39 151.27 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.48 104.57 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' HD21 ' A' ' 134' ' ' LEU . 17.2 p90 -129.24 -167.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -112.73 139.85 48.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.053 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.67 -28.79 15.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.37 -47.59 85.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.973 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.928 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -99.81 -46.5 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.194 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.0 m-85 -93.36 166.5 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -152.18 112.67 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 123' ' ' LEU . 31.5 t80 -54.12 151.65 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 124' ' ' ARG . 48.1 t -130.24 -70.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.885 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 122' ' ' VAL . 5.8 pt-20 -172.52 141.86 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.636 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 148.43 28.04 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.14 0.971 . . . . 0.0 111.721 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 152.25 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.074 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.669 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -113.55 -169.59 1.53 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.969 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.55 -159.81 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.81 35.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.37 -46.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.083 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.665 HG23 ' OG ' ' A' ' 84' ' ' SER . 28.4 m -90.65 173.5 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -121.23 139.28 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 104' ' ' VAL . 2.4 t -136.13 109.28 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.14 119.11 31.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.11 172.27 7.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 107.38 3.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.695 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 tttp -55.38 95.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.948 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 100' ' ' VAL . 5.1 tp -86.45 -28.95 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.41 -174.84 5.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.88 136.54 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 56.94 27.08 56.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.457 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -173.35 123.6 0.39 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.703 ' HA ' HG22 ' A' ' 95' ' ' ILE . 16.5 m -150.27 154.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.885 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.524 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -81.29 152.13 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.924 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.82 93.58 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.905 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.1 mt -75.97 115.28 15.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 90' ' ' VAL . 11.3 t -112.83 145.35 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.016 0.436 . . . . 0.0 111.483 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.7 p -164.32 136.03 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.363 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.603 ' CB ' HG12 ' A' ' 88' ' ' VAL . 32.1 m -84.53 104.62 14.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.54 -15.07 63.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -65.34 -34.75 79.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.78 -16.9 25.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.446 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.34 160.6 29.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 39.2 Cg_exo -56.85 173.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 66' ' ' TYR . 3.8 mp -67.67 134.16 92.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.51 -38.73 71.14 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.508 2.139 . . . . 0.0 112.256 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HA ' HD21 ' A' ' 118' ' ' LEU . . . 59.05 162.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.968 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.9 15.75 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 -163.29 1.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.254 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.824 HG11 ' HD3' ' A' ' 120' ' ' LYS . 39.1 t -76.86 105.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -95.62 -30.18 13.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -158.96 136.03 9.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.421 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.824 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -132.93 111.12 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.323 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 70' ' ' LEU . 56.3 t -86.09 114.83 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD11 ' A' ' 83' ' ' ILE . 54.8 t -75.62 105.44 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.841 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 79' ' ' TYR . 24.7 mt -103.13 108.49 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.598 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.516 ' H ' HG23 ' A' ' 80' ' ' VAL . 38.4 ttm180 -68.9 117.79 11.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.96 80.75 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.872 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.43 -5.27 58.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.3 123.5 2.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.185 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.3 ttpt -61.33 131.37 50.11 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.81 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -133.38 75.84 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.64 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.99 110.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 111.033 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.78 14.61 39.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.553 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.588 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -61.02 86.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 110.276 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 5.6 m120 -60.17 151.36 27.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 132' ' ' SER . 3.5 mp -146.52 139.28 25.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.88 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.0 t -134.98 134.7 40.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.091 0.472 . . . . 0.0 111.6 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.855 HG13 ' CD1' ' A' ' 68' ' ' PHE . 48.4 t -105.02 95.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.482 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.486 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.6 p -102.73 -169.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.486 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.47 20.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.948 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 151' ' ' ILE . 49.9 m -64.26 97.8 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.344 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.412 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -103.74 171.6 7.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 58' ' ' LEU . 19.7 m -144.31 125.11 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 78.36 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.636 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 23.0 t0 -59.41 138.34 57.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.858 0.361 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.5 -28.05 61.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.678 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.13 -27.91 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 110.958 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.96 -11.21 22.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.743 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -114.52 121.02 42.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.6 p -73.4 126.16 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -95.1 93.2 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.078 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -51.15 110.56 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.36 168.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 112.135 -178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -61.03 -141.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.37 176.05 46.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.469 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 37' ' ' LEU . 17.9 m -159.68 149.12 18.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.7 0.286 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -104.32 154.54 19.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 111.588 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.647 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -147.66 155.13 41.45 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.647 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.7 p -138.76 135.27 34.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -119.59 125.52 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.527 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.87 105.7 17.79 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.921 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.1 mt -76.16 143.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -130.74 133.51 63.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.685 -177.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.1 144.52 19.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.231 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.458 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.822 0.344 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 HD23 ' A' ' 58' ' ' LEU . 79.7 t -71.9 152.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.0 t -60.52 -43.5 97.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.345 0.593 . . . . 0.0 109.493 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 66.49 102.92 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.754 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.902 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 18.9 t -160.73 138.73 9.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.517 0.675 . . . . 0.0 112.166 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 151' ' ' ILE . 34.0 m -97.32 134.67 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.266 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 3.8 t -92.11 108.05 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.704 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.598 HD22 ' CG2' ' A' ' 154' ' ' THR . 10.0 tp -97.23 124.52 41.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -140.55 106.99 5.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.687 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -147.65 165.53 30.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.525 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 49' ' ' LEU . 11.0 mt -78.88 -27.53 44.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.701 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.3 OUTLIER 71.97 23.04 3.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HG2' HD11 ' A' ' 161' ' ' ILE . 10.8 tt0 -164.54 129.08 2.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.58 107.91 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.46 125.36 26.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.215 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -29.23 131.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.15 -20.05 46.65 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.439 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -99.56 172.33 7.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB3' HG21 ' A' ' 122' ' ' VAL . 10.0 m-80 -121.52 130.01 53.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -118.45 133.47 55.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.824 ' HG2' HD11 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -113.79 154.01 28.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.566 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 51' ' ' VAL . 24.9 m -125.9 98.22 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.696 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.58 64.49 0.62 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.473 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 136' ' ' VAL . 9.1 p -78.25 95.53 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.667 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.33 -122.56 4.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.032 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.504 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -111.24 129.75 65.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.776 -179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 24.3 t70 -99.19 -37.36 9.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.712 ' HB3' HG21 ' A' ' 32' ' ' THR . 29.2 mt-10 -159.11 130.02 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.589 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 HG11 ' A' ' 31' ' ' VAL . 1.1 tt -159.55 91.58 1.0 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.251 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.733 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -122.06 107.07 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.55 ' CA ' HG22 ' A' ' 31' ' ' VAL . 63.2 m-20 130.18 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.435 1.094 . . . . 0.0 111.543 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -157.92 162.56 38.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -113.85 83.88 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -63.29 111.78 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.526 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -102.26 -38.71 7.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.93 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.91 112.31 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.112 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.4 t80 -105.2 94.34 5.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.864 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -109.12 133.28 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.631 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 47.9 p90 -135.99 171.27 14.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 111.421 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.411 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -119.0 102.71 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.071 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.064 HD21 HD23 ' A' ' 134' ' ' LEU . 9.8 tt -76.88 157.32 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.096 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.692 ' N ' HD23 ' A' ' 70' ' ' LEU . 3.4 m-80 -127.27 130.47 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 1.8 p90 -140.97 -167.42 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.548 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.03 136.3 53.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' CB ' ' HB2' ' A' ' 97' ' ' ASP . 33.3 tt0 -94.07 -6.35 45.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.286 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.59 31.26 2.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.897 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.32 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.651 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 160' ' ' ILE . 3.0 m-85 -100.32 -177.08 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.76 108.86 0.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.9 t80 -48.55 147.65 2.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 122' ' ' VAL . 60.1 t -127.69 -80.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 122' ' ' VAL . 4.8 mt-10 -161.42 138.84 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.92 150.54 26.41 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 122.01 0.91 . . . . 0.0 111.279 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.28 152.38 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.501 -177.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.574 ' HB3' HG23 ' A' ' 90' ' ' VAL . 15.1 p -115.65 -176.93 3.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.72 -156.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -93.65 36.77 1.08 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.875 0.369 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.79 -38.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.216 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 89' ' ' PHE . 26.6 t -87.06 159.03 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.4 t80 -114.85 117.02 29.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 104' ' ' VAL . 10.8 t -115.41 131.98 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.56 115.61 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -95.76 149.8 21.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -136.51 106.86 6.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.713 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 24.5 tttt -55.52 120.38 7.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.362 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.4 tp -112.06 -23.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.834 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.54 -179.19 7.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 111.152 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -47.2 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -106.07 60.57 0.37 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.27 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -174.0 123.72 0.33 Allowed 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.3 m -148.81 155.41 8.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.637 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -99.11 152.34 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.067 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.615 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.3 p -125.21 147.63 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.394 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.38 109.92 18.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 90' ' ' VAL . 21.4 t -109.28 137.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 111.524 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.3 p -164.25 136.06 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.448 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -79.37 104.39 9.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.242 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -70.51 -14.78 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.462 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.5 p -65.26 -28.87 69.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.0 -17.74 22.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.454 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -99.18 147.66 33.58 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 52.4 Cg_exo -54.16 169.88 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 63' ' ' ALA . 51.1 mt -58.23 113.96 7.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 -21.22 51.72 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.406 2.071 . . . . 0.0 112.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 59.56 169.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.849 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.12 27.05 14.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 110.602 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 118' ' ' LEU . 16.7 tt0 -155.38 154.5 32.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.696 HG13 ' HA3' ' A' ' 52' ' ' GLY . 26.9 t -47.43 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.224 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 116' ' ' GLU . 1.1 mm? -92.05 -29.3 16.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -163.0 136.4 5.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.74 0.305 . . . . 0.0 111.513 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.64 ' HD2' HG11 ' A' ' 117' ' ' VAL . 7.2 mtpt -131.85 100.75 5.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.428 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 82' ' ' ALA . 93.1 t -91.69 107.04 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.9 p -83.89 124.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -99.49 114.06 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.411 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 24.5 ttm180 -54.95 116.81 2.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -87.63 67.94 9.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.255 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 -0.83 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.481 0.658 . . . . 0.0 109.312 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.16 123.39 2.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.235 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.74 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.0 ttpt -45.44 142.19 2.32 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.627 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -149.07 59.61 1.04 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.713 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -56.05 118.61 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.167 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.36 13.59 70.49 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.51 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.776 ' O ' HD12 ' A' ' 134' ' ' LEU . 29.6 t -70.35 66.56 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.469 . . . . 0.0 110.144 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.456 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -43.97 138.28 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.482 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.064 HD23 HD21 ' A' ' 70' ' ' LEU . 4.6 mp -119.17 127.14 53.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.458 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.413 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -119.84 126.39 50.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.123 0.487 . . . . 0.0 111.957 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 53' ' ' VAL . 18.7 m -113.87 94.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.479 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -105.82 -159.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.783 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.422 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -63.52 104.74 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 0.0 110.371 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.09 167.17 9.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.493 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 58' ' ' LEU . 8.4 m -141.65 120.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.962 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.71 98.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.669 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -55.81 161.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.74 79.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.87 -46.23 25.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.14 -27.84 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.4 119.31 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.971 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.27 153.42 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -122.13 90.61 3.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.69 103.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.266 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.45 -176.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 111.947 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -64.63 -160.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.53 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.1 -174.29 23.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.019 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.598 ' CG2' HD22 ' A' ' 37' ' ' LEU . 11.6 t -160.62 -171.03 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.429 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 14.0 tt0 -161.8 157.85 24.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 41' ' ' GLU . 2.2 tppm? -143.17 168.73 19.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.186 0.517 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.5 p -141.67 115.7 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.415 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -109.9 119.11 58.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.188 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 105.89 18.09 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.9 mt -78.25 119.68 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.2 132.77 48.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.692 -178.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.12 145.84 45.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.511 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.794 0.331 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.84 HG21 ' HB2' ' A' ' 61' ' ' ALA . 17.0 t -76.26 151.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.764 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 33' ' ' GLY . 1.5 t -84.65 -33.16 23.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.609 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.19 121.74 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.549 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.606 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.5 146.37 31.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.211 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 153' ' ' GLY . 28.7 m -96.07 135.99 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 3.6 t -90.96 107.11 18.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.246 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.829 ' HB2' HG21 ' A' ' 154' ' ' THR . 13.1 tp -97.48 106.26 18.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.833 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -140.95 101.03 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -137.03 166.16 24.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 111.274 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -69.68 -35.87 75.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.626 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' HA ' HG13 ' A' ' 158' ' ' VAL . 5.6 mt-10 68.29 31.46 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 161' ' ' ILE . 15.7 tt0 -164.21 116.47 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.3 p -133.14 165.48 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.901 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.541 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -129.47 113.04 14.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 128' ' ' LYS . 2.1 t -28.11 119.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 121.59 -27.61 6.22 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.43 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -102.47 -175.37 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.74 0.305 . . . . 0.0 110.478 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.65 ' HB3' HG13 ' A' ' 122' ' ' VAL . 23.6 m-80 -113.66 165.06 12.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.188 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.8 tp -117.54 156.76 27.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -136.45 93.95 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.146 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' A' ' 39' ' ' ALA . 8.1 p -103.63 98.13 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.703 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.682 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.53 68.2 3.21 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.924 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 136' ' ' VAL . 7.4 p -78.61 95.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.05 -129.74 6.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.865 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -105.51 138.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 111.543 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -98.55 -37.48 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.04 131.99 0.05 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.551 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -135.62 95.51 3.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.526 178.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -85.27 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.766 ' HB2' HG22 ' A' ' 31' ' ' VAL . 53.1 m-20 96.68 31.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.29 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.39 149.77 41.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.362 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.5 mt-10 -119.76 71.3 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.723 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.09 122.42 15.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.234 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -105.93 -32.84 8.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.654 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.84 112.3 7.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.04 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 112' ' ' LEU . 21.9 t80 -104.25 94.69 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.1 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -102.42 130.23 49.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.749 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 41.6 p90 -132.85 171.11 14.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -132.7 97.27 4.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.186 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.826 ' CD1' HG11 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -77.2 157.71 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.432 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -116.54 104.57 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 24.4 p90 -111.24 -167.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -106.96 125.54 51.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.78 -40.82 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.803 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.68 -35.54 80.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -96.46 -57.95 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 160' ' ' ILE . 8.3 m-85 -93.44 165.38 12.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -145.02 109.74 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.657 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 22.1 t80 -54.01 140.46 31.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.9 t -119.52 -72.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 3.2 mt-10 -169.04 143.57 3.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.74 147.73 28.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 122.169 0.985 . . . . 0.0 111.698 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.41 152.83 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.474 -177.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -166.36 1.16 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.52 -157.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.27 36.25 1.06 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.09 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.969 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 89' ' ' PHE . 38.1 t -86.88 160.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.782 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.613 ' HB2' HD13 ' A' ' 107' ' ' LEU . 12.8 t80 -112.03 136.71 51.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.959 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 104' ' ' VAL . 2.5 t -134.37 105.46 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.34 114.89 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.611 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.657 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.27 -176.98 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.12 107.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.388 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttm -54.82 111.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.039 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -102.58 -28.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.86 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.31 170.71 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.32 133.75 45.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.13 28.48 64.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.323 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.448 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 5.8 ptmt -173.66 122.98 0.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.67 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 20.9 m -150.27 155.92 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -88.28 152.05 22.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.313 -178.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.749 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.17 95.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.525 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.88 114.7 19.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.081 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 90' ' ' VAL . 20.7 m -111.58 153.56 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.692 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -164.69 136.71 4.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.467 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.7 m -85.36 104.47 15.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 89' ' ' PHE . 4.4 mp -72.51 -12.19 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.681 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -65.28 -30.86 71.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.38 -19.12 22.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.27 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.39 147.17 34.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 44.6 Cg_exo -56.45 176.27 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.547 2.165 . . . . 0.0 112.365 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -57.04 121.96 49.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.813 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 -36.85 62.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.282 1.988 . . . . 0.0 112.158 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 59.91 163.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.888 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 28.62 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.492 . . . . 0.0 110.241 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -164.48 156.48 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.996 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.789 HG11 ' HD3' ' A' ' 120' ' ' LYS . 30.9 t -44.4 104.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.26 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -95.47 -29.98 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.969 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.914 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -163.79 135.7 4.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.797 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.789 ' HD3' HG11 ' A' ' 117' ' ' VAL . 12.9 mtmm -124.86 113.69 18.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.826 HG11 ' CD1' ' A' ' 70' ' ' LEU . 7.1 p -86.66 110.45 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.452 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.777 HG22 HD11 ' A' ' 83' ' ' ILE . 41.7 t -76.92 106.29 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 79' ' ' TYR . 10.2 mt -106.21 108.6 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.768 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.529 ' HB2' HG21 ' A' ' 80' ' ' VAL . 39.3 ttm180 -69.05 117.92 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -68.55 80.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.185 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 124' ' ' ARG . 4.8 mm-40 -86.06 -12.81 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 109.55 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.79 124.35 2.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.564 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 7.3 ttpp -45.56 155.9 0.14 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.11 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -161.7 56.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -56.21 98.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.677 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 110.59 26.77 4.66 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.911 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -69.97 65.81 0.25 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.918 0.39 . . . . 0.0 111.067 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.51 ' HA ' HG22 ' A' ' 157' ' ' THR . 1.8 t-20 -45.04 110.53 0.24 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.111 0.481 . . . . 0.0 112.003 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 132' ' ' SER . 2.0 mp -106.02 165.2 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.868 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.9 t -158.37 119.74 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.385 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 53' ' ' VAL . 35.6 t -87.16 94.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.441 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.456 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.2 p -100.19 -170.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' C ' ' A' ' 137' ' ' THR . 4.2 p30 43.23 23.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.757 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -64.61 93.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.575 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -97.24 167.5 10.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.136 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -140.18 129.39 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.59 77.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 24.7 t0 -57.14 146.86 26.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.6 -26.38 73.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.89 -44.32 82.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.28 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.26 -10.22 4.12 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.853 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -117.64 132.22 56.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.755 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.5 p -77.26 115.19 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.152 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 141' ' ' VAL . 77.2 m-70 -86.34 95.0 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.71 108.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.792 0.329 . . . . 0.0 110.187 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.516 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.23 166.42 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -56.16 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 35' ' ' VAL . . . -159.08 -167.97 20.49 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.892 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.829 HG21 ' HB2' ' A' ' 37' ' ' LEU . 6.8 t -166.09 179.58 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.958 0.379 . . . . 0.0 111.56 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 tm-20 -143.51 143.8 31.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.809 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -149.44 155.32 40.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.14 0.495 . . . . 0.0 111.232 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.648 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 8.2 p -128.73 140.22 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.219 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -119.65 139.03 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 111.49 23.78 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.027 0.441 . . . . 0.0 111.12 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.688 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.3 mt -88.16 127.5 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -112.13 132.19 61.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.077 -177.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.07 145.86 49.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.223 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.821 0.343 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.831 HG11 HD13 ' A' ' 58' ' ' LEU . 77.5 t -100.7 153.2 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 59' ' ' VAL . 9.3 t -64.05 -42.5 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.448 0.642 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.675 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 61.96 104.93 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.214 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 40.9 t -156.31 136.48 12.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.697 0.76 . . . . 0.0 112.213 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 151' ' ' ILE . 34.2 m -93.35 145.47 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.492 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 17.9 p -104.38 113.31 26.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.014 HD12 HG22 ' A' ' 154' ' ' THR . 5.5 mt -96.79 121.38 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 111.32 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.1 101.3 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.365 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -151.15 152.08 32.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.45 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.88 -22.72 59.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.529 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 2.3 mp0 66.68 23.35 10.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -165.12 127.89 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -144.54 106.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.164 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -69.16 133.07 47.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.489 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -33.83 133.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.57 -22.48 35.74 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.515 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.13 172.18 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -104.34 153.57 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 158' ' ' VAL . 62.2 tp -93.67 161.03 14.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 21.7 mt-10 -136.57 93.57 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.723 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 25.2 t -105.67 97.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 117' ' ' VAL . . . -85.96 59.08 4.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.157 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 53' ' ' VAL . 9.6 p -78.04 95.35 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.581 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -112.31 -117.58 3.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.037 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.617 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.5 131.38 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 112.046 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 7.3 t0 -103.53 -35.84 8.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -155.89 127.82 7.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.611 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.831 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -150.11 90.7 1.7 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.27 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -115.19 116.53 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.8 m-20 103.15 33.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.934 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -169.31 133.46 1.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -91.96 82.06 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.348 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 111.86 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 112' ' ' LEU . 30.3 m-85 -104.94 -33.82 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.884 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.51 112.3 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.111 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 112' ' ' LEU . 15.2 t80 -109.71 95.03 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.967 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -109.18 143.86 38.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.717 ' CD1' HG13 ' A' ' 136' ' ' VAL . 18.6 p90 -146.41 171.27 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.013 0.435 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -126.29 99.72 5.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -77.2 156.08 31.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.27 112.99 18.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HA ' HD23 ' A' ' 134' ' ' LEU . 26.1 p90 -126.22 -168.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.646 ' OD2' ' HB3' ' A' ' 76' ' ' ALA . 2.2 p-10 -106.06 134.55 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.971 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.72 -29.86 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.09 -41.92 99.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -102.64 -47.94 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -93.38 172.37 8.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.712 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -160.7 114.13 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.725 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 31.9 t80 -54.16 153.46 5.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' HG23 ' A' ' 122' ' ' VAL . 87.1 t -132.8 -77.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -166.02 140.61 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.736 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.85 149.47 27.12 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.89 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.93 152.63 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.339 -177.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -123.13 -165.37 1.31 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.898 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -90.89 -157.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -93.72 36.75 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.399 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.18 -38.73 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 106' ' ' SER . 19.8 t -86.83 149.29 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.926 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -111.28 103.11 11.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 104' ' ' VAL . 2.5 t -105.44 142.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.021 0.438 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -156.46 118.84 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.305 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.725 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.95 -178.9 4.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.413 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -157.31 107.85 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.0 111.54 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 17.8 tttt -54.53 95.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.0 tp -78.12 -27.11 14.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.833 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -165.3 -166.78 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -86.71 134.68 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.28 29.38 60.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 100' ' ' VAL . 3.0 ptpt -173.62 121.36 0.33 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 120.941 0.4 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 95' ' ' ILE . 11.8 m -150.07 155.51 7.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.665 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.563 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 6.9 ttp180 -93.3 151.87 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.28 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.4 p -123.67 129.65 74.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.47 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.413 HD11 ' NZ ' ' A' ' 93' ' ' LYS . 15.8 mt -101.84 104.69 15.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.332 . . . . 0.0 110.714 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 119' ' ' ALA . 23.1 t -103.69 135.68 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.494 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -164.46 136.76 4.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.437 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 88' ' ' VAL . 88.6 p -88.2 117.26 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.41 27.71 2.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.298 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.6 p -102.41 -27.65 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.78 -16.81 23.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.315 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.43 147.62 34.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.2 Cg_exo -54.1 172.96 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.496 2.131 . . . . 0.0 112.306 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 66' ' ' TYR . 3.0 mp -59.28 128.0 84.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 118' ' ' LEU . 31.8 Cg_exo -58.54 -34.05 98.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.376 2.051 . . . . 0.0 112.11 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.56 163.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.94 15.52 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -146.83 -165.72 2.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.31 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.576 HG13 ' CA ' ' A' ' 52' ' ' GLY . 38.9 t -78.71 104.84 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.763 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -94.35 -29.56 14.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.034 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -149.56 134.14 17.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HG3' HG11 ' A' ' 117' ' ' VAL . 7.3 mtmt -126.09 101.81 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 70' ' ' LEU . 9.0 p -92.25 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.338 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.89 ' CG1' HD11 ' A' ' 83' ' ' ILE . 35.7 m -75.59 97.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.737 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.17 113.74 21.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.912 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.2 tpm_? -59.01 113.28 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.68 68.2 7.95 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.49 -6.19 59.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 109.574 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.31 123.59 2.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.578 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.697 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.6 ttmm -41.94 162.47 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.318 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.859 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.43 58.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.018 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.5 tt0 -56.22 116.05 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.119 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.88 15.89 58.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.567 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.859 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.67 66.62 0.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 110.252 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -44.49 140.55 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.264 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -126.83 128.72 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.96 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.431 ' CA ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -115.57 129.83 56.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.696 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 68' ' ' PHE . 39.5 t -106.42 95.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.609 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.471 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 15.9 p -100.11 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.76 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.35 21.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.995 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -61.92 105.54 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.358 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 175.13 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.355 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 149' ' ' HIS . 32.8 m -153.74 126.56 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.008 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.79 104.42 2.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.714 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 13.0 p30 -58.87 -174.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.719 0.295 . . . . 0.0 110.857 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.75 16.58 60.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.909 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.98 -32.17 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.61 -16.96 3.52 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.061 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.99 170.16 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.995 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 148' ' ' VAL . 12.1 p -120.8 125.72 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 141' ' ' VAL . 79.1 m80 -96.12 90.54 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.945 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -49.42 106.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.43 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.451 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -76.19 -146.37 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.677 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.52 41.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.716 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 1.014 HG22 HD12 ' A' ' 37' ' ' LEU . 24.0 m -161.14 153.34 20.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.434 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 8.7 tt0 -110.0 161.98 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -139.5 166.75 23.73 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.435 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.1 p -142.23 116.21 9.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.67 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -111.65 122.37 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.253 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.42 105.85 17.95 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.679 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 18.1 mt -80.49 112.45 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.597 0.713 . . . . 0.0 109.842 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -94.55 131.77 40.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.038 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.01 145.84 49.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.077 0.465 . . . . 0.0 110.957 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.628 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 14.6 t -60.74 155.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -77.5 -46.85 21.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.26 114.21 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.208 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.943 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 6.7 t -162.08 136.7 6.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.138 0.494 . . . . 0.0 111.542 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 154' ' ' THR . 5.8 m -91.41 134.1 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.553 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 t -96.42 107.44 19.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.341 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.837 HD12 HG22 ' A' ' 154' ' ' THR . 3.7 mt -97.1 117.3 30.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.251 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.49 101.42 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.57 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -144.08 160.19 41.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -31.67 68.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' C ' HG12 ' A' ' 158' ' ' VAL . 11.1 mt-10 69.41 24.2 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.5 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HD21 ' A' ' 49' ' ' LEU . 6.8 tt0 -165.04 122.83 1.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.813 0.34 . . . . 0.0 111.657 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -143.34 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -67.51 132.19 47.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.0 t -32.76 132.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-O 121.549 0.69 . . . . 0.0 112.776 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.85 -24.89 30.34 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.536 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.3 171.85 8.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.746 0.307 . . . . 0.0 110.666 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -116.46 150.89 37.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.785 HD23 HG11 ' A' ' 158' ' ' VAL . 6.8 tp -130.08 142.1 50.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.862 ' HG2' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -123.51 117.05 24.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.1 p -93.55 98.65 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.19 69.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 53' ' ' VAL . 7.9 p -78.58 95.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.19 -135.1 8.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.809 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -107.51 127.37 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.553 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -94.29 -37.34 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 32' ' ' THR . 22.9 mp0 -161.07 132.21 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HG ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -162.49 91.61 0.77 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.108 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.0 p -121.46 109.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.565 ' N ' HG22 ' A' ' 31' ' ' VAL . 63.9 m-20 130.41 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.451 1.101 . . . . 0.0 111.606 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -150.41 -179.16 6.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.699 0.285 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER -126.93 85.16 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.362 . . . . 0.0 110.575 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.59 111.94 2.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.145 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.3 m-85 -115.28 -49.12 2.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.67 112.3 17.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.997 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.552 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 t80 -85.75 136.6 33.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.453 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -147.62 109.64 4.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.271 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 29.9 p90 -130.24 171.27 13.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.364 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 104.84 8.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.864 HD13 HG11 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -77.35 149.73 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.118 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -125.28 104.64 8.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HA ' HD23 ' A' ' 134' ' ' LEU . 19.1 p90 -121.33 -170.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -97.64 136.79 37.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -93.6 -26.8 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -76.54 -29.78 56.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.103 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -108.78 -49.32 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.327 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CE2' HD11 ' A' ' 160' ' ' ILE . 5.0 m-85 -93.31 -177.08 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ARG . 2.0 tt0 -170.28 108.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.806 ' HA ' HD23 ' A' ' 123' ' ' LEU . 38.9 t80 -47.47 152.73 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.399 . . . . 0.0 111.119 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.3 t -134.53 -78.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 122' ' ' VAL . 4.2 mt-10 -153.47 148.73 26.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.457 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -102.25 147.96 26.02 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.207 1.003 . . . . 0.0 111.638 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.791 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -133.78 174.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.103 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.67 -177.29 5.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HG23 ' A' ' 88' ' ' VAL . 20.1 p-10 -61.97 -161.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.713 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 36.71 1.1 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.44 -40.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.26 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.473 HG23 ' OD1' ' A' ' 85' ' ' ASP . 16.4 t -86.98 146.86 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -108.25 103.04 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.801 ' CG2' HG13 ' A' ' 104' ' ' VAL . 2.6 t -101.96 132.17 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -145.4 109.73 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.82 -179.23 4.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.342 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -161.11 117.92 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.387 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 tttt -54.03 113.35 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.389 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -109.49 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -158.44 172.91 17.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.839 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.85 131.91 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.25 29.47 63.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.441 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.8 ptmt -173.57 129.87 0.43 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.727 ' HA ' HG22 ' A' ' 95' ' ' ILE . 18.2 m -150.06 155.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.925 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -83.26 147.35 28.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 -178.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.1 p -130.68 129.89 64.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -111.05 109.94 20.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 90' ' ' VAL . 4.1 t -106.17 144.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.508 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.438 ' C ' HG13 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -164.38 139.78 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.305 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -88.57 104.34 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.108 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -67.75 -17.83 64.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 p -65.23 -34.81 79.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.22 -19.9 28.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.389 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.73 153.77 43.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 40.9 Cg_exo -56.72 164.8 5.43 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.629 2.219 . . . . 0.0 112.437 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 118' ' ' LEU . 2.3 mp -59.33 127.55 84.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.749 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.85 -32.14 96.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.409 2.072 . . . . 0.0 112.085 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.44 162.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 15.04 9.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.25 -164.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.218 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.841 HG11 ' HD3' ' A' ' 120' ' ' LYS . 31.0 t -78.97 104.66 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.57 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.55 -33.23 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 90' ' ' VAL . . . -168.68 133.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.319 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.841 ' HD3' HG11 ' A' ' 117' ' ' VAL . 3.9 mtmt -122.92 100.76 7.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.06 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.864 HG11 HD13 ' A' ' 70' ' ' LEU . 11.4 p -74.25 110.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 110.437 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.862 HG22 ' HG2' ' A' ' 50' ' ' GLU . 15.5 t -75.55 115.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.787 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 79' ' ' TYR . 15.9 mt -102.09 169.12 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.642 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 12.8 tpp180 -115.28 125.16 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -92.08 73.12 5.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.546 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -87.74 -5.11 58.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.435 0.636 . . . . 0.0 109.639 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.563 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 4.3 ttmm -49.74 134.2 20.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.176 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -138.69 64.29 1.49 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.47 114.42 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.151 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.51 21.25 52.07 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.814 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -71.02 66.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 0.8 OUTLIER -46.98 142.78 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.858 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -121.68 165.05 16.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.801 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.19 106.24 3.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 21.8 t -96.4 94.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.456 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -103.33 -160.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.81 19.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HD11 ' A' ' 151' ' ' ILE . 74.7 m -59.81 90.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.123 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.45 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -116.44 138.47 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.212 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 148' ' ' VAL . 10.4 p -115.01 153.29 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.03 100.19 2.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.786 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 25.9 t0 -52.51 162.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.779 0.324 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.39 -43.88 95.51 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.548 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.22 -30.85 71.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.98 -27.76 3.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.536 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.7 155.34 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 141' ' ' VAL . 12.1 p -114.43 138.63 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -110.52 96.93 6.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.56 104.99 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.159 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.39 -176.76 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.1 -158.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.577 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -154.88 175.35 32.96 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 37' ' ' LEU . 86.0 m -164.12 146.73 9.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.925 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 11.2 pt-20 -101.75 166.7 10.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.635 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -152.4 154.67 36.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.879 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.635 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.9 p -126.77 143.6 51.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.605 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.69 130.02 52.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.58 105.93 16.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 120.933 0.397 . . . . 0.0 111.011 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.8 mt -80.15 115.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.491 0.662 . . . . 0.0 109.455 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.29 128.74 48.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.116 -178.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.08 145.9 29.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.107 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.524 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 60' ' ' ASN . 24.9 t -60.68 155.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -84.44 -45.06 13.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.01 120.28 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.422 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.8 t -162.95 140.47 7.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.06 0.457 . . . . 0.0 111.421 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 154' ' ' THR . 11.2 m -97.82 129.26 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.37 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 56' ' ' ASP . 47.5 p -95.01 108.21 20.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.948 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.077 HD12 HG23 ' A' ' 154' ' ' THR . 1.4 mt -97.71 122.09 40.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.55 112.28 10.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.595 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -153.01 155.6 37.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 111.417 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.48 -29.15 66.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 69.98 23.87 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.624 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' N ' HG12 ' A' ' 158' ' ' VAL . 19.9 tt0 -164.68 128.95 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 112.112 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -134.03 171.19 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.117 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.5 tt0 -133.05 120.15 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.0 t -28.72 132.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 121.576 0.703 . . . . 0.0 112.381 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.05 49.55 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.28 174.92 10.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.515 0.326 . . . . 0.0 110.15 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -127.42 147.93 50.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.875 0.369 . . . . 0.0 110.986 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -102.52 164.12 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 122' ' ' VAL . 11.6 mt-10 -130.0 93.32 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.682 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 p -103.16 97.9 6.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -91.48 85.2 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.258 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 136' ' ' VAL . 3.5 p -78.55 95.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 110.086 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -96.37 -134.9 8.2 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.499 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -103.08 134.63 43.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 111.606 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 22.1 t0 -103.28 -34.32 8.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.425 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 32' ' ' THR . 4.0 mp0 -165.54 134.05 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.926 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 141' ' ' VAL . 1.6 tt -162.27 91.61 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.759 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 59' ' ' VAL . 11.9 p -119.31 103.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 35.2 m-20 133.1 24.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.262 1.025 . . . . 0.0 111.413 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -160.6 171.95 18.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -121.19 86.05 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.716 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.59 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -62.5 133.52 55.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 12.7 m-85 -127.63 -42.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.04 112.44 15.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.752 ' O ' HG22 ' A' ' 104' ' ' VAL . 5.4 t80 -85.98 100.66 12.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -109.33 112.44 24.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 50.4 p90 -142.97 171.54 13.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.519 HG22 HD21 ' A' ' 138' ' ' ASN . 1.8 t -128.48 121.29 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 ' CG1' ' A' ' 121' ' ' VAL . 7.2 tt -95.03 126.34 40.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -98.32 106.59 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.455 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 50.0 p90 -107.13 -169.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.702 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.69 120.27 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -29.46 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -27.42 69.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.704 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -125.95 -44.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.384 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.8 OUTLIER -93.14 161.06 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -145.65 130.39 18.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD1' HG21 ' A' ' 100' ' ' VAL . 19.5 t80 -55.02 149.13 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 55.7 t -132.16 -85.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 122' ' ' VAL . 58.1 mm-40 -160.4 135.84 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.88 150.58 26.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.147 0.975 . . . . 0.0 111.393 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.682 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -120.19 153.29 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.571 -177.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -117.25 -165.89 1.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.714 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.5 -157.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.618 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.6 37.15 1.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.863 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.67 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.169 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 89' ' ' PHE . 40.5 t -86.74 158.85 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.2 t80 -112.36 125.38 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.952 HG22 ' CG1' ' A' ' 104' ' ' VAL . 3.5 t -122.57 135.93 61.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.33 120.53 7.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.612 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.96 156.77 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 107.25 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.174 0.512 . . . . 0.0 111.337 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.3 ttpt -55.1 95.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.5 tp -82.73 -22.21 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.765 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.8 -166.74 0.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.81 133.18 33.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.87 29.56 62.0 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' C ' HG13 ' A' ' 100' ' ' VAL . 13.3 ptpt -173.26 121.59 0.36 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 95' ' ' ILE . 7.1 m -149.91 154.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.676 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.09 152.16 22.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.204 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 8.6 p -126.45 93.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.15 111.0 17.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.952 ' CG1' HG22 ' A' ' 90' ' ' VAL . 4.2 m -117.25 158.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.022 0.439 . . . . 0.0 111.804 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -164.49 136.09 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.265 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -79.01 113.67 17.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 31.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.983 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.2 p -109.65 -34.64 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.48 -21.84 11.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.142 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -91.17 155.69 44.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.757 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 59.1 Cg_endo -72.4 174.5 11.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.481 2.121 . . . . 0.0 112.476 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 114' ' ' ALA . 4.0 tt -54.49 107.55 0.9 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.86 -32.11 94.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.344 2.029 . . . . 0.0 111.926 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.733 ' H ' HD23 ' A' ' 112' ' ' LEU . . . 59.77 170.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.168 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.6 16.15 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.087 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -148.26 -179.85 7.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.0 t -70.95 105.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.649 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 114' ' ' ALA . 2.3 mm? -87.56 -31.55 19.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.214 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -166.11 131.0 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.679 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -119.89 118.6 31.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.9 ' CG1' HD13 ' A' ' 70' ' ' LEU . 7.1 p -97.98 94.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.182 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 81' ' ' GLU . 21.5 m -75.63 118.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 134' ' ' LEU . 2.4 mm? -92.24 169.2 10.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.0 tpm_? -105.51 118.25 36.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -90.86 71.07 6.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.785 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.36 -4.3 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.96 124.31 2.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.042 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.669 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 3.1 ptmt -40.6 163.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.704 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -178.2 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.971 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 pt-20 -55.63 112.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.69 4.14 39.85 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.647 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -62.84 87.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.932 0.396 . . . . 0.0 110.24 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.798 ' C ' HD12 ' A' ' 134' ' ' LEU . 3.9 m120 -60.49 166.68 2.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 133' ' ' ASN . 9.5 mp -140.13 104.84 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.649 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.41 130.14 45.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.227 0.537 . . . . 0.0 112.093 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 53' ' ' VAL . 30.6 m -115.4 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.17 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.496 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 7.5 p -108.91 -167.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.547 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.519 HD21 HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER 37.41 29.87 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.449 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB3' HD11 ' A' ' 151' ' ' ILE . 50.6 m -62.34 89.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.034 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.95 171.66 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.357 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.013 HG21 HD11 ' A' ' 58' ' ' LEU . 15.4 m -147.33 122.46 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 99.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 46.4 t0 -56.41 162.53 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.41 -29.16 70.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.61 -49.05 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.6 -28.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.392 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.33 170.2 16.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.23 153.39 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -123.03 94.82 4.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.23 104.97 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.503 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.53 -176.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -67.93 -160.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -159.78 175.54 36.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 1.077 HG23 HD12 ' A' ' 37' ' ' LEU . 1.3 t -162.93 -170.91 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.849 -0.207 . . . . 0.0 110.574 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -151.21 152.06 32.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.198 0.523 . . . . 0.0 112.061 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 37' ' ' LEU . 4.1 tppt? -129.34 169.26 15.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.867 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.46 HG22 ' ND2' ' A' ' 133' ' ' ASN . 1.1 p -143.01 144.38 32.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.59 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -134.24 126.37 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -90.35 116.13 28.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.775 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 77' ' ' PHE . 4.6 mt -85.56 116.66 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.69 -178.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.89 146.6 51.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.016 0.436 . . . . 0.0 111.016 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.502 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 61' ' ' ALA . 12.3 t -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' GLY . 6.7 t -80.42 -32.27 37.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.43 120.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.596 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.602 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 28.6 t -149.94 155.01 39.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.277 0.56 . . . . 0.0 111.944 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -108.06 123.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -92.13 107.38 19.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 154' ' ' THR . 1.9 mt -97.16 126.59 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.27 101.42 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.734 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -146.2 154.56 41.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.346 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.57 -26.62 61.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.58 23.53 7.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.424 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 158' ' ' VAL . 27.0 tt0 -164.7 126.55 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 160' ' ' ILE . 3.6 p -128.62 171.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.493 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -133.83 113.4 12.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.512 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.8 t -28.37 114.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 125.06 -25.6 5.75 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.884 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.8 -175.52 2.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.913 0.387 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -114.9 167.74 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.747 HD11 HG11 ' A' ' 158' ' ' VAL . 1.3 tp -114.74 159.43 20.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.469 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.8 m -105.54 98.05 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.476 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.785 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.1 71.48 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.153 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.68 HG21 HG11 ' A' ' 136' ' ' VAL . 8.2 p -78.22 97.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.965 0.412 . . . . 0.0 110.872 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.35 -128.47 5.79 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.852 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -112.05 134.8 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.037 0.446 . . . . 0.0 111.431 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.02 -33.05 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.234 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 3.4 pt-20 -174.46 130.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.642 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -152.61 91.67 1.59 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.093 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 31' ' ' VAL . 10.6 p -100.11 117.82 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.6 m-20 100.78 22.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.596 0.758 . . . . 0.0 112.352 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.851 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -142.69 138.59 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.8 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.1 mp0 -102.19 87.18 3.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -62.2 112.12 2.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.42 -32.06 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.63 111.96 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.666 ' HD1' HG12 ' A' ' 141' ' ' VAL . 0.8 OUTLIER -87.45 136.5 32.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.341 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.495 ' OD2' HD23 ' A' ' 103' ' ' LEU . 8.3 t0 -147.83 109.86 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.314 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.703 ' CD1' HG13 ' A' ' 136' ' ' VAL . 5.0 p90 -125.0 171.12 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.375 . . . . 0.0 111.352 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 115.56 17.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.587 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 136' ' ' VAL . 10.5 tp -77.3 141.45 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.257 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -119.96 104.59 10.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.568 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.426 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 50.3 p90 -133.0 -170.87 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.82 132.43 54.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -27.39 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -56.31 -30.04 62.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.35 -48.15 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.17 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.38 178.9 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -171.7 119.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.734 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 15.2 t80 -54.54 156.02 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.714 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 122' ' ' VAL . 58.4 t -130.46 -84.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 14.2 pt-20 -153.07 132.14 12.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.83 150.19 26.72 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.141 0.972 . . . . 0.0 111.649 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.543 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.99 152.38 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.353 -177.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.6 ' HB2' HG23 ' A' ' 88' ' ' VAL . 51.9 p -115.07 -168.41 1.38 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.852 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -93.87 -160.12 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.86 37.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.29 -42.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.167 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 106' ' ' SER . 28.3 m -96.08 173.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.336 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 156.82 26.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.575 HG13 ' CG2' ' A' ' 102' ' ' VAL . 21.5 t -147.85 123.94 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -134.01 110.78 9.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.028 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.734 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.15 131.02 44.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.311 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -118.84 108.04 14.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HA ' HG23 ' A' ' 100' ' ' VAL . 12.8 tttt -70.51 97.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.831 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -78.1 -0.06 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.12 -168.76 0.08 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.35 115.39 27.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 79.92 38.72 18.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.075 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -172.68 123.42 0.44 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 94' ' ' LYS . 12.4 p -151.61 131.86 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.593 -174.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 15.7 ttp180 -101.28 151.97 21.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.848 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.575 ' CG2' HG13 ' A' ' 90' ' ' VAL . 12.8 p -123.59 157.29 29.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 111.824 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.495 HD23 ' OD2' ' A' ' 67' ' ' ASP . 84.8 mt -123.56 106.94 11.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.525 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 118' ' ' LEU . 11.1 t -105.27 143.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 111.686 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 p -164.29 136.17 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.767 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -89.08 112.22 23.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 111.258 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mt -93.77 31.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.929 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -109.7 -30.92 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.968 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.65 -20.67 11.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.223 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -94.43 155.93 39.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.615 0.245 . . . . 0.0 110.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 177.07 7.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.574 2.183 . . . . 0.0 112.547 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -56.72 119.15 27.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.901 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.62 -42.41 39.95 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.931 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.765 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 66.08 163.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.29 15.49 10.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.271 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.2 -169.76 3.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.284 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.785 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.6 t -74.04 104.92 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -96.81 -28.79 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -155.16 129.4 8.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -118.96 101.01 7.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.534 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.6 p -95.8 97.97 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 81' ' ' GLU . 20.2 m -75.51 124.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.067 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.733 ' CD2' HD21 ' A' ' 134' ' ' LEU . 4.2 mp -95.33 169.19 10.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.792 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.474 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -111.28 120.4 42.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.492 . . . . 0.0 112.069 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -89.72 69.52 7.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.991 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.5 -9.51 47.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.34 0.591 . . . . 0.0 109.623 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.49 124.3 3.1 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.736 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.691 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.4 ttpp -43.66 155.24 0.08 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.433 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.771 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -165.82 59.51 0.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.892 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.53 116.27 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.188 -179.111 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.7 18.56 51.26 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.334 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.771 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.55 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.939 0.399 . . . . 0.0 110.456 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.96 133.93 4.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.255 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.733 HD21 ' CD2' ' A' ' 123' ' ' LEU . 1.2 mp -116.42 118.31 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.1 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 p -99.6 124.15 44.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.553 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.775 HG22 HD12 ' A' ' 70' ' ' LEU . 25.0 t -110.22 95.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.546 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.8 p -111.98 -159.78 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.761 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 20.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.601 ' CB ' HD11 ' A' ' 151' ' ' ILE . 26.9 m -68.05 92.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.26 163.85 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.39 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.666 HG12 ' HD1' ' A' ' 66' ' ' TYR . 27.6 m -139.07 130.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.68 82.84 0.93 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 9.1 t70 -55.18 139.96 40.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.76 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.2 -38.39 25.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.06 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -53.51 -26.58 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.56 10.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.668 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.18 170.15 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 148' ' ' VAL . 10.9 p -120.51 122.98 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 5.3 m-70 -92.74 99.62 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.081 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.33 110.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' A' ' 139' ' ' SER . 0.3 OUTLIER -84.23 171.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.208 0.528 . . . . 0.0 111.922 -178.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.4 -146.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.487 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.55 167.44 37.73 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.518 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.83 HG22 HD12 ' A' ' 37' ' ' LEU . 9.5 m -168.14 148.74 4.95 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -118.6 179.12 4.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.622 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.64 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppt? -144.7 168.85 19.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.0 p -142.12 115.78 9.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -114.68 122.12 68.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.291 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -89.3 112.34 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.555 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.822 HG23 HG13 ' A' ' 43' ' ' VAL . 2.4 mt -81.62 120.65 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.375 0.607 . . . . 0.0 109.634 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.49 131.25 55.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.922 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.74 146.06 47.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.094 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.489 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.779 0.324 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.749 HG11 HD23 ' A' ' 58' ' ' LEU . 72.5 t -68.03 153.25 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.683 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.4 t -62.91 -43.09 99.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.376 0.607 . . . . 0.0 109.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 65.66 104.71 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.536 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.904 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -162.35 133.73 5.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.419 0.628 . . . . 0.0 112.105 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 151' ' ' ILE . 23.2 m -91.68 143.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.546 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.0 t -93.9 111.63 23.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.796 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -97.08 120.51 37.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.141 0.496 . . . . 0.0 111.596 -179.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -141.22 129.93 22.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.59 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -176.06 155.38 1.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -29.22 68.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.354 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.4 mt-10 72.45 24.7 2.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.62 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' CG ' HD11 ' A' ' 161' ' ' ILE . 2.3 tt0 -164.82 128.15 2.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 0.0 112.013 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -143.97 107.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.332 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -69.91 127.71 33.81 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.8 t -29.26 131.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 112.727 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.14 -18.54 56.52 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.422 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.54 172.89 6.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.776 0.322 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.39 149.1 47.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.662 HD22 HG11 ' A' ' 158' ' ' VAL . 3.1 pp -102.56 164.28 11.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HA ' HG12 ' A' ' 122' ' ' VAL . 40.1 tt0 -135.69 93.88 3.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -103.82 98.02 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.91 80.6 1.82 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 136' ' ' VAL . 14.9 p -78.35 97.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.172 0.51 . . . . 0.0 110.754 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -101.74 -128.7 6.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.96 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -110.68 131.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.605 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.8 t0 -100.68 -36.41 9.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HB3' HG21 ' A' ' 32' ' ' THR . 21.4 mt-10 -158.21 131.57 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.651 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.749 HD23 HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -163.34 91.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.246 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.708 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.32 107.84 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.554 ' CA ' HG22 ' A' ' 31' ' ' VAL . 64.2 m-20 130.22 20.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.55 1.14 . . . . 0.0 111.637 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB1' ' CD2' ' A' ' 149' ' ' HIS . . . -155.69 165.82 35.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.771 0.319 . . . . 0.0 110.795 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.52 85.11 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.62 120.24 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 5.5 m-85 -112.71 -30.92 6.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.74 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.42 112.5 7.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' O ' HG22 ' A' ' 104' ' ' VAL . 1.1 t80 -85.69 132.82 34.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.46 110.01 4.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.648 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 10.0 p90 -127.84 171.12 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.137 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 101' ' ' ARG . 0.3 OUTLIER -128.77 113.03 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.789 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 HG11 ' A' ' 121' ' ' VAL . 7.9 tt -92.77 153.36 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.003 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 70' ' ' LEU . 3.4 m-80 -123.16 137.97 54.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.763 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 46.1 p90 -140.46 -175.28 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.92 120.21 40.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -78.32 -3.78 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.35 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.1 20.8 8.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.855 0.36 . . . . 0.0 111.1 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.813 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.58 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.584 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.783 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -107.17 155.27 20.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.5 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -151.88 131.11 12.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.763 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.0 t80 -53.15 150.84 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.726 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 122' ' ' VAL . 47.6 t -126.62 -84.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 122' ' ' VAL . 3.5 mt-10 -157.91 132.49 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.73 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.87 145.65 29.33 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.176 0.988 . . . . 0.0 111.437 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -126.44 154.8 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.56 -1.654 . . . . 0.0 112.64 -177.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.827 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -120.09 -165.09 1.14 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.77 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -91.0 -158.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.11 37.15 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 -38.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.01 155.51 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -112.41 112.79 24.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.874 HG22 HG12 ' A' ' 104' ' ' VAL . 3.6 t -101.95 155.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.3 t30 -164.12 109.29 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.763 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.5 140.07 32.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.202 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -120.38 108.43 14.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.71 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.03 -29.17 43.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.987 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 178.16 -168.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.205 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.41 123.51 24.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 64.16 41.05 98.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.184 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.38 127.33 0.54 Allowed 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 79' ' ' TYR . 10.3 p -151.88 136.17 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.3 tpp85 -107.28 152.2 24.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.365 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 13.9 p -129.89 146.32 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.431 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.3 mt -131.69 98.39 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.316 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 90' ' ' VAL . 1.3 m -98.12 160.73 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.419 . . . . 0.0 111.655 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 p -163.86 135.4 4.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.324 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p -77.19 110.68 12.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.305 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.8 tp -92.87 29.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.956 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 p -108.94 -27.2 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.971 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.25 -18.02 12.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.225 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -101.84 157.11 34.31 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.28 . . . . 0.0 110.719 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 62.3 Cg_endo -73.5 -175.54 2.09 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.537 2.158 . . . . 0.0 112.459 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.704 ' CD2' HD21 ' A' ' 118' ' ' LEU . 1.3 tt -56.52 114.53 7.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.91 -39.54 32.46 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.563 2.176 . . . . 0.0 112.126 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 67.71 168.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.56 15.81 10.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.127 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.62 -168.54 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.414 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.2 t -76.87 105.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.785 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.24 -32.66 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -168.03 131.42 1.6 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.754 0.312 . . . . 0.0 111.262 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -115.62 113.93 24.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.481 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.9 HG11 HD13 ' A' ' 70' ' ' LEU . 7.2 p -97.52 95.08 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.233 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 81' ' ' GLU . 26.0 m -75.6 115.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.841 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.677 ' CD2' HD21 ' A' ' 134' ' ' LEU . 3.6 mm? -83.6 169.33 15.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.954 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -108.74 124.9 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.999 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -100.47 69.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.782 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -5.45 55.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.483 0.659 . . . . 0.0 109.448 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.69 124.27 2.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.453 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.9 ttpt -44.11 135.02 4.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.562 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.813 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -144.27 59.77 1.35 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.852 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.93 -5.28 59.53 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.787 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.1 m -56.25 91.32 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.321 . . . . 0.0 110.543 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.7 m120 -65.27 160.04 22.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.194 0.521 . . . . 0.0 111.499 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 133' ' ' ASN . 4.7 mp -137.08 104.3 5.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.612 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.2 p -102.37 125.45 49.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 53' ' ' VAL . 19.5 m -111.32 94.95 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.472 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -99.05 -161.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.472 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.24 19.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 151' ' ' ILE . 66.6 m -60.26 101.32 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.14 173.1 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.427 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.719 HG21 HD11 ' A' ' 58' ' ' LEU . 3.4 m -147.95 127.23 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.34 97.89 0.89 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.433 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 32.0 t0 -55.26 161.57 1.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.95 -34.95 91.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.45 -31.59 68.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.99 -31.96 2.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.436 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -69.14 170.08 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.36 150.53 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.492 ' CD2' ' HB1' ' A' ' 61' ' ' ALA . 88.8 m-70 -121.77 95.16 4.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -55.85 105.56 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.552 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.38 -176.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.331 0.586 . . . . 0.0 111.742 -179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -65.68 -156.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.49 166.97 36.16 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.667 ' HB ' HD23 ' A' ' 37' ' ' LEU . 14.9 m -163.14 155.68 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -126.58 173.08 9.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.316 0.579 . . . . 0.0 112.088 -179.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.796 ' HE2' HD12 ' A' ' 37' ' ' LEU . 1.4 tppt? -139.56 168.7 19.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.426 HG22 ' ND2' ' A' ' 133' ' ' ASN . 1.2 p -143.09 116.33 8.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.662 HG11 HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -104.73 130.47 55.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.484 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.58 18.7 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.414 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.1 mt -78.89 119.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.44 0.638 . . . . 0.0 109.712 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.506 HD11 ' CG ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.5 136.96 33.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.82 145.03 53.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 111.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.509 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.785 0.326 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 60' ' ' ASN . 61.5 t -89.72 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.444 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -73.06 -42.54 62.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 59.1 110.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.286 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.502 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 30.6 t -150.11 140.01 21.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.731 0.777 . . . . 0.0 111.956 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -93.36 144.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.066 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -103.07 107.55 18.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.756 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.871 HD12 HG22 ' A' ' 154' ' ' THR . 6.0 mt -96.88 112.51 24.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -136.25 117.42 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -166.8 164.2 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.307 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -68.33 -29.51 68.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.486 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 1.2 mt-10 66.71 33.36 6.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -164.22 120.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 111.772 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.0 p -127.79 167.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.564 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.6 tm0? -130.46 118.27 20.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.2 t -28.55 131.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 121.575 0.703 . . . . 0.0 112.355 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.48 13.19 61.83 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.618 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -132.08 174.61 10.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.497 0.319 . . . . 0.0 110.238 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -123.59 149.27 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.861 0.363 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.717 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -112.18 160.05 17.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -136.14 93.76 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p -103.27 97.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.6 96.33 1.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.927 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 53' ' ' VAL . 10.2 p -87.18 95.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.46 -137.4 9.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.83 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.727 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -108.04 134.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 0.0 111.641 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.11 -33.44 11.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.7 mp0 -168.39 134.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.6 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -153.83 90.99 1.42 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.358 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.641 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.2 p -110.12 116.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.0 m-20 102.34 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.843 0.857 . . . . 0.0 111.932 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -169.52 143.05 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 82.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.75 111.77 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.655 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -100.74 -34.33 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.745 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.02 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.064 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 20.1 t80 -108.88 94.84 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -100.11 110.27 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.199 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.862 ' O ' HG12 ' A' ' 102' ' ' VAL . 14.6 p90 -102.3 171.4 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.42 . . . . 0.0 111.549 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' ND2' ' A' ' 138' ' ' ASN . 81.5 m -135.85 100.95 4.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.488 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 121' ' ' VAL . 8.7 tt -79.43 154.54 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.225 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.467 ' N ' HD23 ' A' ' 70' ' ' LEU . 2.8 m-80 -123.58 104.32 8.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.438 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.1 p90 -114.59 -167.3 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.959 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.32 123.94 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.4 -30.45 53.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -63.8 -30.97 72.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.027 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.75 -50.93 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -93.33 -176.97 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 109.65 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.99 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.533 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.6 t80 -51.96 147.77 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 122' ' ' VAL . 39.3 t -132.3 -74.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.829 ' O ' HG22 ' A' ' 122' ' ' VAL . 5.9 mt-10 -166.91 140.01 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.1 151.97 25.52 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 122.195 0.997 . . . . 0.0 111.525 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.15 174.39 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.375 -1.739 . . . . 0.0 112.167 -177.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -144.7 -165.69 2.21 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -93.99 -158.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.36 36.68 1.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.882 0.373 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.94 -42.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.117 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 105' ' ' SER . 13.0 t -89.98 148.42 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -103.15 137.69 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.44 HG13 ' CG2' ' A' ' 102' ' ' VAL . 25.1 t -133.7 144.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.33 116.99 4.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.568 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.53 157.05 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -141.05 107.26 5.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 22.3 tttt -55.11 115.01 1.99 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.2 tp -109.81 -25.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.881 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -160.1 165.69 31.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -66.87 128.69 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 62.73 30.69 77.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' C ' HG13 ' A' ' 100' ' ' VAL . 20.9 ptmt -173.77 122.86 0.34 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.907 0.384 . . . . 0.0 110.058 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.675 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 12.9 m -150.09 155.57 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 152.37 20.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.4 p -127.97 139.94 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.89 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.57 107.27 16.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 118' ' ' LEU . 4.6 t -106.88 147.0 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.56 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.45 ' C ' HG13 ' A' ' 88' ' ' VAL . 22.1 p -164.49 136.1 4.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.504 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 88' ' ' VAL . 93.7 p -83.99 104.88 14.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -94.94 31.15 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.152 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -99.02 -33.1 10.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.12 -25.1 6.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.307 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.57 155.07 41.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.845 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.36 173.67 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.58 2.187 . . . . 0.0 112.376 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.733 ' HG ' HD11 ' A' ' 118' ' ' LEU . 1.6 mp -58.89 116.87 17.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.12 -30.08 89.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.353 2.035 . . . . 0.0 111.844 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.727 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 56.49 169.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.278 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.15 17.86 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.08 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.02 -164.44 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.556 HG11 ' HE3' ' A' ' 120' ' ' LYS . 21.5 t -80.36 104.62 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.914 0.388 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.733 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -92.43 -32.84 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -172.69 132.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.31 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.818 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -122.66 132.09 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.556 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 70' ' ' LEU . 11.8 p -104.47 118.43 51.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.367 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.846 ' CG1' HD11 ' A' ' 83' ' ' ILE . 20.2 m -92.89 118.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.7 109.88 21.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.98 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.0 tpp85 -55.17 117.45 3.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.89 71.76 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.531 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.9 -3.28 58.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.538 0.685 . . . . 0.0 109.41 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.43 123.14 2.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.206 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.627 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.8 ttpm? -46.02 157.55 0.12 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.259 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.027 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -169.77 59.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.773 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.8 OUTLIER -56.16 116.03 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.937 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.87 21.61 49.56 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.261 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.752 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -68.14 70.91 0.16 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.044 0.45 . . . . 0.0 110.377 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 1.7 t-20 -43.8 121.87 2.55 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.643 HD23 HD11 ' A' ' 70' ' ' LEU . 5.8 mp -116.22 161.07 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.159 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 150.41 26.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.346 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 68' ' ' PHE . 15.2 t -123.33 95.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.475 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.7 p -101.55 -166.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.94 22.86 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.123 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -65.17 107.07 1.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.84 0.352 . . . . 0.0 110.523 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.95 171.26 7.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.44 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 58' ' ' LEU . 11.3 m -144.69 132.26 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.703 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.71 96.38 1.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.898 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.451 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 23.8 t0 -55.98 161.82 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.767 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.37 -27.94 73.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -74.48 -47.59 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.96 -25.75 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.58 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.52 158.01 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.993 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 148' ' ' VAL . 14.6 p -115.89 115.01 47.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.451 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 7.5 m-70 -87.5 93.19 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -48.3 108.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.238 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.535 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.35 166.58 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.27 0.557 . . . . 0.0 111.738 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -59.5 -144.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.327 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 35' ' ' VAL . . . -170.81 -177.21 40.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.108 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.871 HG22 HD12 ' A' ' 37' ' ' LEU . 25.4 m -161.24 148.95 15.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.723 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 15.6 tt0 -102.01 158.14 16.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.276 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.793 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppp? -151.28 164.23 37.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.555 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.628 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 4.0 p -142.62 153.91 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.768 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.05 133.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.849 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -99.42 115.03 28.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.159 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.8 mt -86.76 118.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -100.66 128.35 52.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.194 -178.007 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -55.96 146.63 21.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.182 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.494 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.802 0.334 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.86 73.33 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -102.69 173.91 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.61 132.99 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -132.15 176.85 8.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -152.39 33.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -156.7 141.98 17.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 m80 60.43 175.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.52 166.54 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -176.61 -175.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m 60.7 105.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 t -109.55 -53.8 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.64 160.28 19.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.53 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 14' ' ' LEU . 12.8 mt -114.12 -38.65 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.84 150.73 77.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -32.35 101.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.616 2.878 . . . . 0.0 113.244 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -153.44 -68.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.89 -154.16 20.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.35 168.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -108.57 -31.84 7.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -176.97 4.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.03 169.29 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 141.82 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.87 154.52 50.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tp -95.73 -40.7 9.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 136.68 58.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.9 -176.7 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.26 177.13 8.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 60' ' ' ASN . . . -175.24 77.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.57 125.22 35.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 61' ' ' ALA . 21.8 t -94.2 146.38 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 57' ' ' GLU . 12.6 t -68.1 -36.3 79.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.44 109.24 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.159 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.651 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 3.2 m -151.32 141.23 21.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.522 0.677 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.9 m -95.82 143.3 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.693 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -102.8 105.2 15.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.035 178.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 156' ' ' LYS . 12.1 tp -109.02 125.21 51.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.6 tt0 -140.22 121.91 15.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.019 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -149.32 162.76 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.382 . . . . 0.0 111.68 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -70.71 -28.91 65.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.274 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 74.24 24.26 1.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.656 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 7.7 tt0 -164.92 128.28 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.2 p -146.14 107.4 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.131 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.58 126.83 30.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.178 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.5 t -29.27 124.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 113.85 -19.2 18.73 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.684 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 43' ' ' VAL . 2.9 tt0 -110.42 173.11 6.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.662 0.267 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -114.53 167.62 10.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.741 ' O ' HG12 ' A' ' 122' ' ' VAL . 18.1 mt -108.8 161.43 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -136.08 93.71 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.564 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.019 HG12 ' HB2' ' A' ' 39' ' ' ALA . 7.9 m -105.06 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.455 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.791 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.41 72.98 1.87 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.176 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -78.38 99.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.957 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.76 -118.42 3.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.782 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.576 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -120.4 135.14 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.014 0.435 . . . . 0.0 111.921 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -36.47 7.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 32' ' ' THR . 81.8 mm-40 -158.99 131.34 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.323 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -154.12 90.62 1.37 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.463 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.774 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.7 p -111.39 114.83 48.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.749 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.6 m-20 102.68 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.055 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -145.93 133.63 21.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.777 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.6 tp10 -100.82 86.16 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.582 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.091 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.5 125.83 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.519 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 111' ' ' PRO . 3.5 m-85 -118.41 -37.85 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.487 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.24 112.79 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.994 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 2.6 t80 -85.75 135.77 33.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 111.508 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -148.06 110.01 4.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.275 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 11.7 p90 -128.04 171.42 11.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.996 0.427 . . . . 0.0 111.429 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.72 101.14 5.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.687 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.796 HD21 HD22 ' A' ' 134' ' ' LEU . 8.0 tt -77.21 153.66 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.923 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.26 114.34 20.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.668 ' HA ' HD23 ' A' ' 134' ' ' LEU . 37.2 p90 -122.83 -172.37 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.13 126.17 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -82.47 -32.19 28.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -74.99 -29.75 60.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.881 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -107.39 -52.81 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.061 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 160' ' ' ILE . 4.7 m-85 -93.43 171.91 8.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.3 115.75 4.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.71 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.601 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.7 t80 -48.42 148.65 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' A' ' 122' ' ' VAL . 48.7 t -130.6 -84.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.871 ' O ' HG22 ' A' ' 122' ' ' VAL . 24.7 mm-40 -157.37 138.65 13.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.197 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.7 153.77 25.17 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.217 1.008 . . . . 0.0 111.757 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.877 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.49 174.7 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.357 -1.747 . . . . 0.0 112.218 -177.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.473 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -154.66 -165.64 2.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.71 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -161.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -95.59 37.77 1.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.53 -39.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.57 HG13 ' C ' ' A' ' 105' ' ' SER . 21.7 t -86.96 140.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.924 0.393 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.79 ' HB2' HD12 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -97.14 118.66 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.026 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 104' ' ' VAL . 6.3 t -116.83 129.96 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.748 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -137.23 120.0 16.26 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.63 148.34 22.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.087 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -131.84 106.69 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.233 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.676 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -55.02 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.137 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.9 tp -83.0 -25.12 8.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.836 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -165.33 -173.39 2.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 61.15 32.13 79.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.452 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.51 120.8 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.823 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.24 155.0 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.698 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -97.05 152.53 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.928 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.6 p -126.66 146.83 31.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.445 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 59.6 mt -115.74 107.41 15.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.774 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.757 HG11 ' CD1' ' A' ' 118' ' ' LEU . 9.9 t -104.77 140.92 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 111.543 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.57 ' C ' HG13 ' A' ' 88' ' ' VAL . 1.8 p -164.48 136.89 4.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.9 m -83.5 111.24 18.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.212 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -93.55 28.8 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.125 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.7 p -104.04 -27.97 11.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.5 -20.04 6.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.217 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.34 158.55 35.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.79 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . 37.2 Cg_endo -66.0 164.14 28.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.532 2.155 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.091 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -55.25 131.78 69.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.424 ' O ' HD23 ' A' ' 118' ' ' LEU . 96.3 Cg_endo -86.81 145.17 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -97.45 168.75 10.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.92 35.11 13.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.14 157.79 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.611 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.791 HG13 ' HA3' ' A' ' 52' ' ' GLY . 36.6 t -50.86 105.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.757 ' CD1' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.54 -30.93 18.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.6 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -176.21 157.71 1.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.733 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.736 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -153.84 131.94 11.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.574 ' O ' HD22 ' A' ' 123' ' ' LEU . 95.3 t -104.62 105.03 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.628 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.877 ' CG1' HD11 ' A' ' 83' ' ' ILE . 26.0 m -75.22 109.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.874 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 121' ' ' VAL . 2.8 mm? -83.15 169.13 16.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 1.7 tpm_? -110.86 118.87 37.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -86.49 67.27 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.243 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.88 -4.76 59.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.45 123.72 2.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.491 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.0 ttmt -39.66 160.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.606 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.41 60.8 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.767 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.51 119.74 6.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.286 -178.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 133' ' ' ASN . . . 86.3 13.18 68.83 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.648 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.813 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -69.08 69.93 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.545 ' HB3' HG22 ' A' ' 157' ' ' THR . 2.0 p-10 -59.56 146.29 41.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.448 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.796 HD22 HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -117.46 165.11 13.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.857 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.5 115.51 9.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.0 111.178 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 53' ' ' VAL . 2.6 m -96.15 95.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.478 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -111.67 -163.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.704 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.89 21.55 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -69.22 96.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -94.87 -178.53 4.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.022 0.439 . . . . 0.0 111.366 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.8 m -156.68 141.66 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 88.38 1.5 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.326 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.42 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 14.4 t0 -52.92 160.61 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.869 0.366 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.7 -49.67 76.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.584 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -55.72 -26.73 46.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.735 0.302 . . . . 0.0 111.053 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.96 23.18 5.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mt -117.73 170.04 9.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 140' ' ' SER . 77.5 t -109.12 142.23 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 143' ' ' ASP . 55.8 m80 -119.38 92.39 3.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -48.62 97.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.173 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.33 164.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.163 0.506 . . . . 0.0 111.69 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.56 -148.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.551 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -170.4 174.58 44.4 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.468 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.749 HG22 HD23 ' A' ' 37' ' ' LEU . 52.2 m -145.44 162.36 37.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.763 0.316 . . . . 0.0 110.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 154' ' ' THR . 0.1 OUTLIER -123.54 154.07 39.71 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.973 0.416 . . . . 0.0 111.152 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -132.22 164.08 27.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.936 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 133' ' ' ASN . 1.2 p -141.77 115.57 9.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.983 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.35 135.74 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.412 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -105.32 108.19 19.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -82.99 116.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -98.46 139.78 19.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.92 145.69 55.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 0.0 111.139 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.46 -133.25 0.62 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.469 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -84.63 176.02 8.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 164' ' ' THR . 1.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.24 -65.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.457 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -141.27 100.95 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.316 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -130.29 -56.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -73.22 79.85 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -173.34 120.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.31 79.69 3.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.935 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.09 154.92 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -162.34 35.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 60.72 95.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 m -98.44 35.29 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t -87.0 79.88 8.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.83 -126.17 8.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.32 -46.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.4 82.99 2.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -32.33 -37.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.618 2.879 . . . . 0.0 113.355 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.08 155.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.87 -161.38 33.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.499 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.58 148.27 51.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -91.63 177.3 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ttm 60.53 106.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.93 101.81 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.179 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -130.73 92.12 3.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 121.31 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -146.12 86.79 1.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -102.13 -64.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 177.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.51 109.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.12 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.92 36.89 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.39 120.62 25.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 59' ' ' VAL . 65.7 t -68.65 155.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 59' ' ' VAL . 8.4 t -72.59 -43.76 62.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 68.6 114.09 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.225 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.843 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 17.5 t -158.16 134.98 9.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.507 0.67 . . . . 0.0 111.977 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.513 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -96.27 143.87 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.7 t -103.85 106.75 17.36 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.318 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 154' ' ' THR . 6.7 tp -107.38 117.41 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.952 0.406 . . . . 0.0 111.329 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -140.28 139.2 35.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.487 ' HB3' ' HZ3' ' A' ' 156' ' ' LYS . . . -177.4 171.42 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -30.86 67.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.534 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' C ' HG12 ' A' ' 158' ' ' VAL . 0.3 OUTLIER 71.88 31.03 2.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' CD ' HD11 ' A' ' 161' ' ' ILE . 2.1 tm-20 -164.68 130.34 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.947 0.403 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -147.57 107.85 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.137 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.495 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.89 126.42 29.65 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.135 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.6 t -29.35 130.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 112.717 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.98 -20.46 35.92 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.357 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -105.62 172.45 6.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.317 . . . . 0.0 110.659 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -100.71 167.72 10.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 111.095 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.813 HD12 HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -110.4 159.55 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.525 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' H ' HD23 ' A' ' 49' ' ' LEU . 4.5 mm-40 -137.24 92.65 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 0.0 110.638 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 49' ' ' LEU . 2.1 m -109.95 96.56 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.411 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.65 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -85.66 70.72 3.0 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.903 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 136' ' ' VAL . 7.1 p -78.38 94.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 118' ' ' LEU . . . -103.06 -129.98 6.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.637 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.723 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -111.44 128.98 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.0 111.562 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.5 t0 -93.37 -28.78 15.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 177.34 136.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.493 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD23 HG12 ' A' ' 55' ' ' ILE . 1.8 pp -153.2 91.56 1.53 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.865 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.687 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.5 p -100.82 114.72 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.994 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.668 ' HB2' HG22 ' A' ' 31' ' ' VAL . 78.8 m-20 105.85 39.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.935 0.894 . . . . 0.0 111.554 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -171.02 148.28 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.64 82.53 1.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.733 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.99 112.14 2.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.64 ' O ' HD13 ' A' ' 112' ' ' LEU . 15.8 m-85 -101.76 -32.21 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.13 112.56 6.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.511 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.8 t80 -108.46 96.66 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 111.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.52 110.46 23.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.326 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.969 ' CE2' HG11 ' A' ' 102' ' ' VAL . 34.7 p90 -101.87 160.55 14.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 0.0 111.341 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -111.38 105.28 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.762 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -77.34 128.56 34.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.569 ' N ' HD13 ' A' ' 70' ' ' LEU . 3.0 m-80 -110.96 115.2 29.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.615 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.6 p90 -139.53 -169.13 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.167 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.56 140.97 41.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.75 -27.37 16.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -59.49 -30.38 68.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -117.62 -47.14 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.195 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.31 -176.81 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.988 0.423 . . . . 0.0 111.008 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 43.9 tp10 -166.27 155.93 11.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.496 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.6 t80 -94.92 148.96 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -132.22 -78.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.032 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 122' ' ' VAL . 6.1 mm-40 -161.06 134.75 6.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.18 148.91 27.17 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 122.31 1.052 . . . . 0.0 111.701 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.689 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 174.58 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.098 -177.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.701 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -146.55 -165.65 2.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.82 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -159.79 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.49 36.66 1.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.69 -42.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.21 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 106' ' ' SER . 17.2 t -87.08 146.02 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -105.3 103.3 12.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.701 HG23 ' OG ' ' A' ' 84' ' ' SER . 5.1 t -92.45 153.71 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -163.24 113.54 1.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.03 166.15 11.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.271 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.86 107.44 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttp -54.69 94.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.11 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -80.68 -23.23 11.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.655 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -169.82 -166.77 0.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.79 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.24 133.56 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 58.54 29.24 63.53 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.516 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' C ' HG13 ' A' ' 100' ' ' VAL . 1.6 ptpm? -173.33 120.05 0.33 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.834 0.35 . . . . 0.0 110.069 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -150.05 155.05 8.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.793 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.56 152.3 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.162 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.969 HG11 ' CE2' ' A' ' 68' ' ' PHE . 9.2 p -128.14 93.41 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.772 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 mt -80.14 111.24 16.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.53 HG23 ' CG2' ' A' ' 90' ' ' VAL . 14.8 p -112.3 151.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.607 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.424 ' C ' HG13 ' A' ' 88' ' ' VAL . 7.9 p -160.81 136.2 7.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.517 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 88' ' ' VAL . 1.1 p -78.34 110.68 13.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.2 tt -94.46 30.31 2.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.133 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.5 p -102.55 -31.58 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.942 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 125.97 -22.6 6.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -110.11 159.19 32.84 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.63 0.253 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.46 179.52 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.583 2.189 . . . . 0.0 112.214 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 118' ' ' LEU . 3.4 mp -56.83 132.28 79.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.94 -39.67 31.58 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.522 2.148 . . . . 0.0 112.204 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 61.55 166.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.108 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 15.78 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.22 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -166.7 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.281 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.65 HG13 ' HA3' ' A' ' 52' ' ' GLY . 38.1 t -70.99 104.87 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.581 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.07 -33.49 20.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.2 131.64 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.212 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 mtmt -112.62 117.23 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.447 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.0 p -99.41 105.02 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.3 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 81' ' ' GLU . 24.2 m -75.79 130.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.921 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.8 mt -113.24 111.51 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.847 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 14.1 tpp85 -55.0 111.47 0.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.0 68.31 7.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -85.83 -5.35 59.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.389 0.614 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.48 123.41 2.53 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.644 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.729 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 18.0 ttmt -41.95 162.13 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.319 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.838 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.69 57.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.913 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 3.5 pt-20 -56.02 117.25 3.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.196 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.03 -0.73 67.02 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.765 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.838 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.3 m -59.17 88.08 0.01 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.437 ' ND2' HG22 ' A' ' 157' ' ' THR . 4.3 m120 -59.92 163.68 4.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 111.533 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 70' ' ' LEU . 3.5 mt -140.3 112.93 8.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.868 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.32 125.67 51.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.506 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.817 HG21 HG21 ' A' ' 53' ' ' VAL . 12.1 m -110.12 94.81 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.715 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.457 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 18.6 p -100.76 -168.33 1.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.44 21.16 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.886 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 100.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.505 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.58 169.99 8.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.422 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 66' ' ' TYR . 31.1 m -132.48 -179.47 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -118.61 84.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -55.63 154.49 6.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.978 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.58 -46.46 93.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.46 -29.47 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.15 -25.44 6.06 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.385 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.49 170.17 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.46 139.73 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -114.01 90.44 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 103.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.718 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.513 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.55 -176.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.291 0.567 . . . . 0.0 111.711 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -69.29 -159.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.404 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -155.94 171.22 33.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.187 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 37' ' ' LEU . 66.4 m -152.9 149.13 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -114.68 148.85 37.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.672 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.6 tppp? -131.81 163.89 27.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.332 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.591 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -142.88 124.62 15.02 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.934 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.805 HG11 HD11 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -114.4 138.36 44.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.13 105.75 16.12 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.893 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.869 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.5 mt -82.44 117.08 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-O 121.439 0.637 . . . . 0.0 109.437 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.25 137.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.549 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.17 145.57 55.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.015 0.436 . . . . 0.0 110.946 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.41 159.09 14.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 170.03 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.87 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.928 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 mtm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.86 0.362 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.06 -85.53 0.48 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.565 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -114.06 174.25 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.8 125.76 29.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -86.66 -59.76 2.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -105.02 -177.64 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.97 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -84.75 105.09 15.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -129.27 -45.85 1.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -59.87 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -106.52 127.17 53.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.66 31.15 5.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m 60.17 36.87 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.78 145.45 16.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -97.07 -31.29 12.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 0.0 110.918 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.78 82.62 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -32.27 135.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.586 2.857 . . . . 0.0 113.306 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -98.35 35.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.49 140.95 10.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.584 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -31.53 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 60.25 86.46 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.04 32.31 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 p -101.45 -74.52 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.0 -43.22 2.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 61.15 155.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' N ' HD23 ' A' ' 25' ' ' LEU . 8.0 tttt -98.54 32.59 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.909 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.47 170.49 22.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.74 -176.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.73 ' HB1' ' CG ' ' A' ' 60' ' ' ASN . . . -90.5 -76.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 53.27 101.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.338 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 21.8 t -60.6 155.7 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.807 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 57' ' ' GLU . 6.5 t -81.33 -46.7 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 67.83 114.63 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.605 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.662 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -150.95 148.41 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.256 0.55 . . . . 0.0 111.574 179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 154' ' ' THR . 5.8 m -99.87 128.88 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.569 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -92.03 106.84 18.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.825 178.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 154' ' ' THR . 4.6 mt -97.48 123.29 41.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.082 0.467 . . . . 0.0 111.523 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -134.88 101.15 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.015 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.3 141.58 33.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -25.75 67.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.25 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 74.55 23.08 1.96 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.566 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HG2' HD11 ' A' ' 161' ' ' ILE . 3.7 tt0 -164.98 128.34 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.99 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.14 108.0 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -68.2 122.86 19.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.781 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.02 131.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 121.469 0.652 . . . . 0.0 112.641 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.04 -23.71 32.73 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.125 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -96.68 172.99 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.692 0.282 . . . . 0.0 110.43 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -94.93 167.78 11.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.0 110.852 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.786 HD11 HG11 ' A' ' 158' ' ' VAL . 4.7 tp -154.93 108.08 2.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HB3' HG12 ' A' ' 122' ' ' VAL . 1.9 pm0 -110.37 146.73 35.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 98.12 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.735 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -67.52 65.88 0.27 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.441 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 136' ' ' VAL . 13.5 p -80.92 102.48 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.413 . . . . 0.0 111.109 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.64 -123.28 3.6 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.548 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.779 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -111.59 137.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 111.737 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.4 -36.14 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.417 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.5 mp0 -166.29 131.4 2.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.537 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 141' ' ' VAL . 1.1 tt -152.57 96.6 2.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 59' ' ' VAL . 10.1 p -122.99 109.41 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.73 ' CG ' ' HB1' ' A' ' 29' ' ' ALA . 65.7 m-20 128.61 20.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.403 1.081 . . . . 0.0 111.414 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -161.31 175.76 11.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.087 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -130.2 85.38 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -63.64 127.53 31.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.519 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.494 ' C ' HD23 ' A' ' 112' ' ' LEU . 7.1 m-85 -111.09 -45.43 3.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.152 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.7 112.71 17.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.237 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 112' ' ' LEU . 34.2 t80 -97.6 95.02 7.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.881 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -106.07 110.15 22.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.652 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.4 p90 -112.19 171.16 7.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.104 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.4 m -120.68 107.67 13.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.493 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.525 HD11 HD23 ' A' ' 134' ' ' LEU . 21.2 tp -79.15 133.35 36.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -116.83 109.03 16.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 15.1 p90 -125.04 -166.74 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.4 t70 -120.44 102.8 8.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 111.119 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.44 -28.16 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.63 -47.24 80.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.964 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -116.87 32.87 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.478 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -167.31 -176.48 3.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.421 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.92 108.95 0.31 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CD1' HG21 ' A' ' 100' ' ' VAL . 8.5 t80 -54.49 149.32 10.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.79 ' HB ' HG23 ' A' ' 122' ' ' VAL . 59.7 t -128.65 -79.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.859 ' O ' HG22 ' A' ' 122' ' ' VAL . 13.3 mm-40 -160.89 145.08 13.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.85 150.56 26.48 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 122.215 1.007 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -124.08 151.31 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.295 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.665 ' HB2' HG12 ' A' ' 90' ' ' VAL . 1.4 m -174.87 129.78 0.31 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.729 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.16 -168.2 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 t0 63.93 63.74 0.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.89 25.41 59.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 86' ' ' ASP . 21.6 t -140.96 114.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 111.051 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -113.33 121.66 45.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 84' ' ' SER . 8.7 p -113.17 153.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.231 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -137.7 123.99 20.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.307 0.575 . . . . 0.0 111.58 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.67 153.53 17.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.761 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 107.11 5.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 111.719 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 7.4 tttt -55.24 117.38 3.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.716 HG22 ' HA ' ' A' ' 100' ' ' VAL . 4.5 tp -109.15 -25.47 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 163.82 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.0 124.22 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 68.57 30.11 72.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.453 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.9 ptmt -174.01 123.21 0.32 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.935 0.397 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HA ' HG22 ' A' ' 95' ' ' ILE . 10.0 m -149.9 154.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.426 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -96.92 152.86 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 112.013 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.3 p -124.35 150.82 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.49 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.4 mt -124.1 108.75 12.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.072 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.661 HG22 ' CG2' ' A' ' 90' ' ' VAL . 97.6 t -102.68 136.64 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.401 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 p -164.39 134.74 4.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.7 m -88.88 130.9 35.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.058 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.07 29.35 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 -26.38 9.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.025 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.27 -24.07 10.13 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.125 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -89.38 155.94 48.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.681 0.277 . . . . 0.0 110.663 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 60.5 Cg_endo -72.68 156.16 53.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.57 2.18 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 63' ' ' ALA . 1.9 pp -51.99 133.44 39.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.878 ' O ' HD21 ' A' ' 118' ' ' LEU . 86.6 Cg_endo -84.72 145.35 10.25 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.408 2.072 . . . . 0.0 111.49 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.779 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -98.51 169.19 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 111.317 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.93 33.89 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.482 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.665 ' O ' HD22 ' A' ' 118' ' ' LEU . 13.6 tt0 -161.1 157.58 26.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.34 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.735 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.3 t -55.34 105.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 113' ' ' PRO . 1.4 mm? -89.57 -31.28 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.93 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . . . -164.38 135.67 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 128.9 40.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.697 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 70' ' ' LEU . 50.2 t -107.13 112.73 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.7 m -75.3 96.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.513 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.488 ' CD1' HD21 ' A' ' 134' ' ' LEU . 36.1 mt -83.17 110.81 18.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.034 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.1 tpp85 -55.37 110.93 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.78 70.46 5.13 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -2.39 58.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.444 0.64 . . . . 0.0 109.562 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.64 123.55 2.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.611 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.652 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 8.8 ttpt -51.87 142.5 15.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.691 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.55 63.73 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.14 111.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.31 22.71 43.22 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.641 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.806 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -70.69 66.96 0.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.518 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.85 131.69 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.121 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.525 HD23 HD11 ' A' ' 70' ' ' LEU . 5.6 mp -111.6 139.28 47.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.941 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.88 110.61 14.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.902 0.382 . . . . 0.0 111.477 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.886 HG21 HG21 ' A' ' 53' ' ' VAL . 21.0 m -99.4 95.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.7 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.45 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 13.8 p -103.65 -165.62 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.45 ' ND2' ' C ' ' A' ' 137' ' ' THR . 2.2 p30 43.52 21.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.976 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.505 ' OG ' HD11 ' A' ' 151' ' ' ILE . 5.6 t -63.83 96.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.791 0.329 . . . . 0.0 110.507 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -101.18 167.47 10.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.385 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 58' ' ' LEU . 4.9 m -128.82 -179.59 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.87 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.5 87.2 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.444 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 17.3 t70 -53.32 162.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.041 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.84 -52.11 55.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.19 -30.83 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.781 0.324 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.41 -28.09 4.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.424 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.78 150.93 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 74.6 t -99.62 149.8 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 24.8 m-70 -123.54 90.55 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.593 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.69 107.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.66 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.505 HD11 ' OG ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.32 -177.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.418 . . . . 0.0 111.42 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.1 -148.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.347 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.23 37.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.151 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 37' ' ' LEU . 67.9 m -164.16 146.67 9.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.759 0.314 . . . . 0.0 110.573 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -107.05 167.81 9.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.948 0.404 . . . . 0.0 111.543 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.685 ' HD2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.61 163.74 31.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.232 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.451 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.2 p -142.4 119.55 11.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.786 HG11 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.34 138.05 48.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.161 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -106.79 105.54 15.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -80.46 129.32 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -114.13 129.54 69.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.819 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.8 145.31 41.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.237 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.74 92.05 0.16 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.48 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -71.27 -177.78 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.483 ' H ' HG22 ' A' ' 164' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mtt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.09 43.02 0.19 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.7 t -140.94 170.55 15.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.48 148.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 59.98 163.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 60.33 103.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -144.28 99.87 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -105.98 -66.11 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.966 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -170.57 126.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -175.85 -65.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m 60.52 177.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -91.65 -62.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.06 161.56 23.84 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.442 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.681 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.486 0.184 . . . . 0.0 110.925 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 14' ' ' LEU . 17.9 m 51.75 152.33 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.168 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.49 -38.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.635 2.89 . . . . 0.0 113.282 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 114.12 0.57 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.516 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 m 60.62 -170.0 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.936 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -145.22 -61.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 63.85 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.39 31.34 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.03 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t 60.56 95.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.831 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 31.75 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.9 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 25' ' ' LEU . 9.5 tp -154.46 164.68 38.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.18 30.81 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.6 -177.8 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.35 146.64 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.73 73.45 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.24 100.96 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.879 HG21 ' HB2' ' A' ' 61' ' ' ALA . 13.4 t -78.57 146.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' GLY . 12.6 t -74.42 -32.6 62.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 57.05 114.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.209 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 13.3 t -147.56 156.44 42.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG23 ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -106.2 129.64 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.035 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -91.41 107.44 19.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.059 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.912 HD12 HG22 ' A' ' 154' ' ' THR . 5.6 mt -96.7 120.26 36.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.439 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -140.18 101.2 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.77 149.64 32.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.444 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.49 -22.25 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.427 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' C ' HG12 ' A' ' 158' ' ' VAL . 2.8 mp0 67.06 24.38 9.45 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.549 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -164.96 128.93 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.97 0.414 . . . . 0.0 111.995 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.93 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -145.51 108.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.207 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.88 125.34 26.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.292 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.6 t -29.38 130.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 121.517 0.675 . . . . 0.0 112.705 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.91 -23.65 30.38 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.34 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.03 172.34 7.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -105.85 167.7 9.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.088 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.883 HD11 HG11 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.93 158.26 24.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.63 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' H ' HD23 ' A' ' 49' ' ' LEU . 5.4 mp0 -137.48 92.35 2.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.741 0.305 . . . . 0.0 110.294 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -112.07 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.05 0.453 . . . . 0.0 110.461 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 119' ' ' ALA . . . -90.01 81.66 1.41 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.468 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 136' ' ' VAL . 14.8 p -78.61 99.53 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.075 0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.33 -117.47 4.34 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.59 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.768 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -121.43 127.23 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.491 . . . . 0.0 112.186 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -101.12 -26.15 13.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.6 mp0 -165.41 136.47 3.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.738 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -169.97 91.49 0.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.213 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.835 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.3 p -103.1 115.45 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.734 ' HB2' HG22 ' A' ' 31' ' ' VAL . 71.0 m-20 101.48 23.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.214 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.879 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -144.49 134.26 23.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.989 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 19.6 tt0 -105.14 83.71 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.472 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.82 2.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.8 m-85 -104.14 -33.35 8.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.24 112.21 9.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.786 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.775 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 t80 -87.53 137.42 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 111.436 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -147.89 109.43 4.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.182 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CE2' HG11 ' A' ' 102' ' ' VAL . 8.2 p90 -130.85 171.31 13.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.447 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.83 111.24 11.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.773 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -77.25 156.17 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.776 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -130.35 104.41 7.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.44 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 12.0 p90 -122.79 -168.35 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -100.94 147.75 25.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.017 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -105.13 14.66 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.252 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -110.17 -31.02 7.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.787 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -113.0 -45.56 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.3 m-85 -93.59 -177.86 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -170.34 112.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.585 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 44.6 t80 -53.35 154.41 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 122' ' ' VAL . 46.9 t -134.49 -73.42 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.86 ' O ' HG22 ' A' ' 122' ' ' VAL . 4.9 mt-10 -163.36 143.62 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.88 155.72 23.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-O 121.918 0.866 . . . . 0.0 111.583 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -131.51 154.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.882 -1.508 . . . . 0.0 112.65 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.674 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -123.54 -164.82 1.26 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.784 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 88' ' ' VAL . 13.9 p-10 -96.66 -157.99 0.63 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.774 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -93.87 36.78 1.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.87 -41.95 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.945 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 112' ' ' LEU . 13.1 t -87.46 153.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.689 0.28 . . . . 0.0 110.694 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.722 ' HB2' HD23 ' A' ' 107' ' ' LEU . 2.7 t80 -110.15 120.7 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.127 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 104' ' ' VAL . 20.2 t -109.29 145.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.81 105.44 1.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.541 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 102' ' ' VAL . . . -96.59 -177.04 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 111.52 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.716 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.697 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 6.8 tttt -54.01 95.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.165 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.815 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.2 tp -75.55 -25.45 17.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.739 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -167.4 -173.21 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.37 132.18 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 56.84 33.03 62.72 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.408 ' C ' HG13 ' A' ' 100' ' ' VAL . 11.9 ptpt -173.94 120.27 0.29 Allowed 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.815 ' HA ' HG22 ' A' ' 95' ' ' ILE . 4.4 m -149.9 156.09 7.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.663 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.717 HH21 HD21 ' A' ' 103' ' ' LEU . 2.6 ttt180 -103.42 151.8 22.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 14.8 p -119.53 143.32 31.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.141 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.717 HD21 HH21 ' A' ' 101' ' ' ARG . 80.1 mt -128.18 98.5 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.651 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 66' ' ' TYR . 8.5 p -105.83 157.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.154 0.502 . . . . 0.0 111.785 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.496 ' N ' HG22 ' A' ' 104' ' ' VAL . 2.5 p -163.35 136.83 5.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.124 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' HG13 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -77.25 104.3 7.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.304 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 89' ' ' PHE . 3.4 mm? -71.52 -16.08 62.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.207 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -65.23 -34.81 79.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.87 -18.86 21.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.92 156.96 49.24 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 33.3 Cg_endo -64.66 142.05 75.39 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.607 2.205 . . . . 0.0 112.34 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 88' ' ' VAL . 8.1 mt -54.49 106.92 0.73 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.535 ' O ' HD21 ' A' ' 118' ' ' LEU . 37.0 Cg_exo -60.83 147.69 94.48 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.438 2.092 . . . . 0.0 111.838 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.768 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -101.52 175.47 5.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.183 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 18.61 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.072 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.92 -165.75 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 36.4 t -84.48 104.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 112' ' ' LEU . 2.0 mm? -90.03 -32.81 16.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.977 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.36 131.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.745 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -128.04 159.17 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 70' ' ' LEU . 9.9 p -130.81 148.16 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.917 HG13 HD11 ' A' ' 83' ' ' ILE . 29.3 m -110.7 103.67 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.747 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.643 ' CD1' HD21 ' A' ' 134' ' ' LEU . 9.3 mt -90.41 108.81 20.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.885 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 17.7 ttm180 -55.4 112.56 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.711 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -80.1 71.73 6.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.31 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -87.43 -3.93 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 109.588 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.71 123.57 2.46 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.518 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.732 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -49.19 140.79 9.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.579 -178.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -143.37 62.99 1.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.541 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.98 121.61 9.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.485 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.45 18.83 79.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.691 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 28.7 t -68.99 71.69 0.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.895 0.378 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -45.31 132.22 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.025 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.643 HD21 ' CD1' ' A' ' 123' ' ' LEU . 5.4 mp -117.87 129.69 55.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.933 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.7 p -108.22 121.06 44.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.939 0.4 . . . . 0.0 111.489 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 53' ' ' VAL . 21.3 t -104.65 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.468 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.4 p -109.98 -164.65 0.94 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.468 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.78 17.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.092 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.606 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -64.71 95.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.88 8.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 111.618 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 66' ' ' TYR . 26.7 m -139.87 -179.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.914 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.27 89.67 0.4 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 5.2 p30 -62.07 168.35 3.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.67 22.21 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.904 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 147' ' ' LEU . 2.6 mt-10 -55.09 -23.42 20.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.684 0.278 . . . . 0.0 111.337 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.18 -17.9 28.8 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.415 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' GLU . 3.0 mp -65.3 170.46 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.01 120.47 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 143' ' ' ASP . 45.6 m-70 -92.46 92.71 8.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -45.91 102.52 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.36 167.41 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 111.738 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.01 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.658 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.1 171.16 40.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.301 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.912 HG22 HD12 ' A' ' 37' ' ' LEU . 50.9 m -165.2 155.95 14.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.656 0.265 . . . . 0.0 110.77 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -118.6 170.14 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.534 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -143.14 166.22 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -143.17 120.57 11.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.634 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -114.66 126.35 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -91.66 105.46 17.75 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 120.994 0.426 . . . . 0.0 110.732 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.93 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.2 mt -81.07 120.65 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -104.45 131.65 52.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.817 -178.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.74 145.88 38.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.11 -50.61 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 165' ' ' SER . 7.9 t -92.81 -143.44 0.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.082 0.468 . . . . 0.0 110.962 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 164' ' ' THR . 3.0 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.869 0.366 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.71 73.06 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.588 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 t -106.23 91.29 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -134.19 93.04 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -165.15 100.37 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -106.76 -178.03 3.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 60.66 -178.53 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -60.43 -66.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -162.53 147.76 12.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -133.17 35.45 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 m -104.49 35.35 2.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -151.74 143.95 23.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.23 -68.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.76 HD12 HG13 ' A' ' 15' ' ' VAL . 3.5 pp -64.16 -31.38 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.76 HG13 HD12 ' A' ' 14' ' ' LEU . 12.2 m -89.43 150.0 43.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -32.23 141.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.551 2.834 . . . . 0.0 113.32 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -176.43 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.09 128.85 1.08 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -71.63 -66.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -115.8 129.65 56.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.4 mtp -88.1 -37.34 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.45 176.4 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 t -156.85 35.57 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -133.44 126.42 31.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.822 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.03 146.18 35.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -119.85 77.53 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER 60.31 167.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.721 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 27' ' ' GLU . . . -123.76 178.17 5.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.31 76.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.03 118.8 36.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 60' ' ' ASN . 43.3 t -74.48 149.58 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 57' ' ' GLU . 15.0 t -65.66 -36.21 83.01 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 58.53 109.94 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.913 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.5 t -155.55 143.19 19.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.567 0.699 . . . . 0.0 111.943 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HD11 ' A' ' 151' ' ' ILE . 35.7 m -101.95 143.95 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.842 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -100.31 106.38 18.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.613 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.92 HD21 ' HB2' ' A' ' 156' ' ' LYS . 4.3 tp -103.87 119.95 39.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.975 0.417 . . . . 0.0 111.484 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.547 ' N ' HD12 ' A' ' 37' ' ' LEU . 40.8 tp10 -139.26 101.4 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.666 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -134.53 151.37 51.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.413 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.93 -28.05 65.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.339 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.3 mt-10 67.68 23.42 8.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.431 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 158' ' ' VAL . 18.3 tt0 -164.81 123.9 1.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 0.0 111.772 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -144.89 108.01 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.289 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.16 127.33 32.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -29.33 131.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.24 -21.48 42.99 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.532 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -97.73 172.33 7.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 110.638 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -112.4 167.73 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.146 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.443 HD22 HG11 ' A' ' 158' ' ' VAL . 9.9 tp -130.2 153.42 48.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 15.2 mp0 -135.65 93.45 2.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.92 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' ALA . 7.2 p -104.16 98.1 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.613 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.801 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -89.37 87.05 1.44 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.867 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 136' ' ' VAL . 8.3 p -78.93 95.18 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.71 -128.82 6.12 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.634 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.585 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.65 128.9 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.053 0.454 . . . . 0.0 111.859 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 18.5 t0 -97.58 -30.06 13.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' HG21 ' A' ' 32' ' ' THR . 1.6 mp0 -167.35 135.12 2.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.024 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -161.53 90.84 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.379 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.738 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.9 p -115.53 126.97 73.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.975 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.748 ' HB2' HG22 ' A' ' 31' ' ' VAL . 75.7 m-20 104.38 15.76 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.786 0.834 . . . . 0.0 112.064 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.724 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.85 176.35 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.42 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 1.1 tt0 -129.98 83.17 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.8 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.683 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.1 120.73 11.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.7 ' C ' HD23 ' A' ' 112' ' ' LEU . 4.1 m-85 -120.37 -43.17 2.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.639 ' N ' HD23 ' A' ' 112' ' ' LEU . . . -134.3 118.31 17.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.048 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 t80 -85.96 137.9 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -147.66 109.85 4.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.455 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 136' ' ' VAL . 14.7 p90 -139.48 171.17 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.417 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -124.19 115.75 21.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.884 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.665 ' CD2' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -88.14 111.16 21.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 1.2 p-10 -95.69 104.61 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.013 0.435 . . . . 0.0 111.129 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CZ ' ' HA2' ' A' ' 98' ' ' GLY . 38.2 p90 -107.91 -168.44 1.37 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.631 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.31 104.72 14.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HB2' ' N ' ' A' ' 98' ' ' GLY . 14.2 tp10 -67.25 -26.72 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.91 -29.19 62.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.144 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.903 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -124.43 -40.35 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.381 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.21 -176.88 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -165.2 121.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 26.5 t80 -56.43 150.67 14.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 46.0 t -132.46 -71.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.993 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.6 pp20? -172.94 140.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 149.57 27.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.118 0.961 . . . . 0.0 111.45 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -115.7 153.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.511 -176.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.752 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -120.68 -167.01 1.4 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.977 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.26 -158.54 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -95.61 36.92 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.83 -45.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.621 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.752 HG23 ' OG ' ' A' ' 84' ' ' SER . 32.8 m -86.66 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.244 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.37 124.19 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.093 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.746 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 t -115.8 136.22 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -148.94 116.57 6.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -97.07 153.53 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -133.48 107.36 7.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.667 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.631 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 11.4 tmtt? -55.15 95.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.799 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.3 tp -84.51 -25.93 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.875 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -166.57 177.62 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.768 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 130.11 40.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 72' ' ' TYR . . . 58.78 33.21 72.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.43 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' ASN . 13.2 ptpt -173.77 118.96 0.28 Allowed 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.799 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.5 m -149.84 154.68 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -89.21 152.27 21.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.91 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.1 p -128.28 96.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.668 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.4 mt -86.69 102.77 14.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.9 p -107.3 153.59 8.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.288 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -164.5 138.51 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.381 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.622 ' OG ' HG12 ' A' ' 88' ' ' VAL . 47.1 m -76.47 104.59 7.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.283 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -13.92 62.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.607 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -65.41 -28.46 69.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.85 -23.1 12.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.954 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.68 155.09 45.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.593 0.235 . . . . 0.0 110.546 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -64.93 153.85 76.11 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.587 2.191 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.72 HD13 HD21 ' A' ' 118' ' ' LEU . 1.8 pp -52.91 132.62 48.75 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 94.1 Cg_endo -88.91 144.99 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.773 2.315 . . . . 0.0 112.209 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -94.57 170.69 9.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.178 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.16 32.91 12.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -163.5 158.2 20.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.598 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HA3' ' A' ' 52' ' ' GLY . 33.8 t -52.96 105.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -85.41 -32.33 22.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.961 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.45 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -173.73 135.24 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.797 ' HD3' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -126.3 149.58 49.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.675 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' A' ' 70' ' ' LEU . 42.0 t -113.06 154.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.532 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' GLU . 23.1 t -119.85 95.26 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.599 HD21 HD22 ' A' ' 70' ' ' LEU . 1.2 mm? -88.04 108.31 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.483 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 37.3 ttm180 -64.97 117.6 7.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -76.77 72.78 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.505 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -87.96 -3.62 58.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 0.0 109.438 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.39 123.49 2.58 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.407 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.731 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.6 ttmt -48.82 138.02 11.73 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.393 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.903 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -143.66 62.91 1.36 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.575 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.12 116.16 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.404 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.89 19.53 59.35 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.702 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.835 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.9 66.28 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.116 0.484 . . . . 0.0 110.455 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.453 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 1.1 t-20 -42.39 129.73 3.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.421 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 132' ' ' SER . 5.2 mp -111.2 150.28 29.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.51 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.07 121.45 14.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.986 0.422 . . . . 0.0 111.579 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 53' ' ' VAL . 8.9 p -99.71 95.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.599 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.484 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.4 p -100.3 -165.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.789 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.37 19.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.065 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -63.35 87.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.933 0.397 . . . . 0.0 110.227 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.664 ' HB2' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -106.38 162.11 13.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.436 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.898 ' O ' HG23 ' A' ' 148' ' ' VAL . 28.5 m -130.32 128.79 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.947 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.77 83.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.694 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 22.8 t70 -57.77 140.8 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.816 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.84 76.08 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.728 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.7 -29.59 66.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.14 15.04 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.746 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.62 115.11 28.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 110.769 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 141' ' ' VAL . 14.1 p -73.08 141.55 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -104.8 99.0 8.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.87 102.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.602 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.27 -176.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.784 -178.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -75.83 -161.59 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.408 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.17 172.65 34.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.791 HG22 HD23 ' A' ' 37' ' ' LEU . 90.8 m -153.69 146.48 24.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.723 0.297 . . . . 0.0 110.849 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.81 161.96 15.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 111.261 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.92 ' HB2' HD21 ' A' ' 37' ' ' LEU . 3.9 tppt? -139.99 169.19 18.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.6 p -142.15 115.93 9.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.592 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -110.52 126.17 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 105.72 17.91 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.2 mt -80.72 122.59 36.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.13 132.98 51.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.623 -178.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.03 145.21 42.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.154 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.61 -138.4 10.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -73.19 -179.11 3.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.78 0.324 . . . . 0.0 110.966 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.459 ' H ' HG22 ' A' ' 164' ' ' THR . 2.1 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.67 -121.32 1.15 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t 60.37 35.54 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 0.0 110.972 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.2 p -135.61 179.15 6.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -160.29 124.79 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -118.81 31.6 6.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.52 -50.29 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -65.58 -31.12 71.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 61.9 153.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -132.85 167.15 20.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -104.5 31.79 4.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.5 p -82.26 133.49 35.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.12 -108.08 0.32 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.3 mp 60.3 96.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 m -130.94 152.73 81.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.31 -53.36 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.537 2.825 . . . . 0.0 113.318 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -169.47 116.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.96 -177.86 15.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 m -71.43 129.22 38.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -60.36 157.14 14.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.07 80.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.823 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 122.63 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.3 m -97.24 83.39 3.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -148.47 152.56 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD12 ' HE2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -156.74 146.51 20.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HE2' HD12 ' A' ' 25' ' ' LEU . 24.7 mttm 60.62 84.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.42 168.47 19.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.71 63.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.51 77.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.079 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -112.93 111.62 22.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 60' ' ' ASN . 15.2 t -60.64 151.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 33' ' ' GLY . 14.6 t -74.52 -46.69 37.55 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 76.09 112.27 0.12 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.692 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.899 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -159.75 139.16 11.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.0 111.428 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD11 ' A' ' 151' ' ' ILE . 19.1 m -98.93 141.15 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.527 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.45 106.38 18.68 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.826 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 HG22 ' A' ' 154' ' ' THR . 6.2 tp -107.17 106.58 17.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 111.355 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -121.94 118.65 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.412 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.74 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.493 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.82 -27.4 68.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.49 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 73.1 22.89 2.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.414 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 158' ' ' VAL . 41.6 tt0 -164.53 128.19 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.995 0.426 . . . . 0.0 112.114 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.4 p -132.52 168.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.735 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.577 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tm0? -131.56 118.49 20.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.1 t -28.57 130.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.488 0.661 . . . . 0.0 112.477 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.62 64.49 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.776 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.98 173.73 6.34 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.331 0.252 . . . . 0.0 110.473 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.524 ' HB3' HG13 ' A' ' 122' ' ' VAL . 16.9 m-80 -119.03 131.39 55.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.094 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.648 ' CD1' HG11 ' A' ' 158' ' ' VAL . 15.4 tp -86.91 154.99 20.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.21 93.47 2.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -105.06 98.17 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -87.75 86.05 1.51 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.89 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 53' ' ' VAL . 12.5 p -82.18 95.24 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -100.62 -127.63 6.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.981 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.942 HG12 HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -115.31 130.29 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 111.724 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.94 -39.3 11.21 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.07 132.79 0.51 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.927 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.942 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -157.25 113.69 2.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.539 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.6 p -128.89 100.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 31' ' ' VAL . 19.0 m-20 139.57 23.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.404 1.065 . . . . 0.0 111.737 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.67 147.42 6.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.776 0.322 . . . . 0.0 111.213 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -105.22 85.87 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 112.93 2.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.541 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 25.3 m-85 -99.77 -32.75 10.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.155 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.94 112.61 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.942 ' O ' HG12 ' A' ' 104' ' ' VAL . 35.6 t80 -102.79 130.67 49.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.771 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.627 ' CG ' HD23 ' A' ' 103' ' ' LEU . 10.7 m-20 -135.06 119.25 17.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.856 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.923 ' CE2' HG11 ' A' ' 102' ' ' VAL . 24.7 p90 -120.63 155.99 32.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.591 HG23 ' HD2' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -123.42 103.39 8.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.457 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 121' ' ' VAL . 1.1 pt? -77.36 156.13 31.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.348 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -124.0 104.4 8.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.695 ' HB3' HD11 ' A' ' 134' ' ' LEU . 18.6 p90 -118.44 -166.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -114.65 143.15 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.81 -25.21 15.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.012 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -62.14 -29.42 70.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.039 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -124.52 -43.92 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.258 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -93.16 169.27 10.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.636 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -159.2 119.71 3.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 23.7 t80 -57.32 153.7 11.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.6 t -131.49 -72.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 122' ' ' VAL . 15.4 pt-20 -170.38 143.94 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.819 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -84.54 150.78 25.0 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.251 1.024 . . . . 0.0 111.538 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.13 153.39 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.336 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.13 -174.43 2.71 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -159.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.745 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.78 36.64 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.92 -39.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.184 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 89' ' ' PHE . 14.1 t -87.18 159.96 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.979 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' N ' HG12 ' A' ' 88' ' ' VAL . 33.3 t80 -115.98 113.05 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 104' ' ' VAL . 2.1 t -104.23 155.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -166.24 110.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.399 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.99 158.14 15.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -145.83 107.15 4.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.166 0.508 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.73 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 20.4 tttt -55.14 117.03 3.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.312 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.5 tp -111.22 -23.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.847 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -167.86 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.24 -75.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 72' ' ' TYR . . . -106.22 53.12 0.65 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.408 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.3 ptmt -174.21 129.74 0.37 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.73 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 14.5 m -149.59 155.18 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.879 -178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.591 ' HD2' HG23 ' A' ' 69' ' ' THR . 0.9 OUTLIER -91.5 152.41 20.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.532 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.923 HG11 ' CE2' ' A' ' 68' ' ' PHE . 10.3 p -139.44 122.17 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.878 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.627 HD23 ' CG ' ' A' ' 67' ' ' ASP . 17.3 mt -109.72 108.92 19.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.9 p -106.7 148.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.414 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 p -155.91 136.48 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.44 104.5 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 111.179 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.5 tp -72.42 -12.85 61.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.536 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 p -65.27 -30.27 71.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.986 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.04 -18.98 18.43 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.412 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -92.93 147.87 34.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.638 0.256 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.3 Cg_exo -53.97 -178.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.476 2.117 . . . . 0.0 112.446 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.785 HD11 ' HG ' ' A' ' 118' ' ' LEU . 8.5 tt -58.57 123.0 64.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.62 -43.82 24.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.463 2.109 . . . . 0.0 112.129 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . . . 62.34 167.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.17 19.75 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.216 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.44 -168.62 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.439 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.693 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.5 t -74.73 104.99 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.728 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -83.63 -34.7 25.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -174.35 132.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 111.297 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.669 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -121.59 137.85 54.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.374 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.749 HG21 HD22 ' A' ' 70' ' ' LEU . 68.9 t -99.3 135.93 32.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.83 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 81' ' ' GLU . 47.6 t -93.47 97.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.887 HD11 HD21 ' A' ' 134' ' ' LEU . 44.7 mt -92.28 108.42 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG21 ' A' ' 80' ' ' VAL . 29.5 ttm180 -69.7 116.39 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -78.02 73.71 4.57 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.252 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -3.6 59.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.544 0.688 . . . . 0.0 109.503 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.88 123.0 2.7 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.121 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.646 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.9 ttpp -44.94 154.12 0.15 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.329 -178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.697 ' HB1' ' HB2' ' A' ' 132' ' ' SER . . . -162.47 59.79 0.22 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.917 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 6.8 tt0 -55.81 117.18 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.972 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.55 61.59 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.371 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.697 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 41.3 t -70.5 87.42 0.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.758 0.313 . . . . 0.0 110.397 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.401 ' ND2' HG22 ' A' ' 157' ' ' THR . 5.0 m120 -57.99 162.83 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.185 0.516 . . . . 0.0 111.401 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.887 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -143.91 104.85 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.645 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.2 t -100.1 131.3 46.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.645 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 53' ' ' VAL . 26.8 t -111.12 94.69 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.532 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.49 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -99.79 -164.45 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.676 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.23 22.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.021 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 151' ' ' ILE . 27.9 m -61.63 100.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 110.436 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 173.17 6.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.4 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.51 -179.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.94 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -126.24 85.46 0.34 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -55.61 -174.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.09 -38.4 10.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.17 -29.45 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 111.102 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.6 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.655 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.69 170.32 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 52.2 t -111.23 129.49 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -106.41 91.09 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.771 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.0 109.39 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.757 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.539 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -89.79 -176.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.226 0.536 . . . . 0.0 111.599 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.86 -160.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.374 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -157.62 168.7 34.36 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.365 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.842 HG22 HD23 ' A' ' 37' ' ' LEU . 88.2 m -155.77 148.12 23.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.786 0.326 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.81 153.27 33.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 111.34 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.797 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 tppp? -135.31 167.03 21.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.238 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 1.1 p -142.83 134.65 26.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 49' ' ' LEU . 1.3 m -125.4 129.96 72.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.31 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.87 107.27 19.09 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.01 0.433 . . . . 0.0 110.484 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.6 mt -76.79 120.48 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.62 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.12 128.32 59.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -178.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -58.74 146.13 37.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.97 176.11 41.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.54 172.45 13.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.951 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.879 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.62 -174.91 13.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.05 98.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.84 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -107.97 -35.65 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -106.3 164.02 12.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -165.05 -70.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -144.37 34.36 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -81.45 -56.3 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -132.59 31.82 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m170 64.09 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -167.02 137.02 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -132.45 102.99 5.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.77 -85.05 1.82 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mt 60.4 32.12 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.4 m -137.82 82.17 26.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -32.34 148.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.532 2.821 . . . . 0.0 113.352 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 60.59 110.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.35 152.24 3.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.0 -52.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -153.88 -53.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.8 ttt -143.93 142.15 30.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.95 109.13 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -143.84 138.02 28.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.67 31.86 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.17 -53.78 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -106.79 154.56 20.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -168.34 165.71 12.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.5 121.06 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.42 77.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.189 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -119.31 112.4 19.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 61' ' ' ALA . 6.8 t -82.64 151.17 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.763 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 33' ' ' GLY . 5.3 t -90.82 -30.99 16.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.595 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 55.31 132.1 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.575 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.69 159.09 43.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.202 0.525 . . . . 0.0 111.605 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG21 ' HA2' ' A' ' 153' ' ' GLY . 0.0 OUTLIER -112.18 123.56 68.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.271 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -92.24 109.57 20.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.386 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.897 HD12 HG22 ' A' ' 154' ' ' THR . 3.8 mt -97.1 120.74 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' HG22 ' A' ' 117' ' ' VAL . 4.5 tm-20 -133.49 101.37 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.344 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -146.63 152.86 39.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.05 -26.43 64.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.393 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 66.56 24.25 10.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.381 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.83 117.22 1.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.796 0.332 . . . . 0.0 111.598 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -136.87 107.65 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.368 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.0 OUTLIER -68.65 128.36 36.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.238 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG23 ' CG2' ' A' ' 160' ' ' ILE . 2.0 t -31.02 132.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 CA-C-O 121.5 0.667 . . . . 0.0 112.709 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 -24.01 32.98 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.39 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.85 172.47 7.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 0.0 110.631 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.63 151.69 26.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 122' ' ' VAL . 21.1 tp -104.48 153.4 21.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 3.1 pt-20 -136.75 93.29 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 110.649 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.2 p -107.01 97.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.795 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.786 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.02 82.59 1.59 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.623 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 136' ' ' VAL . 9.7 p -78.63 95.32 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.004 0.43 . . . . 0.0 110.761 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.29 -134.71 8.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.692 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.69 136.44 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -96.83 -36.34 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.57 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 177.15 131.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.436 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.879 HD13 ' HB3' ' A' ' 61' ' ' ALA . 2.7 pp -141.09 103.49 4.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.764 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.824 ' N ' HG13 ' A' ' 31' ' ' VAL . 12.4 p -94.76 110.18 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.3 m-20 98.68 26.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.435 0.694 . . . . 0.0 112.333 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -136.9 150.2 48.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.227 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -128.78 66.29 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.112 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.49 144.08 56.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.049 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.718 ' O ' HD13 ' A' ' 112' ' ' LEU . 17.6 m-85 -120.23 -35.38 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.51 112.68 13.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.766 ' O ' HG12 ' A' ' 104' ' ' VAL . 41.6 t80 -86.16 148.27 25.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.991 0.425 . . . . 0.0 111.458 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.618 ' OD1' HD23 ' A' ' 103' ' ' LEU . 7.0 m-20 -147.67 111.27 4.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.916 ' CE2' HG11 ' A' ' 102' ' ' VAL . 16.5 p90 -122.97 156.16 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 111.557 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.19 103.15 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.418 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 123' ' ' LEU . 1.5 pt? -77.09 156.05 31.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -126.8 104.49 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.815 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 18.7 p90 -118.3 -167.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.4 113.59 21.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.991 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -27.98 65.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.08 -46.65 86.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.035 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.03 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.59 20.42 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -164.33 -179.69 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -171.56 113.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.706 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.613 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.1 t80 -51.01 149.27 3.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.0 t -129.1 -82.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.01 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 122' ' ' VAL . 11.0 mt-10 -156.17 134.8 11.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.76 151.2 26.25 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.12 0.962 . . . . 0.0 111.478 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.88 HD12 ' HE2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -126.97 158.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.421 -177.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.532 ' CB ' HG23 ' A' ' 90' ' ' VAL . 1.8 t -121.21 -164.68 1.15 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.794 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -93.0 -157.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.754 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.5 37.67 1.12 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.93 0.395 . . . . 0.0 110.863 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.12 -39.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 104' ' ' VAL . 29.5 t -87.05 154.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.639 0.257 . . . . 0.0 110.773 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.91 121.41 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.582 HG22 ' HB ' ' A' ' 104' ' ' VAL . 5.2 t -109.11 155.23 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 t30 -162.78 110.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.86 156.21 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.39 107.09 5.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.229 0.538 . . . . 0.0 111.536 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.1 tttm -54.71 96.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.477 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -84.83 -22.76 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.589 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -166.76 2.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -99.28 52.41 1.08 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.364 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' C ' HG13 ' A' ' 100' ' ' VAL . 19.5 ptmt -174.19 126.14 0.34 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 95' ' ' ILE . 5.5 m -148.71 155.03 9.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.698 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -97.24 152.49 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.916 HG11 ' CE2' ' A' ' 68' ' ' PHE . 7.3 p -133.47 121.97 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.139 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.618 HD23 ' OD1' ' A' ' 67' ' ' ASP . 14.2 mt -107.85 98.97 8.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 66' ' ' TYR . 7.7 p -98.31 149.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.33 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 p -151.61 135.54 16.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.421 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.21 111.56 12.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.912 0.386 . . . . 0.0 111.309 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.28 29.68 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.006 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -106.79 -29.71 9.37 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.988 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.95 -20.8 14.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.166 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -97.39 155.83 36.89 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 56.4 Cg_endo -70.51 173.61 11.38 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.545 2.163 . . . . 0.0 112.446 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.765 HD21 ' HB2' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.27 109.23 1.53 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.26 -22.33 73.97 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.397 2.065 . . . . 0.0 112.147 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 55.97 177.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.876 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.52 25.78 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.634 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -159.31 155.85 27.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.9 t -45.62 104.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 0.0 111.274 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.672 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.48 -31.13 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.962 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -174.3 134.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.123 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.88 ' HE2' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -126.58 116.76 21.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 76.1 t -86.99 111.18 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 83' ' ' ILE . 21.9 t -75.65 111.24 11.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.026 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 70' ' ' LEU . 35.8 mt -92.9 169.28 10.57 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 8.6 ttm180 -116.44 123.39 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.72 72.12 8.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.341 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.03 -6.68 57.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 109.706 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.87 123.62 2.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.739 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.668 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 14.8 ttmt -44.46 162.37 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.517 -1.219 . . . . 0.0 112.349 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.03 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -177.84 61.67 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.79 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 5.4 tt0 -55.27 111.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 23.26 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.138 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.31 65.96 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.895 0.379 . . . . 0.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -44.86 132.88 6.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.161 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.639 HD21 HD11 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -118.74 134.61 55.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.951 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 p -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.888 0.375 . . . . 0.0 111.405 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 53' ' ' VAL . 15.7 m -107.16 94.85 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.814 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.2 p -99.7 -164.11 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.547 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 40.54 25.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 151' ' ' ILE . 1.9 p -68.56 93.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.62 170.17 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m -129.32 179.87 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.989 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.56 64.06 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.452 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.48 138.67 45.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.78 58.31 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.612 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -56.49 -28.1 58.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.6 -1.24 36.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.852 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.62 131.62 56.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.9 t -76.88 123.93 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.05 92.0 5.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.623 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.54 107.28 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.659 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.39 169.01 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.263 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.618 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -57.48 -153.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.723 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -154.41 165.48 31.91 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.224 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.897 HG22 HD12 ' A' ' 37' ' ' LEU . 36.8 m -161.03 147.33 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.734 0.302 . . . . 0.0 110.647 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.9 173.82 6.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.675 ' HB2' HD13 ' A' ' 37' ' ' LEU . 3.8 tppt? -144.72 168.69 19.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.081 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.431 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 1.9 p -142.43 115.66 8.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.04 127.38 68.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -97.49 105.79 18.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 43' ' ' VAL . 14.9 mt -83.92 116.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.397 0.617 . . . . 0.0 109.748 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.5 143.47 13.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.677 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.75 146.36 54.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.898 0.38 . . . . 0.0 110.924 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -148.73 -143.6 3.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -107.48 175.91 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.758 0.313 . . . . 0.0 110.938 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.421 ' H ' HG22 ' A' ' 164' ' ' THR . 48.4 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.9 -62.33 0.45 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.52 87.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 110.994 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m 60.36 35.16 20.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -159.1 154.45 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.981 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 60.47 171.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 64.15 -78.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -98.42 96.19 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.9 m170 60.37 108.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -112.59 169.1 9.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -99.29 91.43 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.38 -78.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.99 46.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.394 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -77.2 -31.61 55.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.827 0.346 . . . . 0.0 110.878 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' VAL . 18.5 m -134.15 82.17 48.66 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -32.31 -44.55 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.654 2.903 . . . . 0.0 113.285 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -97.06 -53.97 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 -53.19 4.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 m -65.85 -51.15 61.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -138.9 160.16 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.67 155.69 17.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.09 108.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -113.95 31.65 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -62.51 141.68 58.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -67.86 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -177.62 38.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -109.09 163.38 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.17 98.24 4.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.17 77.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.989 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -101.83 115.85 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.588 HG22 ' C ' ' A' ' 59' ' ' VAL . 29.6 t -61.06 155.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 33' ' ' GLY . 6.0 t -78.73 -47.15 17.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 72.03 113.12 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.672 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.9 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.5 m -156.57 138.42 14.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.455 0.645 . . . . 0.0 111.507 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 19.8 m -91.48 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.8 t -90.95 134.29 34.6 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.183 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.818 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -110.73 118.69 36.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 tt0 -140.7 116.94 10.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -169.48 144.29 2.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.672 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.05 -27.0 66.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.055 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' C ' HG12 ' A' ' 158' ' ' VAL . 4.8 mt-10 73.17 21.86 3.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.691 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 158' ' ' VAL . 1.7 tm-20 -165.15 127.66 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.873 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.9 p -146.16 107.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.353 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -65.4 123.93 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.026 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -28.91 130.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.629 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.1 -23.05 24.12 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -107.9 174.97 5.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 110.413 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -128.78 148.25 50.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.883 0.373 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.59 128.19 51.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.619 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 3.4 pt-20 -101.43 131.34 47.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.384 . . . . 0.0 111.19 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 39' ' ' ALA . 11.1 t -108.4 97.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.728 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -70.19 62.09 0.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.102 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 136' ' ' VAL . 7.2 p -81.17 112.45 19.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.291 . . . . 0.0 110.396 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.755 ' HA3' HD23 ' A' ' 118' ' ' LEU . . . -126.61 -91.24 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.618 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.527 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -135.65 134.86 51.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.075 0.464 . . . . 0.0 111.985 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -102.64 -38.93 7.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HA ' ' HZ3' ' A' ' 115' ' ' LYS . 77.2 mm-40 -159.35 129.0 5.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.006 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.767 HD21 ' CD2' ' A' ' 149' ' ' HIS . 1.0 OUTLIER -153.19 90.84 1.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.729 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 ' C ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -121.45 110.74 28.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.563 ' N ' HG22 ' A' ' 31' ' ' VAL . 72.6 m-20 127.6 17.92 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.499 1.119 . . . . 0.0 111.493 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -157.79 -178.04 7.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.966 0.413 . . . . 0.0 111.078 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -137.0 76.57 1.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.589 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.9 111.93 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.511 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 11.3 m-85 -89.37 -34.4 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.048 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.03 112.35 8.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.36 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' H ' HD11 ' A' ' 112' ' ' LEU . 11.3 t80 -98.68 94.12 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.03 0.443 . . . . 0.0 110.918 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD2' HD23 ' A' ' 103' ' ' LEU . 9.1 t0 -100.5 135.94 41.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' O ' HG12 ' A' ' 102' ' ' VAL . 47.0 p90 -140.97 171.21 14.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.238 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.29 91.2 3.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.635 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.783 ' HB2' HG12 ' A' ' 136' ' ' VAL . 8.2 tt -77.03 152.96 34.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.108 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' HD23 ' A' ' 70' ' ' LEU . 28.0 p30 -131.41 155.93 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.989 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 21.0 p90 -155.55 -169.34 3.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.67 140.89 28.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CB ' ' HB3' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -105.84 -13.75 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -96.26 25.81 4.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.765 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -170.6 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.905 0.384 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.745 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.1 m-85 -93.3 -176.89 4.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -170.85 111.84 0.38 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.644 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 18.2 t80 -50.14 152.83 1.59 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.809 ' HB ' HG23 ' A' ' 122' ' ' VAL . 66.9 t -131.04 -78.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -163.61 143.2 8.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.864 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.63 150.23 26.95 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-O 122.04 0.924 . . . . 0.0 111.439 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -140.35 151.77 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.268 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -129.6 -176.17 3.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.077 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -160.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.88 23.49 4.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.59 -44.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.906 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 105' ' ' SER . 16.3 t -97.05 143.27 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.687 0.28 . . . . 0.0 110.626 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -117.23 109.41 16.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 103' ' ' LEU . 7.1 p -102.18 144.13 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.918 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.18 124.81 29.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -98.06 161.27 13.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.682 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.21 107.05 5.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.107 0.479 . . . . 0.0 111.719 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.668 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.28 95.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.08 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -83.91 -30.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.882 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.18 -168.38 2.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.429 ' HB3' ' CB ' ' A' ' 74' ' ' GLU . 4.6 m-20 -84.31 130.07 34.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.34 31.67 70.48 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.345 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.416 ' C ' HG13 ' A' ' 100' ' ' VAL . 12.8 ptpt -173.75 122.08 0.33 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.848 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.3 m -149.89 154.7 8.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.731 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -85.75 152.26 23.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.184 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.2 p -125.48 136.99 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.308 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.467 ' C ' HG23 ' A' ' 90' ' ' VAL . 12.0 mt -123.79 109.69 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 111.087 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.7 p -109.86 147.32 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 112.018 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 88' ' ' VAL . 2.7 p -164.78 135.44 4.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.029 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 88' ' ' VAL . 17.1 m -73.68 104.18 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -69.66 -17.56 63.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.182 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -65.36 -32.91 74.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.02 -17.11 20.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.91 155.29 37.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.653 0.264 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 37.4 Cg_exo -60.13 164.85 11.63 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.558 2.172 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.915 HD22 HD12 ' A' ' 118' ' ' LEU . 91.1 mt -59.82 113.65 7.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.64 -20.88 67.03 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.3 2.0 . . . . 0.0 112.282 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 62.93 173.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HZ3' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 56.79 24.28 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -142.21 -164.34 1.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.323 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.69 HG13 ' HA3' ' A' ' 52' ' ' GLY . 29.1 t -91.49 104.63 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.408 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.915 HD12 HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -91.97 -33.65 14.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -157.72 136.76 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.512 ' O ' HG13 ' A' ' 83' ' ' ILE . 2.2 mtpt -135.16 100.71 4.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.271 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.2 t -88.84 114.36 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.809 HG23 ' HB ' ' A' ' 80' ' ' VAL . 9.1 m -87.19 108.05 17.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.198 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -85.57 108.44 17.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 20.3 ttm180 -55.54 117.09 3.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -84.59 69.39 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.217 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -87.55 -3.93 58.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.58 123.71 2.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.544 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.738 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 6.2 ttpt -42.63 155.13 0.05 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.325 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -168.56 58.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.799 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 7.3 pt-20 -55.73 111.65 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.224 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.5 -12.65 39.47 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.519 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.571 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 39.9 t -54.65 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 2.1 p-10 -83.6 138.66 33.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.261 0.553 . . . . 0.0 112.19 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 134' ' ' LEU . 4.7 mp -110.77 132.14 54.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.615 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.4 126.5 46.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.019 0.438 . . . . 0.0 111.65 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.921 HG21 HG21 ' A' ' 53' ' ' VAL . 22.5 m -101.51 94.72 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.665 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 20.9 p -100.63 -169.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.695 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.72 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.928 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER -64.98 105.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 0.0 110.607 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -178.47 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.293 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 148' ' ' VAL . 4.0 m -141.45 -179.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.67 81.82 0.31 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.956 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . 27.6 t0 -45.92 160.94 0.05 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.838 0.351 . . . . 0.0 111.271 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.05 97.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -66.52 -31.34 72.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.767 0.317 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.04 -28.41 3.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.39 168.89 2.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.811 HG22 ' O ' ' A' ' 141' ' ' VAL . 56.6 t -123.99 141.56 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.052 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.767 ' CD2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.14 94.23 4.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -46.97 104.62 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.743 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.451 HD11 ' HE1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -85.71 -176.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.9 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -72.5 -158.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.28 168.85 35.99 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.231 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.797 ' HB ' HD23 ' A' ' 37' ' ' LEU . 44.4 m -164.7 163.95 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 110.662 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 154' ' ' THR . 15.9 pt-20 -134.64 177.44 7.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.169 0.509 . . . . 0.0 111.692 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.818 ' HE2' HD12 ' A' ' 37' ' ' LEU . 10.3 tppt? -146.59 169.74 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 0.6 OUTLIER -141.64 115.9 9.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.42 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -104.61 137.94 31.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.226 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -103.77 105.38 15.58 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.571 179.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.6 mt -83.63 121.44 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-O 121.305 0.574 . . . . 0.0 109.621 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -104.24 148.8 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.396 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.71 145.66 48.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.902 0.382 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.73 -174.38 33.5 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -104.57 -176.93 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.332 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.478 ' H ' HG22 ' A' ' 164' ' ' THR . 1.8 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.856 0.36 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.42 -35.33 2.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.01 -70.21 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -80.87 112.58 18.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -123.13 31.99 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.816 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -176.61 92.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -91.32 141.97 28.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -108.99 36.04 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 62.47 118.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.0 m80 60.93 159.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -130.8 -73.91 0.54 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -127.97 -74.61 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.69 117.47 0.45 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.709 HD12 ' H ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -111.72 -36.27 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 110.911 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 17' ' ' ARG . 38.3 t -128.53 83.45 66.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -32.29 -59.51 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.614 2.876 . . . . 0.0 113.285 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.744 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -97.07 173.2 7.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.1 69.15 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.6 m -132.38 172.18 12.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.802 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -82.71 -60.21 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.71 142.0 28.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.47 36.51 2.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.3 m -155.19 147.75 24.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -135.7 -67.38 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.866 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD23 ' HB3' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -152.62 155.9 38.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.9 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.92 106.52 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -158.0 178.64 9.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 60.02 30.91 20.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.34 77.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -94.83 101.43 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 23.7 t -60.65 155.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -81.47 -46.04 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 74.43 117.4 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.301 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.956 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -163.48 136.77 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.19 0.519 . . . . 0.0 111.465 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.5 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.631 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -91.55 106.3 18.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.089 178.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.915 HD23 HG22 ' A' ' 154' ' ' THR . 6.4 tp -112.35 116.86 31.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -140.35 108.48 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.279 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.635 ' HB3' ' HD3' ' A' ' 156' ' ' LYS . . . -138.6 161.95 35.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.563 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.373 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 69.24 24.87 5.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.703 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 158' ' ' VAL . 28.3 tt0 -164.71 125.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -147.6 107.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.343 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -67.92 126.32 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.131 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.442 HG23 ' CG2' ' A' ' 160' ' ' ILE . 1.5 t -29.45 127.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.81 12.85 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.628 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -175.63 2.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.87 148.61 52.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.818 HD22 HG11 ' A' ' 158' ' ' VAL . 4.2 pp -97.01 159.93 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HA ' HG12 ' A' ' 122' ' ' VAL . 3.7 mt-10 -128.26 93.57 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.707 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.3 p -102.37 98.16 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.835 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.35 79.94 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.559 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 136' ' ' VAL . 9.6 p -78.46 102.92 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -111.96 -130.12 5.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.096 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.518 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -109.36 127.42 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.624 -179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 28.1 t0 -96.81 -37.06 10.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 22.4 mp0 -162.09 130.77 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.169 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 61' ' ' ALA . 1.6 tt -158.86 91.05 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.636 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.4 p -118.65 104.25 15.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.582 ' N ' HG22 ' A' ' 31' ' ' VAL . 34.3 m-20 134.0 23.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 111.519 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -152.68 -170.9 3.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.642 0.258 . . . . 0.0 110.75 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -139.7 82.21 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.36 . . . . 0.0 110.661 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.37 121.19 12.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.276 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' HA2' ' A' ' 144' ' ' GLY . 3.7 m-85 -117.8 -40.68 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.2 11.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.557 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.4 t80 -86.07 135.7 33.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.388 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.71 109.62 4.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.792 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.2 p90 -124.82 171.24 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.54 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 104.58 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.512 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 71' ' ' ASN . 5.2 tt -77.11 153.48 34.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 111.141 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' HD23 ' A' ' 70' ' ' LEU . 3.3 m-80 -127.56 107.35 9.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' HB3' HD22 ' A' ' 134' ' ' LEU . 16.7 p90 -122.67 -168.54 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.04 139.97 37.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.071 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -24.66 15.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.15 -28.27 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.285 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.744 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -120.76 -44.68 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.5 m-85 -93.31 -178.38 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.082 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 3.2 tt0 -171.61 115.66 0.39 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.292 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.837 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 36.5 t80 -46.49 134.49 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.737 ' HB ' HG23 ' A' ' 122' ' ' VAL . 33.6 t -106.41 -81.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 122' ' ' VAL . 20.2 mm-40 -162.14 137.73 7.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.65 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 121' ' ' VAL . . . -82.57 146.28 29.26 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.987 0.899 . . . . 0.0 111.342 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.57 154.62 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.444 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.816 ' OG ' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -115.44 163.65 15.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.916 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.92 -160.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -94.9 37.56 1.14 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.816 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.1 -40.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.015 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.816 HG23 ' OG ' ' A' ' 84' ' ' SER . 8.9 m -86.95 169.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 0.0 110.918 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.83 144.47 45.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 104' ' ' VAL . 7.5 t -141.86 140.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -156.97 107.8 2.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.837 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.31 178.25 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -154.39 110.93 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.9 tttm -53.99 95.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.181 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.842 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.1 tp -78.51 -24.52 13.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.727 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.74 -166.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.751 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.9 132.97 34.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.91 29.85 65.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.423 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HE3' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -173.91 122.17 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.842 ' HA ' HG22 ' A' ' 95' ' ' ILE . 6.4 m -149.3 155.12 8.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.722 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 16.9 tpp85 -92.71 151.75 19.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.969 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 68' ' ' PHE . 4.0 p -127.51 137.14 58.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.862 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -119.79 102.86 8.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.901 HG11 ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -108.03 155.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.058 0.456 . . . . 0.0 111.424 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 p -164.41 137.16 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.39 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.715 ' HA ' HG12 ' A' ' 88' ' ' VAL . 10.4 m -75.81 104.83 6.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.977 0.418 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.1 tt -93.29 26.32 2.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.114 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.4 p -99.02 -31.49 11.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.995 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.89 -25.37 5.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.144 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.28 158.21 32.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.606 0.241 . . . . 0.0 110.692 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 36.4 Cg_endo -65.38 -175.72 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.548 2.165 . . . . 0.0 112.473 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.713 ' CD2' HD21 ' A' ' 118' ' ' LEU . 0.8 OUTLIER -54.87 114.6 7.23 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.942 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.44 -38.87 31.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.052 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.518 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.61 168.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.4 16.14 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.071 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.42 -166.81 2.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.338 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.835 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.7 t -78.45 105.07 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.796 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.58 -31.17 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.901 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -169.15 135.52 1.7 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.874 0.368 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.821 ' HD3' HG11 ' A' ' 117' ' ' VAL . 4.2 mtmt -124.92 112.34 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.595 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 82' ' ' ALA . 24.9 t -99.8 96.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' VAL . 19.2 m -75.43 119.87 24.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.03 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 3.1 mm? -87.01 169.36 12.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.678 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.6 tpm_? -106.57 119.35 39.05 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -88.94 68.13 8.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.452 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.83 -6.42 58.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.47 124.06 2.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.714 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.681 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 9.3 ttpp -40.74 158.01 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.373 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.744 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -171.61 58.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.743 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.2 pm0 -55.66 117.18 3.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.221 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 20.93 51.01 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.478 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.543 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 8.0 t -71.15 65.54 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.046 0.451 . . . . 0.0 110.309 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.1 t-20 -43.22 131.71 4.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.517 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -112.08 150.15 31.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.49 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -133.95 125.88 29.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 111.618 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 53' ' ' VAL . 23.3 m -113.46 94.77 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.683 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.489 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.5 p -101.66 -159.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 42.67 22.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.473 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -62.51 82.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.15 141.08 46.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.093 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.072 HG21 ' HB1' ' A' ' 63' ' ' ALA . 7.8 p -118.35 150.69 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 99.61 2.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.895 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 27.1 t0 -50.37 161.99 0.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 110.961 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' CD1' ' A' ' 64' ' ' PHE . . . -59.49 -45.05 96.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.547 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.15 -31.17 72.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.42 -28.22 3.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.44 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.72 168.74 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 141' ' ' VAL . 8.0 p -122.92 148.33 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 38.4 m-70 -125.5 91.06 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.2 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.8 104.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.113 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.502 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.36 -177.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.328 0.585 . . . . 0.0 112.079 -178.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.956 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -60.89 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.349 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.93 176.73 34.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.915 HG22 HD23 ' A' ' 37' ' ' LEU . 51.5 m -164.96 145.47 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.554 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.07 163.43 13.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.166 0.508 . . . . 0.0 111.7 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.645 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -133.5 164.06 28.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.592 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.446 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.3 p -142.71 115.42 8.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.29 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.818 HG11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.02 128.8 69.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 111.227 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.27 105.69 17.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.712 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.844 HD11 ' CE2' ' A' ' 77' ' ' PHE . 15.4 mt -83.22 115.96 26.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.479 0.657 . . . . 0.0 109.717 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.78 141.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.65 -178.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.11 146.07 55.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.931 0.396 . . . . 0.0 111.018 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.3 -147.13 7.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.435 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -50.36 177.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.048 0.451 . . . . 0.0 111.389 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.492 ' N ' ' OG1' ' A' ' 164' ' ' THR . 14.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.922 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.835 0.35 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.73 43.4 1.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.11 166.18 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 m -131.98 178.31 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -98.6 34.11 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.25 -39.46 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 60.36 89.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -132.4 -177.98 4.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -126.85 98.33 5.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -131.5 -46.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.35 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.95 -70.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.64 -110.12 0.68 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.32 81.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.949 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.72 88.42 4.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.47 145.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.57 2.847 . . . . 0.0 113.203 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 60.76 31.21 20.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.25 93.02 0.88 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.459 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.4 p -138.59 147.14 42.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.907 0.384 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -40.04 14.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 ttm 60.53 171.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.72 -169.66 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.43 -68.33 0.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -83.18 147.32 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.817 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.72 -70.5 0.7 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 179.95 -53.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.31 178.79 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.91 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.6 77.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -96.04 126.21 41.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.2 t -76.16 151.68 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.9 t -69.21 -47.97 63.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 151' ' ' ILE . . . 77.91 107.22 0.18 Allowed Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.064 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.965 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 4.0 t -166.11 136.2 3.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.45 0.643 . . . . 0.0 111.762 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 151' ' ' ILE . 27.4 m -95.66 144.75 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.504 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 6.2 t -105.54 111.5 24.23 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.072 HD12 HG22 ' A' ' 154' ' ' THR . 3.6 mt -97.25 125.53 41.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.044 0.449 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.16 101.38 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.308 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HB2' HG13 ' A' ' 51' ' ' VAL . . . -145.92 152.28 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.485 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.64 -29.11 67.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.236 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.49 24.93 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.455 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 158' ' ' VAL . 20.1 tt0 -164.68 128.08 2.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.859 0.361 . . . . 0.0 111.925 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.6 p -148.4 107.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.259 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HB2' HD12 ' A' ' 161' ' ' ILE . 1.2 tt0 -68.32 128.13 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.036 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -29.86 132.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.313 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.14 -21.85 38.51 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.298 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.96 173.45 6.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -112.56 167.34 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.637 ' CD1' HG23 ' A' ' 51' ' ' VAL . 3.7 pp -125.41 160.72 28.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -136.67 110.19 7.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.964 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 39' ' ' ALA . 12.7 t -109.61 97.67 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 0.0 110.981 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.78 68.15 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.636 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.0 HG21 HG11 ' A' ' 136' ' ' VAL . 10.3 p -78.19 95.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.18 -122.49 4.6 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.98 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -113.54 130.81 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 112.138 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.0 t70 -101.72 -32.8 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' HG21 ' A' ' 32' ' ' THR . 36.4 mt-10 -157.2 128.66 6.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.418 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -161.22 90.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.92 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.9 p -125.57 106.02 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.566 ' N ' HG22 ' A' ' 31' ' ' VAL . 1.2 m120 131.5 18.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.462 1.101 . . . . 0.0 111.418 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . . . -148.43 -179.41 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.945 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 2.8 mm-40 -126.4 77.16 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.936 0.398 . . . . 0.0 110.58 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.47 112.1 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.229 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 10.6 m-85 -115.72 -59.88 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.802 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.23 112.62 24.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.589 ' OH ' HD11 ' A' ' 151' ' ' ILE . 1.5 t80 -86.16 138.65 31.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -147.55 110.27 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.265 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.732 ' CE2' HG11 ' A' ' 102' ' ' VAL . 12.9 p90 -137.69 171.55 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 111.369 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -131.99 106.09 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.656 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.693 HD22 HD23 ' A' ' 134' ' ' LEU . 1.3 mt -77.29 157.19 30.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.825 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -121.62 104.37 9.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.97 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.9 p90 -114.95 -167.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' PHE . 1.3 t70 -112.05 132.38 54.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.38 -28.02 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -60.24 -30.28 69.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.981 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.83 -46.26 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.4 m-85 -93.34 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.751 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -165.29 113.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.773 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.749 ' CD1' HG21 ' A' ' 100' ' ' VAL . 20.0 t80 -46.68 155.91 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 61.2 t -137.73 -81.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 14.4 pt-20 -152.42 131.64 12.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.06 149.54 26.86 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.304 1.049 . . . . 0.0 111.774 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -133.4 174.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.073 -177.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -168.33 2.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.811 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.91 -161.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.17 37.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.933 0.397 . . . . 0.0 110.816 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.54 -37.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' SER . 30.1 t -86.71 143.86 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.843 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -106.27 107.08 17.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 111.005 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -105.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -143.43 117.9 9.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.349 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.72 173.01 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.946 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.22 107.33 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.443 . . . . 0.0 111.697 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.5 tttp -54.77 115.19 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.271 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.6 tp -111.5 -22.37 5.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.919 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.79 -166.84 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.58 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -101.42 50.84 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.591 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -173.61 129.83 0.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.749 HG21 ' CD1' ' A' ' 79' ' ' TYR . 17.4 m -150.1 155.2 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -80.94 152.05 28.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.352 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.732 HG11 ' CE2' ' A' ' 68' ' ' PHE . 8.9 p -134.13 110.7 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.403 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 mt -88.54 114.34 25.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.907 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.623 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 13.4 t -107.43 137.73 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.508 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.472 ' C ' HG13 ' A' ' 88' ' ' VAL . 3.8 p -164.27 136.21 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.392 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.37 104.49 15.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.877 0.37 . . . . 0.0 111.211 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.85 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.3 p -65.34 -34.76 79.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.84 -19.76 30.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.382 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.33 154.64 71.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.763 0.316 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 55.6 Cg_endo -70.42 157.99 57.43 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.658 2.239 . . . . 0.0 112.364 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 ' CD1' ' A' ' 118' ' ' LEU . 35.5 mt -59.9 111.1 3.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.8 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.89 -21.35 73.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.395 2.064 . . . . 0.0 112.26 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 65.1 175.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.602 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.72 24.27 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 110.383 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.81 -166.62 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.201 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.769 HG13 ' HA3' ' A' ' 52' ' ' GLY . 21.5 t -85.9 104.69 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.635 ' CD1' HD22 ' A' ' 112' ' ' LEU . 1.7 mm? -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -160.05 135.23 8.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.843 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.711 ' HD2' HG11 ' A' ' 117' ' ' VAL . 10.3 mtpt -128.22 100.87 6.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.034 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.8 p -81.29 107.02 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 110.268 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 83' ' ' ILE . 23.0 t -75.69 106.9 5.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.037 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 134' ' ' LEU . 12.1 mt -89.99 169.22 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 5.5 ttm180 -114.38 122.99 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -91.57 68.96 5.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.294 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.51 -5.68 58.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.413 0.625 . . . . 0.0 109.529 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.03 123.83 2.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.49 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.3 ttmt -41.59 159.94 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.272 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.782 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -174.98 57.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.017 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.3 mt-10 -56.18 113.39 1.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.097 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.31 46.97 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.544 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.782 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 2.5 m -61.06 86.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.936 0.398 . . . . 0.0 110.235 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.417 ' ND2' HG22 ' A' ' 157' ' ' THR . 3.5 m120 -58.67 171.49 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.654 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -146.84 108.72 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.116 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.4 p -97.46 122.58 40.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.021 0.439 . . . . 0.0 111.407 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 53' ' ' VAL . 7.2 p -107.48 95.16 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.457 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.4 p -102.45 -166.92 1.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.573 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.457 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.91 20.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 m -61.88 88.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.961 0.41 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.55 166.33 11.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.486 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 63' ' ' ALA . 13.2 p -140.33 159.95 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.982 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -97.36 91.39 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.648 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 17.1 t70 -48.61 161.46 0.13 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.913 0.387 . . . . 0.0 110.903 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.37 78.39 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -72.12 -30.47 65.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.49 -26.85 4.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.595 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.3 mt -68.39 169.98 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.66 148.22 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -119.22 90.85 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -49.98 102.03 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.589 HD11 ' OH ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -89.38 -176.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.325 0.583 . . . . 0.0 111.659 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -70.62 -158.08 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 35' ' ' VAL . . . -161.2 171.73 37.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.034 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 1.072 HG22 HD12 ' A' ' 37' ' ' LEU . 55.1 m -158.85 146.52 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.97 151.79 25.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.033 0.444 . . . . 0.0 111.413 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 37' ' ' LEU . 6.5 tppt? -128.97 167.49 17.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.975 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.417 HG22 ' ND2' ' A' ' 133' ' ' ASN . 0.8 OUTLIER -143.17 126.21 16.34 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.11 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -113.3 131.6 64.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -98.14 106.45 18.75 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.833 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.84 HG23 ' O ' ' A' ' 43' ' ' VAL . 11.4 mt -85.44 116.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.384 0.612 . . . . 0.0 109.922 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -99.01 146.21 8.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.556 -178.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.98 145.91 54.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.019 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.84 -171.44 45.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -75.76 -176.81 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.301 . . . . 0.0 110.894 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.486 ' H ' HG22 ' A' ' 164' ' ' THR . 8.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.74 102.46 0.31 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.53 110.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.309 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.35 -177.99 3.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -100.07 -38.94 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.06 111.5 4.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -96.85 175.96 6.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.6 m80 60.61 81.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -146.14 176.78 9.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -100.43 137.44 38.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.19 -57.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.3 m -74.81 -63.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.48 59.53 1.62 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 110.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 110.847 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG13 ' HD2' ' A' ' 16' ' ' PRO . 22.0 t -78.39 136.02 60.79 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.026 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' HG13 ' A' ' 15' ' ' VAL . 80.7 Cg_exo -32.36 109.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.477 2.784 . . . . 0.0 113.221 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.56 -71.59 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.51 60.25 1.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.509 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -141.99 83.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -147.38 151.05 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.9 mtm -148.79 -68.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.04 -73.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.8 p -152.54 168.24 26.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.51 150.29 24.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.0 115.6 30.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -176.56 -40.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -156.5 -176.89 6.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -127.67 80.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.75 62.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -111.32 112.48 24.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 60' ' ' ASN . 13.1 t -60.54 147.76 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 57' ' ' GLU . 14.6 t -70.89 -45.54 64.19 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 73.51 109.43 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.583 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -159.49 138.71 11.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.603 0.716 . . . . 0.0 111.754 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 151' ' ' ILE . 21.3 m -98.26 141.52 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.207 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 21.3 p -100.6 111.01 23.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.949 HD12 HG22 ' A' ' 154' ' ' THR . 3.2 mt -97.14 126.48 42.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 101.55 4.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -147.93 151.32 35.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -61.47 -28.3 69.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.7 mt-10 72.92 24.31 2.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.605 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HG2' HD11 ' A' ' 161' ' ' ILE . 12.6 tt0 -164.81 128.37 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.849 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.882 ' O ' HG23 ' A' ' 160' ' ' ILE . 4.1 p -144.58 108.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.394 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.25 125.25 26.09 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.038 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.7 t -28.86 130.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.01 -15.0 52.09 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.753 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 43' ' ' VAL . 5.4 tp10 -106.34 171.36 7.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.795 0.331 . . . . 0.0 110.736 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -106.63 167.81 9.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 158' ' ' VAL . 11.2 mt -120.2 150.99 39.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.63 93.28 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.493 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.944 HG12 ' CB ' ' A' ' 39' ' ' ALA . 27.3 m -106.88 97.06 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.103 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.815 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -76.91 76.36 1.6 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.659 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 136' ' ' VAL . 12.5 p -78.54 95.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -105.79 -129.79 6.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.828 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -106.72 132.01 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 111.69 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 5.1 t0 -97.84 -31.43 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.122 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -178.17 133.4 0.15 Allowed 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.485 0.66 . . . . 0.0 111.894 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 55' ' ' ILE . 1.3 pp -159.41 115.52 2.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.634 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 59' ' ' VAL . 13.8 p -133.53 102.38 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.594 ' N ' HG22 ' A' ' 31' ' ' VAL . 22.4 m-20 138.37 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.384 1.053 . . . . 0.0 111.914 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.3 174.44 14.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.33 87.02 2.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -62.84 112.67 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.446 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -103.6 -35.3 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.129 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.49 112.38 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.348 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.826 ' O ' HG12 ' A' ' 104' ' ' VAL . 67.2 t80 -99.11 152.02 20.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.19 116.94 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.891 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.903 ' O ' HG12 ' A' ' 102' ' ' VAL . 5.7 p90 -117.8 140.18 50.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.081 0.467 . . . . 0.0 111.459 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 94.17 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.731 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.773 HD12 HG13 ' A' ' 136' ' ' VAL . 2.2 tp -80.02 139.68 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -111.65 104.36 12.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.846 ' HA ' HD23 ' A' ' 134' ' ' LEU . 38.9 p90 -100.16 -170.79 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -97.75 126.15 42.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.192 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -85.45 -17.26 37.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.021 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -96.47 29.21 2.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.868 0.366 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.906 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -171.86 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.6 m-85 -93.25 170.52 9.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -153.11 109.09 3.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.539 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 14.4 t80 -53.23 143.72 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' ARG . 41.5 t -123.09 -72.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.33 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.69 142.71 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.94 153.62 24.95 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 122.125 0.965 . . . . 0.0 111.655 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.84 152.68 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.455 -177.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -124.91 -173.22 2.75 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.92 -158.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.691 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -93.5 37.41 1.06 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.6 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.315 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 89' ' ' PHE . 11.2 t -86.74 157.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.422 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -115.04 102.99 10.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.95 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 119' ' ' ALA . 3.5 t -104.65 120.76 55.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.658 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -134.14 118.38 17.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.23 0.538 . . . . 0.0 111.526 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.94 146.79 24.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.013 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -132.44 106.81 8.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.399 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 12.2 tttp -55.47 95.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.811 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -81.34 -30.32 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.809 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.32 -168.02 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.62 128.83 34.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 59.12 33.23 73.75 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.549 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.413 ' C ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -173.71 121.41 0.32 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.811 ' HA ' HG22 ' A' ' 95' ' ' ILE . 3.9 m -149.71 155.58 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.643 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -96.94 152.46 18.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.986 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.5 p -128.67 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.968 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.08 108.16 14.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 66' ' ' TYR . 11.8 p -108.47 137.55 39.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.09 0.472 . . . . 0.0 111.042 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.8 p -161.83 135.86 6.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -78.91 104.42 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.39 -13.01 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.0 p -65.21 -27.17 68.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.34 -20.74 12.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.35 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.44 142.34 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.625 0.25 . . . . 0.0 110.661 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 50.7 Cg_exo -54.0 150.91 29.13 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.446 2.097 . . . . 0.0 112.358 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -56.3 128.61 73.38 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.714 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.836 ' O ' HD12 ' A' ' 112' ' ' LEU . 13.0 Cg_exo -69.9 -159.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.541 2.161 . . . . 0.0 112.318 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.586 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . -155.91 166.87 32.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 14.7 9.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.85 -165.79 1.8 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.078 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.815 HG13 ' HA3' ' A' ' 52' ' ' GLY . 30.6 t -84.78 104.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -86.83 -34.95 19.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -166.81 131.87 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.499 ' HD2' HG11 ' A' ' 117' ' ' VAL . 3.8 mtpt -117.05 120.92 39.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.497 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.673 HG11 HD22 ' A' ' 70' ' ' LEU . 8.6 p -88.85 142.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.056 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 83' ' ' ILE . 23.4 t -113.7 117.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.658 HD22 ' CD1' ' A' ' 72' ' ' TYR . 2.5 mt -115.79 108.52 16.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.49 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG21 ' A' ' 80' ' ' VAL . 26.6 ttm180 -64.18 115.25 4.81 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -74.27 74.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.378 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.34 -4.28 59.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.486 0.66 . . . . 0.0 109.452 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.72 123.48 2.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.352 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 16.9 ttmt -47.59 139.96 6.53 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.365 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.906 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -146.16 62.25 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.852 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.34 112.9 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.205 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.92 49.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.607 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.799 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.327 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.38 133.28 4.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.301 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -117.82 116.0 26.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.841 179.265 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 p -109.76 128.65 55.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.598 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 53' ' ' VAL . 9.6 m -106.13 94.96 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.718 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.458 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 p -97.27 -163.78 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.64 21.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.959 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.478 ' HB3' HD11 ' A' ' 151' ' ' ILE . 73.6 m -59.06 101.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -113.5 165.28 12.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 141' ' ' VAL . 27.6 m -143.72 125.48 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.013 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.21 100.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.584 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.15 161.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -28.18 72.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.71 -34.8 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.54 2.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.492 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 147' ' ' LEU . 13.5 mt -72.89 161.24 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 140' ' ' SER . 11.5 p -113.45 136.4 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.102 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -109.74 90.67 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -51.08 107.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.39 177.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.612 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -62.36 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.974 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.13 168.56 41.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.399 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.949 HG22 HD12 ' A' ' 37' ' ' LEU . 65.4 m -156.21 146.83 21.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.2 167.77 10.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 111.435 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' A' ' 37' ' ' LEU . 2.9 tppt? -139.57 168.8 19.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.246 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.425 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.3 p -142.32 115.83 9.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.742 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.48 HG22 HD11 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -110.53 126.67 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.13 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.05 105.88 18.11 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.789 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.882 HG23 ' O ' ' A' ' 43' ' ' VAL . 12.4 mt -78.76 122.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -106.02 131.2 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.594 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.18 145.02 44.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.043 0.449 . . . . 0.0 111.214 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.54 -140.82 5.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -59.97 178.74 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.728 0.299 . . . . 0.0 110.982 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 164' ' ' THR . 1.4 m . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtm . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 97.68 1.02 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -169.35 110.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -84.92 126.43 33.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -96.79 -31.61 12.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -171.35 133.32 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -98.97 34.02 2.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -90.77 -33.88 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -137.31 112.68 9.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -64.97 148.7 51.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.6 t -105.92 170.8 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 -31.38 66.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.78 -84.23 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.87 100.43 3.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 21.4 t -58.84 -52.68 73.07 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.53 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 71.3 Cg_exo -32.29 144.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.292 2.661 . . . . 0.0 113.397 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -31.07 23.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.75 23.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.467 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 m -61.08 -36.31 79.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.996 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -106.19 141.87 36.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.1 mtt -79.62 -57.3 3.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.38 71.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 m 60.6 97.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.67 31.18 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.965 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.82 174.0 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -73.89 -39.29 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.27 164.72 29.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.0 31.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 60' ' ' ASN . . . 59.66 37.62 22.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.37 106.18 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.976 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 61' ' ' ALA . 25.2 t -82.02 146.95 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -66.82 -35.14 79.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.665 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 56.18 108.19 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.035 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.547 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 t -153.43 138.82 17.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.707 0.765 . . . . 0.0 111.977 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG12 HD11 ' A' ' 151' ' ' ILE . 34.1 m -91.02 145.3 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.247 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 t -104.9 107.57 18.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.492 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 154' ' ' THR . 6.8 mt -96.8 111.6 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.173 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -140.18 101.47 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.483 ' CB ' HG12 ' A' ' 51' ' ' VAL . . . -144.0 158.45 43.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -56.86 -23.45 44.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.729 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.8 mt-10 65.62 23.02 11.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.444 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.554 ' CD ' HD11 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -164.87 128.26 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 0.0 111.854 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.921 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.1 p -143.14 108.78 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.192 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -71.59 126.5 29.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.612 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 44' ' ' GLN . 2.1 t -29.08 133.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.477 0.656 . . . . 0.0 112.723 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.12 -26.88 22.53 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.126 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -90.02 172.65 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.488 ' HB3' HG13 ' A' ' 122' ' ' VAL . 5.8 m120 -110.31 137.44 48.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.699 HD11 HG11 ' A' ' 158' ' ' VAL . 21.6 tp -92.02 149.92 21.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' CD ' HD12 ' A' ' 83' ' ' ILE . 6.2 tt0 -136.21 101.66 4.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' CB ' ' A' ' 39' ' ' ALA . 5.8 m -106.32 97.96 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.778 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -77.62 67.62 2.85 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.607 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 136' ' ' VAL . 8.5 p -78.4 95.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.005 0.431 . . . . 0.0 110.515 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -109.06 -120.07 4.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.107 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.92 133.4 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.015 0.435 . . . . 0.0 111.993 -179.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.49 -37.89 8.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' SER . 2.5 mt-10 -155.62 130.79 9.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.122 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.941 HD21 ' HB3' ' A' ' 61' ' ' ALA . 10.3 tt -156.66 90.97 1.19 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.502 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.76 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.3 p -110.98 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.9 m-20 100.38 20.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.715 0.806 . . . . 0.0 111.797 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.941 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -140.2 139.14 35.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.673 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -101.06 80.65 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.619 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.41 111.84 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.243 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 22.4 m-85 -113.53 -31.33 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.723 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.23 114.78 9.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.685 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.1 t80 -85.59 127.18 34.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.12 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -141.62 109.93 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.428 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.855 ' CD1' HG13 ' A' ' 136' ' ' VAL . 15.0 p90 -140.69 171.11 14.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.985 0.421 . . . . 0.0 111.315 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.419 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -117.36 114.49 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.663 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.518 HD12 HG22 ' A' ' 136' ' ' VAL . 23.7 tp -77.39 151.27 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.48 104.57 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' HD21 ' A' ' 134' ' ' LEU . 17.2 p90 -129.24 -167.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -112.73 139.85 48.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.053 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.67 -28.79 15.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.37 -47.59 85.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.973 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.928 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -99.81 -46.5 5.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.194 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 160' ' ' ILE . 2.0 m-85 -93.36 166.5 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -152.18 112.67 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.76 ' HA ' HD23 ' A' ' 123' ' ' LEU . 31.5 t80 -54.12 151.65 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 124' ' ' ARG . 48.1 t -130.24 -70.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.885 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 122' ' ' VAL . 5.8 pt-20 -172.52 141.86 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.636 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.57 148.43 28.04 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.14 0.971 . . . . 0.0 111.721 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.77 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 152.25 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 113.515 -1.675 . . . . 0.0 112.074 -177.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.669 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -113.55 -169.59 1.53 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.969 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.55 -159.81 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -93.81 35.85 1.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.37 -46.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.083 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.665 HG23 ' OG ' ' A' ' 84' ' ' SER . 28.4 m -90.65 173.5 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -121.23 139.28 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 104' ' ' VAL . 2.4 t -136.13 109.28 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.14 119.11 31.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.11 172.27 7.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 107.38 3.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.695 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 tttp -55.38 95.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.948 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 100' ' ' VAL . 5.1 tp -86.45 -28.95 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.41 -174.84 5.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.88 136.54 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 56.94 27.08 56.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.457 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -173.35 123.6 0.39 Allowed 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.703 ' HA ' HG22 ' A' ' 95' ' ' ILE . 16.5 m -150.27 154.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.885 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.524 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -81.29 152.13 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.924 -178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.82 93.58 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.905 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.1 mt -75.97 115.28 15.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 90' ' ' VAL . 11.3 t -112.83 145.35 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.016 0.436 . . . . 0.0 111.483 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.7 p -164.32 136.03 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.363 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.603 ' CB ' HG12 ' A' ' 88' ' ' VAL . 32.1 m -84.53 104.62 14.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.54 -15.07 63.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -65.34 -34.75 79.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.78 -16.9 25.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.446 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.34 160.6 29.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 39.2 Cg_exo -56.85 173.95 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.532 2.154 . . . . 0.0 112.296 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 66' ' ' TYR . 3.8 mp -67.67 134.16 92.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.746 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.51 -38.73 71.14 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.508 2.139 . . . . 0.0 112.256 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HA ' HD21 ' A' ' 118' ' ' LEU . . . 59.05 162.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.968 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.9 15.75 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.88 -163.29 1.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.254 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.824 HG11 ' HD3' ' A' ' 120' ' ' LYS . 39.1 t -76.86 105.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -95.62 -30.18 13.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -158.96 136.03 9.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.421 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.824 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -132.93 111.12 10.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.323 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HB ' HD22 ' A' ' 70' ' ' LEU . 56.3 t -86.09 114.83 26.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD11 ' A' ' 83' ' ' ILE . 54.8 t -75.62 105.44 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.841 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 79' ' ' TYR . 24.7 mt -103.13 108.49 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.598 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.516 ' H ' HG23 ' A' ' 80' ' ' VAL . 38.4 ttm180 -68.9 117.79 11.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.96 80.75 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.872 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.43 -5.27 58.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.3 123.5 2.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.185 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.3 ttpt -61.33 131.37 50.11 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.81 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.928 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -133.38 75.84 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.64 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.99 110.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 111.033 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.78 14.61 39.65 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.553 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.588 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -61.02 86.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 110.276 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 5.6 m120 -60.17 151.36 27.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 132' ' ' SER . 3.5 mp -146.52 139.28 25.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.88 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.0 t -134.98 134.7 40.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.091 0.472 . . . . 0.0 111.6 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.855 HG13 ' CD1' ' A' ' 68' ' ' PHE . 48.4 t -105.02 95.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.482 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.486 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 17.6 p -102.73 -169.89 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.486 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.47 20.9 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.948 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 151' ' ' ILE . 49.9 m -64.26 97.8 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 110.344 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.412 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -103.74 171.6 7.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 58' ' ' LEU . 19.7 m -144.31 125.11 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.999 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 78.36 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.636 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 23.0 t0 -59.41 138.34 57.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.858 0.361 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.5 -28.05 61.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.678 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.13 -27.91 64.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 110.958 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.96 -11.21 22.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.743 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -114.52 121.02 42.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.6 p -73.4 126.16 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -95.1 93.2 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.078 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -51.15 110.56 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.2 OUTLIER -84.36 168.88 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 112.135 -178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -61.03 -141.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.37 176.05 46.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.469 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 37' ' ' LEU . 17.9 m -159.68 149.12 18.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.7 0.286 . . . . 0.0 110.735 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -104.32 154.54 19.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 0.0 111.588 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.647 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -147.66 155.13 41.45 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.541 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.647 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.7 p -138.76 135.27 34.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.639 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -119.59 125.52 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.527 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.87 105.7 17.79 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.921 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.1 mt -76.16 143.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -130.74 133.51 63.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.685 -177.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.1 144.52 19.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -116.68 -137.94 6.11 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.458 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -74.12 176.08 6.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.482 ' H ' HG22 ' A' ' 164' ' ' THR . 32.2 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.734 0.302 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.83 -116.05 5.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.439 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -79.75 166.75 21.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -32.65 74.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -106.18 158.4 16.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 m170 60.51 -177.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -131.98 -173.62 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 60.27 159.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -85.9 150.53 24.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -70.69 -59.15 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 t -132.04 135.66 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -159.73 -177.76 6.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.92 76.91 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 tt -132.03 -61.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 t 63.78 81.98 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.018 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -32.25 123.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.63 2.887 . . . . 0.0 113.276 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.14 112.4 18.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.01 -147.47 4.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.544 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -143.07 92.98 2.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -96.66 -40.69 8.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.5 mtt -104.75 -52.04 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.61 103.75 7.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.98 161.48 33.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -104.99 100.98 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.1 pp -93.64 79.51 4.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.6 -62.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -148.24 178.24 8.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.8 142.82 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.38 77.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -86.67 106.94 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 HD23 ' A' ' 58' ' ' LEU . 79.7 t -71.9 152.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.0 t -60.52 -43.5 97.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.345 0.593 . . . . 0.0 109.493 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 66.49 102.92 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.754 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.902 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 18.9 t -160.73 138.73 9.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.517 0.675 . . . . 0.0 112.166 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 151' ' ' ILE . 34.0 m -97.32 134.67 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.266 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASP . 3.8 t -92.11 108.05 19.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.704 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.598 HD22 ' CG2' ' A' ' 154' ' ' THR . 10.0 tp -97.23 124.52 41.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -140.55 106.99 5.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.687 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -147.65 165.53 30.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.525 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 49' ' ' LEU . 11.0 mt -78.88 -27.53 44.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.701 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 0.3 OUTLIER 71.97 23.04 3.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.616 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HG2' HD11 ' A' ' 161' ' ' ILE . 10.8 tt0 -164.54 129.08 2.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.8 p -146.58 107.91 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' ILE . 1.0 OUTLIER -69.46 125.36 26.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.215 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.4 t -29.23 131.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.15 -20.05 46.65 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.439 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -99.56 172.33 7.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.29 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB3' HG21 ' A' ' 122' ' ' VAL . 10.0 m-80 -121.52 130.01 53.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -118.45 133.47 55.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.824 ' HG2' HD11 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -113.79 154.01 28.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.566 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 51' ' ' VAL . 24.9 m -125.9 98.22 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.696 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.58 64.49 0.62 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.473 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 136' ' ' VAL . 9.1 p -78.25 95.53 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.667 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.33 -122.56 4.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.032 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.504 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -111.24 129.75 65.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.014 0.435 . . . . 0.0 111.776 -179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 24.3 t70 -99.19 -37.36 9.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.712 ' HB3' HG21 ' A' ' 32' ' ' THR . 29.2 mt-10 -159.11 130.02 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.589 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.795 HD23 HG11 ' A' ' 31' ' ' VAL . 1.1 tt -159.55 91.58 1.0 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.251 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.733 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -122.06 107.07 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.55 ' CA ' HG22 ' A' ' 31' ' ' VAL . 63.2 m-20 130.18 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.435 1.094 . . . . 0.0 111.543 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -157.92 162.56 38.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -113.85 83.88 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -63.29 111.78 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.526 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 111' ' ' PRO . 3.1 m-85 -102.26 -38.71 7.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.93 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.91 112.31 10.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.112 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.4 t80 -105.2 94.34 5.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.864 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -109.12 133.28 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.631 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 47.9 p90 -135.99 171.27 14.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.036 0.446 . . . . 0.0 111.421 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.411 ' OG1' ' ND2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -119.0 102.71 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.071 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.064 HD21 HD23 ' A' ' 134' ' ' LEU . 9.8 tt -76.88 157.32 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.096 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.692 ' N ' HD23 ' A' ' 70' ' ' LEU . 3.4 m-80 -127.27 130.47 49.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 1.8 p90 -140.97 -167.42 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.548 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.03 136.3 53.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.319 . . . . 0.0 111.003 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' CB ' ' HB2' ' A' ' 97' ' ' ASP . 33.3 tt0 -94.07 -6.35 45.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.286 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.59 31.26 2.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.809 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.897 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.32 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.651 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 160' ' ' ILE . 3.0 m-85 -100.32 -177.08 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.76 108.86 0.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.9 t80 -48.55 147.65 2.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.502 ' HB ' HG13 ' A' ' 122' ' ' VAL . 60.1 t -127.69 -80.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG12 ' A' ' 122' ' ' VAL . 4.8 mt-10 -161.42 138.84 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.92 150.54 26.41 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 122.01 0.91 . . . . 0.0 111.279 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.28 152.38 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.501 -177.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.574 ' HB3' HG23 ' A' ' 90' ' ' VAL . 15.1 p -115.65 -176.93 3.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.884 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.72 -156.96 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -93.65 36.77 1.08 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.875 0.369 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.79 -38.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.216 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 89' ' ' PHE . 26.6 t -87.06 159.03 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.142 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.4 t80 -114.85 117.02 29.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 104' ' ' VAL . 10.8 t -115.41 131.98 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.56 115.61 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -95.76 149.8 21.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -136.51 106.86 6.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.713 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 24.5 tttt -55.52 120.38 7.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.362 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.4 tp -112.06 -23.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.834 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.54 -179.19 7.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 111.152 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -47.2 -83.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.378 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.508 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . -106.07 60.57 0.37 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.27 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -174.0 123.72 0.33 Allowed 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 5.3 m -148.81 155.41 8.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.637 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -99.11 152.34 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.067 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' CG2' HG13 ' A' ' 90' ' ' VAL . 14.3 p -125.21 147.63 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.394 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.38 109.92 18.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.765 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 90' ' ' VAL . 21.4 t -109.28 137.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 111.524 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.3 p -164.25 136.06 4.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.448 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -79.37 104.39 9.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.242 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -70.51 -14.78 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.462 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.5 p -65.26 -28.87 69.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.0 -17.74 22.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.454 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -99.18 147.66 33.58 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' A' ' 64' ' ' PHE . 52.4 Cg_exo -54.16 169.88 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 63' ' ' ALA . 51.1 mt -58.23 113.96 7.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.32 -21.22 51.72 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.406 2.071 . . . . 0.0 112.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 59.56 169.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.849 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.12 27.05 14.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 110.602 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 118' ' ' LEU . 16.7 tt0 -155.38 154.5 32.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.365 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.696 HG13 ' HA3' ' A' ' 52' ' ' GLY . 26.9 t -47.43 105.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.224 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 116' ' ' GLU . 1.1 mm? -92.05 -29.3 16.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 90' ' ' VAL . . . -163.0 136.4 5.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.74 0.305 . . . . 0.0 111.513 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.64 ' HD2' HG11 ' A' ' 117' ' ' VAL . 7.2 mtpt -131.85 100.75 5.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.428 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 82' ' ' ALA . 93.1 t -91.69 107.04 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.9 p -83.89 124.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 123' ' ' LEU . 2.8 mm? -99.49 114.06 26.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.411 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 24.5 ttm180 -54.95 116.81 2.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -87.63 67.94 9.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.255 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 -0.83 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.481 0.658 . . . . 0.0 109.312 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.16 123.39 2.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.235 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.74 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.0 ttpt -45.44 142.19 2.32 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.627 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -149.07 59.61 1.04 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.713 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -56.05 118.61 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.167 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.36 13.59 70.49 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.51 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.776 ' O ' HD12 ' A' ' 134' ' ' LEU . 29.6 t -70.35 66.56 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.469 . . . . 0.0 110.144 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.456 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 0.9 OUTLIER -43.97 138.28 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.482 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.064 HD23 HD21 ' A' ' 70' ' ' LEU . 4.6 mp -119.17 127.14 53.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.458 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.413 ' CB ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -119.84 126.39 50.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.123 0.487 . . . . 0.0 111.957 -178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.087 HG21 HG21 ' A' ' 53' ' ' VAL . 18.7 m -113.87 94.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.479 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -105.82 -159.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.783 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.422 ' HB3' HD11 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -63.52 104.74 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 0.0 110.371 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.09 167.17 9.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.493 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 58' ' ' LEU . 8.4 m -141.65 120.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.962 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.71 98.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.669 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -55.81 161.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.29 -31.74 79.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.87 -46.23 25.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.372 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.14 -27.84 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.542 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.4 119.31 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.768 0.318 . . . . 0.0 110.971 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.27 153.42 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -122.13 90.61 3.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.69 103.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.266 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.499 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.45 -176.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 111.947 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -64.63 -160.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.53 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -153.1 -174.29 23.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.019 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.598 ' CG2' HD22 ' A' ' 37' ' ' LEU . 11.6 t -160.62 -171.03 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.429 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 14.0 tt0 -161.8 157.85 24.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 41' ' ' GLU . 2.2 tppm? -143.17 168.73 19.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.186 0.517 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.5 p -141.67 115.7 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.415 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -109.9 119.11 58.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.188 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 105.89 18.09 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.935 0.397 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.9 mt -78.25 119.68 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.2 132.77 48.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.692 -178.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.12 145.84 45.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.102 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 168.31 120.2 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.511 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.67 170.29 9.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.861 -179.954 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.04 58.16 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -72.09 161.27 31.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 t -65.22 79.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -114.99 -178.24 3.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t60 60.81 31.65 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.61 -64.18 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -87.12 158.11 19.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.33 29.23 7.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 58.01 31.08 20.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.7 158.24 15.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.11 -170.07 3.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.72 -124.51 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mt -121.57 128.42 51.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.7 t -104.89 81.86 0.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.086 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -32.35 -55.8 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.534 2.823 . . . . 0.0 113.287 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -164.32 -56.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.13 75.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -167.37 97.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -146.07 160.44 41.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 60.49 32.48 20.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -170.45 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t -136.14 -57.3 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.854 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -154.22 117.73 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 25' ' ' LEU . 1.5 tt -93.95 -31.43 14.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -83.6 -30.81 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 61.29 158.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.93 137.39 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.37 77.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -92.11 93.66 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.84 HG21 ' HB2' ' A' ' 61' ' ' ALA . 17.0 t -76.26 151.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.764 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 33' ' ' GLY . 1.5 t -84.65 -33.16 23.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.609 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.19 121.74 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.549 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.606 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -145.5 146.37 31.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.211 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 153' ' ' GLY . 28.7 m -96.07 135.99 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.648 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 3.6 t -90.96 107.11 18.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.246 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.829 ' HB2' HG21 ' A' ' 154' ' ' THR . 13.1 tp -97.48 106.26 18.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.833 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -140.95 101.03 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -137.03 166.16 24.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 111.274 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -69.68 -35.87 75.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.626 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' HA ' HG13 ' A' ' 158' ' ' VAL . 5.6 mt-10 68.29 31.46 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 161' ' ' ILE . 15.7 tt0 -164.21 116.47 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 3.3 p -133.14 165.48 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.901 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.541 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -129.47 113.04 14.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 128' ' ' LYS . 2.1 t -28.11 119.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 121.59 -27.61 6.22 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.43 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -102.47 -175.37 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.74 0.305 . . . . 0.0 110.478 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.65 ' HB3' HG13 ' A' ' 122' ' ' VAL . 23.6 m-80 -113.66 165.06 12.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.188 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.8 tp -117.54 156.76 27.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -136.45 93.95 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.146 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' A' ' 39' ' ' ALA . 8.1 p -103.63 98.13 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.703 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.682 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.53 68.2 3.21 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.924 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 136' ' ' VAL . 7.4 p -78.61 95.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.05 -129.74 6.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.865 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -105.51 138.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.982 0.42 . . . . 0.0 111.543 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 0.4 OUTLIER -98.55 -37.48 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.04 131.99 0.05 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.551 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -135.62 95.51 3.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.526 178.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -85.27 107.05 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.766 ' HB2' HG22 ' A' ' 31' ' ' VAL . 53.1 m-20 96.68 31.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.29 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -141.39 149.77 41.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.362 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.5 mt-10 -119.76 71.3 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.723 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.09 122.42 15.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.234 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -105.93 -32.84 8.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.654 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.84 112.3 7.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.04 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 112' ' ' LEU . 21.9 t80 -104.25 94.69 5.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.1 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -102.42 130.23 49.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.428 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.749 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 41.6 p90 -132.85 171.11 14.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.8 m -132.7 97.27 4.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.186 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.826 ' CD1' HG11 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -77.2 157.71 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.432 -179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -116.54 104.57 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CE1' ' N ' ' A' ' 99' ' ' LYS . 24.4 p90 -111.24 -167.38 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.714 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -106.96 125.54 51.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.78 -40.82 27.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.803 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.68 -35.54 80.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -96.46 -57.95 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 160' ' ' ILE . 8.3 m-85 -93.44 165.38 12.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -145.02 109.74 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.657 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 22.1 t80 -54.01 140.46 31.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.613 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 124' ' ' ARG . 39.9 t -119.52 -72.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 122' ' ' VAL . 3.2 mt-10 -169.04 143.57 3.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -82.74 147.73 28.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 122.169 0.985 . . . . 0.0 111.698 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.777 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.41 152.83 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.474 -177.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -166.36 1.16 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.52 -157.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.27 36.25 1.06 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 111.026 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.09 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.969 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 89' ' ' PHE . 38.1 t -86.88 160.01 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.782 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.613 ' HB2' HD13 ' A' ' 107' ' ' LEU . 12.8 t80 -112.03 136.71 51.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.959 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 104' ' ' VAL . 2.5 t -134.37 105.46 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.34 114.89 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.611 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.657 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.27 -176.98 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.12 107.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.388 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 1.4 tttm -54.82 111.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.039 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 100' ' ' VAL . 0.5 OUTLIER -102.58 -28.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.86 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.31 170.71 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.32 133.75 45.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 59.13 28.48 64.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.323 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.448 ' N ' ' CE1' ' A' ' 72' ' ' TYR . 5.8 ptmt -173.66 122.98 0.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.67 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 20.9 m -150.27 155.92 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -88.28 152.05 22.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.313 -178.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.749 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 7.1 p -131.17 95.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.525 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.88 114.7 19.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.081 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 90' ' ' VAL . 20.7 m -111.58 153.56 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.692 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -164.69 136.71 4.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.467 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.7 m -85.36 104.47 15.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 111.15 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 89' ' ' PHE . 4.4 mp -72.51 -12.19 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.681 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -65.28 -30.86 71.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.38 -19.12 22.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.27 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.39 147.17 34.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.653 0.263 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 44.6 Cg_exo -56.45 176.27 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.547 2.165 . . . . 0.0 112.365 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -57.04 121.96 49.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.813 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 -36.85 62.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.282 1.988 . . . . 0.0 112.158 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 59.91 163.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.888 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.38 28.62 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.492 . . . . 0.0 110.241 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -164.48 156.48 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.996 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.789 HG11 ' HD3' ' A' ' 120' ' ' LYS . 30.9 t -44.4 104.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.26 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -95.47 -29.98 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.969 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.914 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -163.79 135.7 4.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.797 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.789 ' HD3' HG11 ' A' ' 117' ' ' VAL . 12.9 mtmm -124.86 113.69 18.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.826 HG11 ' CD1' ' A' ' 70' ' ' LEU . 7.1 p -86.66 110.45 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.452 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.777 HG22 HD11 ' A' ' 83' ' ' ILE . 41.7 t -76.92 106.29 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 79' ' ' TYR . 10.2 mt -106.21 108.6 20.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.768 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.529 ' HB2' HG21 ' A' ' 80' ' ' VAL . 39.3 ttm180 -69.05 117.92 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -68.55 80.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.185 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 124' ' ' ARG . 4.8 mm-40 -86.06 -12.81 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 109.55 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.79 124.35 2.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.564 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.65 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 7.3 ttpp -45.56 155.9 0.14 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.11 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -161.7 56.78 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -56.21 98.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.677 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 110.59 26.77 4.66 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.911 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -69.97 65.81 0.25 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.918 0.39 . . . . 0.0 111.067 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.51 ' HA ' HG22 ' A' ' 157' ' ' THR . 1.8 t-20 -45.04 110.53 0.24 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.111 0.481 . . . . 0.0 112.003 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 132' ' ' SER . 2.0 mp -106.02 165.2 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.868 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.9 t -158.37 119.74 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.385 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 53' ' ' VAL . 35.6 t -87.16 94.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.441 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.456 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 18.2 p -100.19 -170.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' C ' ' A' ' 137' ' ' THR . 4.2 p30 43.23 23.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.757 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -64.61 93.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.575 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -97.24 167.5 10.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.136 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -140.18 129.39 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.59 77.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 24.7 t0 -57.14 146.86 26.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.6 -26.38 73.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -56.89 -44.32 82.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.687 0.28 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.26 -10.22 4.12 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.853 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -117.64 132.22 56.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.755 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 148' ' ' VAL . 13.5 p -77.26 115.19 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.152 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 141' ' ' VAL . 77.2 m-70 -86.34 95.0 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.71 108.02 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.792 0.329 . . . . 0.0 110.187 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.516 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.23 166.42 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -56.16 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 35' ' ' VAL . . . -159.08 -167.97 20.49 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.892 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.829 HG21 ' HB2' ' A' ' 37' ' ' LEU . 6.8 t -166.09 179.58 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.958 0.379 . . . . 0.0 111.56 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 1.7 tm-20 -143.51 143.8 31.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.986 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.809 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -149.44 155.32 40.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.14 0.495 . . . . 0.0 111.232 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.648 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 8.2 p -128.73 140.22 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.219 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -119.65 139.03 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 111.49 23.78 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.027 0.441 . . . . 0.0 111.12 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.688 HD11 ' CE2' ' A' ' 77' ' ' PHE . 2.3 mt -88.16 127.5 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -112.13 132.19 61.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.077 -177.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.07 145.86 49.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.223 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.14 159.24 24.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -102.5 179.88 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.857 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.461 ' H ' HG22 ' A' ' 164' ' ' THR . 57.9 m . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.938 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.735 0.303 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.92 178.01 53.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 p -85.64 99.46 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 0.0 110.94 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.95 -60.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -64.67 170.18 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 86.51 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -143.02 35.64 1.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -119.03 -170.23 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 m170 60.66 110.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -96.26 142.89 27.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.2 m -114.16 118.48 34.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.14 146.87 27.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.6 -128.58 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.482 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.89 162.39 34.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.31 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.2 p -169.07 88.27 0.61 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -32.46 120.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.658 2.905 . . . . 0.0 113.24 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -91.56 -61.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.13 -105.53 1.17 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 p -63.33 177.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 110.813 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.6 31.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.804 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 60.01 171.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.7 160.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.08 29.14 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 58.47 33.55 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.99 -62.21 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.897 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 48.1 tttp 61.01 162.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -101.05 154.09 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.77 -174.67 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.09 71.6 0.45 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.24 142.66 30.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.831 HG11 HD13 ' A' ' 58' ' ' LEU . 77.5 t -100.7 153.2 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.075 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 59' ' ' VAL . 9.3 t -64.05 -42.5 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.448 0.642 . . . . 0.0 109.436 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.675 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 61.96 104.93 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.214 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 40.9 t -156.31 136.48 12.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.697 0.76 . . . . 0.0 112.213 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 151' ' ' ILE . 34.2 m -93.35 145.47 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.492 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 17.9 p -104.38 113.31 26.79 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.014 HD12 HG22 ' A' ' 154' ' ' THR . 5.5 mt -96.79 121.38 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 111.32 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.1 101.3 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.365 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -151.15 152.08 32.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.45 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.88 -22.72 59.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.529 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' CG ' ' HD2' ' A' ' 156' ' ' LYS . 2.3 mp0 66.68 23.35 10.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.445 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -165.12 127.89 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -144.54 106.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.164 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -69.16 133.07 47.52 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.489 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.9 t -33.83 133.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.57 -22.48 35.74 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.515 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.13 172.18 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -104.34 153.57 20.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 158' ' ' VAL . 62.2 tp -93.67 161.03 14.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 21.7 mt-10 -136.57 93.57 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.723 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 25.2 t -105.67 97.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 117' ' ' VAL . . . -85.96 59.08 4.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.157 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 53' ' ' VAL . 9.6 p -78.04 95.35 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.581 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -112.31 -117.58 3.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.037 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.617 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -116.5 131.38 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 112.046 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 7.3 t0 -103.53 -35.84 8.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -155.89 127.82 7.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.611 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.831 HD13 HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -150.11 90.7 1.7 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.27 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -115.19 116.53 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.77 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.8 m-20 103.15 33.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.934 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -169.31 133.46 1.38 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -91.96 82.06 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.348 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 111.86 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.658 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 112' ' ' LEU . 30.3 m-85 -104.94 -33.82 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.884 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.51 112.3 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.111 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 112' ' ' LEU . 15.2 t80 -109.71 95.03 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.967 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -109.18 143.86 38.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.717 ' CD1' HG13 ' A' ' 136' ' ' VAL . 18.6 p90 -146.41 171.27 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.013 0.435 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -126.29 99.72 5.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -77.2 156.08 31.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -122.27 112.99 18.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HA ' HD23 ' A' ' 134' ' ' LEU . 26.1 p90 -126.22 -168.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.646 ' OD2' ' HB3' ' A' ' 76' ' ' ALA . 2.2 p-10 -106.06 134.55 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.971 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.72 -29.86 18.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.09 -41.92 99.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 128' ' ' LYS . . . -102.64 -47.94 4.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -93.38 172.37 8.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.712 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -160.7 114.13 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.688 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.725 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 31.9 t80 -54.16 153.46 5.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.988 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' HG23 ' A' ' 122' ' ' VAL . 87.1 t -132.8 -77.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -166.02 140.61 4.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.736 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.85 149.47 27.12 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.89 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.93 152.63 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.339 -177.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -123.13 -165.37 1.31 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.898 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -90.89 -157.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -93.72 36.75 1.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.937 0.399 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.18 -38.73 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 106' ' ' SER . 19.8 t -86.83 149.29 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.926 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -111.28 103.11 11.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 104' ' ' VAL . 2.5 t -105.44 142.17 19.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.021 0.438 . . . . 0.0 110.987 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -156.46 118.84 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.305 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.725 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.95 -178.9 4.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.413 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -157.31 107.85 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.0 111.54 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 17.8 tttt -54.53 95.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.0 tp -78.12 -27.11 14.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.833 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -165.3 -166.78 1.04 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -86.71 134.68 33.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.965 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.28 29.38 60.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 100' ' ' VAL . 3.0 ptpt -173.62 121.36 0.33 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 120.941 0.4 . . . . 0.0 109.977 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.804 ' HA ' HG22 ' A' ' 95' ' ' ILE . 11.8 m -150.07 155.51 7.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.665 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.563 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 6.9 ttp180 -93.3 151.87 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.28 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 12.4 p -123.67 129.65 74.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.47 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.413 HD11 ' NZ ' ' A' ' 93' ' ' LYS . 15.8 mt -101.84 104.69 15.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.332 . . . . 0.0 110.714 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' A' ' 119' ' ' ALA . 23.1 t -103.69 135.68 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.494 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -164.46 136.76 4.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.437 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 88' ' ' VAL . 88.6 p -88.2 117.26 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.41 27.71 2.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.298 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.6 p -102.41 -27.65 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.863 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.78 -16.81 23.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.315 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.43 147.62 34.68 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 51.2 Cg_exo -54.1 172.96 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.496 2.131 . . . . 0.0 112.306 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 66' ' ' TYR . 3.0 mp -59.28 128.0 84.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 118' ' ' LEU . 31.8 Cg_exo -58.54 -34.05 98.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.376 2.051 . . . . 0.0 112.11 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.56 163.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.94 15.52 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -146.83 -165.72 2.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.31 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.576 HG13 ' CA ' ' A' ' 52' ' ' GLY . 38.9 t -78.71 104.84 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.763 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 114' ' ' ALA . 1.9 mm? -94.35 -29.56 14.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.034 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -149.56 134.14 17.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HG3' HG11 ' A' ' 117' ' ' VAL . 7.3 mtmt -126.09 101.81 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 70' ' ' LEU . 9.0 p -92.25 101.52 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.338 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.89 ' CG1' HD11 ' A' ' 83' ' ' ILE . 35.7 m -75.59 97.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.737 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.17 113.74 21.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.912 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.2 tpm_? -59.01 113.28 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.68 68.2 7.95 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.49 -6.19 59.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 109.574 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . . . -162.31 123.59 2.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.578 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.697 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.6 ttmm -41.94 162.47 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.318 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.859 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -173.43 58.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.018 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 30.5 tt0 -56.22 116.05 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.119 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.88 15.89 58.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.567 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.859 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -70.67 66.62 0.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.12 0.486 . . . . 0.0 110.252 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -44.49 140.55 2.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.264 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -126.83 128.72 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.96 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.431 ' CA ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -115.57 129.83 56.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 111.696 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.717 HG13 ' CD1' ' A' ' 68' ' ' PHE . 39.5 t -106.42 95.09 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.609 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.471 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 15.9 p -100.11 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.76 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.35 21.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.995 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -61.92 105.54 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.358 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 175.13 5.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.355 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 149' ' ' HIS . 32.8 m -153.74 126.56 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.008 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.79 104.42 2.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.714 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 13.0 p30 -58.87 -174.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.719 0.295 . . . . 0.0 110.857 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.75 16.58 60.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.909 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.98 -32.17 4.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.669 0.271 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.61 -16.96 3.52 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.061 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.99 170.16 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.995 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 148' ' ' VAL . 12.1 p -120.8 125.72 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 141' ' ' VAL . 79.1 m80 -96.12 90.54 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.945 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -49.42 106.2 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.43 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.451 -179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -76.19 -146.37 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.677 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.25 -179.52 41.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.716 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 1.014 HG22 HD12 ' A' ' 37' ' ' LEU . 24.0 m -161.14 153.34 20.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.434 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 8.7 tt0 -110.0 161.98 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 37' ' ' LEU . 1.3 tppt? -139.5 166.75 23.73 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.435 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 2.1 p -142.23 116.21 9.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.67 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -111.65 122.37 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.253 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -92.42 105.85 17.95 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.679 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 43' ' ' VAL . 18.1 mt -80.49 112.45 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.597 0.713 . . . . 0.0 109.842 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -94.55 131.77 40.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.038 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.01 145.84 49.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.077 0.465 . . . . 0.0 110.957 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.81 110.65 0.45 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.628 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -98.47 175.12 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.897 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.448 ' H ' HG22 ' A' ' 164' ' ' THR . 1.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.841 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.805 0.336 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.35 152.52 5.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.549 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.28 124.61 49.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 m -131.98 -67.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -98.47 35.14 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -102.28 -176.3 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 t60 60.65 94.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -176.1 87.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -76.45 110.66 11.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -105.32 -32.43 8.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 t -146.24 119.54 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -131.25 165.57 23.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.42 -152.5 6.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mt -146.81 137.91 24.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.807 0.337 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.4 m -105.29 82.43 0.75 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -32.48 107.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.606 2.871 . . . . 0.0 113.248 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -61.3 -44.78 96.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.23 162.68 11.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -176.35 95.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.822 0.344 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -129.5 132.98 47.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.8 tpt -82.16 -31.35 30.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.45 122.05 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -161.93 -74.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.67 158.59 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.823 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mp 60.53 -176.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -99.92 80.78 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -60.41 -177.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.783 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -174.04 -169.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB1' ' OD1' ' A' ' 60' ' ' ASN . . . -177.22 78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.6 133.54 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.105 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 14.6 t -60.74 155.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -77.5 -46.85 21.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.26 114.21 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.208 178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.943 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 6.7 t -162.08 136.7 6.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.138 0.494 . . . . 0.0 111.542 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 154' ' ' THR . 5.8 m -91.41 134.1 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.553 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 t -96.42 107.44 19.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.341 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.837 HD12 HG22 ' A' ' 154' ' ' THR . 3.7 mt -97.1 117.3 30.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.251 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -140.49 101.42 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.57 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . . . -144.08 160.19 41.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -31.67 68.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' C ' HG12 ' A' ' 158' ' ' VAL . 11.1 mt-10 69.41 24.2 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.5 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HD21 ' A' ' 49' ' ' LEU . 6.8 tt0 -165.04 122.83 1.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.813 0.34 . . . . 0.0 111.657 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.914 ' O ' HG23 ' A' ' 160' ' ' ILE . 2.7 p -143.34 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.412 ' HA ' ' H ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -67.51 132.19 47.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.0 t -32.76 132.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-O 121.549 0.69 . . . . 0.0 112.776 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.85 -24.89 30.34 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.536 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.3 171.85 8.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.746 0.307 . . . . 0.0 110.666 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -116.46 150.89 37.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.785 HD23 HG11 ' A' ' 158' ' ' VAL . 6.8 tp -130.08 142.1 50.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.862 ' HG2' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -123.51 117.05 24.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.1 p -93.55 98.65 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -69.19 69.78 0.47 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.854 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 53' ' ' VAL . 7.9 p -78.58 95.02 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.19 -135.1 8.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.809 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.587 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -107.51 127.37 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.553 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -94.29 -37.34 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 32' ' ' THR . 22.9 mp0 -161.07 132.21 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HG ' HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -162.49 91.61 0.77 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.108 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 59' ' ' VAL . 12.0 p -121.46 109.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.565 ' N ' HG22 ' A' ' 31' ' ' VAL . 63.9 m-20 130.41 18.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.451 1.101 . . . . 0.0 111.606 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -150.41 -179.16 6.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.699 0.285 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER -126.93 85.16 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.362 . . . . 0.0 110.575 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB1' HG21 ' A' ' 141' ' ' VAL . . . -62.59 111.94 2.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.145 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.3 m-85 -115.28 -49.12 2.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.67 112.3 17.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.997 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.552 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 t80 -85.75 136.6 33.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.453 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -147.62 109.64 4.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.271 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' O ' HG12 ' A' ' 102' ' ' VAL . 29.9 p90 -130.24 171.27 13.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.364 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 104.84 8.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.567 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.864 HD13 HG11 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -77.35 149.73 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.118 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -125.28 104.64 8.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HA ' HD23 ' A' ' 134' ' ' LEU . 19.1 p90 -121.33 -170.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -97.64 136.79 37.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -93.6 -26.8 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -76.54 -29.78 56.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.103 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -108.78 -49.32 3.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.327 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CE2' HD11 ' A' ' 160' ' ' ILE . 5.0 m-85 -93.31 -177.08 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.969 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ARG . 2.0 tt0 -170.28 108.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.806 ' HA ' HD23 ' A' ' 123' ' ' LEU . 38.9 t80 -47.47 152.73 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.399 . . . . 0.0 111.119 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 59.3 t -134.53 -78.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 122' ' ' VAL . 4.2 mt-10 -153.47 148.73 26.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.457 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -102.25 147.96 26.02 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.207 1.003 . . . . 0.0 111.638 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.791 HD11 ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -133.78 174.61 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.103 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.67 -177.29 5.56 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HG23 ' A' ' 88' ' ' VAL . 20.1 p-10 -61.97 -161.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.713 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.92 36.71 1.1 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.44 -40.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.26 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG23 ' OD1' ' A' ' 85' ' ' ASP . 16.4 t -86.98 146.86 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -108.25 103.04 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.057 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.801 ' CG2' HG13 ' A' ' 104' ' ' VAL . 2.6 t -101.96 132.17 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.645 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -145.4 109.73 4.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.82 -179.23 4.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.342 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -161.11 117.92 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.387 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.702 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 tttt -54.03 113.35 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.389 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 100' ' ' VAL . 6.6 tp -109.49 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -158.44 172.91 17.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.839 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.85 131.91 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 58.25 29.47 63.0 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.171 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' C ' HG13 ' A' ' 100' ' ' VAL . 2.8 ptmt -173.57 129.87 0.43 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.727 ' HA ' HG22 ' A' ' 95' ' ' ILE . 18.2 m -150.06 155.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.925 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -83.26 147.35 28.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.029 -178.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 68' ' ' PHE . 7.1 p -130.68 129.89 64.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -111.05 109.94 20.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 90' ' ' VAL . 4.1 t -106.17 144.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.508 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.438 ' C ' HG13 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -164.38 139.78 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.305 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -88.57 104.34 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.108 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -67.75 -17.83 64.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 p -65.23 -34.81 79.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.971 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.22 -19.9 28.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.389 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.73 153.77 43.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 40.9 Cg_exo -56.72 164.8 5.43 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.629 2.219 . . . . 0.0 112.437 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 118' ' ' LEU . 2.3 mp -59.33 127.55 84.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.749 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.85 -32.14 96.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.409 2.072 . . . . 0.0 112.085 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 58.44 162.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.51 15.04 9.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.25 -164.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.218 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.841 HG11 ' HD3' ' A' ' 120' ' ' LYS . 31.0 t -78.97 104.66 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.57 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -88.55 -33.23 17.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 90' ' ' VAL . . . -168.68 133.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.319 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.841 ' HD3' HG11 ' A' ' 117' ' ' VAL . 3.9 mtmt -122.92 100.76 7.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.06 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.864 HG11 HD13 ' A' ' 70' ' ' LEU . 11.4 p -74.25 110.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.868 0.366 . . . . 0.0 110.437 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.862 HG22 ' HG2' ' A' ' 50' ' ' GLU . 15.5 t -75.55 115.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.787 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 79' ' ' TYR . 15.9 mt -102.09 169.12 8.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.642 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 12.8 tpp180 -115.28 125.16 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -92.08 73.12 5.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.546 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -87.74 -5.11 58.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.435 0.636 . . . . 0.0 109.639 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.563 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 4.3 ttmm -49.74 134.2 20.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.176 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -138.69 64.29 1.49 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.47 114.42 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.151 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.51 21.25 52.07 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.814 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -71.02 66.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.06 0.457 . . . . 0.0 110.489 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 157' ' ' THR . 0.8 OUTLIER -46.98 142.78 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.858 -179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -121.68 165.05 16.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.801 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.19 106.24 3.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.971 0.415 . . . . 0.0 111.489 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.45 ' CG1' ' CD1' ' A' ' 68' ' ' PHE . 21.8 t -96.4 94.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.456 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.3 p -103.33 -160.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 44.81 19.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HD11 ' A' ' 151' ' ' ILE . 74.7 m -59.81 90.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.123 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.45 ' HB3' HG21 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -116.44 138.47 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.212 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 148' ' ' VAL . 10.4 p -115.01 153.29 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.005 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -91.03 100.19 2.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.786 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 25.9 t0 -52.51 162.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.779 0.324 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.39 -43.88 95.51 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.548 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.22 -30.85 71.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.98 -27.76 3.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.536 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.7 155.34 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 110.841 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 141' ' ' VAL . 12.1 p -114.43 138.63 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -110.52 96.93 6.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.56 104.99 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.159 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 139' ' ' SER . 0.1 OUTLIER -84.39 -176.76 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -68.1 -158.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.577 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -154.88 175.35 32.96 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 37' ' ' LEU . 86.0 m -164.12 146.73 9.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.925 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 11.2 pt-20 -101.75 166.7 10.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.635 ' HE2' ' N ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -152.4 154.67 36.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.879 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.635 ' N ' ' HE2' ' A' ' 156' ' ' LYS . 2.9 p -126.77 143.6 51.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.605 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.785 HG11 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.69 130.02 52.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.58 105.93 16.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 120.933 0.397 . . . . 0.0 111.011 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.8 mt -80.15 115.39 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.491 0.662 . . . . 0.0 109.455 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -97.29 128.74 48.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.116 -178.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.08 145.9 29.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.107 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.08 -118.47 4.47 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.524 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.39 172.77 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.946 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtp . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.805 0.336 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.92 102.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.474 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m 60.36 -178.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.26 -58.67 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -149.13 141.56 24.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -101.96 34.21 2.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -128.48 165.31 20.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -105.39 109.45 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.17 112.63 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -28.78 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.006 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 p -151.36 131.56 13.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -104.91 -59.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.59 109.79 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.44 -53.71 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.74 0.305 . . . . 0.0 110.823 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.6 m -78.93 150.18 74.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.088 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -32.26 140.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.65 2.9 . . . . 0.0 113.25 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -138.49 -60.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.28 78.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.91 178.7 8.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.796 0.332 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -105.73 -171.84 1.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 tpt 68.59 -67.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 109.96 7.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.077 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -100.03 178.31 4.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 78.77 4.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -151.6 116.96 5.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.55 39.67 17.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.94 168.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.87 134.65 52.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.3 77.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.09 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -114.34 108.4 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 60' ' ' ASN . 24.9 t -60.68 155.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 57' ' ' GLU . 10.4 t -84.44 -45.06 13.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' CA ' ' HB ' ' A' ' 151' ' ' ILE . . . 71.01 120.28 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.422 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.8 t -162.95 140.47 7.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.06 0.457 . . . . 0.0 111.421 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 154' ' ' THR . 11.2 m -97.82 129.26 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.37 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 56' ' ' ASP . 47.5 p -95.01 108.21 20.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.948 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.077 HD12 HG23 ' A' ' 154' ' ' THR . 1.4 mt -97.71 122.09 40.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.55 112.28 10.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.595 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -153.01 155.6 37.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.902 0.382 . . . . 0.0 111.417 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.48 -29.15 66.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.213 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 69.98 23.87 5.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.624 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' N ' HG12 ' A' ' 158' ' ' VAL . 19.9 tt0 -164.68 128.95 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.995 0.426 . . . . 0.0 112.112 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -134.03 171.19 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.117 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.5 tt0 -133.05 120.15 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 2.0 t -28.72 132.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 121.576 0.703 . . . . 0.0 112.381 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.05 49.55 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -143.28 174.92 10.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.515 0.326 . . . . 0.0 110.15 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -127.42 147.93 50.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.875 0.369 . . . . 0.0 110.986 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -102.52 164.12 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.613 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 122' ' ' VAL . 11.6 mt-10 -130.0 93.32 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.682 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.0 p -103.16 97.9 6.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -91.48 85.2 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.258 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 136' ' ' VAL . 3.5 p -78.55 95.06 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.826 0.346 . . . . 0.0 110.086 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -96.37 -134.9 8.2 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.499 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -103.08 134.63 43.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 111.606 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 22.1 t0 -103.28 -34.32 8.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.425 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 32' ' ' THR . 4.0 mp0 -165.54 134.05 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.926 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 141' ' ' VAL . 1.6 tt -162.27 91.61 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.759 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 59' ' ' VAL . 11.9 p -119.31 103.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 35.2 m-20 133.1 24.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.262 1.025 . . . . 0.0 111.413 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -160.6 171.95 18.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -121.19 86.05 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.716 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.59 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -62.5 133.52 55.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 12.7 m-85 -127.63 -42.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.04 112.44 15.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.29 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.752 ' O ' HG22 ' A' ' 104' ' ' VAL . 5.4 t80 -85.98 100.66 12.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -109.33 112.44 24.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 50.4 p90 -142.97 171.54 13.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.519 HG22 HD21 ' A' ' 138' ' ' ASN . 1.8 t -128.48 121.29 28.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.002 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 ' CG1' ' A' ' 121' ' ' VAL . 7.2 tt -95.03 126.34 40.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -98.32 106.59 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.455 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 50.0 p90 -107.13 -169.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.702 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.69 120.27 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -29.46 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -27.42 69.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.704 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -125.95 -44.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.384 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.915 ' CE2' HD11 ' A' ' 160' ' ' ILE . 0.8 OUTLIER -93.14 161.06 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -145.65 130.39 18.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CD1' HG21 ' A' ' 100' ' ' VAL . 19.5 t80 -55.02 149.13 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 124' ' ' ARG . 55.7 t -132.16 -85.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.014 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 122' ' ' VAL . 58.1 mm-40 -160.4 135.84 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.88 150.58 26.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 122.147 0.975 . . . . 0.0 111.393 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.682 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -120.19 153.29 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.571 -177.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -117.25 -165.89 1.12 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.714 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.5 -157.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.618 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.6 37.15 1.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.863 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.67 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.169 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 89' ' ' PHE . 40.5 t -86.74 158.85 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.954 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.2 t80 -112.36 125.38 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.952 HG22 ' CG1' ' A' ' 104' ' ' VAL . 3.5 t -122.57 135.93 61.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.33 120.53 7.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.612 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -96.96 156.77 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 107.25 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.174 0.512 . . . . 0.0 111.337 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 2.3 ttpt -55.1 95.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.864 HG22 ' HA ' ' A' ' 100' ' ' VAL . 7.5 tp -82.73 -22.21 9.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.765 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.8 -166.74 0.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.81 133.18 33.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 57.87 29.56 62.0 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.465 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' C ' HG13 ' A' ' 100' ' ' VAL . 13.3 ptpt -173.26 121.59 0.36 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.864 ' HA ' HG22 ' A' ' 95' ' ' ILE . 7.1 m -149.91 154.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.676 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.09 152.16 22.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.204 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 8.6 p -126.45 93.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.15 111.0 17.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.952 ' CG1' HG22 ' A' ' 90' ' ' VAL . 4.2 m -117.25 158.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.022 0.439 . . . . 0.0 111.804 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -164.49 136.09 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.265 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -79.01 113.67 17.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 31.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.983 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.2 p -109.65 -34.64 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.48 -21.84 11.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.142 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -91.17 155.69 44.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.757 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 59.1 Cg_endo -72.4 174.5 11.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.481 2.121 . . . . 0.0 112.476 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 114' ' ' ALA . 4.0 tt -54.49 107.55 0.9 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.86 -32.11 94.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.344 2.029 . . . . 0.0 111.926 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.733 ' H ' HD23 ' A' ' 112' ' ' LEU . . . 59.77 170.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.168 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.6 16.15 10.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.087 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -148.26 -179.85 7.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 47.0 t -70.95 105.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.649 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 114' ' ' ALA . 2.3 mm? -87.56 -31.55 19.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.214 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.742 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -166.11 131.0 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.679 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -119.89 118.6 31.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.305 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.9 ' CG1' HD13 ' A' ' 70' ' ' LEU . 7.1 p -97.98 94.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.182 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 81' ' ' GLU . 21.5 m -75.63 118.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.026 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 134' ' ' LEU . 2.4 mm? -92.24 169.2 10.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 2.0 tpm_? -105.51 118.25 36.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -90.86 71.07 6.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.785 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.36 -4.3 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 0.0 109.195 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.96 124.31 2.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.042 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.669 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 3.1 ptmt -40.6 163.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.704 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -178.2 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.971 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 pt-20 -55.63 112.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.69 4.14 39.85 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.647 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -62.84 87.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.932 0.396 . . . . 0.0 110.24 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.798 ' C ' HD12 ' A' ' 134' ' ' LEU . 3.9 m120 -60.49 166.68 2.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 133' ' ' ASN . 9.5 mp -140.13 104.84 4.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.649 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.41 130.14 45.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.227 0.537 . . . . 0.0 112.093 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 53' ' ' VAL . 30.6 m -115.4 108.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.17 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.496 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 7.5 p -108.91 -167.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.547 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.519 HD21 HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER 37.41 29.87 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.449 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB3' HD11 ' A' ' 151' ' ' ILE . 50.6 m -62.34 89.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.034 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.95 171.66 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.357 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.013 HG21 HD11 ' A' ' 58' ' ' LEU . 15.4 m -147.33 122.46 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.63 99.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 46.4 t0 -56.41 162.53 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.41 -29.16 70.27 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.61 -49.05 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.6 -28.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.392 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 mt -79.33 170.2 16.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.23 153.39 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -123.03 94.82 4.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.23 104.97 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.503 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -84.53 -176.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -67.93 -160.85 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' ' CG1' ' A' ' 35' ' ' VAL . . . -159.78 175.54 36.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 1.077 HG23 HD12 ' A' ' 37' ' ' LEU . 1.3 t -162.93 -170.91 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.849 -0.207 . . . . 0.0 110.574 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -151.21 152.06 32.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.198 0.523 . . . . 0.0 112.061 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 37' ' ' LEU . 4.1 tppt? -129.34 169.26 15.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.867 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.46 HG22 ' ND2' ' A' ' 133' ' ' ASN . 1.1 p -143.01 144.38 32.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.976 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.59 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -134.24 126.37 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -90.35 116.13 28.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.039 0.447 . . . . 0.0 110.775 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.915 HD11 ' CE2' ' A' ' 77' ' ' PHE . 4.6 mt -85.56 116.66 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.69 -178.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.89 146.6 51.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.016 0.436 . . . . 0.0 111.016 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.94 161.78 35.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -50.12 177.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.362 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.479 ' N ' ' OG1' ' A' ' 164' ' ' THR . 67.1 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.743 0.306 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.99 158.13 53.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -106.34 178.24 4.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.99 99.67 3.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.75 143.3 30.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -135.8 178.26 7.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.41 156.87 28.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -172.29 -53.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -132.15 124.29 28.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 60.24 -176.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -140.66 -60.3 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t 60.38 88.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.61 82.88 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 15' ' ' VAL . 5.0 mp -124.35 -44.42 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 14' ' ' LEU . 13.3 t -159.46 -64.58 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' CD ' ' HB ' ' A' ' 15' ' ' VAL . 94.5 Cg_exo -32.11 123.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.31 2.673 . . . . 0.0 113.289 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -62.8 -58.11 8.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.24 168.74 24.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 -31.36 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m170 60.35 35.74 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -76.94 81.51 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.85 112.52 1.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.17 -59.1 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' C ' HD22 ' A' ' 25' ' ' LEU . 1.6 mptm? -113.13 80.37 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 24' ' ' LYS . 4.4 mm? -119.4 -44.25 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -151.34 -47.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 60.49 166.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.59 165.99 21.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.54 31.66 0.81 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -81.01 122.63 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 61' ' ' ALA . 12.3 t -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' GLY . 6.7 t -80.42 -32.27 37.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 52.43 120.67 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.596 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.602 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 28.6 t -149.94 155.01 39.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.277 0.56 . . . . 0.0 111.944 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -108.06 123.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -92.13 107.38 19.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.567 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 154' ' ' THR . 1.9 mt -97.16 126.59 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.27 101.42 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.517 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.734 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -146.2 154.56 41.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.346 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.57 -26.62 61.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.58 23.53 7.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.424 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 158' ' ' VAL . 27.0 tt0 -164.7 126.55 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 160' ' ' ILE . 3.6 p -128.62 171.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.493 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 43' ' ' VAL . 1.2 tt0 -133.83 113.4 12.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.512 ' H ' HG22 ' A' ' 160' ' ' ILE . 1.8 t -28.37 114.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ALA . . . 125.06 -25.6 5.75 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.884 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -103.8 -175.52 2.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.913 0.387 . . . . 0.0 110.808 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -114.9 167.74 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.747 HD11 HG11 ' A' ' 158' ' ' VAL . 1.3 tp -114.74 159.43 20.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.469 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.734 HG12 ' HB2' ' A' ' 39' ' ' ALA . 3.8 m -105.54 98.05 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.476 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.785 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -82.1 71.48 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.153 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.68 HG21 HG11 ' A' ' 136' ' ' VAL . 8.2 p -78.22 97.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.965 0.412 . . . . 0.0 110.872 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -108.35 -128.47 5.79 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.852 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.865 HD13 HD22 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -112.05 134.8 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.037 0.446 . . . . 0.0 111.431 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.02 -33.05 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.234 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 3.4 pt-20 -174.46 130.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.642 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -152.61 91.67 1.59 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.093 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 31' ' ' VAL . 10.6 p -100.11 117.82 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.737 ' HB2' HG22 ' A' ' 31' ' ' VAL . 69.6 m-20 100.78 22.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.596 0.758 . . . . 0.0 112.352 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.851 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -142.69 138.59 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.8 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 143' ' ' ASP . 3.1 mp0 -102.19 87.18 3.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -62.2 112.12 2.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 0.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.42 -32.06 7.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.349 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.63 111.96 6.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.666 ' HD1' HG12 ' A' ' 141' ' ' VAL . 0.8 OUTLIER -87.45 136.5 32.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.341 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' OD2' HD23 ' A' ' 103' ' ' LEU . 8.3 t0 -147.83 109.86 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.314 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.703 ' CD1' HG13 ' A' ' 136' ' ' VAL . 5.0 p90 -125.0 171.12 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.375 . . . . 0.0 111.352 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 115.56 17.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.587 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 136' ' ' VAL . 10.5 tp -77.3 141.45 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.257 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -119.96 104.59 10.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.568 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.426 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 50.3 p90 -133.0 -170.87 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.82 132.43 54.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -27.39 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -56.31 -30.04 62.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -121.35 -48.15 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.17 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.753 ' CE2' HD11 ' A' ' 160' ' ' ILE . 1.1 m-85 -93.38 178.9 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -171.7 119.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.734 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 15.2 t80 -54.54 156.02 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.714 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 122' ' ' VAL . 58.4 t -130.46 -84.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 122' ' ' VAL . 14.2 pt-20 -153.07 132.14 12.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.83 150.19 26.72 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 122.141 0.972 . . . . 0.0 111.649 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.543 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.99 152.38 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.353 -177.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.6 ' HB2' HG23 ' A' ' 88' ' ' VAL . 51.9 p -115.07 -168.41 1.38 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.852 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -93.87 -160.12 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.86 37.01 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.978 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.29 -42.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.167 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 106' ' ' SER . 28.3 m -96.08 173.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.336 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 156.82 26.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.575 HG13 ' CG2' ' A' ' 102' ' ' VAL . 21.5 t -147.85 123.94 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -134.01 110.78 9.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.028 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.734 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.15 131.02 44.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.311 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -118.84 108.04 14.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HA ' HG23 ' A' ' 100' ' ' VAL . 12.8 tttt -70.51 97.21 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.831 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -78.1 -0.06 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.12 -168.76 0.08 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.35 115.39 27.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 79.92 38.72 18.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.075 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -172.68 123.42 0.44 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 94' ' ' LYS . 12.4 p -151.61 131.86 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.593 -174.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 15.7 ttp180 -101.28 151.97 21.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.848 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.575 ' CG2' HG13 ' A' ' 90' ' ' VAL . 12.8 p -123.59 157.29 29.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 111.824 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.495 HD23 ' OD2' ' A' ' 67' ' ' ASP . 84.8 mt -123.56 106.94 11.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.525 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 118' ' ' LEU . 11.1 t -105.27 143.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 111.686 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 p -164.29 136.17 4.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.767 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -89.08 112.22 23.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 111.258 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mt -93.77 31.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.929 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -109.7 -30.92 7.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.968 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.65 -20.67 11.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.223 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -94.43 155.93 39.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.615 0.245 . . . . 0.0 110.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 177.07 7.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.574 2.183 . . . . 0.0 112.547 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.865 HD22 HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -56.72 119.15 27.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.901 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.62 -42.41 39.95 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.931 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.765 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 66.08 163.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.29 15.49 10.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.271 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.2 -169.76 3.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.284 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.785 HG13 ' HA3' ' A' ' 52' ' ' GLY . 23.6 t -74.04 104.92 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HG ' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -96.81 -28.79 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -155.16 129.4 8.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -118.96 101.01 7.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.534 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.6 p -95.8 97.97 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 81' ' ' GLU . 20.2 m -75.51 124.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.067 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.733 ' CD2' HD21 ' A' ' 134' ' ' LEU . 4.2 mp -95.33 169.19 10.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.792 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.474 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -111.28 120.4 42.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.492 . . . . 0.0 112.069 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -89.72 69.52 7.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.991 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.5 -9.51 47.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.34 0.591 . . . . 0.0 109.623 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.49 124.3 3.1 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.736 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.691 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 18.4 ttpp -43.66 155.24 0.08 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.433 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.771 ' HB1' ' OG ' ' A' ' 132' ' ' SER . . . -165.82 59.51 0.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.892 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -55.53 116.27 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.188 -179.111 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.7 18.56 51.26 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.334 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.771 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -70.71 66.55 0.35 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.939 0.399 . . . . 0.0 110.456 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' LYS . 1.0 OUTLIER -43.96 133.93 4.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.255 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.733 HD21 ' CD2' ' A' ' 123' ' ' LEU . 1.2 mp -116.42 118.31 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.1 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 p -99.6 124.15 44.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.408 . . . . 0.0 111.553 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.775 HG22 HD12 ' A' ' 70' ' ' LEU . 25.0 t -110.22 95.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.546 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 15.8 p -111.98 -159.78 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.761 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 43.56 20.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.601 ' CB ' HD11 ' A' ' 151' ' ' ILE . 26.9 m -68.05 92.3 0.38 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.26 163.85 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.39 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.666 HG12 ' HD1' ' A' ' 66' ' ' TYR . 27.6 m -139.07 130.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.68 82.84 0.93 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 9.1 t70 -55.18 139.96 40.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.804 0.335 . . . . 0.0 110.76 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.2 -38.39 25.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.06 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -53.51 -26.58 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.94 -18.56 10.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.668 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mt -94.18 170.15 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 148' ' ' VAL . 10.9 p -120.51 122.98 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 5.3 m-70 -92.74 99.62 12.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.081 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.33 110.73 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' A' ' 139' ' ' SER . 0.3 OUTLIER -84.23 171.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.208 0.528 . . . . 0.0 111.922 -178.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -58.4 -146.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.487 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.55 167.44 37.73 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.518 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.83 HG22 HD12 ' A' ' 37' ' ' LEU . 9.5 m -168.14 148.74 4.95 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -118.6 179.12 4.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.622 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.64 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppt? -144.7 168.85 19.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.432 ' CG2' ' ND2' ' A' ' 133' ' ' ASN . 4.0 p -142.12 115.78 9.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.747 HG11 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -114.68 122.12 68.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.291 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -89.3 112.34 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.555 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.822 HG23 HG13 ' A' ' 43' ' ' VAL . 2.4 mt -81.62 120.65 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.375 0.607 . . . . 0.0 109.634 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -105.49 131.25 55.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.922 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.74 146.06 47.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.094 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -160.97 -109.91 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.489 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -62.83 174.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.462 ' H ' HG22 ' A' ' 164' ' ' THR . 5.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.734 0.302 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.07 39.21 5.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.8 p -84.37 130.36 34.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.992 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -153.82 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -169.44 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -147.01 169.1 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -98.88 139.84 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -144.67 163.31 34.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -155.33 31.69 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -159.53 120.82 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.848 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.45 -175.59 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 m -155.4 159.12 39.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.87 46.29 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.53 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mt -135.75 163.92 29.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.373 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.0 m -106.71 150.17 39.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -32.27 -50.68 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.591 2.86 . . . . 0.0 113.318 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -131.87 134.04 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.53 37.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.98 -47.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -66.48 179.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.33 93.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.27 149.97 43.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.064 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -146.03 168.07 21.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.31 -64.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -136.32 126.54 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.429 ' N ' HD23 ' A' ' 25' ' ' LEU . 14.4 tttt -140.14 -67.67 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.931 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.25 -176.88 4.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.77 172.02 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -175.21 55.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -80.81 122.34 27.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.749 HG11 HD23 ' A' ' 58' ' ' LEU . 72.5 t -68.03 153.25 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.683 HG21 ' HB3' ' A' ' 57' ' ' GLU . 9.4 t -62.91 -43.09 99.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.376 0.607 . . . . 0.0 109.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 65.66 104.71 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.536 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.904 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 7.6 t -162.35 133.73 5.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.419 0.628 . . . . 0.0 112.105 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 151' ' ' ILE . 23.2 m -91.68 143.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.546 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.0 t -93.9 111.63 23.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.042 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.796 HD12 ' HE2' ' A' ' 156' ' ' LYS . 0.2 OUTLIER -97.08 120.51 37.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.141 0.496 . . . . 0.0 111.596 -179.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -141.22 129.93 22.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.59 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -176.06 155.38 1.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.651 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -29.22 68.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.354 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' C ' HG12 ' A' ' 158' ' ' VAL . 3.4 mt-10 72.45 24.7 2.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.62 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' CG ' HD11 ' A' ' 161' ' ' ILE . 2.3 tt0 -164.82 128.15 2.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.377 . . . . 0.0 112.013 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 160' ' ' ILE . 3.0 p -143.97 107.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.332 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -69.91 127.71 33.81 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 1.8 t -29.26 131.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 112.727 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.14 -18.54 56.52 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.422 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.54 172.89 6.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.776 0.322 . . . . 0.0 110.644 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.39 149.1 47.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.662 HD22 HG11 ' A' ' 158' ' ' VAL . 3.1 pp -102.56 164.28 11.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HA ' HG12 ' A' ' 122' ' ' VAL . 40.1 tt0 -135.69 93.88 3.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -103.82 98.02 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.752 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -84.91 80.6 1.82 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 136' ' ' VAL . 14.9 p -78.35 97.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.172 0.51 . . . . 0.0 110.754 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 118' ' ' LEU . . . -101.74 -128.7 6.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.96 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -110.68 131.08 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.605 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 17.8 t0 -100.68 -36.41 9.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HB3' HG21 ' A' ' 32' ' ' THR . 21.4 mt-10 -158.21 131.57 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.651 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.749 HD23 HG11 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -163.34 91.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.246 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.708 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -122.32 107.84 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.554 ' CA ' HG22 ' A' ' 31' ' ' VAL . 64.2 m-20 130.22 20.12 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.55 1.14 . . . . 0.0 111.637 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB1' ' CD2' ' A' ' 149' ' ' HIS . . . -155.69 165.82 35.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.771 0.319 . . . . 0.0 110.795 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -120.52 85.11 2.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.62 120.24 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 5.5 m-85 -112.71 -30.92 6.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.74 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.42 112.5 7.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' O ' HG22 ' A' ' 104' ' ' VAL . 1.1 t80 -85.69 132.82 34.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.192 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.46 110.01 4.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.648 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 10.0 p90 -127.84 171.12 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.137 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 101' ' ' ARG . 0.3 OUTLIER -128.77 113.03 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.789 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.9 HD13 HG11 ' A' ' 121' ' ' VAL . 7.9 tt -92.77 153.36 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.003 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 70' ' ' LEU . 3.4 m-80 -123.16 137.97 54.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.763 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CD2' ' HA2' ' A' ' 98' ' ' GLY . 46.1 p90 -140.46 -175.28 4.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.92 120.21 40.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.842 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -78.32 -3.78 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.35 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.1 20.8 8.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.855 0.36 . . . . 0.0 111.1 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.813 ' CB ' ' HB2' ' A' ' 129' ' ' ALA . . . -177.58 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.584 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.783 ' CE2' HD11 ' A' ' 160' ' ' ILE . 2.8 m-85 -107.17 155.27 20.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.5 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -151.88 131.11 12.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.763 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 25.0 t80 -53.15 150.84 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.726 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.693 ' HB ' HG23 ' A' ' 122' ' ' VAL . 47.6 t -126.62 -84.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 122' ' ' VAL . 3.5 mt-10 -157.91 132.49 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.73 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -82.87 145.65 29.33 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.176 0.988 . . . . 0.0 111.437 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -126.44 154.8 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.56 -1.654 . . . . 0.0 112.64 -177.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.827 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -120.09 -165.09 1.14 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.77 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -91.0 -158.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.685 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.11 37.15 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 -38.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.01 155.51 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -112.41 112.79 24.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.874 HG22 HG12 ' A' ' 104' ' ' VAL . 3.6 t -101.95 155.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.706 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.3 t30 -164.12 109.29 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.095 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.763 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -97.5 140.07 32.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.202 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -120.38 108.43 14.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.607 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -55.71 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 tp -68.03 -29.17 43.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.987 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 178.16 -168.42 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.205 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.41 123.51 24.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 72' ' ' TYR . . . 64.16 41.05 98.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.184 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.38 127.33 0.54 Allowed 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 79' ' ' TYR . 10.3 p -151.88 136.17 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.3 tpp85 -107.28 152.2 24.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.365 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . 13.9 p -129.89 146.32 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.431 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.3 mt -131.69 98.39 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.316 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 90' ' ' VAL . 1.3 m -98.12 160.73 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.419 . . . . 0.0 111.655 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 p -163.86 135.4 4.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.324 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p -77.19 110.68 12.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.305 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.8 tp -92.87 29.78 1.73 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.956 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.6 p -108.94 -27.2 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.971 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.25 -18.02 12.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.225 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -101.84 157.11 34.31 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.687 0.28 . . . . 0.0 110.719 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 62.3 Cg_endo -73.5 -175.54 2.09 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.537 2.158 . . . . 0.0 112.459 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.704 ' CD2' HD21 ' A' ' 118' ' ' LEU . 1.3 tt -56.52 114.53 7.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.91 -39.54 32.46 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.563 2.176 . . . . 0.0 112.126 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 55' ' ' ILE . . . 67.71 168.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.56 15.81 10.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.127 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -147.62 -168.54 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.414 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HA3' ' A' ' 52' ' ' GLY . 22.2 t -76.87 105.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.785 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 ' CD2' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -86.24 -32.66 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.803 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -168.03 131.42 1.6 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.754 0.312 . . . . 0.0 111.262 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HD3' HG11 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -115.62 113.93 24.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.481 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.9 HG11 HD13 ' A' ' 70' ' ' LEU . 7.2 p -97.52 95.08 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.233 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 81' ' ' GLU . 26.0 m -75.6 115.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.841 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.677 ' CD2' HD21 ' A' ' 134' ' ' LEU . 3.6 mm? -83.6 169.33 15.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.954 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 3.4 tpm_? -108.74 124.9 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.999 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -100.47 69.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.782 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -5.45 55.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.483 0.659 . . . . 0.0 109.448 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -162.69 124.27 2.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.453 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 10.9 ttpt -44.11 135.02 4.52 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.562 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.813 ' HB2' ' CB ' ' A' ' 76' ' ' ALA . . . -144.27 59.77 1.35 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.852 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.92 116.39 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.93 -5.28 59.53 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.55 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.787 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 1.1 m -56.25 91.32 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.321 . . . . 0.0 110.543 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.7 m120 -65.27 160.04 22.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.194 0.521 . . . . 0.0 111.499 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 133' ' ' ASN . 4.7 mp -137.08 104.3 5.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.612 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.2 p -102.37 125.45 49.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 53' ' ' VAL . 19.5 m -111.32 94.95 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.472 ' C ' ' ND2' ' A' ' 138' ' ' ASN . 16.3 p -99.05 -161.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.472 ' ND2' ' C ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 45.24 19.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 151' ' ' ILE . 66.6 m -60.26 101.32 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.14 173.1 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.427 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.719 HG21 HD11 ' A' ' 58' ' ' LEU . 3.4 m -147.95 127.23 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.34 97.89 0.89 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.584 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.433 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 32.0 t0 -55.26 161.57 1.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.95 -34.95 91.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -70.45 -31.59 68.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.99 -31.96 2.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.436 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -69.14 170.08 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.36 150.53 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.492 ' CD2' ' HB1' ' A' ' 61' ' ' ALA . 88.8 m-70 -121.77 95.16 4.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -55.85 105.56 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.552 HD11 HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -84.38 -176.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.331 0.586 . . . . 0.0 111.742 -179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -65.68 -156.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.924 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.49 166.97 36.16 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.667 ' HB ' HD23 ' A' ' 37' ' ' LEU . 14.9 m -163.14 155.68 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -126.58 173.08 9.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.316 0.579 . . . . 0.0 112.088 -179.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.796 ' HE2' HD12 ' A' ' 37' ' ' LEU . 1.4 tppt? -139.56 168.7 19.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.426 HG22 ' ND2' ' A' ' 133' ' ' ASN . 1.2 p -143.09 116.33 8.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.662 HG11 HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -104.73 130.47 55.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.484 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.58 18.7 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.414 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.1 mt -78.89 119.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.44 0.638 . . . . 0.0 109.712 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.506 HD11 ' CG ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -103.5 136.96 33.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 -178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.82 145.03 53.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 111.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.97 150.01 19.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.509 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 165' ' ' SER . 0.6 OUTLIER -133.36 173.9 10.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 111.0 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.488 ' H ' HG22 ' A' ' 164' ' ' THR . 2.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.793 0.33 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.42 47.36 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.4 p -77.59 113.68 15.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 111.003 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -144.13 172.11 13.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -171.54 -42.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -92.77 179.67 5.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -135.89 115.09 12.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -69.15 -68.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -150.58 103.64 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.945 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -140.03 82.02 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 m -106.48 152.96 22.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -139.51 174.94 10.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.52 -76.77 1.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tt 60.73 44.95 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 21.2 t -58.14 -52.76 72.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.49 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 71.6 Cg_exo -32.3 132.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.309 2.673 . . . . 0.0 113.315 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 mtt-85 -84.5 -178.7 6.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.97 107.93 2.16 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.526 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -134.66 164.07 28.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -106.61 -178.51 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtt -97.44 96.68 8.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.2 137.15 14.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.093 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.26 124.12 49.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -41.4 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD13 ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -90.41 114.6 26.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' HD13 ' A' ' 25' ' ' LEU . 18.3 mmtt -60.43 157.32 14.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.16 -171.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.98 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.63 122.47 8.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.26 39.75 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.12 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -77.96 135.7 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 60' ' ' ASN . 61.5 t -89.72 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.444 HG21 ' HB3' ' A' ' 57' ' ' GLU . 8.7 t -73.06 -42.54 62.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 31' ' ' VAL . . . 59.1 110.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.286 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.502 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 30.6 t -150.11 140.01 21.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.731 0.777 . . . . 0.0 111.956 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 HD11 ' A' ' 151' ' ' ILE . 26.5 m -93.36 144.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.066 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -103.07 107.55 18.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.756 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.871 HD12 HG22 ' A' ' 154' ' ' THR . 6.0 mt -96.88 112.51 24.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -136.25 117.42 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -166.8 164.2 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.307 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -68.33 -29.51 68.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.486 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 156' ' ' LYS . 1.2 mt-10 66.71 33.36 6.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -164.22 120.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 111.772 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 6.0 p -127.79 167.96 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.564 ' N ' HG22 ' A' ' 43' ' ' VAL . 1.6 tm0? -130.46 118.27 20.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' H ' HG22 ' A' ' 160' ' ' ILE . 2.2 t -28.55 131.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-O 121.575 0.703 . . . . 0.0 112.355 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.48 13.19 61.83 Favored Glycine 0 N--CA 1.434 -1.442 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.618 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -132.08 174.61 10.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.497 0.319 . . . . 0.0 110.238 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -123.59 149.27 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.861 0.363 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.717 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -112.18 160.05 17.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -136.14 93.76 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.204 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p -103.27 97.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' HG13 ' A' ' 117' ' ' VAL . . . -79.6 96.33 1.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.927 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 53' ' ' VAL . 10.2 p -87.18 95.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.46 -137.4 9.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.83 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.727 ' CG2' ' HB1' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -108.04 134.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 0.0 111.641 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.11 -33.44 11.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HB3' HG21 ' A' ' 32' ' ' THR . 3.7 mp0 -168.39 134.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.6 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -153.83 90.99 1.42 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.358 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.641 ' N ' HG13 ' A' ' 31' ' ' VAL . 14.2 p -110.12 116.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.729 ' HB2' HG22 ' A' ' 31' ' ' VAL . 73.0 m-20 102.34 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.843 0.857 . . . . 0.0 111.932 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.628 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -169.52 143.05 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.22 82.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 141' ' ' VAL . . . -62.75 111.77 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.655 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -100.74 -34.33 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.745 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.02 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.064 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 20.1 t80 -108.88 94.84 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.079 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -100.11 110.27 22.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.199 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.862 ' O ' HG12 ' A' ' 102' ' ' VAL . 14.6 p90 -102.3 171.4 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.981 0.42 . . . . 0.0 111.549 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' ND2' ' A' ' 138' ' ' ASN . 81.5 m -135.85 100.95 4.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.488 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 121' ' ' VAL . 8.7 tt -79.43 154.54 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.225 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.467 ' N ' HD23 ' A' ' 70' ' ' LEU . 2.8 m-80 -123.58 104.32 8.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.438 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 16.1 p90 -114.59 -167.3 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.959 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.32 123.94 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.4 -30.45 53.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -63.8 -30.97 72.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.027 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -109.75 -50.93 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -93.33 -176.97 4.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -159.0 109.65 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.99 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.533 ' OH ' ' HB3' ' A' ' 92' ' ' ALA . 17.6 t80 -51.96 147.77 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 122' ' ' VAL . 39.3 t -132.3 -74.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.285 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.829 ' O ' HG22 ' A' ' 122' ' ' VAL . 5.9 mt-10 -166.91 140.01 3.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . . . -83.1 151.97 25.52 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 122.195 0.997 . . . . 0.0 111.525 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.846 HD11 ' CG1' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.15 174.39 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.375 -1.739 . . . . 0.0 112.167 -177.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -144.7 -165.69 2.21 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -93.99 -158.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.36 36.68 1.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.882 0.373 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -160.94 -42.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.117 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 105' ' ' SER . 13.0 t -89.98 148.42 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -103.15 137.69 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.44 HG13 ' CG2' ' A' ' 102' ' ' VAL . 25.1 t -133.7 144.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.33 116.99 4.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.568 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . . . -96.53 157.05 16.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.398 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -141.05 107.26 5.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HA ' ' CG1' ' A' ' 100' ' ' VAL . 22.3 tttt -55.11 115.01 1.99 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' VAL . 1.2 tp -109.81 -25.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.881 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -160.1 165.69 31.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -66.87 128.69 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 72' ' ' TYR . . . 62.73 30.69 77.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' C ' HG13 ' A' ' 100' ' ' VAL . 20.9 ptmt -173.77 122.86 0.34 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 120.907 0.384 . . . . 0.0 110.058 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.675 ' CG1' ' HA ' ' A' ' 94' ' ' LYS . 12.9 m -150.09 155.57 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.01 152.37 20.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 68' ' ' PHE . 9.4 p -127.97 139.94 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.89 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -111.57 107.27 16.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 118' ' ' LEU . 4.6 t -106.88 147.0 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 111.56 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.45 ' C ' HG13 ' A' ' 88' ' ' VAL . 22.1 p -164.49 136.1 4.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.504 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 88' ' ' VAL . 93.7 p -83.99 104.88 14.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.095 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -94.94 31.15 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.152 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -99.02 -33.1 10.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.12 -25.1 6.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.307 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.57 155.07 41.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.845 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.36 173.67 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.58 2.187 . . . . 0.0 112.376 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.733 ' HG ' HD11 ' A' ' 118' ' ' LEU . 1.6 mp -58.89 116.87 17.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.12 -30.08 89.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.353 2.035 . . . . 0.0 111.844 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.727 ' HB1' ' CG2' ' A' ' 55' ' ' ILE . . . 56.49 169.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.278 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.15 17.86 9.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.08 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.02 -164.44 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.556 HG11 ' HE3' ' A' ' 120' ' ' LYS . 21.5 t -80.36 104.62 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.914 0.388 . . . . 0.0 110.605 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.733 HD11 ' HG ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -92.43 -32.84 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -172.69 132.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.31 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.818 ' HG3' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -122.66 132.09 54.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.556 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 70' ' ' LEU . 11.8 p -104.47 118.43 51.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.367 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.846 ' CG1' HD11 ' A' ' 83' ' ' ILE . 20.2 m -92.89 118.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.7 109.88 21.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.98 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 13.0 tpp85 -55.17 117.45 3.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -81.89 71.76 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.531 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -87.9 -3.28 58.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.538 0.685 . . . . 0.0 109.41 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -161.43 123.14 2.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.206 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.627 ' HA ' ' HB ' ' A' ' 160' ' ' ILE . 5.8 ttpm? -46.02 157.55 0.12 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.259 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.027 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . . . -169.77 59.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.773 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 0.8 OUTLIER -56.16 116.03 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.937 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.87 21.61 49.56 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.261 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.752 ' OG ' ' HB1' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -68.14 70.91 0.16 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.044 0.45 . . . . 0.0 110.377 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.416 ' OD1' ' HG2' ' A' ' 155' ' ' GLU . 1.7 t-20 -43.8 121.87 2.55 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.643 HD23 HD11 ' A' ' 70' ' ' LEU . 5.8 mp -116.22 161.07 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.159 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 150.41 26.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.346 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 68' ' ' PHE . 15.2 t -123.33 95.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.475 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 17.7 p -101.55 -166.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 41.94 22.86 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.123 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -65.17 107.07 1.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.84 0.352 . . . . 0.0 110.523 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.95 171.26 7.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.44 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 58' ' ' LEU . 11.3 m -144.69 132.26 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.703 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.71 96.38 1.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.898 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.451 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 23.8 t0 -55.98 161.82 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 110.767 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.37 -27.94 73.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -74.48 -47.59 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.96 -25.75 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.58 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.52 158.01 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 110.993 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 148' ' ' VAL . 14.6 p -115.89 115.01 47.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.451 ' CD2' ' HB2' ' A' ' 143' ' ' ASP . 7.5 m-70 -87.5 93.19 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -48.3 108.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.238 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.535 ' HB ' ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -84.35 166.58 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.27 0.557 . . . . 0.0 111.738 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 34' ' ' SER . . . -59.5 -144.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.327 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 35' ' ' VAL . . . -170.81 -177.21 40.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.108 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.871 HG22 HD12 ' A' ' 37' ' ' LEU . 25.4 m -161.24 148.95 15.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.723 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.416 ' HG2' ' OD1' ' A' ' 133' ' ' ASN . 15.6 tt0 -102.01 158.14 16.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.276 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.793 ' HB2' HD13 ' A' ' 37' ' ' LEU . 1.5 tppp? -151.28 164.23 37.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.555 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.628 ' N ' ' HG3' ' A' ' 156' ' ' LYS . 4.0 p -142.62 153.91 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.768 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.05 133.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.849 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -99.42 115.03 28.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.159 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 2.8 mt -86.76 118.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -100.66 128.35 52.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.194 -178.007 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -55.96 146.63 21.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.182 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.74 -80.68 0.67 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.494 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 165' ' ' SER . 7.8 t -80.03 -143.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 110.945 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.495 ' N ' ' OG1' ' A' ' 164' ' ' THR . 29.1 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 stop_ save_